PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huggett, B				Huggett, Brady			Biotech's wellspring: the health of private biotech in 2012	NATURE BIOTECHNOLOGY			English	Article								Academic tech transfer keeps on spinning out startups, but the pool of capital to sustain such ventures is dwindling.											0	5	6	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					396	403		10.1038/nbt.2577	http://dx.doi.org/10.1038/nbt.2577			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23657390	Bronze			2022-12-27	WOS:000318589600015
J	Garside, EL; MacMillan, AM				Garside, Erin L.; MacMillan, Andrew M.			Cas9 in close-up	NATURE BIOTECHNOLOGY			English	Editorial Material							RNA; DNA; ENDONUCLEASE; IMMUNITY; SYSTEMS		[Garside, Erin L.; MacMillan, Andrew M.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	University of Alberta	Garside, EL (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB, Canada.	andrew.macmillan@ualberta.ca			Alberta Innovates [201001348] Funding Source: researchfish	Alberta Innovates		Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	11	3	3	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					338	340		10.1038/nbt.2872	http://dx.doi.org/10.1038/nbt.2872			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24714483				2022-12-27	WOS:000334340800017
J	Chatterjee, SK; Rohrbaugh, ML				Chatterjee, Sabarni K.; Rohrbaugh, Mark L.			NIH inventions translate into drugs and biologics with high public health impact	NATURE BIOTECHNOLOGY			English	Article							DISCOVERY; PATENTS	Compared with other US public-sector research institutions, the US National Institutes of Health has contributed inventions that have had a disproportionately greater impact on the overall number of products produced, drugs granted orphan status and drugs granted priority review.	[Chatterjee, Sabarni K.; Rohrbaugh, Mark L.] US Natl Inst Hlth, Off Technol Transfer, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA	Chatterjee, SK (corresponding author), US Natl Inst Hlth, Off Technol Transfer, Rockville, MD 20852 USA.	mark.rohrbaugh@nih.gov			NIH Office of Budget	NIH Office of Budget	We thank H. Feindt (NIH Office of Technology Transfer) for helpful insights on commercial sales of products, J. Duberman (Informationalist, NIH Library) for his assistance in gaining access to publications and sources of data, the NIH Office of Budget for NIH extramural funding data and L. Pressman for her valuable insights.	Cohen WM., 1998, CHALLENGES RES U, V171, P59; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Grimaldi R, 2011, RES POLICY, V40, P1045, DOI 10.1016/j.respol.2011.04.005; JAFFE AB, 1989, AM ECON REV, V79, P957; Kesselheim AS, 2011, MILBANK Q, V89, P450, DOI 10.1111/j.1468-0009.2011.00636.x; Kneller R, 2010, NAT REV DRUG DISCOV, V9, P867, DOI 10.1038/nrd3251; Macho-Stadler I, 2010, INT J IND ORGAN, V28, P362, DOI 10.1016/j.ijindorg.2010.02.009; MANSFIELD E, 1991, RES POLICY, V20, P1, DOI 10.1016/0048-7333(91)90080-A; Milstein J.B., 2005, VACCINES DRUGS CHARA; Morgan S, 2011, HEALTH POLICY, V100, P4, DOI 10.1016/j.healthpol.2010.12.002; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; Mullin R, 2004, CHEM ENG NEWS, V82, P6; National Institutes of Health, 2009, NIH INTR RES THRESH; National Institutes of Health, 2010, ACT OBL I CTR FY 200; National Institutes of Health Office of Technology Transfer, 2003, FLUD NEW BENCHM CAS; Pressman L, 2006, NAT BIOTECHNOL, V24, P31, DOI 10.1038/nbt0106-31; Pressman L., 2012, BNA LIFE SCI LA 0323; Roessner D, 2013, RES POLICY, V42, P23, DOI 10.1016/j.respol.2012.04.015; Sampat BN, 2011, HEALTH AFFAIR, V30, P332, DOI 10.1377/hlthaff.2009.0917; Sampat BN, 2009, AM J PUBLIC HEALTH, V99, P9, DOI 10.2105/AJPH.2007.128769; Stevens AJ, 2011, NEW ENGL J MED, V364, P535, DOI 10.1056/NEJMsa1008268; Zycher B, 2010, AM J THER, V17, P101, DOI 10.1097/MJT.0b013e3181ca7f10	22	11	11	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					52	58		10.1038/nbt.2785	http://dx.doi.org/10.1038/nbt.2785			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	287BM	24406928				2022-12-27	WOS:000329513000014
J	Mali, P; Aach, J; Stranges, PB; Esvelt, KM; Moosburner, M; Kosuri, S; Yang, LH; Church, GM				Mali, Prashant; Aach, John; Stranges, P. Benjamin; Esvelt, Kevin M.; Moosburner, Mark; Kosuri, Sriram; Yang, Luhan; Church, George M.			CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; GENE-EXPRESSION; TAL EFFECTORS; RNA; CRISPR; SYSTEMS; IMMUNITY; CELLS; ENDONUCLEASE; CLEAVAGE	Prokaryotic type II CRISPR-Cas systems can be adapted to enable targeted genome modifications across a range of eukaryotes(1-7). Here we engineer this system to enable RNA-guided genome regulation in human cells by tethering transcriptional activation domains either directly to a nuclease-null Cas9 protein or to an aptamer-modified single guide RNA (sgRNA). Using this functionality we developed a transcriptional activation-based assay to determine the landscape of off-target binding of sgRNA: Cas9 complexes and compared it with the off-target activity of transcription activator-like (TALs) effectors(8,9). Our results reveal that specificity profiles are sgRNA dependent, and that sgRNA: Cas9 complexes and 18-mer TAL effectors can potentially tolerate 1-3 and 1-2 target mismatches, respectively. By engineering a requirement for cooperativity through offset nicking for genome editing or through multiple synergistic sgRNAs for robust transcriptional activation, we suggest methods to mitigate off-target phenomena. Our results expand the versatility of the sgRNA: Cas9 tool and highlight the critical need to engineer improved specificity.	[Mali, Prashant; Aach, John; Stranges, P. Benjamin; Moosburner, Mark; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Esvelt, Kevin M.; Kosuri, Sriram; Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Yang, Luhan] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	gchurch@genetics.med.harvard.edu		Moosburner, Mark/0000-0002-8672-8742; Kosuri, Sriram/0000-0002-4661-0600; church, george/0000-0001-6232-9969; Esvelt, Kevin/0000-0001-8797-3945; Stranges, Peter Benjamin/0000-0003-1377-7321	US National Institutes of Health [P50 HG005550]; Department of Energy [DE-FG02-02ER63445]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	P.M. thanks R. Kalhor for insightful discussions. This work was supported by US National Institutes of Health grant P50 HG005550 and Department of Energy grant DE-FG02-02ER63445.	Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	30	1226	1502	16	555	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					833	+		10.1038/nbt.2675	http://dx.doi.org/10.1038/nbt.2675			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	23907171	Green Submitted, Green Accepted			2022-12-27	WOS:000324306300024
J	Albertsen, M; Hugenholtz, P; Skarshewski, A; Nielsen, KL; Tyson, GW; Nielsen, PH				Albertsen, Mads; Hugenholtz, Philip; Skarshewski, Adam; Nielsen, Kare L.; Tyson, Gene W.; Nielsen, Per H.			Genome sequences of rare, uncultured bacteria obtained by differential coverage binning of multiple metagenomes	NATURE BIOTECHNOLOGY			English	Article							BIOLOGICAL PHOSPHORUS REMOVAL; MICROBIAL COMMUNITIES; DIVISION TM7; ANNOTATION; METABOLISM; PHYSIOLOGY; DIVERSITY; PHYLOGENY; SELECTION; DATABASE	Reference genomes are required to understand the diverse roles of microorganisms in ecology, evolution, human and animal health, but most species remain uncultured. Here we present a sequence composition-independent approach to recover high-quality microbial genomes from deeply sequenced metagenomes. Multiple metagenomes of the same community, which differ in relative population abundances, were used to assemble 31 bacterial genomes, including rare (< 1% relative abundance) species, from an activated sludge bioreactor. Twelve genomes were assembled into complete or near-complete chromosomes. Four belong to the candidate bacterial phylum TM7 and represent the most complete genomes for this phylum to date (relative abundances, 0.06-1.58%). Reanalysis of published metagenomes reveals that differential coverage binning facilitates recovery of more complete and higher fidelity genome bins than other currently used methods, which are primarily based on sequence composition. This approach will be an important addition to the standard metagenome toolbox and greatly improve access to genomes of uncultured microorganisms.	[Albertsen, Mads; Nielsen, Kare L.; Nielsen, Per H.] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark; [Hugenholtz, Philip; Skarshewski, Adam; Tyson, Gene W.] Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogen, St Lucia, Qld, Australia; [Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Tyson, Gene W.] Univ Queensland, Adv Water Management Ctr, St Lucia, Qld, Australia	Aalborg University; University of Queensland; University of Queensland; University of Queensland	Nielsen, PH (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark.	phn@bio.aau.dk	Hugenholtz, Philip/AAD-9138-2019; Tyson, Gene W/C-6558-2013; Nielsen, Per Halkjær/T-6796-2018; Nielsen, Kåre Lehmann L/A-1181-2013; Albertsen, Mads/T-7358-2018	Hugenholtz, Philip/0000-0001-5386-7925; Tyson, Gene W/0000-0001-8559-9427; Nielsen, Per Halkjær/0000-0002-6402-1877; Nielsen, Kåre Lehmann L/0000-0002-5598-4401; Mangelson, Hayley/0000-0002-1520-9099; Albertsen, Mads/0000-0002-6151-190X	Aalborg University; Danish Research Council for Strategic Research via the Centre "EcoDesign-MBR"; Obelske Family foundation; Discovery Outstanding Researcher Award (DORA) from the Australian Research Council [DP120103498]; QEII fellowship from the Australian Research Council [DP1093175]	Aalborg University; Danish Research Council for Strategic Research via the Centre "EcoDesign-MBR"; Obelske Family foundation; Discovery Outstanding Researcher Award (DORA) from the Australian Research Council(Australian Research Council); QEII fellowship from the Australian Research Council(Australian Research Council)	This study was funded by Aalborg University and the Danish Research Council for Strategic Research via the Centre "EcoDesign-MBR" and the Obelske Family foundation. P.H. was supported by a Discovery Outstanding Researcher Award (DORA) from the Australian Research Council, grant DP120103498 and G.W.T. was supported by a QEII fellowship from the Australian Research Council, grant DP1093175. We thank S. McIlroy and P. Larsen for assistance with FISH analyses, A.M. Saunders for 16S rRNA data generation and J.P. Euzeby for suggesting the new genus name.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battistuzzi FU, 2009, MOL BIOL EVOL, V26, P335, DOI 10.1093/molbev/msn247; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gupta RS, 2011, ANTON LEEUW INT J G, V100, P171, DOI 10.1007/s10482-011-9616-8; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hoiczyk E, 2000, J BACTERIOL, V182, P1191, DOI 10.1128/JB.182.5.1191-1199.2000; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Hugenholtz P., GENOME BIOL; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hyatt D, 2012, BIOINFORMATICS, V28, P2223, DOI 10.1093/bioinformatics/bts429; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuehbacher T, 2008, J MED MICROBIOL, V57, P1569, DOI 10.1099/jmm.0.47719-0; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luo CW, 2012, ISME J, V6, P898, DOI 10.1038/ismej.2011.147; Luo CL, 2009, APPL ENVIRON MICROB, V75, P4644, DOI 10.1128/AEM.00283-09; Mande SS, 2012, BRIEF BIOINFORM, V13, P669, DOI 10.1093/bib/bbs054; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Nielsen PH, 2012, CURR OPIN BIOTECH, V23, P452, DOI 10.1016/j.copbio.2011.11.027; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sutcliffe IC, 2011, ENVIRON MICROBIOL, V13, P279, DOI 10.1111/j.1462-2920.2010.02339.x; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thomsen TR, 2002, ENVIRON MICROBIOL, V4, P383, DOI 10.1046/j.1462-2920.2002.00316.x; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vezzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052210; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	60	800	830	21	520	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					533	+		10.1038/nbt.2579	http://dx.doi.org/10.1038/nbt.2579			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23707974				2022-12-27	WOS:000320113200025
J	Relman, DA				Relman, David A.			Restoration of the gut microbial habitat as a disease therapy	NATURE BIOTECHNOLOGY			English	Editorial Material							INFECTION; MICE		[Relman, David A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Relman, DA (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	relman@stanford.edu		Relman, David A./0000-0001-8331-1354	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964] Funding Source: NIH RePORTER; NIH HHS [DP1 OD000964] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BOHNHOFF M, 1962, J INFECT DIS, V111, P117, DOI 10.1093/infdis/111.2.117; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Guarner F, 2012, J CLIN GASTROENTEROL, V46, P468, DOI 10.1097/MCG.0b013e3182549092; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Pray L, 2012, HUMAN MICROBIOME DIE, P99	10	8	8	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					35	37		10.1038/nbt.2475	http://dx.doi.org/10.1038/nbt.2475			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23302933				2022-12-27	WOS:000313563600019
J	DeFrancesco, L				DeFrancesco, Laura			Drug pipeline: Q312	NATURE BIOTECHNOLOGY			English	News Item																			0	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1164	1164		10.1038/nbt.2446	http://dx.doi.org/10.1038/nbt.2446			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222776	Bronze			2022-12-27	WOS:000312092400009
J	Ebbers, HC; Crow, SA; Vulto, AG; Schellekens, H				Ebbers, Hans C.; Crow, Stacy A.; Vulto, Arnold G.; Schellekens, Huub			Interchangeability, immunogenicity and biosimilars	NATURE BIOTECHNOLOGY			English	Editorial Material							GENERIC SUBSTITUTION; EPOETIN-ALPHA; RENAL ANEMIA; SAFETY; NEED		[Ebbers, Hans C.] Univ Utrecht, UIPS, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Crow, Stacy A.; Vulto, Arnold G.] Erasmus Univ, Dept Hosp Pharm, Med Ctr, Rotterdam, Netherlands; [Schellekens, Huub] Univ Utrecht, Copernicus Inst, Dept Innovat & Environm Studies, Utrecht, Netherlands; [Schellekens, Huub] Univ Utrecht, Dept Pharmaceut, UIPS, Utrecht, Netherlands	Utrecht University; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University	Ebbers, HC (corresponding author), Univ Utrecht, UIPS, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	h.ebbers@uu.nl						Brinks V, 2011, PHARM RES-DORDR, V28, P386, DOI 10.1007/s11095-010-0288-2; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Covic A, 2008, NEPHROL DIAL TRANSPL, V23, P3731, DOI 10.1093/ndt/gfn519; Declerck PJ, 2010, CURR MED RES OPIN, V26, P1219, DOI 10.1185/03007991003719642; Dellanna F, 2011, INT J CLIN PRACT, V65, P64, DOI 10.1111/j.1742-1241.2010.02551.x; Directive, 2001, OFFICIAL J EUROPEA L; Duerden MG, 2010, BRIT J CLIN PHARMACO, V70, P335, DOI 10.1111/j.1365-2125.2010.03718.x; Ebbers HC, 2012, EXPERT OPIN BIOL TH, V12, P1473, DOI 10.1517/14712598.2012.711308; European Commission, 2004, OFF J EUR UNION, V136, P34; European Medicines Agency, 2007, GUID IMM ASS BIOT DE; European Medicines Agency, SCI GUID DOC BIOS ME; European Medicines Agency, EPARS AUTH MED PROD; European Medicines Agency, 2008, RUL GOV MED PROD E A; European Medicines Agency, 2006, GUID SIM BIOL MED PR; Frau S, 2010, EUR J CLIN PHARMACOL, V66, P785, DOI 10.1007/s00228-010-0848-8; Gascon P, 2010, ANN ONCOL, V21, P1419, DOI 10.1093/annonc/mdp574; Haag-Weber M, 2012, CLIN NEPHROL, V77, P8, DOI 10.5414/CN107304; Health I.M.S, 2011, SHAP BIOS OPP GLOB P; Jiang YJ, 2009, J PHARM SCI-US, V98, P4695, DOI 10.1002/jps.21778; Kresse GB, 2009, EUR J PHARM BIOPHARM, V72, P479, DOI 10.1016/j.ejpb.2009.02.014; Macdougall IC, 2009, NEW ENGL J MED, V361, P1848, DOI 10.1056/NEJMoa074037; Meredith PA, 2009, CURR MED RES OPIN, V25, P2179, DOI 10.1185/03007990903116867; Minghetti P, 2011, NEPHRON CLIN PRACT, V117, pC1, DOI 10.1159/000319640; Niederwieser D, 2011, EUR J HAEMATOL, V86, P277, DOI 10.1111/j.1600-0609.2010.01566.x; Peterson G.M., 2011, BR J CLIN PHARM, V71, P968; Peterson GM, 2011, BRIT J CLIN PHARMACO, V71, P966, DOI 10.1111/j.1365-2125.2010.03872.x; Praditpornsilpa K, 2011, KIDNEY INT, V80, P88, DOI 10.1038/ki.2011.68; Rovira J., 2011, IMPACK BIOSIMILARS E; Schiestl M, 2011, NAT BIOTECHNOL, V29, P310, DOI 10.1038/nbt.1839; Seidl A, 2012, PHARM RES-DORDR, V29, P1454, DOI 10.1007/s11095-011-0621-4; Shankar G, 2007, NAT BIOTECHNOL, V25, P555, DOI 10.1038/nbt1303; Storring PL, 1998, BRIT J HAEMATOL, V100, P79; Vanrenterghem Y, 2002, KIDNEY INT, V62, P2167, DOI 10.1046/j.1523-1755.2002.00657.x; Walsh G, 2010, DRUG DISCOV TODAY, V15, P773, DOI 10.1016/j.drudis.2010.06.009	34	82	87	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1186	1190		10.1038/nbt.2438	http://dx.doi.org/10.1038/nbt.2438			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222784				2022-12-27	WOS:000312092400017
J	Mercier, PP; Lysaght, AC; Bandyopadhyay, S; Chandrakasan, AP; Stankovic, KM				Mercier, Patrick P.; Lysaght, Andrew C.; Bandyopadhyay, Saurav; Chandrakasan, Anantha P.; Stankovic, Konstantina M.			Energy extraction from the biologic battery in the inner ear	NATURE BIOTECHNOLOGY			English	Article							BIOFUEL CELL; ELECTRICITY; CIRCUIT; HEARING	Endocochlear potential (EP) is a battery-like electrochemical gradient found in and actively maintained by the inner ear(1,2). Here we demonstrate that the mammalian EP can be used as a power source for electronic devices. We achieved this by designing an anatomically sized, ultra-low quiescent-power energy harvester chip integrated with a wireless sensor capable of monitoring the EP itself. Although other forms of in vivo energy harvesting have been described in lower organisms(3-5), and thermoelectric(6), piezoelectric(7) and biofuel(8,9) devices are promising for mammalian applications, there have been few, if any, in vivo demonstrations in the vicinity of the ear, eye and brain. In this work, the chip extracted a minimum of 1.12 nW from the EP of a guinea pig for up to 5 h, enabling a 2.4 GHz radio to transmit measurement of the EP every 40-360 s. With future optimization of electrode design, we envision using the biologic battery in the inner ear to power chemical and molecular sensors, or drug-delivery actuators for diagnosis and therapy of hearing loss and other disorders.	[Mercier, Patrick P.; Bandyopadhyay, Saurav; Chandrakasan, Anantha P.] MIT, Microsyst Technol Labs, Cambridge, MA 02139 USA; [Lysaght, Andrew C.; Stankovic, Konstantina M.] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Lysaght, Andrew C.; Stankovic, Konstantina M.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Lysaght, Andrew C.; Stankovic, Konstantina M.] Harvard Massachusetts Inst Technol, Program Speech & Hearing Biosci & Technol, Joint Div Hlth Sci & Technol, Cambridge, MA USA; [Stankovic, Konstantina M.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard University; Harvard Medical School	Chandrakasan, AP (corresponding author), MIT, Microsyst Technol Labs, Cambridge, MA 02139 USA.	anantha@mtl.mit.edu; konstantina_stankovich@meei.harvard.edu		Mercier, Patrick/0000-0003-1488-5076	C2S2 Focus Center; Interconnect Focus Center; Focus Center Research Program (FCRP); Semiconductor Research Corporation entity; US National Institutes of Health [K08 DC010419, T32 DC00038]; Bertarelli Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC010419, T32DC000038] Funding Source: NIH RePORTER	C2S2 Focus Center; Interconnect Focus Center; Focus Center Research Program (FCRP); Semiconductor Research Corporation entity; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bertarelli Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We acknowledge support from the C2S2 Focus Center and the Interconnect Focus Center, two of six research centers funded under the Focus Center Research Program (FCRP), a Semiconductor Research Corporation entity (A. P. C., P. P. M., S. B.), and from US National Institutes of Health grants K08 DC010419 (K. M. S.) and T32 DC00038 (A. C. L.) and the Bertarelli Foundation (K. M. S.). We thank J.J. Guinan Jr. for experimental assistance and advice, and B. Zhu for preliminary studies.	Bullen RA, 2006, BIOSENS BIOELECTRON, V21, P2015, DOI 10.1016/j.bios.2006.01.030; Chen G., 2011, 2011 IEEE International Solid-State Circuits Conference (ISSCC 2011), P310, DOI 10.1109/ISSCC.2011.5746332; Chen P., 2011, 2011 IEEE International Solid-State Circuits Conference (ISSCC 2011), P216, DOI 10.1109/ISSCC.2011.5746290; Chow EY, 2010, IEEE T BIOMED CIRC S, V4, P340, DOI 10.1109/TBCAS.2010.2081364; DALLOS P, 1983, HEARING RES, V12, P89, DOI 10.1016/0378-5955(83)90120-X; Donelan JM, 2008, SCIENCE, V319, P807, DOI 10.1126/science.1149860; Fayad JN, 2009, OTOL NEUROTOL, V30, P1122, DOI 10.1097/MAO.0b013e3181be645d; FERNANDEZ C, 1952, J ACOUST SOC AM, V24, P519, DOI 10.1121/1.1906929; Gao YL, 2012, PROC IEEE INT SYMP, P298, DOI 10.1109/ISIE.2012.6237101; Halamkova L, 2012, J AM CHEM SOC, V134, P5040, DOI 10.1021/ja211714w; Hibino H, 2010, PFLUG ARCH EUR J PHY, V459, P521, DOI 10.1007/s00424-009-0754-z; Himes C, 2010, IEEE T NANOTECHNOL, V9, P2, DOI 10.1109/TNANO.2009.2032293; Hochbaum AI, 2008, NATURE, V451, P163, DOI 10.1038/nature06381; Lang H, 2002, HEARING RES, V172, P118, DOI 10.1016/S0378-5955(02)00552-X; Mason MJ, 2001, J ZOOL, V255, P467; MILLS DM, 1993, J ACOUST SOC AM, V94, P2108, DOI 10.1121/1.407483; Mowry SE, 2012, OTOLARYNG CLIN N AM, V45, P187, DOI 10.1016/j.otc.2011.09.001; Qin Y, 2008, NATURE, V451, P809, DOI [10.1038/nature06601, 10.1038/nature066O1]; Ramadass YK, 2011, IEEE J SOLID-ST CIRC, V46, P333, DOI 10.1109/JSSC.2010.2074090; Rapoport BI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038436; Rasmussen M, 2012, J AM CHEM SOC, V134, P1458, DOI 10.1021/ja210794c; Roy K, 2003, P IEEE, V91, P305, DOI 10.1109/JPROC.2002.808156; Shimamura T., 2010, IEEE ISSCC, P540; Starner T, 2004, LOW POWER ELECT DESI, V45, P1, DOI DOI 10.1201/9781420039559.CH45; Swanson R.M., 1972, IEEE ISSCC, P192; Takeuchi S, 2000, BIOPHYS J, V79, P2572, DOI 10.1016/S0006-3495(00)76497-6; VONBEKESY G, 1952, NATURE, V169, P241; VONBEKESY G, 1952, J ACOUST SOC AM, V24, P72; Wieckowski M, 2009, SYMP VLSI CIRCUITS, P166; ZIDANIC M, 1990, BIOPHYS J, V57, P1253, DOI 10.1016/S0006-3495(90)82644-8	31	141	150	6	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1240	+		10.1038/nbt.2394	http://dx.doi.org/10.1038/nbt.2394			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23138225	Green Accepted			2022-12-27	WOS:000312092400028
J	Song, CX; Yi, CQ; He, C				Song, Chun-Xiao; Yi, Chengqi; He, Chuan			Mapping recently identified nucleotide variants in the genome and transcriptome	NATURE BIOTECHNOLOGY			English	Review							ACTIVE DNA DEMETHYLATION; CELL SELF-RENEWAL; THYMINE DNA; GLOBAL 5-HYDROXYMETHYLCYTOSINE; COMPREHENSIVE ANALYSIS; DEOXYRIBONUCLEIC-ACID; GENE-EXPRESSION; WIDE ANALYSIS; TET PROTEINS; RNA	Nucleotide variants, especially those related to epigenetic functions, provide critical regulatory information beyond simple genomic sequence, and they define cell status in higher organisms. 5-methylcytosine, which is found in DNA, was until recently the only nucleotide variant studied in terms of epigenetics in eukaryotes. However, 5-methylcytosine has turned out to be just one component of a dynamic DNA epigenetic regulatory network that also includes 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxylcytosine. Recently, reversible methylation of N-6-methyladenosine in RNA has also been demonstrated. The discovery of these new nucleotide variants triggered an explosion of new information in the epigenetics field. This rapid research progress has benefited significantly from timely developments of new technologies that specifically recognize, enrich and sequence nucleotide modifications, as evidenced by the wide application of the bisulfite sequencing of 5-methylcytosine and very recent modifications of bisulfite sequencing to resolve 5-hydroxymethylcytosine from 5-methylcytosine with base-resolution information.	[Song, Chun-Xiao; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Song, Chun-Xiao; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Yi, Chengqi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Yi, Chengqi] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	University of Chicago; University of Chicago; Peking University	He, C (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	chuanhe@uchicago.edu		Song, Chun-Xiao/0000-0002-7781-6521; Yi, Chengqi/0000-0003-2540-9729	US National Institutes of Health [HG006827]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by US National Institutes of Health (HG006827 to C.H.). We thank S.F. Reichard, for editing the manuscript.	Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Behm-Ansmant I, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/408053; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bokar JA, 1997, RNA, V3, P1233; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; CHU BCF, 1983, NUCLEIC ACIDS RES, V11, P6513, DOI 10.1093/nar/11.18.6513; Cohen-Karni D, 2011, P NATL ACAD SCI USA, V108, P11040, DOI 10.1073/pnas.1018448108; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dai Q, 2007, NUCLEIC ACIDS RES, V35, P6322, DOI 10.1093/nar/gkm657; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Durairaj A, 2008, ANAL CHIM ACTA, V612, P173, DOI 10.1016/j.aca.2008.02.026; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Fouse SD, 2010, EPIGENOMICS-UK, V2, P105, DOI 10.2217/EPI.09.35; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; GRIPPO P, 1965, BIOCHIM BIOPHYS ACTA, V95, P1, DOI 10.1016/0005-2787(65)90204-2; Grosjean H., 2005, FINE TUNING RNA FUNC; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Haffner MC, 2011, ONCOTARGET, V2, P627; Hayatsu H, 2008, MUTAT RES-REV MUTAT, V659, P77, DOI 10.1016/j.mrrev.2008.04.003; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hobartner C, 2011, ANGEW CHEM INT EDIT, V50, P4268, DOI 10.1002/anie.201100350; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; JOSSE J, 1962, J BIOL CHEM, V237, P1968; Kellinger MW, 2012, NAT STRUCT MOL BIOL, V19, P831, DOI 10.1038/nsmb.2346; Kinney SM, 2011, J BIOL CHEM, V286, P24685, DOI 10.1074/jbc.M110.217083; Kleinman CL, 2012, SCIENCE, V335, DOI [10.1126/science.1209658, 10.1126/science.1210624]; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Korlach J, 2012, CURR OPIN STRUC BIOL, V22, P251, DOI 10.1016/j.sbi.2012.04.002; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li WW, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/870726; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Liutkeviciute Z, 2011, ANGEW CHEM INT EDIT, V50, P2090, DOI 10.1002/anie.201007169; Loenarz C, 2009, CHEM BIOL, V16, P580, DOI 10.1016/j.chembiol.2009.06.002; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Matarese F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.95; Matsuo K, 2011, TETRAHEDRON LETT, V52, P5688, DOI 10.1016/j.tetlet.2011.08.104; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mirsaidov U, 2009, BIOPHYS J, V96, pL32, DOI 10.1016/j.bpj.2008.12.3760; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Motorin Y, 2007, METHOD ENZYMOL, V425, P21; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; Munzel M, 2011, ANGEW CHEM INT EDIT, V50, P6460, DOI 10.1002/anie.201101547; Munzel M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq724; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Nestor C, 2010, BIOTECHNIQUES, V48, P317, DOI 10.2144/000113403; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Raiber EA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r69; Robertson AB, 2012, NAT PROTOC, V7, P340, DOI 10.1038/nprot.2011.443; Robertson AB, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr051; Saikia M, 2010, RNA, V16, P1317, DOI 10.1261/rna.2057810; Sakurai M, 2010, NAT CHEM BIOL, V6, P733, DOI 10.1038/nchembio.434; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Schiesser S, 2012, ANGEW CHEM INT EDIT, V51, P6516, DOI 10.1002/anie.201202583; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Serandour AA, 2012, NUCLEIC ACIDS RES, V40, P8255, DOI 10.1093/nar/gks595; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P687, DOI 10.1093/nar/18.3.687; Song CX, 2012, NAT METHODS, V9, P75, DOI [10.1038/NMETH.1779, 10.1038/nmeth.1779]; Song CX, 2011, EPIGENOMICS-UK, V3, P521, DOI [10.2217/epi.11.74, 10.2217/EPI.11.74]; Song CX, 2011, BIOORG MED CHEM LETT, V21, P5075, DOI 10.1016/j.bmcl.2011.03.118; Song CX, 2011, CHEMBIOCHEM, V12, P1682, DOI 10.1002/cbic.201100278; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Sulewska A, 2007, FOLIA HISTOCHEM CYTO, V45, P315; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Szwagierczak A, 2011, NUCLEIC ACIDS RES, V39, P5149, DOI 10.1093/nar/gkr118; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Terragni J, 2012, BIOCHEMISTRY-US, V51, P1009, DOI 10.1021/bi2014739; Thuc L, 2011, ANAL BIOCHEM, V412, P203, DOI 10.1016/j.ab.2011.01.026; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/NNANO.2011.129, 10.1038/nnano.2011.129]; Wallace EVB, 2010, CHEM COMMUN, V46, P8195, DOI 10.1039/c0cc02864a; Wang H, 2011, NUCLEIC ACIDS RES, V39, P9294, DOI 10.1093/nar/gkr607; Wanunu M, 2011, J AM CHEM SOC, V133, P486, DOI 10.1021/ja107836t; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu SY, 2011, NUCLEIC ACIDS RES, V39, P5597, DOI 10.1093/nar/gkr098; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yi CQ, 2011, ACCOUNTS CHEM RES, V44, P1380, DOI 10.1021/ar200057m; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Zhao XL, 2004, RNA, V10, P996, DOI 10.1261/rna.7110804; Zheng Y, 2010, NUCLEIC ACIDS RES, V38, P5527, DOI 10.1093/nar/gkq327	123	163	167	0	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1107	1116		10.1038/nbt.2398	http://dx.doi.org/10.1038/nbt.2398			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138310	Green Accepted			2022-12-27	WOS:000311087500030
J	Rai, AK; Sampat, BN				Rai, Arti K.; Sampat, Bhaven N.			Accountability in patenting of federally funded research	NATURE BIOTECHNOLOGY			English	Editorial Material									[Rai, Arti K.] Duke Univ, Sch Law, Durham, NC 27706 USA; [Sampat, Bhaven N.] Columbia Univ, Sch Publ Hlth, New York, NY USA	Duke University; Columbia University	Rai, AK (corresponding author), Duke Univ, Sch Law, Durham, NC 27706 USA.	rai@law.duke.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003391, P50HG003391] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Azoulay P, 2007, NEW ENGL J MED, V357, P2049, DOI 10.1056/NEJMsa067417; Bayh B., 1979, US SENATE REPORT COM; Eisenberg R., 2004, 2 HDB STEM CELLS EMB, V2, P793; Ewing Tom, 2012, STAN TECH L REV, P1; Government Accountability Office, 2003, TECHN TRANSF AG RIGH; Government Accountability Office, 1999, TECHN TRANSF REP REQ; National Academy of Sciences, 2010, MAN U INT PROP PUBL; Rai Arti K., 2009, N CAROLINA L REV, V87, P101; Rai Arti K., 2003, LAW CONTEMP PROBL, V66, P289; Sampat BN, 2011, HEALTH AFFAIR, V30, P332, DOI 10.1377/hlthaff.2009.0917; Smith Mitch, 2012, INSIDE HIGHER E 0517	11	30	30	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					953	957		10.1038/nbt.2382	http://dx.doi.org/10.1038/nbt.2382			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	022NG	23051811	Bronze, Green Published, Green Accepted			2022-12-27	WOS:000309965500018
J	von Krogh, G; Battistini, B; Pachidou, F; Baschera, P				von Krogh, Georg; Battistini, Boris; Pachidou, Fotini; Baschera, Pius			The changing face of corporate venturing in biotechnology	NATURE BIOTECHNOLOGY			English	Editorial Material									[von Krogh, Georg; Battistini, Boris; Pachidou, Fotini; Baschera, Pius] ETH, Dept Management Technol & Econ, Zurich, Switzerland	ETH Zurich	von Krogh, G (corresponding author), ETH, Dept Management Technol & Econ, Zurich, Switzerland.	gvkrogh@ethz.ch		von Krogh, Georg/0000-0002-1203-3569				Basu S, 2011, J BUS VENTURING, V26, P153, DOI 10.1016/j.jbusvent.2009.07.001; Booth BL, 2011, NAT BIOTECHNOL, V29, P579, DOI 10.1038/nbt.1908; Booth BL, 2009, NAT BIOTECHNOL, V27, P705, DOI 10.1038/nbt0809-705; Dushnitsky G., 2011, BUSINESS STRATEGY RE, V22, P44; Dushnitsky G, 2010, STRATEGIC MANAGE J, V31, P990, DOI 10.1002/smj.851; Ernst & Young, 2011, BORD GLOB REP 2011; GOMPERS P, 2002, EC REV FEDERAL RESER, V87, P1; Henderson J., 2009, INT J TECHNOENTREPRE, V2, P29; Huggett B, 2012, NAT BIOTECHNOL, V30, P395, DOI 10.1038/nbt.2209; Kessel M, 2011, NAT BIOTECHNOL, V29, P27, DOI 10.1038/nbt.1748; Kneller R, 2010, NAT REV DRUG DISCOV, V9, P867, DOI 10.1038/nrd3251; PricewaterhouseCoopers & National Venture Capital Association, 2012, MONEYTREE REP Q2 201; Singh V., 2012, BURRILL REPORT, V2, P10	13	8	8	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					911	915		10.1038/nbt.2383	http://dx.doi.org/10.1038/nbt.2383			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	23051802	Bronze			2022-12-27	WOS:000309965500009
J	Wegmann, F; Gartlan, KH; Harandi, AM; Brinckmann, SA; Coccia, M; Hillson, WR; Kok, WL; Cole, S; Ho, LP; Lambe, T; Puthia, M; Svanborg, C; Scherer, EM; Krashias, G; Williams, A; Blattman, JN; Greenberg, PD; Flavell, RA; Moghaddam, AE; Sheppard, NC; Sattentau, QJ				Wegmann, Frank; Gartlan, Kate H.; Harandi, Ali M.; Brinckmann, Sarah A.; Coccia, Margherita; Hillson, William R.; Kok, Wai Ling; Cole, Suzanne; Ho, Ling-Pei; Lambe, Teresa; Puthia, Manoj; Svanborg, Catharina; Scherer, Erin M.; Krashias, George; Williams, Adam; Blattman, Joseph N.; Greenberg, Philip D.; Flavell, Richard A.; Moghaddam, Amin E.; Sheppard, Neil C.; Sattentau, Quentin J.			Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens	NATURE BIOTECHNOLOGY			English	Article							INTRANASAL DELIVERY; PROTECTIVE IMMUNITY; ANTIBODY-RESPONSES; NALP3 INFLAMMASOME; DENDRITIC CELLS; GENE DELIVERY; BELLS-PALSY; VACCINE; INNATE; MUTANT	Protection against mucosally transmitted infections probably requires immunity at the site of pathogen entry(1), yet there are no mucosal adjuvant formulations licensed for human use. Polyethyleneimine (PEI) represents a family of organic polycations used as nucleic acid transfection reagents in vitro and DNA vaccine delivery vehicles in vivo(2,3). Here we show that diverse PEI forms have potent mucosal adjuvant activity for viral subunit glycoprotein antigens. A single intranasal administration of influenza hemagglutinin or herpes simplex virus type-2 (HSV-2) glycoprotein D with PEI elicited robust antibody-mediated protection from an otherwise lethal infection, and was superior to existing experimental mucosal adjuvants. PEI formed nanoscale complexes with antigen, which were taken up by antigen-presenting cells in vitro and in vivo, promoted dendritic cell trafficking to draining lymph nodes and induced non-proinflammatory cytokine responses. PEI adjuvanticity required release of host double-stranded DNA that triggered Irf3-dependent signaling. PEI therefore merits further investigation as a mucosal adjuvant for human use.	[Wegmann, Frank; Gartlan, Kate H.; Brinckmann, Sarah A.; Coccia, Margherita; Hillson, William R.; Krashias, George; Moghaddam, Amin E.; Sheppard, Neil C.; Sattentau, Quentin J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Harandi, Ali M.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Kok, Wai Ling; Cole, Suzanne; Ho, Ling-Pei] John Radcliffe Hosp, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Lambe, Teresa] Univ Oxford, Jenner Inst, Oxford, England; [Puthia, Manoj; Svanborg, Catharina] Lund Univ, Div Microbiol Immunol & Glycobiol, Lund, Sweden; [Scherer, Erin M.; Blattman, Joseph N.; Greenberg, Philip D.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Williams, Adam; Flavell, Richard A.] Yale Univ, Sch Med, New Haven, CT USA	University of Oxford; University of Gothenburg; University of Oxford; University of Oxford; Jenner Institute; Lund University; University of Washington; University of Washington Seattle; Yale University	Sattentau, QJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	quentin.sattentau@path.ox.ac.uk	Ho, Ling-Pei/AAL-4776-2021; Lambe, Teresa/E-5733-2016; Brinckmann, Steffen/G-7075-2011; Gartlan, Kate/C-5315-2009; Moghaddam, Amin/N-2300-2014; Gartlan, Kate H/B-7279-2012; Gartlan, Kate/S-7187-2019	Lambe, Teresa/0000-0001-7711-897X; Brinckmann, Steffen/0000-0003-0930-082X; Gartlan, Kate/0000-0002-0343-1274; Moghaddam, Amin/0000-0001-8668-1609; Sheppard, Neil/0000-0002-9551-9491; Coccia, Margherita/0000-0003-1947-4735; Ho, Ling Pei/0000-0001-8319-301X; Wegmann, Frank/0000-0002-9821-1492; Puthia, Manoj/0000-0001-6048-7234	MRC UK; EU Network of Excellence 'Europrise'; International AIDS Vaccine Initiative Neutralizing Antibody Consortium (IAVI); Bill and Melinda Gates Foundation Collaboration for Vaccine Design (CAVD); Dormeur Investment Service Ltd.; FP7; EuroNanoMed-European Commission; Medical Research Council [G0600371, G0000635] Funding Source: researchfish; National Institute for Health Research [DHCS/04/G121/68] Funding Source: researchfish; MRC [G0000635, G0600371] Funding Source: UKRI	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU Network of Excellence 'Europrise'; International AIDS Vaccine Initiative Neutralizing Antibody Consortium (IAVI); Bill and Melinda Gates Foundation Collaboration for Vaccine Design (CAVD); Dormeur Investment Service Ltd.; FP7; EuroNanoMed-European Commission; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from The MRC UK, The EU Network of Excellence 'Europrise', The International AIDS Vaccine Initiative Neutralizing Antibody Consortium (IAVI), The Bill and Melinda Gates Foundation Collaboration for Vaccine Design (CAVD), Dormeur Investment Service Ltd., the FP7-funded High Impact Project Advanced Immunization Technologies (ADITEC) and The EuroNanoMed-European Commission funded iNanoDCs. Q.J.S. is a Jenner Institute Investigator and a James Martin Senior Fellow.	Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Chen JA, 2011, INT J NANOMED, V6, P77, DOI 10.2147/IJN.S15457; Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; Del Campo J, 2010, VACCINE, V28, P1193, DOI 10.1016/j.vaccine.2009.11.035; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Gunther M, 2011, EUR J PHARM BIOPHARM, V77, P438, DOI 10.1016/j.ejpb.2010.11.007; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hu K, 2011, VACCINE, V29, P1455, DOI 10.1016/j.vaccine.2010.12.031; Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kong L, 2010, J MOL BIOL, V403, P131, DOI 10.1016/j.jmb.2010.08.033; Krashias G, 2010, VACCINE, V28, P2482, DOI 10.1016/j.vaccine.2010.01.046; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Lindqvist M, 2009, J IMMUNOL, V182, P6435, DOI 10.4049/jimmunol.0900136; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Ma YF, 2010, EUR J PHARM SCI, V40, P75, DOI 10.1016/j.ejps.2010.02.009; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Orr G, 2009, TOXICOL APPL PHARM, V236, P210, DOI 10.1016/j.taap.2009.01.022; Park K, 2009, J CONTROL RELEASE, V141, P109; Roman VRG, 2010, J IMMUNOL METHODS, V363, P29, DOI 10.1016/j.jim.2010.09.030; Rudolph C, 2005, J GENE MED, V7, P59, DOI 10.1002/jgm.646; SKEHEL JJ, 1975, P NATL ACAD SCI USA, V72, P93, DOI 10.1073/pnas.72.1.93; Sogaard OS, 2010, CLIN INFECT DIS, V51, P42, DOI 10.1086/653112; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Torrieri-Dramard L, 2011, MOL THER, V19, P602, DOI 10.1038/mt.2010.222; Wegmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015861; Wegrowski Y, 2006, CLIN EXP IMMUNOL, V144, P485, DOI 10.1111/j.1365-2249.2006.03059.x; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267	39	157	170	5	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					883	U116		10.1038/nbt.2344	http://dx.doi.org/10.1038/nbt.2344			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22922673	Green Accepted			2022-12-27	WOS:000308705700023
J	Bendall, SC; Nolan, GP				Bendall, Sean C.; Nolan, Garry P.			From single cells to deep phenotypes in cancer	NATURE BIOTECHNOLOGY			English	Review							ACUTE MYELOID-LEUKEMIA; IMAGING MASS-SPECTROMETRY; SIGNALING NETWORKS; STEM-CELL; PERIPHERAL-BLOOD; CLONAL EVOLUTION; FLOW-CYTOMETRY; BONE-MARROW; RNA-SEQ; HETEROGENEITY	In recent years, major advances in single-cell measurement systems have included the introduction of high-throughput versions of traditional flow cytometry that are now capable of measuring intracellular network activity, the emergence of isotope labels that can enable the tracking of a greater variety of cell markers and the development of super-resolution microscopy techniques that allow measurement of RNA expression in single living cells. These technologies will facilitate our capacity to catalog and bring order to the inherent diversity present in cancer cell populations. Alongside these developments, new computational approaches that mine deep data sets are facilitating the visualization of the shape of the data and enabling the extraction of meaningful outputs. These applications have the potential to reveal new insights into cancer biology at the intersections of stem cell function, tumor-initiating cells and multilineage tumor development. In the clinic, they may also prove important not only in the development of new diagnostic modalities but also in understanding how the emergence of tumor cell clones harboring different sets of mutations predispose patients to relapse or disease progression.	[Bendall, Sean C.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA	Stanford University	Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Bendall, Sean/AGG-0126-2022; Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043; Bendall, Sean/0000-0003-1341-2453	Rachford and Carlota A. Harris Endowed Professorship; European Commission [HEALTH.2010.1.2-1]; Bill and Melinda Gates Foundation [GF12141-137101]; Damon Runyon Cancer Research Foundation [DRG-2017-09];  [U19 AI057229];  [P01 CA034233];  [HHSN272200700038C];  [1R01CA130826];  [CIRM DR1-01477];  [RB2-01592];  [NCI RFA CA 09-011];  [NHLBI-HV-10-05(2)]; NATIONAL CANCER INSTITUTE [F32CA009011, P01CA034233, R01CA130826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627, U19AI057229] Funding Source: NIH RePORTER	Rachford and Carlota A. Harris Endowed Professorship; European Commission(European CommissionEuropean Commission Joint Research Centre); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Damon Runyon Cancer Research Foundation; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	G.P.N. is supported by the Rachford and Carlota A. Harris Endowed Professorship and grants from U19 AI057229, P01 CA034233, HHSN272200700038C, 1R01CA130826, CIRM DR1-01477 and RB2-01592, NCI RFA CA 09-011, NHLBI-HV-10-05(2), European Commission HEALTH.2010.1.2-1, and the Bill and Melinda Gates Foundation (GF12141-137101). S.C.B. is supported by the Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09). The authors would also like to thank M. Angelo for useful discussions pertaining to the information in Table 1.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Barnes JH, 2004, J AM SOC MASS SPECTR, V15, P769, DOI 10.1016/j.jasms.2004.01.010; Barnes JH, 2004, ANAL CHEM, V76, P2531, DOI 10.1021/ac030337u; Barnes JH, 2002, ANAL CHEM, V74, P5327, DOI 10.1021/ac020304z; Behbehani G., CYTOMETRY A IN PRESS; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bragado P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029974; CANTOR H, 1975, CELL IMMUNOL, V15, P180, DOI 10.1016/0008-8749(75)90174-4; Cesano A, 2012, CYTOM PART B-CLIN CY, V82B, P158, DOI 10.1002/cyto.b.21007; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Choijamts B, 2011, STEM CELLS, V29, P1485, DOI 10.1002/stem.711; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; DESTEFANO JA, 1990, J PROTOZOOL, V37, P436; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Engelhard C, 2011, ANAL BIOANAL CHEM, V399, P213, DOI 10.1007/s00216-010-4299-y; Fienberg HG, 2012, CYTOM PART A, V81A, P467, DOI 10.1002/cyto.a.22067; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghosn EEB, 2012, P NATL ACAD SCI USA, V109, P5394, DOI 10.1073/pnas.1121632109; Gibbs KD, 2012, CELL STEM CELL, V10, P210, DOI 10.1016/j.stem.2012.01.004; Giesen C, 2011, ANAL CHEM, V83, P8177, DOI 10.1021/ac2016823; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Kapranov Philipp, 2012, Methods Mol Biol, V822, P219, DOI 10.1007/978-1-61779-427-8_15; Knoepfler Paul, 2009, Nature, V457, P361, DOI 10.1038/457361e; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Liu AY, 2004, AM J PATHOL, V165, P1543, DOI 10.1016/S0002-9440(10)63412-8; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Longo DL, 2012, NEW ENGL J MED, V366, P956, DOI 10.1056/NEJMe1200656; Longo DM, 2012, J IMMUNOL, V188, P1717, DOI 10.4049/jimmunol.1102514; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Moreno-Gordaliza E, 2011, ANAL CHEM, V83, P7933, DOI 10.1021/ac201933x; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Nishiguchi M, 2008, EUR J MASS SPECTROM, V14, P7, DOI 10.1255/ejms.907; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Ornatsky OI, 2008, ANAL CHEM, V80, P2539, DOI 10.1021/ac702128m; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Palazzo AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024592; PARKS DR, 1979, P NATL ACAD SCI USA, V76, P1962, DOI 10.1073/pnas.76.4.1962; Perez OD, 2001, IMMUNITY, V15, P687, DOI 10.1016/S1074-7613(01)00238-2; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rosen DB, 2012, LEUKEMIA RES, V36, P900, DOI 10.1016/j.leukres.2012.02.022; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012405; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sachs K, 2009, IEEE ENG MED BIO, P6624, DOI 10.1109/IEMBS.2009.5332563; Sachs K, 2009, J COMPUT BIOL, V16, P201, DOI 10.1089/cmb.2008.07TT; Schilling GD, 2007, ANAL CHEM, V79, P7662, DOI 10.1021/ac070785s; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Tung JW, 2007, CLIN LAB MED, V27, P453, DOI 10.1016/j.cll.2007.05.001; Vincent M, 2012, BIOESSAYS, V34, P72, DOI 10.1002/bies.201100049; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Werner M, 2011, LAB CHIP, V11, P2432, DOI 10.1039/c1lc20181f; Wlodkowic D, 2011, METHOD CELL BIOL, V102, P105, DOI 10.1016/B978-0-12-374912-3.00005-5; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yang JY, 2012, CELL BIOCHEM BIOPHYS, V62, P221, DOI 10.1007/s12013-011-9286-1; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	82	171	181	0	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					639	647		10.1038/nbt.2283	http://dx.doi.org/10.1038/nbt.2283			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781693				2022-12-27	WOS:000306293400023
J	Theodosiou, M; Rennard, JP; Amir-Aslani, A				Theodosiou, Maria; Rennard, Jean-Philippe; Amir-Aslani, Arsia			The rise of the professional master's degree: the answer to the postdoc/PhD bubble	NATURE BIOTECHNOLOGY			English	Editorial Material									[Theodosiou, Maria; Rennard, Jean-Philippe; Amir-Aslani, Arsia] Grenoble Sch Management, Grenoble, France	Grenoble Ecole Management	Theodosiou, M (corresponding author), Grenoble Sch Management, Grenoble, France.	arsia.amir-aslani@grenoble-em.com						Huggett B, 2011, NAT BIOTECHNOL, V29, P585, DOI 10.1038/nbt.1913; Schuster SM, 2011, BIOCHEM MOL BIOL EDU, V39, P61, DOI 10.1002/bmb.20475; Schuster SM, 2009, BIOCHEM MOL BIOL EDU, V37, P381, DOI 10.1002/bmb.20337	3	10	10	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2012	30	4					367	368		10.1038/nbt.2180	http://dx.doi.org/10.1038/nbt.2180			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	925TR	22491294				2022-12-27	WOS:000302785000029
J	Blum, B; Hrvatin, S; Schuetz, C; Bonal, C; Rezania, A; Melton, DA				Blum, Barak; Hrvatin, Sinisa; Schuetz, Christian; Bonal, Claire; Rezania, Alireza; Melton, Douglas A.			Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3	NATURE BIOTECHNOLOGY			English	Article							INSULIN-SECRETION; IN-VIVO; PANCREAS; CHANNELS; MAINTAIN; ISLETS	Insulin-expressing cells that have been differentiated from human pluripotent stem cells in vitro lack the glucose responsiveness characteristic of mature beta cells. Beta-cell maturation in mice was studied to find genetic markers that enable screens for factors that induce bona fide beta cells in vitro. We find that functional beta-cell maturation is marked by an increase in the glucose threshold for insulin secretion and by expression of the gene urocortin 3.	[Blum, Barak; Hrvatin, Sinisa; Schuetz, Christian; Bonal, Claire; Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Rezania, Alireza] Janssen Res & Dev LLC, BetaL Venture, Raritan, NJ USA	Harvard University; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Melton, DA (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Schuetz, Christian/K-5234-2013; Young, Richard A/F-6495-2012	Schuetz, Christian/0000-0002-6828-4543; Young, Richard A/0000-0001-8855-8647; Blum, Barak/0000-0002-5308-4194; Hrvatin, Sinisa/0000-0001-7303-4218	European Molecular Biology Organization; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072505, U01DK072473] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W. Vale (Salk Institute) for providing anti-human Ucn3 antibody, K. Blum for writing the MATLAB BioGUI for analysis of GSIS, A. Kweudjeu for help with transcriptional arrays, C. Honore for help with FACS analyses, A. Roose, A. Cheng and F. Deng for excellent technical assistance, and D. Cohen, Y. Mayshar and F. Pagliuca for critical reading of the manuscript. We are grateful to all members of the Melton laboratory and the Harvard Medical School Critical Discussion Group for helpful discussions and experimental advice. B. B. was supported by European Molecular Biology Organization and Juvenile Diabetes Research Foundation post-doctoral fellowships. D. A. M. is an Investigator of the Howard Hughes Medical Institute.	Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Carvalho CPF, 2010, DIABETOLOGIA, V53, P1428, DOI 10.1007/s00125-010-1726-8; Gao N, 2010, MOL ENDOCRINOL, V24, P1594, DOI 10.1210/me.2009-0513; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Li C, 2003, ENDOCRINOLOGY, V144, P3216, DOI 10.1210/en.2002-0087; Li C, 2007, P NATL ACAD SCI USA, V104, P4206, DOI 10.1073/pnas.0611641104; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Richardson CC, 2007, DIABETOLOGIA, V50, P1000, DOI 10.1007/s00125-007-0644-x; RORSMAN P, 1989, P NATL ACAD SCI USA, V86, P4505, DOI 10.1073/pnas.86.12.4505; Rozzo A, 2009, ANN NY ACAD SCI, V1152, P53, DOI 10.1111/j.1749-6632.2008.04003.x; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Taniguchi S, 2000, HORM METAB RES, V32, P97, DOI 10.1055/s-2007-978598	13	238	241	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					261	264		10.1038/nbt.2141	http://dx.doi.org/10.1038/nbt.2141			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22371083	Green Accepted			2022-12-27	WOS:000301303800022
J	Allison, M				Allison, Malorye			Reinventing clinical trials	NATURE BIOTECHNOLOGY			English	Article							CANCER	As R&D costs spiral for drug developers, disruptive approaches to clinical trial design and management are gaining traction. Get ready for electronic data capture, precompetitive data sharing, virtual trials and a variety of bold new paradigms.										Adams CP, 2010, HEALTH ECON, V19, P130, DOI 10.1002/hec.1454; Allison M, 2010, NAT BIOTECHNOL, V28, P383, DOI 10.1038/nbt0510-383; Allison M, 2010, NAT BIOTECHNOL, V28, P117, DOI 10.1038/nbt0210-117; [Anonymous], 2010, NAT BIOTECHNOL, V28, P431; [Anonymous], CUTTING EDGE; [Anonymous], EC TIMES; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Benkler Yochai, 2006, WEALTH NETWORKS; DHHS Office of the Inspector General, 2001, GLOB CLIN TRIALS GRO; El Emam K, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1120; Getz KA, 2011, DRUG INF J, V45, P265, DOI 10.1177/009286151104500307; Hirschler B., REUTERS; Hughes B, 2010, NAT REV DRUG DISCOV, V9, P89, DOI 10.1038/nrd3101; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kling J, 2011, NAT BIOTECHNOL, V29, P197, DOI 10.1038/nbt.1793; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Patel SM, 2005, NEUROGASTROENT MOTIL, V17, P332, DOI 10.1111/j.1365-2982.2005.00650.x; Pozzilli P, 1998, METABOLISM, V47, P1205, DOI 10.1016/S0026-0495(98)90324-9; Silberman S., 2009, WIRED           0824; Sutter S., PINK SHEET, V73; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; Wagner JA, 2009, CLIN PHARMACOL THER, V86, P619, DOI 10.1038/clpt.2009.88; Wood S., DRUGS MONEY GLORY IS	25	52	53	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					41	49		10.1038/nbt.2083	http://dx.doi.org/10.1038/nbt.2083			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22231093	hybrid			2022-12-27	WOS:000299110600016
J	Anastassiadis, T; Deacon, SW; Devarajan, K; Ma, HC; Peterson, JR				Anastassiadis, Theonie; Deacon, Sean W.; Devarajan, Karthik; Ma, Haiching; Peterson, Jeffrey R.			Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity	NATURE BIOTECHNOLOGY			English	Article							INTERACTION MAP; DRUG DISCOVERY; CANCER KINOME; UPDATE; EGFR	Small-molecule protein kinase inhibitors are widely used to elucidate cellular signaling pathways and are promising therapeutic agents. Owing to evolutionary conservation of the ATP-binding site, most kinase inhibitors that target this site promiscuously inhibit multiple kinases. Interpretation of experiments that use these compounds is confounded by a lack of data on the comprehensive kinase selectivity of most inhibitors. Here we used functional assays to profile the activity of 178 commercially available kinase inhibitors against a panel of 300 recombinant protein kinases. Quantitative analysis revealed complex and often unexpected interactions between protein kinases and kinase inhibitors, with a wide spectrum of promiscuity. Many off-target interactions occur with seemingly unrelated kinases, revealing how large-scale profiling can identify multitargeted inhibitors of specific, diverse kinases. The results have implications for drug development and provide a resource for selecting compounds to elucidate kinase function and for interpreting the results of experiments involving kinase inhibitors.	[Anastassiadis, Theonie; Devarajan, Karthik; Peterson, Jeffrey R.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Deacon, Sean W.; Ma, Haiching] React Biol Corp, Malvern, PA USA	Fox Chase Cancer Center	Peterson, JR (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	jeffrey.peterson@fccc.edu		Peterson, Jeffrey/0000-0002-0604-718X	W.W. Smith Foundation; Fox Chase Cancer Center; US National Institutes of Health [RO1 GM083025, P30 CA006927, RO1 HG003818, R44 CA114995]; NATIONAL CANCER INSTITUTE [P30CA006927, R44CA114995] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083025] Funding Source: NIH RePORTER	W.W. Smith Foundation; Fox Chase Cancer Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge B. Turk, A. Andrews and members of the Peterson laboratory for comments on the manuscript and R. Hartman of Reaction Biology Corp. for developing the Kinase Inhibitor Resource (KIR) web application tool. This work was supported by a W.W. Smith Foundation Award, funding from the Keystone Program in Head and Neck Cancer of Fox Chase Cancer Center and by US National Institutes of Health awards RO1 GM083025 to J.R.P. and P30 CA006927 to Fox Chase Cancer Center. HotSpot technology development was partially supported by the US National Institutes of Health (RO1 HG003818 and R44 CA114995 to H.M.).	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cockerill S, 2001, BIOORG MED CHEM LETT, V11, P1401, DOI 10.1016/S0960-894X(01)00219-0; Cuny GD, 2010, BIOORG MED CHEM LETT, V20, P3491, DOI 10.1016/j.bmcl.2010.04.150; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dodson CA, 2010, BIOCHEM J, V427, P19, DOI 10.1042/BJ20091530; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Faivre S, 2006, SEMIN ONCOL, V33, P407, DOI 10.1053/j.seminoncol.2006.04.005; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Graczyk PP, 2007, J MED CHEM, V50, P5773, DOI 10.1021/jm070562u; Huertas D, 2012, ONCOGENE, V31, P1408, DOI 10.1038/onc.2011.335; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Ma HC, 2008, EXPERT OPIN DRUG DIS, V3, P607, DOI 10.1517/17460441.3.6.607; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mencher Simon K, 2005, BMC Clin Pharmacol, V5, P3, DOI 10.1186/1472-6904-5-3; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Miduturu CV, 2011, CHEM BIOL, V18, P868, DOI 10.1016/j.chembiol.2011.05.010; Morphy R, 2004, DRUG DISCOV TODAY, V9, P641, DOI 10.1016/S1359-6446(04)03163-0; Morphy R, 2010, J MED CHEM, V53, P1413, DOI 10.1021/jm901132v; Patnaik D, 2008, J BIOMOL SCREEN, V13, P1025, DOI 10.1177/1087057108326081; Smyth Lynette A, 2009, J Chem Biol, V2, P131, DOI 10.1007/s12154-009-0023-9; van der Loo M.P.J, 2010, 10003 STAT NETH; Yarrow JC, 2005, CHEM BIOL, V12, P385, DOI 10.1016/j.chembiol.2005.01.015; Yee TW, 2003, STAT MODEL, V3, P15, DOI 10.1191/1471082X03st045oa; Zhang Q, 2006, J AM CHEM SOC, V128, P2182, DOI 10.1021/ja0567485	36	617	653	3	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1039	U117		10.1038/nbt.2017	http://dx.doi.org/10.1038/nbt.2017			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22037377	Green Accepted			2022-12-27	WOS:000296801300027
J	Harris, AF; Nimmo, D; McKemey, AR; Kelly, N; Scaife, S; Donnelly, CA; Beech, C; Petrie, WD; Alphey, L				Harris, Angela F.; Nimmo, Derric; McKemey, Andrew R.; Kelly, Nick; Scaife, Sarah; Donnelly, Christl A.; Beech, Camilla; Petrie, William D.; Alphey, Luke			Field performance of engineered male mosquitoes	NATURE BIOTECHNOLOGY			English	Article							AEDES-AEGYPTI; DOMINANT; FITNESS; DIPTERA; TEPHRITIDAE; SYSTEMS	Dengue is the most medically important arthropod-borne viral disease, with 50-100 million cases reported annually worldwide(1). As no licensed vaccine or dedicated therapy exists for dengue, the most promising strategies to control the disease involve targeting the predominant mosquito vector, Aedes aegypti. However, the current methods to do this are inadequate. Various approaches involving genetically engineered mosquitoes have been proposed(2-4), including the release of transgenic sterile males(5-10). However, the ability of laboratory-reared, engineered male mosquitoes to effectively compete with wild males in terms of finding and mating with wild females, which is critical to the success of these strategies, has remained untested. We report data from the first open-field trial involving a strain of engineered mosquito. We demonstrated that genetically modified male mosquitoes, released across 10 hectares for a 4-week period, mated successfully with wild females and fertilized their eggs. These findings suggest the feasibility of this technology to control dengue by suppressing field populations of A. aegypti.	[Nimmo, Derric; McKemey, Andrew R.; Scaife, Sarah; Beech, Camilla; Alphey, Luke] Oxitec Ltd, Oxford, England; [Harris, Angela F.; Kelly, Nick; Petrie, William D.] Mosquito Res & Control Unit MRCU, Grand Cayman, KY USA; [Harris, Angela F.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Donnelly, Christl A.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Liverpool School of Tropical Medicine; University of Liverpool; Imperial College London; University of Oxford	Alphey, L (corresponding author), Oxitec Ltd, Oxford, England.	luke.alphey@oxitec.com		Donnelly, Christl/0000-0002-0195-2463; Alphey, Luke/0000-0002-2916-3802	Adapco; Bayer; Central Life Sciences; UK Medical Research Council; Medical Research Council [G0600719B] Funding Source: researchfish	Adapco; Bayer(Bayer AG); Central Life Sciences; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Z. Ebanks, I. Black, Z. Curtis, C. Phillips, A. Miles and T. Matthews for technical and logistical assistance, G. Labbe and P. Gray for strain development, and G. Labbe and N. Morrison for manuscript review. We are grateful to the Lands & Survey Department of the Cayman Islands Government for permission to use imagery and data. A. F. H. thanks Adapco, Bayer and Central Life Sciences for supporting her PhD studentship. C. A. D. thanks the UK Medical Research Council for Centre funding.	Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Alphey L, 2002, MOL BIOCHEM PARASIT, V121, P173, DOI 10.1016/S0166-6851(02)00040-3; Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Alphey Luke, 2009, Journal of Biology (London), V8, P40, DOI 10.1186/jbiol143; [Anonymous], 2009, RISK ANAL OX513A AED; ANSARI MA, 1977, INDIAN J MED RES, V65, P91; Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Dyck V.A., 2006, STERILE INSECT TECHN; FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; Lee H. L., 2009, Dengue Bulletin, V33, P103; Lenhart AE, 2005, ACTA TROP, V96, P56, DOI 10.1016/j.actatropica.2005.06.020; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mayer DG, 1998, PREV VET MED, V36, P1, DOI 10.1016/S0167-5877(98)00078-6; McKemey A., 2008, P 2 INT WORKSH WILD; Nazni W. A., 2009, Dengue Bulletin, V33, P124; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Polson K. A., 2002, Dengue Bulletin, V26, P178; Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547; Shelly TE, 2007, J ECON ENTOMOL, V100, P273, DOI 10.1603/0022-0493(2007)100[273:SITAMF]2.0.CO;2; Simmons GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024110; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Vasan S, 2008, SCI REPORT INNOVATIV; Vreysen MJB, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P325, DOI 10.1007/1-4020-4051-2_12; WHO-TDR, 2006, SCI WORK GROUP REP D, P162; Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x	38	259	276	1	152	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1034	U109		10.1038/nbt.2019	http://dx.doi.org/10.1038/nbt.2019			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22037376				2022-12-27	WOS:000296801300026
J	Wu, XB; Scott, DA; Kriz, AJ; Chiu, AC; Hsu, PD; Dadon, DB; Cheng, AW; Trevino, AE; Konermann, S; Chen, SD; Jaenisch, R; Zhang, F; Sharp, PA				Wu, Xuebing; Scott, David A.; Kriz, Andrea J.; Chiu, Anthony C.; Hsu, Patrick D.; Dadon, Daniel B.; Cheng, Albert W.; Trevino, Alexandro E.; Konermann, Silvana; Chen, Sidi; Jaenisch, Rudolf; Zhang, Feng; Sharp, Phillip A.			Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells	NATURE BIOTECHNOLOGY			English	Article							RNA-POLYMERASE III; TRANSCRIPTION TERMINATION; DNA ENDONUCLEASE; TARGET DNA; SYSTEM; SPECIFICITY; ACTIVATION; BACTERIA; GENES; MOUSE	Bacterial type II CRISPR-Cas9 systems have been widely adapted for RNA-guided genome editing and transcription regulation in eukaryotic cells, yet their in vivo target specificity is poorly understood. Here we mapped genome-wide binding sites of a catalytically inactive Cas9 (dCas9) from Streptococcus pyogenes loaded with single guide RNAs (sgRNAs) in mouse embryonic stem cells (mESCs). Each of the four sgRNAs we tested targets dCas9 to between tens and thousands of genomic sites, frequently characterized by a 5-nucleotide seed region in the sgRNA and an NGG protospacer adjacent motif (PAM). Chromatin inaccessibility decreases dCas9 binding to other sites with matching seed sequences; thus 70% of off-target sites are associated with genes. Targeted sequencing of 295 dCas9 binding sites in mESCs transfected with catalytically active Cas9 identified only one site mutated above background levels. We propose a two-state model for Cas9 binding and cleavage, in which a seed match triggers binding but extensive pairing with target DNA is required for cleavage.	[Wu, Xuebing; Chiu, Anthony C.; Chen, Sidi; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Wu, Xuebing; Cheng, Albert W.] MIT, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA; [Scott, David A.; Hsu, Patrick D.; Trevino, Alexandro E.; Konermann, Silvana; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Scott, David A.; Hsu, Patrick D.; Trevino, Alexandro E.; Konermann, Silvana; Zhang, Feng] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Dept Biol Engn, Cambridge, MA 02139 USA; [Kriz, Andrea J.; Chiu, Anthony C.; Dadon, Daniel B.; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA USA; [Hsu, Patrick D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Dadon, Daniel B.; Cheng, Albert W.; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang@broadinstitute.org; sharppa@mit.edu	Hsu, Patrick/ABD-5749-2021; Wu, Xuebing/C-9152-2013; Macrae, Rhiannon/AAX-1536-2020; CHEN, SIDI/D-8284-2016	Wu, Xuebing/0000-0003-0369-5269; CHEN, SIDI/0000-0002-3819-5005; Hsu, Patrick/0000-0002-9380-2648; Cheng, Albert/0000-0003-2653-5743	United States Public Health Service from the National Institutes of Health [RO1-GM34277, R01-CA133404]; National Cancer Institute [PO1-CA42063]; Cancer Center Support (core) grant from the National Cancer Institute [P30-CA14051]; US National Institutes of Health Director's Pioneer Award [1DP1-MH100706]; Keck Foundation; McKnight Foundation; Poitras Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation; Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA133404, P01CA042063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034277, R01GM034277, T32GM007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	United States Public Health Service from the National Institutes of Health; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support (core) grant from the National Cancer Institute; US National Institutes of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Poitras Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank J. Zamudio and T. Kelly for optimizing the ChIP protocol, and the entire Sharp lab for support and discussion. We also thank the Core Facility in the Swanson Biotechnology Center at the David H. Koch Institute for Integrative Cancer Research at MIT for their assistance with high-throughput sequencing. This work was supported by United States Public Health Service grants RO1-GM34277, R01-CA133404 from the National Institutes of Health, and PO1-CA42063 from the National Cancer Institute to P. A. S., and partially by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. F.Z. is supported by an US National Institutes of Health Director's Pioneer Award (1DP1-MH100706), the Keck, McKnight, Poitras, Merkin, Vallee, Damon Runyon, Searle Scholars, Klingenstein, and Simons Foundations, Bob Metcalfe, and Jane Pauley. X. W. is a Howard Hughes Medical Institute International Student Research Fellow. S. C. is a Damon Runyon Fellow (DRG-2117-12). P. D. H. is a James Mills Pierce Fellow. D. A. S. is an US National Science Foundation pre-doctoral fellow.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Carroll D, 2013, NAT BIOTECHNOL, V31, P807, DOI 10.1038/nbt.2684; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chiu H, 2013, GENETICS, V195, P1167, DOI 10.1534/genetics.113.155879; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2013, TRENDS MICROBIOL, V21, P562, DOI 10.1016/j.tim.2013.09.001; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nielsen S, 2013, SCIENCE, V340, P1577, DOI 10.1126/science.1237934; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Orioli A, 2011, NUCLEIC ACIDS RES, V39, P5499, DOI 10.1093/nar/gkr074; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	47	617	755	7	212	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2014	32	7					670	+		10.1038/nbt.2889	http://dx.doi.org/10.1038/nbt.2889			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AK8VE	24752079	Green Accepted, Green Submitted			2022-12-27	WOS:000338705900033
J	Buenrostro, JD; Araya, CL; Chircus, LM; Layton, CJ; Chang, HY; Snyder, MP; Greenleaf, WJ				Buenrostro, Jason D.; Araya, Carlos L.; Chircus, Lauren M.; Layton, Curtis J.; Chang, Howard Y.; Snyder, Michael P.; Greenleaf, William J.			Quantitative analysis of RNA-protein interactions on a massively parallel array reveals biophysical and evolutionary landscapes	NATURE BIOTECHNOLOGY			English	Article							LONG NONCODING RNA; R17 COAT PROTEIN; SECONDARY STRUCTURE; BINDING; EPISTASIS; AFFINITY; SPECIFICITY; MUTATIONS; COMPLEXES; CHROMATIN	RNA-protein interactions drive fundamental biological processes and are targets for molecular engineering, yet quantitative and comprehensive understanding of the sequence determinants of affinity remains limited. Here we repurpose a high-throughput sequencing instrument to quantitatively measure binding and dissociation of a fluorescently labeled protein to > 10(7) RNA targets generated on a flow cell surface by in situ transcription and intermolecular tethering of RNA to DNA. Studying the MS2 coat protein, we decompose the binding energy contributions from primary and secondary RNA structure, and observe that differences in affinity are often driven by sequence-specific changes in both association and dissociation rates. By analyzing the biophysical constraints and modeling mutational paths describing the molecular evolution of MS2 from low-to high-affinity hairpins, we quantify widespread molecular epistasis and a long-hypothesized, structure-dependent preference for G: U base pairs over C: A intermediates in evolutionary trajectories. Our results suggest that quantitative analysis of RNA on a massively parallel array (RNA-MaP) provides generalizable insight into the biophysical basis and evolutionary consequences of sequence-function relationships.	[Buenrostro, Jason D.; Araya, Carlos L.; Chircus, Lauren M.; Layton, Curtis J.; Snyder, Michael P.; Greenleaf, William J.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Chircus, Lauren M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Buenrostro, Jason D.; Araya, Carlos L.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Greenleaf, WJ (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	wjg@stanford.edu	, 周一珉/AAQ-9453-2020	Layton, Curtis/0000-0003-2689-907X; Snyder, Michael/0000-0003-0784-7987; Chircus, Lauren/0000-0003-3082-605X; Araya, Carlos/0000-0002-5512-3062	National Institutes of Health (NIH) [NIH R01- HG004361]; National Science Foundation Graduate Research Fellowships; NIH training grant [T32HG000044, T32GM067586]; National Science Foundation graduate research fellowship; National Human Genome Research Institute (NHGRI) [5U54HG00455805]; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361, T32HG000044, U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067586] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation graduate research fellowship(National Science Foundation (NSF)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) NIH R01- HG004361 (to H.Y.C.); H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute. J.D.B. and L.M.C. acknowledge support from the National Science Foundation Graduate Research Fellowships. J.D.B. also acknowledges support from NIH training grant T32HG000044. L.M.C. acknowledges support from NIH training grant T32GM067586. J.D.B. and L.M.C. each acknowledge support of a National Science Foundation graduate research fellowship. M.P.S. and C.L.A. acknowledge the NIH and the National Human Genome Research Institute (NHGRI) for funding through 5U54HG00455805. We thank D. Herschlag for feedback and advice throughout the methods development, and G. Sherlock and D. Herschlag for critical readings of earlier versions of this manuscript. We thank R. Landick for discussions regarding the design of our synthetic DNA library and K. Bajaj for discussions regarding quantification of cluster fluorescence. We also thank O.D. Phanstiel, M. Sikora and O. Cornejo for discussions on the modeling and evolutionary analyses.	Araya CL, 2012, P NATL ACAD SCI USA, V109, P16858, DOI 10.1073/pnas.1209751109; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARDWELL VJ, 1990, NUCLEIC ACIDS RES, V18, P6587, DOI 10.1093/nar/18.22.6587; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butter F, 2009, P NATL ACAD SCI USA, V106, P10626, DOI 10.1073/pnas.0812099106; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2601, DOI 10.1021/bi00280a002; CAREY J, 1983, BIOCHEMISTRY-US, V22, P4723, DOI 10.1021/bi00289a017; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Gell C, 2008, J MOL BIOL, V384, P264, DOI 10.1016/j.jmb.2008.08.088; Grahn E, 2001, RNA, V7, P1616; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Guenther UP, 2013, NATURE, V502, P385, DOI 10.1038/nature12543; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hobson D, 2006, J MOL BIOL, V356, P613, DOI 10.1016/j.jmb.2005.11.046; Hunt ME, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011517, 10.1371/journal.pone.0015499]; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; LIM F, 1994, NUCLEIC ACIDS RES, V22, P3748, DOI 10.1093/nar/22.18.3748; Martin L, 2012, NAT METHODS, V9, P1192, DOI [10.1038/NMETH.2225, 10.1038/nmeth.2225]; Matzas M, 2010, NAT BIOTECHNOL, V28, P1291, DOI 10.1038/nbt.1710; McCandlish DM, 2013, NATURE, V497, pE1, DOI 10.1038/nature12219; Myllykangas S, 2011, NAT BIOTECHNOL, V29, P1024, DOI 10.1038/nbt.1996; Natarajan C, 2013, SCIENCE, V340, P1324, DOI 10.1126/science.1236862; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; ROMANIUK PJ, 1987, BIOCHEMISTRY-US, V26, P1563, DOI 10.1021/bi00380a011; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; ROUSSET F, 1991, P NATL ACAD SCI USA, V88, P10032, DOI 10.1073/pnas.88.22.10032; SantaLucia J, 1997, BIOPOLYMERS, V44, P309, DOI 10.1002/(SICI)1097-0282(1997)44:3<309::AID-BIP8>3.3.CO;2-Y; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Valegard K, 1997, J MOL BIOL, V270, P724, DOI 10.1006/jmbi.1997.1144; VALEGARD K, 1994, NATURE, V371, P623, DOI 10.1038/371623a0; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	50	134	137	5	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					562	+		10.1038/nbt.2880	http://dx.doi.org/10.1038/nbt.2880			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24727714	Green Accepted			2022-12-27	WOS:000337233800019
J	Brussow, H; Parkinson, SJ				Bruessow, Harald; Parkinson, Scott J.			You are what you eat	NATURE BIOTECHNOLOGY			English	Editorial Material							BIFIDOBACTERIA; METABOLISM		[Bruessow, Harald] Nestle Res Ctr, CH-1000 Lausanne, Switzerland; [Parkinson, Scott J.] Nestle Inst Hlth Sci, Lausanne, Switzerland	Nestle SA; Nestle SA	Brussow, H (corresponding author), Nestle Res Ctr, CH-1000 Lausanne, Switzerland.	harald.bruessow@rdls.nestle.com; scottjames.parkinson@rd.nestle.com						Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Delaere F, 2013, MOL METAB, V2, P47, DOI 10.1016/j.molmet.2012.11.003; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; GIBSON GR, 1995, GASTROENTEROLOGY, V108, P975, DOI 10.1016/0016-5085(95)90192-2; Gruber C, 2010, J ALLERGY CLIN IMMUN, V126, P791, DOI 10.1016/j.jaci.2010.07.022; Hayes MT, 2011, OBES SURG, V21, P759, DOI 10.1007/s11695-011-0380-7; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Metchnikoff E., 1908, PROLONGATION LIFE OP; Robertson MD, 2005, AM J CLIN NUTR, V82, P559, DOI 10.1093/ajcn/82.3.559; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444	12	60	64	4	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					243	245		10.1038/nbt.2845	http://dx.doi.org/10.1038/nbt.2845			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24727777				2022-12-27	WOS:000332819800021
J	Burton, JN; Adey, A; Patwardhan, RP; Qiu, RL; Kitzman, JO; Shendure, J				Burton, Joshua N.; Adey, Andrew; Patwardhan, Rupali P.; Qiu, Ruolan; Kitzman, Jacob O.; Shendure, Jay			Chromosome-scale scaffolding of de novo genome assemblies based on chromatin interactions	NATURE BIOTECHNOLOGY			English	Article							MAMMALIAN GENOMES; PRINCIPLES; ALIGNMENT; MODEL; MAPS	Genomes assembled de novo from short reads are highly fragmented relative to the finished chromosomes of Homo sapiens and key model organisms generated by the Human Genome Project. To address this problem, we need scalable, cost-effective methods to obtain assemblies with chromosome-scale contiguity. Here we show that genome-wide chromatin interaction data sets, such as those generated by Hi-C, are a rich source of long-range information for assigning, ordering and orienting genomic sequences to chromosomes, including across centromeres. To exploit this finding, we developed an algorithm that uses Hi-C data for ultra-long-range scaffolding of de novo genome assemblies. We demonstrate the approach by combining shotgun fragment and short jump mate-pair sequences with Hi-C data to generate chromosome-scale de novo assemblies of the human, mouse and Drosophila genomes, achieving-for the human genome-98% accuracy in assigning scaffolds to chromosome groups and 99% accuracy in ordering and orienting scaffolds within chromosome groups. Hi-C data can also be used to validate chromosomal translocations in cancer genomes.	[Burton, Joshua N.; Adey, Andrew; Patwardhan, Rupali P.; Qiu, Ruolan; Kitzman, Jacob O.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jnburton@uw.edu; shendure@uw.edu	Shendure, Jay/AAU-3684-2021	Burton, Joshua/0000-0003-2817-7353; Shendure, Jay/0000-0002-1516-1865; Kitzman, Jacob/0000-0002-6145-882X	National Human Genome Research Institute (NHGRI) [HG006283]; National Science Foundation [DGE-0718124]; NHGRI [T32HG000035]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006283, T32HG000035] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank F. Ay, E. Eichler, J. Felsenstein, P. Green, L. Hillier, M. van Min, W. Noble, R. Waterston and members of the Shendure lab for helpful discussions. Some of the sequencing data used in this research were derived from a HeLa cell line. Henrietta Lacks, and the HeLa cell line that was established from her tumor cells without her knowledge or consent in 1951, have made significant contributions to scientific progress and advances in human health. We are grateful to Henrietta Lacks, now deceased, and to her surviving family members for their contributions to biomedical research. Our work was supported by grant HG006283 from the National Human Genome Research Institute (NHGRI; to J.S.); a graduate research fellowship DGE-0718124 from the National Science Foundation (to A.A. and J.O.K.); and grant T32HG000035 from the NHGRI (to J.N.B.).	Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Jung J, 2003, J GLOBAL OPTIM, V25, P91; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Macville M, 1999, CANCER RES, V59, P141; Moissiard G, 2012, SCIENCE, V336, P1448, DOI 10.1126/science.1221472; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]; van Berkum Nynke L, 2010, J Vis Exp, DOI 10.3791/1869; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang QX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2290	33	673	702	24	176	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1119	+		10.1038/nbt.2727	http://dx.doi.org/10.1038/nbt.2727			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24185095	Green Accepted			2022-12-27	WOS:000328251900025
J	Mittleman, B; Neil, G; Cutcher-Gershenfeld, J				Mittleman, Barbara; Neil, Garry; Cutcher-Gershenfeld, Joel			Precompetitive consortia in biomedicine-how are we doing?	NATURE BIOTECHNOLOGY			English	Article							DRUG DISCOVERY; INNOVATION		[Mittleman, Barbara] US NIH, Bethesda, MD 20892 USA; [Neil, Garry] Johnson & Johnson, New Brunswick, NJ USA; [Cutcher-Gershenfeld, Joel] Univ Illinois, Urbana, IL 61801 USA	National Institutes of Health (NIH) - USA; Johnson & Johnson; Johnson & Johnson USA; University of Illinois System; University of Illinois Urbana-Champaign	Mittleman, B (corresponding author), Nodality, San Francisco, CA USA.	barbara.mittleman@nodality.com	Gershenfeld, Joel/ABF-5729-2020	Cutcher-Gershenfeld, Joel/0000-0001-7659-7024				[Anonymous], 2009, NATURE, V461, P168, DOI DOI 10.1038/461168A; Bunin BA, 2011, DRUG DISCOV TODAY, V16, P643, DOI 10.1016/j.drudis.2011.06.012; Cutcher-Gershenfeld J., 2012, 0956472 NSFVOSS EAGE; Cutcher-Gershenfeld J., 2010, VALUING COMMONS FUND; CUTCHERGERSHENF.JE, 2005, BUILDING INTERNAL OR; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; FDA, 2011, BEG LAB AN STUD INF; Hunter J, 2010, NAT REV DRUG DISCOV, V9, P87, DOI 10.1038/nrd3099; Lessl M, 2011, NAT REV DRUG DISCOV, V10, P241, DOI 10.1038/nrd3412; Masum H., 2011, OPEN SOURCE NEGLECTE; Miller G., 2013, NECESSITY DRIVING LE; Munos B, 2010, CLIN PHARMACOL THER, V87, P534, DOI 10.1038/clpt.2010.26; Pollack A, 2012, NY TIMES; Wagner JA, 2009, CLIN PHARMACOL THER, V86, P619, DOI 10.1038/clpt.2009.88; Waitz I., 2004, AVIATION ENV NATL VI; Walton RE, 1965, BEHAV THEORY LABOR N, V2nd; Woelfle M, 2011, NAT CHEM, V3, P745, DOI 10.1038/nchem.1149	17	9	9	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					979	985		10.1038/nbt.2731	http://dx.doi.org/10.1038/nbt.2731			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24213770	Bronze			2022-12-27	WOS:000326921200015
J	Park, JY; Kricka, LJ; Fortina, P				Park, Jason Y.; Kricka, Larry J.; Fortina, Paolo			Next-generation sequencing in the clinic	NATURE BIOTECHNOLOGY			English	Editorial Material							OFF-LABEL USE; CANCER		[Park, Jason Y.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Park, Jason Y.] Childrens Med Ctr, Dallas, TX 75235 USA; [Park, Jason Y.] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Kricka, Larry J.] Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Fortina, Paolo] Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Dept Canc Biol,Canc Genom Lab, Philadelphia, PA 19107 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Jefferson University	Park, JY (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.	jaspar@childrens.com	Fortina, Paolo/ABE-8350-2020	Fortina, Paolo/0000-0002-5898-2081; Park, Jason/0000-0001-6797-4000				Alberts SR, 2012, JAMA-J AM MED ASSOC, V307, P1383, DOI 10.1001/jama.2012.385; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; CAP Laboratory Accreditation Program, MOL PATH CHECKL; Conti RM, 2013, J CLIN ONCOL, V31, P1134, DOI 10.1200/JCO.2012.42.7252; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Garber K., 2011, JNCI-J NATL CANCER I, V03, P84; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Krzyzanowska MK, 2013, J CLIN ONCOL, V31, P1125, DOI 10.1200/JCO.2012.46.9460; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979	10	30	30	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					990	992		10.1038/nbt.2743	http://dx.doi.org/10.1038/nbt.2743			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24213773				2022-12-27	WOS:000326921200017
J	Sharon, D; Tilgner, H; Grubert, F; Snyder, M				Sharon, Donald; Tilgner, Hagen; Grubert, Fabian; Snyder, Michael			A single-molecule long-read survey of the human transcriptome	NATURE BIOTECHNOLOGY			English	Article							NONCODING RNAS; MESSENGER-RNA; ANNOTATION; LANDSCAPE; REVEALS; GENCODE; SEQ	Global RNA studies have become central to understanding biological processes, but methods such as microarrays and short-read sequencing are unable to describe an entire RNA molecule from 5' to 3' end. Here we use single-molecule long-read sequencing technology from Pacific Biosciences to sequence the polyadenylated RNA complement of a pooled set of 20 human organs and tissues without the need for fragmentation or amplification. We show that full-length RNA molecules of up to 1.5 kb can readily be monitored with little sequence loss at the 5' ends. For longer RNA molecules more 5' nucleotides are missing, but complete intron structures are often preserved. In total, we identify similar to 14,000 spliced GENCODE genes. High-confidence mappings are consistent with GENCODE annotations, but >10% of the alignments represent intron structures that were not previously annotated. As a group, transcripts mapping to unannotated regions have features of long, noncoding RNAs. Our results show the feasibility of deep sequencing full-length RNA from complex eukaryotic transcriptomes on a single-molecule level.	[Sharon, Donald; Tilgner, Hagen; Grubert, Fabian; Snyder, Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Sharon, Donald] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA	Stanford University; Yale University	Snyder, M (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu		Snyder, Michael/0000-0003-0784-7987	US National Institutes of Health [5P01GM099130-02, 5U54HG00699602-02, 5U01HL107393-03, 5 T32 HD07149]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007149] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK102556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099130] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Eid and L. Hickey at Pacific Biosciences for providing alignment statistics of reads to reference genomes. We thank J. Kelley, C. Araya, D. Phanstiel, S. Shringarpure and M. Sikora at Stanford as well as J. Korlach at Pacific Biosciences for comments on this manuscript. We would like to also thank T. Daley and A. Smith at USC for advice on modeling library complexity. This work was supported by US National Institutes of Health grants 5P01GM099130-02, 5U54HG00699602-02 and 5U01HL107393-03, and by US National Institutes of Health training grant 5 T32 HD07149.	Au KF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046679; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Daley T, 2013, NAT METHODS, V10, P325, DOI 10.1038/nmeth.2375; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Eyras E, 2004, GENOME RES, V14, P976, DOI 10.1101/gr.1862204; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Gingeras T, 2009, NAT BIOTECHNOL, V27, P346, DOI 10.1038/nbt0409-346; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Himmelmann L., 2010, R LANG ENV STAT COMP; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; R Development Core Team, 2012, R LANG ENV STAT COMP; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tilgner H, 2013, G3-GENES GENOM GENET, V3, P387, DOI 10.1534/g3.112.004812; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	27	376	394	3	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					1009	+		10.1038/nbt.2705	http://dx.doi.org/10.1038/nbt.2705			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24108091	Green Accepted			2022-12-27	WOS:000326921200022
J	Hamilton, AL				Hamilton, Aimee L.			The Langer Lab's secret sauce	NATURE BIOTECHNOLOGY			English	Editorial Material									Univ Denver, Daniels Coll Business, Denver, CO 80208 USA	University of Denver	Hamilton, AL (corresponding author), Univ Denver, Daniels Coll Business, Denver, CO 80208 USA.	aimee.hamilton@du.edu							0	0	0	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					490	490		10.1038/nbt.2608	http://dx.doi.org/10.1038/nbt.2608			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23752425	Bronze			2022-12-27	WOS:000320113200011
J	Langer, R				Langer, Robert			A personal account of translating discoveries in an academic lab	NATURE BIOTECHNOLOGY			English	Editorial Material							CONTROLLED-RELEASE; HEPARIN		MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Langer, R (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rlanger@mit.edu						BALL P, 1997, MADE MEASURE NEW MAT; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; BROWN L, 1986, DIABETES, V35, P692, DOI 10.2337/diabetes.35.6.692; Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Farra R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003276; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; LANGER R, 1982, SCIENCE, V217, P261, DOI 10.1126/science.7089564; LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0; Langer RS, 2012, CHEM ENG NEWS, V90, P20; Prescott JH, 2006, NAT BIOTECHNOL, V24, P437, DOI 10.1038/nbt1199; Santini JT, 1999, NATURE, V397, P335, DOI 10.1038/16898; SASISEKHARAN R, 1993, P NATL ACAD SCI USA, V90, P3660, DOI 10.1073/pnas.90.8.3660; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; YANG VC, 1985, J BIOL CHEM, V260, P1849	17	8	8	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					487	489		10.1038/nbt.2609	http://dx.doi.org/10.1038/nbt.2609			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23752424				2022-12-27	WOS:000320113200010
J	Giniatullina, A; Boorsma, M; Mulder, GJ; van Deventer, S				Giniatullina, Asiya; Boorsma, Marco; Mulder, Geert-Jan; van Deventer, Sander			Building for big pharma	NATURE BIOTECHNOLOGY			English	Editorial Material									[Giniatullina, Asiya; Boorsma, Marco; Mulder, Geert-Jan; van Deventer, Sander] Forb Capital Partners, Naarden, Netherlands; [van Deventer, Sander] Leiden Univ, Dept Gastroenterol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Giniatullina, A (corresponding author), Forb Capital Partners, Naarden, Netherlands.	sander.van.deventer@forbion.com						Daghlian M., 2013, BURRILL REPORT  0104; Nutt David, 2011, Eur Neuropsychopharmacol, V21, P495, DOI 10.1016/j.euroneuro.2011.05.004; Silicon Valley Bank, 2012, CONT REB TRENDS LIF; Tufts Center for the Study of Drug Development, 2011, IMP REP NEW MOD IND, V13	4	13	13	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2013	31	4					A1	A4		10.1038/nbt.2533	http://dx.doi.org/10.1038/nbt.2533			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	120TI	23563416				2022-12-27	WOS:000317195500012
J	Nordstrom, KJV; Albani, MC; James, GV; Gutjahr, C; Hartwig, B; Turck, F; Paszkowski, U; Coupland, G; Schneeberger, K				Nordstroem, Karl J. V.; Albani, Maria C.; James, Geo Velikkakam; Gutjahr, Caroline; Hartwig, Benjamin; Turck, Franziska; Paszkowski, Uta; Coupland, George; Schneeberger, Korbinian			Mutation identification by direct comparison of whole-genome sequencing data from mutant and wild-type individuals using k-mers	NATURE BIOTECHNOLOGY			English	Article							DE-BRUIJN GRAPHS; ARABIDOPSIS-THALIANA; ARABIS-ALPINA; RESISTANCE; GENES; SPECTRUM; CONFERS	Genes underlying mutant phenotypes can be isolated by combining marker discovery, genetic mapping and resequencing, but a more straightforward strategy for mapping mutations would be the direct comparison of mutant and wild-type genomes. Applying such an approach, however, is hampered by the need for reference sequences and by mutational loads that confound the unambiguous identification of causal mutations. Here we introduce NIKS (needle in the k-stack), a reference-free algorithm based on comparing k-mers in whole-genome sequencing data for precise discovery of homozygous mutations. We applied NIKS to eight mutants induced in nonreference rice cultivars and to two mutants of the nonmodel species Arabis alpina. In both species, comparing pooled F-2 individuals selected for mutant phenotypes revealed small sets of mutations including the causal changes. Moreover, comparing M-3 seedlings of two allelic mutants unambiguously identified the causal gene. Thus, for any species amenable to mutagenesis, NIKS enables forward genetics without requiring segregating populations, genetic maps and reference sequences.	[Nordstroem, Karl J. V.; Albani, Maria C.; James, Geo Velikkakam; Hartwig, Benjamin; Turck, Franziska; Coupland, George; Schneeberger, Korbinian] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Gutjahr, Caroline] Univ Munich, Inst Genet, Bioctr Martinsried, Martinsried, Germany; [Gutjahr, Caroline; Paszkowski, Uta] Univ Lausanne, Dept Plant Mol Biol, Lausanne, Switzerland	Max Planck Society; University of Munich; University of Lausanne	Schneeberger, K (corresponding author), Max Planck Inst Plant Breeding Res, Cologne, Germany.	schneeberger@mpipz.mpg.de	Coupland, George/AAP-8609-2020; Schneeberger, Korbinian/U-6329-2019; Gutjahr, Caroline/H-8390-2013; Turck, Franziska/G-1240-2013	Coupland, George/0000-0001-6988-4172; Schneeberger, Korbinian/0000-0002-5512-0443; Gutjahr, Caroline/0000-0001-6163-745X; Turck, Franziska/0000-0002-4982-5949; Paszkowski, Uta/0000-0002-7279-7632; Albani, Maria/0000-0002-8215-020X	 [DFG SPP1530]		The authors would like to thank D. Weigel for helpful discussions and suggestions on the manuscript, G. Marcais for support in using the Jellyfish software, P. Nick for providing hebiba mutant seeds, M. Riemann for support during the hebiba mutant analysis and the Max Planck Genome Center Cologne for their help on mutant sequencing. This work has been supported by grant DFG SPP1530 ("Flowering time control: from natural variation to crop improvement") (M. C. A. and K.S.).	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Birkeland SR, 2010, GENETICS, V186, P1127, DOI 10.1534/genetics.110.123232; Blumenstiel JP, 2009, GENETICS, V182, P25, DOI 10.1534/genetics.109.101998; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Cai DG, 1997, SCIENCE, V275, P832, DOI 10.1126/science.275.5301.832; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cuperus JT, 2010, P NATL ACAD SCI USA, V107, P466, DOI 10.1073/pnas.0913203107; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Galvao VC, 2012, PLANT J, V71, P517, DOI 10.1111/j.1365-313X.2012.04993.x; Greene EA, 2003, GENETICS, V164, P731; Hartwig B, 2012, PLANT PHYSIOL, V160, P591, DOI 10.1104/pp.112.200311; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Laitinen RAE, 2010, PLANT PHYSIOL, V153, P652, DOI 10.1104/pp.110.156448; Leshchiner I, 2012, GENOME RES, V22, P1541, DOI 10.1101/gr.135541.111; Li X, 2001, PLANT J, V27, P235, DOI 10.1046/j.1365-313x.2001.01084.x; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Page DR, 2002, NAT REV GENET, V3, P124, DOI 10.1038/nrg730; Peterlongo P, 2010, LECT NOTES COMPUT SC, V6393, P147, DOI 10.1007/978-3-642-16321-0_14; Ratan A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-130; Riemann M, 2003, PLANT PHYSIOL, V133, P1820, DOI 10.1104/pp.103.027490; Riemann M., 2013, PLANT IN PRESS  0124, DOI DOI 10.1111/TPJ.12115; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schneeberger K, 2011, TRENDS PLANT SCI, V16, P282, DOI 10.1016/j.tplants.2011.02.006; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; The Arabidopsis Genome Initiative, 2000, NATURE, V408, P796; Turner TL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001336; Wang RH, 2011, PLANT CELL, V23, P1307, DOI 10.1105/tpc.111.083451; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988; Wurtzel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015628; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zuryn S, 2010, GENETICS, V186, P427, DOI 10.1534/genetics.110.119230	36	107	113	2	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2013	31	4					325	+		10.1038/nbt.2515	http://dx.doi.org/10.1038/nbt.2515			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	120TI	23475072	Bronze			2022-12-27	WOS:000317195500025
J	Cibulskis, K; Lawrence, MS; Carter, SL; Sivachenko, A; Jaffe, D; Sougnez, C; Gabriel, S; Meyerson, M; Lander, ES; Getz, G				Cibulskis, Kristian; Lawrence, Michael S.; Carter, Scott L.; Sivachenko, Andrey; Jaffe, David; Sougnez, Carrie; Gabriel, Stacey; Meyerson, Matthew; Lander, Eric S.; Getz, Gad			Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples	NATURE BIOTECHNOLOGY			English	Article							EVOLUTION; LANDSCAPE; DISCOVERY; CATALOG; GENOMES	Detection of somatic point substitutions is a key step in characterizing the cancer genome. However, existing methods typically miss low-allelic-fraction mutations that occur in only a subset of the sequenced cells owing to either tumor heterogeneity or contamination by normal cells. Here we present MuTect, a method that applies a Bayesian classifier to detect somatic mutations with very low allele fractions, requiring only a few supporting reads, followed by carefully tuned filters that ensure high specificity. We also describe benchmarking approaches that use real, rather than simulated, sequencing data to evaluate the sensitivity and specificity as a function of sequencing depth, base quality and allelic fraction. Compared with other methods, MuTect has higher sensitivity with similar specificity, especially for mutations with allelic fractions as low as 0.1 and below, making MuTect particularly useful for studying cancer subclones and their evolution in standard exome and genome sequencing data.	[Cibulskis, Kristian; Lawrence, Michael S.; Carter, Scott L.; Sivachenko, Andrey; Jaffe, David; Sougnez, Carrie; Gabriel, Stacey; Meyerson, Matthew; Lander, Eric S.; Getz, Gad] Broad Inst Harvard, Cambridge, MA USA; [Cibulskis, Kristian; Lawrence, Michael S.; Carter, Scott L.; Sivachenko, Andrey; Jaffe, David; Sougnez, Carrie; Gabriel, Stacey; Meyerson, Matthew; Lander, Eric S.; Getz, Gad] MIT, Cambridge, MA 02139 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Div Canc Biol, Boston, MA 02115 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Getz, G (corresponding author), Broad Inst Harvard, Cambridge, MA USA.	gadgetz@broadinstitute.org	Peng, Bo/A-6920-2009; Lawrence, Michael/AAC-8202-2020; Cibulskis, Kristian/AAC-7380-2019	Peng, Bo/0000-0001-8225-2284; Cibulskis, Kristian/0000-0003-1343-1582; Meyerson, Matthew/0000-0002-9133-8108	US National Institutes of Health [U54HG003067, U24CA143845]; NATIONAL CANCER INSTITUTE [U24CA143845] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by US National Institutes of Health grants U54HG003067 and U24CA143845. We thank the Genome Analysis ToolKit (GATK) group, and our beta test users for their valuable feedback.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Roth A, 2012, BIOINFORMATICS, V28, P907, DOI 10.1093/bioinformatics/bts053; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	44	2783	2839	4	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					213	219		10.1038/nbt.2514	http://dx.doi.org/10.1038/nbt.2514			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23396013	Bronze, Green Accepted, Green Submitted			2022-12-27	WOS:000316439500014
J	Francisco, M				Francisco, Michael			Fourth-quarter biotech job picture	NATURE BIOTECHNOLOGY			English	Editorial Material																		2012, NAT BIOTECHNOL, V30, P1149	1	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					175	175		10.1038/nbt.2505	http://dx.doi.org/10.1038/nbt.2505			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23392515	Bronze			2022-12-27	WOS:000315322100031
J	Liu, Y; Aryee, MJ; Padyukov, L; Fallin, MD; Hesselberg, E; Runarsson, A; Reinius, L; Acevedo, N; Taub, M; Ronninger, M; Shchetynsky, K; Scheynius, A; Kere, J; Alfredsson, L; Klareskog, L; Ekstrom, TJ; Feinberg, AP				Liu, Yun; Aryee, Martin J.; Padyukov, Leonid; Fallin, M. Daniele; Hesselberg, Espen; Runarsson, Arni; Reinius, Lovisa; Acevedo, Nathalie; Taub, Margaret; Ronninger, Marcus; Shchetynsky, Klementy; Scheynius, Annika; Kere, Juha; Alfredsson, Lars; Klareskog, Lars; Ekstrom, Tomas J.; Feinberg, Andrew P.			Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis	NATURE BIOTECHNOLOGY			English	Article							GLUTATHIONE-S-TRANSFERASE; POLYMORPHISMS; EXPRESSION; SMOKING; PROTEINS; ETIOLOGY; MHC; M1; T1; P1	Epigenetic mechanisms integrate genetic and environmental causes of disease, but comprehensive genome-wide analyses of epigenetic modifications have not yet demonstrated robust association with common diseases. Using II lumina HumanMethylation450 arrays on 354 anti-citrullinated protein antibody-associated rheumatoid arthritis cases and 337 controls, we identified two clusters within the major histocompatibility complex (MHC) region whose differential methylation potentially mediates genetic risk for rheumatoid arthritis. To reduce confounding factors that have hampered previous epigenome-wide studies, we corrected for cellular heterogeneity by estimating and adjusting for cell-type proportions in our blood-derived DNA samples and used mediation analysis to filter out associations likely to be a consequence of disease. Four CpGs also showed an association between genotype and variance of methylation. The associations for both clusters replicated at least one CpG (P < 0.01), with the rest showing suggestive association, in monocyte cell fractions in an independent cohort of 12 cases and 12 controls. Thus, DNA methylation is a potential mediator of genetic risk.	[Liu, Yun; Aryee, Martin J.; Fallin, M. Daniele; Runarsson, Arni; Taub, Margaret; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD USA; [Liu, Yun; Runarsson, Arni; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Aryee, Martin J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Padyukov, Leonid; Hesselberg, Espen; Ronninger, Marcus; Shchetynsky, Klementy; Klareskog, Lars] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Padyukov, Leonid; Hesselberg, Espen; Ronninger, Marcus; Shchetynsky, Klementy; Klareskog, Lars; Ekstrom, Tomas J.] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Fallin, M. Daniele; Taub, Margaret; Feinberg, Andrew P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Fallin, M. Daniele] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Reinius, Lovisa; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Acevedo, Nathalie; Scheynius, Annika] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Ekstrom, Tomas J.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Karolinska Institutet; Karolinska Institutet; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Klareskog, L (corresponding author), Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden.	lars.klareskog@ki.se; tomas.ekstrom@ki.se; afeinberg@jhu.edu	Feinberg, Andrew/AAY-7666-2020; Aryee, Martin/AAC-8113-2020; Kere, Juha/AAX-9117-2021; Alfredsson, Lars/AAC-9007-2019; Ekström, Tomas/B-7764-2013; Reinius, Lovisa/C-4555-2014; Kere, Juha/A-9179-2008; Padyukov, Leonid/A-4890-2009	Kere, Juha/0000-0003-1974-0271; Alfredsson, Lars/0000-0003-1688-6697; Reinius, Lovisa/0000-0001-5029-0120; Kere, Juha/0000-0003-1974-0271; Acevedo, Nathalie/0000-0002-5154-2964; Padyukov, Leonid/0000-0003-2950-5670; Shchetynsky, Klementy/0000-0003-4578-5588; Feinberg, Andrew/0000-0002-8364-1991; Klareskog, Lars/0000-0001-9601-6186; Liu, Yun/0000-0001-5753-1265	US National Institutes of Health Centers of Excellence in Genomic Science [5P50HG003233]; Swedish Research Council; Swedish Combine project; Swedish Strategic Foundations; AFA Insurance; European Research Council (ERC); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER	US National Institutes of Health Centers of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Combine project; Swedish Strategic Foundations; AFA Insurance; European Research Council (ERC)(European Research Council (ERC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Rosenblum for helpful discussions on the application of statistical mediation methodology. We thank R.A. Irizarry for his contributions to the concepts in this work, his statistical insights on batch effects and helpful comments. We thank E.A. Houseman for codes used for estimating cell proportions. We also thank the EIRA study group<SUP>18</SUP> for contributing invaluable clinical information and biological samples. This work was supported by the US National Institutes of Health Centers of Excellence in Genomic Science, 5P50HG003233 to A.P.F., and by the Swedish Research Council, the Swedish Combine project, the Swedish Strategic Foundations, the AFA Insurance and the European Research Council (ERC).	Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Chen LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r219; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Grabar PB, 2009, CLIN EXP RHEUMATOL, V27, P229; Hao K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008695; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kang EY, 2010, J COMPUT BIOL, V17, P533, DOI 10.1089/cmb.2009.0176; Keenan BT, 2010, ARTHRITIS RHEUM-US, V62, P3196, DOI 10.1002/art.27639; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lundstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017880; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Mahdi H, 2009, NAT GENET, V41, P1319, DOI 10.1038/ng.480; Millstein J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-23; Mueller RB, 2007, RHEUMATOLOGY, V46, P931, DOI 10.1093/rheumatology/kem025; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Strange RC, 2000, TOXICOL LETT, V112, P357, DOI 10.1016/S0378-4274(99)00230-1; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Thurlings RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007865; van der Laan M.J., 2004, STAT APPL GENET MOL, V3, DOI [DOI 10.2202/1544-6115.1041, 10.2202/1544-6115.1041]; Yun BR, 2005, J RHEUMATOL, V32, P992	41	648	661	3	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					142	147		10.1038/nbt.2487	http://dx.doi.org/10.1038/nbt.2487			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23334450	Green Accepted			2022-12-27	WOS:000315322100025
J	Huang, JK; Hu, RF; Cai, JY; Wang, XB				Huang, Jikun; Hu, Ruifa; Cai, Jinyang; Wang, Xiaobing			Human research capacity in Chinese agbiotech	NATURE BIOTECHNOLOGY			English	Editorial Material									[Huang, Jikun; Cai, Jinyang; Wang, Xiaobing] Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Ctr Chinese Agr Policy, Beijing 100101, Peoples R China; [Hu, Ruifa] Beijing Inst Technol, Sch Management & Econ, Beijing 100081, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Beijing Institute of Technology	Huang, JK (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Ctr Chinese Agr Policy, Beijing 100101, Peoples R China.	jkhuang.ccap@igsnrr.ac.cn							0	17	17	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					1007	1007		10.1038/nbt.2386	http://dx.doi.org/10.1038/nbt.2386			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	23051817	Bronze			2022-12-27	WOS:000309965500029
J	Peng, WN				Peng, Wayne			Trends in biotech literature 2011	NATURE BIOTECHNOLOGY			English	News Item																			0	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					910	910		10.1038/nbt.2384	http://dx.doi.org/10.1038/nbt.2384			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	23051801	Bronze			2022-12-27	WOS:000309965500008
J	Senter, PD; Sievers, EL				Senter, Peter D.; Sievers, Eric L.			The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma	NATURE BIOTECHNOLOGY			English	Article							ANTIBODY-DRUG CONJUGATE; METASTATIC BREAST-CANCER; POTENT ANTITUMOR-ACTIVITY; ACUTE MYELOID-LEUKEMIA; MONOCLONAL-ANTIBODY; PHASE-II; HEMATOLOGIC MALIGNANCIES; GEMTUZUMAB OZOGAMICIN; ANTINEOPLASTIC AGENTS; ANTICANCER DRUGS	Progress has been made recently in developing antibody-drug conjugates (ADCs) that can selectively deliver cancer drugs to tumor cells. In principle, the idea is simple: by attaching drugs to tumor-seeking antibodies, target cells will be killed and nontarget cells will be spared. In practice, many parameters needed to be addressed to develop safe and effective ADCs, including the expression profiles of tumor versus normal tissues, the potency of the drug, the linker attaching the drug and placement of the drug on the antibody, and the pharmacokinetic and stability profiles of the resulting ADC. All these issues had been taken into account in developing brentuximab vedotin (Adcetris), an ADC that recently received accelerated approval by the US Food and Drug Administration for the treatment of relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL). Research is under way to extend the applications of brentuximab vedotin and to advance the field by developing other ADCs with new linker and conjugation strategies.	[Senter, Peter D.; Sievers, Eric L.] Seattle Genet, Bothell, WA USA	Seattle Genetics	Senter, PD (corresponding author), Seattle Genet, Bothell, WA USA.	psenter@seagen.com		Sievers, Eric/0000-0002-0794-9441				Alley SC, 2008, BIOCONJUGATE CHEM, V19, P759, DOI 10.1021/bc7004329; Andersen DC, 2004, CURR OPIN BIOTECH, V15, P456, DOI 10.1016/j.copbio.2004.08.002; Ansell SM, 2007, J CLIN ONCOL, V25, P2764, DOI 10.1200/JCO.2006.07.8972; ARNON R, 1982, IMMUNOL REV, V62, P5, DOI 10.1111/j.1600-065X.1982.tb00387.x; Baselga J, 2005, J CLIN ONCOL, V23, P2162, DOI 10.1200/JCO.2005.01.014; Beck A, 2011, MABS-AUSTIN, V3, P331, DOI 10.4161/mabs.3.4.16612; Bernardes GJL, 2012, ANGEW CHEM INT EDIT, V51, P941, DOI 10.1002/anie.201106527; Boghaert ER, 2008, CANCER CHEMOTH PHARM, V61, P1027, DOI 10.1007/s00280-007-0560-2; Bross PF, 2001, CLIN CANCER RES, V7, P1490; Burnett AK, 2011, J CLIN ONCOL, V29, P369, DOI 10.1200/JCO.2010.31.4310; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Carter PJ, 2008, CANCER J, V14, P154, DOI 10.1097/PPO.0b013e318172d704; Castaigne S, 2012, LANCET, V379, P1508, DOI 10.1016/S0140-6736(12)60485-1; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Connors JM, 2005, J CLIN ONCOL, V23, P6400, DOI 10.1200/JCO.2005.05.016; Deutsch YE, 2011, LEUKEMIA LYMPHOMA, V52, P1641, DOI 10.3109/10428194.2011.574761; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Dubowchik GM, 1998, BIOORG MED CHEM LETT, V8, P3347, DOI 10.1016/S0960-894X(98)00610-6; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Fanale MA, 2012, CLIN CANCER RES, V18, P248, DOI 10.1158/1078-0432.CCR-11-1425; Forero-Torres A, 2009, BRIT J HAEMATOL, V146, P171, DOI 10.1111/j.1365-2141.2009.07740.x; Friedman M, 2009, BIOTECHNOL APPL BIOC, V53, P1, DOI 10.1042/BA20080287; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Hartley JA, 2010, CANCER RES, V70, P6849, DOI 10.1158/0008-5472.CAN-10-0790; Hollander I, 2008, BIOCONJUGATE CHEM, V19, P358, DOI 10.1021/bc700321z; Hurvitz SA, 2013, CANCER TREAT REV, V39, P219, DOI 10.1016/j.ctrv.2012.04.008; JAIN RK, 1990, FRONT RADIAT THER ON, V24, P32; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Kantarjian H, 2012, LANCET ONCOL, V13, P403, DOI 10.1016/S1470-2045(11)70386-2; Keir CH, 2012, EXPERT OPIN BIOL TH, V12, P259, DOI 10.1517/14712598.2012.642357; Kim KM, 2008, MOL CANCER THER, V7, P2486, DOI 10.1158/1535-7163.MCT-08-0388; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Krop IE, 2012, J CLIN ONCOL, V30, P3234, DOI 10.1200/JCO.2011.40.5902; Krop IE, 2010, J CLIN ONCOL, V28, P2698, DOI 10.1200/JCO.2009.26.2071; Leonard JP, 2003, J CLIN ONCOL, V21, P3051, DOI 10.1200/JCO.2003.01.082; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; LoRusso PM, 2011, CLIN CANCER RES, V17, P6437, DOI 10.1158/1078-0432.CCR-11-0762; Lyon RP, 2012, METHOD ENZYMOL, V502, P123, DOI 10.1016/B978-0-12-416039-2.00006-9; McDonagh CF, 2006, PROTEIN ENG DES SEL, V19, P299, DOI 10.1093/protein/gzl013; Moldenhauer G, 2012, JNCI-J NATL CANCER I, V104, P622, DOI 10.1093/jnci/djs140; Oflazoglu E, 2008, BRIT J HAEMATOL, V142, P69, DOI 10.1111/j.1365-2141.2008.07146.x; Perez EA, 2005, INVEST NEW DRUG, V23, P257, DOI 10.1007/s10637-005-6735-y; Petersdorf S, 2009, BLOOD, V114; PETERSEN BH, 1991, CANCER RES, V51, P2286; PETTIT GR, 1987, J AM CHEM SOC, V109, P6883, DOI 10.1021/ja00256a070; Pettit GR, 1998, ANTI-CANCER DRUG DES, V13, P243; Pro B, 2012, J CLIN ONCOL, V30, P2190, DOI 10.1200/JCO.2011.38.0402; Ravandi F, 2011, J CLIN ONCOL, V29, P349, DOI 10.1200/JCO.2010.32.2693; Schnell R, 2002, CLIN CANCER RES, V8, P1779; Schwartz RS, 2004, NEW ENGL J MED, V350, P1079, DOI 10.1056/NEJMp048021; Senter PD, 2009, CURR OPIN CHEM BIOL, V13, P235, DOI 10.1016/j.cbpa.2009.03.023; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Sievers EL, 2001, CURR OPIN ONCOL, V13, P522, DOI 10.1097/00001622-200111000-00016; Sun MMC, 2005, BIOCONJUGATE CHEM, V16, P1282, DOI 10.1021/bc050201y; Tijink BM, 2006, CLIN CANCER RES, V12, P6064, DOI 10.1158/1078-0432.CCR-06-0910; Tolcher AW, 1999, J CLIN ONCOL, V17, P478, DOI 10.1200/JCO.1999.17.2.478; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wahl AF, 2002, CANCER RES, V62, P3736; Walter R.B., 2012, BLOOD           0127, DOI DOI 10.1182/BLOOD-2011-11-325050; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Wu P, 2009, P NATL ACAD SCI USA, V106, P3000, DOI 10.1073/pnas.0807820106; Younes A, 2012, J CLIN ONCOL, V30, P2183, DOI 10.1200/JCO.2011.38.0410; Younes A, 2010, NEW ENGL J MED, V363, P1812, DOI 10.1056/NEJMoa1002965	65	524	553	15	260	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					631	637		10.1038/nbt.2289	http://dx.doi.org/10.1038/nbt.2289			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781692				2022-12-27	WOS:000306293400022
J	Rychlik, B				Rychlik, Bruce			Pay increases for executives at private life sciences companies hit a 12-year low	NATURE BIOTECHNOLOGY			English	Editorial Material									J Robert Scott, Boston, MA USA		Rychlik, B (corresponding author), J Robert Scott, Boston, MA USA.	bruce.rychlik@fmr.com							0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					289	291		10.1038/nbt.2155	http://dx.doi.org/10.1038/nbt.2155			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22398627				2022-12-27	WOS:000301303800027
J	Palazzoli, F; Bire, S; Bigot, Y; Bonnin-Rouleux, F				Palazzoli, Fabien; Bire, Solenne; Bigot, Yves; Bonnin-Rouleux, Florence			Landscape of chromatin control element patents: positioning effects in pharmaceutical bioproduction	NATURE BIOTECHNOLOGY			English	Editorial Material							TRANSGENE EXPRESSION; ALLOWS		[Palazzoli, Fabien; Bire, Solenne; Bigot, Yves; Bonnin-Rouleux, Florence] Univ Tours, GICC, Tours, France	Universite de Tours	Palazzoli, F (corresponding author), Univ Tours, GICC, Tours, France.	yves.bigot@univ-tours.fr						Benton T, 2002, CYTOTECHNOLOGY, V38, P43, DOI 10.1023/A:1021141712344; Buceta M, 2011, GENE THER, V18, P7, DOI 10.1038/gt.2010.115; Chen WY, 1997, P NATL ACAD SCI USA, V94, P5798, DOI 10.1073/pnas.94.11.5798; Girod PA, 2007, NAT METHODS, V4, P747, DOI 10.1038/NMETH1076; Harraghy N, 2008, CURR GENE THER, V8, P353, DOI 10.2174/156652308786071032; Kwaks THJ, 2006, TRENDS BIOTECHNOL, V24, P137, DOI 10.1016/j.tibtech.2006.01.007; Kwaks THJ, 2003, NAT BIOTECHNOL, V21, P553, DOI 10.1038/nbt814; LEDERGERBER W, 2003, WORLD PATENT INFORM, V25, P57; van Blokland HJM, 2007, J BIOTECHNOL, V128, P237, DOI 10.1016/j.jbiotec.2006.09.023; Williams S, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-17; WILLIAMS S, 2008, INNOV PHARM TECHNOL, V26, P52	11	11	12	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2011	29	7					593	598		10.1038/nbt.1907	http://dx.doi.org/10.1038/nbt.1907			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	790NM	21747382				2022-12-27	WOS:000292595200015
J	Tsai, SQ; Wyvekens, N; Khayter, C; Foden, JA; Thapar, V; Reyon, D; Goodwin, MJ; Aryee, MJ; Joung, JK				Tsai, Shengdar Q.; Wyvekens, Nicolas; Khayter, Cyd; Foden, Jennifer A.; Thapar, Vishal; Reyon, Deepak; Goodwin, Mathew J.; Aryee, Martin J.; Joung, J. Keith			Dimeric CRISPR RNA-guided Fokl nucleases for highly specific genome editing	NATURE BIOTECHNOLOGY			English	Article							CAS9; ACTIVATION; ENDONUCLEASE; TALENS	Monomeric CRISPR-Cas9 nucleases are widely used for targeted genome editing but can induce unwanted off-target mutations with high frequencies. Here we describe dimeric RNA-guided FokI nucleases (RFNs) that can recognize extended sequences and edit endogenous genes with high efficiencies in human cells. RFN cleavage activity depends strictly on the binding of two guide RNAs (gRNAs) to DNA with a defined spacing and orientation substantially reducing the likelihood that a suitable target site will occur more than once in the genome and therefore improving specificities relative to wild-type Cas9 monomers. RFNs guided by a single gRNA generally induce lower levels of unwanted mutations than matched monomeric Cas9 nickases. In addition, we describe a simple method for expressing multiple gRNAs bearing any 5' end nucleotide, which gives dimeric RFNs a broad targeting range. RFNs combine the ease of RNA-based targeting with the specificity enhancement inherent to dimerization and are likely to be useful in applications that require highly precise genome editing.	[Tsai, Shengdar Q.; Wyvekens, Nicolas; Khayter, Cyd; Foden, Jennifer A.; Thapar, Vishal; Reyon, Deepak; Goodwin, Mathew J.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Tsai, Shengdar Q.; Wyvekens, Nicolas; Khayter, Cyd; Foden, Jennifer A.; Thapar, Vishal; Reyon, Deepak; Goodwin, Mathew J.; Aryee, Martin J.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Tsai, Shengdar Q.; Wyvekens, Nicolas; Khayter, Cyd; Foden, Jennifer A.; Reyon, Deepak; Goodwin, Mathew J.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Tsai, Shengdar Q.; Reyon, Deepak; Aryee, Martin J.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	jjoung@mgh.harvard.edu	Tsai, Shengdar Q./G-4600-2012; Reyon, Deepak/HCH-3183-2022; Aryee, Martin/AAC-8113-2020; Wilson, Matthew H/K-3193-2013	Tsai, Shengdar Q./0000-0001-9161-3993; 	National Institutes of Health (NIH) Director's Pioneer Award [DP1 GM105378, NIH R01 GM088040, NIH P50 HG005550, NIH R01 AR063070]; Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; NIH [F32 GM105189]; US Army Research Laboratory and the US Army Research Office [W911NF-11-2-0056]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM105189, DP1GM105378, R01GM088040] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Director's Pioneer Award; Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Research Laboratory and the US Army Research Office; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Fu and M. Maeder for helpful discussions and Y. Fu, J. Angstman and B. Kleinstiver for comments on the manuscript. This work was funded by a National Institutes of Health (NIH) Director's Pioneer Award (DP1 GM105378), NIH R01 GM088040, NIH P50 HG005550, NIH R01 AR063070, and the Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award. S.Q.T. was supported by NIH F32 GM105189. This material is based upon work supported by, or in part by, the US Army Research Laboratory and the US Army Research Office under grant number W911NF-11-2-0056. Plasmids described in this work will be deposited with and made available through the nonprofit plasmid distribution service Addgene (http://www. addgene. org/crispr-cas).	Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842	31	671	932	7	196	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					569	+		10.1038/nbt.2908	http://dx.doi.org/10.1038/nbt.2908			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24770325	Green Accepted, Green Submitted			2022-12-27	WOS:000337233800020
J	Barzel, B; Barabasi, AL				Barzel, Baruch; Barabasi, Albert-Laszlo			Network link prediction by global silencing of indirect correlations	NATURE BIOTECHNOLOGY			English	Article							PROTEIN INTERACTIONS; REGULATORY NETWORKS; MAP; LANDSCAPE	Predictions of physical and functional links between cellular components are often based on correlations between experimental measurements, such as gene expression. However, correlations are affected by both direct and indirect paths, confounding our ability to identify true pairwise interactions. Here we exploit the fundamental properties of dynamical correlations in networks to develop a method to silence indirect effects. The method receives as input the observed correlations between node pairs and uses a matrix transformation to turn the correlation matrix into a highly discriminative silenced matrix, which enhances only the terms associated with direct causal links. Against empirical data for Escherichia coli regulatory interactions, the method enhanced the discriminative power of the correlations by twofold, yielding >50% predictive improvement over traditional correlation measures and 6% over mutual information. Overall this silencing method will help translate the abundant correlation data into insights about a system's interactions, with applications ranging from link prediction to inferring the dynamical mechanisms governing biological networks.	[Barzel, Baruch; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Barzel, Baruch; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Barzel, Baruch; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Comp Sci, Boston, MA 02115 USA; [Barzel, Baruch; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Barzel, Baruch] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA	Northeastern University; Northeastern University; Northeastern University; Northeastern University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Barabasi, AL (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.	barabasi@gmail.com	Barabasi, Albert-Laszlo/S-6474-2017	Barabasi, Albert/0000-0002-4028-3522	US National Institutes of Health (NIH), Center of Excellence of Genomic Science (CEGS) [NIH CEGS 1P50HG4233]; NIH [1U01HL108630-01]; DARPA [11645021]; DARPA Social Media in Strategic Communications project [W911NF-12-C-0028]; Network Science Collaborative Technology Alliance; US Army Research Laboratory [NS-CTA W911NF-09-02-0053]; Office of Naval Research [N000141010968]; Defense Threat Reduction Agency [WMD BRBAA07-J-2-0035, BRBAA08-Per4-C-2-0033]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL108630] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES027302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062449] Funding Source: NIH RePORTER	US National Institutes of Health (NIH), Center of Excellence of Genomic Science (CEGS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DARPA Social Media in Strategic Communications project; Network Science Collaborative Technology Alliance; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Office of Naval Research(Office of Naval Research); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Alipanahi and B. Frey for their valuable insights, A. Sharma, F. Simini, J. Menche, S. Rabello, G. Ghoshal, Y.-Y. Liu, T. Jia, M. Posfai, C. Song, Y.-Y. Ahn, N. Blumm, D. Wang, Z. Qu, M. Schich, D. Ghiassian, S. Gil, P. Hovel, J. Gao, M. Kitsak, M. Martino, R. Sinatra, G. Tsekenis, L. Chi, B. Gabriel, Q. Jin and Y. Li for discussions, and S. S. Aleva, S. Morrison, J. De Nicolo and A. Pawling for their support. This work was supported by the US National Institutes of Health (NIH), Center of Excellence of Genomic Science (CEGS), Grant number NIH CEGS 1P50HG4233; and the NIH, award number 1U01HL108630-01; DARPA Grant Number 11645021; DARPA Social Media in Strategic Communications project under agreement number W911NF-12-C-0028; the Network Science Collaborative Technology Alliance sponsored by the US Army Research Laboratory under agreement number NS-CTA W911NF-09-02-0053; the Office of Naval Research under agreement number N000141010968; and the Defense Threat Reduction Agency awards WMD BRBAA07-J-2-0035 and BRBAA08-Per4-C-2-0033.	Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alon U., 2006, INTRO SYSTEMS BIOL D; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barzel B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046104; Bollobas B., 2001, RANDOM GRAPHS; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Buchanan M., 2010, NETWORKS CELL BIOL; Butte A J, 2000, Pac Symp Biocomput, P418; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Caldarelli G., 2007, SCALE FREE NETWORKS; Chen L, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r3; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ERDOS P, 1960, B INT STATIST INST, V38, P343; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Guo SX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000087; Han L, 2008, BIOSYSTEMS, V91, P158, DOI 10.1016/j.biosystems.2007.08.008; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kauffman S, 2004, PHYSICA A, V340, P733, DOI 10.1016/j.physa.2004.05.018; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lezon TR, 2006, P NATL ACAD SCI USA, V103, P19033, DOI 10.1073/pnas.0609152103; Liu YY, 2013, P NATL ACAD SCI USA, V110, P2460, DOI 10.1073/pnas.1215508110; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Ramani AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.19; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; STAUFFER D, 1994, INTRO PERCOLATION TH; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yuan YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016835	41	176	184	3	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					720	725		10.1038/nbt.2601	http://dx.doi.org/10.1038/nbt.2601			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23851447	Green Accepted, Green Submitted, Bronze			2022-12-27	WOS:000322911000021
J	Wynn, JP				Wynn, James P.			Taking the fish out of fish oil	NATURE BIOTECHNOLOGY			English	Editorial Material									MBI, Lansing, MI USA		Wynn, JP (corresponding author), MBI, Lansing, MI USA.	wynn@mbi.org						Ashley JTF, 2013, FOOD ADDIT CONTAM A, V30, P506, DOI 10.1080/19440049.2012.753161; Haslam RP, 2013, PLANT BIOTECHNOL J, V11, P157, DOI 10.1111/pbi.12012; Nobre MEP, 2013, NUTR RES, V33, P422, DOI 10.1016/j.nutres.2013.02.011; Shanahan C., 2013, NATURAL PRODUCTS INS; Wynn J. P., 2005, BAILEYS IND OIL FAT, V3, P121; Xue ZX, 2013, NAT BIOTECHNOL, V31, P734, DOI 10.1038/nbt.2622; Zaslavskaia LA, 2001, SCIENCE, V292, P2073, DOI 10.1126/science.160015	7	2	3	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					716	717		10.1038/nbt.2656	http://dx.doi.org/10.1038/nbt.2656			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23929348				2022-12-27	WOS:000322911000019
J	Lee, S; Raw, A; Yu, L; Lionberger, R; Ya, N; Verthelyi, D; Rosenberg, A; Kozlowski, S; Webber, K; Woodcock, J				Lee, Sau; Raw, Andre; Yu, Lawrence; Lionberger, Robert; Ya, Naiqi; Verthelyi, Daniela; Rosenberg, Amy; Kozlowski, Steve; Webber, Keith; Woodcock, Janet			Scientific considerations in the review and approval of generic enoxaparin in the United States	NATURE BIOTECHNOLOGY			English	Review							MOLECULAR-WEIGHT HEPARINS; FACTOR 4/HEPARIN ANTIBODIES; INDUCED THROMBOCYTOPENIA; SEQUENCING APPROACH; SULFATE; ANTITHROMBIN; RECOMMENDATIONS; GUIDELINES; BINDING; PHARMACOKINETICS	In 2010, the US Food and Drug Administration (FDA) approved a generic low-molecular-weight heparin without clinical safety or efficacy data under the Abbreviated New Drug Application (ANDA) pathway. To enable a determination of active ingredient sameness of generic and innovator enoxaparin products, the FDA developed a scientifically rigorous approach based on five criteria: first, equivalence of physicochemical properties; second, equivalence of heparin source material and mode of depolymerization; third, equivalence in disaccharide building blocks, fragment mapping and sequence of oligosaccharide species; fourth, equivalence in biological and biochemical assays; and finally, equivalence of in vivo pharmacodynamic profile. In addition to fulfillment of these criteria, FDA also used in vitro, ex vivo and model animal data to ensure there was no increased immunogenicity risk of the generic enoxaparin product relative to the brand name product. The approval of the highly complex enoxaparin product using this framework under the ANDA pathway represents a major development. It also suggests that analytical and scientific advancements may in certain cases allow the elimination of unnecessary in vivo testing in animals and humans.	[Lee, Sau; Raw, Andre; Yu, Lawrence; Lionberger, Robert; Ya, Naiqi; Webber, Keith] US FDA, Ctr Drug Evaluat & Res, Off Gener Drugs, Rockville, MD 20857 USA; [Verthelyi, Daniela; Rosenberg, Amy; Kozlowski, Steve] US FDA, Ctr Biol Evaluat & Res, Off Biotechnol Prod, Bethesda, MD USA; [Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Raw, A (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off Gener Drugs, Rockville, MD 20857 USA.	andre.raw@fda.hhs.gov	Lionberger, Robert/L-4923-2017	Lionberger, Robert/0000-0002-0598-1771				[Anonymous], OFFICIAL MONOGRAPPHS; Arepally GM, 2010, ANNU REV MED, V61, P77, DOI 10.1146/annurev.med.042808.171814; Bisio A, 2009, THROMB HAEMOSTASIS, V102, P865, DOI 10.1160/TH09-02-0081; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chuang WL, 2001, ANAL CHEM, V73, P2310, DOI 10.1021/ac0100291; Chuang WL, 2001, J CHROMATOGR A, V932, P65, DOI 10.1016/S0021-9673(01)01241-9; Chuang YJ, 2001, J BIOL CHEM, V276, P14961, DOI 10.1074/jbc.M011550200; Cohen M, 2012, J THROMB THROMBOLYS, V33, P230, DOI 10.1007/s11239-012-0680-3; DEBRIE R, 1995, Patent No. 5389618; ERIKSSON BI, 1995, THROMB HAEMOSTASIS, V73, P398; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; European Medicines Agency, 2013, GUID NONCL CLIN DEV; Garcia-Arieta Alfredo, 2012, Curr Drug Discov Technol, V9, P137; Girolami B, 2006, SEMIN THROMB HEMOST, V32, P803, DOI 10.1055/s-2006-955463; Greinacher A, 2007, J THROMB HAEMOST, V5, P1666, DOI 10.1111/j.1538-7836.2007.02617.x; GREINACHER A, 1995, THROMB HAEMOSTASIS, V74, P886; Greinacher A, 2006, ARTERIOSCL THROM VAS, V26, P2386, DOI 10.1161/01.ATV.0000238350.89477.88; Guerrini M, 2001, SEMIN THROMB HEMOST, V27, P473, DOI 10.1055/s-2001-17958; Guerrini M, 2010, J MED CHEM, V53, P8030, DOI 10.1021/jm100771s; Harenberg J, 2009, J THROMB HAEMOST, V7, P1222, DOI 10.1111/j.1538-7836.2009.03349.x; Harenberg J, 2011, CLIN APPL THROMB-HEM, V17, pE158, DOI 10.1177/1076029610392216; Harenberg J, 2011, THROMB RES, V127, pS100, DOI 10.1016/S0049-3848(11)70027-5; Heinzelmann M, 1999, ANN SURG, V229, P542, DOI 10.1097/00000658-199904000-00014; Hirsh J, 2004, CHEST, V126, p188S, DOI 10.1378/chest.126.3_suppl.188S; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; Hochart H, 2008, THROMB HAEMOSTASIS, V99, P570, DOI 10.1160/TH07-06-0424; Hursting MJ, 2010, AM J CLIN PATHOL, V134, P774, DOI 10.1309/AJCPG0MNR5NGKNFX; Imanari T., 1999, J CHROMATOGR A, V830, P197; Jeske W, 1999, SEMIN THROMB HEMOST, V25, P27; Kalodiki E, 2009, CLIN APPL THROMB-HEM, V15, P8, DOI 10.1177/1076029608329113; Kamberi M, 2004, J CHROMATOGR B, V810, P151, DOI 10.1016/j.jchromb.2004.07.026; Kozlowski S, 2011, NEW ENGL J MED, V365, P385, DOI 10.1056/NEJMp1107285; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LEVIN S, 1991, BIOMED CHROMATOGR, V5, P133, DOI 10.1002/bmc.1130050308; Linhardt RJ, 2003, J MED CHEM, V46, P2551, DOI 10.1021/jm030176m; Linhardt RJ, 1999, SEMIN THROMB HEMOST, V25, P5; MACCARANA M, 1994, J BIOL CHEM, V269, P3903; MACCARANA M, 1993, GLYCOBIOLOGY, V3, P271, DOI 10.1093/glycob/3.3.271; Maddineni J, 2006, CLIN APPL THROMB-HEM, V12, P267, DOI 10.1177/1076029606291434; Martel N, 2005, BLOOD, V106, P2710, DOI 10.1182/blood-2005-04-1546; Merli GJ, 2001, J THROMB THROMBOLYS, V11, P247, DOI 10.1023/A:1011969005756; Mourier P., 2005, U.S. Patent Application, Patent No. [2005/0119477 A1, 20050119477]; Mourier PAJ, 2004, ANAL BIOCHEM, V332, P299, DOI 10.1016/j.ab.2004.06.020; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; Newman PM, 1998, THROMB HAEMOSTASIS, V80, P292, DOI 10.1055/s-0037-1615190; NIGHTINGALE SL, 1993, JAMA J AM MED ASSOC, V270, P1672; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P10301, DOI 10.1073/pnas.97.19.10301; Ofosu FA, 2012, THROMB HAEMOSTASIS, V107, P201, DOI 10.1160/TH11-06-0409; Pattnaik P, 2005, APPL BIOCHEM BIOTECH, V126, P79, DOI 10.1385/ABAB:126:2:079; Planes A, 1999, THROMB HAEMOSTASIS, V81, P22; Rauova L, 2005, BLOOD, V105, P131, DOI 10.1182/blood-2004-04-1544; ROSENBERG RD, 1975, NEW ENGL J MED, V292, P146; Samama MM, 2000, SEMIN THROMB HEMOST, V26, P31, DOI 10.1055/s-2000-9497; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Selleng S, 2010, AM HEART J, V160, P362, DOI 10.1016/j.ahj.2010.05.026; Shriver Z, 2000, P NATL ACAD SCI USA, V97, P10359, DOI 10.1073/pnas.97.19.10359; Stringer SE, 2003, GLYCOBIOLOGY, V13, P97, DOI 10.1093/glycob/cwg006; Sundaram M, 2003, P NATL ACAD SCI USA, V100, P651, DOI 10.1073/pnas.252643299; Thanawiroon C, 2004, J BIOL CHEM, V279, P2608, DOI 10.1074/jbc.M304772200; Torri G, 2008, NMR SPECTROSCOPY IN PHARMACEUTICAL ANALYSIS, P407, DOI 10.1016/B978-0-444-53173-5.00016-0; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; US Food and Drug Administration, GEN EN QUEST ANSW; US Food and Drug Administration, PROD LAB LOV EN SOD; US Food and Drug Administration, 2012, FDA APPR 1 GEN EN SO; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Yamada S, 1999, BIOCHEMISTRY-US, V38, P838, DOI 10.1021/bi981889n	67	55	58	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					220	226		10.1038/nbt.2528	http://dx.doi.org/10.1038/nbt.2528			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23471071				2022-12-27	WOS:000316439500015
J	Hane, F				Hane, Francis			Intellectual property rights and user facility agreements	NATURE BIOTECHNOLOGY			English	Editorial Material								The maturation of tomato fruits is accompanied by widespread reprogramming of the epigenome.	Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Hane, F (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	fthane@uwaterloo.ca		Hane, Francis/0000-0002-2738-584X				Fridman G., 2005, LAW CONTRACT; Smalheiser NR, 2005, PLOS BIOL, V3, P963, DOI 10.1371/journal.pbio.0030217	2	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					116	118		10.1038/nbt.2494	http://dx.doi.org/10.1038/nbt.2494			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23392507				2022-12-27	WOS:000315322100017
J	Na, D; Yoo, SM; Chung, H; Park, H; Park, JH; Lee, SY				Na, Dokyun; Yoo, Seung Min; Chung, Hannah; Park, Hyegwon; Park, Jin Hwan; Lee, Sang Yup			Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs	NATURE BIOTECHNOLOGY			English	Article							MESSENGER-RNA; EXPRESSION; MODEL	Small regulatory RNAs (sRNAs) regulate gene expression in bacteria. We designed synthetic sRNAs to identify and modulate the expression of target genes for metabolic engineering in Escherichia coli. Using synthetic sRNAs for the combinatorial knockdown of four candidate genes in 14 different strains, we isolated an engineered E. coli strain (tyrR- and csrA-repressed S17-1) capable of producing 2 g per liter of tyrosine. Using a library of 130 synthetic sRNAs, we also identified chromosomal gene targets that enabled substantial increases in cadaverine production. Repression of murE led to a 55% increase in cadaverine production compared to the reported engineered strain (XQ56 harboring the plasmid p15CadA)(1). The design principles and the engineering strategy using synthetic sRNAs reported here are generalizable to other bacteria and applicable in developing superior producer strains. The ability to fine-tune target genes with designed sRNAs provides substantial advantages over gene-knockout strategies and other large-scale target identification strategies owing to its easy implementation, ability to modulate chromosomal gene expression without modifying those genes and because it does not require construction of strain libraries.	[Na, Dokyun; Yoo, Seung Min; Chung, Hannah; Park, Hyegwon; Park, Jin Hwan; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Metab & Biomol Engn Natl Res Lab, Program BK21, Taejon 305701, South Korea; [Na, Dokyun; Yoo, Seung Min; Park, Jin Hwan; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Inst BioCentury, Ctr Syst & Synthet Biotechnol, BioProc Engn Res Ctr,Bioinformat Res Ctr, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Lee, SY (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Metab & Biomol Engn Natl Res Lab, Program BK21, Taejon 305701, South Korea.	leesy@kaist.ac.kr	Lee, Sang Yup/C-1526-2011	Lee, Sang Yup/0000-0003-0599-3091; Na, Dokyun/0000-0002-9107-7040	Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries [NRF-2012-C1AAA001-2012M1A2A2026556]; Intelligent Synthetic Biology Center through the Global Frontier Project of the Ministry of Education, Science and Technology (MEST) through the National Research Foundation of Korea [2011-0031963]; World Class University program of MEST [R32-2008-000-10142-0]	Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries; Intelligent Synthetic Biology Center through the Global Frontier Project of the Ministry of Education, Science and Technology (MEST) through the National Research Foundation of Korea(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); World Class University program of MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We would like to thank M.-H. Lee for measuring tyrosine and cadaverine concentrations using high-performance liquid chromatography, Y.H. Lee for 2D-PAGE experiments, J.A. Im for large-scale cloning of synthetic sRNAs and cultivation experiments, and S.J. Choi for fermentation experiments. This work was supported by the Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries (NRF-2012-C1AAA001-2012M1A2A2026556); the Intelligent Synthetic Biology Center through the Global Frontier Project (2011-0031963) of the Ministry of Education, Science and Technology (MEST) through the National Research Foundation of Korea; and the World Class University program (R32-2008-000-10142-0) of MEST.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Carothers JM, 2011, SCIENCE, V334, P1716, DOI 10.1126/science.1212209; Culver GM, 2001, STRUCTURE, V9, P751, DOI 10.1016/S0969-2126(01)00649-9; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Desai SK, 2004, J AM CHEM SOC, V126, P13247, DOI 10.1021/ja048634j; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Hua Q, 2003, J BACTERIOL, V185, P7053, DOI 10.1128/JB.185.24.7053-7067.2003; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Juminaga D, 2012, APPL ENVIRON MICROB, V78, P89, DOI 10.1128/AEM.06017-11; Kadir TAA, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-88; Kang Z, 2012, BIOTECHNOL LETT, V34, P527, DOI 10.1007/s10529-011-0794-2; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; LEE SY, 1994, BIOTECHNOL BIOENG, V44, P1337, DOI 10.1002/bit.260441110; Liang JC, 2011, MOL CELL, V43, P915, DOI 10.1016/j.molcel.2011.08.023; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Luetke-Eversloh T, 2008, METAB ENG, V10, P69, DOI 10.1016/j.ymben.2007.12.001; Lutke-Eversloh T, 2007, APPL MICROBIOL BIOT, V75, P103, DOI 10.1007/s00253-006-0792-9; Man SA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr034; Na D, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-71; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Pichon C, 2012, NUCLEIC ACIDS RES, V40, P2846, DOI 10.1093/nar/gkr1141; Qian ZG, 2011, BIOTECHNOL BIOENG, V108, P93, DOI 10.1002/bit.22918; Saito H, 2009, INT J BIOCHEM CELL B, V41, P398, DOI 10.1016/j.biocel.2008.08.017; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; Sharma V, 2012, ACS SYNTH BIOL, V1, P6, DOI 10.1021/sb200001q; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311	30	409	450	20	313	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					170	174		10.1038/nbt.2461	http://dx.doi.org/10.1038/nbt.2461			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23334451				2022-12-27	WOS:000315322100030
J	Yang, W				Yang, Walter			Q312: Biotech on a roll	NATURE BIOTECHNOLOGY			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1165	1165		10.1038/nbt.2457	http://dx.doi.org/10.1038/nbt.2457			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222777	Bronze			2022-12-27	WOS:000312092400010
J	Hegde, D				Hegde, Deepak			Funding and performance at the US Patent and Trademark Office	NATURE BIOTECHNOLOGY			English	Editorial Material								Despite recent patent law reforms, the US Patent and Trademark Office's ability to deal with inefficiencies in patent examination will continue to rely on the annual Congressional appropriations process.	NYU, Stern Sch Business, New York, NY 10003 USA	New York University	Hegde, D (corresponding author), NYU, Stern Sch Business, New York, NY 10003 USA.	dhegde@stern.nyu.edu						[Anonymous], 2005, J TECHNOLOGY TRANSFE; [Anonymous], 2011, NATURE, V477, P249; [Anonymous], 2005, US PATENT TRADEMARK; Bessen James, 2008, PATENT FAILURE JUDGE; Committee on Intellectual Property Rights in the Knowledge-Based Economy National Research Council, 2004, PAT SYST 21 CENT; Hegde D, 2009, MANAGE SCI, V55, P1214, DOI 10.1287/mnsc.1090.1016; Jaffe A.B., 2004, INNOVATION ITS DISCO; Lemley M., 2008, EMORY LAW J, V58, P415; Quinn G, 2011, IP WATCHDOG     0622; Shapiro Carl, 2004, BERKELEY TECH LJ, V19, P1017	10	10	11	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					148	151		10.1038/nbt.2110	http://dx.doi.org/10.1038/nbt.2110			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22318030				2022-12-27	WOS:000300269100014
J	Chitsaz, H; Yee-Greenbaum, JL; Tesler, G; Lombardo, MJ; Dupont, CL; Badger, JH; Novotny, M; Rusch, DB; Fraser, LJ; Gormley, NA; Schulz-Trieglaff, O; Smith, GP; Evers, DJ; Pevzner, PA; Lasken, RS				Chitsaz, Hamidreza; Yee-Greenbaum, Joyclyn L.; Tesler, Glenn; Lombardo, Mary-Jane; Dupont, Christopher L.; Badger, Jonathan H.; Novotny, Mark; Rusch, Douglas B.; Fraser, Louise J.; Gormley, Niall A.; Schulz-Trieglaff, Ole; Smith, Geoffrey P.; Evers, Dirk J.; Pevzner, Pavel A.; Lasken, Roger S.			Efficient de novo assembly of single-cell bacterial genomes from short-read data sets	NATURE BIOTECHNOLOGY			English	Article							AMPLIFICATION; POLYMERASE; SEQUENCE	Whole genome amplification by the multiple displacement amplification (MDA) method allows sequencing of DNA from single cells of bacteria that cannot be cultured. Assembling a genome is challenging, however, because MDA generates highly nonuniform coverage of the genome. Here we describe an algorithm tailored for short-read data from single cells that improves assembly through the use of a progressively increasing coverage cutoff. Assembly of reads from single Escherichia coli and Staphylococcus aureus cells captures >91% of genes within contigs, approaching the 95% captured from an assembly based on many E. coli cells. We apply this method to assemble a genome from a single cell of an uncultivated SAR324 clade of Deltaproteobacteria, a cosmopolitan bacterial lineage in the global ocean. Metabolic reconstruction suggests that SAR324 is aerobic, motile and chemotaxic. Our approach enables acquisition of genome assemblies for individual uncultivated bacteria using only short reads, providing cell-specific genetic information absent from metagenomic studies.	[Yee-Greenbaum, Joyclyn L.; Lombardo, Mary-Jane; Dupont, Christopher L.; Badger, Jonathan H.; Novotny, Mark; Lasken, Roger S.] J Craig Venter Inst, San Diego, CA USA; [Chitsaz, Hamidreza; Pevzner, Pavel A.] Univ Calif San Diego, Dept Comp Sci, La Jolla, CA 92093 USA; [Tesler, Glenn] Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA; [Rusch, Douglas B.] J Craig Venter Inst, Rockville, MD USA; [Fraser, Louise J.; Gormley, Niall A.; Schulz-Trieglaff, Ole; Smith, Geoffrey P.; Evers, Dirk J.] Illumina Cambridge Ltd, Saffron Walden, Essex, England	J. Craig Venter Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; J. Craig Venter Institute; Illumina	Lasken, RS (corresponding author), J Craig Venter Inst, San Diego, CA USA.	rlasken@jcvi.org			National Human Genome Research Institute [NIH-2 R01 HG003647]; Alfred P. Sloan Foundation [Sloan Foundation-2007-10-19]; US National Institutes of Health (NIH) [3P41RR024851-02S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR024851] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003647] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was partially supported by grants to R. S. L. from the National Human Genome Research Institute (NIH-2 R01 HG003647) and the Alfred P. Sloan Foundation (Sloan Foundation-2007-10-19), and by a grant to P. A. P. and G. T. from the US National Institutes of Health (NIH grant 3P41RR024851-02S1). We thank M. Kim (J. Craig Venter Institute) for bioinformatics support.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Callister SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001542; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Iizuka T, 2003, INT J SYST EVOL MICR, V53, P189, DOI 10.1099/ijs.0.02418-0; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; King GM, 2007, FEMS MICROBIOL ECOL, V59, P2, DOI 10.1111/j.1574-6941.2006.00215.x; Kvist T, 2007, APPL MICROBIOL BIOT, V74, P926, DOI 10.1007/s00253-006-0725-7; Lasken R., 2005, WHOLE GENOME AMPLIFI, P119; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MITREVA M, 2008, BACTERIAL CORE GENE; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Ramirez-Flandes S, 2008, BIOINFORMATICS, V24, P2539, DOI 10.1093/bioinformatics/btn466; Rich VI, 2011, ENVIRON MICROBIOL, V13, P116, DOI 10.1111/j.1462-2920.2010.02314.x; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tanenbaum DM, 2010, STAND GENOMIC SCI, V2, P229, DOI 10.4056/sigs.651139; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; WILGENBUSCH JC, 2003, CURR PROT BIOINFORMA; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wright TD, 1997, APPL ENVIRON MICROB, V63, P1441, DOI 10.1128/AEM.63.4.1441-1448.1997; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	47	161	166	3	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					915	U214		10.1038/nbt.1966	http://dx.doi.org/10.1038/nbt.1966			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21926975	Green Accepted			2022-12-27	WOS:000296273000018
J	Li, YR; Zheng, HC; Luo, RB; Wu, HL; Zhu, HM; Li, RQ; Cao, HZ; Wu, BX; Huang, SJ; Shao, HJ; Ma, HZ; Zhang, F; Feng, SJ; Zhang, W; Du, HL; Tian, G; Li, JX; Zhang, XQ; Li, SG; Bolund, L; Kristiansen, K; De Smith, AJ; Blakemore, AIF; Coin, LJM; Yang, HM; Wang, J; Wang, J				Li, Yingrui; Zheng, Hancheng; Luo, Ruibang; Wu, Honglong; Zhu, Hongmei; Li, Ruiqiang; Cao, Hongzhi; Wu, Boxin; Huang, Shujia; Shao, Haojing; Ma, Hanzhou; Zhang, Fan; Feng, Shuijian; Zhang, Wei; Du, Hongli; Tian, Geng; Li, Jingxiang; Zhang, Xiuqing; Li, Songgang; Bolund, Lars; Kristiansen, Karsten; De Smith, Adam J.; Blakemore, Alexandra I. F.; Coin, Lachlan J. M.; Yang, Huanming; Wang, Jian; Wang, Jun			Structural variation in two human genomes mapped at single-nucleotide resolution by whole genome de novo assembly	NATURE BIOTECHNOLOGY			English	Article							SHORT READ ALIGNMENT; COMPLEX TRAITS; COPY-NUMBER; SEQUENCE; INSERTIONS; ALGORITHMS; DELETIONS; GENES; TOOL; DNA	Here we use whole-genome de novo assembly of second-generation sequencing reads to map structural variation (SV) in an Asian genome and an African genome. Our approach identifies small-and intermediate-size homozygous variants (1-50 kb) including insertions, deletions, inversions and their precise breakpoints, and in contrast to other methods, can resolve complex rearrangements. In total, we identified 277,243 SVs ranging in length from 1-23 kb. Validation using computational and experimental methods suggests that we achieve overall <6% false-positive rate and <10% false-negative rate in genomic regions that can be assembled, which outperforms other methods. Analysis of the SVs in the genomes of 106 individuals sequenced as part of the 1000 Genomes Project suggests that SVs account for a greater fraction of the diversity between individuals than do single-nucleotide polymorphisms (SNPs). These findings demonstrate that whole-genome de novo assembly is a feasible approach to deriving more comprehensive maps of genetic variation.	[Li, Yingrui; Zheng, Hancheng; Luo, Ruibang; Wu, Honglong; Zhu, Hongmei; Li, Ruiqiang; Cao, Hongzhi; Wu, Boxin; Huang, Shujia; Shao, Haojing; Ma, Hanzhou; Zhang, Fan; Feng, Shuijian; Zhang, Wei; Tian, Geng; Li, Jingxiang; Zhang, Xiuqing; Li, Songgang; Bolund, Lars; Kristiansen, Karsten; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Luo, Ruibang; Huang, Shujia; Shao, Haojing; Ma, Hanzhou; Zhang, Fan; Du, Hongli] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Peoples R China; [Luo, Ruibang] Univ Hong Kong, Dept Comp Sci, Hong Kong, Peoples R China; [Wu, Honglong; Cao, Hongzhi] Shenzhen Univ Med Sch, Genome Res Inst, Shenzhen, Peoples R China; [Bolund, Lars] Univ Aarhus, Inst Human Genet, Aarhus, Denmark; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [De Smith, Adam J.; Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, Sch Publ Hlth, London, England; [Coin, Lachlan J. M.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	Beijing Genomics Institute (BGI); South China University of Technology; University of Hong Kong; Shenzhen University; Aarhus University; University of Copenhagen; Imperial College London; Imperial College London; Novo Nordisk Foundation; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	wangj@genomics.org.cn	Wang, Jun/A-7261-2013; Shao, Haojing/C-5429-2017; Coin, Lachlan JM/A-9001-2014; Li, Yingrui/K-1064-2015; Huang, Shujia/GXG-8583-2022; Coin, Lachlan/O-4976-2019; Blakemore, Alexandra I F/D-2253-2009; Kristiansen, Karsten/J-5148-2014; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Shao, Haojing/0000-0002-8806-197X; Coin, Lachlan JM/0000-0002-4300-455X; Huang, Shujia/0000-0003-2100-2534; Coin, Lachlan/0000-0002-4300-455X; Blakemore, Alexandra I F/0000-0003-0661-564X; Kristiansen, Karsten/0000-0002-6024-0917; Zhang, Wei/0000-0002-6968-6974; de Smith, Adam/0000-0003-4880-7543; Luo, Ruibang/0000-0001-9711-6533; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	National Basic Research Program of China (973 program) [2011CB809200]; National Natural Science Foundation of China [30725008, 30890032, 30811130531, 30221004]; Chinese 863 program [2006AA02Z177, 2006AA02Z334, 2006AA02A302, 2009AA022707]; Shenzhen Municipal Government of China [JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, ZYC200903240 076A, ZYC200903240080A]; Danish Natural Science Research Council; Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; Diabetes UK; Wellcome Trust; Medical Research Council; Comprehensive Biomedical Research Centre, Imperial College Healthcare NHS Trust; National Basic Research Program of China (973 program) [2011CB809200]; National Natural Science Foundation of China [30725008, 30890032, 30811130531, 30221004]; Chinese 863 program [2006AA02Z177, 2006AA02Z334, 2006AA02A302, 2009AA022707]; Shenzhen Municipal Government of China [JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, ZYC200903240 076A, ZYC200903240080A]; Danish Natural Science Research Council; Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; Diabetes UK; Wellcome Trust; Medical Research Council; Comprehensive Biomedical Research Centre, Imperial College Healthcare NHS Trust; Diabetes UK [08/0003775] Funding Source: researchfish	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Danish Natural Science Research Council(Danish Natural Science Research Council); Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; Diabetes UK(Diabetes UK); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Comprehensive Biomedical Research Centre, Imperial College Healthcare NHS Trust; National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Danish Natural Science Research Council(Danish Natural Science Research Council); Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; Diabetes UK(Diabetes UK); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Comprehensive Biomedical Research Centre, Imperial College Healthcare NHS Trust; Diabetes UK(Diabetes UK)	This work was supported by a National Basic Research Program of China (973 program no. 2011CB809200), the National Natural Science Foundation of China (30725008; 30890032; 30811130531; 30221004), the Chinese 863 program (2006AA02Z177; 2006AA02Z334; 2006AA02A302; 2009AA022707), the Shenzhen Municipal Government of China (grants JC200903190767A; JC200903190772A; ZYC200903240076A; CXB200903110066A; ZYC200903240077A; ZYC200903240 076A and ZYC200903240080A) and the Ole Romer grant from the Danish Natural Science Research Council. This project is also funded by the Shenzhen Municipal Government and the Local Government of Yantian District of Shenzhen. The 1000 Genomes Project Consortium provided the data for population analysis. AIFB is supported by Diabetes UK, the Wellcome Trust, the Medical Research Council and the Comprehensive Biomedical Research Centre, Imperial College Healthcare NHS Trust. Thanks to X. Wang from School of Biosciences & Bioengineering, SCUT, for his excellent coordination. Thanks to J. El-Sayed Moustafa for her help analyzing the experimental validation data. L. Goodman, S. Edmunds and A. Basford edited the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ben-Shachar S, 2008, AM J HUM GENET, V82, P214, DOI 10.1016/j.ajhg.2007.09.014; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chanock S, 2009, NAT GENET, V41, P765, DOI 10.1038/ng0709-765; Chen FC, 2007, GENOME RES, V17, P16, DOI 10.1101/gr.5429606; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Harris R.S., 2007, THESIS PENN STATE U; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; TRAVERS AA, 1987, PHILOS T ROY SOC B, V317, P537, DOI 10.1098/rstb.1987.0080; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wong K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r128; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yi L., 2010, NAT GENET, V42, P969; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	48	95	96	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					723	+		10.1038/nbt.1904	http://dx.doi.org/10.1038/nbt.1904			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21785424	Bronze			2022-12-27	WOS:000293696500024
J	Elliott, TS; Townsley, FM; Bianco, A; Ernst, RJ; Sachdeva, A; Elsasser, SJ; Davis, L; Lang, K; Pisa, R; Greiss, S; Lilley, KS; Chin, JW				Elliott, Thomas S.; Townsley, Fiona M.; Bianco, Ambra; Ernst, Russell J.; Sachdeva, Amit; Elsaesser, Simon J.; Davis, Lloyd; Lang, Kathrin; Pisa, Rudolf; Greiss, Sebastian; Lilley, Kathryn S.; Chin, Jason W.			Proteome labeling and protein identification in specific tissues and at specific developmental stages in an animal	NATURE BIOTECHNOLOGY			English	Article							NONCANONICAL AMINO-ACIDS; TRANSFER-RNA SYNTHETASE; DIELS-ALDER REACTIONS; MAMMALIAN-CELLS; GENETIC-CODE; TETRAZINE CYCLOADDITIONS; DROSOPHILA-MELANOGASTER; RECOMBINANT PROTEINS; TRANS-CYCLOOCTENES; LIVING CELLS	Identifying the proteins synthesized at specific times in cells of interest in an animal will facilitate the study of cellular functions and dynamic processes. Here we introduce stochastic orthogonal recoding of translation with chemoselective modification (SORT-M) to address this challenge. SORT-M involves modifying cells to express an orthogonal aminoacyl-tRNA synthetase/tRNA pair to enable the incorporation of chemically modifiable analogs of amino acids at diverse sense codons in cells in rich media. We apply SORT-M to Drosophila melanogaster fed standard food to label and image proteins in specific tissues at precise developmental stages with diverse chemistries, including cyclopropene-tetrazine inverse electron demand Diels-Alder cycloaddition reactions. We also use SORT-M to identify proteins synthesized in germ cells of the fly ovary without dissection. SORT-M will facilitate the definition of proteins synthesized in specific sets of cells to study development, and learning and memory in flies, and may be extended to animals.	[Elliott, Thomas S.; Townsley, Fiona M.; Bianco, Ambra; Ernst, Russell J.; Sachdeva, Amit; Elsaesser, Simon J.; Davis, Lloyd; Lang, Kathrin; Pisa, Rudolf; Greiss, Sebastian; Chin, Jason W.] Med Res Council Lab Mol Biol, Cambridge, England; [Pisa, Rudolf; Chin, Jason W.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Lilley, Kathryn S.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge	Chin, JW (corresponding author), Med Res Council Lab Mol Biol, Cambridge, England.	chin@mrc-lmb.cam.ac.uk	Elsässer, Simon/AAM-3986-2020; Pisa, Rudolf/AAT-2951-2020; Lang, Kathrin/AAD-2559-2020; Lilley, Kathryn/ABF-5787-2020; Greiss, Sebastian/B-2395-2015; Singh, Pramod K./F-1379-2016; Lang, Kathrin/M-6472-2015	Elsässer, Simon/0000-0001-8724-4849; Pisa, Rudolf/0000-0001-7571-7135; Lilley, Kathryn/0000-0003-0594-6543; Singh, Pramod K./0000-0002-3155-6621; Greiss, Sebastian/0000-0001-9130-0831; Lang, Kathrin/0000-0002-1318-6567	Herchel Smith Fund; Cambridge University Department of Chemistry the Medical Research Council [U105181009, UD99999908]; European Research Council for funding; MRC [MC_UP_A024_1008, MC_U105181009] Funding Source: UKRI; Medical Research Council [MC_U105181009, MC_UP_A024_1008] Funding Source: researchfish	Herchel Smith Fund; Cambridge University Department of Chemistry the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council for funding; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are exceptionally grateful to M. Skehl and S. Maslen of the LMB Mass Spectrometry service for mass spectrometry, R. Feret of the Cambridge Centre for Proteomics for assistance with DIGE, and S. Bullock (LMB) for advice and comments. We are grateful to the Herchel Smith Fund (S.J.E., administered through Cambridge University Department of Chemistry) the Medical Research Council (U105181009, UD99999908) and the European Research Council for funding.	Ambrogelly A, 2007, P NATL ACAD SCI USA, V104, P3141, DOI 10.1073/pnas.0611634104; Bianco A, 2012, NAT CHEM BIOL, V8, P748, DOI [10.1038/nchembio.1043, 10.1038/NCHEMBIO.1043]; Blackman ML, 2008, J AM CHEM SOC, V130, P13518, DOI 10.1021/ja8053805; Borrmann A, 2012, CHEMBIOCHEM, V13, P2094, DOI 10.1002/cbic.201200407; BOWNES M, 1986, ANNU REV ENTOMOL, V31, P507, DOI 10.1146/annurev.en.31.010186.002451; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Chin JW, 2012, SCIENCE, V336, P428, DOI 10.1126/science.1221761; Cole CM, 2013, CHEMBIOCHEM, V14, P205, DOI 10.1002/cbic.201200719; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; Devaraj NK, 2011, ACCOUNTS CHEM RES, V44, P816, DOI 10.1021/ar200037t; Dubnau J, 2012, SCIENCE, V335, P664, DOI 10.1126/science.1218171; Feret R., 2014, CURR PROTOC PROTEIN, V75, P222; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; Hancock SM, 2010, J AM CHEM SOC, V132, P14819, DOI 10.1021/ja104609m; Harper S., 2001, CURR PROTOC PROTEIN, V11, P104, DOI DOI 10.4; Hinz FI, 2012, ACS CHEM NEUROSCI, V3, P40, DOI 10.1021/cn2000876; Howden AJM, 2013, NAT METHODS, V10, P343, DOI [10.1038/NMETH.2401, 10.1038/nmeth.2401]; Karp NA, 2004, PROTEOMICS, V4, P1421, DOI 10.1002/pmic.200300681; Keene AC, 2012, TRENDS NEUROSCI, V35, P104, DOI 10.1016/j.tins.2011.11.003; Lang K, 2012, J AM CHEM SOC, V134, P10317, DOI 10.1021/ja302832g; Lang K, 2012, NAT CHEM, V4, P298, DOI 10.1038/nchem.1250; Leon A, 1999, MOL BIOL CELL, V10, P3825, DOI 10.1091/mbc.10.11.3825; LIANG L, 1994, DEVELOPMENT, V120, P1201; Link AJ, 2006, P NATL ACAD SCI USA, V103, P10180, DOI 10.1073/pnas.0601167103; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Ngo JT, 2013, P NATL ACAD SCI USA, V110, P4992, DOI 10.1073/pnas.1216375110; Ngo JT, 2011, ACCOUNTS CHEM RES, V44, P677, DOI 10.1021/ar200144y; Ngo JT, 2009, NAT CHEM BIOL, V5, P715, DOI 10.1038/nchembio.200; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; Patterson DM, 2012, J AM CHEM SOC, V134, P18638, DOI 10.1021/ja3060436; Plass T, 2012, ANGEW CHEM INT EDIT, V51, P4166, DOI 10.1002/anie.201108231; Seitchik JL, 2012, J AM CHEM SOC, V134, P2898, DOI 10.1021/ja2109745; Sopko R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009050; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Truong F, 2012, J AM CHEM SOC, V134, P8551, DOI 10.1021/ja3004667; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/nchembio.426, 10.1038/NCHEMBIO.426]; Von Stetina JR, 2011, G3-GENES GENOM GENET, V1, P607, DOI 10.1534/g3.111.001438; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Wu JS, 2006, NAT PROTOC, V1, P2583, DOI 10.1038/nprot.2006.320; Yang J, 2012, ANGEW CHEM INT EDIT, V51, P7476, DOI 10.1002/anie.201202122; Yu ZP, 2012, ANGEW CHEM INT EDIT, V51, P10600, DOI 10.1002/anie.201205352	49	133	135	2	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					465	U186		10.1038/nbt.2860	http://dx.doi.org/10.1038/nbt.2860			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24727715	Green Accepted			2022-12-27	WOS:000336036100022
J	Koike-Yusa, H; Li, YL; Tan, EP; Velasco-Herrera, MD; Yusa, K				Koike-Yusa, Hiroko; Li, Yilong; Tan, E-Pien; Velasco-Herrera, Martin Del Castillo; Yusa, Kosuke			Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; CAS9; MOUSE; SPECIFICITY; GENERATION; NUCLEASES; DESIGN; MICE; ART; INTERFERENCE	Identification of genes influencing a phenotype of interest is frequently achieved through genetic screening by RNA interference (RNAi) or knockouts. However, RNAi may only achieve partial depletion of gene activity, and knockout-based screens are difficult in diploid mammalian cells. Here we took advantage of the efficiency and high throughput of genome editing based on type II, clustered, regularly interspaced, short palindromic repeats (CRISPR)-CRISPR-associated (Gas) systems to introduce genome-wide targeted mutations in mouse embryonic stem cells (ESCs). We designed 87,897 guide RNAs (gRNAs) targeting 19,150 mouse protein-coding genes and used a lentiviral vector to express these gRNAs in ESCs that constitutively express Cas9. Screening the resulting ESC mutant libraries for resistance to either Clostridium septicum alpha-toxin or 6-thioguanine identified 27 known and 4 previously unknown genes implicated in these phenotypes. Our results demonstrate the potential for efficient loss-of-function screening using the CRISPR-Cas9 system.	[Koike-Yusa, Hiroko; Li, Yilong; Tan, E-Pien; Velasco-Herrera, Martin Del Castillo; Yusa, Kosuke] Wellcome Trust Sanger Inst, Cambridge, England	Wellcome Trust Sanger Institute	Yusa, K (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	ky1@sanger.ac.uk		Del Castillo Velasco Herrera, Martin/0000-0001-5956-0211	Wellcome Trust PhD program; Cancer Research UK; Wellcome Trust [WT077187]; Cancer Research UK [14356] Funding Source: researchfish	Wellcome Trust PhD program(Wellcome Trust); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	We thank A. Bradley for comments on the manuscript, B. Ng and W Cheng for the flow cytometry analyses, and the Sanger Institute DNA pipeline for the sequence analyses. We also thank J. Takeda and T. Kinoshita for providing us alpha-toxin and the cDNA expression vectors, respectively. Y.L. is supported by the Wellcome Trust PhD program. M.D.C.V.-H. is supported by the Cancer Research UK and Wellcome Trust PhD program. This work was supported by Wellcome Trust (WT077187). The mouse CRISPR library is available through Addgene. The plasmid DNAs are available at the Wellcome Trust Sanger Institute Archives (http://www.sangetac.ulthechnology/clonerequests/).	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gordon VM, 1999, J BIOL CHEM, V274, P27274, DOI 10.1074/jbc.274.38.27274; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang H, 2013, CELL RES, V23, P1187, DOI 10.1038/cr.2013.93; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002	35	679	783	4	206	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					267	273		10.1038/nbt.2800	http://dx.doi.org/10.1038/nbt.2800			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24535568				2022-12-27	WOS:000332819800025
J	Aggarwal, SR				Aggarwal, Saurabh Rob			What's fueling the biotech engine-2012 to 2013	NATURE BIOTECHNOLOGY			English	Article							TRIAL; PRICE	Biologics sales grew at an incredible rate during the past 18 months, especially when compared with pharmaceuticals. But with pressure on pricing and biosimilars looming, how long will it be until biologics' last hurrah?	[Aggarwal, Saurabh Rob] Novel Hlth Strategies LLC, Bethesda, MD 20814 USA; [Aggarwal, Saurabh Rob] Inst Global Policy Res, Washington, DC USA		Aggarwal, SR (corresponding author), Novel Hlth Strategies LLC, Bethesda, MD 20814 USA.	sa2@novelhealthstrategies.com	Plakhotnik, Xenia/L-2185-2016		Novel Health Strategies; Institute for Global Policy Research; American Society of Clinical Oncology; American College of Rheumatology; American Association of Liver Diseases; American Heart Association; American Society of Hematology; Biotechnology Industry Association	Novel Health Strategies; Institute for Global Policy Research; American Society of Clinical Oncology; American College of Rheumatology(General Electric); American Association of Liver Diseases; American Heart Association(American Heart Association); American Society of Hematology; Biotechnology Industry Association	The author thanks Novel Health Strategies, the Institute for Global Policy Research, the American Society of Clinical Oncology, the American College of Rheumatology, the American Association of Liver Diseases, American Heart Association, the American Society of Hematology and the Biotechnology Industry Association for providing support for this article.	Abboud C, 2013, BLOOD, V121, P4439, DOI 10.1182/blood-2013-03-490003; Aggarwal S, 2008, NAT BIOTECHNOL, V26, P1227, DOI 10.1038/nbt1108-1227; Aggarwal S, 2007, NAT BIOTECHNOL, V25, P1097, DOI 10.1038/nbt1007-1097; Aggarwal S, 2011, NAT BIOTECHNOL, V29, P1083, DOI 10.1038/nbt.2060; Aggarwal S, 2010, NAT BIOTECHNOL, V28, P1165, DOI 10.1038/nbt1110-1165; Aggarwal S, 2009, NAT BIOTECHNOL, V27, P987, DOI 10.1038/nbt1109-987; Aggarwal S, 2012, NAT BIOTECHNOL, V30, P1191, DOI 10.1038/nbt.2437; [Anonymous], 2013, NAT BIOTECHNOL, V31, P264; [Anonymous], 2013, NAT BIOTECHNOL, V31, P947; [Anonymous], 2013, ASCO DAILY NEWS 0604; [Anonymous], 2013, NAT BIOTECHNOL, V31, P1; Bach P, 2012, NY TIMES; Fellner Chris, 2012, P T, V37, P503; Fox JL, 2013, NAT BIOTECHNOL, V31, P8, DOI 10.1038/nbt0113-8; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Powell JS, 2013, NEW ENGL J MED, V369, P2313, DOI 10.1056/NEJMoa1305074; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Volovat C., 2013, CLIN BREAST IN PRESS	19	205	216	2	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					32	39		10.1038/nbt.2794	http://dx.doi.org/10.1038/nbt.2794			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24406926				2022-12-27	WOS:000329513000012
J	Mascetti, VL; Pedersen, RA				Mascetti, Victoria L.; Pedersen, Roger A.			Naivete of the human pluripotent stem cell	NATURE BIOTECHNOLOGY			English	Editorial Material								Human pluripotent stem cells can be stabilized in a state resembling the inner cell mass of the blastocyst.	[Mascetti, Victoria L.; Pedersen, Roger A.] Wellcome Trust Med Res Council Cambridge Stem Cel, Anne McLaren Lab Regenerat Med, Cambridge, England; [Mascetti, Victoria L.; Pedersen, Roger A.] Univ Cambridge, Dept Surg, Cambridge, England	University of Cambridge; University of Cambridge	Mascetti, VL (corresponding author), Wellcome Trust Med Res Council Cambridge Stem Cel, Anne McLaren Lab Regenerat Med, Cambridge, England.	vlm37@cam.ac.uk; ralp2@cam.ac.uk			MRC [G0800784, G0600275, G1000847] Funding Source: UKRI; Medical Research Council [G0600275, G0800784, G1000847] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; De Los Angeles A, 2012, CURR OPIN GENET DEV, V22, P272, DOI 10.1016/j.gde.2012.03.001; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; Krtolica A, 2007, STEM CELLS, V25, P2215, DOI 10.1634/stemcells.2007-0230; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Nichols J, 2001, DEVELOPMENT, V128, P2333; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972	10	14	14	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					68	70		10.1038/nbt.2789	http://dx.doi.org/10.1038/nbt.2789			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24406934				2022-12-27	WOS:000329513000019
J	Stoevesandt, O; Taussig, MJ				Stoevesandt, Oda; Taussig, Michael J.			Phospho-specific antibodies by design	NATURE BIOTECHNOLOGY			English	Editorial Material							GENERATION	Antibodies specific to phosphorylated peptides are readily generated through structure-based engineering and in vitro selection.	[Stoevesandt, Oda; Taussig, Michael J.] Babraham Inst, Prot Technol Grp, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Stoevesandt, O (corresponding author), Babraham Inst, Prot Technol Grp, Cambridge, England.	oda.stoevesandt@babraham.ac.uk; mike.taussig@babraham.ac.uk						Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Brumbaugh K, 2011, METHODS MOL BIOL, V717, P3, DOI 10.1007/978-1-61779-024-9_1; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Koerber JT, 2013, NAT BIOTECHNOL, V31, P916, DOI 10.1038/nbt.2672; Marx V, 2013, NAT METHODS, V10, P829, DOI 10.1038/nmeth.2607; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Shih HH, 2012, J BIOL CHEM, V287, P44425, DOI 10.1074/jbc.M112.415935; Stoevesandt O, 2012, NEW BIOTECHNOL, V29, P511, DOI 10.1016/j.nbt.2012.05.003; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248	10	7	8	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2013	31	10					889	891		10.1038/nbt.2712	http://dx.doi.org/10.1038/nbt.2712			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233CA	24104753				2022-12-27	WOS:000325541300014
J	Gamm, DM; Wright, LS				Gamm, David M.; Wright, Lynda S.			From embryonic stem cells to mature photoreceptors	NATURE BIOTECHNOLOGY			English	Editorial Material							VESICLE-LIKE STRUCTURES; VISUAL FUNCTION; TRANSPLANTATION; PRECURSORS; RESTORATION; INTEGRATION; CAPACITY; RETINA		[Gamm, David M.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; [Gamm, David M.] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI USA; [Wright, Lynda S.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gamm, DM (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA.	dgamm@wisc.edu			NEI NIH HHS [R01 EY021218] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY021218] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Pearson RA, 2010, CELL TRANSPLANT, V19, P487, DOI 10.3727/096368909X486057; Phillips MJ, 2012, INVEST OPHTH VIS SCI, V53, P2007, DOI 10.1167/iovs.11-9313; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Singh MS, 2013, P NATL ACAD SCI USA, V110, P1101, DOI 10.1073/pnas.1119416110; West EL, 2012, STEM CELLS, V30, P1424, DOI 10.1002/stem.1123	12	8	8	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					712	713		10.1038/nbt.2648	http://dx.doi.org/10.1038/nbt.2648			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23929346				2022-12-27	WOS:000322911000017
J	Wills, QF; Livak, KJ; Tipping, AJ; Enver, T; Goldson, AJ; Sexton, DW; Holmes, C				Wills, Quin F.; Livak, Kenneth J.; Tipping, Alex J.; Enver, Tariq; Goldson, Andrew J.; Sexton, Darren W.; Holmes, Chris			Single-cell gene expression analysis reveals genetic associations masked in whole-tissue experiments	NATURE BIOTECHNOLOGY			English	Article							RNA	Gene expression in multiple individual cells from a tissue or culture sample varies according to cell-cycle, genetic, epigenetic and stochastic differences between the cells. However, single-cell differences have been largely neglected in the analysis of the functional consequences of genetic variation. Here we measure the expression of 92 genes affected by Wnt signaling in 1,440 single cells from 15 individuals to associate single-nucleotide polymorphisms (SNPs) with gene-expression phenotypes, while accounting for stochastic and cell-cycle differences between cells. We provide evidence that many heritable variations in gene function-such as burst size, burst frequency, cell cycle-specific expression and expression correlation/noise between cells-are masked when expression is averaged over many cells. Our results demonstrate how single-cell analyses provide insights into the mechanistic and network effects of genetic variability, with improved statistical power to model these effects on gene expression.	[Wills, Quin F.; Holmes, Chris] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Livak, Kenneth J.] Fluidigm Corp, San Francisco, CA USA; [Tipping, Alex J.; Enver, Tariq] UCL, UCL Canc Inst, Stem Cell Lab, London, England; [Goldson, Andrew J.] Univ E Anglia, Sch Biol Sci, UEA Flow Cytometry Serv, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England; [Sexton, Darren W.] Univ E Anglia, Norwich Med Sch, BioMed Res Ctr, Norwich NR4 7TJ, Norfolk, England; [Holmes, Chris] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Holmes, Chris] Univ Oxford, Nuffield Dept Med, Oxford, England; [Holmes, Chris] Med Res Council Harwell, Harwell, Berks, England	University of Oxford; University of London; University College London; University of East Anglia; University of East Anglia; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Wills, QF (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	wills@stats.ox.ac.uk	Sexton, Darren/AAF-3171-2020	Sexton, Darren/0000-0003-3344-3150	Medical Research Council of the UK; Leukaemia Lymphoma Research; EuroSyStem; Cancer Research UK [12796] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K014463/1] Funding Source: researchfish; Medical Research Council [MC_UP_A390_1107, MC_U137973817] Funding Source: researchfish; EPSRC [EP/K014463/1] Funding Source: UKRI; MRC [MC_U137973817, MC_UP_A390_1107] Funding Source: UKRI	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia Lymphoma Research; EuroSyStem(European Commission); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Many thanks to L. Toji at the Coriell Institute for her valuable input on the cell line growth and transformation characteristics. Also, thanks to the following people at Fluidigm: B. Jones for his overall support, G. Harris and D. Wang for their help with primer design, and the meticulous technical assistance of K. Datta and R. Mittal. C. H. and T. E. are funded by the Medical Research Council of the UK. T. E. is also funded by Leukaemia Lymphoma Research and EuroSyStem.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Bublik DR, 2010, J BIOL CHEM, V285, P5274, DOI 10.1074/jbc.M109.045948; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Im HK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002525; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; JOHNSTONE IM, 1985, J AM STAT ASSOC, V80, P1041; Li H, 2010, GENETICA, V138, P915, DOI 10.1007/s10709-010-9480-x; Livak KJ, 2013, METHODS, V59, P71, DOI 10.1016/j.ymeth.2012.10.004; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; SIEGEL AF, 1982, BIOMETRIKA, V69, P242, DOI 10.1093/biomet/69.1.242; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Wu B, 2011, CURR OPIN CELL BIOL, V23, P310, DOI 10.1016/j.ceb.2010.12.004	22	162	163	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					748	+		10.1038/nbt.2642	http://dx.doi.org/10.1038/nbt.2642			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23873083				2022-12-27	WOS:000322911000025
J	Kuo, AH; Clarke, MF				Kuo, Angera H.; Clarke, Michael F.			Identifying the metastatic seeds of breast cancer	NATURE BIOTECHNOLOGY			English	Editorial Material							STEM-CELLS; TUMOR-CELLS; IDENTIFICATION		[Kuo, Angera H.; Clarke, Michael F.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University	Kuo, AH (corresponding author), Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	mfclarke@stanford.edu						Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sleijfer S, 2007, EUR J CANCER, V43, P2645, DOI 10.1016/j.ejca.2007.09.016; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006376	12	7	7	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					504	505		10.1038/nbt.2599	http://dx.doi.org/10.1038/nbt.2599			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23752434				2022-12-27	WOS:000320113200019
J	Weirauch, MT; Cote, A; Norel, R; Annala, M; Zhao, Y; Riley, TR; Saez-Rodriguez, J; Cokelaer, T; Vedenko, A; Talukder, S; Bussemaker, HJ; Morris, QD; Bulyk, ML; Stolovitzky, G; Hughes, TR				Weirauch, Matthew T.; Cote, Atina; Norel, Raquel; Annala, Matti; Zhao, Yue; Riley, Todd R.; Saez-Rodriguez, Julio; Cokelaer, Thomas; Vedenko, Anastasia; Talukder, Shaheynoor; Bussemaker, Harmen J.; Morris, Quaid D.; Bulyk, Martha L.; Stolovitzky, Gustavo; Hughes, Timothy R.		DREAM5 Consortium	Evaluation of methods for modeling transcription factor sequence specificity	NATURE BIOTECHNOLOGY			English	Article							DNA-BINDING SPECIFICITY; REGULATORY SEQUENCE; SITES; GENOME; RESOLUTION; PROTEIN; IDENTIFICATION; RECOGNITION; LANDSCAPES; EXPRESSION	Genomic analyses often involve scanning for potential transcription factor (TF) binding sites using models of the sequence specificity of DNA binding proteins. Many approaches have been developed to model and learn a protein's DNA-binding specificity, but these methods have not been systematically compared. Here we applied 26 such approaches to in vitro protein binding microarray data for 66 mouse TFs belonging to various families. For nine TFs, we also scored the resulting motif models on in vivo data, and found that the best in vitro-derived motifs performed similarly to motifs derived from the in vivo data. Our results indicate that simple models based on mononucleotide position weight matrices trained by the best methods perform similarly to more complex models for most TFs examined, but fall short in specific cases (<10% of the TFs examined here). In addition, the best-performing motifs typically have relatively low information content, consistent with widespread degeneracy in eukaryotic TF sequence preferences.	[Weirauch, Matthew T.; Cote, Atina; Talukder, Shaheynoor; Morris, Quaid D.; Hughes, Timothy R.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Weirauch, Matthew T.; Cote, Atina; Talukder, Shaheynoor; Morris, Quaid D.; Hughes, Timothy R.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH USA; [Norel, Raquel; Stolovitzky, Gustavo] IBM Computat Biol Ctr, New York, NY USA; [Annala, Matti] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Zhao, Yue] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Riley, Todd R.; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Riley, Todd R.; Bussemaker, Harmen J.] Columbia Univ, Ctr Computat Biol & Bioinformat, Med Ctr, New York, NY 10027 USA; [Saez-Rodriguez, Julio; Cokelaer, Thomas] EMBL EBI European Bioinformat Inst, Cambridge, England; [Vedenko, Anastasia; Bulyk, Martha L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Vedenko, Anastasia; Bulyk, Martha L.] Harvard Univ, Sch Med, Boston, MA USA; [Morris, Quaid D.; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston, MA USA	University of Toronto; University of Toronto; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Tampere University; University of Pennsylvania; Columbia University; Columbia University; European Molecular Biology Laboratory (EMBL); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hughes, TR (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada.	t.hughes@utoronto.ca	Cokelaer, Thomas/AAN-8240-2020; Norel, Raquel/ABB-3422-2021; Shamir, Ron/E-6514-2011; Weirauch, Matthew/M-5459-2019; Kursa, Miron/B-4405-2013; Saez-Rodriguez, Julio/H-7114-2019; Kiełbasa, Szymon/G-1636-2018; Morris, Quaid/ABE-8343-2020; Rudnicki, Witold R/B-6670-2012; Grau, Jan/H-5465-2019	Cokelaer, Thomas/0000-0001-6286-1138; Norel, Raquel/0000-0001-7737-4172; Shamir, Ron/0000-0003-1889-9870; Kursa, Miron/0000-0001-7672-648X; Saez-Rodriguez, Julio/0000-0002-8552-8976; Kiełbasa, Szymon/0000-0003-2805-6535; Rudnicki, Witold R/0000-0002-7928-4944; Grau, Jan/0000-0003-2081-6405; Sung, Wing-Kin/0000-0001-7806-7086; van Bommel, Alena/0000-0002-8434-8586; Arvey, Aaron/0000-0002-8789-0290; CHEN, CHIEN-YU/0000-0002-6940-6389; Kinney, Justin/0000-0003-1897-3778; Nykter, Matti/0000-0001-6956-2843; Keilwagen, Jens/0000-0002-6792-7076; Morris, Quaid/0000-0002-2760-6999; Orenstein, Yaron/0000-0002-3583-3112; Klein, Holger/0000-0002-6904-2319; Ruan, Jianhua/0000-0002-5622-3137	Canadian Institutes of Health Research (CIHR); Canadian Institute for Advanced Research (CIFAR); Ontario Research Fund; Genome Canada through the Ontario Genomics Institute; March of Dimes; CIHR [MOP-77721]; US National Institutes of Health/National Human Genome Research Institute [R01 HG003985]; US National Institutes of Health [R01HG003008, U54CAl21852]; John Simon Guggenheim Foundation; Academy of Finland [260403]; EU ERASysBio ERA-NET; European Community [HEALTH-F4-2009-223575]; Israel Science Foundation [802/08]; Edmond J. Safra Bioinformatics Program at Tel Aviv University; Ministry of Culture of Saxony-Anhalt [XP3624HP/0606T]; US National Science Foundation (NSF) [PHY-1022140]; NSF [PHY-0957573]; Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory; Direct For Computer & Info Scie & Enginr [1218201] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008, R01HG003985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM086305] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Ontario Research Fund; Genome Canada through the Ontario Genomics Institute(Genome Canada); March of Dimes(March of Dimes); CIHR(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Simon Guggenheim Foundation; Academy of Finland(Academy of Finland); EU ERASysBio ERA-NET; European Community(European Commission); Israel Science Foundation(Israel Science Foundation); Edmond J. Safra Bioinformatics Program at Tel Aviv University; Ministry of Culture of Saxony-Anhalt; US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank H. van Balcel and M. Albu for database assistance, and members of the Hughes laboratory for helpful discussion. M.T.W. was supported by fellowships from the Canadian Institutes of Health Research (CIHR) and the Canadian Institute for Advanced Research (CIFAR) Junior Fellows Genetic Networks Program. This work was supported in part by the Ontario Research Fund and Genome Canada through the Ontario Genomics Institute, and the March of Dimes (T.R.H.). Funding was also provided by Operating Grant MOP-77721 from CIHR to T.R.H. and M.L.B., and grant no. R01 HG003985 from the US National Institutes of Health/National Human Genome Research Institute to M.L.B., as well as US National Institutes of Health grants R01HG003008 and U54CAl21852 and a John Simon Guggenheim Foundation Fellowship to H.J.B. M.A., K.L., H.L. and M.L. were supported by the Academy of Finland (project 260403) and EU ERASysBio ERA-NET. Y.O., C.L. and R.S. were funded by the European Community's Seventh Framework Programme under grant agreement no. HEALTH-F4-2009-223575 for the TRIREME project, and by the Israel Science Foundation (grant no. 802/08). Y.O. was supported in part by a fellowship from the Edmond J. Safra Bioinformatics Program at Tel Aviv University. J.G., I.G., S.P. and J.K. were supported by grant XP3624HP/0606T by the Ministry of Culture of Saxony-Anhalt. A.M. was supported by US National Science Foundation (NSF) grant PHY-1022140. C.C. was supported by NSF grant PHY-0957573. J.B.K. was supported by the Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory.	Agius P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000916; Annala M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020059; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Chen CY, 2008, P NATL ACAD SCI USA, V105, P2527, DOI 10.1073/pnas.0712188105; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Boer CG, 2012, NUCLEIC ACIDS RES, V40, pD169, DOI 10.1093/nar/gkr993; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; Jaeger SA, 2010, GENOMICS, V95, P185, DOI 10.1016/j.ygeno.2010.01.002; John S, 1996, J EXP MED, V183, P743, DOI 10.1084/jem.183.3.743; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Keilwagen J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001070; Kinney JB, 2007, P NATL ACAD SCI USA, V104, P501, DOI 10.1073/pnas.0609908104; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Kulakovskiy IV, 2010, BIOINFORMATICS, V26, P2622, DOI 10.1093/bioinformatics/btq488; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schutz F, 2008, BIOINFORMATICS, V24, P1399, DOI 10.1093/bioinformatics/btn201; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sharon E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000154; Siddharthan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009722; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Stormo G.D., 1990, METHODS ENZYMOL, V183, P211; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Zhao XY, 2005, J COMPUT BIOL, V12, P894, DOI 10.1089/cmb.2005.12.894; Zhao Y, 2012, GENETICS, V191, P781, DOI 10.1534/genetics.112.138685; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	48	237	238	0	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					126	134		10.1038/nbt.2486	http://dx.doi.org/10.1038/nbt.2486			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23354101	Green Submitted, Green Accepted, Bronze			2022-12-27	WOS:000315322100023
J	Francisco, M				Francisco, Michael			Rising compensation for biotech R&D officers	NATURE BIOTECHNOLOGY			English	Editorial Material																		[Anonymous], 2012, BIOWORLD EXECUTIVE C	1	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					82	82		10.1038/nbt.2474	http://dx.doi.org/10.1038/nbt.2474			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23302935	Bronze			2022-12-27	WOS:000313563600026
J	Wong, SS; Webby, RJ				Wong, Sook-San; Webby, Richard J.			An mRNA vaccine for influenza	NATURE BIOTECHNOLOGY			English	Editorial Material							ANTIBODIES		[Wong, Sook-San; Webby, Richard J.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Wong, SS (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, 332 N Lauderdale St, Memphis, TN 38105 USA.	sook-san.wong@stjude.org; richard.webby@stjude.org	Webby, Richard J/N-5657-2018	Wong, Sook-San/0000-0002-1290-191X				Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Hoerr I, 2000, EUR J IMMUNOL, V30, P1; Lothar S, 2012, NAT BIOTECHNOL, V30, P1210; Louz D, 2012, CRIT REV MICROBIOL; Pearce MB, 2011, VACCINE, V29, P2887, DOI 10.1016/j.vaccine.2011.02.014; Richardson JS, 2010, HUM VACCINES, V6, P439, DOI 10.4161/hv.6.6.11097; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Ulmer JB, 2012, VACCINE, V30, P4414, DOI 10.1016/j.vaccine.2012.04.060	11	17	36	5	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1202	1204		10.1038/nbt.2439	http://dx.doi.org/10.1038/nbt.2439			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222788				2022-12-27	WOS:000312092400020
J	Ward, LD; Kellis, M				Ward, Lucas D.; Kellis, Manolis			Interpreting noncoding genetic variation in complex traits and human disease	NATURE BIOTECHNOLOGY			English	Review							GENOME-WIDE ASSOCIATION; TRANSCRIPTION-FACTOR-BINDING; PROTEIN-DNA INTERACTIONS; MISSING HERITABILITY; STATISTICAL-ANALYSIS; FUNCTIONAL ELEMENTS; BIOLOGICAL PATHWAYS; ALLELIC EXPRESSION; REGULATORY NETWORK; SEQUENCE VARIANTS	Association studies provide genome-wide information about the genetic basis of complex disease, but medical research has focused primarily on protein-coding variants, owing to the difficulty of interpreting noncoding mutations. This picture has changed with advances in the systematic annotation of functional noncoding elements. Evolutionary conservation, functional genomics, chromatin state, sequence motifs and molecular quantitative trait loci all provide complementary information about the function of noncoding sequences. These functional maps can help with prioritizing variants on risk haplotypes, filtering mutations encountered in the clinic and performing systems-level analyses to reveal processes underlying disease associations. Advances in predictive modeling can enable data-set integration to reveal pathways shared across loci and alleles, and richer regulatory models can guide the search for epistatic interactions. Lastly, new massively parallel reporter experiments can systematically validate regulatory predictions. Ultimately, advances in regulatory and systems genomics can help unleash the value of whole-genome sequencing for personalized genomic risk assessment, diagnosis and treatment.	[Ward, Lucas D.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ward, Lucas D.; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ward, LD (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lukeward@mit.edu; manoli@mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630; Ward, Lucas/0000-0002-8017-809X	NIH [R01HG004037, RC1HG005334]; US National Science Foundation [0644282]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005334, R01HG004037] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	L.D.W. and M.K. were funded by NIH grants R01HG004037 and RC1HG005334 and US National Science Foundation CAREER grant 0644282.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; [Anonymous], 2012, NAT GENET, V44, P733, DOI 10.1038/ng.2345; Asthana S, 2007, P NATL ACAD SCI USA, V104, P12410, DOI 10.1073/pnas.0705140104; Audrezet M, 2004, HUM MUTAT, V23, P343, DOI 10.1002/humu.20009; Baker M, 2012, NATURE, V482, P257, DOI 10.1038/482257a; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bisio A, 2010, HUM MOL GENET, V19, P1479, DOI 10.1093/hmg/ddq022; Bonafe L, 2005, PLOS GENET, V1, P444, DOI 10.1371/journal.pgen.0010047; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Bray NJ, 2004, HUM MOL GENET, V13, P2885, DOI 10.1093/hmg/ddh299; Bream J H, 1999, Science, V284, P223; Brownstein JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000840; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burke MK, 2010, NATURE, V467, P587, DOI 10.1038/nature09352; Bussemaker HJ, 2007, ANNU REV BIOPH BIOM, V36, P329, DOI 10.1146/annurev.biophys.36.040306.132725; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Chen LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r219; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Cheng C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002190; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dering C, 2011, GENET EPIDEMIOL, V35, pS12, DOI 10.1002/gepi.20643; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Garrod A.E., 1909, INBORN ERRORS METABO; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Goldstein DB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001008; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Henikoff JG, 2011, P NATL ACAD SCI USA, V108, P18318, DOI 10.1073/pnas.1110731108; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Knight J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014808; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; LANDER ES, 1989, GENETICS, V121, P185; Lappalainen T, 2011, AM J HUM GENET, V89, P459, DOI 10.1016/j.ajhg.2011.08.004; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lewinger JP, 2007, GENET EPIDEMIOL, V31, P871, DOI 10.1002/gepi.20248; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lou XY, 2008, AM J HUM GENET, V83, P457, DOI 10.1016/j.ajhg.2008.09.001; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Maynard ND, 2008, NAT METHODS, V5, P307, DOI [10.1038/NMETH.1194, 10.1038/nmeth.1194]; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKinney B. A., 2012, Frontiers in Genetics, V2, P109, DOI 10.3389/fgene.2011.00109; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Mechanic LE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-146; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Musani SK, 2007, HUM HERED, V63, P67, DOI 10.1159/000099179; Nebert DW, 2008, DRUG METAB REV, V40, P187, DOI [10.1080/03602530801952864, 10.1080/03602530801952864 ]; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Ng PC, 2009, NATURE, V461, P724, DOI 10.1038/461724a; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Papatsenko D, 2006, GENOMICS, V88, P431, DOI 10.1016/j.ygeno.2006.03.012; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prendergast JGD, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-6; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roberts NJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003380; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roque FS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002141; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sakabe NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-238; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visscher PM, 2010, GENET RES, V92, P371, DOI 10.1017/S0016672310000571; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; WATSON JD, 1990, SCIENCE, V248, P44, DOI 10.1126/science.2181665; Wilke RA, 2011, CLIN PHARMACOL THER, V89, P379, DOI 10.1038/clpt.2010.260; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0; Wu YF, 2008, J COMPUT BIOL, V15, P667, DOI 10.1089/cmb.2007.0116; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yngvadottir B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-237; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zschocke J, 2003, HUM MUTAT, V21, P345, DOI 10.1002/humu.10192; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	199	307	311	1	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1095	1106		10.1038/nbt.2422	http://dx.doi.org/10.1038/nbt.2422			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138309	Green Accepted, Green Submitted			2022-12-27	WOS:000311087500029
J	Christini, A				Christini, Amanda			Why universities should step up in venture investing	NATURE BIOTECHNOLOGY			English	Letter									Hosp Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Christini, A (corresponding author), Hosp Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	amanda.christini@uphs.upenn.edu						Booth BL, 2011, NAT BIOTECHNOL, V29, P579, DOI 10.1038/nbt.1908; Booth BL, 2009, NAT BIOTECHNOL, V27, P705, DOI 10.1038/nbt0809-705; Kneller R, 2010, NAT REV DRUG DISCOV, V9, P867, DOI 10.1038/nrd3251	3	7	7	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					933	936		10.1038/nbt.2390	http://dx.doi.org/10.1038/nbt.2390			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	23051808				2022-12-27	WOS:000309965500015
J	Cunningham, JJ; Ulbright, TM; Pera, MF; Looijenga, LHJ				Cunningham, Justine J.; Ulbright, Thomas M.; Pera, Martin F.; Looijenga, Leendert H. J.			Lessons from human teratomas to guide development of safe stem cell therapies	NATURE BIOTECHNOLOGY			English	Article							GERM-CELLS; GENETIC-ANALYSIS; SACROCOCCYGEAL TERATOMA; EMBRYONAL CARCINOMA; IMMATURE TERATOMAS; TUMORS; DIFFERENTIATION; EXPRESSION; CHILDREN; LINES	The potential for the formation of teratomas or other neoplasms is a major safety roadblock to clinical application of pluripotent stem cell therapies. Preclinical assessment of the risk of tumor formation in this context poses considerable scientific and regulatory challenges, especially because animal xenograft models may not properly reflect the long-term tumorigenic potential of human cells. A better understanding of the biology of spontaneously occurring teratomas and related tumors in humans can help to guide efforts to assess and minimize the potential hazards of embryonic stem cell or induced pluripotent stem cell therapeutics. Here we review the features of teratomas derived experimentally from human pluripotent stem cells and argue that they most closely resemble spontaneous benign teratomas that occur early in both mouse and human life. The natural history and pathology of these spontaneously occurring teratomas provide important clues for preclinical safety assessment and patient monitoring in trials of stem cell therapies.	[Cunningham, Justine J.] Allergan Pharmaceut Inc, Dept Drug Safety Evaluat, Irvine, CA USA; [Ulbright, Thomas M.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; [Ulbright, Thomas M.] Indiana Univ Hlth Partners, Indianapolis, IN USA; [Pera, Martin F.] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Florey Neurosci Inst, Melbourne, Vic, Australia; [Looijenga, Leendert H. J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Pathol, Dr Daniel Den Hoed Canc Ctr, Josephine Nefkens Inst, Rotterdam, Netherlands	AbbVie; Allergan; Indiana University System; Indiana University Bloomington; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Cunningham, JJ (corresponding author), Allergan Pharmaceut Inc, Dept Drug Safety Evaluat, Irvine, CA USA.	cunningham_justine@allergan.com	PERA, MARTIN/A-9812-2012; Looijenga, Leendert/B-8145-2019	PERA, MARTIN/0000-0001-6239-0428; Looijenga, Leendert/0000-0002-8146-1911				Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Akst J, 2009, SCIENTIST, P27; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; [Anonymous], 2021, CANC INCIDENCE 5 CON; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Baker BA, 1998, GYNECOL ONCOL, V71, P14, DOI 10.1006/gyno.1998.5102; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Blum B, 2007, STEM CELLS, V25, P1924, DOI 10.1634/stemcells.2007-0073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Busch C, 2008, HISTOPATHOLOGY, V52, P717, DOI 10.1111/j.1365-2559.2008.03017.x; Busch C, 2009, J PATHOL, V217, P589, DOI 10.1002/path.2486; Cao F, 2009, CANCER RES, V69, P2709, DOI 10.1158/0008-5472.CAN-08-4122; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chu LF, 2011, CURR BIOL, V21, P1759, DOI 10.1016/j.cub.2011.09.010; Cooke MJ, 2006, STEM CELLS DEV, V15, P254, DOI 10.1089/scd.2006.15.254; Crabbe A, 2010, CELL TRANSPLANT, V19, P919, DOI 10.3727/096368910X494623; De Backer A, 2006, J PEDIATR SURG, V41, P173, DOI 10.1016/j.jpedsurg.2005.10.022; De Backer A, 2004, J PERINAT MED, V32, P500, DOI 10.1515/JPM.2004.122; DEGRAAFF WE, 1992, LAB INVEST, V66, P166; Eriksson L, 2007, NUCL INSTRUM METH A, V580, P836, DOI 10.1016/j.nima.2007.06.112; Sarasquete ME, 2005, HAEMATOLOGICA, V90, P1365; Fazeli A, 2011, INT J DEV BIOL, V55, P175, DOI 10.1387/ijdb.103177af; Fu W, 2012, STEM CELLS DEV, V21, P521, DOI 10.1089/scd.2011.0131; Furukawa S, 2009, CANCER SCI, V100, P698, DOI 10.1111/j.1349-7006.2009.01102.x; Gertow K, 2004, STEM CELLS DEV, V13, P421, DOI 10.1089/scd.2004.13.421; Gertow K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027741; Gillis AJM, 2011, INT J ANDROL, V34, pE160, DOI 10.1111/j.1365-2605.2011.01148.x; Gobel U, 2000, ANN ONCOL, V11, P263, DOI 10.1023/A:1008360523160; Golas MM, 2010, CANCER GENET CYTOGEN, V197, P95, DOI 10.1016/j.cancergencyto.2009.10.013; GONZALEZCRUSSI F, 1978, ARCH PATHOL LAB MED, V102, P420; Gopalakrishna-Pillai S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-12; Griscelli F, 2012, AM J PATHOL, V180, P2084, DOI 10.1016/j.ajpath.2012.01.011; Harrison NJ, 2007, INT J ANDROL, V30, P275, DOI 10.1111/j.1365-2605.2007.00762.x; HAVRANEK P, 1992, J PEDIATR SURG, V27, P1447, DOI 10.1016/0022-3468(92)90197-F; Heifetz SA, 1998, AM J SURG PATHOL, V22, P1115, DOI 10.1097/00000478-199809000-00011; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Herszfeld D, 2006, NAT BIOTECHNOL, V24, P351, DOI 10.1038/nbt1197; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lawrenz B, 2004, CYTOTHERAPY, V6, P212, DOI 10.1080/14653240410006031; Lebkowski JS, 2001, CANCER J, V7, pS83; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Li JS, 2009, ANAL CHEM, V81, P9723, DOI 10.1021/ac901983s; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Mason KD, 2008, LEUKEMIA LYMPHOMA, V49, P177, DOI 10.1080/10428190701824601; Minami K, 2010, CLIN CANCER RES, V16, P2751, DOI 10.1158/1078-0432.CCR-09-3338; Moon SH, 2011, STEM CELL RES, V6, P50, DOI 10.1016/j.scr.2010.08.006; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mostert M, 2000, LAB INVEST, V80, P1055, DOI 10.1038/labinvest.3780110; Netto GJ, 2008, MODERN PATHOL, V21, P1337, DOI 10.1038/modpathol.2008.127; NORRIS HJ, 1976, CANCER, V37, P2359, DOI 10.1002/1097-0142(197605)37:5<2359::AID-CNCR2820370528>3.0.CO;2-Q; OCONNOR DM, 1994, INT J GYNECOL PATHOL, V13, P283, DOI 10.1097/00004347-199410000-00001; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Oosterhuis JW, 2007, INT J ANDROL, V30, P256, DOI 10.1111/j.1365-2605.2007.00793.x; Oosterhuis JW, 1997, CANCER GENET CYTOGEN, V95, P96, DOI 10.1016/S0165-4608(96)00275-0; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; ORAHILLY R, 1994, CIBA F SYMP, V181, P70; Prokhorova TA, 2009, STEM CELLS DEV, V18, P47, DOI 10.1089/scd.2007.0266; Przyborski SA, 2005, STEM CELLS, V23, P1242, DOI 10.1634/stemcells.2005-0014; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rijlaarsdam MA, 2011, BRIT J CANCER, V105, P854, DOI 10.1038/bjc.2011.270; Roche S, 2013, INT J PHARMACEUT, V440, P72, DOI 10.1016/j.ijpharm.2011.12.041; ROSSANT J, 1984, CELL DIFFER DEV, V15, P155, DOI 10.1016/0045-6039(84)90068-X; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Runyan C, 2008, INT J DEV BIOL, V52, P333, DOI 10.1387/ijdb.072486cr; Sano K, 1999, J NEUROSURG, V90, P258, DOI 10.3171/jns.1999.90.2.0258; Sauvageau M, 2008, PLOS BIOL, V6, P678, DOI 10.1371/journal.pbio.0060113; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Schneider DT, 2006, MODERN PATHOL, V19, P864, DOI 10.1038/modpathol.3800607; Schneider DT, 2002, GENE CHROMOSOME CANC, V34, P115, DOI 10.1002/gcc.10053; Schneider DT, 2001, KLIN PADIATR, V213, P204, DOI 10.1055/s-2001-16852; Shih CC, 2007, STEM CELLS DEV, V16, P893, DOI 10.1089/scd.2007.0070; Simmonds PD, 1996, J UROLOGY, V155, P939, DOI 10.1016/S0022-5347(01)66352-3; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; St Ledger K, 2009, J IMMUNOL METHODS, V350, P161, DOI 10.1016/j.jim.2009.08.012; Su WJ, 2011, J CELL BIOCHEM, V112, P840, DOI 10.1002/jcb.22982; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; SURTI U, 1990, AM J HUM GENET, V47, P635; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Tavakoli T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-44; Veltman IM, 2003, APMIS, V111, P152, DOI 10.1034/j.1600-0463.2003.1110119_1.x; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Vortmeyer AO, 1999, AM J PATHOL, V154, P987, DOI 10.1016/S0002-9440(10)65350-3; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; West JA, 2006, NAT PROTOC, V1, P2026, DOI 10.1038/nprot.2006.303; Zhou WJ, 2011, ANAL CHEM, V83, P3897, DOI 10.1021/ac200422u; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	92	128	130	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					849	857		10.1038/nbt.2329	http://dx.doi.org/10.1038/nbt.2329			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22965062				2022-12-27	WOS:000308705700019
J	Chambers, SM; Qi, YC; Mica, Y; Lee, G; Zhang, XJ; Niu, L; Bilsland, J; Cao, LS; Stevens, E; Whiting, P; Shi, SH; Studer, L				Chambers, Stuart M.; Qi, Yuchen; Mica, Yvonne; Lee, Gabsang; Zhang, Xin-Jun; Niu, Lei; Bilsland, James; Cao, Lishuang; Stevens, Edward; Whiting, Paul; Shi, Song-Hai; Studer, Lorenz			Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors	NATURE BIOTECHNOLOGY			English	Article							SENSORY NEURON DEVELOPMENT; FATE SPECIFICATION; SODIUM-CHANNELS; HUMAN ES; CREST; DIFFERENTIATION; RECEPTOR; DISTINCT; NEUROGENESIS; DERIVATION	Considerable progress has been made in identifying signaling pathways that direct the differentiation of human pluripotent stem cells (hPSCs) into specialized cell types, including neurons. However, differentiation of hPSCs with extrinsic factors is a slow, step-wise process, mimicking the protracted timing of human development. Using a small-molecule screen, we identified a combination of five small-molecule pathway inhibitors that yield hPSC-derived neurons at >75% efficiency within 10 d of differentiation. The resulting neurons express canonical markers and functional properties of human nociceptors, including tetrodotoxin (TTX)-resistant, SCN10A-dependent sodium currents and response to nociceptive stimuli such as ATP and capsaicin. Neuronal fate acquisition occurs about threefold faster than during in vivo development(1), suggesting that use of small-molecule pathway inhibitors could become a general strategy for accelerating developmental timing in vitro. The quick and high-efficiency derivation of nociceptors offers unprecedented access to this medically relevant cell type for studies of human pain.	[Chambers, Stuart M.; Qi, Yuchen; Mica, Yvonne; Lee, Gabsang; Studer, Lorenz] Sloan Kettering Inst, Ctr Stem Cell Biol, New York, NY USA; [Chambers, Stuart M.; Qi, Yuchen; Mica, Yvonne; Lee, Gabsang; Zhang, Xin-Jun; Niu, Lei; Shi, Song-Hai; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Qi, Yuchen] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA; [Mica, Yvonne] Gerstner Sloan Kettering Grad Sch Biomed Sci, Sloan Kettering Inst, New York, NY USA; [Bilsland, James; Cao, Lishuang; Stevens, Edward; Whiting, Paul] Pfizer Global Res & Dev, Neusentis, Cambridge, England; [Studer, Lorenz] Sloan Kettering Inst, Dept Neurosurg, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Pfizer; Memorial Sloan Kettering Cancer Center	Studer, L (corresponding author), Sloan Kettering Inst, Ctr Stem Cell Biol, New York, NY USA.	chambers@mskcc.org; studerl@mskcc.org	Niu, Lei/G-5066-2012; Studer, Lorenz/ABH-1491-2021; Zhang, Xin-Jun/O-2994-2013	Studer, Lorenz/0000-0003-0741-7987; Whiting, Paul/0000-0002-4121-1379; Qi, Yuchen/0000-0003-2036-9852; Zhang, Xin-Jun/0000-0002-0846-0584	National Institute of Neurological Disorders and Stroke/US National Institutes of Health (NIH) [NS066390]; New York State Stem Cell Science (NYSTEM) [C026447]; National Institute on Drug Abuse/NIH [R01DA024681]; National Institute of Mental Health/NIH [PO1NS048120]; NYSTEM [C026399]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066390, P01NS048120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke/US National Institutes of Health (NIH); New York State Stem Cell Science (NYSTEM); National Institute on Drug Abuse/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NYSTEM; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Hendrikx (SKI Flow Cytometry Core lab), A. Viale (SKI Genomics Core lab), E. Tu (SKI stem cell facility), and M. Tomishima (SKI stem cell facility) for excellent technical support. We also thank R. McKernan for support of functional analysis, M. Postlethwaite for assistance with electrophysiology, C. Benn for help in gene expression analysis and S. Kriks for assistance with hPSC culturing. The work was supported in part through grants NS066390 from National Institute of Neurological Disorders and Stroke/US National Institutes of Health (NIH) and C026447 from New York State Stem Cell Science (NYSTEM) to L.S., R01DA024681 from the National Institute on Drug Abuse/NIH to S.-H.S., PO1NS048120 from the National Institute of Mental Health/NIH to S.-H.S., and C026399 from NYSTEM to S.M.C.	Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bystron I, 2006, NAT NEUROSCI, V9, P880, DOI 10.1038/nn1726; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Cornell RA, 2002, DEVELOPMENT, V129, P2639; Dib-Hajj SD, 1999, FEBS LETT, V462, P117, DOI 10.1016/S0014-5793(99)01519-7; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Gascon E, 2010, J NEUROSCI, V30, P12414, DOI 10.1523/JNEUROSCI.3135-10.2010; George L, 2007, NAT NEUROSCI, V10, P1287, DOI 10.1038/nn1962; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; GERRERO MR, 1993, P NATL ACAD SCI USA, V90, P10841, DOI 10.1073/pnas.90.22.10841; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Ibanez CF, 2007, NEURON, V54, P673, DOI 10.1016/j.neuron.2007.05.023; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kitao Y, 1996, J COMP NEUROL, V371, P249, DOI 10.1002/(SICI)1096-9861(19960722)371:2<249::AID-CNE5>3.0.CO;2-2; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; North R Alan, 2003, Curr Opin Investig Drugs, V4, P833; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Schlosser G, 2000, J COMP NEUROL, V418, P121; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Sun L, 1999, J MED CHEM, V42, P5120, DOI 10.1021/jm9904295; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Yoshikawa M, 2007, DEV BIOL, V303, P663, DOI 10.1016/j.ydbio.2006.12.007; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zhang XQ, 2010, METHODS MOL BIOL, V584, P355, DOI 10.1007/978-1-60761-369-5_19; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	45	359	376	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					715	+		10.1038/nbt.2249	http://dx.doi.org/10.1038/nbt.2249			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22750882	Green Accepted			2022-12-27	WOS:000306293400031
J	June, C; Rosenberg, SA; Sadelain, M; Weber, JS				June, Carl; Rosenberg, Steven A.; Sadelain, Michel; Weber, Jeffrey S.			T-cell therapy at the threshold	NATURE BIOTECHNOLOGY			English	Article								Despite impressive clinical activity in B-cell lymphoma and melanoma, questions remain about the immunobiology of adoptive T-cell therapies.	[June, Carl] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA; [Weber, Jeffrey S.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Donald A Adam Comprehens Melanoma Res Ctr, Tampa, FL 33612 USA	University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	June, C (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	cjune@exchange.upenn.edu; sar@nih.gov; m-sadelain@ski.mskcc.org; jeffrey.weber@moffitt.org			Intramural NIH HHS [Z01 BC010984-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010984, ZIABC010985] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		2010, BLOOD, V116, P4099; 2011, J CLIN ONCOLOGY, V29, P917	2	45	47	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					611	614		10.1038/nbt.2305	http://dx.doi.org/10.1038/nbt.2305			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781680	Green Accepted			2022-12-27	WOS:000306293400016
J	[Anonymous]				[Anonymous]			Recasting cancer trials Wanted: faster, more effective ways of testing experimental cancer drugs for both single-agent and combination treatments.	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					567	567		10.1038/nbt.2315	http://dx.doi.org/10.1038/nbt.2315			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781659	Bronze			2022-12-27	WOS:000306293400001
J	Drukker, M; Tang, C; Ardehali, R; Rinkevich, Y; Seita, J; Lee, AS; Mosley, AR; Weissman, IL; Soen, Y				Drukker, Micha; Tang, Chad; Ardehali, Reza; Rinkevich, Yuval; Seita, Jun; Lee, Andrew S.; Mosley, Adriane R.; Weissman, Irving L.; Soen, Yoav			Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							BONE MORPHOGENETIC PROTEIN-4; TRANSCRIPTION FACTOR; HUMAN PLACENTA; MOUSE; EXPRESSION; DIFFERENTIATION; RECEPTOR; GENE; IDENTIFICATION; LOCALIZATION	To identify early populations of committed progenitors derived from human embryonic stem cells (hESCs), we screened self-renewing, BMP4-treated and retinoic acid-treated cultures with >400 antibodies recognizing cell-surface antigens. Sorting of >30 subpopulations followed by transcriptional analysis of developmental genes identified four distinct candidate progenitor groups. Subsets detected in self-renewing cultures, including CXCR4(+) cells, expressed primitive endoderm genes. Expression of Cxcr4 in primitive endoderm was confirmed in visceral endoderm of mouse embryos. BMP4-induced progenitors exhibited gene signatures of mesoderm, trophoblast and vascular endothelium, suggesting correspondence to gastrulation-stage primitive streak, chorion and allantois precursors, respectively. Functional studies in vitro and in vivo confirmed that ROR2(+) cells produce mesoderm progeny, APA(+) cells generate syncytiotrophoblasts and CD87(+) cells give rise to vasculature. The same progenitor classes emerged during the differentiation of human induced pluripotent stem cells (hiPSCs). These markers and progenitors provide tools for purifying human tissue-regenerating progenitors and for studying the commitment of pluripotent stem cells to lineage progenitors.	[Drukker, Micha; Tang, Chad; Ardehali, Reza; Rinkevich, Yuval; Seita, Jun; Mosley, Adriane R.; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Lee, Andrew S.] Stanford Univ, Sch Med, Dept Radiol, Div Cardiol, Stanford, CA 94305 USA; [Lee, Andrew S.] Stanford Univ, Dept Med, Sch Med, Div Cardiol, Stanford, CA 94305 USA; [Soen, Yoav] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Stanford University; Stanford University; Stanford University; Weizmann Institute of Science	Drukker, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Stem Cell Res, Neuherberg, Germany.	dmicha@stanford.edu; irv@stanford.edu; yoavs@weizmann.ac.il	Rinkevich, Yuval/B-7854-2018; Seita, Jun/AAM-1478-2020; Lee, Andrew/GVU-2817-2022; Rinkevich, Yuval/B-7647-2018; Palmer, Theo/GSI-6635-2022	Rinkevich, Yuval/0000-0001-6290-7271; Seita, Jun/0000-0002-3008-3615; Rinkevich, Yuval/0000-0002-9022-7668; Drukker, Micha/0000-0002-4279-1125	California Institute of Regenerative Medicine (CIRM) [RC1-00354-1, RT2-02060]; Human Frontier Science Organization (HFSPO) [CDA0063/2007-C]; Stanford Medical Scholars Program; Human Frontier Science Program (HFSP) Long Term Fellowship; NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099995, U01HL099999] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Human Frontier Science Organization (HFSPO); Stanford Medical Scholars Program; Human Frontier Science Program (HFSP) Long Term Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funds provided by the California Institute of Regenerative Medicine (CIRM) (Comprehensive grants RC1-00354-1, RT2-02060). Y.S. was supported by a CDA award from the Human Frontier Science Organization (HFSPO, CDA0063/2007-C). C. T. and A. S. L. are supported by the Howard Hughes Medical Institute Medical Fellows and the Stanford Medical Scholars Program. Y.R. is supported by a Human Frontier Science Program (HFSP) Long Term Fellowship. M. D., C. T. and R. A. are supported by CIRM (Comprehensive grants RC1-00354-1, RT2-02060). We would like to thank C. Chan for pentachrome stainings.	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akeson AL, 2001, MICROVASC RES, V61, P75, DOI 10.1006/mvre.2000.2257; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Aydin S, 2008, AM J PHYSIOL-CELL PH, V294, pC543, DOI 10.1152/ajpcell.00307.2007; Baldwin HS, 1996, CARDIOVASC RES, V31, pE34; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chen CP, 2008, PLACENTA, V29, P309, DOI 10.1016/j.placenta.2008.01.002; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Fujiwara T, 2001, P NATL ACAD SCI USA, V98, P13739, DOI 10.1073/pnas.241508898; GARVEY W, 1986, STAIN TECHNOL, V61, P60, DOI 10.3109/10520298609110708; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Inman KE, 2007, GENESIS, V45, P237, DOI 10.1002/dvg.20281; Inman KE, 2006, GENE EXPR PATTERNS, V6, P783, DOI 10.1016/j.modgep.2006.01.010; Ito N, 2003, EARLY HUM DEV, V71, P29, DOI 10.1016/S0378-3782(02)00112-3; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kukk E, 1996, DEVELOPMENT, V122, P3829; Leksa V, 2005, J CELL SCI, V118, P4577, DOI 10.1242/jcs.02587; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Mao QC, 2008, PHARM RES-DORDR, V25, P1244, DOI 10.1007/s11095-008-9537-z; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Mitsui T, 2003, MOL MED, V9, P57, DOI 10.1007/BF03402108; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Peng LH, 2004, MOL ENDOCRINOL, V18, P2049, DOI 10.1210/me.2004-0028; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Pierleoni C, 2003, PLACENTA, V24, P677, DOI 10.1016/S0143-4004(03)00082-1; Rivera-Perez JA, 2003, DEV BIOL, V261, P470, DOI 10.1016/S0012-1606(03)00302-6; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; ROSSANT J, 1979, DEV BIOL, V70, P255, DOI 10.1016/0012-1606(79)90022-8; SALIDO EC, 1990, J CLIN ENDOCR METAB, V70, P1564, DOI 10.1210/jcem-70-6-1564; Schwabe GC, 2004, DEV DYNAM, V229, P400, DOI 10.1002/dvdy.10466; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Solberg H, 2003, DEVELOPMENT, V130, P4439, DOI 10.1242/dev.00642; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wang P, 2011, CELL STEM CELL, V8, P335, DOI 10.1016/j.stem.2011.01.017; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; WILSON V, 1993, DEVELOPMENT, V117, P1321; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yamada K, 1999, J BIOL CHEM, V274, P32279, DOI 10.1074/jbc.274.45.32279; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yusuf F, 2005, ANAT EMBRYOL, V210, P35, DOI 10.1007/s00429-005-0013-9; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	70	78	84	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					531	+		10.1038/nbt.2239	http://dx.doi.org/10.1038/nbt.2239			14	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22634564	Green Accepted			2022-12-27	WOS:000305158600023
J	Xu, X; Liu, X; Ge, S; Jensen, JD; Hu, FY; Li, X; Dong, Y; Gutenkunst, RN; Fang, L; Huang, L; Li, JX; He, WM; Zhang, GJ; Zheng, XM; Zhang, FM; Li, YR; Yu, C; Kristiansen, K; Zhang, XQ; Wang, J; Wright, M; McCouch, S; Nielsen, R; Wang, J; Wang, W				Xu, Xun; Liu, Xin; Ge, Song; Jensen, Jeffrey D.; Hu, Fengyi; Li, Xin; Dong, Yang; Gutenkunst, Ryan N.; Fang, Lin; Huang, Lei; Li, Jingxiang; He, Weiming; Zhang, Guojie; Zheng, Xiaoming; Zhang, Fumin; Li, Yingrui; Yu, Chang; Kristiansen, Karsten; Zhang, Xiuqing; Wang, Jian; Wright, Mark; McCouch, Susan; Nielsen, Rasmus; Wang, Jun; Wang, Wen			Resequencing 50 accessions of cultivated and wild rice yields markers for identifying agronomically important genes	NATURE BIOTECHNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; ARTIFICIAL SELECTION; STRUCTURAL VARIATION; ORYZA-SATIVA; DOMESTICATION PROCESS; DIVERSITY; SEQUENCE; GENETICS; MAIZE; LOCI	Rice is a staple crop that has undergone substantial phenotypic and physiological changes during domestication. Here we resequenced the genomes of 40 cultivated accessions selected from the major groups of rice and 10 accessions of their wild progenitors (Oryza rufipogon and Oryza nivara) to >15 x raw data coverage. We investigated genome-wide variation patterns in rice and obtained 6.5 million high-quality single nucleotide polymorphisms (SNPs) after excluding sites with missing data in any accession. Using these population SNP data, we identified thousands of genes with significantly lower diversity in cultivated but not wild rice, which represent candidate regions selected during domestication. Some of these variants are associated with important biological features, whereas others have yet to be functionally characterized. The molecular markers we have identified should be valuable for breeding and for identifying agronomically important genes in rice.	[Xu, Xun; Li, Xin; Dong, Yang; Zhang, Guojie; Nielsen, Rasmus; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, CAS Max Planck Jr Res Grp Evolutionary Genom, Kunming, Peoples R China; [Xu, Xun; Liu, Xin; Fang, Lin; Li, Jingxiang; He, Weiming; Zhang, Guojie; Li, Yingrui; Yu, Chang; Kristiansen, Karsten; Zhang, Xiuqing; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Xu, Xun; Huang, Lei; Zheng, Xiaoming; Zhang, Fumin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ge, Song; Huang, Lei; Zhang, Guojie; Zheng, Xiaoming] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Jensen, Jeffrey D.] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Hu, Fengyi] Yunnan Acad Agr Sci, Food Crops Res Inst, Kunming, Peoples R China; [Gutenkunst, Ryan N.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [He, Weiming] S China Univ Technol, Guangzhou, Guangdong, Peoples R China; [Kristiansen, Karsten; Nielsen, Rasmus; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wright, Mark; McCouch, Susan] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Kunming Institute of Zoology; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Yunnan Academy of Agricultural Sciences; University of Arizona; South China University of Technology; University of Copenhagen; Cornell University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wang, W (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, CAS Max Planck Jr Res Grp Evolutionary Genom, Kunming, Peoples R China.	rasmus_nielsen@berkeley.edu; wangj@genomics.org.cn; wwang@mail.kiz.ac.cn	Li, Xin/A-4137-2011; Zhang, Guojie/B-6188-2014; Kristiansen, Karsten/J-5148-2014; Nielsen, Rasmus/D-4405-2009; Li, Yingrui/K-1064-2015; Wang, Wen/AAP-9873-2020; Xu, Xun/AAI-6763-2020; Zhang, Guojie/J-7273-2019; , zhengxiaoming/K-2325-2019; Jensen, Jeffrey/S-1084-2016; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Li, Xin/0000-0001-8328-4894; Zhang, Guojie/0000-0001-6860-1521; Kristiansen, Karsten/0000-0002-6024-0917; Nielsen, Rasmus/0000-0003-0513-6591; Xu, Xun/0000-0002-5338-5173; Zhang, Guojie/0000-0001-6860-1521; Liu, Xin/0000-0003-3256-2940; Jensen, Jeffrey/0000-0002-4786-8064; Wang, Jun/0000-0002-2113-5874; Wang, Wen/0000-0002-7801-2066; Wang, Jun/0000-0002-8540-8931; Wright, Mark/0000-0001-8036-1161	Chinese 973 program [2007CB815700]; National Natural Science Foundation of China [30990242]; Provincial Key Grant of Yunnan Province [2008CC017, 2008GA002]; Shenzhen Municipal Government; Yantian District local government of Shenzhen; Danish Natural Science Research Council; CAS-Max Planck Society; CAS; Chinese Ministry of Agriculture; Shenzhen Municipal Government of China; Shenzhen Bureau of Science Technology & Information, China [ZYC200903240077A, CXB200903110066A]; Direct For Biological Sciences [1026555] Funding Source: National Science Foundation	Chinese 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Key Grant of Yunnan Province; Shenzhen Municipal Government; Yantian District local government of Shenzhen; Danish Natural Science Research Council(Danish Natural Science Research Council); CAS-Max Planck Society(Max Planck Society); CAS(Chinese Academy of Sciences); Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Shenzhen Municipal Government of China; Shenzhen Bureau of Science Technology & Information, China; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C.-H. Shi (Zhejiang University, China) and X.-H. Wei (China National Rice Research Institute) for assistance in growing rice materials. We are grateful to the International Rice Research Institute (Los Banos, Philippines) for providing most seed samples. This work was supported by the Chinese 973 program (2007CB815700), the National Natural Science Foundation of China (30990242), the Provincial Key Grant of Yunnan Province (2008CC017; 2008GA002), the Shenzhen Municipal Government and the Yantian District local government of Shenzhen, the Ole Romer grant from the Danish Natural Science Research Council, and a CAS-Max Planck Society Fellowship and the 100 talent program of CAS to W.W., J.W. and S.G. We also acknowledge funding support from the Chinese Ministry of Agriculture (948 program), the Shenzhen Municipal Government of China and grants from Shenzhen Bureau of Science Technology & Information, China (ZYC200903240077A; CXB200903110066A).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; HUDSON RR, 1992, GENETICS, V132, P583; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Paponov IA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-126; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Retief J D, 2000, Methods Mol Biol, V132, P243; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; SECOND G, 1982, JPN J GENET, V57, P25, DOI 10.1266/jjg.57.25; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wright S., 1977, EVOLUTION GENETICS P, V3; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Yamasaki M, 2007, ANN BOT-LONDON, V100, P967, DOI 10.1093/aob/mcm173; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	63	588	629	18	310	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					105	U157		10.1038/nbt.2050	http://dx.doi.org/10.1038/nbt.2050			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22158310				2022-12-27	WOS:000299110600027
J	Lohr, JG; Adalsteinsson, VA; Cibulskis, K; Choudhury, AD; Rosenberg, M; Cruz-Gordillo, P; Francis, JM; Zhang, CZ; Shalek, AK; Satija, R; Trombetta, JJ; Lu, D; Tallapragada, N; Tahirova, N; Kim, S; Blumenstiel, B; Sougnez, C; Lowe, A; Wong, B; Auclair, D; Van Allen-, EM; Nakabayashi, M; Lis, RT; Lee, GSM; Li, T; Chabot, MS; Taplin, ME; Taplin, ME; Clancy, TE; Loda, M; Regev, A; Meyerson, M; Hahn, WC; Kantoff, PW; Golub, TR; Getz, G; Boehm, JS; Love, JC				Lohr, Jens G.; Adalsteinsson, Viktor A.; Cibulskis, Kristian; Choudhury, Atish D.; Rosenberg, Mara; Cruz-Gordillo, Peter; Francis, Joshua M.; Zhang, Cheng-Zhong; Shalek, Alex K.; Satija, Rahul; Trombetta, John J.; Lu, Diana; Tallapragada, Naren; Tahirova, Narmin; Kim, Sora; Blumenstiel, Brendan; Sougnez, Carrie; Lowe, Alarice; Wong, Bang; Auclair, Daniel; Van Allen-, Eliezer M.; Nakabayashi, Mari; Lis, Rosina T.; Lee, Gwo-Shu M.; Li, Tiantian; Chabot, Matthew S.; Ly, Amy; Taplin, Mary-Ellen; Clancy, Thomas E.; Loda, Massimo; Regev, Aviv; Meyerson, Matthew; Hahn, William C.; Kantoff, Philip W.; Golub, Todd R.; Getz, Gad; Boehm, Jesse S.; Love, J. Christopher			Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer	NATURE BIOTECHNOLOGY			English	Article							COPY-NUMBER; MUTATIONAL LANDSCAPE; RNA-SEQ; HETEROGENEITY; PROGRESSION; EVOLUTION; FRAMEWORK; GENOMICS; SURVIVAL; REVEALS	Comprehensive analyses of cancer genomes promise to inform prognoses and precise cancer treatments. A major barrier, however, is inaccessibility of metastatic tissue. A potential solution is to characterize circulating tumor cells (CTCs), but this requires overcoming the challenges of isolating rare cells and sequencing low-input material. Here we report an integrated process to isolate, qualify and sequence whole exomes of CTCs with high fidelity using a census-based sequencing strategy. Power calculations suggest that mapping of > 99.995% of the standard exome is possible in CTCs. We validated our process in two patients with prostate cancer, including one for whom we sequenced CTCs, a lymph node metastasis and nine cores of the primary tumor. Fifty-one of 73 CTC mutations (70%) were present in matched tissue. Moreover, we identified 10 early trunk and 56 metastatic trunk mutations in the non-CTC tumor samples and found 90% and 73% of these mutations, respectively, in CTC exomes. This study establishes a foundation for CTC genomics in the clinic.	[Lohr, Jens G.; Adalsteinsson, Viktor A.; Cibulskis, Kristian; Choudhury, Atish D.; Rosenberg, Mara; Cruz-Gordillo, Peter; Francis, Joshua M.; Zhang, Cheng-Zhong; Satija, Rahul; Trombetta, John J.; Lu, Diana; Kim, Sora; Blumenstiel, Brendan; Sougnez, Carrie; Wong, Bang; Auclair, Daniel; Van Allen-, Eliezer M.; Loda, Massimo; Regev, Aviv; Meyerson, Matthew; Hahn, William C.; Golub, Todd R.; Getz, Gad; Boehm, Jesse S.; Love, J. Christopher] Eli & Edythe L Broad Inst & Harvard, Cambridge, MA 02142 USA; [Lohr, Jens G.; Choudhury, Atish D.; Francis, Joshua M.; Zhang, Cheng-Zhong; Satija, Rahul; Trombetta, John J.; Lu, Diana; Van Allen-, Eliezer M.; Nakabayashi, Mari; Lis, Rosina T.; Lee, Gwo-Shu M.; Li, Tiantian; Chabot, Matthew S.; Meyerson, Matthew; Hahn, William C.; Kantoff, Philip W.; Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Lohr, Jens G.; Choudhury, Atish D.; Van Allen-, Eliezer M.; Clancy, Thomas E.; Loda, Massimo; Meyerson, Matthew; Hahn, William C.; Kantoff, Philip W.; Golub, Todd R.] Harvard Univ, Sch Med, Boston, MA USA; [Adalsteinsson, Viktor A.; Tallapragada, Naren; Tahirova, Narmin; Love, J. Christopher] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Shalek, Alex K.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Lowe, Alarice; Hahn, William C.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Ly, Amy] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Love, J. Christopher] Ragon Inst MGH & Harvard, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Love, JC (corresponding author), Eli & Edythe L Broad Inst & Harvard, Cambridge, MA 02142 USA.	gadgetz@broadinstitute.org; boehm@broadinstitute.org; clove@mit.edu	Cibulskis, Kristian/AAC-7380-2019; Satija, Rahul/AAF-9564-2019; Shalek, Alex/Y-2434-2019; Kim, Sora/D-7707-2015	Shalek, Alex/0000-0001-5670-8778; Kim, Sora/0000-0002-9856-9574; Cruz-Gordillo, Peter/0000-0002-0264-7348; Choudhury, Atish/0000-0001-9344-6631; Boehm, Jesse/0000-0002-6795-6336; Lowe, Alarice/0000-0002-3235-9013; Meyerson, Matthew/0000-0002-9133-8108; Kantoff, Philip/0000-0001-7275-0597; Rosenberg, Mara/0000-0001-6400-3161; Cibulskis, Kristian/0000-0003-1343-1582	Conquer Cancer Foundation Young Investigator Award; US National Institutes of Health (DF/HCC SPORE) [5P50CA100707-10]; Wong Family Award; National Science Foundation; Prostate Cancer Foundation Young Investigator Award; Department of Defense Physician Scientist Training Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014051, P50CA100707, T32CA009172] Funding Source: NIH RePORTER	Conquer Cancer Foundation Young Investigator Award; US National Institutes of Health (DF/HCC SPORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wong Family Award; National Science Foundation(National Science Foundation (NSF)); Prostate Cancer Foundation Young Investigator Award; Department of Defense Physician Scientist Training Award(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	G. L. was supported by a Conquer Cancer Foundation Young Investigator Award, US National Institutes of Health grant 5P50CA100707-10 (DF/HCC SPORE) and the Wong Family Award. V. A. A. was supported in part by a graduate fellowship from the National Science Foundation. A. D. C. is supported by the Prostate Cancer Foundation Young Investigator Award and the Department of Defense Physician Scientist Training Award. J. C. L. is a Camille Dreyfus Teacher-Scholar. We acknowledge the Arthur and Linda Gelb Center for Translational Research for the acquisition and annotation of clinical samples and A. Abbott and A. Van Den Abbeele from the Dana-Farber Cancer Institute (DFCI) Department of Imaging for positron-emission tomography (PET) images. We also acknowledge P. K. Brastianos (Department of Medical Oncology, DFCI) and I. Dunn (Department of Neurosurgery, Brigham and Women's Hospital) for contributing samples for CTC analysis, D. Peck for help with technology development, O. Voznesensky and S. Balk for purification of DNA from the metastatic tumor for sequencing, C. Whittaker and S. S. Levine for advice on sequencing and analysis and the Broad Genomics Platform for the development of new sequencing approaches used here. This work was also supported in part by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute, and we thank the Koch Institute Swanson Biotechnology Center for technical support, specifically the BioMicroCenter. This work was also supported in part by Janssen Pharmaceuticals, Inc. and the Klarman Family Foundation. We would like to thank Illumina for providing the MagSweeper. The authors dedicate this paper to the memory of Officer Sean Collier, for his caring service to the MIT community and for his sacrifice.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Beltran H, 2013, CLIN CANCER RES, V19, P517, DOI 10.1158/1078-0432.CCR-12-1452; Cann GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049144; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; El Gammal AT, 2010, CLIN CANCER RES, V16, P56, DOI 10.1158/1078-0432.CCR-09-1423; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lindberg J, 2013, EUR UROL, V63, P347, DOI 10.1016/j.eururo.2012.03.050; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Ni XH, 2013, P NATL ACAD SCI USA, V110, P21083, DOI 10.1073/pnas.1320659110; Nickerson ML, 2013, HUM MUTAT, V34, P1231, DOI 10.1002/humu.22346; Oh WK, 2006, CLIN GENITOURIN CANC, V5, P61, DOI 10.3816/CGC.2006.n.019; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Ross RW, 2005, CLIN CANCER RES, V11, P8109, DOI 10.1158/1078-0432.CCR-05-1250; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Swennenhuis JF, 2013, GENOME MED, V5, DOI 10.1186/gm510; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zhang LX, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005109; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	41	407	426	7	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					479	U202		10.1038/nbt.2892	http://dx.doi.org/10.1038/nbt.2892			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24752078	Green Accepted, Green Submitted			2022-12-27	WOS:000336036100024
J	Ford, D; Nelsen, B				Ford, Dennis; Nelsen, Barbara			The view beyond venture capital	NATURE BIOTECHNOLOGY			English	Editorial Material								Fundraising is an integral part of almost every young biotech's business strategy, yet many entrepreneurs do not have a systematic approach for identifying and prioritizing potential investors-many of whom work outside of traditional venture capital.	[Ford, Dennis] Life Sci Nation, Boston, MA 02108 USA; [Nelsen, Barbara] Nelsen Biomed, St Paul, MN USA		Ford, D (corresponding author), Life Sci Nation, Boston, MA 02108 USA.	dford@lifesciencenation.com; barbara@nelsenbiomedical.com						Angel Resource Institute & Silicon Valley Bank, 2013, HAL REP ANG GROUP UP; Beylin D, 2011, NAT BIOTECHNOL, V29, P567, DOI 10.1038/bioe.2011.5; Cromwell Schmisseur LLC, 2013, INF OBS STAT VENT CA; Ewing Marion Kauffman Foundation, 2012, I LTD PARTN MUST ACC; Laursen Lucas, 2012, Nature, V486, P559; Ledford H, 2013, NATURE, V501, P476, DOI 10.1038/501476a; Mulcahy D., 2012, WE HAVE MET ENEMY HE; PitchBook, 2013, 4Q 2013 VENT CAP VAL; PricewaterhouseCoopers, 2013, LIF SCI VENT CAP FUN; Senior M, 2013, NAT BIOTECHNOL, V31, P473, DOI 10.1038/nbt0613-473; Timmerman L., 2012, XCONOMY; US National Institutes of Health, 2013, EST FUND VAR RES CON; von Krogh G, 2012, NAT BIOTECHNOL, V30, P911, DOI 10.1038/nbt.2383	13	21	21	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					15	23		10.1038/nbt.2780	http://dx.doi.org/10.1038/nbt.2780			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24406920				2022-12-27	WOS:000329513000007
J	Cannon, JJ; Kessel, M				Cannon, John J., III; Kessel, Mark			Stock options and beyond	NATURE BIOTECHNOLOGY			English	Editorial Material									[Cannon, John J., III; Kessel, Mark] Shearman & Sterling LLP, New York, NY USA		Cannon, JJ (corresponding author), Shearman & Sterling LLP, New York, NY USA.	jcannon@shearman.com; mark.kessel@shearman.com							0	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					676	680		10.1038/nbt.2662	http://dx.doi.org/10.1038/nbt.2662			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23929334	Bronze			2022-12-27	WOS:000322911000007
J	Chitale, S; Lawler, C; Macfarlane, S				Chitale, Sadhana; Lawler, Colm; Macfarlane, Scott			Licensing lessons learned: if I knew then what I know now	NATURE BIOTECHNOLOGY			English	Editorial Material									[Chitale, Sadhana] NYU, Off Ind Liaison, Langone Med Ctr, New York, NY 10003 USA; [Lawler, Colm] Tufts Univ, Off Technol Licensing & Ind Collaborat, Boston, MA 02111 USA; [Macfarlane, Scott] SUNY Upstate Med Univ, Dept Technol Transfer, Syracuse, NY 13210 USA	New York University; NYU Langone Medical Center; Tufts University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Chitale, S (corresponding author), NYU, Off Ind Liaison, Langone Med Ctr, New York, NY 10003 USA.	sadhana.chitale@nyumc.org						Chitale S., 2013, ASS U TECHN ANN M SA	1	0	0	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2013	31	4					362	363		10.1038/nbt.2551	http://dx.doi.org/10.1038/nbt.2551			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	120TI	23563432				2022-12-27	WOS:000317195500031
J	Aggarwal, S				Aggarwal, Saurabh (Rob)			What's fueling the biotech engine-2011 to 2012	NATURE BIOTECHNOLOGY			English	Article							RHEUMATOID-ARTHRITIS; TOFACITINIB; INHIBITOR	Sales in the biologics sector show modest but healthy growth rates for the fourth consecutive year, with cancer drugs garnering the greatest revenues. As the diabetes epidemic grows and innovation of insulins continues, drug companies in that space are moving up in the ranks.	Novel Hlth Strategies LLC, Bethesda, MD USA		Aggarwal, S (corresponding author), Novel Hlth Strategies LLC, Bethesda, MD USA.	sa2@novelhealthstrategies.com			American Society of Clinical Oncology (ASCO); American College of Rheumatology (ACR); American Association of Liver Diseases (AASLD); American Heart Association (AHA); American Society of Hematology (ASH); Biotechnology Industry Association (BIO)	American Society of Clinical Oncology (ASCO); American College of Rheumatology (ACR); American Association of Liver Diseases (AASLD); American Heart Association (AHA)(American Heart Association); American Society of Hematology (ASH); Biotechnology Industry Association (BIO)	SA thanks American Society of Clinical Oncology (ASCO), American College of Rheumatology (ACR), American Association of Liver Diseases (AASLD), American Heart Association (AHA), American Society of Hematology (ASH) and Biotechnology Industry Association (BIO) for providing support for this article.	Aggarwal S., 2012, INT SOC PHARM OUTC R; Aggarwal S, 2012, 15 ANN EUR C NOV 3 7; Aggarwal S, 2011, NAT BIOTECHNOL, V29, P1083, DOI 10.1038/nbt.2060; Aggarwal S, 2010, NAT BIOTECHNOL, V28, P1165, DOI 10.1038/nbt1110-1165; Aggarwal S, 2010, NAT REV DRUG DISCOV, V9, P427, DOI 10.1038/nrd3186; Aggarwal S, 2009, NAT BIOTECHNOL, V27, P987, DOI 10.1038/nbt1109-987; Bach P, 2012, NY TIMES; Collins AJ, 2012, ESRD PAYMENT POLICY; de Claro RA, 2012, CLIN CANCER RES, V18, P5845, DOI 10.1158/1078-0432.CCR-12-1803; Garber K, 2011, NAT BIOTECHNOL, V29, P467, DOI 10.1038/nbt0611-467; Hamlin PA, 2010, CURR ONCOL REP, V12, P355, DOI 10.1007/s11912-010-0124-1; Hayes E, 2010, PINK SHEET DAILY, V71; Heitz F, 2012, ADV THER, V29, P723, DOI 10.1007/s12325-012-0041-9; Helwick C., 2012, ASCO POST, V3; Polonsky KS, 2012, NEW ENGL J MED, V367, P1332, DOI 10.1056/NEJMra1110560; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Zinman B, 2011, LANCET, V377, P924, DOI 10.1016/S0140-6736(10)62305-7	18	52	53	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1191	1197		10.1038/nbt.2437	http://dx.doi.org/10.1038/nbt.2437			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222785				2022-12-27	WOS:000312092400018
J	Frangioni, JV				Frangioni, John V.			Nonprofit foundations for open-source biomedical technology development	NATURE BIOTECHNOLOGY			English	Letter									Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Mol Imaging, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Frangioni, JV (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Mol Imaging, Boston, MA 02215 USA.	jfrangio@bidmc.harvard.edu						Choi HS, 2011, ANGEW CHEM INT EDIT, V50, P6258, DOI 10.1002/anie.201102459; Frangioni JV, 2008, J CLIN ONCOL, V26, P4012, DOI 10.1200/JCO.2007.14.3065; Frangioni JV, 2008, NAT BIOTECHNOL, V26, P503, DOI 10.1038/nbt0508-503; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Huggett B, 2012, NAT BIOTECHNOL, V30, P395, DOI 10.1038/nbt.2209; Hutteman M, 2011, ANN SURG ONCOL, V18, P1006, DOI 10.1245/s10434-010-1426-0; Lee BT, 2010, PLAST RECONSTR SURG, V126, P1472, DOI 10.1097/PRS.0b013e3181f059c7; Mieog JSD, 2011, ANN SURG ONCOL, V18, P2483, DOI 10.1245/s10434-011-1566-x; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; van der Vorst JR, 2011, INT J GYNECOL CANCER, V21, P1472, DOI 10.1097/IGC.0b013e31822b451d	10	3	3	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					928	932		10.1038/nbt.2392	http://dx.doi.org/10.1038/nbt.2392			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	23051807				2022-12-27	WOS:000309965500014
J	Creixell, P; Schoof, EM; Erler, JT; Linding, R				Creixell, Pau; Schoof, Erwin M.; Erler, Janine T.; Linding, Rune			Navigating cancer network attractors for tumor-specific therapy	NATURE BIOTECHNOLOGY			English	Review							EDGETIC PERTURBATION; SOMATIC MUTATION; MOUSE MODELS; PROTEIN; PHOSPHORYLATION; EVOLUTION; PREDICTION; ONCOGENE; PATHWAY; GROWTH	Cells employ highly dynamic signaling networks to drive biological decision processes. Perturbations to these signaling networks may attract cells to new malignant signaling and phenotypic states, termed cancer network attractors, that result in cancer development. As different cancer cells reach these malignant states by accumulating different molecular alterations, uncovering these mechanisms represents a grand challenge in cancer biology. Addressing this challenge will require new systems-based strategies that capture the intrinsic properties of cancer signaling networks and provide deeper understanding of the processes by which genetic lesions perturb these networks and lead to disease phenotypes. Network biology will help circumvent fundamental obstacles in cancer treatment, such as drug resistance and metastasis, empowering personalized and tumor-specific cancer therapies.	[Erler, Janine T.] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Creixell, Pau; Schoof, Erwin M.; Linding, Rune] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal CBS, C SIG, DK-2800 Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Erler, JT (corresponding author), Univ Copenhagen, BRIC, Copenhagen, Denmark.	janine.erler@bric.ku.dk; linding@cbs.dtu.dk		Schoof, Erwin Marten/0000-0002-3117-7832; Erler, Janine/0000-0001-8675-6527; Linding, Rune/0000-0003-0420-4839	Danish Council for Independent Research; Career Development Award from Human Frontier Science Program; Novo Nordisk Foundation	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Career Development Award from Human Frontier Science Program; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We apologize to our colleagues whose work could not be cited due to space limitations. We thank all members of the C-SIG (DTU), the ErlerLab (BRIC), M. Yaffe (MIT) and N. Brunner (KU) for critical input on this manuscript. R. L. is a Lundbeck Foundation Fellow and is supported by a Sapere Aude Starting Grant from The Danish Council for Independent Research and a Career Development Award from Human Frontier Science Program. J.T.E. is supported by a Hallas Moller Stipend from the Novo Nordisk Foundation. Visit http://www.networkbio.org/, http://www.lindinglab.org/ and http://www.erlerlab.org/ for more information on cancer-related network biology.	Abreu-Martin MT, 1999, AM J PHYSIOL-GASTR L, V276, pG599, DOI 10.1152/ajpgi.1999.276.3.G599; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bendall SC, 2012, NAT BIOTECHNOL, V30, P639, DOI 10.1038/nbt.2283; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Blumenthal RD, 2007, MOL BIOTECHNOL, V35, P185, DOI 10.1007/BF02686104; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Brinkworth RI, 2003, P NATL ACAD SCI USA, V100, P74, DOI 10.1073/pnas.0134224100; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dixit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007485; Dreze M, 2009, NAT METHODS, V6, P843, DOI [10.1038/NMETH.1394, 10.1038/nmeth.1394]; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Erler JT, 2012, CELL, V149, P731, DOI 10.1016/j.cell.2012.04.014; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Geiger T, 2010, NAT METHODS, V7, P383, DOI 10.1038/nmeth.1446; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoffman RM, 2010, EXPERT OPIN DRUG DIS, V5, P851, DOI 10.1517/17460441.2010.510129; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Hunter KW, 2012, NAT REV CANCER, V12, P144, DOI 10.1038/nrc3206; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jensen LJ, 2002, J MOL BIOL, V319, P1257, DOI 10.1016/S0022-2836(02)00379-0; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KAUFFMAN S, 1987, J THEOR BIOL, V128, P11, DOI 10.1016/S0022-5193(87)80029-2; KAUFFMAN SA, 1989, J THEOR BIOL, V141, P211, DOI 10.1016/S0022-5193(89)80019-0; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Ledford H, 2010, NATURE, V464, P972, DOI 10.1038/464972a; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Gonzalez-Angulo AM, 2010, J CLIN ONCOL, V28, P2777, DOI 10.1200/JCO.2009.27.0777; Meyer P, 2011, NAT BIOTECHNOL, V29, P811, DOI 10.1038/nbt.1968; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Pawson T, 2008, FEBS LETT, V582, P1266, DOI 10.1016/j.febslet.2008.02.011; Pazos F, 2006, CURR BIOINFORM, V1, P15, DOI 10.2174/157489306775330633; Pe'er D, 2011, CELL, V144, P864, DOI 10.1016/j.cell.2011.03.001; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Roque FS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002141; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Turk BE, 2008, CURR OPIN CHEM BIOL, V12, P4, DOI 10.1016/j.cbpa.2008.01.018; Uribesalgo I, 2012, CELL CYCLE, V11, P1757, DOI 10.4161/cc.19883; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Waddington C H, 1957, STRATEGY GENES DISCU; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; WHO, 2012, WHO FACT SHEET 297; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	81	104	104	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					842	848		10.1038/nbt.2345	http://dx.doi.org/10.1038/nbt.2345			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22965061	Bronze			2022-12-27	WOS:000308705700018
J	Haanes, EJ; Canaves, JM				Haanes, Elizabeth J.; Canaves, Jaume M.			Stealing fire: a retrospective survey of biotech patent claims in the wake of Mayo v. Prometheus	NATURE BIOTECHNOLOGY			English	Editorial Material									[Haanes, Elizabeth J.; Canaves, Jaume M.] Sterne Kessler Goldstein & Fox PLLC, Washington, DC USA		Haanes, EJ (corresponding author), Sterne Kessler Goldstein & Fox PLLC, Washington, DC USA.	bhaanes@skgf.com						Fox JL, 2012, NAT BIOTECHNOL, V30, P373, DOI 10.1038/nbt0512-373; Goldstein J.A., 2011, INTELLECT PROP TODAY, V18, P18; Sterne R.G., 2011, SED PAT LIT C 2011 C; US Patent and Trademark Office, 2012, INT PROC SUBJ MATT E	4	7	7	3	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					758	761		10.1038/nbt.2318	http://dx.doi.org/10.1038/nbt.2318			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22871711				2022-12-27	WOS:000307416900016
J	Cheong, H; Lu, C; Lindsten, T; Thompson, CB				Cheong, Heesun; Lu, Chao; Lindsten, Tullia; Thompson, Craig B.			Therapeutic targets in cancer cell metabolism and autophagy	NATURE BIOTECHNOLOGY			English	Review							HISTONE DEACETYLASE INHIBITOR; MALIGNANT GLIOMA-CELLS; PYRUVATE-KINASE M2; ISOLATED RAT HEPATOCYTES; BREAST-CANCER; GLUTAMINE-METABOLISM; TUMOR PROGRESSION; MAMMARY TUMORIGENESIS; INDUCED APOPTOSIS; ARSENIC TRIOXIDE	The metabolism of cancer cells is reprogrammed both by oncogene signaling and by dysregulation of metabolic enzymes. The resulting altered metabolism supports cellular proliferation and survival but leaves cancer cells dependent on a continuous supply of nutrients. Thus, many metabolic enzymes have become targets for new cancer therapies. Recently, two processes-expression of specific isoforms of metabolic enzymes and autophagy-have been shown to be crucial for the adaptation of tumor cells to changes in nutrient availability. An increasing number of approved and experimental therapeutics target these two processes. A better understanding of the molecular basis of cancer-associated metabolic changes may lead to improved cancer therapies.	[Cheong, Heesun; Lu, Chao; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; [Lu, Chao] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Lindsten, Tullia] Mem Sloan Kettering Canc Ctr, Program Immunol, Sloan Kettering Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center	Thompson, CB (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	craig@mskcc.org	Lu, Chao/E-8047-2012	Cheong, Heesun/0000-0003-1946-107X; Lu, Chao/0000-0003-0982-8122	US National Institutes of Health; National Cancer Institute; NATIONAL CANCER INSTITUTE [P01CA104838] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank members of the Thompson laboratory for helpful discussions. C.B.T. is supported by grants from the US National Institutes of Health and National Cancer Institute.	AHLUWALIA GS, 1990, PHARMACOL THERAPEUT, V46, P243, DOI 10.1016/0163-7258(90)90094-I; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Boxer MB, 2010, J MED CHEM, V53, P1048, DOI 10.1021/jm901577g; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bueno V, 2007, TRANSPLANTATION, V84, P1204, DOI 10.1097/01.tp.0000287543.91765.41; Cairns RA, 2007, P NATL ACAD SCI USA, V104, P9445, DOI 10.1073/pnas.0611662104; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Chen N, 2011, CANCER BIOL THER, V11, P157, DOI 10.4161/cbt.11.2.14622; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Cheung CWY, 2010, ANTI-CANCER AGENT ME, V10, P186; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Crazzolara R, 2009, BLOOD, V113, P3297, DOI 10.1182/blood-2008-02-137752; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169; Ellis L, 2009, BLOOD, V114, P380, DOI 10.1182/blood-2008-10-182758; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fujii S, 2008, CANCER SCI, V99, P1813, DOI 10.1111/j.1349-7006.2008.00893.x; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gorzalczany Y, 2011, CANCER LETT, V310, P207, DOI 10.1016/j.canlet.2011.07.002; Granchi C, 2011, J MED CHEM, V54, P1599, DOI 10.1021/jm101007q; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hsu KF, 2009, AUTOPHAGY, V5, P451, DOI 10.4161/auto.5.4.7666; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Jiang JK, 2010, BIOORG MED CHEM LETT, V20, P3387, DOI 10.1016/j.bmcl.2010.04.015; Kanematsu S, 2010, ANTICANCER RES, V30, P3381; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Kita K, 2012, J BIOL CHEM, V287, P18163, DOI 10.1074/jbc.M112.362699; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Martin AP, 2009, MOL PHARMACOL, V76, P327, DOI 10.1124/mol.109.056309; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Miao YF, 2010, HEPATO-GASTROENTEROL, V57, P257; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Milano V, 2009, MOL CANCER THER, V8, P394, DOI 10.1158/1535-7163.MCT-08-0669; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Peng G, 2006, MOL CARCINOGEN, V45, P309, DOI 10.1002/mc.20166; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Qing GL, 2010, CANCER RES, V70, P10351, DOI 10.1158/0008-5472.CAN-10-0740; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rahim R, 2009, ANTI-CANCER DRUG, V20, P736, DOI 10.1097/CAD.0b013e32832f4e50; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Wei Y, 2010, CLIN CANCER RES, V16, P3923, DOI 10.1158/1078-0432.CCR-10-0032; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yazbeck VY, 2008, EXP HEMATOL, V36, P443, DOI 10.1016/j.exphem.2007.12.008; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Yu Y, 2001, BIOCHEM PHARMACOL, V62, P81, DOI 10.1016/S0006-2952(01)00636-0; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zhan TZ, 2011, J CELL BIOCHEM, V112, P849, DOI 10.1002/jcb.22984; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	109	257	266	3	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					671	678		10.1038/nbt.2285	http://dx.doi.org/10.1038/nbt.2285			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781696	Green Accepted			2022-12-27	WOS:000306293400026
J	Koren, S; Schatz, MC; Walenz, BP; Martin, J; Howard, JT; Ganapathy, G; Wang, Z; Rasko, DA; McCombie, WR; Jarvis, ED; Phillippy, AM				Koren, Sergey; Schatz, Michael C.; Walenz, Brian P.; Martin, Jeffrey; Howard, Jason T.; Ganapathy, Ganeshkumar; Wang, Zhong; Rasko, David A.; McCombie, W. Richard; Jarvis, Erich D.; Phillippy, Adam M.			Hybrid error correction and de novo assembly of single-molecule sequencing reads	NATURE BIOTECHNOLOGY			English	Article							PYROSEQUENCING READS; STRUCTURAL VARIATION; LARGE GENOMES; GENE; EXPRESSION; SPEECH; FOXP2; COMPLEXITY; GENERATION; RECEPTORS	Single-molecule sequencing instruments can generate multikilobase sequences with the potential to greatly improve genome and transcriptome assembly. However, the error rates of single-molecule reads are high, which has limited their use thus far to resequencing bacteria. To address this limitation, we introduce a correction algorithm and assembly strategy that uses short, high-fidelity sequences to correct the error in single-molecule sequences. We demonstrate the utility of this approach on reads generated by a PacBio RS instrument from phage, prokaryotic and eukaryotic whole genomes, including the previously unsequenced genome of the parrot Melopsittacus undulatus, as well as for RNA-Seq reads of the corn (Zea mays) transcriptome. Our long-read correction achieves >99.9% base-call accuracy, leading to substantially better assemblies than current sequencing strategies: in the best example, the median contig size was quintupled relative to high-coverage, second-generation assemblies. Greater gains are predicted if read lengths continue to increase, including the prospect of single-contig bacterial chromosome assembly.	[Koren, Sergey; Phillippy, Adam M.] Natl Biodef Anal & Countermeasures Ctr, Frederick, MD USA; [Koren, Sergey] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Schatz, Michael C.; McCombie, W. Richard] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Walenz, Brian P.] J Craig Venter Inst, Rockville, MD USA; [Martin, Jeffrey; Wang, Zhong] DOE Joint Genome Inst, Walnut Creek, CA USA; [Howard, Jason T.; Ganapathy, Ganeshkumar; Jarvis, Erich D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; [Rasko, David A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland College Park; Cold Spring Harbor Laboratory; J. Craig Venter Institute; United States Department of Energy (DOE); Duke University; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore	Koren, S (corresponding author), Natl Biodef Anal & Countermeasures Ctr, Frederick, MD USA.	korens@nbacc.net; phillippya@nbacc.net	Jarvis, Erich D/A-2319-2008; Wang, Zhong/J-3244-2019; Phillippy, Adam M/U-5731-2018; Koren, Sergey/AAE-8314-2019; Schatz, Michael/L-2690-2019	Jarvis, Erich D/0000-0001-8931-5049; Wang, Zhong/0000-0002-6307-0458; Phillippy, Adam M/0000-0003-2983-8934; Schatz, Michael/0000-0002-4118-4446; Howard, Jason/0000-0003-3265-5127; Koren, Sergey/0000-0002-1472-8962; David, Rasko/0000-0002-7337-7154; McCombie, W. Richard/0000-0003-1899-0682	US Department of Homeland Security for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC) [HSHQDC-07-C-00020]; Federally Funded Research and Development Center; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; US National Institutes of Health (NIH) [R01-HG006677-12]; NIH [2R01GM077117-04A1]; state of Maryland; National Science Foundation [IOS-1032105]; Howard Hughes Medical Institute; NIH Directors Pioneer Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200398, R01HG006677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000448] Funding Source: NIH RePORTER	US Department of Homeland Security for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC)(United States Department of Homeland Security (DHS)); Federally Funded Research and Development Center; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); state of Maryland; National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH Directors Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Pacific Biosciences, Roche 454, Illumina, BGI and the Duke Genome Center for the generation and/or release of many of the data sets examined herein, and to the Assemblathon working group for the coordination and release of the parrot genome data. This publication was developed and funded in part under Agreement No. HSHQDC-07-C-00020 awarded by the US Department of Homeland Security for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC), a Federally Funded Research and Development Center. The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the US Department of Homeland Security. The Department of Homeland Security does not endorse any products or commercial services mentioned in this publication. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. This work was also funded in part by the US National Institutes of Health (NIH) R01-HG006677-12 (M.C.S.), NIH 2R01GM077117-04A1 (B.P.W.), the state of Maryland (D.A.R.), National Science Foundation IOS-1032105 to W.R.M., and Howard Hughes Medical Institute and NIH Directors Pioneer Award to E.D.J.	Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fraser CM, 2002, J BACTERIOL, V184, P6403, DOI 10.1128/JB.184.23.6403-6405.2002; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Maes T, 2002, GENOMICS, V80, P21, DOI 10.1006/geno.2002.6799; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsunaga E, 2009, DEV GROWTH DIFFER, V51, P45, DOI 10.1111/j.1440-169X.2008.01080.x; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Nagarajan N, 2009, J COMPUT BIOL, V16, P897, DOI 10.1089/cmb.2009.0005; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schadt EE, 2010, HUM MOL GENET, V19, pR227, DOI 10.1093/hmg/ddq416; Schatz MC, 2013, BRIEF BIOINFORM, V14, P213, DOI 10.1093/bib/bbr074; Schatz MC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-243; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vezzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031002; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	50	671	706	5	211	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					692	+		10.1038/nbt.2280	http://dx.doi.org/10.1038/nbt.2280			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22750884	Green Accepted, Green Submitted			2022-12-27	WOS:000306293400028
J	Cheung, WC; Beausoleil, SA; Zhang, XW; Sato, S; Schieferl, SM; Wieler, JS; Beaudet, JG; Ramenani, RK; Popova, L; Comb, MJ; Rush, J; Polakiewicz, RD				Cheung, Wan Cheung; Beausoleil, Sean A.; Zhang, Xiaowu; Sato, Shuji; Schieferl, Sandra M.; Wieler, James S.; Beaudet, Jason G.; Ramenani, Ravi K.; Popova, Lana; Comb, Michael J.; Rush, John; Polakiewicz, Roberto D.			A proteomics approach for the identification and cloning of monoclonal antibodies from serum	NATURE BIOTECHNOLOGY			English	Article							PHOSPHORYLATION ANALYSIS; PROTEIN-PHOSPHORYLATION; IMMUNOGLOBULIN GENES; MASS-SPECTROMETRY; PASSIVE-IMMUNITY; B-CELLS; GENERATION; SEQUENCES; VH; REPERTOIRES	We describe a proteomics approach that identifies antigen-specific antibody sequences directly from circulating polyclonal antibodies in the serum of an immunized animal. The approach involves affinity purification of antibodies with high specific activity and then analyzing digested antibody fractions by nano-flow liquid chromatography coupled to tandem mass spectrometry. High-confidence peptide spectral matches of antibody variable regions are obtained by searching a reference database created by next-generation DNA sequencing of the B-cell immunoglobulin repertoire of the immunized animal. Finally, heavy and light chain sequences are paired and expressed as recombinant monoclonal antibodies. Using this technology, we isolated monoclonal antibodies for five antigens from the sera of immunized rabbits and mice. The antigen-specific activities of the monoclonal antibodies recapitulate or surpass those of the original affinity-purified polyclonal antibodies. This technology may aid the discovery and development of vaccines and antibody therapeutics, and help us gain a deeper understanding of the humoral response.	[Cheung, Wan Cheung; Beausoleil, Sean A.; Zhang, Xiaowu; Sato, Shuji; Schieferl, Sandra M.; Wieler, James S.; Beaudet, Jason G.; Ramenani, Ravi K.; Popova, Lana; Comb, Michael J.; Rush, John; Polakiewicz, Roberto D.] Cell Signaling Technol Inc, Danvers, MA 01923 USA		Polakiewicz, RD (corresponding author), Cell Signaling Technol Inc, Danvers, MA 01923 USA.	rpolakiewicz@cellsignal.com						BALTIMORE D, 1981, CELL, V24, P592, DOI 10.1016/0092-8674(81)90082-9; Bandeira N, 2008, NAT BIOTECHNOL, V26, P1336, DOI 10.1038/nbt1208-1336; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BECKER RS, 1990, EUR J IMMUNOL, V20, P397, DOI 10.1002/eji.1830200224; BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Castellana NE, 2011, PROTEOMICS, V11, P395, DOI 10.1002/pmic.201000487; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fischer N, 2011, MABS-AUSTIN, V3, P17, DOI 10.4161/mabs.3.1.14169; HARLOW E, 1998, USING ANTIBODIES LAB; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; KIM S, 1981, CELL, V27, P573, DOI 10.1016/0092-8674(81)90399-8; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; KNIGHT KL, 1992, ANNU REV IMMUNOL, V10, P593, DOI 10.1146/annurev.iy.10.040192.003113; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; LAMBERT JS, 1993, ANN NY ACAD SCI, V693, P186, DOI 10.1111/j.1749-6632.1993.tb26267.x; Lanzavecchia A, 2007, CURR OPIN BIOTECH, V18, P523, DOI 10.1016/j.copbio.2007.10.011; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; Meijer PJ, 2006, J MOL BIOL, V358, P764, DOI 10.1016/j.jmb.2006.02.040; O'Brien PM, 2002, ANTIBODY PHAGE DISPL; Pasqualini R, 2004, P NATL ACAD SCI USA, V101, P257, DOI 10.1073/pnas.0305834101; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Sullivan Meghan, 2011, F1000 Biol Rep, V3, P17, DOI 10.3410/B3-17; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	35	131	142	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					447	+		10.1038/nbt.2167	http://dx.doi.org/10.1038/nbt.2167			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22446692				2022-12-27	WOS:000303803200025
J	Peng, ZY; Cheng, YB; Tan, BCM; Kang, L; Tian, ZJ; Zhu, YK; Zhang, WW; Liang, Y; Hu, XD; Tan, XM; Guo, J; Dong, ZR; Liang, Y; Bao, L; Wang, J				Peng, Zhiyu; Cheng, Yanbing; Tan, Bertrand Chin-Ming; Kang, Lin; Tian, Zhijian; Zhu, Yuankun; Zhang, Wenwei; Liang, Yu; Hu, Xueda; Tan, Xuemei; Guo, Jing; Dong, Zirui; Liang, Yan; Bao, Li; Wang, Jun			Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome	NATURE BIOTECHNOLOGY			English	Article							NONCODING RNA; GENOME SEQUENCE; WIDESPREAD RNA; ADENOSINE; IDENTIFICATION; EXPRESSION; DISCOVERY; SITES; TOOL	RNA editing is a post-transcriptional event that recodes hereditary information. Here we describe a comprehensive profile of the RNA editome of a male Han Chinese individual based on analysis of similar to 767 million sequencing reads from poly(A)(+), poly(A)(-) and small RNA samples. We developed a computational pipeline that carefully controls for false positives while calling RNA editing events from genome and whole-transcriptome data of the same individual. We identified 22,688 RNA editing events in noncoding genes and introns, untranslated regions and coding sequences of protein-coding genes. Most changes (similar to 93%) converted A to I(G), consistent with known editing mechanisms based on adenosine deaminase acting on RNA (ADAR). We also found evidence of other types of nucleotide changes; however, these were validated at lower rates. We found 44 editing sites in microRNAs (miRNAs), suggesting a potential link between RNA editing and miRNA-mediated regulation. Our approach facilitates large-scale studies to profile and compare editomes across a wide range of samples.	[Peng, Zhiyu; Cheng, Yanbing; Kang, Lin; Tian, Zhijian; Zhu, Yuankun; Zhang, Wenwei; Liang, Yu; Hu, Xueda; Tan, Xuemei; Guo, Jing; Dong, Zirui; Liang, Yan; Bao, Li; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Coll Med, Dept Biomed Sci, Tao Yuan, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Beijing Genomics Institute (BGI); Chang Gung University; Chang Gung University; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	wangj@genomics.org.cn	Kang, Lin/AAA-2260-2019; DONG, Elvis/AAM-9274-2020; Peng, Zhiyu/GXV-5301-2022; Wang, Jun/A-7261-2013; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Kang, Lin/0000-0002-9186-9574; DONG, Elvis/0000-0002-3626-6500; Peng, Zhiyu/0000-0003-2349-750X; Tan, Bertrand/0000-0002-2218-7115; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931	National Basic Research Program of China (973 program) [2011CB809200, 2011CB809202, 2011CB809203]; National Natural Science Foundation of China [30725008, 30890032, 30811130531]; Chinese 863 program [2006AA02A302, 2009AA022707]; Shenzhen Municipal Government of China; Local Government of Yantian District of Shenzhen [JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, ZYC200903240080A]; Danish Natural Science Research Council	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Local Government of Yantian District of Shenzhen; Danish Natural Science Research Council(Danish Natural Science Research Council)	This project was supported by a National Basic Research Program of China (973 program no. 2011CB809200, 2011CB809202 and 2011CB809203), the National Natural Science Foundation of China (30725008, 30890032 and 30811130531), the Chinese 863 program (2006AA02A302 and 2009AA022707), the Shenzhen Municipal Government of China and the Local Government of Yantian District of Shenzhen (grants JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A and ZYC200903240080A) and the Ole Romer grant from the Danish Natural Science Research Council.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eisenberg E, 2005, TRENDS GENET, V21, P77, DOI 10.1016/j.tig.2004.12.005; Eisenberg E, 2010, RNA BIOL, V7, P248, DOI 10.4161/rna.7.2.11565; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; He T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018129; Huang Songbo, 2011, Frontiers in Genetics, V2, P46, DOI 10.3389/fgene.2011.00046; Hundley HA, 2010, TRENDS BIOCHEM SCI, V35, P377, DOI 10.1016/j.tibs.2010.02.008; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Maas S, 2011, BIOCHEM BIOPH RES CO, V412, P407, DOI 10.1016/j.bbrc.2011.07.075; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Paz-Yaacov N, 2010, P NATL ACAD SCI USA, V107, P12174, DOI 10.1073/pnas.1006183107; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pullirsch D, 2010, RNA BIOL, V7, P205, DOI 10.4161/rna.7.2.11286; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tian Z, 2011, GIGA SCI; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	50	379	394	6	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					253	+		10.1038/nbt.2122	http://dx.doi.org/10.1038/nbt.2122			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22327324	Bronze			2022-12-27	WOS:000301303800021
J	Patel, SJ; Milwid, JM; King, KR; Bohr, S; Iracheta-Velle, A; Li, M; Vitalo, A; Parekkadan, B; Jindal, R; Yarmush, ML				Patel, Suraj J.; Milwid, Jack M.; King, Kevin R.; Bohr, Stefan; Iracheta-Velle, Arvin; Li, Matthew; Vitalo, Antonia; Parekkadan, Biju; Jindal, Rohit; Yarmush, Martin L.			Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure	NATURE BIOTECHNOLOGY			English	Article							HEPATOTOXICITY; SURVEILLANCE; MECHANISMS	Drug-induced liver injury (DILI) limits the development and application of many therapeutic compounds and presents major challenges to the pharmaceutical industry and clinical medicine(1,2). Acetaminophen-containing compounds are among the most frequently prescribed drugs and are also the most common cause of DILI3. Here we describe a pharmacological strategy that targets gap junction communication to prevent amplification of fulminant hepatic failure and acetaminophen-induced hepatotoxicity. We demonstrate that connexin 32 (Cx32), a key hepatic gap junction protein, is an essential mediator of DILI by showing that mice deficient in Cx32 are protected against liver damage, acute inflammation and death caused by liver-toxic drugs. We identify a small-molecule inhibitor of Cx32 that protects against liver failure and death in wild-type mice when co-administered with known hepatotoxic drugs. These findings indicate that gap junction inhibition could provide a pharmaceutical strategy to limit DILI and improve drug safety.	[Patel, Suraj J.; Milwid, Jack M.; King, Kevin R.; Bohr, Stefan; Iracheta-Velle, Arvin; Li, Matthew; Vitalo, Antonia; Parekkadan, Biju; Jindal, Rohit; Yarmush, Martin L.] Massachusetts Gen Hosp, Dept Surg, Ctr Engn Med, Boston, MA 02114 USA; [Patel, Suraj J.; Milwid, Jack M.; King, Kevin R.; Bohr, Stefan; Iracheta-Velle, Arvin; Li, Matthew; Vitalo, Antonia; Parekkadan, Biju; Jindal, Rohit; Yarmush, Martin L.] Shriners Burns Hosp, Boston, MA USA; [Patel, Suraj J.; Milwid, Jack M.; Yarmush, Martin L.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, MIT, Cambridge, MA 02138 USA; [Jindal, Rohit; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Rutgers State University New Brunswick	Yarmush, ML (corresponding author), Massachusetts Gen Hosp, Dept Surg, Ctr Engn Med, Boston, MA 02114 USA.	ireis@sbi.org	; Iracheta-Vellve, Arvin/K-6140-2014	Parekkadan, Biju/0000-0002-3408-8085; Iracheta-Vellve, Arvin/0000-0002-6635-3904; Yarmush, Martin/0000-0003-4986-8444	Department of Defense; Shriners Hospitals for Children; US National Institutes of Health [DK059766, P41 EB-002503]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059766] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Shriners Hospitals for Children; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank K. Willecke (University of Bonn) and D. Paul (Harvard University) for the generous gift of Cx32<SUP>-/-</SUP> mice, K. Willecke (University of Bonn) for connexin expressing HeLa cells, H. Duffy (Harvard Medical School) for development of the tissue scrape-and-load assay, and M. Izamis (Harvard Medical School) for high-performance liquid chromatography assistance. S.J.P. was supported in part by a Department of Defense Congressionally Directed Medical Research Program Prostate Cancer Predoctoral Training Award and a Shriners Hospitals for Children Postdoctoral Fellowship Award. The work was supported by grants from the US National Institutes of Health (DK059766 and P41 EB-002503) and from the Shriners Hospitals for Children.	BARTOLONE JB, 1989, FUND APPL TOXICOL, V13, P859, DOI 10.1016/0272-0590(89)90339-4; BIRNBAUM J, 1985, AM J MED, V78, P3, DOI 10.1016/0002-9343(85)90097-X; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chun LJ, 2009, J CLIN GASTROENTEROL, V43, P342, DOI 10.1097/MCG.0b013e31818a3854; Ferret PJ, 2001, HEPATOLOGY, V33, P1173, DOI 10.1053/jhep.2001.24267; Hutson S, 2010, NAT MED, V16, P10, DOI 10.1038/nm0110-10a; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Lee WM, 2007, HEPATOLOGY, V46, P966, DOI 10.1002/hep.21926; Lee WM, 2009, GASTROENTEROLOGY, V137, P856, DOI 10.1053/j.gastro.2009.06.006; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Lindros KO, 1997, GEN PHARMACOL, V28, P191, DOI 10.1016/S0306-3623(96)00183-8; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; Naiki-Ito A, 2010, TOXICOL PATHOL, V38, P280, DOI 10.1177/0192623309357951; Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Platt R, 2008, PHARMACOEPIDEM DR S, V17, P1175, DOI 10.1002/pds.1668; Rohr S, 2004, CARDIOVASC RES, V62, P309, DOI 10.1016/j.cardiores.2003.11.035; Roth RA, 2010, J PHARMACOL EXP THER, V332, P692, DOI 10.1124/jpet.109.162651; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Shenton JM, 2004, CHEM-BIOL INTERACT, V150, P53, DOI 10.1016/j.cbi.2004.09.001; Taha AS, 1996, NEW ENGL J MED, V334, P1435, DOI 10.1056/NEJM199605303342204; Tao L, 2007, MOL PHARMACOL, V71, P570, DOI 10.1124/mol.106.027508; Tujios S, 2011, NAT REV GASTRO HEPAT, V8, P202, DOI 10.1038/nrgastro.2011.22; Wit AL, 2008, AM J PHYSIOL-HEART C, V294, pH16, DOI 10.1152/ajpheart.01031.2007; Wysowski DK, 2005, ARCH INTERN MED, V165, P1363, DOI 10.1001/archinte.165.12.1363	27	90	99	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					179	183		10.1038/nbt.2089	http://dx.doi.org/10.1038/nbt.2089			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22252509	Green Accepted			2022-12-27	WOS:000300269100021
J	Lam, HYK; Clark, MJ; Chen, R; Chen, R; Natsoulis, G; O'Huallachain, M; Dewey, FE; Habegger, L; Ashley, EA; Gerstein, MB; Butte, AJ; Ji, HP; Snyder, M				Lam, Hugo Y. K.; Clark, Michael J.; Chen, Rui; Chen, Rong; Natsoulis, Georges; O'Huallachain, Maeve; Dewey, Frederick E.; Habegger, Lukas; Ashley, Euan A.; Gerstein, Mark B.; Butte, Atul J.; Ji, Hanlee P.; Snyder, Michael			Performance comparison of whole-genome sequencing platforms	NATURE BIOTECHNOLOGY			English	Article							MACULAR DEGENERATION; STRUCTURAL VARIATION; PERSONAL GENOME; SHORT-READ; VARIANTS; GENE; ACCURATE; CFH	Whole-genome sequencing is becoming commonplace, but the accuracy and completeness of variant calling by the most widely used platforms from Illumina and Complete Genomics have not been reported. Here we sequenced the genome of an individual with both technologies to a high average coverage of similar to 76x, and compared their performance with respect to sequence coverage and calling of single-nucleotide variants (SNVs), insertions and deletions (indels). Although 88.1% of the similar to 3.7 million unique SNVs were concordant between platforms, there were tens of thousands of platform-specific calls located in genes and other genomic regions. In contrast, 26.5% of indels were concordant between platforms. Target enrichment validated 92.7% of the concordant SNVs, whereas validation by genotyping array revealed a sensitivity of 99.3%. The validation experiments also suggested that >60% of the platform-specific variants were indeed present in the genome. Our results have important implications for understanding the accuracy and completeness of the genome sequencing platforms.	[Lam, Hugo Y. K.; Clark, Michael J.; Chen, Rui; O'Huallachain, Maeve; Snyder, Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Chen, Rong; Butte, Atul J.] Stanford Univ, Dept Pediat, Div Syst Med, Stanford, CA 94305 USA; [Natsoulis, Georges; Ji, Hanlee P.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Dewey, Frederick E.; Ashley, Euan A.] Stanford Univ, Ctr Inherited Cardiovasc Dis, Div Cardiovasc Med, Stanford, CA 94305 USA; [Habegger, Lukas; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA	Stanford University; Stanford University; Stanford University; Stanford University; Yale University; Yale University; Yale University	Snyder, M (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	O'Huallachain, Maeve/AAO-4312-2020	O'Huallachain, Maeve/0000-0002-0618-6032; Snyder, Michael/0000-0003-0784-7987	Stanford Department of Genetics; US National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357, RC2HG005570, R01HG006137] Funding Source: NIH RePORTER	Stanford Department of Genetics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by the Stanford Department of Genetics and the US National Institutes of Health.	Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Kaur I, 2008, INVEST OPHTH VIS SCI, V49, P1771, DOI 10.1167/iovs.07-0560; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Rios J, 2010, HUM MOL GENET, V19, P4313, DOI 10.1093/hmg/ddq352; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Snyder M, 2010, GENE DEV, V24, P423, DOI 10.1101/gad.1864110; Tam POS, 2008, INVEST OPHTH VIS SCI, V49, P2357, DOI 10.1167/iovs.07-1520; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980	23	207	214	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					78	U118		10.1038/nbt.2065	http://dx.doi.org/10.1038/nbt.2065			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22178993	Green Accepted			2022-12-27	WOS:000299110600023
J	Reumers, J; De Rijk, P; Zhao, H; Liekens, A; Smeets, D; Cleary, J; Van Loo, P; Van Den Bossche, M; Catthoor, K; Sabbe, B; Despierre, E; Vergote, I; Hilbush, B; Lambrechts, D; Del-Favero, J				Reumers, Joke; De Rijk, Peter; Zhao, Hui; Liekens, Anthony; Smeets, Dominiek; Cleary, John; Van Loo, Peter; Van Den Bossche, Maarten; Catthoor, Kirsten; Sabbe, Bernard; Despierre, Evelyn; Vergote, Ignace; Hilbush, Brian; Lambrechts, Diether; Del-Favero, Jurgen			Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing	NATURE BIOTECHNOLOGY			English	Article							COMPUTATIONAL TOOL; MUTATIONS; FRAMEWORK; SPECTRUM; DATABASE; BROWSER; COMMON	Distinguishing single-nucleotide variants (SNVs) from errors in whole-genome sequences remains challenging. Here we describe a set of filters, together with a freely accessible software tool, that selectively reduce error rates and thereby facilitate variant detection in data from two short-read sequencing technologies, Complete Genomics and Illumina. By sequencing the nearly identical genomes from monozygotic twins and considering shared SNVs as 'true variants' and discordant SNVs as 'errors', we optimized thresholds for 12 individual filters and assessed which of the 1,048 filter combinations were effective in terms of sensitivity and specificity. Cumulative application of all effective filters reduced the error rate by 290-fold, facilitating the identification of genetic differences between monozygotic twins. We also applied an adapted, less stringent set of filters to reliably identify somatic mutations in a highly rearranged tumor and to identify variants in the NA19240 HapMap genome relative to a reference set of SNVs.	[Reumers, Joke; Zhao, Hui; Smeets, Dominiek; Lambrechts, Diether] VIB, Vesalius Res Ctr, Louvain, Belgium; [Reumers, Joke; Zhao, Hui; Smeets, Dominiek; Lambrechts, Diether] Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [De Rijk, Peter; Liekens, Anthony; Van Den Bossche, Maarten; Del-Favero, Jurgen] VIB, Appl Mol Genom Grp, Dept Mol Genet, Antwerp, Belgium; [De Rijk, Peter; Liekens, Anthony; Van Den Bossche, Maarten; Del-Favero, Jurgen] Univ Antwerp, Appl Mol Genom Grp, B-2020 Antwerp, Belgium; [Cleary, John; Hilbush, Brian] Real Time Genom, San Francisco, CA USA; [Van Loo, Peter] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Van Loo, Peter] Univ Leuven, Dept Human Genet, Louvain, Belgium; [Van Den Bossche, Maarten; Sabbe, Bernard] Univ Antwerp, CAPRI, Fac Med, B-2020 Antwerp, Belgium; [Van Den Bossche, Maarten; Sabbe, Bernard] PC Sint Norbertushuis, Duffel, Belgium; [Catthoor, Kirsten] ZNA Psychiat Hosp Stuivenberg, Antwerp, Belgium; [Despierre, Evelyn; Vergote, Ignace] Univ Hosp Gasthuisberg, Div Gynaecol Oncol, Dept Obstet & Gynaecol, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Antwerp; KU Leuven; University Hospital Leuven	Lambrechts, D (corresponding author), VIB, Vesalius Res Ctr, Louvain, Belgium.	diether.lambrechts@vib-kuleuven.be; jurgen.delfavero@molgen.vib-ua.be	Sabbe, Bernard/J-3598-2013; Lambrechts, Diether/AAJ-3167-2020; De Rijk, Peter/GXH-9837-2022; Van Loo, Peter/A-3287-2012; Verdrengh, Evelien/H-4571-2012	Sabbe, Bernard/0000-0002-1426-802X; Lambrechts, Diether/0000-0002-3429-302X; De Rijk, Peter/0000-0001-8558-9288; Van Loo, Peter/0000-0003-0292-1949; Del Favero, jurgen/0000-0002-7427-7489; Reumers, Joke/0000-0001-5434-6515; Van Den Bossche, Maarten/0000-0002-2989-6600	Fund for Scientific Research Flanders (FWO-F); Agency for Innovation by Science and Technology (IWT); Stichting tegen Kanker, FWO-F; KULeuven [KULPFV/10/016-SymBioSysII]	Fund for Scientific Research Flanders (FWO-F)(FWO); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Stichting tegen Kanker, FWO-F; KULeuven(KU Leuven)	We appreciate the assistance of M. Veugelers and S. Plaisance (VIB Technology Watch). We acknowledge G. Peuteman, T. Van Brussel, S. Cammaerts, M. Strazisar and the Genetic Service Facility (http://www.vibgeneticservicefacility.be/) for technical assistance. We highly appreciate the helpful comments from the reviewers. The research was supported by the Fund for Scientific Research Flanders (FWO-F) to J.R. and P.V.L., the Agency for Innovation by Science and Technology (IWT) to M.V.D.B., the Stichting tegen Kanker, FWO-F and the KULeuven (KULPFV/10/016-SymBioSysII)) to D.L.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gorringe KL, 2009, MOL ONCOL, V3, P157, DOI 10.1016/j.molonc.2008.12.005; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Karlsson H, 2001, P NATL ACAD SCI USA, V98, P4634, DOI 10.1073/pnas.061021998; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Leunen K, 2009, HUM MUTAT, V30, P1693, DOI 10.1002/humu.21135; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Sheridan C, 2011, NAT BIOTECHNOL, V29, P463, DOI [10.1038/nbt0611-465, 10.1038/nbt.1901]; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316	49	164	165	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					61	U103		10.1038/nbt.2053	http://dx.doi.org/10.1038/nbt.2053			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22178994	Bronze			2022-12-27	WOS:000299110600021
J	Baltera, B				Baltera, Bob			Shape shifting	NATURE BIOTECHNOLOGY			English	Editorial Material								Faced with limited funding and the need to find the most time- and cost-efficient route to proof of concept and relevance, how should you reorganize your company to facilitate development of your most valuable assets?	[Baltera, Bob] Amira Pharmaceut, San Diego, CA USA			info@panmira.com						2008, NAT MED, V14, P45	1	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1069	1071		10.1038/bioe.2011.10	http://dx.doi.org/10.1038/bioe.2011.10			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22158353				2022-12-27	WOS:000298038700008
J	Peng, W				Peng, Wayne			Drug pipeline: Q311	NATURE BIOTECHNOLOGY			English	News Item																			0	1	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					859	859		10.1038/nbt.1999	http://dx.doi.org/10.1038/nbt.1999			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21997619	Bronze			2022-12-27	WOS:000296273000005
J	Guilinger, JP; Thompson, DB; Liu, DR				Guilinger, John P.; Thompson, David B.; Liu, David R.			Fusion of catalytically inactive Cas9 to Fokl nuclease improves the specificity of genome modification	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; DNA-CLEAVAGE; HUMAN-CELLS; TARGET DNA; RNA; CRISPR; NICKASES; PROTEINS; IMMUNITY; REVEALS	Genome editing by Cas9, which cleaves double-stranded DNA at a sequence programmed by a short single-guide RNA (sgRNA), can result in off-target DNA modification that may be detrimental in some applications. To improve DNA cleavage specificity, we generated fusions of catalytically inactive Cas9 and Fokl nuclease (fCas9). DNA cleavage by fCas9 requires association of two fCas9 monomers that simultaneously bind target sites similar to 15 or 25 base pairs apart. In human cells, fCas9 modified target DNA sites with > 140-fold higher specificity than wild-type Cas9 and with an efficiency similar to that of paired Cas9 'nickases', recently engineered variants that cleave only one DNA strand per monomer. The specificity of fCas9 was at least fourfold higher than that of paired nickases at loci with highly similar off-target sites. Target sites that conform to the substrate requirements of fCas9 occur on average every 34 bp in the human genome, suggesting the versatility of this approach for highly specific genome-wide editing.	[Guilinger, John P.; Thompson, David B.; Liu, David R.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Guilinger, John P.; Thompson, David B.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022; Wilson, Matthew H/K-3193-2013		Defense Advanced Research Projects Agency [HR0011-11-2-0003, N66001-12-C-4207]; US National Institutes of Health [NIGMS R01 GM095501]; Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095501] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.P.G., D.B.T. and D.R.L. were supported by Defense Advanced Research Projects Agency HR0011-11-2-0003 and N66001-12-C-4207, US National Institutes of Health NIGMS R01 GM095501 (D.R.L.) and the Howard Hughes Medical Institute (HHMI). D.R.L. was supported as a HHMI Investigator. We thank R. McDonald for technical assistance and V. Pattanayak for helpful comments.	Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/nmeth.2364, 10.1038/NMETH.2364]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sander JD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt716; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Vanamee ES, 2001, J MOL BIOL, V309, P69, DOI 10.1006/jmbi.2001.4635; Wang JB, 2012, GENOME RES, V22, P1316, DOI 10.1101/gr.122879.111; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889	32	582	805	7	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					577	+		10.1038/nbt.2909	http://dx.doi.org/10.1038/nbt.2909			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24770324	Green Accepted			2022-12-27	WOS:000337233800021
J	Senior, M				Senior, Melanie			Going it alone	NATURE BIOTECHNOLOGY			English	News Item																		[Anonymous], 2013, NAT BIOTECHNOL, V31, P1	1	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					411	414		10.1038/nbt.2896	http://dx.doi.org/10.1038/nbt.2896			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24811507				2022-12-27	WOS:000336036100008
J	Beug, ST; Tang, VA; LaCasse, EC; Cheung, HH; Beauregard, CE; Brun, J; Nuyens, JP; Earl, N; St-Jean, M; Holbrook, J; Dastidar, H; Mahoney, DJ; Ilkow, C; Le Boeuf, F; Bell, JC; Korneluk, RG				Beug, Shawn T.; Tang, Vera A.; LaCasse, Eric C.; Cheung, Herman H.; Beauregard, Caroline E.; Brun, Jan; Nuyens, Jeffrey P.; Earl, Nathalie; St-Jean, Martine; Holbrook, Janelle; Dastidar, Himika; Mahoney, Douglas J.; Ilkow, Carolina; Le Boeuf, Fabrice; Bell, John C.; Korneluk, Robert G.			Smac mimetics and innate immune stimuli synergize to promote tumor death	NATURE BIOTECHNOLOGY			English	Article							NF-KAPPA-B; APOPTOSIS PROTEINS; ONCOLYTIC VIRUSES; VACCINIA VIRUS; IAP ANTAGONIST; CANCER-CELL; ALPHA; RECOGNITION; INTERFERON; INHIBITORS	Smac mimetic compounds (SMC), a class of drugs that sensitize cells to apoptosis by counteracting the activity of inhibitor of apoptosis (IAP) proteins, have proven safe in phase 1 clinical trials in cancer patients. However, because SMCs act by enabling transduction of pro-apoptotic signals, SMC monotherapy may be efficacious only in the subset of patients whose tumors produce large quantities of death-inducing proteins such as inflammatory cytokines. Therefore, we reasoned that SMCs would synergize with agents that stimulate a potent yet safe "cytokine storm." Here we show that oncolytic viruses and adjuvants such as poly(I: C) and CpG induce bystander death of cancer cells treated with SMCs that is mediated by interferon beta (IFN-beta), tumor necrosis factor alpha (TNF-alpha) and/or TNF-related apoptosis-inducing ligand (TRAIL). This combinatorial treatment resulted in tumor regression and extended survival in two mouse models of cancer. As these and other adjuvants have been proven safe in clinical trials, it may be worthwhile to explore their clinical efficacy in combination with SMCs.	[Beug, Shawn T.; Tang, Vera A.; LaCasse, Eric C.; Cheung, Herman H.; Beauregard, Caroline E.; Brun, Jan; Nuyens, Jeffrey P.; Earl, Nathalie; St-Jean, Martine; Holbrook, Janelle; Korneluk, Robert G.] Eastern Ontario Res Inst, Childrens Hosp, Apoptosis Res Ctr, Solange Gauthier Karsh Mol Genet Lab, Ottawa, ON, Canada; [Dastidar, Himika; Mahoney, Douglas J.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Ilkow, Carolina; Le Boeuf, Fabrice; Bell, John C.] Ottawa Hosp Res Inst, Ctr Innovat Canc Therapeut, Ottawa, ON, Canada; [Bell, John C.; Korneluk, Robert G.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Calgary; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Korneluk, RG (corresponding author), Eastern Ontario Res Inst, Childrens Hosp, Apoptosis Res Ctr, Solange Gauthier Karsh Mol Genet Lab, Ottawa, ON, Canada.	bob@arc.cheo.ca		Ilkow, Carolina/0000-0003-3488-4062	Canadian Institutes of Health Research (CIHR, MOP) [86627]; Ottawa Regional Cancer Foundation (ORCF); Ottawa Kiwanis Medical Foundation; Children's Hospital of Eastern Ontario (CHEO) Foundation; The Lotte & John Hecht Memorial Foundation Innovation Grant of the Canadian Cancer Society; OICR; The Terry Fox Foundation; Alliance for Cancer Gene Therapy (USA); CIHR; Alberta Innovates [201201214] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR, MOP)(Canadian Institutes of Health Research (CIHR)); Ottawa Regional Cancer Foundation (ORCF); Ottawa Kiwanis Medical Foundation; Children's Hospital of Eastern Ontario (CHEO) Foundation; The Lotte & John Hecht Memorial Foundation Innovation Grant of the Canadian Cancer Society; OICR; The Terry Fox Foundation; Alliance for Cancer Gene Therapy (USA); CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	We thank D. Porter, B. Firestone, L. Zawel and J.S. Cameron of Novartis for providing LCL161. We thank S. Wang (University of Michigan) for providing SM-122 and SM-164. We thank R. Al-awar and her medicinal chemistry team at the Ontario Institute for Cancer Research (OICR) for providing OICR720. We thank S. Pichette for her assistance with the creation of VSV Delta 51-TNF-alpha. This work is supported by grants awarded to R.G.K. by the Canadian Institutes of Health Research (CIHR, MOP #86627), the Ottawa Regional Cancer Foundation (ORCF), the Ottawa Kiwanis Medical Foundation, the Children's Hospital of Eastern Ontario (CHEO) Foundation, and The Lotte & John Hecht Memorial Foundation Innovation Grant of the Canadian Cancer Society. J.C.B. is supported by OICR and The Terry Fox Foundation. F. L.B. was supported by an industrial fellowship from CIHR. D.J.M. is the recipient of a New Investigator Award from the Alliance for Cancer Gene Therapy (USA). R.G.K. is a Fellow of the Royal Society of Canada and a distinguished professor of the University of Ottawa. We thank D. Stojdl (Children's Hospital of Eastern Ontario Research Institute) for SNB75.	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Beug ST, 2012, TRENDS IMMUNOL, V33, P535, DOI 10.1016/j.it.2012.06.004; Bose S, 2003, P NATL ACAD SCI USA, V100, P10890, DOI 10.1073/pnas.1832775100; Breitbach CJ, 2007, MOL THER, V15, P1686, DOI 10.1038/sj.mt.6300215; Brun J, 2010, MOL THER, V18, P1440, DOI 10.1038/mt.2010.103; Butowski N, 2009, J NEURO-ONCOL, V91, P175, DOI 10.1007/s11060-008-9693-3; Butowski N, 2009, J NEURO-ONCOL, V91, P183, DOI 10.1007/s11060-008-9705-3; Cantaert T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3150; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen KF, 2012, BIOCHEM PHARMACOL, V84, P268, DOI 10.1016/j.bcp.2012.04.023; Cheung HH, 2010, J BIOL CHEM, V285, P40612, DOI 10.1074/jbc.M110.183616; Cheung HH, 2009, CANCER RES, V69, P7729, DOI 10.1158/0008-5472.CAN-09-1794; CHOU TC, 1977, J BIOL CHEM, V252, P6438; Dhuria S, 2013, J CLIN PHARMACOL, V53, P642, DOI 10.1002/jcph.79; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Enwere EK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003086; Erickson RI, 2013, TOXICOL SCI, V131, P247, DOI 10.1093/toxsci/kfs265; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Houghton PJ, 2012, PEDIATR BLOOD CANCER, V58, P636, DOI 10.1002/pbc.23167; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Krieg AM, 2012, NUCLEIC ACID THER, V22, P77, DOI 10.1089/nat.2012.0340; LaCasse EC, 2013, CANCER LETT, V332, P215, DOI 10.1016/j.canlet.2012.06.015; Le Boeuf F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2974; Le Boeuf F, 2010, MOL THER, V18, P888, DOI 10.1038/mt.2010.44; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Lu JF, 2011, MOL CANCER THER, V10, P902, DOI 10.1158/1535-7163.MCT-10-0864; Lun XQ, 2010, MOL THER, V18, P1927, DOI 10.1038/mt.2010.183; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; McFadden G, 2009, NAT REV IMMUNOL, V9, P645, DOI 10.1038/nri2623; Mikus Judith, 2000, Parasitology International, V48, P265, DOI 10.1016/S1383-5769(99)00020-3; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rosenfeld MR, 2010, NEURO-ONCOLOGY, V12, P1071, DOI 10.1093/neuonc/noq071; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Sun HY, 2007, J AM CHEM SOC, V129, P15279, DOI 10.1021/ja074725f; Vaha-Koskela MJV, 2013, J VIROL, V87, P2363, DOI 10.1128/JVI.01609-12; Vandenabeele P, 2012, NAT REV IMMUNOL, V12, P833, DOI 10.1038/nri3325; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wong H, 2012, TOXICOL SCI, V130, P205, DOI 10.1093/toxsci/kfs235; Yarilina A, 2010, CURR DIR AUTOIMMUN, V11, P94, DOI 10.1159/000289199	47	92	99	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					182	+		10.1038/nbt.2806	http://dx.doi.org/10.1038/nbt.2806			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24463573	Green Accepted			2022-12-27	WOS:000331074000024
J	Georgiou, G; Ippolito, GC; Beausang, J; Busse, CE; Wardemann, H; Quake, SR				Georgiou, George; Ippolito, Gregory C.; Beausang, John; Busse, Christian E.; Wardemann, Hedda; Quake, Stephen R.			The promise and challenge of high-throughput sequencing of the antibody repertoire	NATURE BIOTECHNOLOGY			English	Review							MEMORY B-CELLS; HUMAN-IMMUNOGLOBULIN HEAVY; HUMAN MONOCLONAL-ANTIBODIES; MINIMAL RESIDUAL DISEASE; NEUTRALIZING ANTIBODIES; GENE REPERTOIRE; V-H; HIV-1-NEUTRALIZING ANTIBODIES; SOMATIC HYPERMUTATION; SELF-REACTIVITY	Efforts to determine the antibody repertoire encoded by B cells in the blood or lymphoid organs using high-throughput DNA sequencing technologies have been advancing at an extremely rapid pace and are transforming our understanding of humoral immune responses. Information gained from high-throughput DNA sequencing of immunoglobulin genes (Ig-seq) can be applied to detect B-cell malignancies with high sensitivity, to discover antibodies specific for antigens of interest, to guide vaccine development and to understand autoimmunity. Rapid progress in the development of experimental protocols and informatics analysis tools is helping to reduce sequencing artifacts, to achieve more precise quantification of clonal diversity and to extract the most pertinent biological information. That said, broader application of Ig-seq, especially in clinical settings, will require the development of a standardized experimental design framework that will enable the sharing and meta-analysis of sequencing data generated by different laboratories.	[Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Georgiou, George; Ippolito, Gregory C.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Georgiou, George; Ippolito, Gregory C.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Beausang, John; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Beausang, John; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Busse, Christian E.; Wardemann, Hedda] Max Planck Inst Infect Biol, Berlin, Germany; [Quake, Stephen R.] Stanford Univ, Biophys Grad Program, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Stanford University; Howard Hughes Medical Institute; Stanford University; Max Planck Society; Stanford University; Stanford University	Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	gg@che.utexas.edu	Ippolito, Gregory C./AAR-2930-2021	Ippolito, Gregory C./0000-0002-7565-7002; Busse, Christian/0000-0001-7553-905X; Wardemann, Hedda/0000-0003-3921-5933	Clayton Foundation; Defense Threat Reduction Agency; US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	Clayton Foundation; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. DeKosky, J. Lavinder & K. Hon Hoi for reading this manuscript; J. Lavinder and C. Chrysostomou for help with the figures; and A. Fire for coining the term Ig-seq. We are also very grateful to the Nature Biotechnology Editorial staff for their meticulous editing and for numerous useful suggestions. This work was supported by grants from the Clayton Foundation, Defense Threat Reduction Agency and US National Institutes of Health (G.G.).	Ademokun A, 2011, AGING CELL, V10, P922, DOI 10.1111/j.1474-9726.2011.00732.x; Amara K, 2013, J EXP MED, V210, P445, DOI 10.1084/jem.20121486; [Anonymous], 2013, SCI TRANSL MED; Aoki-Ota M, 2012, J IMMUNOL, V188, P2305, DOI 10.4049/jimmunol.1103484; Apostoaei AJ, 2010, REV SYNTHESIS APPL I; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Baum PD, 2012, EUR J IMMUNOL, V42, P2834, DOI 10.1002/eji.201242999; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Benichou J, 2013, J IMMUNOL, V190, P5567, DOI 10.4049/jimmunol.1201929; Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Bolotin DA, 2012, EUR J IMMUNOL, V42, P3073, DOI 10.1002/eji.201242517; Boyd SD, 2013, CURR OPIN IMMUNOL, V25, P511, DOI 10.1016/j.coi.2013.07.007; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Brady BL, 2010, J IMMUNOL, V185, P3801, DOI 10.4049/jimmunol.1001158; Briney BS, 2012, GENES IMMUN, V13, P523, DOI 10.1038/gene.2012.28; Briney BS, 2012, GENES IMMUN, V13, P469, DOI 10.1038/gene.2012.20; Briney BS, 2012, IMMUNOLOGY, V137, P56, DOI 10.1111/j.1365-2567.2012.03605.x; Brusic V, 2014, NAT BIOTECHNOL, V32, P146, DOI 10.1038/nbt.2777; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Busse CE, 2014, EUR J IMMUNOL, V44, P597, DOI 10.1002/eji.201343917; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; CAPRA JD, 1974, P NATL ACAD SCI USA, V71, P845, DOI 10.1073/pnas.71.3.845; Castro R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003098; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chen Zhiliang, 2010, Immunome Res, V6 Suppl 1, pS4, DOI 10.1186/1745-7580-6-S1-S4; Cheung WC, 2012, NAT BIOTECHNOL, V30, P447, DOI 10.1038/nbt.2167; Church G. M., 2013, US Patent, Patent No. [US20130296535, 20130296535]; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Darzentas Nikos, 2013, Methods Mol Biol, V971, P135, DOI 10.1007/978-1-62703-269-8_8; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; Edgar R, 2006, NAT BIOTECHNOL, V24, P1471, DOI 10.1038/nbt1206-1471; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; Faham M, 2012, BLOOD, V120, P5173, DOI 10.1182/blood-2012-07-444042; Fischer N, 2011, MABS-AUSTIN, V3, P17, DOI 10.4161/mabs.3.1.14169; Fu GK, 2011, P NATL ACAD SCI USA, V108, P9026, DOI 10.1073/pnas.1017621108; Gawad C, 2012, BLOOD, V120, P4407, DOI 10.1182/blood-2012-05-429811; Ge X, 2010, BIOTECHNOL BIOENG, V106, P347, DOI 10.1002/bit.22712; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Gronwall C, 2012, J IMMUNOL, V189, P850, DOI 10.4049/jimmunol.1200245; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; He J, 2011, ONCOTARGET, V2, P178; HIBI T, 1986, EUR J IMMUNOL, V16, P139, DOI 10.1002/eji.1830160206; Hirano M, 2013, NATURE, V501, P435, DOI 10.1038/nature12467; Hoi KH, 2013, GENES IMMUN, V14, P271, DOI 10.1038/gene.2013.10; Ippolito GC, 2006, J EXP MED, V203, P1567, DOI 10.1084/jem.20052217; Ippolito GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035497; Jackson KJL, 2012, IMMUNOGENETICS, V64, P3, DOI 10.1007/s00251-011-0559-z; Janeway C., 2004, IMMUNOBIOLOGY; Jiang N, 2011, P NATL ACAD SCI USA, V108, P5348, DOI 10.1073/pnas.1014277108; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kidd BA, 2014, NAT IMMUNOL, V15, P118, DOI 10.1038/ni.2787; Kidd MJ, 2012, J IMMUNOL, V188, P1333, DOI 10.4049/jimmunol.1102097; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; Klein U, 1997, BLOOD, V89, P1288, DOI 10.1182/blood.V89.4.1288; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Krause JC, 2011, J IMMUNOL, V187, P3704, DOI 10.4049/jimmunol.1101823; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; Lakhani KR, 2013, NAT BIOTECHNOL, V31, P108, DOI 10.1038/nbt.2495; Larimore K, 2012, J IMMUNOL, V189, P3221, DOI 10.4049/jimmunol.1201303; Larman HB, 2012, P NATL ACAD SCI USA, V109, P18523, DOI 10.1073/pnas.1215549109; Larsen PA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-52; Lavinder J.J., 2013, US patent, Patent No. 20130178370; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; Logan AC, 2011, P NATL ACAD SCI USA, V108, P21194, DOI 10.1073/pnas.1118357109; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Maecker HT, 2012, NAT REV RHEUMATOL, V8, P317, DOI 10.1038/nrrheum.2012.66; Mahon CM, 2013, J MOL BIOL, V425, P1712, DOI 10.1016/j.jmb.2013.02.015; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Mehr R, 2012, IMMUNOL LETT, V148, P11, DOI 10.1016/j.imlet.2012.08.002; Meijer PJ, 2006, J MOL BIOL, V358, P764, DOI 10.1016/j.jmb.2006.02.040; Michaeli M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00386; Mohr S, 2013, RNA, V19, P958, DOI 10.1261/rna.039743.113; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Nguyen Phuong, 2011, BMC Genomics, V12, P106, DOI 10.1186/1471-2164-12-106; Ota M, 2010, J IMMUNOL, V185, P4128, DOI 10.4049/jimmunol.1002176; Parameswaran P, 2013, CELL HOST MICROBE, V13, P691, DOI 10.1016/j.chom.2013.05.008; Prabakaran Ponraj, 2012, Front Microbiol, V3, P277, DOI 10.3389/fmicb.2012.00277; Prabakaran Ponraj, 2011, BMC Res Notes, V4, P404, DOI 10.1186/1756-0500-4-404; Racanelli V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025606; Ravn U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq789; Ravn U, 2013, METHODS, V60, P99, DOI 10.1016/j.ymeth.2013.03.001; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Rempala GA, 2011, J THEOR BIOL, V269, P1, DOI 10.1016/j.jtbi.2010.10.001; Rubelt F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049774; Saggy I, 2012, PROTEIN ENG DES SEL, V25, P539, DOI 10.1093/protein/gzs060; Sato S, 2012, NAT BIOTECHNOL, V30, P1039, DOI 10.1038/nbt.2406; Scheid JF, 2011, P NATL ACAD SCI USA, V108, P18044, DOI 10.1073/pnas.1113395108; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Schoettler N, 2012, MOL IMMUNOL, V51, P273, DOI 10.1016/j.molimm.2012.03.028; Schroeder HW, 2006, DEV COMP IMMUNOL, V30, P119, DOI 10.1016/j.dci.2005.06.006; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Silverstein A M, 1979, Cell Immunol, V42, P1; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Tschumper RC, 2012, ONCOTARGET, V3, P502; Varettoni M, 2013, LEUKEMIA LYMPHOMA, V54, P2485, DOI 10.3109/10428194.2013.779689; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110; von Budingen HC, 2012, J CLIN INVEST, V122, P4533, DOI 10.1172/JCI63842; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Wang Y, 2011, SCAND J IMMUNOL, V73, P496, DOI 10.1111/j.1365-3083.2011.02525.x; Wang Y, 2011, IMMUNOGENETICS, V63, P259, DOI 10.1007/s00251-010-0510-8; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Watson CT, 2013, AM J HUM GENET, V92, P530, DOI 10.1016/j.ajhg.2013.03.004; Weinstein JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067624; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Wenniger LJMD, 2013, HEPATOLOGY, V57, P2390, DOI 10.1002/hep.26232; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Wiley SR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002135; Wilson PC, 2012, NAT REV IMMUNOL, V12, P709, DOI 10.1038/nri3285; Wine Y, 2013, P NATL ACAD SCI USA, V110, P2993, DOI 10.1073/pnas.1213737110; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu LY, 2012, J IMMUNOL, V188, P322, DOI 10.4049/jimmunol.1102466; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yaari G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks457; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007; Zhang ZX, 2007, TRENDS IMMUNOL, V28, P132, DOI 10.1016/j.it.2007.01.003; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110; Zhu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00315	140	418	444	3	194	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					158	168		10.1038/nbt.2782	http://dx.doi.org/10.1038/nbt.2782			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24441474	Green Accepted, Bronze, Green Published			2022-12-27	WOS:000331074000021
J	Mendenhall, EM; Williamson, KE; Reyon, D; Zou, JY; Ram, O; Joung, JK; Bernstein, BE				Mendenhall, Eric M.; Williamson, Kaylyn E.; Reyon, Deepak; Zou, James Y.; Ram, Oren; Joung, J. Keith; Bernstein, Bradley E.			Locus-specific editing of histone modifications at endogenous enhancers	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION; TAL EFFECTORS; GENOME; DNA; CHROMATIN; TRANSCRIPTION; DEMETHYLATION; ELEMENTS; REGIONS; CELLS	Mammalian gene regulation is dependent on tissue-specific enhancers that can act across large distances to influence transcriptional activity(1-3). Mapping experiments have identified hundreds of thousands of putative enhancers whose functionality is supported by cell type-specific chromatin signatures and striking enrichments for disease-associated sequence variants(4-11). However, these studies did not address the in vivo functions of the putative elements or their chromatin states and did not determine which genes, if any, a given enhancer regulates. Here we present a strategy to investigate endogenous regulatory elements by selectively altering their chromatin state using programmable reagents. Transcription activator-like (TAL) effector repeat domains fused to the LSD1 histone demethylase efficiently remove enhancer-associated chromatin modifications from target loci, without affecting control regions. We find that inactivation of enhancer chromatin by these fusion proteins frequently causes downregulation of proximal genes, revealing enhancer target genes. Our study demonstrates the potential of epigenome editing tools to characterize an important class of functional genomic elements.	[Mendenhall, Eric M.; Williamson, Kaylyn E.; Zou, James Y.; Ram, Oren; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Mendenhall, Eric M.; Williamson, Kaylyn E.; Reyon, Deepak; Zou, James Y.; Ram, Oren; Joung, J. Keith; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mendenhall, Eric M.; Williamson, Kaylyn E.; Reyon, Deepak; Zou, James Y.; Ram, Oren; Joung, J. Keith; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Mendenhall, Eric M.; Williamson, Kaylyn E.; Reyon, Deepak; Zou, James Y.; Ram, Oren; Joung, J. Keith; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA USA; [Mendenhall, Eric M.; Williamson, Kaylyn E.; Zou, James Y.; Ram, Oren; Bernstein, Bradley E.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Mendenhall, Eric M.; Williamson, Kaylyn E.; Ram, Oren; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Zou, James Y.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University	Bernstein, BE (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	bernstein.bradley@mgh.harvard.edu	Reyon, Deepak/HCH-3183-2022	Mendenhall, Eric/0000-0002-7395-6295; Williamson, Kaylyn/0000-0002-3252-5050	Howard Hughes Medical Institute; National Human Genome Research Institute's ENCODE Project [U54 HG004570, U54 HG006991]; US National Institutes of Health Common Fund for Epigenomics [U01 ES017155]; NIH [DP1 GM105378, P50 HG005550]; Jim and Ann Orr MGH Research Scholar Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570, U54HG006991, P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Human Genome Research Institute's ENCODE Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health Common Fund for Epigenomics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr MGH Research Scholar Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Bernstein laboratory and the Broad Institute's Epigenomics Program and for constructive comments and criticisms. We thank N. Shoresh, S. Kadri, M. Guttman and M. Garber for assistance with analysis. This research was supported by the Howard Hughes Medical Institute (to B.E.B.), the National Human Genome Research Institute's ENCODE Project U54 HG004570, U54 HG006991 (to B.E.B.), US National Institutes of Health Common Fund for Epigenomics U01 ES017155 (to B. E.B.), NIH Director's Pioneer Award DP1 GM105378 (to J.K.J.), NIH P50 HG005550 (to J.K.J.), and the Jim and Ann Orr MGH Research Scholar Award (to J.K.J.).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dhami P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009059; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Ng JH, 2013, DEV CELL, V24, P324, DOI 10.1016/j.devcel.2012.12.011; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Yoon OK, 2010, RNA, V16, P1256, DOI 10.1261/rna.2038810; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	31	264	300	2	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1133	+		10.1038/nbt.2701	http://dx.doi.org/10.1038/nbt.2701			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24013198	Green Accepted, Green Submitted			2022-12-27	WOS:000328251900027
J	Frampton, GM; Fichtenholtz, A; Otto, GA; Wang, K; Downing, SR; He, J; Schnall-Levin, M; White, J; Sanford, EM; An, P; Sun, J; Juhn, F; Brennan, K; Iwanik, K; Maillet, A; Buell, J; White, E; Zhao, M; Balasubramanian, S; Terzic, S; Richards, T; Banning, V; Garcia, L; Mahoney, K; Zwirko, Z; Donahue, A; Beltran, H; Mosquera, JM; Rubin, MA; Dogan, S; Hedvat, CV; Berger, MF; Pusztai, L; Lechner, M; Boshoff, C; Jarosz, M; Vietz, C; Parker, A; Miller, VA; Ross, JS; Curran, J; Cronin, MT; Stephens, PJ; Lipson, D; Yelensky, R				Frampton, Garrett M.; Fichtenholtz, Alex; Otto, Geoff A.; Wang, Kai; Downing, Sean R.; He, Jie; Schnall-Levin, Michael; White, Jared; Sanford, Eric M.; An, Peter; Sun, James; Juhn, Frank; Brennan, Kristina; Iwanik, Kiel; Maillet, Ashley; Buell, Jamie; White, Emily; Zhao, Mandy; Balasubramanian, Sohail; Terzic, Selmira; Richards, Tina; Banning, Vera; Garcia, Lazaro; Mahoney, Kristen; Zwirko, Zac; Donahue, Amy; Beltran, Himisha; Mosquera, Juan Miguel; Rubin, Mark A.; Dogan, Snjezana; Hedvat, Cyrus V.; Berger, Michael F.; Pusztai, Lajos; Lechner, Matthias; Boshoff, Chris; Jarosz, Mirna; Vietz, Christine; Parker, Alex; Miller, Vincent A.; Ross, Jeffrey S.; Curran, John; Cronin, Maureen T.; Stephens, Philip J.; Lipson, Doron; Yelensky, Roman			Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing	NATURE BIOTECHNOLOGY			English	Article							NEGATIVE BREAST-CANCER; TUMOR SAMPLES; MUTATIONAL PROCESSES; DRUG-SENSITIVITY; LUNG-CANCER; GENES; IMMUNOHISTOCHEMISTRY; IDENTIFICATION; AMPLIFICATION; LANDSCAPE	As more clinically relevant cancer genes are identified, comprehensive diagnostic approaches are needed to match patients to therapies, raising the challenge of optimization and analytical validation of assays that interrogate millions of bases of cancer genomes altered by multiple mechanisms. Here we describe a test based on massively parallel DNA sequencing to characterize base substitutions, short insertions and deletions (indels), copy number alterations and selected fusions across 287 cancer-related genes from routine formalin-fixed and paraffin-embedded (FFPE) clinical specimens. We implemented a practical validation strategy with reference samples of pooled cell lines that model key determinants of accuracy, including mutant allele frequency, indel length and amplitude of copy change. Test sensitivity achieved was 95-99% across alteration types, with high specificity (positive predictive value >99%). We confirmed accuracy using 249 FFPE cancer specimens characterized by established assays. Application of the test to 2,221 clinical cases revealed clinically actionable alterations in 76% of tumors, three times the number of actionable alterations detected by current diagnostic tests.	[Frampton, Garrett M.; Fichtenholtz, Alex; Otto, Geoff A.; Wang, Kai; Downing, Sean R.; He, Jie; Schnall-Levin, Michael; White, Jared; Sanford, Eric M.; An, Peter; Sun, James; Juhn, Frank; Brennan, Kristina; Iwanik, Kiel; Maillet, Ashley; Buell, Jamie; White, Emily; Zhao, Mandy; Balasubramanian, Sohail; Terzic, Selmira; Richards, Tina; Banning, Vera; Garcia, Lazaro; Mahoney, Kristen; Zwirko, Zac; Donahue, Amy; Jarosz, Mirna; Vietz, Christine; Parker, Alex; Miller, Vincent A.; Ross, Jeffrey S.; Curran, John; Cronin, Maureen T.; Stephens, Philip J.; Lipson, Doron; Yelensky, Roman] Fdn Med, Cambridge, MA USA; [Beltran, Himisha] Cornell Univ, Weill Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY 10021 USA; [Beltran, Himisha; Mosquera, Juan Miguel; Rubin, Mark A.] Weill Cornell Med Coll, Inst Precis Med, New York, NY USA; [Beltran, Himisha; Mosquera, Juan Miguel; Rubin, Mark A.] New York Presbyterian Hosp, New York, NY USA; [Mosquera, Juan Miguel; Rubin, Mark A.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Dogan, Snjezana; Hedvat, Cyrus V.; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Pusztai, Lajos] Yale Univ, Sch Med, Yale Canc Ctr, Genet & Genom Program, New Haven, CT USA; [Lechner, Matthias; Boshoff, Chris] UCL, UCL Canc Inst, London, England; [Ross, Jeffrey S.] Albany Med Coll, Dept Pathol & Lab Med, Albany, NY 12208 USA	Foundation Medicine; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Cornell University; Memorial Sloan Kettering Cancer Center; Yale University; University of London; University College London; Albany Medical College	Lipson, D (corresponding author), Fdn Med, Cambridge, MA USA.	dlipson@foundationmedicine.com; ryelensky@foundationmedicine.com	Pusztai, Lajos/AAB-2901-2019	Rubin, Mark/0000-0002-8321-9950; Frampton, Garrett/0000-0002-2361-2750; HEDVAT, CYRUS/0000-0003-0045-3491; Sanford, Eric/0000-0002-9232-9334	Damon Runyon Cancer Research Foundation [CI-67-13]; Wellcome Trust Fellowship [WT093855MA]; Austrian Science Fund [J2856]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Wellcome Trust Fellowship(Wellcome Trust); Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge L. Gay for advice and assistance with manuscript preparation. H. B. is the Damon Runyon-Gordon Family Clinical Investigator supported (in part) by the Damon Runyon Cancer Research Foundation (CI-67-13). M. L. was supported by a Wellcome Trust Fellowship (WT093855MA) and by the Austrian Science Fund (J2856).	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Djordjeyic B, 2012, MODERN PATHOL, V25, P699, DOI 10.1038/modpathol.2011.208; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Giulino-Roth L, 2012, BLOOD, V120, P5181, DOI 10.1182/blood-2012-06-437624; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043192; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Lovly CM, 2013, J CLIN ONCOL S, V31; MacConaill LE, 2010, J CLIN ONCOL, V28, P5219, DOI 10.1200/JCO.2009.27.4944; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Mardis ER, 2012, CURR OPIN GENET DEV, V22, P245, DOI 10.1016/j.gde.2012.03.005; McCourt CM, 2013, J CLIN PATHOL, V66, P58, DOI 10.1136/jclinpath-2012-201140; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pao W., P AM THORAC SOC; Reis JS, 2006, MODERN PATHOL, V19, P999, DOI 10.1038/modpathol.3800621; Ross JS, 2011, BIOMARK MED, V5, P307, DOI [10.2217/BMM.11.31, 10.2217/bmm.11.31]; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Stegmeier F, 2010, CLIN PHARMACOL THER, V87, P543, DOI 10.1038/clpt.2009.297; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Swanton C, 2012, LANCET ONCOL, V13, P668, DOI 10.1016/S1470-2045(12)70312-1; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Yau C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r92	53	1357	1439	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					1023	+		10.1038/nbt.2696	http://dx.doi.org/10.1038/nbt.2696			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24142049	Green Accepted			2022-12-27	WOS:000326921200025
J	Guerette, PA; Hoon, S; Seow, Y; Raida, M; Masic, A; Wong, FT; Ho, VHB; Kong, KW; Demirel, MC; Pena-Francesch, A; Amini, S; Tay, GZ; Ding, D; Miserez, A				Guerette, Paul A.; Hoon, Shawn; Seow, Yiqi; Raida, Manfred; Masic, Admir; Wong, Fong T.; Ho, Vincent H. B.; Kong, Kiat Whye; Demirel, Melik C.; Pena-Francesch, Abdon; Amini, Shahrouz; Tay, Gavin Z.; Ding, Dawei; Miserez, Ali			Accelerating the design of biomimetic materials by integrating RNA-seq with proteomics and materials science	NATURE BIOTECHNOLOGY			English	Article							PROTEIN; SILK; ADHESION; QUANTIFICATION; ELASTICITY; FIBERS	Efforts to engineer new materials inspired by biological structures are hampered by the lack of genomic data from many model organisms studied in biomimetic research. Here we show that biomimetic engineering can be accelerated by integrating high-throughput RNA-seq with proteomics and advanced materials characterization. This approach can be applied to a broad range of systems, as we illustrate by investigating diverse high-performance biological materials involved in embryo protection, adhesion and predation. In one example, we rapidly engineer recombinant squid sucker ring teeth proteins into a range of structural and functional materials, including nanopatterned surfaces and photo-cross-linked films that exceed the mechanical properties of most natural and synthetic polymers. Integrating RNA-seq with proteomics and materials science facilitates the molecular characterization of natural materials and the effective translation of their molecular designs into a wide range of bio-inspired materials.	[Guerette, Paul A.; Tay, Gavin Z.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Hoon, Shawn; Seow, Yiqi; Wong, Fong T.; Ho, Vincent H. B.; Kong, Kiat Whye] Agcy Sci Technol & Res, Inst Biomed Sci, Mol Engn Lab, Proteos, Singapore; [Hoon, Shawn; Miserez, Ali] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Raida, Manfred] Agcy Sci Technol & Res, Expt Therapeut Ctr, Nanos, Singapore; [Masic, Admir] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Demirel, Melik C.; Pena-Francesch, Abdon] Penn State Univ, Dept Engn Sci, University Pk, PA 16802 USA; [Demirel, Melik C.; Pena-Francesch, Abdon] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Max Planck Society; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Miserez, A (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.	ali.miserez@ntu.edu.sg	Seow, Yiqi/ABF-7704-2020; Miserez, Ali/D-1074-2010; Miserez, Ali/CAF-2662-2022; Demirel, Melik C/E-3775-2016; Pena-Francesch, Abdon/AAK-1314-2020	Miserez, Ali/0000-0003-0864-8170; Miserez, Ali/0000-0003-0864-8170; Wong, Fong T./0000-0001-6145-5904; Pena-Francesch, Abdon/0000-0002-7779-1651; Demirel, Melik/0000-0003-0466-7649; Amini, Shahrouz/0000-0002-1928-2760; Masic, Admir/0000-0002-1207-4926; Seow, Yiqi/0000-0001-7040-3006	Singapore National Research Foundation (NRF) through a NRF Fellowship; Singapore Ministry of Education Tier 2 grant [MOE2011-T2-2-044]; Agency for Science, Technology and Research (A*Star) of Singapore; US National Institutes of Health [1R21HL112114-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL112114] Funding Source: NIH RePORTER	Singapore National Research Foundation (NRF) through a NRF Fellowship(National Research Foundation, Singapore); Singapore Ministry of Education Tier 2 grant(Ministry of Education, Singapore); Agency for Science, Technology and Research (A*Star) of Singapore(Agency for Science Technology & Research (A*STAR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to H. Waite and S. Brenner for insightful discussions and suggestions. We thank J. Weaver, C. Salinas and D. DeMartini for help with Jumbo squid sucker teeth sample collection. G. Muniraj, L. Sellou and C. Sutanto assisted with extraction and purification of P. viridis and squid sucker teeth proteins. V. Gangu provided informatics support and S. Seah provided assistance with tyrosinase modeling. V. Lipik assisted with the acquisition of MALDI-TOF data. W.M. Guo helped with cell culture experiments. We thank K.S. Tan for his advice on snail biology and animal collection. V. Seow, E. Tay and A. Hermawan helped with sample collection and mechanical testing of P. cochlidium egg cases. This research was funded by the Singapore National Research Foundation (NRF) through a NRF Fellowship (A. Miserez), a Singapore Ministry of Education Tier 2 grant (A. Miserez, MOE2011-T2-2-044) and the Agency for Science, Technology and Research (A*Star) of Singapore (S.H., Y.S., F.T.W., V.H.B.H.). M.C.D. and A.P.-F. were supported by US National Institutes of Health grant no. 1R21HL112114-01.	Armstrong CT, 2011, BIOINFORMATICS, V27, P1908, DOI 10.1093/bioinformatics/btr299; Arslan M, 2011, COMPUT METHOD BIOMEC, V14, P483, DOI 10.1080/10255842.2011.560147; Boyle AL, 2011, CHEM SOC REV, V40, P4295, DOI 10.1039/c0cs00152j; Cranford SW, 2013, ADV MATER, V25, P802, DOI 10.1002/adma.201202553; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328; Dunlop J., 2010, MATER TODAY, V14, P70; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Gosline JM, 1999, J EXP BIOL, V202, P3295; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Guvendiren M, 2008, BIOMACROMOLECULES, V9, P122, DOI 10.1021/bm700886b; Hancock MJ, 2012, ADV FUNCT MATER, V22, P2223, DOI 10.1002/adfm.201103017; Harrington MJ, 2007, J EXP BIOL, V210, P4307, DOI 10.1242/jeb.009753; Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z; Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601; Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157; Jaenicke E, 2010, BIOCHEM J, V426, P373, DOI 10.1042/BJ20091501; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; Kim S, 2012, NAT PHOTONICS, V6, P817, DOI [10.1038/NPHOTON.2012.264, 10.1038/nphoton.2012.264]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Matoba Y, 2011, J BIOL CHEM, V286, P30219, DOI 10.1074/jbc.M111.256818; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miserez A, 2013, CHEM SOC REV, V42, P1973, DOI 10.1039/c2cs35294j; Miserez A, 2009, NAT MATER, V8, P910, DOI [10.1038/NMAT2547, 10.1038/nmat2547]; Miserez A, 2009, ADV MATER, V21, P401, DOI 10.1002/adma.200801197; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Savage KN, 2008, J EXP BIOL, V211, P1937, DOI 10.1242/jeb.014217; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Sendovski M, 2011, J MOL BIOL, V405, P227, DOI 10.1016/j.jmb.2010.10.048; Steinhart M, 2002, SCIENCE, V296, P1997, DOI 10.1126/science.1071210; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477; Waite JH, 2012, J EXP BIOL, V215, P873, DOI 10.1242/jeb.058925; Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602; WAITE JH, 1981, ANAL BIOCHEM, V111, P131, DOI 10.1016/0003-2697(81)90240-2; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Yu J, 2011, NAT CHEM BIOL, V7, P588, DOI [10.1038/NCHEMBIO.630, 10.1038/nchembio.630]; Zhang JE, 2012, P NATL ACAD SCI USA, V109, P11981, DOI 10.1073/pnas.1206210109; Zhao H, 2006, J BIOL CHEM, V281, P11090, DOI 10.1074/jbc.M510792200; Zhao H, 2006, BIOCHEMISTRY-US, V45, P14223, DOI 10.1021/bi061677n; Zok FW, 2007, ACTA MATER, V55, P6365, DOI 10.1016/j.actamat.2007.07.042	53	140	146	7	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2013	31	10					908	+		10.1038/nbt.2671	http://dx.doi.org/10.1038/nbt.2671			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233CA	24013196				2022-12-27	WOS:000325541300019
J	Fu, YF; Foden, JA; Khayter, C; Maeder, ML; Reyon, D; Joung, JK; Sander, JD				Fu, Yanfang; Foden, Jennifer A.; Khayter, Cyd; Maeder, Morgan L.; Reyon, Deepak; Joung, J. Keith; Sander, Jeffry D.			High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; SYSTEMS; ENDONUCLEASE; GENERATION; BACTERIA; ARCHAEA; MICE	Clustered, regularly interspaced, short palindromic repeat (CRISPR) RNA-guided nucleases (RGNs) have rapidly emerged as a facile and efficient platform for genome editing. Here, we use a human cell-based reporter assay to characterize off-target cleavage of CRISPR-associated (Cas) 9-based RGNs. We find that single and double mismatches are tolerated to varying degrees depending on their position along the guide RNA (gRNA)-DNA interface. We also readily detected off-target alterations induced by four out of six RGNs targeted to endogenous loci in human cells by examination of partially mismatched sites. The off-target sites we identified harbored up to five mismatches and many were mutagenized with frequencies comparable to (or higher than) those observed at the intended on-target site. Our work demonstrates that RGNs can be highly active even with imperfectly matched RNA-DNA interfaces in human cells, a finding that might confound their use in research and therapeutic applications.	[Fu, Yanfang; Foden, Jennifer A.; Khayter, Cyd; Maeder, Morgan L.; Reyon, Deepak; Joung, J. Keith; Sander, Jeffry D.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Fu, Yanfang; Foden, Jennifer A.; Khayter, Cyd; Maeder, Morgan L.; Reyon, Deepak; Joung, J. Keith; Sander, Jeffry D.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Fu, Yanfang; Foden, Jennifer A.; Khayter, Cyd; Maeder, Morgan L.; Reyon, Deepak; Joung, J. Keith; Sander, Jeffry D.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Fu, Yanfang; Reyon, Deepak; Joung, J. Keith; Sander, Jeffry D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Maeder, Morgan L.; Joung, J. Keith] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	jjoung@partners.org; jsander@partners.org	Reyon, Deepak/HCH-3183-2022		US National Institutes of Health (NIH) [DP1 GM105378, NIH R01 GM088040, NIH P50 HG005550]; Defense Advanced Research Projects Agency (DARPA) [W911NF-11-2-0056]; Jim and Ann Orr Massachusetts General Hospital Research Scholar Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088040, DP1GM105378] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Jim and Ann Orr Massachusetts General Hospital Research Scholar Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a US National Institutes of Health (NIH) Director's Pioneer Award DP1 GM105378, NIH R01 GM088040, NIH P50 HG005550, Defense Advanced Research Projects Agency (DARPA) W911NF-11-2-0056, and the Jim and Ann Orr Massachusetts General Hospital Research Scholar Award. We thank S.Q. Tsai for helpful discussions and encouragement.	Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	20	2048	2355	21	709	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					822	+		10.1038/nbt.2623	http://dx.doi.org/10.1038/nbt.2623			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	23792628	Green Accepted, Green Submitted			2022-12-27	WOS:000324306300022
J	Liu, Y; Weick, JP; Liu, HS; Krencik, R; Zhang, XQ; Ma, LX; Zhou, GM; Ayala, M; Zhang, SC				Liu, Yan; Weick, Jason P.; Liu, Huisheng; Krencik, Robert; Zhang, Xiaoqing; Ma, Lixiang; Zhou, Guo-min; Ayala, Melvin; Zhang, Su-Chun			Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits	NATURE BIOTECHNOLOGY			English	Article							SPINAL MOTOR-NEURONS; HUMAN ES; CHOLINERGIC NEURONS; BASAL FOREBRAIN; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; EXTRINSIC SIGNALS; DOPAMINE NEURONS; SONIC HEDGEHOG; WORKING-MEMORY	Dysfunction of basal forebrain cholinergic neurons (BFCNs) and gamma-aminobutyric acid (GABA) interneurons, derived from medial ganglionic eminence (MGE), is implicated in disorders of learning and memory. Here we present a method for differentiating human embryonic stem cells (hESCs) to a nearly uniform population of NKX2.1(+) MGE-like progenitor cells. After transplantation into the hippocampus of mice in which BFCNs and some GABA neurons in the medial septum had been destroyed by mu P75-saporin, human MGE-like progenitors, but not ventral spinal progenitors, produced BFCNs that synaptically connected with endogenous neurons, whereas both progenitors generated similar populations of GABA neurons. Mice transplanted with MGE-like but not spinal progenitors showed improvements in learning and memory deficits. These results suggest that progeny of the MGE-like progenitors, particularly BFCNs, contributed to learning and memory. Our findings support the prospect of using human stem cell-derived MGE-like progenitors in developing therapies for neurological disorders of learning and memory.	[Liu, Yan; Weick, Jason P.; Liu, Huisheng; Krencik, Robert; Zhang, Xiaoqing; Ma, Lixiang; Ayala, Melvin; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Liu, Yan; Ma, Lixiang; Zhou, Guo-min] Fudan Univ, Dept Human Anat & Histol, Shanghai Med Sch, Shanghai 200433, Peoples R China; [Krencik, Robert; Zhang, Su-Chun] Univ Wisconsin, Neurosci Training Program, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Zhang, Su-Chun] Univ Wisconsin, Dept Neurosci, Sch Med & Publ Hlth, Madison, WI USA; [Zhang, Su-Chun] Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Fudan University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, SC (corresponding author), Univ Wisconsin, Waisman Ctr, Sch Med & Publ Hlth, Madison, WI 53705 USA.	zhang@waisman.wisc.edu	Zhang, Xiaoqing/O-3424-2017; zhou, guomin/M-2871-2016; Ritter, Stefanie L/D-9312-2012	Zhang, Xiaoqing/0000-0002-7405-1893; Krencik, Robert/0000-0002-2968-3162; ma, lixiang/0000-0001-9399-155X; Ayala, Melvin/0000-0002-8669-1046	US National Institute of Neurological Disorders and Stroke [NS045926]; National Institute of Child Health and Human Development [P30 HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045926] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. E. Andrzejewski and H. Mitchell for help in analyzing animal behavioral data. This study was supported in part by the US National Institute of Neurological Disorders and Stroke (NS045926) and the National Institute of Child Health and Human Development (P30 HD03352).	Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Berger-Sweeney J, 2001, J NEUROSCI, V21, P8164, DOI 10.1523/JNEUROSCI.21-20-08164.2001; Bissonnette CJ, 2011, STEM CELLS, V29, P802, DOI 10.1002/stem.626; Campbell K, 2003, CURR OPIN NEUROBIOL, V13, P50, DOI 10.1016/S0959-4388(03)00009-6; Cassel JC, 2002, NEUROSCIENCE, V113, P871, DOI 10.1016/S0306-4522(02)00226-9; Cooper O, 2010, MOL CELL NEUROSCI, V45, P258, DOI 10.1016/j.mcn.2010.06.017; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; Du ZW, 2009, STEM CELLS, V27, P1032, DOI 10.1002/stem.38; Dwyer TA, 2007, J NEUROSCI, V27, P299, DOI 10.1523/JNEUROSCI.4189-06.2007; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Emborg ME, 2008, CELL TRANSPLANT, V17, P383; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Francis PT, 2003, INT J GERIATR PSYCH, V18, pS15, DOI 10.1002/gps.934; GAGE FH, 1984, SCIENCE, V225, P533, DOI 10.1126/science.6539949; GAGE FH, 1987, CIBA F SYMP, V126, P143; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Jinno S, 2011, NEUROSCIENCE, V180, P41, DOI 10.1016/j.neuroscience.2011.02.013; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; LaVaute TM, 2009, STEM CELLS, V27, P1741, DOI 10.1002/stem.99; Leanza G, 1998, EUR J NEUROSCI, V10, P2353, DOI 10.1046/j.1460-9568.1998.00247.x; Lecourtier L, 2011, HIPPOCAMPUS, V21, P1277, DOI 10.1002/hipo.20837; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Manabe T, 2005, J NEUROCHEM, V94, P723, DOI 10.1111/j.1471-4159.2005.03261.x; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Oliveira Alcyr A. Jr, 2005, Current Alzheimer Research, V2, P79, DOI 10.2174/1567205052772759; Pang KCH, 2011, HIPPOCAMPUS, V21, P835, DOI 10.1002/hipo.20799; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Peterson DA, 1999, METHODS, V18, P493, DOI 10.1006/meth.1999.0818; Reilly JO, 2002, MOL CELL NEUROSCI, V19, P88, DOI 10.1006/mcne.2001.1063; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Sussel L, 1999, DEVELOPMENT, V126, P3359; Walsh TJ, 1996, BRAIN RES, V726, P69, DOI 10.1016/S0006-8993(96)00271-5; Weick JP, 2011, P NATL ACAD SCI USA, V108, P20189, DOI 10.1073/pnas.1108487108; Weick JP, 2010, STEM CELLS, V28, P2008, DOI 10.1002/stem.514; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Xi JJ, 2012, STEM CELLS, V30, P1655, DOI 10.1002/stem.1152; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100	53	169	177	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					440	+		10.1038/nbt.2565	http://dx.doi.org/10.1038/nbt.2565			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23604284	Green Accepted			2022-12-27	WOS:000318589600024
J	Maranhao, AC; Ellington, AD				Maranhao, Andre C.; Ellington, Andrew D.			Endowing cells with logic and memory	NATURE BIOTECHNOLOGY			English	Editorial Material							GENE NETWORKS; EXPRESSION; CRISPR	Genetic circuits that process and permanently store information are created with recombinases that flip the orientation of DNA cassettes.	[Maranhao, Andre C.; Ellington, Andrew D.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Maranhao, AC (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	ellingtonlab@gmail.com		Maranhao, Andre/0000-0001-8181-7589				Adleman LM, 1999, J COMPUT BIOL, V6, P53, DOI 10.1089/cmb.1999.6.53; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bonnet J., 2013, SCIENCE         0328, DOI [10.1126/science.1232758, DOI 10.1126/SCIENCE.1232758]; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Weber W, 2009, CHEM BIOL, V16, P287, DOI 10.1016/j.chembiol.2009.02.005; Yamamoto S, 2006, J BACTERIOL, V188, P958, DOI 10.1128/JB.188.3.958-967.2006; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506	12	8	8	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					413	415		10.1038/nbt.2573	http://dx.doi.org/10.1038/nbt.2573			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23657394				2022-12-27	WOS:000318589600018
J	DeKosky, BJ; Ippolito, GC; Deschner, RP; Lavinder, JJ; Wine, Y; Rawlings, BM; Varadarajan, N; Giesecke, C; Dorner, T; Andrews, SF; Wilson, PC; Hunicke-Smith, SP; Willson, CG; Ellington, AD; Georgiou, G				DeKosky, Brandon J.; Ippolito, Gregory C.; Deschner, Ryan P.; Lavinder, Jason J.; Wine, Yariv; Rawlings, Brandon M.; Varadarajan, Navin; Giesecke, Claudia; Doerner, Thomas; Andrews, Sarah F.; Wilson, Patrick C.; Hunicke-Smith, Scott P.; Willson, C. Grant; Ellington, Andrew D.; Georgiou, George			High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire	NATURE BIOTECHNOLOGY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; PLASMA-CELLS; NEXT-GENERATION; CLONING; ANTIGEN	Each B-cell receptor consists of a pair of heavy and light chains. High-throughput sequencing can identify large numbers of heavy- and light-chain variable regions (V-H and V-L) in a given B-cell repertoire, but information about endogenous pairing of heavy and light chains is lost after bulk lysis of B-cell populations. Here we describe a way to retain this pairing information. In our approach, single B cells (>5 x 10(4) capacity per experiment) are deposited in a high-density microwell plate (125 pl/well) and lysed in situ. mRNA is then captured on magnetic beads, reverse transcribed and amplified by emulsion V-H:V-L linkage PCR. The linked transcripts are analyzed by Illumina high-throughput sequencing. We validated the fidelity of V-H:V-L pairs identified by this approach and used the method to sequence the repertoire of three human cell subsets-peripheral blood IgG(+) B cells, peripheral plasmablasts isolated after tetanus toxoid immunization and memory B cells isolated after seasonal influenza vaccination.	[DeKosky, Brandon J.; Deschner, Ryan P.; Wine, Yariv; Rawlings, Brandon M.; Willson, C. Grant; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Ippolito, Gregory C.; Georgiou, George] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Lavinder, Jason J.; Hunicke-Smith, Scott P.; Ellington, Andrew D.; Georgiou, George] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Varadarajan, Navin] Univ Houston, Dept Chem & Biomol Engn, Houston, TX USA; [Giesecke, Claudia; Doerner, Thomas] Charite, Dept Med Rheumatol & Clin Immunol, D-13353 Berlin, Germany; [Giesecke, Claudia; Doerner, Thomas] German Rheumatism Res Ctr DRFZ, Berlin, Germany; [Andrews, Sarah F.; Wilson, Patrick C.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Willson, C. Grant; Ellington, Andrew D.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Houston System; University of Houston; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Chicago; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	gg@che.utexas.edu	Wilson, Patrick/HGC-3157-2022; Ippolito, Gregory C./AAR-2930-2021	Ippolito, Gregory C./0000-0002-7565-7002; Giesecke-Thiel, Claudia/0000-0002-5927-7018; Varadarajan, Navin/0000-0001-7524-8228	Hertz Foundation; University of Texas Donald D. Harrington Foundation; National Science Foundation; US National Institutes of Health [U19AI057234-09, U54AI057156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156, U19AI057234] Funding Source: NIH RePORTER	Hertz Foundation; University of Texas Donald D. Harrington Foundation; National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Iverson and M. Pogson for insightful discussions and thoughtful advice, C. Das for assistance with antibody expression, and S. Reddy for help with initial studies. This work was funded by fellowships to B.J.D. from the Hertz Foundation, the University of Texas Donald D. Harrington Foundation and the National Science Foundation, and also by the US National Institutes of Health U19AI057234-09 (P.C.W.), U19AI057234-09 (G.G.), and U54AI057156 (G.G. and A.E.D.).	Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Cheung WC, 2012, NAT BIOTECHNOL, V30, P447, DOI 10.1038/nbt.2167; Fischer N, 2011, MABS-AUSTIN, V3, P17, DOI 10.4161/mabs.3.1.14169; Frolich D, 2010, J IMMUNOL, V185, P3103, DOI 10.4049/jimmunol.1000911; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Ippolito GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035497; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Meijer PJ, 2006, J MOL BIOL, V358, P764, DOI 10.1016/j.jmb.2006.02.040; Reddy ST, 2011, CURR OPIN BIOTECH, V22, P584, DOI 10.1016/j.copbio.2011.04.015; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Sanchez-Freire V, 2012, NAT PROTOC, V7, P829, DOI 10.1038/nprot.2012.021; Sato S, 2012, NAT BIOTECHNOL, V30, P1039, DOI 10.1038/nbt.2406; Scheid JF, 2011, P NATL ACAD SCI USA, V108, P18044, DOI 10.1073/pnas.1113395108; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seidl KJ, 1997, INT IMMUNOL, V9, P689, DOI 10.1093/intimm/9.5.689; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Tanaka Y, 2010, CANCER RES, V70, P6181, DOI 10.1158/0008-5472.CAN-10-0678; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; Wilson PC, 2012, NAT REV IMMUNOL, V12, P709, DOI 10.1038/nri3285; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532	23	317	373	5	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					166	169		10.1038/nbt.2492	http://dx.doi.org/10.1038/nbt.2492			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23334449	Green Accepted			2022-12-27	WOS:000315322100029
J	Sadaf, S; Akhtar, MW; Iqbal, Z				Sadaf, Saima; Akhtar, Muhammad W.; Iqbal, Zarina			Uncertainty over pharmaceutical and biotech product patents in Pakistan	NATURE BIOTECHNOLOGY			English	Editorial Material									[Sadaf, Saima] Univ Punjab, Inst Biochem & Biotechnol, Lahore, Pakistan; [Akhtar, Muhammad W.] Univ Punjab, Sch Biol Sci, Lahore, Pakistan; [Iqbal, Zarina] United Trademark & Patent Serv, Lahore, Pakistan	University of Punjab; University of Punjab	Sadaf, S (corresponding author), Univ Punjab, Inst Biochem & Biotechnol, Lahore, Pakistan.	zarinazeen@rocketmail.com	Nadeem, Muhammad Shahid/H-2372-2017	Nadeem, Muhammad Shahid/0000-0003-4112-0925				[Anonymous], 1995, OJ EPO, P388; [Anonymous], 2002, OJ EPO, V307, P11; [Anonymous], 2002, OJ EPO, V293, P9	3	0	0	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1198	1200		10.1038/nbt.2444	http://dx.doi.org/10.1038/nbt.2444			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222786				2022-12-27	WOS:000312092400019
J	Francisco, M				Francisco, Michael			Third-quarter biotech job picture	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1149	1149		10.1038/nbt.2417	http://dx.doi.org/10.1038/nbt.2417			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138312	Bronze			2022-12-27	WOS:000311087500036
J	Harper, AR; Topol, EJ				Harper, Andrew R.; Topol, Eric J.			Pharmacogenomics in clinical practice and drug development	NATURE BIOTECHNOLOGY			English	Review							GENOME-WIDE ASSOCIATION; CHRONIC HEPATITIS-C; INFLUENCING ANTIHYPERTENSIVE RESPONSE; INDUCED LIVER-INJURY; GENETIC-VARIATION; MULTIPLE LOCI; IL28B; VARIANTS; GENOTYPE; THERAPY	Genome-wide association studies (GWAS) of responses to drugs, including clopidogrel, pegylated-interferon and carbamazepine, have led to the identification of specific patient subgroups that benefit from therapy. However, the identification and replication of common sequence variants that are associated with either efficacy or safety for most prescription medications at odds ratios (ORs) > 3.0 (equivalent to > 300% increased efficacy or safety) has yet to be translated to clinical practice. Although some of the studies have been completed, the results have not been incorporated into therapy, and a large number of commonly used medications have not been subject to proper pharmacogenomic analysis. Adoption of GWAS, exome or whole genome sequencing by drug development and treatment programs is the most striking near-term opportunity for improving the drug candidate pipeline and boosting the efficacy of medications already in use.	[Harper, Andrew R.; Topol, Eric J.] Scripps Res Inst & Scripps Hlth, Scripps Translat Sci Inst, La Jolla, CA USA; [Harper, Andrew R.] Newcastle Univ, Fac Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Scripps Research Institute; Newcastle University - UK	Topol, EJ (corresponding author), Scripps Res Inst & Scripps Hlth, Scripps Translat Sci Inst, La Jolla, CA USA.	etopol@scripps.edu	Harper, Andrew/B-7044-2017	Harper, Andrew/0000-0001-5327-0328; Topol, Eric/0000-0002-1478-4729	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000109] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NCATS NIH HHS [TR000109, UL1 TR000109] Funding Source: Medline; NCRR NIH HHS [UL1 RR025774] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Aithal GP, 2010, NAT GENET, V42, P650, DOI 10.1038/ng0810-650; Allison M, 2012, NAT BIOTECHNOL, V30, P41, DOI 10.1038/nbt.2083; Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Belluck Pam, 2012, NY TIMES; Berry DA, 2012, NAT REV CLIN ONCOL, V9, P199, DOI 10.1038/nrclinonc.2011.165; Bonafede MMK, 2012, ADV THER, V29, P234, DOI 10.1007/s12325-012-0007-y; Byun E, 2008, ARCH NEUROL-CHICAGO, V65, P337, DOI 10.1001/archneurol.2008.47; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Clark PJ, 2011, AM J GASTROENTEROL, V106, P38, DOI 10.1038/ajg.2010.370; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; Daly AK, 2012, ANNU REV PHARMACOL, V52, P21, DOI 10.1146/annurev-pharmtox-010611-134743; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Epstein RS, 2010, J AM COLL CARDIOL, V55, P2804, DOI 10.1016/j.jacc.2010.03.009; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Furberg CD, 2001, CURR CONTR TRIALS C, V2, P205, DOI 10.1186/CVM-2-5-205; Garriock HA, 2010, BIOL PSYCHIAT, V67, P133, DOI 10.1016/j.biopsych.2009.08.029; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Giacomini KM, 2012, SCI TRANSL MED, V4; Himes BE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002824; Hindorff LA, CATALOG PUBLISHED GE; Ising M, 2009, ARCH GEN PSYCHIAT, V66, P966, DOI 10.1001/archgenpsychiatry.2009.95; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Krintel SB, 2012, PHARMACOGENET GENOM, V22, P577, DOI 10.1097/FPC.0b013e3283544043; Lavedan C, 2009, MOL PSYCHIATR, V14, P804, DOI 10.1038/mp.2008.56; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Liu CY, 2008, MOL MED, V14, P575, DOI 10.2119/2008-00056.Liu; Lucena MI, 2011, GASTROENTEROLOGY, V141, P338, DOI 10.1053/j.gastro.2011.04.001; Lynch T, 2007, AM FAM PHYSICIAN, V76, P391; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Mega JL, 2011, JAMA-J AM MED ASSOC, V306, P2221, DOI 10.1001/jama.2011.1703; Mick E, 2008, AM J MED GENET B, V147B, P1412, DOI 10.1002/ajmg.b.30865; Moore TJ, 2012, QUARTERWATCH MONITOR; Mullard A, 2011, NAT REV DRUG DISCOV, V10, P561, DOI 10.1038/nrd3526; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Norman TC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002678; Ozeki T, 2011, HUM MOL GENET, V20, P1034, DOI 10.1093/hmg/ddq537; Pare G, 2012, EUR SOC CARD 2012 C; Patay BA, 2012, AM J MED, V125, P5, DOI 10.1016/j.amjmed.2011.05.005; Pirmohamed M, 2011, DRUG DISCOV TODAY, V16, P852, DOI 10.1016/j.drudis.2011.08.006; Pollack A., 2012, NY TIMES, pB3; Ramirez AH, 2013, PHARMACOGENOMICS J, V13, P325, DOI 10.1038/tpj.2012.14; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Roberts JD, 2012, LANCET, V379, P1705, DOI 10.1016/S0140-6736(12)60161-5; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Roujeau JC, 2005, TOXICOLOGY, V209, P123, DOI 10.1016/j.tox.2004.12.022; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Shih JY, 2005, NEW ENGL J MED, V353, P207, DOI 10.1056/NEJM200507143530217; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Singer JB, 2010, NAT GENET, V42, P711, DOI 10.1038/ng.632; Smith DA, 2006, CURR OPIN DRUG DISC, V9, P38; Soriano V, 2012, J ANTIMICROB CHEMOTH, V67, P523, DOI 10.1093/jac/dkr506; Stanek EJ, 2012, CLIN PHARMACOL THER, V91, P450, DOI 10.1038/clpt.2011.306; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tantisira KG, 2012, AM J RESP CRIT CARE, V185, P1286, DOI 10.1164/rccm.201111-2061OC; Tantisira KG, 2011, NEW ENGL J MED, V365, P1173, DOI 10.1056/NEJMoa0911353; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Topol EJ, 2011, TXB INTERVENTIONAL C; Topol EJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001067; Trevin LR, 2009, J CLIN ONCOL, V27, P5972, DOI 10.1200/JCO.2008.20.4156; Turner ST, 2008, HYPERTENSION, V52, P359, DOI 10.1161/HYPERTENSIONAHA.107.104273; Turner ST, 2012, HYPERTENSION, V59, P1204, DOI 10.1161/HYP.0b013e31825b30f8; US Department of Health and Human Services US Food and Drug Administration, VOL EXPL DAT SUBM VX; US Department of Health and Human Services US Food and Drug Administration Center for Drug Evaluation and Research & Center for Biologics Evaluation and Research, 2011, E16 BIOM REL DRUG BI; van Vollenhoven RF, 2007, ANN RHEUM DIS, V66, P849, DOI 10.1136/ard.2007.069872; Veldt BJ, 2012, AM J TRANSPLANT, V12, P737, DOI 10.1111/j.1600-6143.2011.03843.x; Wilke RA, 2012, CLIN PHARMACOL THER, V92, P112, DOI 10.1038/clpt.2012.57; Zhang W, 2012, PHARMACOGENOMICS, V13, P223, DOI [10.2217/pgs.11.137, 10.2217/PGS.11.137]; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735	79	72	77	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1117	1124		10.1038/nbt.2424	http://dx.doi.org/10.1038/nbt.2424			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138311	Green Accepted			2022-12-27	WOS:000311087500031
J	Mak, C				Mak, Craig			Drug pipeline: 1Q12	NATURE BIOTECHNOLOGY			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					383	383		10.1038/nbt.2210	http://dx.doi.org/10.1038/nbt.2210			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22565954				2022-12-27	WOS:000303803200009
J	Kessel, M				Kessel, Mark			Know before you go	NATURE BIOTECHNOLOGY			English	Editorial Material									[Kessel, Mark] Sagent Advisors Inc, New York, NY USA; [Kessel, Mark] Symphony Capital LLC, New York, NY USA		Kessel, M (corresponding author), Sagent Advisors Inc, New York, NY USA.	mkessel@SagentAdvisors.com							0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					219	220		10.1038/nbt.2115	http://dx.doi.org/10.1038/nbt.2115			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22398611				2022-12-27	WOS:000301303800010
J	Milias-Argeitis, A; Summers, S; Stewart-Ornstein, J; Zuleta, I; Pincus, D; El-Samad, H; Khammash, M; Lygeros, J				Milias-Argeitis, Andreas; Summers, Sean; Stewart-Ornstein, Jacob; Zuleta, Ignacio; Pincus, David; El-Samad, Hana; Khammash, Mustafa; Lygeros, John			In silico feedback for in vivo regulation of a gene expression circuit	NATURE BIOTECHNOLOGY			English	Article							SYNTHETIC BIOLOGY; LIGHT	We show that difficulties in regulating cellular behavior with synthetic biological circuits may be circumvented using in silico feedback control. By tracking a circuit's output in Saccharomyces cerevisiae in real time, we precisely control its behavior using an in silico feedback algorithm to compute regulatory inputs implemented through a genetically encoded light-responsive module. Moving control functions outside the cell should enable more sophisticated manipulation of cellular processes whenever real-time measurements of cellular variables are possible.	[Stewart-Ornstein, Jacob; Zuleta, Ignacio; Pincus, David; El-Samad, Hana] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Milias-Argeitis, Andreas; Summers, Sean; Lygeros, John] Swiss Fed Inst Technol, Automat Control Lab, Dept Elect Engn, Zurich, Switzerland; [Khammash, Mustafa] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland	University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	El-Samad, H (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	hana.el-samad@ucsf.edu; mustafa.khammash@bsse.ethz.ch; lygeros@control.ee.ethz.ch	Milias-Argeitis, Andreas/O-9434-2017	Milias-Argeitis, Andreas/0000-0002-4291-4228; Zuleta, Ignacio/0000-0002-1113-7083	National Science Foundation [CCF-0943385, ECCS-0835847]; MoVeS [FP7-ICT-2009-257005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); MoVeS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank P. Quail (UC, Berkeley) for the generous gift of the PIF3 construct and W. Lim (UCSF) and J. Stelling (ETH, Zurich) for providing PCB. The work was supported by National Science Foundation grant CCF-0943385 (H.E.-S.), ECCS-0835847 (M. K.), and MoVeS FP7-ICT-2009-257005 (J.L.).	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Haynes KA, 2009, J CELL BIOL, V187, P589, DOI 10.1083/jcb.200908138; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Leung DW, 2008, P NATL ACAD SCI USA, V105, P12797, DOI 10.1073/pnas.0801232105; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Morari M, 1999, COMPUT CHEM ENG, V23, P667, DOI 10.1016/S0098-1354(98)00301-9; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Sorokina Oxana, 2009, J Biol Eng, V3, P15, DOI 10.1186/1754-1611-3-15; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]	13	186	189	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1114	1116		10.1038/nbt.2018	http://dx.doi.org/10.1038/nbt.2018			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22057053	Green Accepted			2022-12-27	WOS:000298038700021
J	Smith-Doerr, L; Kemekliene, G; Teutonico, R; Lange, L; Villa-Komaroff, L; Matthiessen-Guyader, L; Murray, F				Smith-Doerr, Laurel; Kemekliene, Gintare; Teutonico, Rita; Lange, Lene; Villa-Komaroff, Lydia; Matthiessen-Guyader, Line; Murray, Fiona			A global need for women's biotech leadership	NATURE BIOTECHNOLOGY			English	Editorial Material							GENDER; SCIENCE		[Smith-Doerr, Laurel] Boston Univ, Dept Sociol, Boston, MA 02215 USA; [Kemekliene, Gintare; Matthiessen-Guyader, Line] Commiss European Communities, DG Res, B-1049 Brussels, Belgium; [Teutonico, Rita] Natl Sci Fdn, Directorate Social Behav & Econ Sci, Arlington, VA 22230 USA; [Lange, Lene] Aalborg Univ, Copenhagen Inst Technol, Ballerup, Denmark; [Villa-Komaroff, Lydia] CytonomeST, Boston, MA USA; [Murray, Fiona] MIT, Sloan Sch Management, Cambridge, MA 02139 USA	Boston University; National Science Foundation (NSF); NSF - Directorate for Social, Behavioral & Economic Sciences (SBE); Aalborg University; Massachusetts Institute of Technology (MIT)	Smith-Doerr, L (corresponding author), Boston Univ, Dept Sociol, Boston, MA 02215 USA.	ldoerr@bu.edu	Lange, Lene/Q-8051-2016; McBee, David J/F-3968-2012	Lange, Lene/0000-0002-5336-1155; 				Adams RB, 2009, J FINANC ECON, V94, P291, DOI 10.1016/j.jfineco.2008.10.007; CLAVEL F, 2009, EC US TASKF WORKSH S; Desvaux G., 2008, MCKINSEY Q, V4, P26; *EC US TASK FORC B, 2009, GLOB LOOK WOM LEAD B; *EUR COMM, 2006, WOM SCI STAT IND SHE; Herring C, 2009, AM SOCIOL REV, V74, P208, DOI 10.1177/000312240907400203; Murray F, 2007, IND CORP CHANGE, V16, P657, DOI 10.1093/icc/dtm021; NAIR S, 2009, EC US TASKF WORKSH S; Page SE, 2007, DIFFERENCE POWER DIV; Palackal A, 2007, INDIAN J GEND STUD, V14, P231, DOI 10.1177/097152150701400202; Rhoten D, 2004, SCIENCE, V306, P2046, DOI 10.1126/science.1103628; Rhoten D, 2007, RES POLICY, V36, P56, DOI 10.1016/j.respol.2006.08.001; Ridgeway CL, 2009, GENDER SOC, V23, P145, DOI 10.1177/0891243208330313; Smith-Doerr Laurel, 2004, WOMENS WORK GENDER E	14	1	1	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					948	949		10.1038/nbt.1998	http://dx.doi.org/10.1038/nbt.1998			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	838FQ	21997636				2022-12-27	WOS:000296273000023
J	Gole, J; Gore, A; Richards, A; Chiu, YJ; Fung, HL; Bushman, D; Chiang, HI; Chun, J; Lo, YH; Zhang, K				Gole, Jeff; Gore, Athurva; Richards, Andrew; Chiu, Yu-Jui; Fung, Ho-Lim; Bushman, Diane; Chiang, Hsin-I; Chun, Jerold; Lo, Yu-Hwa; Zhang, Kun			Massively parallel polymerase cloning and genome sequencing of single cells using nanoliter microwells	NATURE BIOTECHNOLOGY			English	Article							SPERM CELLS; ANEUPLOIDY; RECOMBINATION; AMPLIFICATION; NUCLEOTIDE; MOSAICISM; EVOLUTION; RARE	Genome sequencing of single cells has a variety of applications, including characterizing difficult-to-culture microorganisms and identifying somatic mutations in single cells from mammalian tissues. A major hurdle in this process is the bias in amplifying the genetic material from a single cell, a procedure known as polymerase cloning. Here we describe the microwell displacement amplification system (MIDAS), a massively parallel polymerase cloning method in which single cells are randomly distributed into hundreds to thousands of nanoliter wells and their genetic material is simultaneously amplified for shotgun sequencing. MIDAS reduces amplification bias because polymerase cloning occurs in physically separated, nanoliter-scale reactors, facilitating the de novo assembly of near-complete microbial genomes from single Escherichia coli cells. In addition, MIDAS allowed us to detect single-copy number changes in primary human adult neurons at 1- to 2-Mb resolution. MIDAS can potentially further the characterization of genomic diversity in many heterogeneous cell populations.	[Gole, Jeff; Gore, Athurva; Richards, Andrew; Fung, Ho-Lim; Chiang, Hsin-I; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, Inst Genom Med, La Jolla, CA 92093 USA; [Gole, Jeff; Gore, Athurva; Richards, Andrew; Fung, Ho-Lim; Chiang, Hsin-I; Zhang, Kun] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Chiu, Yu-Jui] Univ Calif San Diego, Mat Sci & Engn Program, La Jolla, CA 92093 USA; [Bushman, Diane; Chun, Jerold] Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Lo, Yu-Hwa] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego	Zhang, K (corresponding author), Univ Calif San Diego, Dept Bioengn, Inst Genom Med, La Jolla, CA 92093 USA.	kzhang@bioeng.ucsd.edu	t, lf/AAJ-4924-2020; Chun, Jerold/Y-4670-2019; Chiang, Hsin-I/AAF-6578-2020; Zhang, Kun/ABE-6349-2020	Chiang, Hsin-I/0000-0002-2815-4314; Zhang, Kun/0000-0002-7596-5224; CHIU, YU-JUI/0000-0002-5382-106X	US National Institutes of Health [R01HG004876, R01GM097253, U01MH098977, P50HG005550]; National Science Foundation [OCE-1046368]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550, R01HG004876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM097253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH098977] Funding Source: NIH RePORTER; Directorate For Geosciences [1046368] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank C. Chen, H. Choi and the UCSD Nano3 facility for initial help with microwell fabrication, E Liang for initial technical assistance and P. Pevzner for advice on de novo genome assembly. This project was funded by US National Institutes of Health grants R01HG004876, R01GM097253, U01MH098977 and P50HG005550, and National Science Foundation grant OCE-1046368.	Adey A, 2012, GENOME RES, V22, P1139, DOI 10.1101/gr.136242.111; Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Fitzsimons MS, 2013, GENOME RES, V23, P878, DOI 10.1101/gr.142208.112; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Hutchison CA, 2005, P NATL ACAD SCI USA, V102, P17332, DOI 10.1073/pnas.0508809102; Inoue J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl350; Kirkness EF, 2013, GENOME RES, V23, P826, DOI 10.1101/gr.144600.112; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Westra JW, 2008, J COMP NEUROL, V507, P1944, DOI 10.1002/cne.21648; Westra JW, 2010, J COMP NEUROL, V518, P3981, DOI 10.1002/cne.22436; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yang AH, 2003, J NEUROSCI, V23, P10454; Yoon HS, 2011, SCIENCE, V332, P714, DOI 10.1126/science.1203163; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	39	163	178	5	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1126	+		10.1038/nbt.2720	http://dx.doi.org/10.1038/nbt.2720			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24213699	Green Accepted			2022-12-27	WOS:000328251900026
J	Song, RJ; Oren, DA; Franco, D; Seaman, MS; Ho, DD				Song, Ruijiang; Oren, Deena A.; Franco, David; Seaman, Michael S.; Ho, David D.			Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity	NATURE BIOTECHNOLOGY			English	Article							ANTIRETROVIRAL ACTIVITY; HIV-INFECTION; PREEXPOSURE PROPHYLAXIS; NEUTRALIZING ANTIBODIES; RATIONAL DESIGN; IBALIZUMAB; ENVELOPE; BROAD; CD4; PROTECTION	Ibalizumab is a humanized monoclonal antibody that binds human CD4-a key receptor for HIV-and blocks HIV-1 infection. However, HIV-1 strains with mutations resulting in loss of an N-linked glycan from the V5 loop of the envelope glycoprotein gp120 are resistant to ibalizumab. Previous structural analysis suggests that this glycan fills a void between the gp120 V5 loop and the ibalizumab light chain, perhaps causing steric hindrance that disrupts viral entry. If this void contributes to HIV-1 resistance to ibalizumab, we reasoned that 'refilling' it by engineering an N-linked glycan into the ibalizumab light chain at a position spatially proximal to gp120 V5 may restore susceptibility to ibalizumab. Indeed, one such ibalizumab variant neutralized 100% of 118 diverse HIV-1 strains tested in vitro, including 10 strains resistant to parental ibalizumab. These findings demonstrate that the strategic placement of a glycan in the variable region of a monoclonal antibody can substantially enhance its activity.	[Song, Ruijiang; Franco, David; Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Oren, Deena A.] Rockefeller Univ, Struct Biol Resource Ctr, New York, NY 10021 USA; [Seaman, Michael S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Rockefeller University; Rockefeller University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ho, DD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA.	dho@adarc.org	Franco, David/AAQ-6839-2021		Bill and Melinda Gates Foundation via the Collaboration for AIDS Vaccine Discovery [OPP50714, OPP1040731]; US National Institutes of Health [1DP1DA033263-01]; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA033263] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation via the Collaboration for AIDS Vaccine Discovery; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank N. Padte for project management; Y. Huang, M. Tsuji, M.-W. Chen, C. Andrews, M. Sun and J. Yu for helpful discussions; and M. C. Nussenzweig for reagents. We also thank T.-L. Hsu, P.-C. Chen and the MS Core Facility at the Genomics Research Center, Academia Sinica ( Taiwan), for glycoform profiling. Funding support for this study was provided by the Bill and Melinda Gates Foundation (OPP50714 and OPP1040731) via the Collaboration for AIDS Vaccine Discovery. Additional funding support was provided by the US National Institutes of Health grant number 1DP1DA033263-01.	Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Boon L, 2002, TOXICOLOGY, V172, P191, DOI 10.1016/S0300-483X(02)00002-1; BURKLY LC, 1992, J IMMUNOL, V149, P1779; Dimitrov A, 2007, CURR OPIN INVEST DR, V8, P653; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Freeman MM, 2010, STRUCTURE, V18, P1632, DOI 10.1016/j.str.2010.09.017; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huber M, 2008, CURR TOP MICROBIOL, V317, P39; Jacobson JM, 2008, J INFECT DIS, V198, P1345, DOI 10.1086/592169; Jacobson JM, 2009, ANTIMICROB AGENTS CH, V53, P450, DOI 10.1128/AAC.00942-08; Kuritzkes DR, 2004, J INFECT DIS, V189, P286, DOI 10.1086/380802; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; OLDEN K, 1978, CELL, V13, P461, DOI 10.1016/0092-8674(78)90320-3; Pace CS, 2013, P NATL ACAD SCI USA, V110, P13540, DOI 10.1073/pnas.1304985110; Pace CS, 2013, JAIDS-J ACQ IMM DEF, V62, P1, DOI 10.1097/QAI.0b013e3182732746; Pepinsky RB, 2010, PROTEIN SCI, V19, P954, DOI 10.1002/pro.372; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seaman MS, 2007, VIROLOGY, V367, P175, DOI 10.1016/j.virol.2007.05.024; Song RJ, 2010, J VIROL, V84, P6935, DOI 10.1128/JVI.00453-10; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Toma J, 2011, J VIROL, V85, P3872, DOI 10.1128/JVI.02237-10; Vallee F, 2000, J BIOL CHEM, V275, P41287, DOI 10.1074/jbc.M006927200; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu SJ, 2010, PROTEIN ENG DES SEL, V23, P643, DOI 10.1093/protein/gzq037; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang XQ, 2006, ANTIMICROB AGENTS CH, V50, P2231, DOI 10.1128/AAC.00761-05	38	41	43	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					1047	+		10.1038/nbt.2677	http://dx.doi.org/10.1038/nbt.2677			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24097413	Green Accepted, Green Submitted			2022-12-27	WOS:000326921200028
J	Feizi, S; Marbach, D; Medard, M; Kellis, M				Feizi, Soheil; Marbach, Daniel; Medard, Muriel; Kellis, Manolis			Network deconvolution as a general method to distinguish direct dependencies in networks	NATURE BIOTECHNOLOGY			English	Article							REGULATORY NETWORKS; TRANSCRIPTIONAL REGULATION; STRUCTURE PREDICTION; RESIDUE CONTACTS; INFORMATION; INFERENCE; ALGORITHM; DISCOVERY	Recognizing direct relationships between variables connected in a network is a pervasive problem in biological, social and information sciences as correlation-based networks contain numerous indirect relationships. Here we present a general method for inferring direct effects from an observed correlation matrix containing both direct and indirect effects. We formulate the problem as the inverse of network convolution, and introduce an algorithm that removes the combined effect of all indirect paths of arbitrary length in a closed-form solution by exploiting eigen-decomposition and infinite-series sums. We demonstrate the effectiveness of our approach in several network applications: distinguishing direct targets in gene expression regulatory networks; recognizing directly interacting amino-acid residues for protein structure prediction from sequence alignments; and distinguishing strong collaborations in co-authorship social networks using connectivity information alone. In addition to its theoretical impact as a foundational graph theoretic tool, our results suggest network deconvolution is widely applicable for computing direct dependencies in network science across diverse disciplines.	[Feizi, Soheil; Marbach, Daniel; Kellis, Manolis] MIT, CSAIL, Cambridge, MA 02139 USA; [Feizi, Soheil; Marbach, Daniel; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA USA; [Feizi, Soheil; Medard, Muriel] MIT, Elect Res Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Kellis, M (corresponding author), MIT, CSAIL, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	manoli@mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630	US National Institutes of Health [R01 HG004037, HG005639]; Swiss National Science Foundation; National Science Foundation [0644282]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, RC2HG005639, RC1HG005334] Funding Source: NIH RePORTER; Direct For Biological Sciences [0644282] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank B. Holmes for suggestions on the initial aspects of this work, M. Bansal on the protein structural constraints, Y. Liu for initial analysis of DREAM5 networks and R. Kuffner for discussions and code used for network motif analysis. The work was supported by US National Institutes of Health grants R01 HG004037 and HG005639 to M. K., a Swiss National Science Foundation fellowship to D. M. and National Science Foundation CAREER award 0644282 to M.K.	ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Butte A J, 2000, Pac Symp Biocomput, P418; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Ekeberg M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012707; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Ferrara E., 2012, PREPRINT; FRIEDKIN NE, 1982, SOC NETWORKS, V3, P273, DOI 10.1016/0378-8733(82)90003-X; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Giraud BG, 1999, PHYS REV E, V59, P4983, DOI 10.1103/PhysRevE.59.4983; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; HARTEMINK AJ, 2001, PAC S BIOCOMPUT, V6, P422; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; HEMELRIJK CK, 1990, J THEOR BIOL, V143, P405, DOI 10.1016/S0022-5193(05)80036-0; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Koetter R, 2003, IEEE ACM T NETWORK, V11, P782, DOI 10.1109/TNET.2003.818197; Kuffner R, 2012, BIOINFORMATICS, V28, P1376, DOI 10.1093/bioinformatics/bts143; Lapedes A., 2012, USING SEQUENCE ALIGN; Lapedes A.S., 1999, LECT NOTES MONOGR SE, V33, P236, DOI [10.1214/lnms/1215455556, DOI 10.1214/LNMS/1215455556]; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Quinn CJ, 2011, J COMPUT NEUROSCI, V30, P17, DOI 10.1007/s10827-010-0247-2; Reiss DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-280; Seth A., 2007, SCHOLARPEDIA, V2, P1667, DOI [DOI 10.4249/SCHOLARPEDIA.1667, 10.4249/ scholarpedia.1667]; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Shi XL, 2007, PHYSICA A, V378, P33, DOI 10.1016/j.physa.2006.11.072; Song X., 2006, SIGIR 2006 P 29 ANN, P509, DOI [10.1145/1148170.1148258, DOI 10.1145/1148170.1148258>(2006)]; Veiga DFT, 2007, GENET MOL RES, V6, P730; Wainwright MJ, 2008, FOUND TRENDS MACH LE, V1, P1, DOI 10.1561/2200000001; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Witten IH, 2011, MOR KAUF D, P1	57	168	175	4	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					726	+		10.1038/nbt.2635	http://dx.doi.org/10.1038/nbt.2635			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23851448	Green Submitted, Green Accepted, Bronze			2022-12-27	WOS:000322911000022
J	Allison, M				Allison, Malorye			Genomic testing reaches into the womb	NATURE BIOTECHNOLOGY			English	Article							NONINVASIVE PRENATAL DETECTION; CELL-FREE DNA; FETAL ANEUPLOIDY; ABNORMALITIES; DIAGNOSIS											Agarwal A, 2013, PRENATAL DIAG, V33, P521, DOI 10.1002/pd.4101; Allyse M.A., 2013, PRENAT DIAGN, V33, P1; American Congress of Obstetricians and Gynecologists, 2012, NON PREN TEST FET AN; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; FDA, 2011, GUID COMM D IN PRESS; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Mazloom AR, 2013, PRENATAL DIAG, V33, P591, DOI 10.1002/pd.4127; Nicolaides KH, 2013, PRENATAL DIAG, V33, P575, DOI 10.1002/pd.4103; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Ray T. Amid, 2013, GENOMEWEB PHARM 0213; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Sparks AB, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.030; Sparks AB, 2012, PRENATAL DIAG, V32, P3, DOI 10.1002/pd.2922; Srinivasan A, 2013, AM J HUM GENET, V92, P167, DOI 10.1016/j.ajhg.2012.12.006; Timmermans DRM, 2005, INT CONGR SER, V1279, P234, DOI 10.1016/j.ics.2004.12.057; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Weaver C, 2013, WALL STREET J, pB1; WERTZ DC, 1986, AM J HUM GENET, V39, P253	22	10	11	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2013	31	7					595	601		10.1038/nbt.2627	http://dx.doi.org/10.1038/nbt.2627			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	180FS	23839142				2022-12-27	WOS:000321579700013
J	Shen, BZ; Sun, XG; Zuo, X; Shilling, T; Apgar, J; Ross, M; Bougri, O; Samoylov, V; Parker, M; Hancock, E; Lucero, H; Gray, B; Ekborg, NA; Zhang, DC; Johnson, JCS; Lazar, G; Raab, RM				Shen, Binzhang; Sun, Xueguang; Zuo, Xiao; Shilling, Taran; Apgar, James; Ross, Mary; Bougri, Oleg; Samoylov, Vladimir; Parker, Matthew; Hancock, Elaina; Lucero, Hector; Gray, Benjamin; Ekborg, Nathan A.; Zhang, Dongcheng; Johnson, Jeremy C. Schley; Lazar, Gabor; Raab, R. Michael			Engineering a thermoregulated intein-modified xylanase into maize for consolidated lignocellulosic biomass processing	NATURE BIOTECHNOLOGY			English	Article							PROTEIN-STRUCTURE; TRANSGENIC MAIZE; SWISS-MODEL; IN-VITRO; ZEA-MAYS; MYCOBACTERIUM-TUBERCULOSIS; AGROBACTERIUM-TUMEFACIENS; STRUCTURE PREDICTION; SCREENING SYSTEM; RECA INTEIN	Plant cellulosic biomass is an abundant, low-cost feedstock for producing biofuels and chemicals. Expressing cell wall-degrading (CWD) enzymes (e.g. xylanases) in plant feedstocks could reduce the amount of enzymes required for feedstock pretreatment and hydrolysis during bioprocessing to release soluble sugars. However, in planta expression of xylanases can reduce biomass yield and plant fertility. To overcome this problem, we engineered a thermostable xylanase (XynB) with a thermostable self-splicing bacterial intein to control the xylanase activity. Intein-modified XynB (iXynB) variants were selected that have < 10% wild-type enzymatic activity but recover > 60% enzymatic activity upon intein self-splicing at temperatures > 59 degrees C. Greenhouse-grown xynB maize expressing XynB has shriveled seeds and low fertility, but ixynB maize had normal seeds and fertility. Processing dried ixynB maize stover by temperature-regulated xylanase activation and hydrolysis in a cocktail of commercial CWD enzymes produced > 90% theoretical glucose and > 63% theoretical xylose yields.	[Shen, Binzhang; Sun, Xueguang; Zuo, Xiao; Shilling, Taran; Apgar, James; Ross, Mary; Bougri, Oleg; Samoylov, Vladimir; Parker, Matthew; Hancock, Elaina; Lucero, Hector; Gray, Benjamin; Ekborg, Nathan A.; Zhang, Dongcheng; Johnson, Jeremy C. Schley; Lazar, Gabor; Raab, R. Michael] Agrivida Inc, Medford, MA USA		Raab, RM (corresponding author), Agrivida Inc, Medford, MA USA.	rmraab@agrivida.com		Apgar, James/0000-0002-4669-0188				Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Berrondo M, 2008, STRUCTURE, V16, P513, DOI 10.1016/j.str.2008.01.012; Blanch HW, 2011, BIOTECHNOL J, V6, P1086, DOI 10.1002/biot.201000180; Chin HG, 2003, P NATL ACAD SCI USA, V100, P4510, DOI 10.1073/pnas.0736538100; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Dun BQ, 2007, APPL ENVIRON MICROB, V73, P7997, DOI 10.1128/AEM.00956-07; Evanko D, 2007, NAT METHODS, V4, P112, DOI 10.1038/nmeth0207-112a; Gangopadhyay JP, 2003, ANAL CHEM, V75, P2456, DOI 10.1021/ac020756b; Gangopadhyay JP, 2003, BBA-GEN SUBJECTS, V1619, P193, DOI 10.1016/S0304-4165(02)00495-6; Gils M, 2008, PLANT BIOTECHNOL J, V6, P226, DOI 10.1111/j.1467-7652.2007.00318.x; Gray BN, 2011, PLANT BIOTECHNOL J, V9, P1100, DOI 10.1111/j.1467-7652.2011.00632.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harholt J, 2010, PLANT BIOTECHNOL J, V8, P351, DOI 10.1111/j.1467-7652.2009.00490.x; Harrison MD, 2011, PLANT BIOTECHNOL J, V9, P884, DOI 10.1111/j.1467-7652.2011.00597.x; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hiei Y, 2008, NAT PROTOC, V3, P824, DOI 10.1038/nprot.2008.46; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hood EE, 2003, PLANT BIOTECHNOL J, V1, P129, DOI 10.1046/j.1467-7652.2003.00014.x; Hood EE, 2007, PLANT BIOTECHNOL J, V5, P709, DOI 10.1111/j.1467-7652.2007.00275.x; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; Jensen LG, 1996, P NATL ACAD SCI USA, V93, P3487, DOI 10.1073/pnas.93.8.3487; Jeoh T, 2007, BIOTECHNOL BIOENG, V98, P112, DOI 10.1002/bit.21408; Kempe Katja, 2009, Plant Biotechnol J, V7, P283, DOI 10.1111/j.1467-7652.2008.00399.x; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; Krause P. F., 1997, TEC0099 US ARM CORPS; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leber J., 2010, NY TIMES; Lew BM, 2002, GENE, V282, P169, DOI 10.1016/S0378-1119(01)00836-8; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; McCarthy AA, 2000, ACTA CRYSTALLOGR D, V56, P1367, DOI 10.1107/S0907444900009896; Mootz HD, 2003, J AM CHEM SOC, V125, P10561, DOI 10.1021/ja0362813; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Negrotto D, 2000, PLANT CELL REP, V19, P798, DOI 10.1007/s002999900187; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; ROGERS JC, 1985, J BIOL CHEM, V260, P3731; Rohl CA, 2005, METHOD ENZYMOL, V394, P244, DOI 10.1016/S0076-6879(05)94009-3; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selig MJ, 2008, BIORESOURCE TECHNOL, V99, P4997, DOI 10.1016/j.biortech.2007.09.064; Sivamani E, 2006, PLANT MOL BIOL, V60, P225, DOI 10.1007/s11103-005-3853-z; Southworth MW, 1996, P NATL ACAD SCI USA, V93, P5281, DOI 10.1073/pnas.93.11.5281; Taylor LE, 2008, TRENDS BIOTECHNOL, V26, P413, DOI 10.1016/j.tibtech.2008.05.002; Tori K, 2010, J BIOL CHEM, V285, P2515, DOI 10.1074/jbc.M109.069567; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Yang JJ, 2003, P NATL ACAD SCI USA, V100, P3513, DOI 10.1073/pnas.0635899100; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979; Zhang D, 2011, BIOENERG RES, V4, P276, DOI 10.1007/s12155-011-9138-2	59	60	65	1	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1131	+		10.1038/nbt.2402	http://dx.doi.org/10.1038/nbt.2402			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23086202				2022-12-27	WOS:000311087500033
J	Gerngross, T				Gerngross, Tillman			It's the problem, stupid!	NATURE BIOTECHNOLOGY			English	Editorial Material									[Gerngross, Tillman] Dartmouth Coll, Hanover, NH 03755 USA; [Gerngross, Tillman] GlycoFi, Lebanon, NH USA; [Gerngross, Tillman] Adimab LLC, Lebanon, NH USA; [Gerngross, Tillman] Arsanis Inc, Lebanon, NH USA; [Gerngross, Tillman] Arsanis Inc, Vienna, Austria; [Gerngross, Tillman] SV Life Sci, Boston, MA USA	Dartmouth College	Gerngross, T (corresponding author), Dartmouth Coll, Hanover, NH 03755 USA.	tillman.gerngross@dartmouth.edu						Gerngross TU, 1999, NAT BIOTECHNOL, V17, P541, DOI 10.1038/9843; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256	2	2	2	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					742	744		10.1038/nbt.2301	http://dx.doi.org/10.1038/nbt.2301			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22871706				2022-12-27	WOS:000307416900011
J	Jong, S				Jong, Simcha			Commercializing a disruptive technology	NATURE BIOTECHNOLOGY			English	Editorial Material									UCL, Dept Management Sci & Innovat, London WC1E 6BT, England	University of London; University College London	Jong, S (corresponding author), UCL, Dept Management Sci & Innovat, Gower St, London WC1E 6BT, England.	s.jong@ucl.ac.uk	Jong, Simcha/A-3361-2009	Jong, Simcha/0000-0002-3281-5381	Economic and Social Research Council [ES/H008470/1] Funding Source: researchfish; ESRC [ES/H008470/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Chandrasekharan S, 2009, NAT BIOTECHNOL, V27, P140, DOI 10.1038/nbt0209-140; Cyert R. M., 1963, BEHAV THEORY FIRM; Dennis C, 2003, NATURE, V423, P105, DOI 10.1038/423105a; March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71; SHIH W, 2010, ALNYLAM PHARM BUILDI; Simon BM, 2011, NAT BIOTECHNOL, V29, P229, DOI 10.1038/nbt.1795	6	4	4	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					685	688		10.1038/bioe.2011.6	http://dx.doi.org/10.1038/bioe.2011.6			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21936068	Bronze			2022-12-27	WOS:000293696500010
J	Kelly, OG; Chan, MY; Martinson, LA; Kadoya, K; Ostertag, TM; Ross, KG; Richardson, M; Carpenter, MK; D'Amour, KA; Kroon, E; Moorman, M; Baetge, EE; Bang, AG				Kelly, Olivia G.; Chan, Man Yin; Martinson, Laura A.; Kadoya, Kuniko; Ostertag, Traci M.; Ross, Kelly G.; Richardson, Mike; Carpenter, Melissa K.; D'Amour, Kevin A.; Kroon, Evert; Moorman, Mark; Baetge, Emmanuel E.; Bang, Anne G.			Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells	NATURE BIOTECHNOLOGY			English	Article							PROGENITOR CELLS; TISSUE FACTOR; BETA-CELLS; ISLET TRANSPLANTATION; ENDOCRINE-CELLS; ROCK INHIBITOR; ALPHA-CELLS; EXPRESSION; INSULIN; NEOGENESIS	Using a flow cytometry-based screen of commercial antibodies, we have identified cell-surface markers for the separation of pancreatic cell types derived from human embryonic stem (hES) cells. We show enrichment of pancreatic endoderm cells using CD142 and of endocrine cells using CD200 and CD318. After transplantation into mice, enriched pancreatic endoderm cells give rise to all the pancreatic lineages, including functional insulin-producing cells, demonstrating that they are pancreatic progenitors. In contrast, implanted, enriched polyhormonal endocrine cells principally give rise to glucagon cells. These antibodies will aid investigations that use pancreatic cells generated from pluripotent stem cells to study diabetes and pancreas biology.	[Kelly, Olivia G.; Chan, Man Yin; Martinson, Laura A.; Kadoya, Kuniko; Ostertag, Traci M.; Ross, Kelly G.; Richardson, Mike; Carpenter, Melissa K.; D'Amour, Kevin A.; Kroon, Evert; Moorman, Mark; Baetge, Emmanuel E.; Bang, Anne G.] ViaCyte Inc, San Diego, CA USA		Kelly, OG (corresponding author), ViaCyte Inc, San Diego, CA USA.	okelly@viacyte.com		KROON, EVERT/0000-0002-4069-3644	Juvenile Diabetes Research Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	We thank O. Madsen (Hagedorn Research Institute), C. Wright (Vanderbilt University), J. Johnson (UT Southwestern Medical Center) and BD Biosciences for providing antibodies and A. Elefanty and E. Stanley (Monash University) for providing the MEL1 hES cell line. The CyT203 and CyT49 hES cell lines were derived with partial funding from the Juvenile Diabetes Research Foundation.	Beuneu C, 2004, DIABETES, V53, P1407, DOI 10.2337/diabetes.53.6.1407; Braam SR, 2010, ANN NY ACAD SCI, V1188, P52, DOI 10.1111/j.1749-6632.2009.05083.x; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dorrell C, 2008, STEM CELL RES, V1, P183, DOI 10.1016/j.scr.2008.04.001; Gao R, 2005, DIABETOLOGIA, V48, P2296, DOI 10.1007/s00125-005-1935-8; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guo TX, 2009, ENDOCR REV, V30, P214, DOI 10.1210/er.2009-0004; Hald J, 2008, J HISTOCHEM CYTOCHEM, V56, P587, DOI 10.1369/jhc.2008.950675; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hori Y, 2008, STEM CELLS, V26, P2912, DOI 10.1634/stemcells.2008-0192; Jiang W, 2011, STEM CELLS, V29, P609, DOI 10.1002/stem.608; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Luther T, 1996, AM J PATHOL, V149, P101; McKnight KD, 2010, CELL STEM CELL, V6, P300, DOI 10.1016/j.stem.2010.03.003; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4; Murray HE, 2005, MOL CELL ENDOCRINOL, V238, P39, DOI 10.1016/j.mce.2005.03.014; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Sugiyama T, 2008, DIABETES OBES METAB, V10, P179, DOI 10.1111/j.1463-1326.2008.00954.x; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; TEITELMAN G, 1993, DEVELOPMENT, V118, P1031; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Van Hoof D, 2009, STEM CELL RES, V3, P73, DOI 10.1016/j.scr.2009.08.003; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wilson ME, 2002, MECH DEVELOP, V115, P171, DOI 10.1016/S0925-4773(02)00118-1; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N	34	236	284	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					750	U114		10.1038/nbt.1931	http://dx.doi.org/10.1038/nbt.1931			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21804561				2022-12-27	WOS:000293696500028
J	McLean, J				McLean, John			Profiling the reform-era life sciences executive	NATURE BIOTECHNOLOGY			English	Editorial Material									Witt Kieffer, Oak Brook, IL USA		McLean, J (corresponding author), Witt Kieffer, Oak Brook, IL USA.	jmclean@wittkieffer.com						Deloitte, 2013, HLTH CAR REF LIF SCI; PricewaterhouseCoopers, 2013, DEAL DISR 16 ANN GLO	2	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					292	293		10.1038/nbt.2847	http://dx.doi.org/10.1038/nbt.2847			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24727783				2022-12-27	WOS:000332819800033
J	Selvaraj, S; Dixon, JR; Bansal, V; Ren, B				Selvaraj, Siddarth; Dixon, Jesse R.; Bansal, Vikas; Ren, Bing			Whole-genome haplotype reconstruction using proximity-ligation and shotgun sequencing	NATURE BIOTECHNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISEASE ASSOCIATIONS; DNA METHYLATION; VARIANTS; MAP; EXPRESSION; FRAMEWORK; ORIGIN; CELLS; LOCI	Rapid advances in high-throughput sequencing facilitate variant discovery and genotyping, but linking variants into a single haplotype remains challenging. Here we demonstrate HaploSeq, an approach for assembling chromosome-scale haplotypes by exploiting the existence of 'chromosome territories'. We use proximity ligation and sequencing to show that alleles on homologous chromosomes occupy distinct territories, and therefore this experimental protocol preferentially recovers physically linked DNA variants on a homolog. Computational analysis of such data sets allows for accurate (similar to 99.5%) reconstruction of chromosome-spanning haplotypes for similar to 95% of alleles in hybrid mouse cells with 30x sequencing coverage. To resolve haplotypes for a human genome, which has a low density of variants, we coupled HaploSeq with local conditional phasing to obtain haplotypes for similar to 81% of alleles with similar to 98% accuracy from just 17x sequencing. Whereas methods based on proximity ligation were originally designed to investigate spatial organization of genomes, our results lend support for their use as a general tool for haplotyping.	[Selvaraj, Siddarth; Dixon, Jesse R.; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA USA; [Selvaraj, Siddarth] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Dixon, Jesse R.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA; [Bansal, Vikas] Scripps Translat Sci Inst, La Jolla, CA USA; [Bansal, Vikas] Scripps Hlth, La Jolla, CA USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, La Jolla, CA USA.	biren@ucsd.edu	Dixon, Jesse/AAT-2914-2020	Dixon, Jesse/0000-0002-6273-2181	Ludwig Institute for Cancer Research; Roadmap Epigenome Project [U01 ES017166]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; Roadmap Epigenome Project; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank E. Heard for providing the CASTxJ129 hybrid mouse ES cell line for this study. We thank V. Bafna for providing valuable suggestions in the course of the work. We are also grateful for the comments on this manuscript by K. Zhang. Funding for this study is provided by the Ludwig Institute for Cancer Research and the Roadmap Epigenome Project (U01 ES017166).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bansal V, 2008, BIOINFORMATICS, V24, pI153, DOI 10.1093/bioinformatics/btn298; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gribnau J, 2003, GENE DEV, V17, P759, DOI 10.1101/gad.1059603; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kaper F, 2013, P NATL ACAD SCI USA, V110, P5552, DOI 10.1073/pnas.1218696110; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kirkness EF, 2013, GENOME RES, V23, P826, DOI 10.1101/gr.144600.112; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Krueger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038983; Levy S., PLOS BIOL; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ma L, 2010, NAT METHODS, V7, P299, DOI [10.1038/NMETH.1443, 10.1038/nmeth.1443]; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Petersdorf EW, 2007, PLOS MED, V4, P59, DOI 10.1371/journal.pmed.0040008; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yang H, 2011, P NATL ACAD SCI USA, V108, P12, DOI 10.1073/pnas.1016725108; Zeng D, 2005, GENET EPIDEMIOL, V28, P70, DOI 10.1002/gepi.20040; Zschocke J, 2008, J INHERIT METAB DIS, V31, P599, DOI 10.1007/s10545-008-1016-5	46	167	183	3	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1111	+		10.1038/nbt.2728	http://dx.doi.org/10.1038/nbt.2728			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24185094	Green Accepted			2022-12-27	WOS:000328251900024
J	Yla-Herttuala, S; Aavik, E				Yla-Herttuala, Seppo; Aavik, Einari			Modified RNA kick-starts cardiac repair	NATURE BIOTECHNOLOGY			English	Editorial Material							GROWTH; ANGIOGENESIS	The survival of mice after experimental heart attack is greatly improved by a pulse of RNA therapy.	[Yla-Herttuala, Seppo; Aavik, Einari] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland	University of Eastern Finland	Yla-Herttuala, S (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland.	seppo.ylaherttuala@uef.fi		Yla-Herttuala, Seppo/0000-0001-7593-2708				Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Dragneva G, 2013, DIS MODEL MECH, V6, P312, DOI 10.1242/dmm.010413; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Karvinen H, 2011, GENE THER, V18, P1166, DOI 10.1038/gt.2011.66; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; MANDEL LR, 1963, BIOCHEMISTRY-US, V2, P555, DOI 10.1021/bi00903a029; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jacc.2006.09.053; Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682	10	3	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2013	31	10					891	892		10.1038/nbt.2716	http://dx.doi.org/10.1038/nbt.2716			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233CA	24104754				2022-12-27	WOS:000325541300015
J	Borowski, C				Borowski, Christine			Commensal cocktail suppresses gut inflammation	NATURE BIOTECHNOLOGY			English	Editorial Material																		Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037	3	0	0	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					813	813		10.1038/nbt.2680	http://dx.doi.org/10.1038/nbt.2680			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	24022160	Bronze			2022-12-27	WOS:000324306300020
J	Carroll, D				Carroll, Dana			Staying on target with CRISPR-Cas	NATURE BIOTECHNOLOGY			English	Editorial Material							SYSTEMS; RNA; GENERATION; MULTIPLEX; MUTATIONS; GENOMES		Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah	Carroll, D (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA.	dana@biochem.utah.edu						Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025	18	39	66	0	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					807	809		10.1038/nbt.2684	http://dx.doi.org/10.1038/nbt.2684			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	24022156				2022-12-27	WOS:000324306300017
J	Fang, FC				Fang, Ferric C.			Antibiotic and ROS linkage questioned	NATURE BIOTECHNOLOGY			English	Editorial Material							BACTERICIDAL ANTIBIOTICS; CELL-DEATH	New work fuels the controversy over the role of reactive oxygen species (ROS) in the activity of bactericidal antibiotics.	[Fang, Ferric C.] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Fang, Ferric C.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fang, FC (corresponding author), Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA.	fcfang@uw.edu		Fang, Ferric/0000-0002-3243-110X				Brynildsen MP, 2013, NAT BIOTECHNOL, V31, P160, DOI 10.1038/nbt.2458; Farha MA, 2013, NAT BIOTECHNOL, V31, P120, DOI 10.1038/nbt.2500; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Hassett DJ, 2007, ACS CHEM BIOL, V2, P708, DOI 10.1021/cb700232k; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Ricci V, 2012, J ANTIMICROB CHEMOTH, V67, P589, DOI 10.1093/jac/dkr515; Tamae C, 2008, J BACTERIOL, V190, P5981, DOI 10.1128/JB.01982-07; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08	12	32	33	4	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					415	416		10.1038/nbt.2574	http://dx.doi.org/10.1038/nbt.2574			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23657395				2022-12-27	WOS:000318589600019
J	Avalos, JL; Fink, GR; Stephanopoulos, G				Avalos, Jose L.; Fink, Gerald R.; Stephanopoulos, Gregory			Compartmentalization of metabolic pathways in yeast mitochondria improves the production of branched-chain alcohols	NATURE BIOTECHNOLOGY			English	Article							INCREASED ISOBUTANOL PRODUCTION; SACCHAROMYCES-CEREVISIAE; EHRLICH PATHWAY; ACID SYNTHESIS; COENZYME-Q; GENE; BIOGENESIS; BIOSYNTHESIS; LOCALIZATION; SYNTHASE	Efforts to improve the production of a compound of interest in Saccharomyces cerevisiae have mainly involved engineering or overexpression of cytoplasmic enzymes. We show that targeting metabolic pathways to mitochondria can increase production compared with overexpression of the enzymes involved in the same pathways in the cytoplasm. Compartmentalization of the Ehrlich pathway into mitochondria increased isobutanol production by 260%, whereas overexpression of the same pathway in the cytoplasm only improved yields by 10%, compared with a strain overproducing enzymes involved in only the first three steps of the biosynthetic pathway. Subcellular fractionation of engineered strains revealed that targeting the enzymes of the Ehrlich pathway to the mitochondria achieves greater local enzyme concentrations. Other benefits of compartmentalization may include increased availability of intermediates, removing the need to transport intermediates out of the mitochondrion and reducing the loss of intermediates to competing pathways.	[Avalos, Jose L.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Avalos, Jose L.; Fink, Gerald R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Fink, GR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	gfink@wi.mit.edu; gregstep@mit.edu		Avalos, Jose L./0000-0002-7209-4208	US National Institutes of Health under Ruth L. Kirchstein National Research Service Award [1F32GM098022-01A1]; National Institutes of Health [GM040266]; Shell Global Solutions (US) Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085323, R01GM035010, F32GM098022, R01GM040266] Funding Source: NIH RePORTER	US National Institutes of Health under Ruth L. Kirchstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shell Global Solutions (US) Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K.L. Jones Prather and T.D. Fox for helpful discussions, T.J. Helbig for working on GFP subcellular localization experiments, T. DiCesare for preparing figures, S. Lindquist (Whitehead Institute) for strain Y3929, and members of the Stephanopoulos, Fink and Prather laboratories for discussions and advice. J.L.A. is supported by US National Institutes of Health under Ruth L. Kirchstein National Research Service Award 1F32GM098022-01A1. G.R.F. is supported by National Institutes of Health grant GM040266. This work was supported by Shell Global Solutions (US) Inc.	Anthony LC, 2010, US Patent, Patent No. [2010/0129886, 20100129886, US 2010/0129886 A1]; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Bastian S, 2011, METAB ENG, V13, P345, DOI 10.1016/j.ymben.2011.02.004; Blombach Bastian, 2011, Bioeng Bugs, V2, P346, DOI 10.4161/bbug.2.6.17845; Brat D, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-65; Buelter T., 2010, World patent, Patent No. [WO 2010/075504A2, 2010075504]; Chen X, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-21; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Farhi M, 2011, METAB ENG, V13, P474, DOI 10.1016/j.ymben.2011.05.001; Feldman R.M.R., 2011, US patent, Patent No. [US 2011/8017375 B2, 20118017375]; Fukuda H, 2005, INT J BIOCHEM CELL B, V37, P272, DOI 10.1016/j.biocel.2004.04.018; Gregg C, 2009, JOVE-J VIS EXP, V24, P1417, DOI DOI 10.3791/1417; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Higashide W, 2011, APPL ENVIRON MICROB, V77, P2727, DOI 10.1128/AEM.02454-10; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Jia XQ, 2012, APPL BIOCHEM BIOTECH, V168, P1, DOI 10.1007/s12010-011-9268-1; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Kondo T, 2012, J BIOTECHNOL, V159, P32, DOI 10.1016/j.jbiotec.2012.01.022; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Larroy C, 2002, EUR J BIOCHEM, V269, P5738, DOI 10.1046/j.1432-1033.2002.03296.x; Lee WH, 2012, BIOPROC BIOSYST ENG, V35, P1467, DOI 10.1007/s00449-012-0736-y; Li SS, 2011, APPL MICROBIOL BIOT, V91, P577, DOI 10.1007/s00253-011-3280-9; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; MAARSE AC, 1984, EMBO J, V3, P2831, DOI 10.1002/j.1460-2075.1984.tb02216.x; Marquet A, 2001, VITAM HORM, V61, P51; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; Neuburger M, 1996, J BIOL CHEM, V271, P9466, DOI 10.1074/jbc.271.16.9466; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Paltauf F., 1992, MOL CELLULAR BIOL YE, P415, DOI DOI 10.1101/087969365.21B.415; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; SCHNELL N, 1992, CURR GENET, V21, P269, DOI 10.1007/BF00351681; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; SHANNON KW, 1988, J BIOL CHEM, V263, P7717; Sleight SC, 2010, NUCLEIC ACIDS RES, V38, P2624, DOI 10.1093/nar/gkq179; Smith KM, 2010, APPL MICROBIOL BIOT, V87, P1045, DOI 10.1007/s00253-010-2522-6; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; SULO P, 1993, J BIOL CHEM, V268, P17634; Szczebara FM, 2003, NAT BIOTECHNOL, V21, P143, DOI 10.1038/nbt775; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Urano J., 2011, US patent, Patent No. [US 2011/0076733 A1, 20110076733]; URBANGRIMAL D, 1986, EUR J BIOCHEM, V156, P511, DOI 10.1111/j.1432-1033.1986.tb09610.x; Wu SQ, 2006, NAT BIOTECHNOL, V24, P1441, DOI 10.1038/nbt1251; Xu XM, 2008, CHEMBIOCHEM, V9, P2355, DOI 10.1002/cbic.200800384; ZHANG SG, 1994, ARCH BIOCHEM BIOPHYS, V309, P29, DOI 10.1006/abbi.1994.1079	49	306	338	20	326	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2013	31	4					335	+		10.1038/nbt.2509	http://dx.doi.org/10.1038/nbt.2509			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	120TI	23417095	Green Accepted, Green Submitted			2022-12-27	WOS:000317195500027
J	Nawroth, JC; Lee, H; Feinberg, AW; Ripplinger, CM; McCain, ML; Grosberg, A; Dabiri, JO; Parker, KK				Nawroth, Janna C.; Lee, Hyungsuk; Feinberg, Adam W.; Ripplinger, Crystal M.; McCain, Megan L.; Grosberg, Anna; Dabiri, John O.; Parker, Kevin Kit			A tissue-engineered jellyfish with biomimetic propulsion	NATURE BIOTECHNOLOGY			English	Article							THIN-FILMS; PATTERNS; CNIDARIA; MEDUSAE; MUSCLE; FLOW	Reverse engineering of biological form and function requires hierarchical design over several orders of space and time. Recent advances in the mechanistic understanding of biosynthetic compound materials(1-3), computer-aided design approaches in molecular synthetic biology(4,5) and traditional soft robotics(6,7), and increasing aptitude in generating structural and chemical microenvironments that promote cellular self-organization(8-10) have enhanced the ability to recapitulate such hierarchical architecture in engineered biological systems. Here we combined these capabilities in a systematic design strategy to reverse engineer a muscular pump. We report the construction of a freely swimming jellyfish from chemically dissociated rat tissue and silicone polymer as a proof of concept. The constructs, termed 'medusoids', were designed with computer simulations and experiments to match key determinants of jellyfish propulsion and feeding performance by quantitatively mimicking structural design, stroke kinematics and animal-fluid interactions. The combination of the engineering design algorithm with quantitative benchmarks of physiological performance suggests that our strategy is broadly applicable to reverse engineering of muscular organs or simple life forms that pump to survive.	[Lee, Hyungsuk; Feinberg, Adam W.; Ripplinger, Crystal M.; McCain, Megan L.; Grosberg, Anna; Parker, Kevin Kit] Harvard Univ, Dis Biophys Grp, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Lee, Hyungsuk; Feinberg, Adam W.; Ripplinger, Crystal M.; McCain, Megan L.; Grosberg, Anna; Parker, Kevin Kit] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Nawroth, Janna C.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Dabiri, John O.] CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA	Harvard University; Harvard University; California Institute of Technology; California Institute of Technology	Parker, KK (corresponding author), Harvard Univ, Dis Biophys Grp, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	jodabiri@caltech.edu; kkparker@seas.harvard.edu	Feinberg, Adam W/A-7103-2009; Grosberg, Anna/B-3017-2014; Feinberg, Adam W/AAM-8547-2020	Feinberg, Adam W/0000-0003-3338-5456; Feinberg, Adam W/0000-0003-3338-5456; Nawroth, Janna/0000-0003-1898-3968; Ripplinger, Crystal/0000-0002-9908-4106; Grosberg, Anna/0000-0002-8878-0843	Wyss Institute for Biologically Inspired Engineering at Harvard; Harvard Materials Research Science and Engineering Center under National Science Foundation [DMR-0213805]; US National Institutes of Health [1 R01 HL079126]; office of Naval Research; National Science Foundation Program in Fluid Dynamics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100408, R01HL079126] Funding Source: NIH RePORTER	Wyss Institute for Biologically Inspired Engineering at Harvard; Harvard Materials Research Science and Engineering Center under National Science Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); office of Naval Research(Office of Naval Research); National Science Foundation Program in Fluid Dynamics(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge financial support from the Wyss Institute for Biologically Inspired Engineering at Harvard, the Harvard Materials Research Science and Engineering Center under National Science Foundation award number DMR-0213805, US National Institutes of Health grant 1 R01 HL079126 (K.K.P.), and from the office of Naval Research and National Science Foundation Program in Fluid Dynamics (J.O.D.). We acknowledge the Harvard Center for Nanoscale Science for use of facilities and the New England Aquarium for supplying jellyfish. We thank J. Goss, P.W. Alford, K.R. Sutherland, K. Balachandran, C. Regan, P. Campbell, S. Spina and A. Agarwal for comments and technical support.	Alford PW, 2010, BIOMATERIALS, V31, P3613, DOI 10.1016/j.biomaterials.2010.01.079; ANDERSON PAV, 1981, J MORPHOL, V170, P383, DOI 10.1002/jmor.1051700309; Arai MN, 1997, FUNCTIONAL BIOL SCYP; Bar-Cohen Y, 2004, P SOC PHOTO-OPT INS, V5385, P10, DOI 10.1117/12.538698; Bar-Cohen Y, 2006, BIOINSPIR BIOMIM, V1, pP1, DOI 10.1088/1748-3182/1/1/P01; BLANQUET RS, 1981, T AM MICROSC SOC, V100, P109, DOI 10.2307/3225794; Bol M, 2009, COMPUT MECH, V43, P535, DOI 10.1007/s00466-008-0328-5; Chapman DM, 1999, CAN J ZOOL, V77, P34, DOI 10.1139/cjz-77-1-34; Costello JH, 1995, MAR BIOL, V124, P399, DOI 10.1007/BF00363913; Dabiri JO, 2005, J EXP BIOL, V208, P1257, DOI 10.1242/jeb.01519; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Feitl KE, 2009, BIOL BULL-US, V217, P283, DOI 10.1086/BBLv217n3p283; Fu Pengcheng, 2006, Biotechnology Journal, V1, P690, DOI 10.1002/biot.200600019; GLADFELTER WB, 1972, MAR BIOL, V14, P150, DOI 10.1007/BF00373214; GLADFELTER WG, 1973, HELGOLAND WISS MEER, V25, P228, DOI 10.1007/BF01611199; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Grosberg A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001088; Hayward R.T., 2007, THESIS UNCW; Huang AH, 2010, J BIOMECH, V43, P128, DOI 10.1016/j.jbiomech.2009.09.018; Kaznessis YN, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-47; Koehl MAR, 2004, J BIOMECH, V37, P789, DOI 10.1016/j.jbiomech.2003.06.001; Koehl MAR, 2001, SCIENCE, V294, P1948, DOI 10.1126/science.1063724; Marder M, 2007, PHYS TODAY, V60, P33, DOI 10.1063/1.2711634; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; Nawroth JC, 2010, BIOL LETTERS, V6, P389, DOI 10.1098/rsbl.2010.0068; PASSANO LM, 1965, AM ZOOL, V5, P465; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/nmat2441, 10.1038/NMAT2441]; Satterlie RA, 2002, CAN J ZOOL, V80, P1654, DOI 10.1139/Z02-132; Shim J, 2012, J BIOMECH, V45, P832, DOI 10.1016/j.jbiomech.2011.11.024; Vogel S, 2020, LIFE MOVING FLUIDS P; von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5; Widmer CL, 2008, KEEP JELLYFISH AQUAR	32	416	432	21	402	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					792	797		10.1038/nbt.2269	http://dx.doi.org/10.1038/nbt.2269			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22820316	Green Published, Green Accepted			2022-12-27	WOS:000307416900023
J	Khmelinskii, A; Keller, PJ; Bartosik, A; Meurer, M; Barry, JD; Mardin, BR; Kaufmann, A; Trautmann, S; Wachsmuth, M; Pereira, G; Huber, W; Schiebel, E; Knop, M				Khmelinskii, Anton; Keller, Philipp J.; Bartosik, Anna; Meurer, Matthias; Barry, Joseph D.; Mardin, Balca R.; Kaufmann, Andreas; Trautmann, Susanne; Wachsmuth, Malte; Pereira, Gislene; Huber, Wolfgang; Schiebel, Elmar; Knop, Michael			Tandem fluorescent protein timers for in vivo analysis of protein dynamics	NATURE BIOTECHNOLOGY			English	Article							NUCLEAR-PORE COMPLEX; END RULE PATHWAY; SACCHAROMYCES-CEREVISIAE; MONOMERIC RED; UBIQUITIN LIGASES; PLASMA-MEMBRANE; CELL-CYCLE; HALF-LIFE; YEAST; DEGRADATION	The functional state of a cell is largely determined by the spatiotemporal organization of its proteome. Technologies exist for measuring particular aspects of protein turnover and localization, but comprehensive analysis of protein dynamics across different scales is possible only by combining several methods. Here we describe tandem fluorescent protein timers (tFTs), fusions of two single-color fluorescent proteins that mature with different kinetics, which we use to analyze protein turnover and mobility in living cells. We fuse tFTs to proteins in yeast to study the longevity, segregation and inheritance of cellular components and the mobility of proteins between subcellular compartments; to measure protein degradation kinetics without the need for time-course measurements; and to conduct high-throughput screens for regulators of protein turnover. Our experiments reveal the stable nature and asymmetric inheritance of nuclear pore complexes and identify regulators of N-end rule-mediated protein degradation.	[Khmelinskii, Anton; Bartosik, Anna; Meurer, Matthias; Mardin, Balca R.; Schiebel, Elmar; Knop, Michael] Univ Heidelberg ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany; [Khmelinskii, Anton; Keller, Philipp J.; Bartosik, Anna; Meurer, Matthias; Kaufmann, Andreas; Trautmann, Susanne; Wachsmuth, Malte; Knop, Michael] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Keller, Philipp J.] Howard Hughes Med Inst, Ashburn, VA USA; [Barry, Joseph D.; Huber, Wolfgang] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Trautmann, Susanne; Pereira, Gislene; Knop, Michael] German Canc Res Ctr, DKFZ ZMBH Alliance, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Howard Hughes Medical Institute; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ)	Knop, M (corresponding author), Univ Heidelberg ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany.	e.schiebel@zmbh.uni-heidelberg.de; m.knop@zmbh.uni-heidelberg.de	Pereira, Gislene/D-4024-2014; Khmelinskii, Anton/B-2830-2008	Huber, Wolfgang/0000-0002-0474-2218; Keller, Philipp/0000-0003-2896-4920; Barry, Joseph/0000-0002-1177-5771; Mardin, Balca R/0000-0002-3903-9354; Khmelinskii, Anton/0000-0002-0256-5190	Cell Networks cluster; German Research Foundation [SFB638]; Howard Hughes Medical Institute; European Molecular Biology Organization [EMBO ALTF 1124-2010]; EU-FP7 Network of Excellence in Systems Microscopy; Novartis Stiftung	Cell Networks cluster; German Research Foundation(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); EU-FP7 Network of Excellence in Systems Microscopy; Novartis Stiftung	We are grateful to Y. Belyaev, S. Terjung and the Advanced Light Microscopy Facility of EMBL for support with microscopy; A. Riddell, A. P. Gonzalez and the FACS Facility of EMBL for flow cytometry analyses; the Cell Networks cluster for funding to M.K., the German Research Foundation for funding to E.S. (SFB638), the Howard Hughes Medical Institute for funding to P.J.K., the European Molecular Biology Organization for funding to A.Kh. (EMBO ALTF 1124-2010), the EU-FP7 Network of Excellence in Systems Microscopy for funding to J.D.B. and W.H., and the Novartis Stiftung for funding to A.Ka. We thank P.I. Bastiaens, D. Gilmour and A. Kinkhabwala for discussions.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Hardy S, 2010, BIOL CELL, V102, P561, DOI 10.1042/BC20100038; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Khmelinskii A, 2010, NATURE, V466, DOI 10.1038/nature09255; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Makio T, 2009, J CELL BIOL, V185, P459, DOI 10.1083/jcb.200810029; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Newman RH, 2011, CHEM REV, V111, P3614, DOI 10.1021/cr100002u; Ouellet J, 2012, J CELL BIOL, V196, P305, DOI 10.1083/jcb.201102078; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Schoenheimer R., 1942, DYNAMIC STATE BODY C; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Subach FV, 2009, NAT CHEM BIOL, V5, P118, DOI 10.1038/nchembio.138; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Tsuboi T, 2010, MOL BIOL CELL, V21, P87, DOI 10.1091/mbc.E09-08-0722; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Verzijlbergen KF, 2010, P NATL ACAD SCI USA, V107, P64, DOI 10.1073/pnas.0911164107; Winey M, 1997, MOL BIOL CELL, V8, P2119, DOI 10.1091/mbc.8.11.2119; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu B, 2011, CURR OPIN CELL BIOL, V23, P310, DOI 10.1016/j.ceb.2010.12.004; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Yewdell JW, 2011, CELL BIOL INT, V35, P457, DOI 10.1042/CBI20110055; Zabel U, 1996, J CELL BIOL, V133, P1141, DOI 10.1083/jcb.133.6.1141; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang LJ, 2007, BIOTECHNIQUES, V42, P446, DOI 10.2144/000112453	53	160	164	2	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					708	+		10.1038/nbt.2281	http://dx.doi.org/10.1038/nbt.2281			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22729030				2022-12-27	WOS:000306293400030
J	Yang, W				Yang, Walter			Biotech equities heat up in 1Q12	NATURE BIOTECHNOLOGY			English	News Item									BioCentury, Redwood City, CA 94065 USA		Yang, W (corresponding author), BioCentury, Redwood City, CA 94065 USA.								0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					384	384		10.1038/nbt.2211	http://dx.doi.org/10.1038/nbt.2211			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22565955	Bronze			2022-12-27	WOS:000303803200010
J	Clark, MJ; Chen, R; Lam, HYK; Karczewski, KJ; Chen, R; Euskirchen, G; Butte, AJ; Snyder, M				Clark, Michael J.; Chen, Rui; Lam, Hugo Y. K.; Karczewski, Konrad J.; Chen, Rong; Euskirchen, Ghia; Butte, Atul J.; Snyder, Michael			Performance comparison of exome DNA sequencing technologies	NATURE BIOTECHNOLOGY			English	Article							HUMAN GENOME; CAPTURE; OLIGONUCLEOTIDES; SPECIFICITY; SENSITIVITY; MICROARRAYS; MUTATIONS; LIBRARIES; INSERTION; DELETION	Whole exome sequencing by high-throughput sequencing of target-enriched genomic DNA (exome-seq) has become common in basic and translational research as a means of interrogating the interpretable part of the human genome at relatively low cost. We present a comparison of three major commercial exome sequencing platforms from Agilent, Illumina and Nimblegen applied to the same human blood sample. Our results suggest that the Nimblegen platform, which is the only one to use high-density overlapping baits, covers fewer genomic regions than the other platforms but requires the least amount of sequencing to sensitively detect small variants. Agilent and Illumina are able to detect a greater total number of variants with additional sequencing. Illumina captures untranslated regions, which are not targeted by the Nimblegen and Agilent platforms. We also compare exome sequencing and whole genome sequencing (WGS) of the same sample, demonstrating that exome sequencing can detect additional small variants missed by WGS.	[Clark, Michael J.; Chen, Rui; Lam, Hugo Y. K.; Karczewski, Konrad J.; Euskirchen, Ghia; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Chen, Rong; Butte, Atul J.] Stanford Univ, Dept Pediat, Sch Med, Div Syst Med, Stanford, CA 94305 USA; [Euskirchen, Ghia; Snyder, Michael] Stanford Univ, Ctr Genom & Personalized Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Snyder, M (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	Karczewski, Jakub/L-7326-2018	Karczewski, Jakub/0000-0001-9322-7842; Snyder, Michael/0000-0003-0784-7987; Karczewski, Konrad/0000-0003-2878-4671	US National Institutes of Health [HG002357]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank P. LaCroute for assistance with data processing and analysis. Thanks to A. Boyle and Y. Cheng for consulting with data analysis and display methods. We thank representatives from Agilent, Illumina and Nimblegen for their support and feedback as we performed these tests. We also thank the Hewlett Packard Foundation and Lucile Packard Foundation for Children's Health for support in creation of our disease/trait SNP database. This work was supported by the US National Institutes of Health grant no. HG002357.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Glazov EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002027; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; Kucho KI, 2004, GENES GENET SYST, V79, P189, DOI 10.1266/ggs.79.189; Lee H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-646; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Shi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002084; Snape K, 2011, NAT GENET, V43, P527, DOI 10.1038/ng.822; Taylor MS, 2004, GENOME RES, V14, P555, DOI 10.1101/gr.1977804; Wetterstrand K.A., DNA SEQUENCING COSTS; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745	33	336	356	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					908	U206		10.1038/nbt.1975	http://dx.doi.org/10.1038/nbt.1975			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21947028	Green Accepted			2022-12-27	WOS:000296273000017
J	Sim, FJ; McClain, CR; Schanz, SJ; Protack, TL; Windrem, MS; Goldman, SA				Sim, Fraser J.; McClain, Crystal R.; Schanz, Steven J.; Protack, Tricia L.; Windrem, Martha S.; Goldman, Steven A.			CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells	NATURE BIOTECHNOLOGY			English	Article							SUBCORTICAL WHITE-MATTER; ADULT HUMAN BRAIN; GROWTH-FACTOR RECEPTOR; PDGF ALPHA-RECEPTOR; MONOCLONAL-ANTIBODY; MULTIPLE-SCLEROSIS; NG2 PROTEOGLYCAN; PRECURSOR CELLS; STEM-CELLS; RAT-BRAIN	Experimental animals with myelin disorders can be treated by transplanting oligodendrocyte progenitor cells (OPCs) into the affected brain or spinal cord. OPCs have been isolated by their expression of gangliosides recognized by mAb A2B5, but this marker also identifies lineage-restricted astrocytes and immature neurons. To establish a more efficient means of isolating myelinogenic OPCs, we sorted fetal human forebrain cells for CD140a, an epitope of platelet derived growth factor receptor (PDGFR) a, which is differentially expressed by OPCs. CD140a(+) cells were isolated as mitotic bipotential progenitors that initially expressed neither mature neuronal nor astrocytic phenotypic markers, yet could be instructed to either oligodendrocyte or astrocyte fate in vitro. Transplanted CD140a(+) cells were highly migratory and robustly myelinated the hypomyelinated shiverer mouse brain more rapidly and efficiently than did A2B5(+) cells. Microarray analysis of CD140a(+) cells revealed overexpression of the oligodendroglial marker CD9, suggesting that CD9(+)/CD140a(+) cells may constitute an even more highly enriched population of myelinogenic progenitor cells.	[Sim, Fraser J.; McClain, Crystal R.; Schanz, Steven J.; Protack, Tricia L.; Windrem, Martha S.; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Sim, Fraser J.; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Sim, Fraser J.] SUNY Buffalo, Dept Pharmacol, Buffalo, NY 14260 USA	University of Rochester; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sim, FJ (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.	fjsim@buffalo.edu; Steven_Goldman@urmc.rochester.edu	Sim, Fraser/G-3060-2010	Sim, Fraser/0000-0002-3942-6637; Goldman, Steven/0000-0002-5498-4303	National Institute of Neurological Disorders and Stroke (NINDS) [R01NS039559, R01NS75345, P01NS050315]; National Multiple Sclerosis Society; New York State Stem Cell Research Board (NYSTEM); Adelson Medical Research Foundation; Mathers Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS050315, R01NS075345, R01NS039559] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); New York State Stem Cell Research Board (NYSTEM); Adelson Medical Research Foundation; Mathers Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) grants R01NS039559, R01NS75345 and P01NS050315, the National Multiple Sclerosis Society, the New York State Stem Cell Research Board (NYSTEM), the Adelson Medical Research Foundation, and the Mathers Charitable Foundation. We would like to thank X.-J. Li for technical support, and M. Zanche, A. Cardillo and the University of Rochester Medical Center Functional Genomics core for Affymetrix and Taqman array support. O4 supernatant was a gift of R. Bansal and the late S. Pfeiffer (University of Connecticut).	ARMSTRONG RC, 1992, J NEUROSCI, V12, P1538; Back SA, 2001, J NEUROSCI, V21, P1302; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Ben-Hur T, 2008, ANN NY ACAD SCI, V1142, P218, DOI 10.1196/annals.1444.014; Berry M, 2002, J NEUROCYTOL, V31, P457, DOI 10.1023/A:1025735513560; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; ELLISON JA, 1994, J NEUROSCI RES, V37, P116, DOI 10.1002/jnr.490370116; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Furge K., 2006, R PACKAGE VERSION, P1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GOGATE N, 1994, J NEUROSCI, V14, P4571; Goldman SA, 2011, ARCH NEUROL-CHICAGO, V68, P848, DOI 10.1001/archneurol.2011.46; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Keyoung HM, 2007, NEUROSURG CLIN N AM, V18, P93, DOI 10.1016/j.nec.2006.10.009; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; LAROCHELLE WJ, 1993, CELL GROWTH DIFFER, V4, P547; LILLIEN LE, 1990, NEURON, V4, P525, DOI 10.1016/0896-6273(90)90110-2; Mabie PC, 1997, J NEUROSCI, V17, P4112; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Rakic S, 2003, GLIA, V41, P117, DOI 10.1002/glia.10140; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Scolding N, 1998, NEUROSCIENTIST, V4, P264, DOI 10.1177/107385849800400415; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Terada N, 2002, GLIA, V40, P350, DOI 10.1002/glia.10134; Wang S, 2010, J NEUROSCI, V30, P14635, DOI 10.1523/JNEUROSCI.1729-10.2010; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; WOLSWIJK G, 1992, J CELL BIOL, V118, P889, DOI 10.1083/jcb.118.4.889; Zhang SC, 2000, J NEUROSCI RES, V59, P421, DOI 10.1002/(SICI)1097-4547(20000201)59:3<421::AID-JNR17>3.3.CO;2-3	43	140	150	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					934	U123		10.1038/nbt.1972	http://dx.doi.org/10.1038/nbt.1972			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21947029	Green Accepted			2022-12-27	WOS:000296273000021
J	Webber, P				Webber, Philip			Does CRISPR-Cas open new possibilities for patents or present a moral maze?	NATURE BIOTECHNOLOGY			English	Editorial Material							ENDONUCLEASE	CRISPR-Cas systems, which enable the production of new artificial genes, synthetic proteins and new transgenic organisms, will challenge patent practices worldwide.	Dehns Patent & Trade Mark Attorneys, Oxford, England		Webber, P (corresponding author), Dehns Patent & Trade Mark Attorneys, Oxford, England.	pwebber@dehns.com						[Anonymous], 1843, T 0019/90 Onco-Mouse/Harvard, Patent No. 3; [Anonymous], 1998, OFFICIAL J L; [Anonymous], 1998, Official Journal, VL213, P0013, Patent No. [0242236, 0 242 236]; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842	8	14	14	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					331	334		10.1038/nbt.2843	http://dx.doi.org/10.1038/nbt.2843			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24714479				2022-12-27	WOS:000334340800014
J	Browne, LE; Woolf, CJ				Browne, Liam E.; Woolf, Clifford J.			Casting light on pain	NATURE BIOTECHNOLOGY			English	Editorial Material							OPTICAL CONTROL; ACTIVATION		[Browne, Liam E.; Woolf, Clifford J.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Browne, Liam E.; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Browne, LE (corresponding author), Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	clifford.woolf@childrens.harvard.edu	Woolf, Clifford/A-9784-2010	Browne, Liam/0000-0002-5693-7703				Browne LE, 2014, P NATL ACAD SCI USA, V111, P521, DOI 10.1073/pnas.1318582111; Daou I, 2013, J NEUROSCI, V33, P18631, DOI 10.1523/JNEUROSCI.2424-13.2013; Iyer SM, 2014, NAT BIOTECHNOL, V32, P274, DOI 10.1038/nbt.2834; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Towne C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-52; Williams JC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003100; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	10	1	1	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					240	241		10.1038/nbt.2844	http://dx.doi.org/10.1038/nbt.2844			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24727775				2022-12-27	WOS:000332819800019
J	Iyer, SM; Montgomery, KL; Towne, C; Lee, SY; Ramakrishnan, C; Deisseroth, K; Delp, SL				Iyer, Shrivats Mohan; Montgomery, Kate L.; Towne, Chris; Lee, Soo Yeun; Ramakrishnan, Charu; Deisseroth, Karl; Delp, Scott L.			Virally mediated optogenetic excitation and inhibition of pain in freely moving nontransgenic mice	NATURE BIOTECHNOLOGY			English	Article							OPTICAL CONTROL; NOCICEPTIVE NEURONS; ACTIVATION; DELIVERY	Primary nociceptors are the first neurons involved in the complex processing system that regulates normal and pathological pain(1). Because of constraints on pharmacological and electrical stimulation, noninvasive excitation and inhibition of these neurons in freely moving nontransgenic animals has not been possible. Here we use an optogenetic(2) strategy to bidirectionally control nociceptors of nontransgenic mice. Intrasciatic nerve injection of adeno-associated viruses,encoding an excitatory opsin enabled light-inducible stimulation of acute pain, place aversion and optogenetically mediated reductions in withdrawal thresholds to mechanical and thermal stimuli. In contrast, viral delivery of an inhibitory opsin enabled light-inducible inhibition of acute pain perception, and reversed mechanical allodynia and thermal hyperalgesia in a model of neuropathic pain. Light was delivered transdermally, allowing these behaviors to be induced in freely moving animals. This approach may have utility in basic and translational pain research, and enable rapid drug screening and testing of newly engineered opsins.	[Iyer, Shrivats Mohan; Montgomery, Kate L.; Towne, Chris; Lee, Soo Yeun; Ramakrishnan, Charu; Deisseroth, Karl; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Delp, SL (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	delp@stanford.edu	Core, Vector/CAF-4832-2022	Delp, Scott/0000-0002-9643-7551; Ramakrishnan, Charu/0000-0002-3474-6332; Iyer, Shrivats/0000-0003-4648-3637	US National Institutes of Health (National Institute of Neurological Disorders and Stroke) [R01-NS080954]; Stanford Bio-X NeuroVentures program; Stanford Bio-X Interdisciplinary Initiatives program; Office of Technology Licensing Stanford Graduate Fellowship; Howard Hughes Medical Institute International Student Research Fellowship; Bio-X Bioengineering Graduate Fellowship; Stanford Interdisciplinary Graduate Fellowship; Swiss National Science Foundation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080954] Funding Source: NIH RePORTER	US National Institutes of Health (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stanford Bio-X NeuroVentures program; Stanford Bio-X Interdisciplinary Initiatives program; Office of Technology Licensing Stanford Graduate Fellowship; Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); Bio-X Bioengineering Graduate Fellowship; Stanford Interdisciplinary Graduate Fellowship; Swiss National Science Foundation Fellowship(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Liske, X. Qian, S. Mackey, A. Weitz, D.J. Clark, D.C. Yeomans, P. Sabhaie, C. Gorini, S. Young and H. Scutt for useful discussions and assistance with experiments. This study was supported by the US National Institutes of Health (National Institute of Neurological Disorders and Stroke grant R01-NS080954), the Stanford Bio-X NeuroVentures program and the Stanford Bio-X Interdisciplinary Initiatives program. S.M.I. was supported by an Office of Technology Licensing Stanford Graduate Fellowship and by a Howard Hughes Medical Institute International Student Research Fellowship. K.L.M. was supported by a Bio-X Bioengineering Graduate Fellowship and by a Stanford Interdisciplinary Graduate Fellowship. C.T. was supported by a Swiss National Science Foundation Fellowship.	[Anonymous], 2011, NAT BIOTECHNOL, V29, P849, DOI 10.1038/nbt.2016; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Chow BY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003101; Daou I, 2013, J NEUROSCI, V33, P18631, DOI 10.1523/JNEUROSCI.2424-13.2013; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Ji ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032699; Kokel D, 2013, NAT CHEM BIOL, V9, P257, DOI [10.1038/NCHEMBIO.1183, 10.1038/nchembio.1183]; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Liske H, 2013, MUSCLE NERVE, V47, P916, DOI 10.1002/mus.23696; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; Mason MRJ, 2010, MOL THER, V18, P715, DOI 10.1038/mt.2010.19; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Mourot A, 2012, NAT METHODS, V9, P396, DOI [10.1038/NMETH.1897, 10.1038/nmeth.1897]; San Sebastian W, 2013, GENE THER, V20, P1178, DOI 10.1038/gt.2013.48; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P753, DOI 10.1113/jphysiol.1995.sp020766; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Towne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072691; Towne C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-52; Wang H, 2009, J NEUROSCI, V29, P13202, DOI 10.1523/JNEUROSCI.3248-09.2009; Williams JC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003100; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	28	140	174	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					274	278		10.1038/nbt.2834	http://dx.doi.org/10.1038/nbt.2834			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24531797	Green Accepted			2022-12-27	WOS:000332819800026
J	Rosen, CB; Rodriguez-Larrea, D; Bayley, H				Rosen, Christian B.; Rodriguez-Larrea, David; Bayley, Hagan			Single-molecule site-specific detection of protein phosphorylation with a nanopore	NATURE BIOTECHNOLOGY			English	Article							DNA; TRANSLOCATION; PEPTIDE	We demonstrate single-molecule, site-specific detection of protein phosphorylation with protein nanopore technology. A model protein, thioredoxin, was phosphorylated at two adjacent sites. Analysis of the ionic current amplitude and noise, as the protein unfolds and moves through an a-hemolysin pore, enables the distinction between unphosphorylated, monophosphorylated and diphosphorylated variants. Our results provide a step toward nanopore proteomics.	[Rosen, Christian B.; Rodriguez-Larrea, David; Bayley, Hagan] Univ Oxford, Dept Chem, Oxford OX1 3QZ, England; [Rosen, Christian B.] Aarhus Univ, Dept Chem, Ctr DNA Nanotechnol, DK-8000 Aarhus, Denmark; [Rosen, Christian B.] Aarhus Univ, iNANO, Aarhus, Denmark	University of Oxford; Aarhus University; Aarhus University	Rodriguez-Larrea, D (corresponding author), Univ Oxford, Dept Chem, Oxford OX1 3QZ, England.	david.rodriguez-larrea@chem.ox.ac.uk; hagan.bayley@chem.ox.ac.uk	Rodriguez-Larrea, David/ABH-3171-2020	Rodriguez-Larrea, David/0000-0002-5580-7413; Bayley, Hagan/0000-0003-2499-6116	National Institutes of Health; Oxford Nanopore Technologies; European Research Council; Danish National Research Foundation [DNRF78]; Aarhus University, Faculty of Science and Technology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxford Nanopore Technologies; European Research Council(European Research Council (ERC)European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Aarhus University, Faculty of Science and Technology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank E. Mikhailova for the preparation of alpha-hemolysin pores. We thank L. Harrington for the PKA-CAT plasmid and the purification protocol for the catalytic subunit of PKA. This work has been supported by the National Institutes of Health, Oxford Nanopore Technologies and an European Research Council Advanced Grant. C.B.R. is funded by the Danish National Research Foundation (grant number DNRF78) and Aarhus University, Faculty of Science and Technology.	Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Hinner MJ, 2010, CURR OPIN BIOTECH, V21, P766, DOI 10.1016/j.copbio.2010.09.011; Howorka S, 2001, NAT BIOTECHNOL, V19, P636, DOI 10.1038/90236; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Nivala J, 2013, NAT BIOTECHNOL, V31, P247, DOI 10.1038/nbt.2503; Pennisi E, 2012, SCIENCE, V336, P534, DOI 10.1126/science.336.6081.534; Prabakaran S, 2012, WIRES SYST BIOL MED, V4, P565, DOI 10.1002/wsbm.1185; Rodriguez-Larrea D, 2013, NAT NANOTECHNOL, V8, P288, DOI [10.1038/nnano.2013.22, 10.1038/NNANO.2013.22]; Tam JP, 1999, BIOPOLYMERS, V51, P311, DOI 10.1002/(SICI)1097-0282(1999)51:5<311::AID-BIP2>3.0.CO;2-A; Wallace EVB, 2010, CHEM COMMUN, V46, P8195, DOI 10.1039/c0cc02864a; Witus LS, 2010, J AM CHEM SOC, V132, P16812, DOI 10.1021/ja105429n	14	169	175	3	188	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					179	181		10.1038/nbt.2799	http://dx.doi.org/10.1038/nbt.2799			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24441471	Green Accepted			2022-12-27	WOS:000331074000023
J	Xue, ZX; Sharpe, PL; Hong, SP; Yadav, NS; Xie, DM; Short, DR; Damude, HG; Rupert, RA; Seip, JE; Wang, J; Pollak, DW; Bostick, MW; Bosak, MD; Macool, DJ; Hollerbach, DH; Zhang, HX; Arcilla, DM; Bledsoe, SA; Croker, K; McCord, EF; Tyreus, BD; Jackson, EN; Zhu, Q				Xue, Zhixiong; Sharpe, Pamela L.; Hong, Seung-Pyo; Yadav, Narendra S.; Xie, Dongming; Short, David R.; Damude, Howard G.; Rupert, Ross A.; Seip, John E.; Wang, Jamie; Pollak, Dana W.; Bostick, Michael W.; Bosak, Melissa D.; Macool, Daniel J.; Hollerbach, Dieter H.; Zhang, Hongxiang; Arcilla, Dennis M.; Bledsoe, Sidney A.; Croker, Kevin; McCord, Elizabeth F.; Tyreus, Bjorn D.; Jackson, Ethel N.; Zhu, Quinn			Production of omega-3 eicosapentaenoic acid by metabolic engineering of Yarrowia lipolytica	NATURE BIOTECHNOLOGY			English	Article							POLYUNSATURATED FATTY-ACIDS; EUGLENA-GRACILIS; BIOSYNTHESIS; GENE; OMEGA-3-FATTY-ACIDS; IDENTIFICATION; DESATURASES; EXPRESSION; GROWTH; PUFA	The availability of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) is currently limited because they are produced mainly by marine fisheries that cannot keep pace with the demands of the growing market for these products. A sustainable non-animal source of EPA and DHA is needed. Metabolic engineering of the oleaginous yeast Yarrowia lipolytica resulted in a strain that produced EPA at 15% of dry cell weight. The engineered yeast lipid comprises EPA at 56.6% and saturated fatty acids at less than 5% by weight, which are the highest and the lowest percentages, respectively, among known EPA sources. Inactivation of the peroxisome biogenesis gene PEX10 was crucial in obtaining high EPA yields and may increase the yields of other commercially desirable lipid-related products. This technology platform enables the production of lipids with tailored fatty acid compositions and provides a sustainable source of EPA.	[Xue, Zhixiong; Yadav, Narendra S.; Short, David R.; Macool, Daniel J.; Zhang, Hongxiang; Bledsoe, Sidney A.] EI du Pont de Nemours & Co, Ind Biosci, Wilmington, DE USA; [Sharpe, Pamela L.; Hong, Seung-Pyo; Xie, Dongming; Rupert, Ross A.; Seip, John E.; Wang, Jamie; Pollak, Dana W.; Bostick, Michael W.; Bosak, Melissa D.; Hollerbach, Dieter H.; Arcilla, Dennis M.; Croker, Kevin; Tyreus, Bjorn D.; Jackson, Ethel N.; Zhu, Quinn] EI du Pont de Nemours & Co, Cent Res & Dev, Biochem Sci & Engn, Wilmington, DE USA; [Damude, Howard G.] EI du Pont de Nemours & Co, Crop Genet, Wilmington, DE USA; [McCord, Elizabeth F.] EI du Pont de Nemours & Co, Corp Ctr Analyt Sci, Wilmington, DE USA	DuPont; DuPont; DuPont; DuPont	Zhu, Q (corresponding author), EI du Pont de Nemours & Co, Cent Res & Dev, Biochem Sci & Engn, Wilmington, DE USA.	quinn.zhu@usa.dupont.com		Xie, Dongming/0000-0003-3881-7975				Adarme-Vega TC, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-96; [Anonymous], 2003, LIPID ANAL; Aursand M, 2007, J AGR FOOD CHEM, V55, P38, DOI 10.1021/jf061754l; Ausubel FM, 2010, CURRENT PROTOCOLS MO; Barclay W., 2005, SINGLE CELL OIL, P36, DOI [10.1201/9781439822364.ch3, DOI 10.1201/9781439822364.CH3]; BARCLAY WR, 1994, J APPL PHYCOL, V6, P123, DOI 10.1007/BF02186066; Barth G, 2003, TOP CURR GENET, V2, P227; Bays HE, 2011, AM J CARDIOL, V108, P682, DOI 10.1016/j.amjcard.2011.04.015; Beopoulos A, 2011, APPL MICROBIOL BIOT, V90, P1193, DOI 10.1007/s00253-011-3212-8; Blazeck J, 2011, APPL ENVIRON MICROB, V77, P7905, DOI 10.1128/AEM.05763-11; Cahoon EB, 2001, J BIOL CHEM, V276, P2637, DOI 10.1074/jbc.M009188200; Chen DC, 1997, APPL MICROBIOL BIOT, V48, P232, DOI 10.1007/s002530051043; Cheng BF, 2010, TRANSGENIC RES, V19, P221, DOI 10.1007/s11248-009-9302-z; Damude H.G., 2010, US patent, Patent No. [7,709,239, 7709239]; Damude HG, 2008, PHYSIOL PLANTARUM, V132, P1, DOI 10.1111/j.1399-3054.2007.00998.x; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Deckelbaum RJ, 2012, J NUTR, V142, p587S, DOI 10.3945/jn.111.148080; Domergue F, 2003, J BIOL CHEM, V278, P35115, DOI 10.1074/jbc.M305990200; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fickers P, 2003, J MICROBIOL METH, V55, P727, DOI 10.1016/j.mimet.2003.07.003; Flores CL, 2005, EUKARYOT CELL, V4, P356, DOI 10.1128/EC.4.2.356-364.2005; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gillies PJ, 2011, CURR ATHEROSCLER REP, V13, P467, DOI 10.1007/s11883-011-0206-z; GRIFFITHS G, 1988, BIOCHEM J, V252, P641, DOI 10.1042/bj2520641; Groenewald M., 2013, CRIT REV MICROBIOL; Ma DWL, 2004, J NUTR BIOCHEM, V15, P700, DOI 10.1016/j.jnutbio.2004.08.002; Meesapyodsuk D, 2012, LIPIDS, V47, P227, DOI 10.1007/s11745-011-3617-2; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Napier JA, 2005, P NUTR SOC, V64, P387, DOI 10.1079/PNS2005447; Nicaud JM, 2012, YEAST, V29, P409, DOI 10.1002/yea.2921; Petrie JR, 2010, METAB ENG, V12, P233, DOI 10.1016/j.ymben.2009.12.001; Pollak DW, 2012, LIPIDS, V47, P913, DOI 10.1007/s11745-012-3690-1; Prestele J, 2010, P NATL ACAD SCI USA, V107, P14915, DOI 10.1073/pnas.1009174107; Qi BX, 2004, NAT BIOTECHNOL, V22, P739, DOI 10.1038/nbt972; Ratledge C., 2010, SINGLE CELL OILS, DOI [10.1016/B978-1-893997-73-8.50005-0, DOI 10.1016/B978-1-893997-73-8.50005-0]; Schaefer EJ, 2010, CIRCULATION, V122; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sumita T, 2002, FEMS MICROBIOL LETT, V214, P31, DOI 10.1111/j.1574-6968.2002.tb11321.x; Tai M, 2013, METAB ENG, V15, P1, DOI 10.1016/j.ymben.2012.08.007; Tavares S, 2011, APPL ENVIRON MICROB, V77, P1854, DOI 10.1128/AEM.01935-10; Titorenko VI, 2000, CELL BIOCHEM BIOPHYS, V32, P21, DOI 10.1385/CBB:32:1-3:21; TROENG S, 1955, J AM OIL CHEM SOC, V32, P124, DOI 10.1007/BF02640318; Wallis JG, 1999, ARCH BIOCHEM BIOPHYS, V365, P307, DOI 10.1006/abbi.1999.1167; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; Wen Z., 2005, SINGLE CELL OILS, P138; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Xue ZX, 2013, APPL MICROBIOL BIOT, V97, P1973, DOI 10.1007/s00253-012-4068-2; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Zhang HX, 2012, YEAST, V29, P25, DOI 10.1002/yea.1914; Zhu Q., 2010, Single cell oils: microbial and algal oils, P51	50	340	377	23	309	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					734	+		10.1038/nbt.2622	http://dx.doi.org/10.1038/nbt.2622			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23873085				2022-12-27	WOS:000322911000023
J	Siuti, P; Yazbek, J; Lu, TK				Siuti, Piro; Yazbek, John; Lu, Timothy K.			Synthetic circuits integrating logic and memory in living cells	NATURE BIOTECHNOLOGY			English	Article							GENE NETWORKS; MAMMALIAN-CELLS; BIOLOGY; DESIGN; CONSTRUCTION; COMMUNICATION; PROMOTERS; SWITCH	Logic and memory are essential functions of circuits that generate complex, state-dependent responses. Here we describe a strategy for efficiently assembling synthetic genetic circuits that use recombinases to implement Boolean logic functions with stable DNA-encoded memory of events. Application of this strategy allowed us to create all 16 two-input Boolean logic functions in living Escherichia coli cells without requiring cascades comprising multiple logic gates. We demonstrate long-term maintenance of memory for at least 90 cell generations and the ability to interrogate the states of these synthetic devices with fluorescent reporters and PCR. Using this approach we created two-bit digital-to-analog converters, which should be useful in biotechnology applications for encoding multiple stable gene expression outputs using transient inputs of inducers. We envision that this integrated logic and memory system will enable the implementation of complex cellular state machines, behaviors and pathways for therapeutic, diagnostic and basic science applications.	[Siuti, Piro; Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Siuti, Piro; Lu, Timothy K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Yazbek, John] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lu, TK (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	timlu@mit.edu		Lu, Timothy/0000-0002-3918-8923	Office of Naval Research Multidisciplinary University Research Initiative (MURI); Defense Advanced Research Projects Agency (DARPA)	Office of Naval Research Multidisciplinary University Research Initiative (MURI)(MURI); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The bxb1 gene was a generous gift from G. F. Hatfull (Department of Biological Sciences, University of Pittsburgh), and the riboregulator plasmids were donated by J. J. Collins (Biomedical Engineering, Boston University). The authors thank R. Danial and A. A. Cheng for careful comments on the manuscript. This work was supported by an Office of Naval Research Multidisciplinary University Research Initiative (MURI) grant and the Defense Advanced Research Projects Agency (DARPA).	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Bacchus W, 2012, NAT BIOTECHNOL, V30, P991, DOI 10.1038/nbt.2351; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Callura JM, 2012, P NATL ACAD SCI USA, V109, P5850, DOI 10.1073/pnas.1203808109; Cheng AA, 2012, ANNU REV BIOMED ENG, V14, P155, DOI [10.1146/annurev-bioeng-071811-150118, 10.1146/annurev.bioeng-071811-150118]; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ghosh P, 2005, J MOL BIOL, V349, P331, DOI 10.1016/j.jmb.2005.03.043; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gordley RM, 2009, P NATL ACAD SCI USA, V106, P5053, DOI 10.1073/pnas.0812502106; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Lux MW, 2012, TRENDS BIOTECHNOL, V30, P120, DOI 10.1016/j.tibtech.2011.09.001; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Mijakovic I, 2005, CURR OPIN BIOTECH, V16, P329, DOI 10.1016/j.copbio.2005.04.003; Ortiz ME, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-16; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Sambrook J, 1989, MOL CLONING LAB MANU, VII; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	30	321	344	10	296	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					448	+		10.1038/nbt.2510	http://dx.doi.org/10.1038/nbt.2510			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23396014				2022-12-27	WOS:000318589600025
J	Cho, SW; Kim, S; Kim, JM; Kim, JS				Cho, Seung Woo; Kim, Sojung; Kim, Jong Min; Kim, Jin-Soo			Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES	We employ the CRISPR-Cas system of Streptococcus pyogenes as programmable RNA-guided endonucleases (RGENs) to cleave DNA in a targeted manner for genome editing in human cells. We show that complexes of the Cas9 protein and artificial chimeric RNAs efficiently cleave two genomic sites and induce indels with frequencies of up to 33%.	[Cho, Seung Woo; Kim, Sojung; Kim, Jong Min; Kim, Jin-Soo] Seoul Natl Univ, Natl Creat Res Initiat Ctr Genome Engn, Seoul, South Korea; [Cho, Seung Woo; Kim, Sojung; Kim, Jong Min; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, JS (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr Genome Engn, Seoul, South Korea.	jskim01@snu.ac.kr	Cho, Seung Woo/B-2441-2019; KIM, Jin-Soo/M-6918-2013; Wilson, Matthew H/K-3193-2013	Cho, Seung Woo/0000-0001-9091-0937; KIM, Jin-Soo/0000-0003-4847-1306; Kim, Sojung/0000-0002-2690-875X	National Research Foundation of Korea [2012-0001225]; ToolGen, Inc.	National Research Foundation of Korea(National Research Foundation of Korea); ToolGen, Inc.	This work was supported by the National Research Foundation of Korea (2012-0001225) and ToolGen, Inc. We thank Jae Kyung Chon for bioinformatic analysis.	Cohen J, 2011, SCIENCE, V332, P784, DOI 10.1126/science.332.6031.784; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim JS, 2010, NAT METHODS, V7, P91, DOI 10.1038/nmeth0210-91a; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	17	1279	1589	17	518	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					230	232		10.1038/nbt.2507	http://dx.doi.org/10.1038/nbt.2507			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23360966				2022-12-27	WOS:000316439500017
J	Brynildsen, MP; Winkler, JA; Spina, CS; MacDonald, IC; Collins, JJ				Brynildsen, Mark P.; Winkler, Jonathan A.; Spina, Catherine S.; MacDonald, I. Cody; Collins, James J.			Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production	NATURE BIOTECHNOLOGY			English	Article							HYDROGEN-PEROXIDE FORMATION; ESCHERICHIA-COLI; METABOLIC CAPABILITIES; MYCOBACTERIUM-TUBERCULOSIS; BACTERICIDAL ANTIBIOTICS; OXIDATIVE DAMAGE; HIGH-THROUGHPUT; CELL-DEATH; SUPEROXIDE; MUTANTS	The ever-increasing incidence of antibiotic-resistant infections combined with a weak pipeline of new antibiotics has created a global public health crisis(1). Accordingly, novel strategies for enhancing our antibiotic arsenal are needed. As antibiotics kill bacteria in part by inducing reactive oxygen species (ROS)(2-4), we reasoned that targeting microbial ROS production might potentiate antibiotic activity. Here we show that ROS production can be predictably enhanced in Escherichia coli, increasing the bacteria's susceptibility to oxidative attack. We developed an ensemble approach of genome-scale, metabolic models capable of predicting ROS production in E. coli. The metabolic network was systematically perturbed and its flux distribution analyzed to identify targets predicted to increase ROS production. Targets that were predicted in silico were experimentally validated and further shown to confer increased susceptibility to oxidants. Validated targets also increased susceptibility to killing by antibiotics. This work establishes a systems-based method to tune ROS production in bacteria and demonstrates that increased microbial ROS production can potentiate killing by oxidants and antibiotics.	[Brynildsen, Mark P.; Winkler, Jonathan A.; Spina, Catherine S.; MacDonald, I. Cody; Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Brynildsen, Mark P.; Winkler, Jonathan A.; Spina, Catherine S.; MacDonald, I. Cody; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Winkler, Jonathan A.; Collins, James J.] Boston Univ, Program Mol Biol Cell Biol & Biochem, Boston, MA 02215 USA; [Spina, Catherine S.; Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Spina, Catherine S.; Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; Boston University; Harvard University	Collins, JJ (corresponding author), Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu		Spina, Catherine/0000-0001-6067-5024	National Institutes of Health; Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Director's Pioneer Award Program and the Howard Hughes Medical Institute.	AbuOun M, 2009, J BIOL CHEM, V284, P29480, DOI 10.1074/jbc.M109.005868; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; JENSEN PR, 1992, J BACTERIOL, V174, P7635, DOI 10.1128/JB.174.23.7635-7641.1992; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Korshunov S, 2010, MOL MICROBIOL, V75, P1389, DOI 10.1111/j.1365-2958.2010.07059.x; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; LOEWEN PC, 1984, J BACTERIOL, V157, P622, DOI 10.1128/JB.157.2.622-626.1984; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Schilling CH, 2000, J THEOR BIOL, V203, P249, DOI 10.1006/jtbi.2000.1088; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024	29	270	282	15	167	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					160	165		10.1038/nbt.2458	http://dx.doi.org/10.1038/nbt.2458			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23292609	Green Accepted, Green Submitted			2022-12-27	WOS:000315322100028
J	Schneider, CK; Vleminckx, C; Gravanis, I; Ehmann, F; Trouvin, JH; Weise, M; Thirstrup, S				Schneider, Christian K.; Vleminckx, Camille; Gravanis, Iordanis; Ehmann, Falk; Trouvin, Jean-Hugues; Weise, Martina; Thirstrup, Steffen			Setting the stage for biosimilar monoclonal antibodies	NATURE BIOTECHNOLOGY			English	Editorial Material							PRODUCTS		[Schneider, Christian K.; Thirstrup, Steffen] Danish Hlth & Med Author, Copenhagen, Denmark; [Schneider, Christian K.; Vleminckx, Camille; Gravanis, Iordanis; Ehmann, Falk; Trouvin, Jean-Hugues; Weise, Martina] EMA, London, England; [Schneider, Christian K.] Twincore Ctr Expt & Clin Infect Res, Hannover, Germany; [Trouvin, Jean-Hugues] Paris Descartes Univ, Sch Pharm, Paris, France; [Weise, Martina] Bundesinst Arzneimittel & Med Prod, Bonn, Germany; [Thirstrup, Steffen] Univ Copenhagen, European Commiss Project Grp Access & Uptake Bios, DK-1168 Copenhagen, Denmark; [Thirstrup, Steffen] Univ Copenhagen, Fac Pharmaceut Sci, DK-1168 Copenhagen, Denmark	Helmholtz Association; Helmholtz-Center for Infection Research; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; University of Copenhagen	Schneider, CK (corresponding author), Danish Hlth & Med Author, Copenhagen, Denmark.	c_schneid@web.de						[Anonymous], 2012, EMACHMPBMWP403543201; Chirino AJ, 2004, NAT BIOTECHNOL, V22, P1383, DOI 10.1038/nbt1030; English V, 2007, RAJ PHARM MARKETS, V2007, P173; *EUR MED AG, 2006, EMEACHMPBMWP32775200; European Medicines Agency, 2008, EUR PUBL ASS REP FIL; European Medicines Agency, 2006, EMEACHMPBMWP42832200; European Medicines Agency, 2010, EMACHMPBMWP403543201; European Medicines Agency, 2006, EMEACHMPBMWP31329200; European Medicines Agency, 2012, EMA2058862012; European Medicines Agency, 2012, APPL NEW HUM MED EV; European Medicines Agency, 2009, EMEA WORKSH MON ANT; European Medicines Agency, 2012, MULT GUID BIOS; European Medicines Agency, 2012, EUR PUBL ASS REP; European Medicines Agency, 2009, EMEACHMPBMWP63261320; European Medicines Agency, 2011, EUR MED AG WORKSH BI; European Medicines Agency, 2009, EMEACHMPBMWP11826420; European Parliament and Council, 2010, OFF J EUROPEAN UNION, V3L348, P74; Schiestl M, 2011, NAT BIOTECHNOL, V29, P310, DOI 10.1038/nbt.1839; Schneider CK, 2008, NAT REV DRUG DISCOV, V7, P893, DOI 10.1038/nrd2728; Schneider CK, 2008, NAT BIOTECHNOL, V26, P985, DOI 10.1038/nbt0908-985; Schneider CK, 2012, NAT BIOTECHNOL, V30, P745, DOI 10.1038/nbt.2322; Weise M, 2012, BLOOD, V120, P5111, DOI 10.1182/blood-2012-04-425744; Weise M, 2011, NAT BIOTECHNOL, V29, P690, DOI 10.1038/nbt.1936	23	59	61	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1179	1185		10.1038/nbt.2447	http://dx.doi.org/10.1038/nbt.2447			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222783	Green Submitted			2022-12-27	WOS:000312092400016
J	Mak, HC; Baker, S; Joecker, A; Church, G; Snyder, M; West, J; Salzberg, S; Worthey, E; Smith, T; Wang, J; Reid, JG				Mak, H. Craig; Baker, Shawn; Joecker, Anika; Church, George; Snyder, Michael; West, John; Salzberg, Steven; Worthey, Elizabeth; Smith, Todd; Wang, Jun; Reid, Jeffrey G.			Genome interpretation and assembly-recent progress and next steps	NATURE BIOTECHNOLOGY			English	Editorial Material													Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432; church, george/0000-0001-6232-9969; Snyder, Michael/0000-0003-0784-7987					0	7	9	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1081	1083		10.1038/nbt.2425	http://dx.doi.org/10.1038/nbt.2425			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138307	Bronze			2022-12-27	WOS:000311087500027
J	Munns, R; James, RA; Xu, B; Athman, A; Conn, SJ; Jordans, C; Byrt, CS; Hare, RA; Tyerman, SD; Tester, M; Plett, D; Gilliham, M				Munns, Rana; James, Richard A.; Xu, Bo; Athman, Asmini; Conn, Simon J.; Jordans, Charlotte; Byrt, Caitlin S.; Hare, Ray A.; Tyerman, Stephen D.; Tester, Mark; Plett, Darren; Gilliham, Matthew			Wheat grain yield on saline soils is improved by an ancestral Na+ transporter gene	NATURE BIOTECHNOLOGY			English	Article							SALT TOLERANCE; DURUM-WHEAT; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; POTASSIUM-TRANSPORT; EXCLUSION; SODIUM; RICE; LOCUS; NAX2	The ability of wheat to maintain a low sodium concentration ([Na+]) in leaves correlates with improved growth under saline conditions(1,2). This trait, termed Na+ exclusion, contributes to the greater salt tolerance of bread wheat relative to durum wheat(3,4). To improve the salt tolerance of durum wheat, we explored natural diversity in shoot Na+ exclusion within ancestral wheat germplasm. Previously, we showed that crossing of Nax2, a gene locus in the wheat relative Triticum monococcum into a commercial durum wheat (Triticum turgidum ssp. durum var. Tamaroi) reduced its leaf [Na+] (ref. 5). Here we show that a gene in the Nax2 locus, TmHKT1; 5-A, encodes a Na+-selective transporter located on the plasma membrane of root cells surrounding xylem vessels, which is therefore ideally localized to withdraw Na+ from the xylem and reduce transport of Na+ to leaves. Field trials on saline soils demonstrate that the presence of TmHKT1; 5-A significantly reduces leaf [Na+] and increases durum wheat grain yield by 25% compared to near-isogenic lines without the Nax2 locus.	[Xu, Bo; Athman, Asmini; Conn, Simon J.; Jordans, Charlotte; Byrt, Caitlin S.; Tyerman, Stephen D.; Tester, Mark; Plett, Darren; Gilliham, Matthew] Univ Adelaide, Sch Agr Food & Wine, Glen Osmond, SA, Australia; [Xu, Bo; Byrt, Caitlin S.; Tester, Mark; Plett, Darren] Univ Adelaide, Waite Res Inst, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia; [Munns, Rana; James, Richard A.; Byrt, Caitlin S.] CSIRO Plant Ind, Canberra, ACT, Australia; [Munns, Rana] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Xu, Bo; Athman, Asmini; Tyerman, Stephen D.; Gilliham, Matthew] Univ Adelaide, Waite Res Inst, Australian Res Council, Ctr Excellence Plant Energy Biol, Glen Osmond, SA, Australia; [Byrt, Caitlin S.] Univ Adelaide, Waite Res Inst, Australian Res Council, Ctr Excellence Plant Cell Walls, Glen Osmond, SA, Australia; [Hare, Ray A.] NSW Dept Primary Ind, Tamworth, NSW, Australia	University of Adelaide; University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Adelaide; University of Adelaide; NSW Department of Primary Industries	Gilliham, M (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Glen Osmond, SA, Australia.	matthew.gilliham@adelaide.edu.au	Gilliham, Matthew/C-1998-2013; James, Richard A/G-3279-2018; Tester, Mark/J-2368-2017; Byrt, Caitlin/I-9785-2018; Munns, Rana E/B-4237-2013; Xu, Bo/GWQ-7260-2022; Tyerman, Steve D/F-9056-2010; Conn, Simon/G-1191-2012; Gilliham, Matthew/Y-4403-2019; James, Richard A/J-7667-2015; Xu, Bo/AAB-6603-2019	Gilliham, Matthew/0000-0003-0666-3078; James, Richard A/0000-0002-4881-2572; Tester, Mark/0000-0002-5085-8801; Byrt, Caitlin/0000-0001-8549-2873; Munns, Rana E/0000-0002-7519-2698; Tyerman, Steve D/0000-0003-2455-1643; Gilliham, Matthew/0000-0003-0666-3078; Xu, Bo/0000-0002-7583-2384; Conn, Simon/0000-0002-1376-4515; Plett, Darren/0000-0002-9551-8755	Grains Research and Development Corporation (GRDC) of Australia; Australian Research Council (ARC)	Grains Research and Development Corporation (GRDC) of Australia(Grains R&D Corp); Australian Research Council (ARC)(Australian Research Council)	The authors thank grain growers A. and J. Crowe for hosting our field trials on their property at Moree. We acknowledge the assistance of C. Blake (CSIRO), B. Collard, D. Gulliford (NSW DPI) and A. Smart (PCT); J. Dubcovsky, University of California, Davis, for kindly providing the BAC sequence used to design cslinkNax2; D. Cooper, T. Rathjen, A. Webster and J. Able for additional field data on Nax2. We thank S. Ramesh for extracting Xenopus oocytes, Adelaide Microscopy for facilities and training, G. Mayo for assistance with in situ PCR, S. Roy for assistance with confocal microscopy and flame photometry and O. Cotsaftis for the clone of OsHKT1;5. This research was supported by the Grains Research and Development Corporation (GRDC) of Australia and the Australian Research Council (ARC).	Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.106.093476; Conn SJ, 2011, NEW PHYTOL, V190, P583, DOI 10.1111/j.1469-8137.2010.03619.x; Davenport R, 2005, PLANT PHYSIOL, V137, P807, DOI 10.1104/pp.104.057307; Davenport RJ, 2007, PLANT CELL ENVIRON, V30, P497, DOI 10.1111/j.1365-3040.2007.01637.x; DICK DAT, 1969, J PHYSIOL-LONDON, V205, P61, DOI 10.1113/jphysiol.1969.sp008951; Dubcovsky J, 1996, THEOR APPL GENET, V92, P448, DOI 10.1007/BF00223692; DVORAK J, 1994, THEOR APPL GENET, V87, P872, DOI 10.1007/BF00221141; Gassmann W, 1996, PLANT J, V10, P869, DOI 10.1046/j.1365-313X.1996.10050869.x; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gilliham M, 2011, PLANT SIGNAL BEHAV, V6, P1656, DOI 10.4161/psb.6.11.17797; Horie T, 2009, TRENDS PLANT SCI, V14, P660, DOI 10.1016/j.tplants.2009.08.009; Huang S, 2008, J EXP BOT, V59, P927, DOI 10.1093/jxb/ern033; Jabnoune M, 2009, PLANT PHYSIOL, V150, P1955, DOI 10.1104/pp.109.138008; James RA, 2006, PLANT PHYSIOL, V142, P1537, DOI 10.1104/pp.106.086538; James RA, 2006, PLANT CELL ENVIRON, V29, P2185, DOI 10.1111/j.1365-3040.2006.01592.x; James RA, 2011, J EXP BOT, V62, P2939, DOI 10.1093/jxb/err003; Koltai H, 2000, PLANT PHYSIOL, V123, P1203, DOI 10.1104/pp.123.4.1203; Lauchli A, 2008, PLANT CELL ENVIRON, V31, P1565, DOI 10.1111/j.1365-3040.2008.01864.x; Maser P, 2002, FEBS LETT, V531, P157, DOI 10.1016/S0014-5793(02)03488-9; Molendijk AJ, 2008, PLANT J, V53, P909, DOI 10.1111/j.1365-313X.2007.03384.x; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R, 2003, PLANT SOIL, V253, P201, DOI 10.1023/A:1024553303144; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012571; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Rengasamy P, 2010, FUNCT PLANT BIOL, V37, P613, DOI 10.1071/FP09249; RICHARDS RA, 1983, EUPHYTICA, V32, P431, DOI 10.1007/BF00021452; RODRIGUEZNAVARRO A, 1984, J BACTERIOL, V159, P940; Roy SJ, 2008, PLANT CELL ENVIRON, V31, P861, DOI 10.1111/j.1365-3040.2008.01801.x; SCHACHTMAN DP, 1991, CROP SCI, V31, P992, DOI 10.2135/cropsci1991.0011183X003100040030x; SCHACHTMAN DP, 1994, NATURE, V370, P655, DOI 10.1038/370655a0; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Uozumi N, 2000, PLANT PHYSIOL, V122, P1249, DOI 10.1104/pp.122.4.1249; Yao X, 2010, PLANT PHYSIOL, V152, P341, DOI 10.1104/pp.109.145722; YEO AR, 1986, AUST J PLANT PHYSIOL, V13, P161, DOI 10.1071/PP9860161	38	475	515	14	335	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2012	30	4					360	U173		10.1038/nbt.2120	http://dx.doi.org/10.1038/nbt.2120			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	925TR	22407351				2022-12-27	WOS:000302785000025
J	Zhang, FZ; Carothers, JM; Keasling, JD				Zhang, Fuzhong; Carothers, James M.; Keasling, Jay D.			Design of a dynamic sensor-regulator system for production of chemicals and fuels derived from fatty acids	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; ACYL-COENZYME; TRANSCRIPTIONAL REGULATION; FADR; PROTEINS; BINDING; METABOLISM; EXPRESSION; PATHWAYS; PROMOTER	Microbial production of chemicals is now an attractive alternative to chemical synthesis. Current efforts focus mainly on constructing pathways to produce different types of molecules(1-3). However, there are few strategies for engineering regulatory components to improve product titers and conversion yields of heterologous pathways(4). Here we developed a dynamic sensor-regulator system (DSRS) to produce fatty acid-based products in Escherichia coli, and demonstrated its use for biodiesel production. The DSRS uses a transcription factor that senses a key intermediate and dynamically regulates the expression of genes involved in biodiesel production. This DSRS substantially improved the stability of biodiesel-producing strains and increased the titer to 1.5 g/l and the yield threefold to 28% of the theoretical maximum. Given the large number of natural sensors available, this DSRS strategy can be extended to many other biosynthetic pathways to balance metabolism, thereby increasing product titers and conversion yields and stabilizing production hosts.	[Zhang, Fuzhong; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Zhang, Fuzhong; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Zhang, Fuzhong; Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Carothers, James M.; Keasling, Jay D.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Synthet Biol Engn Res Ctr, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Joint BioEnergy Inst, Emeryville, CA USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Zhang, Fuzhong/0000-0001-6979-7909; Carothers, James/0000-0001-6728-7833	Synthetic Biology Engineering Research Center; National Science Foundation [0540879]; US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Natural Sciences and Engineering Research Council of Canada	Synthetic Biology Engineering Research Center; National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors would like to thank W. Holtz, E. Steen and N. Hillson for discussion and critical reading of the manuscript. This work was supported in part by the Synthetic Biology Engineering Research Center, which is funded by National Science Foundation award no. 0540879, and by the Joint BioEnergy Institute, which is funded by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231. F.Z. is supported by the Postdoctoral Fellowships Program of the Natural Sciences and Engineering Research Council of Canada.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Carothers JM, 2011, SCIENCE, V334, P1716, DOI 10.1126/science.1212209; Corchero JL, 1998, BIOTECHNOL BIOENG, V58, P625, DOI 10.1002/(SICI)1097-0290(19980620)58:6<625::AID-BIT8>3.3.CO;2-1; Cronan JE, 1997, J BACTERIOL, V179, P1819, DOI 10.1128/jb.179.5.1819-1823.1997; De Mey M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-34; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; Hajimorad M, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-3; Harcum SW, 1999, APPL BIOCHEM BIOTECH, V80, P23, DOI 10.1385/ABAB:80:1:23; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Iram SH, 2005, J BIOL CHEM, V280, P32148, DOI 10.1074/jbc.M504054200; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; LANZER M, 1988, P NATL ACAD SCI USA, V85, P8973, DOI 10.1073/pnas.85.23.8973; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Ramsey Stephen, 2005, Journal of Bioinformatics and Computational Biology, V3, P415, DOI 10.1142/S0219720005001132; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; SPENCER AK, 1978, J BIOL CHEM, V253, P5922; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024; Zhang FZ, 2011, TRENDS MICROBIOL, V19, P323, DOI 10.1016/j.tim.2011.05.003	29	560	603	11	338	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2012	30	4					354	U166		10.1038/nbt.2149	http://dx.doi.org/10.1038/nbt.2149			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	925TR	22446695				2022-12-27	WOS:000302785000024
J	Giddings, LV; Potrykus, I; Ammann, K; Fedoroff, NV				Giddings, L. Val; Potrykus, Ingo; Ammann, Klaus; Fedoroff, Nina V.			Confronting the Gordian knot	NATURE BIOTECHNOLOGY			English	News Item									[Giddings, L. Val] ITIF, Washington, DC USA; [Potrykus, Ingo] Golden Rice Board & Network, Zurich, Switzerland; [Potrykus, Ingo] Swiss Inst Plant Sci, Zurich, Switzerland; [Ammann, Klaus] Univ Bern, Neuchatel, Switzerland; [Fedoroff, Nina V.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Fedoroff, Nina V.] King Abdullah Univ Sci & Technol, Thuwal, Saudi Arabia	University of Bern; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; King Abdullah University of Science & Technology	Giddings, LV (corresponding author), ITIF, Washington, DC USA.							Arber W, 2010, NEW BIOTECHNOL, V27, P517, DOI 10.1016/j.nbt.2010.05.007; Brookes G, 2011, GM CROPS GLOBAL SOCI; Carson Rachel, 1994, SILENT SPRING; Diamond J, 1998, GUNS GERMS STEEL; James C., 2011, ISAAA BRIEF, V43; Lusser M, 2012, NAT BIOTECHNOL, V30, P231, DOI 10.1038/nbt.2142; Paarlberg R., 2008, STARVED SCI BIOTECHN; Potrykus I, 2010, NEW BIOTECHNOL, V27, P447, DOI [10.1016/j.nbt.2010.07.004, 10.1016/j.nbt.2010.09.013]; Potrykus I, 2010, NATURE, V466, P561, DOI 10.1038/466561a; Ricroch AE, 2011, PLANT PHYSIOL, V155, P1752, DOI 10.1104/pp.111.173609; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	11	15	16	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					208	209		10.1038/nbt.2145	http://dx.doi.org/10.1038/nbt.2145			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22398608				2022-12-27	WOS:000301303800007
J	Cheung, C; Bernardo, AS; Trotter, MWB; Pedersen, RA; Sinha, S				Cheung, Christine; Bernardo, Andreia S.; Trotter, Matthew W. B.; Pedersen, Roger A.; Sinha, Sanjay			Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR-B; CARDIAC NEURAL CREST; AORTIC-ANEURYSMS; MOLECULAR REGULATION; DIFFERENTIATION; MUTATIONS; MESODERM; FATE; ATHEROSCLEROSIS	Heterogeneity of embryological origins is a hallmark of vascular smooth muscle cells (SMCs) and may influence the development of vascular disease. Differentiation of human pluripotent stem cells (hPSCs) into developmental origin specific SMC subtypes remains elusive. Here we describe a chemically defined protocol in which hPSCs were initially induced to form neuroectoderm, lateral plate mesoderm or paraxial mesoderm. These intermediate populations were further differentiated toward SMCs (>80% MYH11(+) and ACTA2(+)), which displayed contractile ability in response to vasoconstrictors and invested perivascular regions in vivo. Derived SMC subtypes recapitulated the unique proliferative and secretory responses to cytokines previously documented in studies using aortic SMCs of distinct origins. Notably, this system predicted increased extracellular matrix degradation by SMCs derived from lateral plate mesoderm, which was confirmed using rat aortic SMCs from corresponding origins. This differentiation approach will have broad applications in modeling origin-dependent disease susceptibility and in developing bioengineered vascular grafts for regenerative medicine.	[Cheung, Christine; Bernardo, Andreia S.; Trotter, Matthew W. B.; Pedersen, Roger A.; Sinha, Sanjay] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England; [Cheung, Christine; Sinha, Sanjay] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge CB2 2QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Sinha, S (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England.	ss661@cam.ac.uk	Sinha, Sanjay/AAF-1692-2021; Cheung, Christine/J-9721-2017	Sinha, Sanjay/0000-0001-5900-1209; Cheung, Christine/0000-0001-7127-9107; Bernardo, Andreia Sofia/0000-0002-5355-6657; Trotter, Matthew/0000-0003-3702-915X	Wellcome Trust; Cambridge National Institute for Health Research Comprehensive Biomedical Research Centre; Agency for Science, Technology and Research (Singapore); Medical Research Council centre; Leukemia and Lymphoma Society; MRC [G0800784, G0600275] Funding Source: UKRI; British Heart Foundation [FS/10/022/28262] Funding Source: researchfish; Medical Research Council [G0600275, G0800784, G0800784B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Cambridge National Institute for Health Research Comprehensive Biomedical Research Centre; Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); Medical Research Council centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank L. Vallier and S.T. Rashid for supplying us the wild-type human iPSCs; K. Jensen for the human fetal gut RNA; N. Figg and M. Ackers-Johnson for help rendered in Matrigel sectioning and the harvesting of rat aortic SMCs, respectively. We also thank T. Faial and D. Ortmann for validation of the mesoderm protocols. This work was supported by a Wellcome Trust Intermediate Clinical Fellowship for S.S. and the Cambridge National Institute for Health Research Comprehensive Biomedical Research Centre. C. Cheung was sponsored by a National Science Scholarship (PhD) from the Agency for Science, Technology and Research (Singapore). R.A.P. and M.W.B.T. were supported by a Medical Research Council centre grant and A.S.B. was supported by a Leukemia and Lymphoma Society grant.	Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cheung C, 2011, J MOL CELL CARDIOL, V51, P651, DOI 10.1016/j.yjmcc.2011.07.014; DEBAKEY ME, 1985, ANN SURG, V201, P115; Dosch R, 1997, DEVELOPMENT, V124, P2325; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Gadson PF, 1997, EXP CELL RES, V230, P169, DOI 10.1006/excr.1996.3398; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Gittenberger-De Groot AC, 2005, PEDIATR RES, V57, P169, DOI 10.1203/01.PDR.0000148710.69159.61; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; HAIMOVICI H, 1964, ARCH SURG-CHICAGO, V89, P961; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Isoda K, 2003, CIRCULATION, V108, P516, DOI 10.1161/01.CIR.0000085567.18648.21; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kalimo H, 2002, BRAIN PATHOL, V12, P371; Kramer J, 2001, J VASC RES, V38, P120, DOI 10.1159/000051039; Leroux-Berger M, 2011, J BONE MINER RES, V26, P1543, DOI 10.1002/jbmr.382; Li J, 2005, P NATL ACAD SCI USA, V102, P8916, DOI 10.1073/pnas.0503741102; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Milewicz DM, 2005, CIRCULATION, V111, pE150, DOI 10.1161/01.CIR.0000155243.70456.F4; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Owens AP, 2010, CIRC RES, V106, P611, DOI 10.1161/CIRCRESAHA.109.212837; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Peeters MPFMV, 1999, ANAT EMBRYOL, V199, P367, DOI 10.1007/s004290050235; Pouget C, 2008, DEV BIOL, V315, P437, DOI 10.1016/j.ydbio.2007.12.045; Ruddy JM, 2008, J THORAC CARDIOV SUR, V136, P1123, DOI 10.1016/j.jtcvs.2008.06.027; Schneider MD, 2003, CYTOKINE GROWTH F R, V14, P1, DOI 10.1016/S1359-6101(02)00053-9; Topouzis S, 1996, DEV BIOL, V178, P430, DOI 10.1006/dbio.1996.0229; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wasteson P, 2008, DEVELOPMENT, V135, P1823, DOI 10.1242/dev.020958; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	45	242	251	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					165	173		10.1038/nbt.2107	http://dx.doi.org/10.1038/nbt.2107			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22252507	Green Accepted, Green Submitted			2022-12-27	WOS:000300269100019
J	Lewis, SM; Wu, X; Pustilnik, A; Sereno, A; Huang, F; Rick, HL; Guntas, G; Leaver-Fay, A; Smith, EM; Ho, C; Hansen-Estruch, C; Chamberlain, AK; Truhlar, SM; Conner, EM; Atwell, S; Kuhlman, B; Demarest, SJ				Lewis, Steven M.; Wu, Xiufeng; Pustilnik, Anna; Sereno, Arlene; Huang, Flora; Rick, Heather L.; Guntas, Gurkan; Leaver-Fay, Andrew; Smith, Eric M.; Ho, Carolyn; Hansen-Estruch, Christophe; Chamberlain, Aaron K.; Truhlar, Stephanie M.; Conner, Elaine M.; Atwell, Shane; Kuhlman, Brian; Demarest, Stephen J.			Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface	NATURE BIOTECHNOLOGY			English	Article							CANCER-THERAPY; TUMOR-GROWTH; SPECIFICITY; BINDING; STABILITY; DOMAIN; HETERODIMERIZATION; TRASTUZUMAB; SURVIVAL; INHIBIT	Robust generation of IgG bispecific antibodies has been a long-standing challenge. Existing methods require extensive engineering of each individual antibody, discovery of common light chains, or complex and laborious biochemical processing. Here we combine computational and rational design approaches with experimental structural validation to generate antibody heavy and light chains with orthogonal Fab interfaces. Parental monoclonal antibodies incorporating these interfaces, when simultaneously co-expressed, assemble into bispecific IgG with improved heavy chain-light chain pairing. Bispecific IgGs generated with this approach exhibit pharmacokinetic and other desirable properties of native IgG, but bind target antigens monovalently. As such, these bispecific reagents may be useful in many biotechnological applications.	[Lewis, Steven M.; Guntas, Gurkan; Leaver-Fay, Andrew; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA; [Wu, Xiufeng; Pustilnik, Anna; Sereno, Arlene; Huang, Flora; Smith, Eric M.; Ho, Carolyn; Hansen-Estruch, Christophe; Chamberlain, Aaron K.; Truhlar, Stephanie M.; Atwell, Shane; Demarest, Stephen J.] Eli Lilly Biotechnol Ctr, San Diego, CA USA; [Kuhlman, Brian] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Eli Lilly; University of North Carolina; University of North Carolina Chapel Hill	Kuhlman, B (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA.	bkuhlman@email.unc.edu; demarestsj@lilly.com			Lilly Research Laboratories; Lilly Research Award Program (LRAP); US DOE [DE-AC02-06CH11357]	Lilly Research Laboratories(Eli Lilly); Lilly Research Award Program (LRAP); US DOE(United States Department of Energy (DOE))	This work was supported by the Lilly Research Laboratories and the Lilly Research Award Program (LRAP). We thank J. Hannah and B. Gutierrez for their help with transient transfection, R. Yuan and D. He for assistance with protein purification, M. Batt and J. Fitchett for their training and up keep of the mass spectrometry facility at Lilly. B. Stranges provided suggestions for the computational docking protocol. Use of the Advanced Photon Source, an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the US DOE under Contract No. DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility. We thank S. Wasserman, S. Sojitra, J. Koss for data collection and operation of the beamline.	Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Casimiro DR, 1997, STRUCTURE, V5, P1407, DOI 10.1016/S0969-2126(97)00291-8; Chames P, 2009, MABS-AUSTIN, V1, P539, DOI 10.4161/mabs.1.6.10015; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; De Groot AS, 2009, CLIN IMMUNOL, V131, P189, DOI 10.1016/j.clim.2009.01.009; Demarest SJ, 2008, CURR OPIN DRUG DISC, V11, P675; Doern A, 2009, J BIOL CHEM, V284, P10254, DOI 10.1074/jbc.M809709200; Dong JY, 2011, J BIOL CHEM, V286, P4703, DOI 10.1074/jbc.M110.184317; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P667, DOI 10.1093/protein/gzq034; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Leaver-Fay A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020937; Lewis SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020872; Li BH, 2013, CANCER RES, V73, P6471, DOI 10.1158/0008-5472.CAN-13-0657; Lum LG, 2011, BIODRUGS, V25, P365, DOI 10.2165/11595950-000000000-00000; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Michaelson JS, 2009, MABS-AUSTIN, V1, P128, DOI 10.4161/mabs.1.2.7631; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Scheer JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051817; Schmiedel J, 2008, CANCER CELL, V13, P365, DOI 10.1016/j.ccr.2008.02.019; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621; Strop P, 2012, J MOL BIOL, V420, P204, DOI 10.1016/j.jmb.2012.04.020; Tan PH, 1998, BIOPHYS J, V75, P1473, DOI 10.1016/S0006-3495(98)74066-4; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268	44	161	230	2	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					191	+		10.1038/nbt.2797	http://dx.doi.org/10.1038/nbt.2797			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24463572				2022-12-27	WOS:000331074000025
J	Denny, JC; Bastarache, L; Ritchie, MD; Carroll, RJ; Zink, R; Mosley, JD; Field, JR; Pulley, JM; Ramirez, AH; Bowton, E; Basford, MA; Carrell, DS; Peissig, PL; Kho, AN; Pacheco, JA; Rasmussen, LV; Crosslin, DR; Crane, PK; Pathak, J; Bielinski, SJ; Pendergrass, SA; Xu, H; Hindorff, LA; Li, RL; Manolio, TA; Chute, CG; Chisholm, RL; Larson, EB; Jarvik, GP; Brilliant, MH; McCarty, CA; Kullo, IJ; Haines, JL; Crawford, DC; Masys, DR; Roden, DM				Denny, Joshua C.; Bastarache, Lisa; Ritchie, Marylyn D.; Carroll, Robert J.; Zink, Raquel; Mosley, Jonathan D.; Field, Julie R.; Pulley, Jill M.; Ramirez, Andrea H.; Bowton, Erica; Basford, Melissa A.; Carrell, David S.; Peissig, Peggy L.; Kho, Abel N.; Pacheco, Jennifer A.; Rasmussen, Luke V.; Crosslin, David R.; Crane, Paul K.; Pathak, Jyotishman; Bielinski, Suzette J.; Pendergrass, Sarah A.; Xu, Hua; Hindorff, Lucia A.; Li, Rongling; Manolio, Teri A.; Chute, Christopher G.; Chisholm, Rex L.; Larson, Eric B.; Jarvik, Gail P.; Brilliant, Murray H.; McCarty, Catherine A.; Kullo, Iftikhar J.; Haines, Jonathan L.; Crawford, Dana C.; Masys, Daniel R.; Roden, Dan M.			Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data	NATURE BIOTECHNOLOGY			English	Article							RISK; VARIANTS; DISEASES; BIOBANK; TRAITS; TOOL; METAANALYSIS; PHENOTYPES; MELANOMA	Candidate gene and genome-wide association studies (GWAS) have identified genetic variants that modulate risk for a human disease; many of these associations require further study to replicate the results. Here we report the first c large-scale application of the phenome-wide association "study (PheWAS) paradigm within electronic medical records E (EMRs), an unbiased approach to replication and discovery. v that interrogates relationships between targeted genotypes 1s and multiple phenotypes. We scanned for associations z between 3,144 single-nucleotide polymorphisms (previously N implicated by GWAS as mediators of human traits) and 1,358 EMR-derived phenotypes in 13,835 individuals of European ancestry. This PheWAS replicated 66% (51/77) of sufficiently powered prior GWAS associations and revealed 63 potentially pleiotropic associations with P < 4.6 x 10(-6) (false discovery rate < 0.1); the strongest of these novel associations were replicated in an independent cohort (n = 7,406). These findings validate PheWAS as a tool to allow unbiased interrogation across multiple phenotypes in EMR-based cohorts and to enhance analysis of the genomic basis of human disease.	[Denny, Joshua C.; Mosley, Jonathan D.; Ramirez, Andrea H.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Denny, Joshua C.; Bastarache, Lisa; Carroll, Robert J.; Zink, Raquel] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Pendergrass, Sarah A.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Syst Genom, University Pk, PA 16802 USA; [Field, Julie R.; Pulley, Jill M.; Bowton, Erica; Basford, Melissa A.] Vanderbilt Univ, Sch Med, Res Off, Nashville, TN 37212 USA; [Pulley, Jill M.] Vanderbilt Univ, Sch Med, Dept Med Adm, Nashville, TN 37212 USA; [Carrell, David S.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Peissig, Peggy L.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Kho, Abel N.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Pacheco, Jennifer A.] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Rasmussen, Luke V.] Northwestern Univ, Dept Preventat Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Crane, Paul K.; Jarvik, Gail P.] Univ Washington, Dept Med, Seattle, WA USA; [Pathak, Jyotishman; Chute, Christopher G.] Mayo Clin, Div Biomed Informat, Rochester, MN USA; [Pathak, Jyotishman; Jarvik, Gail P.] Mayo Clin, Div Stat, Rochester, MN USA; [Bielinski, Suzette J.] Mayo Clin, Div Epidemiol, Rochester, MN USA; [Xu, Hua] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA; [Li, Rongling; Manolio, Teri A.] NHGRI, Div Genom Med, Bethesda, MD 20892 USA; [Chisholm, Rex L.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Brilliant, Murray H.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [McCarty, Catherine A.] Essentia Inst Rural Hlth, Duluth, MN USA; [Kullo, Iftikhar J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Haines, Jonathan L.; Crawford, Dana C.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37212 USA; [Masys, Daniel R.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Vanderbilt University; Vanderbilt University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Northwestern University; Feinberg School of Medicine; Mayo Clinic; Vanderbilt University; University of Washington; University of Washington Seattle; Vanderbilt University	Denny, JC (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	josh.denny@vanderbilt.edu	Chute, Christopher/AAT-8540-2021; Jarvik, Gail P/N-6476-2014; Crawford, Dana/O-5578-2019; Denny, Josh/AAL-3359-2021; Bielinski, Suzette/A-2238-2009; Austin, Eric Douglas/A-6070-2013; Roden, Dan/ABD-5412-2021; Haines, Jonathan/C-3374-2012; Chisholm, Rex/B-3418-2009	Jarvik, Gail P/0000-0002-6710-8708; Crawford, Dana/0000-0002-6437-6248; Denny, Josh/0000-0002-3049-7332; Bielinski, Suzette/0000-0002-2905-5430; Austin, Eric Douglas/0000-0002-1709-9022; Haines, Jonathan/0000-0002-4351-4728; McCarty, Catherine/0000-0003-1089-0142; Pendergrass, Rion/0000-0002-0565-6522; Chisholm, Rex/0000-0002-5638-3990; Crane, Paul/0000-0003-4278-7465; Pacheco, Jennifer/0000-0001-8021-5818; Mosley, Jonathan/0000-0001-6421-2887; Rasmussen, Luke/0000-0002-4497-8049	eMERGE Network; National Human Genome Research Institute (NHGRI); National Institute of General Medical Sciences (NIGMS) (Group Health Cooperative/University of Washington) [U01-HG004610, U01-HG006375]; Marshfield Clinic [U01-HG004608]; Mayo Clinic [U01-HG004599, U01-HG006379]; Northwestern University [U01-HG004609, U01-HG006388]; Essentia Institute of Rural Health/Marshfield Clinic [U01-HG006389]; Vanderbilt University [U01-HG004603, U01-HG006378]; Vanderbilt University serving as the Coordinating Center [U01-HG006385]; NHGRI [U01-HG004424]; Johns Hopkins University, Center for Inherited Disease Research [U01-HG004438]; NIGMS [RC2-GM092318]; National Library of Medicine [R01-LM010685]; National Center for Advancing Translational Sciences [UL1TR000427, UL1 RR024975, 2 UL1 TR000445]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427, UL1TR000150, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006379, U01HG004608, U01HG004609, U01HG004610, U01HG006388, U01HG006389, U01HG004424, U01HG004438, U01HG006378, U01HG006385, U01HG004603, U01HG006375, U01HG004599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007569, R01GM105688] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685, T15LM007450] Funding Source: NIH RePORTER	eMERGE Network; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences (NIGMS) (Group Health Cooperative/University of Washington); Marshfield Clinic; Mayo Clinic; Northwestern University; Essentia Institute of Rural Health/Marshfield Clinic; Vanderbilt University; Vanderbilt University serving as the Coordinating Center; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Johns Hopkins University, Center for Inherited Disease Research; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the eMERGE Network, initiated and funded by the National Human Genome Research Institute (NHGRI), with additional funding from the National Institute of General Medical Sciences (NIGMS), through the following grants: U01-HG004610 and U01-HG006375 (Group Health Cooperative/University of Washington); U01-HG004608 (Marshfield Clinic); U01-HG004599 and U01-HG006379 (Mayo Clinic); U01-HG004609 and U01-HG006388 (Northwestern University); U01-HG006389 (Essentia Institute of Rural Health/Marshfield Clinic); U01-HG004603 and U01-HG006378 (Vanderbilt University); and U01-HG006385 (Vanderbilt University serving as the Coordinating Center). Funding support for eMERGE genotyping was provided by NHGRI through the grants: U01-HG004424 (The Broad Institute) and U01-HG004438 (Johns Hopkins University, Center for Inherited Disease Research). Replication genotypes were derived from a pharmacogenomics resource supported by NIGMS RC2-GM092318. Development of the PheWAS method is also supported by R01-LM010685 from the National Library of Medicine. BioVU received and continues to receive support through the National Center for Research Resources UL1 RR024975, which is now the National Center for Advancing Translational Sciences, 2 UL1 TR000445. Additional support for this work at the University of Washington was partially provided by the National Center for Advancing Translational Sciences grant UL1TR000427.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Cowen ME, 1998, MED CARE, V36, P1108, DOI 10.1097/00005650-199807000-00016; Denny JC, 2008, AM J MED, V121, P239, DOI 10.1016/j.amjmed.2007.09.014; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dokal I, 2011, HEMATOL-AM SOC HEMAT, P480, DOI 10.1182/asheducation-2011.1.480; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Friedman C, 2004, J AM MED INFORM ASSN, V11, P392, DOI 10.1197/jamia.M1552; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Han JL, 2011, CANCER RES, V71, P1533, DOI 10.1158/0008-5472.CAN-10-1818; Hanauer DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005203; He C, 2009, DIABETES OBES METAB, V11, P53, DOI 10.1111/j.1463-1326.2008.01003.x; Hebbring SJ, 2013, GENES IMMUN, V14, P187, DOI 10.1038/gene.2013.2; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kanetsky PA, 2010, CANCER-AM CANCER SOC, V116, P2416, DOI 10.1002/cncr.24994; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Klompas M., 2012, DIABETES CARE, DOI [10.2337/dc12-0964, DOI 10.2337/DCL2-0964]; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; McCarty Catherine A, 2005, Per Med, V2, P49, DOI 10.1517/17410541.2.1.49; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; McDavid A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063481; Pendergrass SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003087; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Ritchie MD, 2013, CIRCULATION, V127, P1377, DOI 10.1161/CIRCULATIONAHA.112.000604; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Roque FS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002141; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496; Turner S., 2011, CURR PROTOC HUM GENE, V68, P19; Wilke RA, 2011, CLIN PHARMACOL THER, V89, P379, DOI 10.1038/clpt.2010.260; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	48	534	540	4	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1102	+		10.1038/nbt.2749	http://dx.doi.org/10.1038/nbt.2749			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24270849	Green Accepted, Bronze			2022-12-27	WOS:000328251900023
J	McKernan, KJ; Spangler, J; Helbert, Y; Zhang, L; Tadigotla, V				McKernan, Kevin J.; Spangler, Jessica; Helbert, Yvonne; Zhang, Lei; Tadigotla, Vasisht			DREAMing of a patent-free human genome for clinical sequencing	NATURE BIOTECHNOLOGY			English	Editorial Material							DNA METHYLATION; GENE PATENTS; SINGLE-MOLECULE; PCR	Can methylation be the key to challenging the interpretation of existing gene patent claims? And can a novel PCR method be used to enable the sequencing of hundreds of genes?	[McKernan, Kevin J.; Spangler, Jessica; Helbert, Yvonne; Zhang, Lei; Tadigotla, Vasisht] Courtagen Life Sci, Woburn, MA USA		McKernan, KJ (corresponding author), Courtagen Life Sci, Woburn, MA USA.	kevin.mckernan@courtagen.com		McKernan, Kevin/0000-0002-3908-1122				Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; [Anonymous], 2010, NATURE, V464, P649, DOI 10.1038/464649a; [Anonymous], 2012, TECHNICAL INFORM TES; Cantara WA, 2013, P NATL ACAD SCI USA, V110, P10964, DOI 10.1073/pnas.1222641110; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Chiu RWK, 2010, CLIN CHEM, V56, P459, DOI 10.1373/clinchem.2009.136507; Christensen C. M., 2001, INNOVATORS DILEMMA N; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Cohen-Karni D., 2011, P NATL ACAD SCI USA, V108; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Fraiser M.S., 1993, DECONTAMINATION NUCL; Graff GD, 2013, NAT BIOTECHNOL, V31, P404, DOI 10.1038/nbt.2568; HAYEK FA, 1966, MONETARY THEORY TRAD; Holliday R, 1998, P NATL ACAD SCI USA, V95, P8727, DOI 10.1073/pnas.95.15.8727; HOLLIDAY R, 1995, SOMAT CELL MOLEC GEN, V21, P215, DOI 10.1007/BF02254772; HOLLIDAY R, 1991, SOMAT CELL MOLEC GEN, V17, P537, DOI 10.1007/BF01233618; Holman CM, 2012, NAT BIOTECHNOL, V30, P240, DOI 10.1038/nbt.2146; Horton JR, 2012, NUCLEIC ACIDS RES, V40, P9763, DOI 10.1093/nar/gks719; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Johansson H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1005; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lander E.S., 2013, BRIEF AMICUS CURIAE; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lo Y.M.D., 2006, METHODS DETECTING FE; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Pollack R., 1994, SIGNS LIFE LANGUAGE; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rosenfeld J, 2013, GENOME MED, V5, DOI 10.1186/gm431; Rothbard M.N. Man, 1962, EC STATE TREATISE EC; Salzberg SL, 2012, CLIN PHARMACOL THER, V91, P969, DOI 10.1038/clpt.2012.6; Schauinger S., 2012, HUMAN GENE PATENT RE; Schiffman JD, 2009, CANCER GENET CYTOGEN, V193, P9, DOI 10.1016/j.cancergencyto.2009.03.005; Teutsch Steven, 2010, GENE PATENTS LICENSI; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; WAGNER I, 1981, BIOCHIM BIOPHYS ACTA, V654, P52, DOI 10.1016/0005-2787(81)90135-0; Wardle J, 2008, NUCLEIC ACIDS RES, V36, P705, DOI 10.1093/nar/gkm1023; WONG KK, 1991, NUCLEIC ACIDS RES, V19, P1081, DOI 10.1093/nar/19.5.1081	37	5	6	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2013	31	10					884	888		10.1038/nbt.2703	http://dx.doi.org/10.1038/nbt.2703			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233CA	24104751				2022-12-27	WOS:000325541300013
J	Hu, J; Locasale, JW; Bielas, JH; O'Sullivan, J; Sheahan, K; Cantley, LC; Vander Heiden, MG; Vitkup, D				Hu, Jie; Locasale, Jason W.; Bielas, Jason H.; O'Sullivan, Jacintha; Sheahan, Kieran; Cantley, Lewis C.; Vander Heiden, Matthew G.; Vitkup, Dennis			Heterogeneity of tumor-induced gene expression changes in the human metabolic network	NATURE BIOTECHNOLOGY			English	Article							GLUTAMINE-METABOLISM; CANCER METABOLISM; PYRUVATE-KINASE; CELL-METABOLISM; HYDROXYLASES; LIPOGENESIS; INHIBITION; MUTATIONS; PATHWAYS; BREAST	Reprogramming of cellular metabolism is an emerging hallmark of neoplastic transformation. However, it is not known how the expression of metabolic genes in tumors differs from that in normal tissues, or whether different tumor types exhibit similar metabolic changes. Here we compare expression patterns of metabolic genes across 22 diverse types of human tumors. Overall, the metabolic gene expression program in tumors is similar to that in the corresponding normal tissues. Although expression changes of some metabolic pathways (e.g., upregulation of nucleotide biosynthesis and glycolysis) are frequently observed across tumors, expression changes of other pathways (e.g., oxidative phosphorylation) are very heterogeneous. Our analysis also suggests that the expression changes of some metabolic genes (e.g., isocitrate dehydrogenase and fumarate hydratase) may enhance or mimic the effects of recurrent mutations in tumors. On the level of individual biochemical reactions, many hundreds of metabolic isoenzymes show significant and tumor-specific expression changes. These isoenzymes are potential targets for anticancer therapy.	[Hu, Jie; Vitkup, Dennis] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA; [Hu, Jie; Vitkup, Dennis] Columbia Univ, Initiat Syst Biol, New York, NY USA; [Locasale, Jason W.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Translat Res Program, Seattle, WA 98104 USA; [Bielas, Jason H.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [O'Sullivan, Jacintha; Sheahan, Kieran] St Vincents Univ Hosp, Dublin 4, Ireland; [Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Cantley, Lewis C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Sch Med, Boston, MA 02215 USA; [Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] MIT, Dept Biol, Cambridge, MA USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Vitkup, Dennis] Columbia Univ, Dept Biomed Informat, New York, NY USA	Columbia University; Columbia University; Cornell University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University College Dublin; Saint Vincent's University Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Columbia University	Vitkup, D (corresponding author), Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA.	dv2121@columbia.edu	damiani, chiara/R-4256-2016; Cantley, Lewis C/D-1800-2014; Hu, Jie/J-5075-2012; Locasale, Jason W/ABE-6505-2020	Cantley, Lewis C/0000-0002-1298-7653; Locasale, Jason W/0000-0002-7766-3502; O'Sullivan, Jacintha/0000-0001-8622-9858	US National Institutes of Health [GM079759]; US National Centers for Biomedical Computing [U54CA121852]; NIH Pathway to Independence Award [R00CA168997]; Ellison Medical Foundation New Scholar [AG-NS-0577-09]; National Institute of Environmental Health Sciences [R01ES019319]; New Development Funds from the Fred Hutchinson Cancer Research Center; Burroughs Wellcome Fund; Damon Runyon Cancer Research Foundation; National Cancer Institute; NATIONAL CANCER INSTITUTE [R00CA168997, U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079759] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Centers for Biomedical Computing; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation New Scholar(Lawrence Ellison Foundation); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); New Development Funds from the Fred Hutchinson Cancer Research Center; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to sincerely thank the members of the Vitkup laboratory for discussions. This work was supported by US National Institutes of Health grant GM079759 to D.V. and US National Centers for Biomedical Computing grant U54CA121852 to Columbia University. J.W.L. is supported by an NIH Pathway to Independence Award R00CA168997. J.H.B. is supported by an Ellison Medical Foundation New Scholar award AG-NS-0577-09, a National Institute of Environmental Health Sciences grant R01ES019319, and New Development Funds from the Fred Hutchinson Cancer Research Center. M.G.V.H. acknowledges support from the Burroughs Wellcome Fund, the Damon Runyon Cancer Research Foundation, the Smith Family and the National Cancer Institute.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; ASAKA M, 1994, J CLIN LAB ANAL, V8, P144, DOI 10.1002/jcla.1860080306; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Costello LC, 2002, HORM METAB RES, V34, P417, DOI 10.1055/s-2002-33598; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Diaz-Ruiz R, 2009, BBA-REV CANCER, V1796, P252, DOI 10.1016/j.bbcan.2009.07.003; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; EVANS CT, 1983, EUR J BIOCHEM, V130, P195; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Frezza C, 2011, J MOL MED, V89, P213, DOI 10.1007/s00109-011-0728-4; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Glazko G, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-51; Habano W, 2003, ONCOL REP, V10, P1375; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hewitson KS, 2007, J BIOL CHEM, V282, P3293, DOI 10.1074/jbc.M608337200; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Khedhaier A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-109; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; KUSAKABE T, 1994, J BIOCHEM-TOKYO, V115, P1172, DOI 10.1093/oxfordjournals.jbchem.a124475; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Nelson D. L., 2008, LEHNINGER PRINCIPLES, V5th, P926; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Romero P, 2005, GENOME BIOL, V6; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; SMITH CAD, 1992, ENVIRON HEALTH PERSP, V98, P107, DOI 10.2307/3431255; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Walenta S, 2004, CURR MED CHEM, V11, P2195, DOI 10.2174/0929867043364711; Warburg O, 1924, BIOCHEM Z, V152, P309; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Zou Y, 2010, BIOCHEM BIOPH RES CO, V402, P378, DOI 10.1016/j.bbrc.2010.10.038; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	50	280	284	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					522	U11		10.1038/nbt.2530	http://dx.doi.org/10.1038/nbt.2530			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23604282	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-27	WOS:000320113200023
J	Kimoto, M; Yamashige, R; Matsunaga, K; Yokoyama, S; Hirao, I				Kimoto, Michiko; Yamashige, Rie; Matsunaga, Ken-ichiro; Yokoyama, Shigeyuki; Hirao, Ichiro			Generation of high-affinity DNA aptamers using an expanded genetic alphabet	NATURE BIOTECHNOLOGY			English	Article							IN-VITRO SELECTION; BASE-PAIR SYSTEMS; SITE; MOLECULES; BIND	DNA aptamers produced with natural or modified natural nucleotides often lack the desired binding affinity and specificity to target proteins. Here we describe a method for selecting DNA aptamers containing the four natural nucleotides and an unnatural nucleotide with the hydrophobic base 7-(2-thienyl)imidazo[4,5-b]pyridine (Ds). We incorporated up to three Ds nucleotides in a random sequence library, which is expected to increase the chemical and structural diversity of the DNA molecules. Selection experiments against two human target proteins, vascular endothelial cell growth factor-165 (VEGF-165) and interferon-gamma (IFN-gamma), yielded DNA aptamers that bind with K-D values of 0.65 pM and 0.038 nM, respectively, affinities that are >100-fold improved over those of aptamers containing only natural bases. These results show that incorporation of unnatural bases can yield aptamers with greatly augmented affinities, suggesting the potential of genetic alphabet expansion as a powerful tool for creating highly functional nucleic acids.	[Kimoto, Michiko; Yamashige, Rie; Matsunaga, Ken-ichiro; Yokoyama, Shigeyuki; Hirao, Ichiro] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Kimoto, Michiko; Hirao, Ichiro] TagCyx Biotechnol, Yokohama, Kanagawa, Japan	RIKEN	Hirao, I (corresponding author), RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan.	ihirao@riken.jp	Hirao, Ichiro/G-3041-2012; Yokoyama, Shigeyuki/N-6911-2015; Kimoto, Michiko/G-1435-2012	Yokoyama, Shigeyuki/0000-0003-3133-7338; 	Targeted Proteins Research Program; RIKEN Structural Genomics/Proteomics Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan; National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan;  [KAKENHI 19201046]	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Structural Genomics/Proteomics Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan; National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	We thank F. E. Romesberg and B. Hodoscek for stimulating discussions and A. Sato for chemical synthesis. This work was supported by Grants-in-Aid for Scientific Research (KAKENHI 19201046 to I. H.) and by the Targeted Proteins Research Program and the RIKEN Structural Genomics/Proteomics Initiative, the National Project on Protein Structural and Functional Analyses, from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Bunka DHJ, 2010, CURR OPIN PHARMACOL, V10, P557, DOI 10.1016/j.coph.2010.06.009; Campbell MA, 2011, CHEM SOC REV, V40, P5680, DOI 10.1039/c1cs15048k; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Hirao I, 2004, BIOCHEMISTRY-US, V43, P3214, DOI 10.1021/bi0356146; Hirao I, 2006, NAT METHODS, V3, P729, DOI 10.1038/nmeth915; Hirao I, 2012, P JPN ACAD B-PHYS, V88, P345, DOI 10.2183/pjab.88.345; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kimoto M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn956; Liu Y, 2010, ANAL CHEM, V82, P8131, DOI 10.1021/ac101409t; Majumder P, 2009, EXPERT OPIN THER PAT, V19, P1603, DOI 10.1517/13543770903313746; Malyshev DA, 2012, P NATL ACAD SCI USA, V109, P12005, DOI 10.1073/pnas.1205176109; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622; Potty ASR, 2009, BIOPOLYMERS, V91, P145, DOI 10.1002/bip.21097; Rich A., 1962, HORIZONS BIOCH, P103; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Seo YJ, 2011, J AM CHEM SOC, V133, P19878, DOI 10.1021/ja207907d; Tam S, 1994, Transpl Immunol, V2, P285, DOI 10.1016/0966-3274(94)90004-3; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tuleuova N, 2010, ANAL CHEM, V82, P1851, DOI 10.1021/ac9025237; Vater A, 2003, CURR OPIN DRUG DI DE, V6, P253; WILLIAMS KP, 1995, NUCLEIC ACIDS RES, V23, P4220, DOI 10.1093/nar/23.20.4220; Xiang Y, 2011, NAT CHEM, V3, P697, DOI [10.1038/NCHEM.1092, 10.1038/nchem.1092]; Yamashige R, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1068; Yang ZY, 2007, NUCLEIC ACIDS RES, V35, P4238, DOI 10.1093/nar/gkm395; Yang ZY, 2011, J AM CHEM SOC, V133, P15105, DOI 10.1021/ja204910n	27	328	342	16	253	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					453	+		10.1038/nbt.2556	http://dx.doi.org/10.1038/nbt.2556			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23563318				2022-12-27	WOS:000318589600026
J	Sturgeon, CM; Ditadi, A; Clarke, RL; Keller, G				Sturgeon, Christopher M.; Ditadi, Andrea; Clarke, Raedun L.; Keller, Gordon			Defining the path to hematopoietic stem cells	NATURE BIOTECHNOLOGY			English	Editorial Material							ENDOTHELIUM; PROGENITOR; EMERGENCE; VESSEL; NOTCH; BLOOD; SOX17	New insights into hemogenic endothelium will facilitate efforts to produce hematopoietic stem cells in vitro.	[Sturgeon, Christopher M.; Ditadi, Andrea; Clarke, Raedun L.; Keller, Gordon] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Sturgeon, CM (corresponding author), Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada.	gkeller@uhnresearch.ca	Ditadi, Andrea/K-3461-2016	Ditadi, Andrea/0000-0003-3283-8943; Keller, Gordon/0000-0001-9309-9297; , Christopher/0000-0003-1508-4414				Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Antas VI, 2013, INT J BIOCHEM CELL B, V45, P692, DOI 10.1016/j.biocel.2012.12.013; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Choi EY, 2012, STEM CELLS, V30, P2297, DOI 10.1002/stem.1192; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Fitch SR, 2012, CELL STEM CELL, V11, P554, DOI 10.1016/j.stem.2012.07.002; Kaimakis P, 2013, BBA-GEN SUBJECTS, V1830, P2395, DOI 10.1016/j.bbagen.2012.10.004; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kim PG, 2013, P NATL ACAD SCI USA, V110, pE141, DOI 10.1073/pnas.1214361110; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; Nakajima-Takagi Y, 2013, BLOOD, V121, P447, DOI 10.1182/blood-2012-05-431403; Rafii S, 2013, BLOOD, V121, P770, DOI 10.1182/blood-2012-07-444208	14	35	36	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					416	418		10.1038/nbt.2571	http://dx.doi.org/10.1038/nbt.2571			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23657396				2022-12-27	WOS:000318589600020
J	Huang, LF; Jin, JM; Deighan, P; Kiner, E; McReynolds, L; Lieberman, J				Huang, Linfeng; Jin, Jingmin; Deighan, Padraig; Kiner, Evgeny; McReynolds, Larry; Lieberman, Judy			Efficient and specific gene knockdown by small interfering RNAs produced in bacteria	NATURE BIOTECHNOLOGY			English	Article							DOUBLE-STRANDED RNAS; SHORT HAIRPIN RNAS; CAENORHABDITIS-ELEGANS; MAMMALIAN-CELLS; EXPRESSION; SIRNAS; PLANTS; INHIBITION; INVASION; DUPLEXES	Synthetic small interfering RNAs (siRNAs) are an indispensable tool to investigate gene function in eukaryotic cells(1,2) and may be used for therapeutic purposes to knock down genes implicated in disease(3). Thus far, most synthetic siRNAs have been produced by chemical synthesis. Here we present a method to produce highly potent siRNAs in Escherichia coli. This method relies on ectopic expression of p19, an siRNA-binding protein found in a plant RNA virus(4,5). When expressed in E. coli, p19 stabilizes an similar to 21-nt siRNA-like species produced by bacterial RNase III. When mammalian cells are transfected by them, siRNAs that were generated in bacteria expressing p19 and a hairpin RNA encoding 200 or more nucleotides of a target gene reproducibly knock down target gene expression by similar to 90% without immunogenicity or off-target effects. Because bacterially produced siRNAs contain multiple sequences against a target gene, they may be especially useful for suppressing polymorphic cellular or viral genes.	[Huang, Linfeng; Kiner, Evgeny; Lieberman, Judy] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Huang, Linfeng; Kiner, Evgeny; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Jin, Jingmin; McReynolds, Larry] New England Biolabs Inc, Ipswich, MA USA; [Deighan, Padraig] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Deighan, Padraig] Univ Cambridge Emmanuel Coll, Dept Biol, Boston, MA USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; New England Biolabs; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	judy.lieberman@childrens.harvard.edu	Lieberman, Judy/A-2717-2015	Huang, Linfeng/0000-0002-0322-4929	National Institutes of Health [AI087431]; GSK-IDI Alliance fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GSK-IDI Alliance fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank J. Carrington (Donald Danforth Plant Science Center) for the p19 clone, C. Zhang and G. Ruvkun (Massachusetts General Hospital) for L4440 plasmid and HT115(DE3) strain, S. Kushner (University of Georgia) for SK7622 strain, D. Higgins (Harvard Medical School) for pLIV-1 plasmid, and S. Ranjbar (Boston Children's Hospital) for HIV strains and cell lines. We thank L.M. Mazzola, J.M. Bybee and D.B. Munafo from New England Biolabs for assistance with RNA deep sequencing and Z. Ansara for technical help. We thank A. Hochschild (Harvard Medical School) for suggestions and critical reading of the manuscript and Lieberman Lab members for technical assistance, helpful discussions and comments on the manuscript. This work was supported by National Institutes of Health grant AI087431 (J.L.) and a GSK-IDI Alliance fellowship (L.H.).	BABITZKE P, 1993, J BACTERIOL, V175, P229, DOI 10.1128/JB.175.1.229-239.1993; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Chu M, 2000, VIROLOGY, V266, P79, DOI 10.1006/viro.1999.0071; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; DAVIS MG, 1988, BIOTECHNOL APPL BIOC, V10, P6; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Jin JM, 2010, BIOTECHNIQUES, V48, pXVII, DOI 10.2144/000113364; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Korb M, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-7; Lee SK, 2005, BLOOD, V106, P818, DOI 10.1182/blood-2004-10-3959; Morlighem JE, 2007, BIOTECHNIQUES, V42, P599, DOI 10.2144/000112444; Myers JW, 2003, NAT BIOTECHNOL, V21, P324, DOI 10.1038/nbt792; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Princen Katrien, 2004, Retrovirology, V1, P2, DOI 10.1186/1742-4690-1-2; Rettig GR, 2012, MOL THER, V20, P483, DOI 10.1038/mt.2011.263; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Spankuch B, 2004, JNCI-J NATL CANCER I, V96, P862, DOI 10.1093/jnci/djh146; Sugiyama R, 2009, J BIOCHEM, V146, P481, DOI 10.1093/jb/mvp093; Tenllado F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-3; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Weinberg DE, 2011, CELL, V146, P262, DOI 10.1016/j.cell.2011.06.021; Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt1211; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Zhao HF, 2005, NAT METHODS, V2, P967, DOI 10.1038/NMETH812	33	44	46	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2013	31	4					350	+		10.1038/nbt.2537	http://dx.doi.org/10.1038/nbt.2537			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	120TI	23475073	Green Submitted, Green Accepted			2022-12-27	WOS:000317195500029
J	Dolinski, K; Botstein, D				Dolinski, Kara; Botstein, David			Automating the construction of gene ontologies	NATURE BIOTECHNOLOGY			English	Editorial Material									[Dolinski, Kara; Botstein, David] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Botstein, David] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Dolinski, K (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	botstein@genomics.princeton.edu	Dolinski, Kara/GPP-4026-2022	Dolinski, Kara/0000-0002-7010-0264				Alterovitz G, 2010, NAT BIOTECHNOL, V28, P128, DOI 10.1038/nbt0210-128; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Dutkowski J, 2013, NAT BIOTECHNOL, V31, P38, DOI 10.1038/nbt.2463	3	6	6	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					34	35		10.1038/nbt.2476	http://dx.doi.org/10.1038/nbt.2476			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23302932				2022-12-27	WOS:000313563600018
J	Chaturvedi, S; Crager, S; Ladikas, M; Muthuswamy, V; Su, YY; Yang, HM				Chaturvedi, Sachin; Crager, Sara; Ladikas, Miltos; Muthuswamy, Vasantha; Su, Yeyang; Yang, Huanming			Harmonizing policy on human genetic resources and benefit sharing	NATURE BIOTECHNOLOGY			English	Letter									[Chaturvedi, Sachin] Res & Informat Syst Developing Countries RIS, New Delhi, India; [Crager, Sara] UCLA Med Ctr, Los Angeles, CA USA; [Ladikas, Miltos] Univ Cent Lancashire, Preston PR1 2HE, Lancs, England; [Muthuswamy, Vasantha] Indian Council Med Res, New Delhi, India; [Su, Yeyang; Yang, Huanming] Beijing Genom Inst Shenzhen, Shenzhen, Guangdong, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Central Lancashire; Indian Council of Medical Research (ICMR); Beijing Genomics Institute (BGI)	Chaturvedi, S (corresponding author), Res & Informat Syst Developing Countries RIS, New Delhi, India.	Sachin@ris.org.in		Ladikas, Miltos/0000-0001-7958-8975				[Anonymous], 2011, CHINA STRENGTHENING; Barnetche T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2379; Ben-Yehudah Ahmi, 2004, Expert Rev Anticancer Ther, V4, P151, DOI 10.1586/14737140.4.1.151; Hopkins MM, 2007, NAT BIOTECHNOL, V25, P185, DOI 10.1038/nbt0207-185; ICMR, 2009, GUID RESTR TRANSF BI; Nijar G., 2009, 7 M AD HOC OP END WO; *VIS, 2009, IN VITR DIAGN MARK A	7	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1169	1170		10.1038/nbt.2441	http://dx.doi.org/10.1038/nbt.2441			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222779	Bronze			2022-12-27	WOS:000312092400012
J	Harris, AF; McKemey, AR; Nimmo, D; Curtis, Z; Black, I; Morgan, SA; Oviedo, MN; Lacroix, R; Naish, N; Morrison, NI; Collado, A; Stevenson, J; Scaife, S; Dafa'alla, T; Fu, GL; Phillips, C; Miles, A; Raduan, N; Kelly, N; Beech, C; Donnelly, CA; Petrie, WD; Alphey, L				Harris, Angela F.; McKemey, Andrew R.; Nimmo, Derric; Curtis, Zoe; Black, Isaac; Morgan, Sian A.; Oviedo, Marco Neira; Lacroix, Renaud; Naish, Neil; Morrison, Neil I.; Collado, Amandine; Stevenson, Jessica; Scaife, Sarah; Dafa'alla, Tarig; Fu, Guoliang; Phillips, Caroline; Miles, Andrea; Raduan, Norzahira; Kelly, Nick; Beech, Camilla; Donnelly, Christl A.; Petrie, William D.; Alphey, Luke			Successful suppression of a field mosquito population by sustained release of engineered male mosquitoes	NATURE BIOTECHNOLOGY			English	Letter							DOMINANT		[Harris, Angela F.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [McKemey, Andrew R.; Nimmo, Derric; Curtis, Zoe; Black, Isaac; Morgan, Sian A.; Oviedo, Marco Neira; Lacroix, Renaud; Naish, Neil; Morrison, Neil I.; Collado, Amandine; Stevenson, Jessica; Scaife, Sarah; Dafa'alla, Tarig; Fu, Guoliang; Phillips, Caroline; Miles, Andrea; Raduan, Norzahira; Beech, Camilla; Alphey, Luke] Oxitec Ltd, Oxford, England; [Black, Isaac; Collado, Amandine; Fu, Guoliang; Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Raduan, Norzahira] Inst Med Res, Infect Dis Res Ctr, Med Entomol Unit, Kuala Lumpur 50588, Malaysia; [Donnelly, Christl A.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Fac Med, MRC,Ctr Outbreak Anal & Modelling, London, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Oxford; Kementerian Kesihatan Malaysia; Imperial College London		luke.alphey@oxitec.com		Donnelly, Christl/0000-0002-0195-2463; Neira, Marco/0000-0001-8068-5772; Alphey, Luke/0000-0002-2916-3802	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council Funding Source: Medline; Medical Research Council [G0600719B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Alphey N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025384; Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Dyck V.A., 2006, STERILE INSECT TECHN; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474	10	253	265	2	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					828	830		10.1038/nbt.2350	http://dx.doi.org/10.1038/nbt.2350			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22965050				2022-12-27	WOS:000308705700013
J	Massaro, S				Massaro, Sebastiano			Managing knowledge-intensive workers	NATURE BIOTECHNOLOGY			English	Editorial Material							HUMAN-RESOURCES; MANAGEMENT	A manager's ability to provide knowledge workers with the personalized goals, motivation and tools they need to perform at their best will bring outstanding results.	[Massaro, Sebastiano] UCL, Management Sci & Innovat Dept, London, England; [Massaro, Sebastiano] Boston Univ, Dept Sociol, Boston, MA 02215 USA	University of London; University College London; Boston University	Massaro, S (corresponding author), UCL, Management Sci & Innovat Dept, London, England.	sebrain1@bu.edu	Massaro, Sebastiano/T-8726-2019	Massaro, Sebastiano/0000-0001-8581-8546				Drucker PF, 1959, LANDMARKS TOMORROW; Felin T, 2009, HUM RESOUR MANAGE-US, V48, P555, DOI 10.1002/hrm.20299; Finegold D, 2006, INT J HUM RESOUR MAN, V17, P1, DOI 10.1080/09585190500366169; Jensen D.G., 2004, BIOENTREPRENEUR 0127, DOI [10.1038/bioent789, DOI 10.1038/BIOENT789]; Massaro S., 2011, P 70 ANN M AC MAN, P1; ROBERTS K, 1994, HUM RESOURCE MANAGE, V33, P561, DOI 10.1002/hrm.3930330406	6	6	6	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					721	723		10.1038/nbt.2299	http://dx.doi.org/10.1038/nbt.2299			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781698				2022-12-27	WOS:000306293400032
J	Fu, J; Bian, XY; Hu, SB; Wang, HL; Huang, F; Seibert, PM; Plaza, A; Xia, LQ; Muller, R; Stewart, AF; Zhang, YM				Fu, Jun; Bian, Xiaoying; Hu, Shengbaio; Wang, Hailong; Huang, Fan; Seibert, Philipp M.; Plaza, Alberto; Xia, Liqiu; Mueller, Rolf; Stewart, A. Francis; Zhang, Youming			Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting	NATURE BIOTECHNOLOGY			English	Article							BACTERIUM PHOTORHABDUS-LUMINESCENS; NONRIBOSOMAL PEPTIDE SYNTHETASES; ESCHERICHIA-COLI; POLYKETIDE SYNTHASES; RECOMBINEERING PIPELINE; ARTIFICIAL CHROMOSOMES; FUNCTIONAL GENOMICS; ANNEALING PROTEINS; CRYSTAL-STRUCTURE; AFFINITY CAPTURE	Functional analysis of genome sequences requires methods for cloning DNA of interest. However, existing methods, such as library cloning and screening, are too demanding or inefficient for high-throughput application to the wealth of genomic data being delivered by massively parallel sequencing. Here we describe direct DNA cloning based on the discovery that the full-length Rac prophage protein RecE and its partner RecT mediate highly efficient linear-linear homologous recombination mechanistically distinct from conventional recombineering mediated by Red alpha beta from lambda phage or truncated versions of RecET. We directly cloned all ten megasynthetase gene clusters (each 10-52 kb in length) from Photorhabdus luminescens into expression vectors and expressed two of them in a heterologous host to identify the metabolites luminmycin A and luminmide A/B. We also directly cloned cDNAs and exactly defined segments from bacterial artificial chromosomes. Direct cloning with full-length RecE expands the DNA engineering toolbox and will facilitate bioprospecting for natural products.	[Fu, Jun; Hu, Shengbaio; Wang, Hailong; Huang, Fan; Seibert, Philipp M.; Stewart, A. Francis] Tech Univ Dresden, BioInnovat Zentrum, D-01062 Dresden, Germany; [Bian, Xiaoying; Plaza, Alberto; Mueller, Rolf] Helmholtz Zentrum Infekt Forsch, Helmholtz Inst Pharmazeut Forsch, Saarbrucken, Germany; [Bian, Xiaoying; Plaza, Alberto; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, Saarbrucken, Germany; [Hu, Shengbaio; Wang, Hailong; Huang, Fan; Xia, Liqiu] Hunan Normal Univ, Coll Life Sci, Key Lab Microbial Mol Biol Hunan Prov, Changsha, Hunan, Peoples R China; [Zhang, Youming] Gene Bridges, Saarbrucken, Germany	Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Hunan Normal University	Stewart, AF (corresponding author), Tech Univ Dresden, BioInnovat Zentrum, D-01062 Dresden, Germany.	rom@mx.uni-saarland.de; stewart@biotec.tu-dresden.de; youming.zhang@genebridges.com	Stewart, A. Francis/E-7789-2010; Bian, Xiaoying/G-1405-2013; Bian, Xiaoying/A-7007-2015; Müller, Rolf/B-1559-2008; Fu, Jun/C-9133-2011	Bian, Xiaoying/0000-0002-1356-3211; Müller, Rolf/0000-0002-1042-5665; 	Bundesministerium fur Bildung und Forschung (MiPro); EU; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; China Scholarship Council	Bundesministerium fur Bildung und Forschung (MiPro)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); China Scholarship Council(China Scholarship Council)	Research work in R&D in Gene Bridges (Y.Z.) was partially funded by the Bundesministerium fur Bildung und Forschung (MiPro). This work was supported by funding to A.F.S. from the EU 6th and 7th Framework projects, EUCOMM and EUCOMMTOOLS. Research in the laboratory of R.M. was funded by the Deutsche Forschungsgemeinschaft and the Bundesministerium fur Bildung und Forschung. X.B. is supported by China Scholarship Council. The authors thank J. Herrmann in the laboratory of R.M. for cytotoxic activity assay.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amrein H, 2004, MOL PLANT MICROBE IN, V17, P90, DOI 10.1094/MPMI.2004.17.1.90; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Banik JJ, 2010, CURR OPIN MICROBIOL, V13, P603, DOI 10.1016/j.mib.2010.08.012; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bode HB, 2005, ANGEW CHEM INT EDIT, V44, P6828, DOI 10.1002/anie.200501080; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; CHU CC, 1989, J BACTERIOL, V171, P2101, DOI 10.1128/jb.171.4.2101-2109.1989; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Court R, 2007, J MOL BIOL, V371, P25, DOI 10.1016/j.jmb.2007.05.037; Craig JW, 2010, APPL ENVIRON MICROB, V76, P1633, DOI 10.1128/AEM.02169-09; Del Vecchio F, 2003, J IND MICROBIOL BIOT, V30, P489, DOI 10.1007/s10295-003-0062-0; Demidov VV, 2002, P NATL ACAD SCI USA, V99, P5953, DOI 10.1073/pnas.092127999; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Erler A, 2009, J MOL BIOL, V391, P586, DOI 10.1016/j.jmb.2009.06.030; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fu J, 2010, METHOD ENZYMOL, V477, P125, DOI 10.1016/S0076-6879(10)77008-7; Fu J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn499; Gaitatzis N, 2001, J BIOCHEM, V129, P119, DOI 10.1093/oxfordjournals.jbchem.a002821; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Homburg S, 2007, FEMS MICROBIOL LETT, V275, P255, DOI 10.1111/j.1574-6968.2007.00889.x; ITO T, 1992, P NATL ACAD SCI USA, V89, P495, DOI 10.1073/pnas.89.2.495; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; Kovall R, 1997, SCIENCE, V277, P1824, DOI 10.1126/science.277.5333.1824; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lagesen K, 2010, MICROBIOL-SGM, V156, P603, DOI 10.1099/mic.0.038257-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maresca M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-54; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Murphy KC, 2007, J MOL BIOL, V371, P19, DOI 10.1016/j.jmb.2007.05.085; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Muyrers JPP, 2000, GENE DEV, V14, P1971; OKA M, 1988, J ANTIBIOT, V41, P1338, DOI 10.7164/antibiotics.41.1338; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Schellenberg B, 2007, ENVIRON MICROBIOL, V9, P1640, DOI 10.1111/j.1462-2920.2007.01278.x; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Swingle B, 2010, MOL MICROBIOL, V75, P138, DOI 10.1111/j.1365-2958.2009.06976.x; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Wang JP, 2006, MOL BIOTECHNOL, V32, P43, DOI 10.1385/MB:32:1:043; Waterfield NR, 2008, P NATL ACAD SCI USA, V105, P15967, DOI 10.1073/pnas.0711114105; Wenzel SC, 2005, CHEM BIOL, V12, P349, DOI 10.1016/j.chembiol.2004.12.012; YAMAMOTO T, 1992, GENETICS, V131, P811; Yonemura I, 2007, GENE, V391, P171, DOI 10.1016/j.gene.2006.12.029; Zhang JJ, 2009, STRUCTURE, V17, P690, DOI 10.1016/j.str.2009.03.008; Zhang Y, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-42; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zhumabayeva B, 1999, BIOTECHNIQUES, V27, P834, DOI 10.2144/99274rr06	56	282	326	6	183	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					440	+		10.1038/nbt.2183	http://dx.doi.org/10.1038/nbt.2183			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22544021				2022-12-27	WOS:000303803200024
J	Menzel, GE; Xanthopoulos, KG				Menzel, Garry E.; Xanthopoulos, Kleanthis G.			The art of the alliance	NATURE BIOTECHNOLOGY			English	Editorial Material							RESEARCH-AND-DEVELOPMENT; PRODUCTIVITY	Securing a partner is only the beginning-you then have to put substantial effort and resources into keeping the collaboration functioning and productive.	[Menzel, Garry E.; Xanthopoulos, Kleanthis G.] Regulus Therapeut Inc, La Jolla, CA USA	Isis Pharmaceuticals Inc	Menzel, GE (corresponding author), Regulus Therapeut Inc, La Jolla, CA USA.	info@regulusrx.com						Berndt E.R., 2010, 16431 NAT BUR EC RES; Czerepak EA, 2008, NAT REV DRUG DISCOV, V7, P197, DOI 10.1038/nrd2531; Danzon PM, 2005, J HEALTH ECON, V24, P317, DOI 10.1016/j.jhealeco.2004.09.006; DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; Garnier JP, 2008, HARVARD BUS REV, V86, P68; Kale P, 2009, ACAD MANAGE PERSPECT, V23, P45, DOI 10.5465/amp.2009.43479263; Ledford H, 2011, NATURE, V474, P433, DOI 10.1038/474433a; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Munos BH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002273; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405; Pharmaceutical Research and Manufacturers of America, 2011, PHARM IND PROF 2011	11	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2012	30	4					313	315		10.1038/nbt.2150	http://dx.doi.org/10.1038/nbt.2150			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	925TR	22491275				2022-12-27	WOS:000302785000010
J	Dubois, NC; Craft, AM; Sharma, P; Elliott, DA; Stanley, EG; Elefanty, AG; Gramolini, A; Keller, G				Dubois, Nicole C.; Craft, April M.; Sharma, Parveen; Elliott, David A.; Stanley, Edouard G.; Elefanty, Andrew G.; Gramolini, Anthony; Keller, Gordon			SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							SIGNAL-REGULATORY PROTEIN; DIFFERENTIATION; CD47; MACROPHAGES; ACTIVATION; SCAFFOLD; SHPS-1; ALPHA	To identify cell-surface markers specific to human cardiomyocytes, we screened cardiovascular cell populations derived from human embryonic stem cells (hESCs) against a panel of 370 known CD antibodies. This screen identified the signal-regulatory protein alpha (SIRPA) as a marker expressed specifically on cardiomyocytes derived from hESCs and human induced pluripotent stem cells (hiPSCs), and PECAM, THY1, PDGFRB and ITGA1 as markers of the nonmyocyte population. Cell sorting with an antibody against SIRPA allowed for the enrichment of cardiac precursors and cardiomyocytes from hESC/hiPSC differentiation cultures, yielding populations of up to 98% cardiac troponin T-positive cells. When plated in culture, SIRPA-positive cells were contracting and could be maintained over extended periods of time. These findings provide a simple method for isolating populations of cardiomyocytes from human pluripotent stem cell cultures, and thereby establish a readily adaptable technology for generating large numbers of enriched cardiomyocytes for therapeutic applications.	[Dubois, Nicole C.; Craft, April M.; Keller, Gordon] Univ Hlth Network, Ontario Canc Inst, McEwen Ctr Regenerat Med, Toronto, ON, Canada; [Sharma, Parveen; Gramolini, Anthony] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Elliott, David A.; Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Monash University	Keller, G (corresponding author), Univ Hlth Network, Ontario Canc Inst, McEwen Ctr Regenerat Med, Toronto, ON, Canada.	gkeller@uhnresearch.ca	Stanley, Ed G/A-2985-2013; Elefanty, Andrew G/A-6066-2008; Elliott, David/H-3334-2012	Stanley, Ed G/0000-0002-6389-3665; Elliott, David/0000-0003-1052-7407; Sharma, Parveen/0000-0002-5534-2417; Elefanty, Andrew/0000-0001-6448-8314; Keller, Gordon/0000-0001-9309-9297	VistaGen Therapeutics (San Francisco); Canadian Institute of Health Research (CIHR) [MOP-84524, MOP-106538]; Ontario's Ministry of Research and Innovation (MRI) [GL2-CBD3P3]; Swiss National Foundation; Heart and Stroke Foundation of Ontario [T6281, NS6636]; Australian Stem Cell Centre, the National Health and Medical Research Council (NHMRC, Australia); National Heart Foundation (Australia)	VistaGen Therapeutics (San Francisco); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario's Ministry of Research and Innovation (MRI); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Australian Stem Cell Centre, the National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation (Australia)(National Heart Foundation of Australia)	We would like to thank members of the Keller laboratory for discussion and critical reading of the manuscript, G. Daley (Harvard Medical School, Boston) for providing the MSC-iPS1 and 38-2 cell line, B. Neel for providing the Sirpa-mutant mice and for discussion and suggestions, L. Ailles, J. Paterson and E. Hyatt from the antibody core facility, R. Hamilton for assistance in obtaining fetal tissue samples and the Sick Kids/UHN Flow Cytometry Facility for their assistance with cell sorting. This work was supported by funding from VistaGen Therapeutics (San Francisco) and by grants from Canadian Institute of Health Research (CIHR, MOP-84524) and Ontario's Ministry of Research and Innovation (MRI, GL2-CBD3P3) to G.K. N.C.D. was supported by a Swiss National Foundation postdoctoral fellowship. A.G. and P.S. were supported by the Heart and Stroke Foundation of Ontario (T6281 and NS6636) and CIHR (MOP-106538). A.G.E., E.G.S. and D.A.E. are supported by grants from the Australian Stem Cell Centre, the National Health and Medical Research Council (NHMRC, Australia) and the National Heart Foundation (Australia). E.G.S. and A.G.E. are Senior Research Fellows of the NHMRC (Australia).	Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303; Braam SR, 2009, TRENDS PHARMACOL SCI, V30, P536, DOI 10.1016/j.tips.2009.07.001; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kisselbach L, 2009, CYTOTECHNOLOGY, V59, P31, DOI 10.1007/s10616-009-9190-3; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ritner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016004; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Seiffert M, 2001, BLOOD, V97, P2741, DOI 10.1182/blood.V97.9.2741; Sharma P, 2011, MOL BIOSYST, V7, P1185, DOI 10.1039/c0mb00235f; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Timms JF, 1999, CURR BIOL, V9, P927, DOI 10.1016/S0960-9822(99)80401-1; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	30	370	396	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1011	U82		10.1038/nbt.2005	http://dx.doi.org/10.1038/nbt.2005			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22020386	Green Accepted			2022-12-27	WOS:000296801300022
J	Leuschner, F; Dutta, P; Gorbatov, R; Novobrantseva, TI; Donahoe, JS; Courties, G; Lee, KM; Kim, JI; Markmann, JF; Marinelli, B; Panizzi, P; Lee, WW; Iwamoto, Y; Milstein, S; Epstein-Barash, H; Cantley, W; Wong, J; Cortez-Retamozo, V; Newton, A; Love, K; Libby, P; Pittet, MJ; Swirski, FK; Koteliansky, V; Langer, R; Weissleder, R; Anderson, DG; Nahrendorf, M				Leuschner, Florian; Dutta, Partha; Gorbatov, Rostic; Novobrantseva, Tatiana I.; Donahoe, Jessica S.; Courties, Gabriel; Lee, Kang Mi; Kim, James I.; Markmann, James F.; Marinelli, Brett; Panizzi, Peter; Lee, Won Woo; Iwamoto, Yoshiko; Milstein, Stuart; Epstein-Barash, Hila; Cantley, William; Wong, Jamie; Cortez-Retamozo, Virna; Newton, Andita; Love, Kevin; Libby, Peter; Pittet, Mikael J.; Swirski, Filip K.; Koteliansky, Victor; Langer, Robert; Weissleder, Ralph; Anderson, Daniel G.; Nahrendorf, Matthias			Therapeutic siRNA silencing in inflammatory monocytes in mice	NATURE BIOTECHNOLOGY			English	Article							LIPID-LIKE MATERIALS; MYOCARDIAL-INFARCTION; SPLENIC RESERVOIR; IN-VIVO; MACROPHAGES; CCR2; DELIVERY; CANCER; ATHEROSCLEROSIS; PROGRESSION	Excessive and prolonged activity of inflammatory monocytes is a hallmark of many diseases with an inflammatory component. In such conditions, precise targeting of these cells could be therapeutically beneficial while sparing many essential functions of the innate immune system, thus limiting unwanted effects. Inflammatory monocytes-but not the noninflammatory subset-depend on the chemokine receptor CCR2 for localization to injured tissue. Here we present an optimized lipid nanoparticle and a CCR2-silencing short interfering RNA that, when administered systemically in mice, show rapid blood clearance, accumulate in spleen and bone marrow, and localize to monocytes. Efficient degradation of CCR2 mRNA in monocytes prevents their accumulation in sites of inflammation. Specifically, the treatment attenuates their number in atherosclerotic plaques, reduces infarct size after coronary artery occlusion, prolongs normoglycemia in diabetic mice after pancreatic islet transplantation, and results in reduced tumor volumes and lower numbers of tumor-associated macrophages.	[Leuschner, Florian; Dutta, Partha; Gorbatov, Rostic; Donahoe, Jessica S.; Courties, Gabriel; Marinelli, Brett; Iwamoto, Yoshiko; Cortez-Retamozo, Virna; Newton, Andita; Pittet, Mikael J.; Swirski, Filip K.; Weissleder, Ralph; Nahrendorf, Matthias] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Leuschner, Florian; Dutta, Partha; Gorbatov, Rostic; Donahoe, Jessica S.; Courties, Gabriel; Marinelli, Brett; Iwamoto, Yoshiko; Cortez-Retamozo, Virna; Newton, Andita; Pittet, Mikael J.; Swirski, Filip K.; Weissleder, Ralph; Nahrendorf, Matthias] Harvard Univ, Sch Med, Boston, MA USA; [Novobrantseva, Tatiana I.; Milstein, Stuart; Epstein-Barash, Hila; Cantley, William; Wong, Jamie; Koteliansky, Victor] Alnylam Pharmaceut, Cambridge, MA USA; [Lee, Kang Mi; Kim, James I.; Markmann, James F.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Panizzi, Peter] Auburn Univ, Harrison Sch Pharm, Dept Pharmacal Sci, Auburn, AL 36849 USA; [Lee, Won Woo] Seoul Natl Univ, Bundang Hosp, Dept Nucl Med, Seoul, South Korea; [Love, Kevin; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Libby, Peter] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Div Hlth Sci Technol, Cambridge, MA 02139 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Auburn University System; Auburn University; Seoul National University (SNU); Seoul National University Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	rweissleder@mgh.harvard.edu; mnahrendorf@mgh.harvard.edu	Libby, Peter/AAY-6404-2021; Lee, Won Woo/J-5589-2012; Panizzi, Peter/A-6072-2019; Swirski, Filip/AAF-1340-2019; Pittet, Mikael/ABD-6300-2021	Libby, Peter/0000-0002-1502-502X; Panizzi, Peter/0000-0003-0141-8807; Swirski, Filip/0000-0002-3163-9152; /0000-0003-0828-4143; Courties, Gabriel/0000-0002-0003-7407	US National Institutes of Health [R01-HL096576, R01-HL095629, R01-EB006432, T32-CA79443, U24-CA92782, P50-CA86355, HHSN268201000044C, R01-CA132091, R01-CA115527, R37-EB000244]; Deutsche Herzstiftung; SNUBH Research Fund [02-2007-013]; NATIONAL CANCER INSTITUTE [R01CA132091, U24CA092782, P50CA086355, T32CA079443, R01CA115527] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095612, R01HL096576, R01HL095629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084880, R01AI057851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006432, R37EB000244] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Herzstiftung; SNUBH Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank M. Waring, A. Chicoine and the Ragon Institute (MGH) for cell sorting, the CSB Mouse Imaging Program (P. Waterman, B. Sena) and B. Bettencourt for designing initial sets of siRNA. We acknowledge the small, medium and large scale RNA synthesis groups at Alnylam as well as analytical, duplex annealing and QC groups for synthesizing and characterizing RNAs. This work was funded in part by grants from the US National Institutes of Health R01-HL096576, R01-HL095629 (M.N.); R01-EB006432, T32-CA79443, U24-CA92782, P50-CA86355, HHSN268201000044C (R.W.); R01-CA132091, R01-CA115527, R37-EB000244 (R.L.); Deutsche Herzstiftung (F.L.); and the SNUBH Research Fund 02-2007-013 (W.W.L.).	Abdi R, 2004, J IMMUNOL, V172, P767, DOI 10.4049/jimmunol.172.2.767; Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Buxton DB, 2011, CIRC RES, V109, P250, DOI 10.1161/RES.0b013e31822a97cd; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; De Palma M, 2011, NATURE, V472, P303, DOI 10.1038/472303a; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Furuichi K, 2003, J AM SOC NEPHROL, V14, P2503, DOI 10.1097/01.ASN.0000089563.63641.A8; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hart KM, 2009, NEOPLASIA, V11, P564, DOI 10.1593/neo.09228; Heyes J, 2005, J CONTROL RELEASE, V107, P276, DOI 10.1016/j.jconrel.2005.06.014; Judge AD, 2009, J CLIN INVEST, V119, P661, DOI 10.1172/JCI37515; Kaikita K, 2004, AM J PATHOL, V165, P439, DOI 10.1016/S0002-9440(10)63309-3; Leuschner F, 2010, CIRC RES, V107, P1364, DOI 10.1161/CIRCRESAHA.110.227454; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Moore DJ, 2004, TRANSPL INT, V17, P261, DOI 10.1111/j.1432-2277.2004.tb00440.x; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nahrendorf M, 2010, P NATL ACAD SCI USA, V107, P7910, DOI 10.1073/pnas.0915163107; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Peer D, 2008, SCIENCE, V319, P627, DOI 10.1126/science.1149859; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; ROBERTS R, 1976, CIRCULATION, V53, P204; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2010, J CLIN INVEST, V120, P2627, DOI 10.1172/JCI42304; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742	43	585	623	10	246	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1005	U73		10.1038/nbt.1989	http://dx.doi.org/10.1038/nbt.1989			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	21983520	Green Accepted, Green Submitted			2022-12-27	WOS:000296801300021
J	Myllykangas, S; Buenrostro, JD; Natsoulis, G; Bell, JM; Ji, HP				Myllykangas, Samuel; Buenrostro, Jason D.; Natsoulis, Georges; Bell, John M.; Ji, Hanlee P.			Efficient targeted resequencing of human germline and cancer genomes by oligonucleotide-selective sequencing	NATURE BIOTECHNOLOGY			English	Article							EXON CAPTURE; GENERATION	We describe an approach for targeted genome resequencing, called oligonucleotide-selective sequencing (OS-Seq), in which we modify the immobilized lawn of oligonucleotide primers of a next-generation DNA sequencer to function as both a capture and sequencing substrate. We apply OS-Seq to resequence the exons of either 10 or 344 cancer genes from human DNA samples. In our assessment of capture performance, >87% of the captured sequence originated from the intended target region with sequencing coverage falling within a tenfold range for a majority of all targets. Single nucleotide variants (SNVs) called from OS-Seq data agreed with >95% of variants obtained from whole-genome sequencing of the same individual. We also demonstrate mutation discovery from a colorectal cancer tumor sample matched with normal tissue. Overall, we show the robust performance and utility of OS-Seq for the resequencing analysis of human germline and cancer genomes.	[Myllykangas, Samuel; Natsoulis, Georges; Ji, Hanlee P.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Buenrostro, Jason D.; Bell, John M.; Ji, Hanlee P.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Ji, HP (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA.	genomics_ji@stanford.edu			US National Institutes of Health [K08CA96879, DK56339, P01HG000205, RC2HG005570, R21CA140089]; Sigrid Juselius Foundation; Academy of Finland; Doris Duke Clinical Foundation; Howard Hughes Medical Foundation; Reddere Foundation; Liu Bie Ju Cha and Family Fellowship in Cancer; Wang Family Foundation; NATIONAL CANCER INSTITUTE [K08CA096879, R21CA140089] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005570, P01HG000205, R01HG006137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Doris Duke Clinical Foundation(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Foundation(Howard Hughes Medical Institute); Reddere Foundation; Liu Bie Ju Cha and Family Fellowship in Cancer; Wang Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US National Institutes of Health grants K08CA96879 (H.P.J.), DK56339 (H.P.J.), P01HG000205 (J.D.B., J.M.B. and H.P.J.), RC2HG005570 (G.N., J.M.B. and H.P.J.), R21CA140089 (G.N., J.M.B. and H.P.J.), the Sigrid Juselius Foundation Fellowship (S.M.), the Academy of Finland Grant (S.M.), Doris Duke Clinical Foundation Clinical Scientist Development Award (H.P.J.), the Howard Hughes Medical Foundation Early Career Grant (H.P.J.), the Reddere Foundation Award (H.P.J.), the Liu Bie Ju Cha and Family Fellowship in Cancer (H.P.J.), and the Wang Family Foundation Research Grant (G.N. and H.P.J.).	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Fedurco M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj023; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; GONZALEZ G, 2008, SUMMIT TRANSLAT BIOI, P26; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Natsoulis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021088; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248	17	34	78	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1024	U95		10.1038/nbt.1996	http://dx.doi.org/10.1038/nbt.1996			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22020387	Green Accepted			2022-12-27	WOS:000296801300024
J	Meyer, P; Alexopoulos, LG; Bonk, T; Califano, A; Cho, CR; de la Fuente, A; de Graaf, D; Hartemink, AJ; Hoeng, J; Ivanov, NV; Koeppl, H; Linding, R; Marbach, D; Norel, R; Peitsch, MC; Rice, JJ; Royyuru, A; Schacherer, F; Sprengel, J; Stolle, K; Vitkup, D; Stolovitzky, G				Meyer, Pablo; Alexopoulos, Leonidas G.; Bonk, Thomas; Califano, Andrea; Cho, Carolyn R.; de la Fuente, Alberto; de Graaf, David; Hartemink, Alexander J.; Hoeng, Julia; Ivanov, Nikolai V.; Koeppl, Heinz; Linding, Rune; Marbach, Daniel; Norel, Raquel; Peitsch, Manuel C.; Rice, J. Jeremy; Royyuru, Ajay; Schacherer, Frank; Sprengel, Joerg; Stolle, Katrin; Vitkup, Dennis; Stolovitzky, Gustavo			Verification of systems biology research in the age of collaborative competition	NATURE BIOTECHNOLOGY			English	Article							NETWORK; DISCOVERY; ATLAS		[Meyer, Pablo; Norel, Raquel; Rice, J. Jeremy; Royyuru, Ajay; Stolovitzky, Gustavo] IBM Computat Biol Ctr, Yorktown Hts, NY USA; [Alexopoulos, Leonidas G.] Natl Tech Univ Athens, Athens, Greece; [Bonk, Thomas; Hoeng, Julia; Ivanov, Nikolai V.; Peitsch, Manuel C.; Stolle, Katrin] Philip Morris Int R&D, Neuchatel, Switzerland; [Califano, Andrea; Vitkup, Dennis] Columbia Univ, Ctr Computat Biol & Bioinformat, Dept Biomed Informat, New York, NY USA; [Cho, Carolyn R.] Merck & Co Inc, Modeling & Simulat, Rahway, NJ 07065 USA; [de la Fuente, Alberto] Ctr Adv Studies Res & Dev Sardinia CRS4, Lab Bioinformat, Pula, Italy; [de Graaf, David] Selventa, Cambridge, MA USA; [Hartemink, Alexander J.] Duke Univ, Durham, NC USA; [Koeppl, Heinz] ETH, Zurich, Switzerland; [Linding, Rune] Tech Univ Denmark DTU, Dept Syst Biol, Ctr Biol Sequence Anal CBS, Cellular Signal Integrat Grp C SIG, Copenhagen, Denmark; [Marbach, Daniel] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Marbach, Daniel] Broad Inst MIT & Harvard, Cambridge, MA USA; [Schacherer, Frank] Biobase GmbH, Wolfenbuettel, Germany; [Sprengel, Joerg] IBM Life Sci Div, Zurich, Switzerland	International Business Machines (IBM); National Technical University of Athens; Philip Morris International Inc; Columbia University; Merck & Company; Duke University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Denmark; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Meyer, P (corresponding author), IBM Computat Biol Ctr, Yorktown Hts, NY USA.	gustavo@us.ibm.com	Cho, Carolyn R/ABA-8797-2021; Norel, Raquel/ABB-3422-2021; Califano, Andrea/F-7239-2012; Alexopoulos, Leonidas/AAN-1148-2021; Peitsch, Manuel/J-7416-2017	Cho, Carolyn R/0000-0002-6480-0889; Norel, Raquel/0000-0001-7737-4172; Califano, Andrea/0000-0003-4742-3679; Alexopoulos, Leonidas G/0000-0003-0425-166X; Rice, John/0000-0001-8280-8529; Royyuru, Ajay/0000-0003-4440-4755; Linding, Rune/0000-0003-0420-4839; Peitsch, Manuel/0000-0001-5324-359X				Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Erler JT, 2010, J PATHOL, V220, P290, DOI 10.1002/path.2646; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Harmston Nathan, 2010, Human Genomics, V5, P17; Hsiao TL, 2010, NAT CHEM BIOL, V6, P34, DOI [10.1038/NCHEMBIO.266, 10.1038/nchembio.266]; Larsen PO, 2010, SCIENTOMETRICS, V84, P575, DOI 10.1007/s11192-010-0202-z; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Mandavilli A, 2011, NATURE, V469, P286, DOI 10.1038/469286a; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Sebastiani P, 2011, SCIENCE, V333, P404, DOI 10.1126/science.333.6041.404-a; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Tamayo P, 2011, J CLIN ONCOL, V29, P1415, DOI 10.1200/JCO.2010.28.1675; TUZHILIN A, 2008, ACM DIGITAL LIB; *US NAT AC SCI, 2009, NEW BIOL 21 CENT; Wolinsky H, 2008, EMBO REP, V9, P1171, DOI 10.1038/embor.2008.217; Zhang Q, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r93	23	49	49	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2011	29	9					811	815		10.1038/nbt.1968	http://dx.doi.org/10.1038/nbt.1968			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	817ZT	21904331	Bronze			2022-12-27	WOS:000294718400021
J	Katsnelson, A				Katsnelson, Alla			Cancer trial assesses clinical benefit of gene-targeted treatment	NATURE BIOTECHNOLOGY			English	News Item																			0	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					306	306		10.1038/nbt0414-306	http://dx.doi.org/10.1038/nbt0414-306			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24714466	Bronze			2022-12-27	WOS:000334340800006
J	Sherwood, RI; Hashimoto, T; O'Donnell, CW; Lewis, S; Barkal, AA; van Hoff, JP; Karun, V; Jaakkola, T; Gifford, DK				Sherwood, Richard I.; Hashimoto, Tatsunori; O'Donnell, Charles W.; Lewis, Sophia; Barkal, Amira A.; van Hoff, John Peter; Karun, Vivek; Jaakkola, Tommi; Gifford, David K.			Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shape	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; IN-VIVO; COMPACTED CHROMATIN; HUMAN GENOME; BINDING; NETWORK; GENES; PLURIPOTENCY; REPRESSION; RESOLUTION	We describe protein interaction quantitation (PIQ), a computational method for modeling the magnitude and shape of genome-wide DNase I hypersensitivity profiles to identify transcription factor (TF) binding sites. Through the use of machine-learning techniques, PIQ identified binding sites for >700 TFs from one DNase I hypersensitivity analysis followed by sequencing (DNase-seq) experiment with accuracy comparable to that of chromatin immunoprecipitation followed by sequencing (ChIP-seq). We applied PIQ to analyze DNase-seq data from mouse embryonic stem cells differentiating into prepancreatic and intestinal endoderm. We identified 120 and experimentally validated eight 'pioneer' TF families that dynamically open chromatin. Four pioneer TF families only opened chromatin in one direction from their motifs. Furthermore, we identified 'settler' TFs whose genomic binding is principally governed by proximity to open chromatin. Our results support a model of hierarchical TF binding in which directional and nondirectional pioneer activity shapes the chromatin landscape for population by settler TFs.	[Sherwood, Richard I.; Lewis, Sophia; Barkal, Amira A.; van Hoff, John Peter; Karun, Vivek] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Sherwood, Richard I.; Lewis, Sophia; Barkal, Amira A.; van Hoff, John Peter; Karun, Vivek] Harvard Univ, Sch Med, Boston, MA USA; [Hashimoto, Tatsunori; O'Donnell, Charles W.; Jaakkola, Tommi; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [O'Donnell, Charles W.; Gifford, David K.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [O'Donnell, Charles W.; Gifford, David K.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University	Gifford, DK (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rsherwood@partners.org; gifford@mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; O'donnell, Colm/0000-0002-8004-450X	US National Institutes of Health Common Fund [5UL1DE019581, RL1DE019021, 5TL1EB008540]; Harvard Stem Cell Institute's Sternlicht Director's Fund; NIH [1U01HG007037, 5P01NS055923]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [TL1EB008540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019581, RL1DE019021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK101684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923] Funding Source: NIH RePORTER	US National Institutes of Health Common Fund; Harvard Stem Cell Institute's Sternlicht Director's Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Losyev, J. Huynh and members of the Massachusetts Institute of Technology BioMicro Center for technical assistance, K. Kawakami (National Institute of Genetics) for Tol2 plasmids, H. Wichterle (Columbia University) for mESCs, and R. Maas for help with the manuscript. We acknowledge funding from the US National Institutes of Health Common Fund 5UL1DE019581, RL1DE019021 and 5TL1EB008540; the Harvard Stem Cell Institute's Sternlicht Director's Fund award to R.I.S., and NIH grants 1U01HG007037 and 5P01NS055923 to D.K.G.	Bhattacharya A, 2003, CANCER RES, V63, P8167; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Budry L, 2012, GENE DEV, V26, P2299, DOI 10.1101/gad.200436.112; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen XY, 2010, BIOINFORMATICS, V26, pi334, DOI 10.1093/bioinformatics/btq175; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eddy J, 2011, NUCLEIC ACIDS RES, V39, P4975, DOI 10.1093/nar/gkr079; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; Guo YC, 2010, BIOINFORMATICS, V26, P3028, DOI 10.1093/bioinformatics/btq590; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; He H.H., 2013, NAT METHODS, DOI [10.1038/nmeth.2762, DOI 10.1038/NMETH.2762]; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hori S, 2010, EUR J IMMUNOL, V40, P664, DOI 10.1002/eji.201040372; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; Iacovino M, 2009, STEM CELLS DEV, V18, P783, DOI 10.1089/scd.2008.0227; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Koohy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069853; Kundaje A, 2012, GENOME RES, V22, P1735, DOI 10.1101/gr.136366.111; Li ZY, 2011, NAT STRUCT MOL BIOL, V18, P742, DOI 10.1038/nsmb.2060; Minka T. P., 2001, PROC 17 C UNCERTAINT, P362; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Sherwood RI, 2011, MECH DEVELOP, V128, P387, DOI 10.1016/j.mod.2011.07.005; Song L, 2010, COLD SPRING HARB PRO, V2010; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Watts JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002277; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	49	284	287	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					171	+		10.1038/nbt.2798	http://dx.doi.org/10.1038/nbt.2798			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24441470	Bronze, Green Submitted, Green Accepted			2022-12-27	WOS:000331074000022
J	Loman, N; Watson, M				Loman, Nick; Watson, Mick			So you want to be a computational biologist?	NATURE BIOTECHNOLOGY			English	Article									[Watson, Mick] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Watson, Mick] Edinburgh Genom, Bioinformat, Edinburgh, Midlothian, Scotland; [Loman, Nick] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Birmingham	Loman, N (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.	n.j.loman@bham.ac.uk; mick.watson@roslin.ed.ac.uk	Loman, Nicholas/Z-1573-2019	Watson, Mick/0000-0003-4211-0358; Loman, Nicholas/0000-0002-9843-8988	Biotechnology and Biological Sciences Research Council [BBS/E/D/20310000] Funding Source: researchfish; BBSRC [BBS/E/D/20310000, BBS/E/D/20211551, BBS/E/D/20211552] Funding Source: UKRI; MRC [MR/J014370/1, MR/K001744/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211552, BBS/E/D/20211551] Funding Source: Medline; Medical Research Council [MR/K001744/1, MR/J014370/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	19	20	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					996	998		10.1038/nbt.2740	http://dx.doi.org/10.1038/nbt.2740			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24213777	Bronze			2022-12-27	WOS:000326921200020
J	Thaker, MN; Wang, WL; Spanogiannopoulos, P; Waglechner, N; King, AM; Medina, R; Wright, GD				Thaker, Maulik N.; Wang, Wenliang; Spanogiannopoulos, Peter; Waglechner, Nicholas; King, Andrew M.; Medina, Ricardo; Wright, Gerard D.			Identifying producers of antibacterial compounds by screening for antibiotic resistance	NATURE BIOTECHNOLOGY			English	Article							BIOSYNTHETIC GENE-CLUSTER; VANCOMYCIN RESISTANCE; NATURAL-PRODUCTS; IDENTIFICATION; STREPTOMYCES; DIVERSITY; RESISTOME; PIPELINE; CLONING	Microbially derived natural products are major sources of antibiotics and other medicines, but discovering new antibiotic scaffolds and increasing the chemical diversity of existing ones are formidable challenges. We have designed a screen to exploit the self-protection mechanism of antibiotic producers to enrich microbial libraries for producers of selected antibiotic scaffolds. Using resistance as a discriminating criterion we increased the discovery rate of producers of both glycopeptide and ansamycin antibacterial compounds by several orders of magnitude in comparison with historical hit rates. Applying a phylogeny-based screening filter for biosynthetic genes enabled the binning of producers of distinct scaffolds and resulted in the discovery of a glycopeptide antibacterial compound, pekiskomycin, with an unusual peptide scaffold. This strategy provides a means to readily sample the chemical diversity available in microbes and offers an efficient strategy for rapid discovery of microbial natural products and their associated biosynthetic enzymes.	[Thaker, Maulik N.; Wang, Wenliang; Spanogiannopoulos, Peter; Waglechner, Nicholas; King, Andrew M.; Wright, Gerard D.] McMaster Univ, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Medina, Ricardo] Cent Univ Las Villas, Chem Bioact Ctr, Dept Microbiol, Santa Clara, Villa Clara, Cuba	McMaster University; Universidad Central "Marta Abreu" de Las Villas	Wright, GD (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada.	wrightge@mcmaster.ca	Wright, G/ABB-7666-2021	Wright, Gerard/0000-0002-9129-7131	Canadian Institutes of Health Research (CIHR) [MT-14981]; Natural Sciences and Engineering Research Council [237480]; Canada Research Chair in Antibiotic Biochemistry	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Antibiotic Biochemistry(Canada Research Chairs)	We are grateful to X.D. Wang for isolation of actinomycetes, K. Koteva for sharing expertise in GPA purification, C. King for genome sequencing and C. Quinn, TA Instruments for help with ITC data. This research was funded by a Canadian Institutes of Health Research (CIHR) Grant MT-14981, Natural Sciences and Engineering Research Council Grant (237480) and by a Canada Research Chair in Antibiotic Biochemistry (G.D.W.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2007, NAT REV DRUG DISCOV, V6, P8; Baltz RH, 2006, J IND MICROBIOL BIOT, V33, P507, DOI 10.1007/s10295-005-0077-9; Banik JJ, 2008, P NATL ACAD SCI USA, V105, P17273, DOI 10.1073/pnas.0807564105; Banik JJ, 2010, J AM CHEM SOC, V132, P15661, DOI 10.1021/ja105825a; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; BIBIKOVA MV, 1981, ANTIBIOT MED BIOTEK, V26, P488; CHEVREUX B., 1999, COMP SCI BIOL P GERM, P45; Chiu HT, 2001, P NATL ACAD SCI USA, V98, P8548, DOI 10.1073/pnas.151246498; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; Cundliffe E, 2010, J IND MICROBIOL BIOT, V37, P643, DOI 10.1007/s10295-010-0721-x; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FOLENAWASSERMAN G, 1987, J CHROMATOGR, V392, P225, DOI 10.1016/S0021-9673(01)94268-2; HAYAKAWA M, 1987, J FERMENT BIOENG, V65, P501, DOI 10.1016/0385-6380(87)90108-7; He WQ, 2006, CURR MICROBIOL, V52, P197, DOI 10.1007/s00284-005-0203-y; Hong HJ, 2008, ADV EXP MED BIOL, V631, P200; Hosaka T, 2009, NAT BIOTECHNOL, V27, P462, DOI 10.1038/nbt.1538; Koteva K, 2010, NAT CHEM BIOL, V6, P327, DOI 10.1038/nchembio.350; Lamb SS, 2005, P NATL ACAD SCI USA, V102, P519, DOI 10.1073/pnas.0408858102; Lanoot B, 2004, SYST APPL MICROBIOL, V27, P84, DOI 10.1078/0723-2020-00257; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Martin JF, 2010, CURR OPIN MICROBIOL, V13, P263, DOI 10.1016/j.mib.2010.02.008; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; NAGARAJAN R, 1988, J AM CHEM SOC, V110, P7896, DOI 10.1021/ja00231a061; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Pootoolal J, 2002, P NATL ACAD SCI USA, V99, P8962, DOI 10.1073/pnas.102285099; Reddy BVB, 2012, APPL ENVIRON MICROB, V78, P3744, DOI 10.1128/AEM.00102-12; SKELTON NJ, 1990, J ORG CHEM, V55, P3718, DOI 10.1021/jo00299a008; Thaker MN, 2012, MEDCHEMCOMM, V3, P1020, DOI 10.1039/c2md20038d; Thaker M. N., 2012, ACS SYNTH BIOL, DOI [10.1021/sb300092n, DOI 10.1021/SB300092N]; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Wright GD, 2012, CHEM BIOL, V19, P3, DOI 10.1016/j.chembiol.2011.10.019; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	35	143	147	2	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2013	31	10					922	+		10.1038/nbt.2685	http://dx.doi.org/10.1038/nbt.2685			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233CA	24056948				2022-12-27	WOS:000325541300021
J	Ranasinghe, S; Walker, BD				Ranasinghe, Srinika; Walker, Bruce D.			Programming CMV for vaccine vector design	NATURE BIOTECHNOLOGY			English	Editorial Material							T-CELL RESPONSES		[Ranasinghe, Srinika; Walker, Bruce D.] MIT & Harvard, Ragon Inst, Cambridge, MA USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Howard Hughes Medical Institute	Ranasinghe, S (corresponding author), MIT & Harvard, Ragon Inst, Cambridge, MA USA.	bwalker@partners.org						Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Cohen, 2013, J SCI, V340, P667; Griffiths P, 2013, VACCINE, V31, pB197, DOI 10.1016/j.vaccine.2012.10.074; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Heemskerk MHM, 2001, P NATL ACAD SCI USA, V98, P6806, DOI 10.1073/pnas.111162298; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Ranasinghe S, 2013, NAT MED, V19, P930, DOI 10.1038/nm.3229; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rist M, 2009, BLOOD, V114, P2244, DOI 10.1182/blood-2009-05-222596	11	6	6	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					811	812		10.1038/nbt.2688	http://dx.doi.org/10.1038/nbt.2688			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	24022159				2022-12-27	WOS:000324306300019
J	Newell, EW; Sigal, N; Nair, N; Kidd, BA; Greenberg, HB; Davis, MM				Newell, Evan W.; Sigal, Natalia; Nair, Nitya; Kidd, Brian A.; Greenberg, Harry B.; Davis, Mark M.			Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization	NATURE BIOTECHNOLOGY			English	Article							CLASS-I LIGANDS; MHC TETRAMERS; MEMORY; EXPRESSION; DIVERSITY; CONTINUUM; RESPONSES; PROTEIN; IMMUNE	It is currently not possible to predict which epitopes will be recognized by T cells in different individuals. This is a barrier to the thorough analysis and understanding of T-cell responses after vaccination or infection. Here, by combining mass cytometry with combinatorial peptide-MHC tetramer staining, we have developed a method allowing the rapid and simultaneous identification and characterization of T cells specific for many epitopes. We use this to screen up to 109 different peptide-MHC tetramers in a single human blood sample, while still retaining at least 23 labels to analyze other markers of T-cell phenotype and function. Among 77 candidate rotavirus epitopes, we identified six T-cell epitopes restricted to human leukocyte antigen (HLA)-A*0201 in the blood of healthy individuals. T cells specific for epitopes in the rotavirus VP3 protein displayed a distinct phenotype and were present at high frequencies in intestinal epithelium. This approach should be useful for the comprehensive analysis of T-cell responses to infectious diseases or vaccines.	[Newell, Evan W.] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Newell, Evan W.; Nair, Nitya; Greenberg, Harry B.; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Sigal, Natalia; Kidd, Brian A.; Greenberg, Harry B.; Davis, Mark M.] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Nair, Nitya; Greenberg, Harry B.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	evan_newell@immunol.a-star.edu.sg; mmdavis@stanford.edu	Newell, Evan W/F-9711-2012; Nair, Nitya/D-2651-2017	Newell, Evan W/0000-0002-2889-243X; Nair, Nitya/0000-0002-9524-9313; Kidd, Brian/0000-0003-2110-1145; Davis, Mark/0000-0001-6868-657X; greenberg, harry/0000-0002-2128-9080	Bill and Melinda Gates Foundation; National Institutes of Health [U19-AI057229, U19-AI090019]; Howard Hughes Medical Institute; American Cancer Society; Singapore Immunology Network; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090019, U19AI057229, R01AI021362] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Cancer Society(American Cancer Society); Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Davis, Holden Maecker and Garry Nolan labs for sharing advice and experience concerning mass cytometry and antibody clone usage, especially M. Leipold for help with the mass cytometry instrument, and X. He, F. Wen, W. O'Gorman, A. Han, S. Bendall, O. Goldberger and Y.-H. Chien for helpful discussions. This work was supported by the Bill and Melinda Gates Foundation Grand Challenges Exploration phase I and II grants, National Institutes of Health grants U19-AI057229 and U19-AI090019, and The Howard Hughes Medical Institute. E.W.N. was supported by The American Cancer Society's Steven Stanley and Edward Albert Bielfelt Post-Doctoral Fellowship and by funding through the Singapore Immunology Network.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Babji S., 2012, CURR OPIN VIROL; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Chang CXL, 2011, FRONT BIOSCI-LANDMRK, V16, P3014, DOI 10.2741/3895; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Davis MM, 2011, NAT REV IMMUNOL, V11, P551, DOI 10.1038/nri3020; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; DeNucci CC, 2010, J IMMUNOL, V184, P2458, DOI 10.4049/jimmunol.0902407; Feng NG, 2002, J CLIN INVEST, V109, P1203, DOI 10.1172/JCI200214397; Fienberg HG, 2012, CYTOM PART A, V81A, P467, DOI 10.1002/cyto.a.22067; Fiocchi C., 2001, CURR PROT IMMUNO S19, V7, P30; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; Lissina A, 2009, J IMMUNOL METHODS, V340, P11, DOI 10.1016/j.jim.2008.09.014; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Lundegaard C, 2011, J IMMUNOL METHODS, V374, P26, DOI 10.1016/j.jim.2010.10.011; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; Ornatsky O, 2006, J IMMUNOL METHODS, V308, P68, DOI 10.1016/j.jim.2005.09.020; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Ramachandiran V, 2007, J IMMUNOL METHODS, V319, P13, DOI 10.1016/j.jim.2006.08.014; Ravkov EV, 2003, J IMMUNOL, V170, P2461, DOI 10.4049/jimmunol.170.5.2461; Rippinger CM, 2010, VIROLOGY, V405, P201, DOI 10.1016/j.virol.2010.06.005; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Ward R, 2009, PEDIATR INFECT DIS J, V28, pS57, DOI 10.1097/INF.0b013e3181967c16; Wei J, 2006, J GEN VIROL, V87, P3393, DOI 10.1099/vir.0.82031-0; Wei J, 2009, VIRAL IMMUNOL, V22, P189, DOI 10.1089/vim.2008.0091	34	198	204	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2013	31	7					623	U81		10.1038/nbt.2593	http://dx.doi.org/10.1038/nbt.2593			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	180FS	23748502	Green Accepted			2022-12-27	WOS:000321579700019
J	Chin, L; de Sauvage, F; Egeblad, M; Olive, KP; Tuveson, D; Weiss, W				Chin, Lynda; de Sauvage, Frederic; Egeblad, Mikala; Olive, Kenneth P.; Tuveson, David; Weiss, William			Recapitulating human cancer in a mouse	NATURE BIOTECHNOLOGY			English	Article								A panel of experts discusses the challenge of translating findings from current mouse models to the clinic.	[Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [de Sauvage, Frederic] Genentech Inc, San Francisco, CA USA; [Egeblad, Mikala; Tuveson, David] Cold Spring Harbor Lab, New York, NY USA; [Olive, Kenneth P.] Columbia Univ, Dept Pathol & Med, New York, NY USA; [Weiss, William] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Weiss, William] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Weiss, William] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Roche Holding; Genentech; Cold Spring Harbor Laboratory; Columbia University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chin, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	lchin@mdanderson.org; desauvage.fred@gene.com; egeblad@cshl.edu; kenolive@columbia.edu; dtuveson@cshl.edu; waweiss@gmail.com	Egeblad, Mikala/GNP-0620-2022; de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584; Egeblad, Mikala/0000-0002-3371-1445; Olive, Kenneth/0000-0002-3392-8994; Weiss, William/0000-0003-2230-9132				2010, BR J CANC, V102, P1555; 2009, SCIENCE, V324, P1457; 2000, NAT CELL BIOL, V2, P737	3	4	4	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					392	395		10.1038/nbt.2575	http://dx.doi.org/10.1038/nbt.2575			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23657389				2022-12-27	WOS:000318589600014
J	Fang, G; Munera, D; Friedman, DI; Mandlik, A; Chao, MC; Banerjee, O; Feng, ZX; Losic, B; Mahajan, MC; Jabado, OJ; Deikus, G; Clark, TA; Luong, K; Murray, IA; Davis, BM; Keren-Paz, A; Chess, A; Roberts, RJ; Korlach, J; Turner, SW; Kumar, V; Waldor, MK; Schadt, EE				Fang, Gang; Munera, Diana; Friedman, David I.; Mandlik, Anjali; Chao, Michael C.; Banerjee, Onureena; Feng, Zhixing; Losic, Bojan; Mahajan, Milind C.; Jabado, Omar J.; Deikus, Gintaras; Clark, Tyson A.; Luong, Khai; Murray, Iain A.; Davis, Brigid M.; Keren-Paz, Alona; Chess, Andrew; Roberts, Richard J.; Korlach, Jonas; Turner, Steve W.; Kumar, Vipin; Waldor, Matthew K.; Schadt, Eric E.			Genome-wide mapping of methylated adenine residues in pathogenic Escherichia coli using single-molecule real-time sequencing	NATURE BIOTECHNOLOGY			English	Article							DNA METHYLTRANSFERASE; BASE-RESOLUTION; DAM METHYLATION; CELL-CYCLE; 5-HYDROXYMETHYLCYTOSINE; VIRULENCE; EXPRESSION; REVEALS; 5-METHYLCYTOSINE; TRANSCRIPTION	Single-molecule real-time (SMRT) DNA sequencing allows the systematic detection of chemical modifications such as methylation but has not previously been applied on a genome-wide scale. We used this approach to detect 49,311 putative 6-methyladenine (m6A) residues and 1,407 putative 5-methylcytosine (m5C) residues in the genome of a pathogenic Escherichia coli strain. We obtained strand-specific information for methylation sites and a quantitative assessment of the frequency of methylation at each modified position. We deduced the sequence motifs recognized by the methyltransferase enzymes present in this strain without prior knowledge of their specificity. Furthermore, we found that deletion of a phage-encoded methyltransferase-endonuclease (restriction-modification; RM) system induced global transcriptional changes and led to gene amplification, suggesting that the role of RM systems extends beyond protecting host genomes from foreign DNA.	[Fang, Gang; Kumar, Vipin] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Munera, Diana; Mandlik, Anjali; Chao, Michael C.; Davis, Brigid M.; Waldor, Matthew K.] Harvard Univ, Brigham & Womens Hosp, Div Infect Dis, Sch Med, Boston, MA 02115 USA; [Munera, Diana; Mandlik, Anjali; Chao, Michael C.; Davis, Brigid M.; Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Friedman, David I.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Banerjee, Onureena; Clark, Tyson A.; Luong, Khai; Korlach, Jonas; Turner, Steve W.] Pacific Biosci, Menlo Pk, CA USA; [Feng, Zhixing] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Feng, Zhixing] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol, Beijing 100084, Peoples R China; [Feng, Zhixing] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Losic, Bojan; Mahajan, Milind C.; Jabado, Omar J.; Deikus, Gintaras; Keren-Paz, Alona; Chess, Andrew; Schadt, Eric E.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Murray, Iain A.; Roberts, Richard J.] New England Biolabs Inc, Ipswich, MA USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Stanford University; Tsinghua University; Tsinghua University; Icahn School of Medicine at Mount Sinai; New England Biolabs	Schadt, EE (corresponding author), Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA.	mwaldor@rics.bwh.harvard.edu; eschadt@pacificbiosciences.com	Friedman, David/G-3198-2015	Friedman, David/0000-0002-2741-4671; Roberts, Richard/0000-0002-4348-0169; Chao, Michael/0000-0002-6046-585X; Chao, Michael/0000-0003-3158-7337; Clark, Tyson/0000-0002-7779-3227; Waldor, Matthew/0000-0003-1843-7000; Fang, Gang/0000-0002-2462-9124	US National Science Foundation [IIS0916439]; NIH [R37 AI-42347]; HHMI; Div Of Information & Intelligent Systems [0916439] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM105125, R44GM100560] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by a US National Science Foundation grant IIS0916439 (G. F. and V. K.) and NIH R37 AI-42347 and HHMI (M.K.W.).	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Broadbent SE, 2007, J BACTERIOL, V189, P4325, DOI 10.1128/JB.01854-06; Camacho EM, 2005, MOL MICROBIOL, V57, P1700, DOI 10.1111/j.1365-2958.2005.04788.x; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DHILLON TS, 1976, JPN J MICROBIOL, V20, P385, DOI 10.1111/j.1348-0421.1976.tb01004.x; Drozdz M, 2012, NUCLEIC ACIDS RES, V40, P2119, DOI 10.1093/nar/gkr1039; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Furuta Y, 2010, NUCLEIC ACIDS RES, V38, P2428, DOI 10.1093/nar/gkp1226; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kahramanoglou C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1878; KAISER AD, 1957, VIROLOGY, V4, P509, DOI 10.1016/0042-6822(57)90083-1; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karam J. D., 1994, MOL BIOL BACTERIOPHA; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Korlach J, 2010, METHOD ENZYMOL, V472, P431, DOI 10.1016/S0076-6879(10)72001-2; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; MESSER W, 1988, CELL, V54, P735, DOI 10.1016/S0092-8674(88)90911-7; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Reisenauer A, 1999, J BACTERIOL, V181, P5135, DOI 10.1128/JB.181.17.5135-5139.1999; ROBERTS D, 1985, CELL, V43, P117, DOI 10.1016/0092-8674(85)90017-0; Roberts R.J., 1993, TYPE 2 RESTRICTION E; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schadt EE, 2013, GENOME RES, V23, P129, DOI 10.1101/gr.136739.111; Schadt EE, 2010, HUM MOL GENET, V19, pR227, DOI 10.1093/hmg/ddq416; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210; SWINTON D, 1983, P NATL ACAD SCI-BIOL, V80, P7400, DOI 10.1073/pnas.80.24.7400; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; vanderWoude M, 1996, TRENDS MICROBIOL, V4, P5, DOI 10.1016/0966-842X(96)81498-3; WARREN RAJ, 1980, ANNU REV MICROBIOL, V34, P137, DOI 10.1146/annurev.mi.34.100180.001033; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; WYATT GR, 1952, NATURE, V170, P1072, DOI 10.1038/1701072a0; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	51	226	249	5	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1232	+		10.1038/nbt.2432	http://dx.doi.org/10.1038/nbt.2432			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23138224	Green Accepted, Bronze			2022-12-27	WOS:000312092400027
J	Getts, DR; Martin, AJ; McCarthy, DP; Terry, RL; Hunter, ZN; Yap, WT; Getts, MT; Pleiss, M; Luo, XR; King, NJC; Shea, LD; Miller, SD				Getts, Daniel R.; Martin, Aaron J.; McCarthy, Derrick P.; Terry, Rachael L.; Hunter, Zoe N.; Yap, Woon Teck; Getts, Meghann Teague; Pleiss, Michael; Luo, Xunrong; King, Nicholas J. C.; Shea, Lonnie D.; Miller, Stephen D.			Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis	NATURE BIOTECHNOLOGY			English	Article							MARGINAL ZONE MACROPHAGES; SCAVENGER RECEPTOR MARCO; MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; GLATIRAMER ACETATE; REGULATORY-CELLS; CLONAL ANERGY; SINGLE COURSE; SR-AI/II; ANTIGEN	Aberrant T-cell activation underlies many autoimmune disorders, yet most attempts to induce T-cell tolerance have failed. Building on previous strategies for tolerance induction that exploited natural mechanisms for clearing apoptotic debris, we show that antigen-decorated microparticles (500-nm diameter) induce long-term T-cell tolerance in mice with relapsing experimental autoimmune encephalomyelitis. Specifically, intravenous infusion of either polystyrene or biodegradable poly(lactide-co-glycolide) microparticles bearing encephalitogenic peptides prevents the onset and modifies the course of the disease. These beneficial effects require microparticle uptake by marginal zone macrophages expressing the scavenger receptor MARCO and are mediated in part by the activity of regulatory T cells, abortive T-cell activation and T-cell anergy. Together these data highlight the potential for using microparticles to target natural apoptotic clearance pathways to inactivate pathogenic T cells and halt the disease process in autoimmunity.	[Getts, Daniel R.; Martin, Aaron J.; McCarthy, Derrick P.; Hunter, Zoe N.; Getts, Meghann Teague; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Getts, Daniel R.; Martin, Aaron J.; McCarthy, Derrick P.; Hunter, Zoe N.; Getts, Meghann Teague; Luo, Xunrong; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Interdept Immunobiol Ctr, Chicago, IL 60611 USA; [Terry, Rachael L.; King, Nicholas J. C.] Univ Sydney, Sch Med Sci, Bosch Inst, Discipline Pathol, Sydney, NSW 2006, Australia; [Yap, Woon Teck; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Pleiss, Michael] Myelin Repair Fdn, Saratoga, CA USA; [Luo, Xunrong] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Sydney; Northwestern University; Northwestern University; Feinberg School of Medicine	Miller, SD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	nickk@pathology.usyd.edu.au; l-shea@northwestern.edu; s-d-miller@northwestern.edu	Shea, Lonnie D/B-7615-2009; Yap, Woon Teck/G-6874-2013	King, Nicholas Jonathan Cole/0000-0002-3877-9772; Terry, Rachael/0000-0002-6260-7372	Myelin Repair Foundation; US National Institutes of Health [NS026543, EB013198]; Juvenile Diabetes Research Foundation [17-2011-343]; Australian National Health and Medical Research Council [512413, 1030897]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026543] Funding Source: NIH RePORTER	Myelin Repair Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the Myelin Repair Foundation, US National Institutes of Health grants NS026543 and EB013198, Juvenile Diabetes Research Foundation grant 17-2011-343 and the Australian National Health and Medical Research Council grants 512413 and 1030897. We also thank V. Kuchroo and L. Kobchik of Harvard University for providing transgenic mice.	Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Arredouani MS, 2007, J IMMUNOL, V178, P5912, DOI 10.4049/jimmunol.178.9.5912; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Chen XW, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3230; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Christen U, 2004, CURR OPIN IMMUNOL, V16, P759, DOI 10.1016/j.coi.2004.09.002; Dahl M, 2007, J CLIN INVEST, V117, P757, DOI 10.1172/JCI29968; DESILVA DR, 1991, J IMMUNOL, V147, P3261; Eagar TN, 2004, J IMMUNOL, V172, P7442, DOI 10.4049/jimmunol.172.12.7442; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Fontoura P, 2010, RESULTS PROBL CELL D, V51, P259, DOI 10.1007/400_2010_36; Freedman MS, 2011, NEUROLOGY, V77, P1551, DOI 10.1212/WNL.0b013e318233b240; Garren H, 2008, ANN NEUROL, V63, P611, DOI 10.1002/ana.21370; Getts DR, 2011, J IMMUNOL, V187, P2405, DOI 10.4049/jimmunol.1004175; Ghosh S, 2011, AM J RESP CELL MOL, V45, P1036, DOI 10.1165/rcmb.2010-0349OC; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Herold KC, 2009, CLIN IMMUNOL, V132, P166, DOI 10.1016/j.clim.2009.04.007; Ilan Y, 2010, J CLIN IMMUNOL, V30, P167, DOI 10.1007/s10875-009-9323-7; Kang YS, 2003, INT IMMUNOL, V15, P177, DOI 10.1093/intimm/dxg019; Kanno S, 2007, TOXICOL SCI, V97, P398, DOI 10.1093/toxsci/kfm050; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Kohm AP, 2005, INT REV IMMUNOL, V24, P361, DOI 10.1080/08830180500371207; KRAAL G, 1989, EUR J IMMUNOL, V19, P675, DOI 10.1002/eji.1830190416; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Lalive PH, 2011, CNS DRUGS, V25, P401, DOI 10.2165/11588120-000000000-00000; LIBLAU RS, 1994, IMMUNOL REV, V142, P193, DOI 10.1111/j.1600-065X.1994.tb00890.x; Ludvigsson J, 2012, NEW ENGL J MED, V366, P433, DOI 10.1056/NEJMoa1107096; Luo XR, 2008, P NATL ACAD SCI USA, V105, P14527, DOI 10.1073/pnas.0805204105; Luo XR, 2010, IMMUNITY, V32, P488, DOI 10.1016/j.immuni.2010.04.002; Lyszkiewicz M, 2011, J LEUKOCYTE BIOL, V89, P607, DOI 10.1189/jlb.0610368; Martin AJ, 2010, J IMMUNOL, V185, P3326, DOI 10.4049/jimmunol.1000802; Miller SD, 2007, NAT REV IMMUNOL, V7, P665, DOI 10.1038/nri2153; Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497; Papadopoulou A, 2012, J NEUROL, V259, P1375, DOI 10.1007/s00415-011-6361-x; Racke MK, 2011, J IMMUNOL, V186, P1887, DOI 10.4049/jimmunol.1090138; Schreiner B, 2008, EUR J IMMUNOL, V38, P2706, DOI 10.1002/eji.200838137; Sherr J, 2008, NAT CLIN PRACT ENDOC, V4, P334, DOI 10.1038/ncpendmet0832; Smarr CB, 2011, J IMMUNOL, V187, P5090, DOI 10.4049/jimmunol.1100608; Smith CE, 2005, P NATL ACAD SCI USA, V102, P9595, DOI 10.1073/pnas.0504131102; Thakur SA, 2009, TOXICOL SCI, V107, P238, DOI 10.1093/toxsci/kfn210; Thelen T, 2010, J IMMUNOL, V185, P4328, DOI 10.4049/jimmunol.1000989; Turley DM, 2007, J IMMUNOL, V178, P2212, DOI 10.4049/jimmunol.178.4.2212; Tyner K, 2011, METHODS MOL BIOL, V697, P17, DOI 10.1007/978-1-60327-198-1_3; Vanderlugt CL, 2000, J IMMUNOL, V164, P670, DOI 10.4049/jimmunol.164.2.670; Viorritto ICB, 2007, CLIN IMMUNOL, V122, P125, DOI 10.1016/j.clim.2006.07.012; Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082	49	280	296	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1217	+		10.1038/nbt.2434	http://dx.doi.org/10.1038/nbt.2434			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23159881	Green Accepted			2022-12-27	WOS:000312092400025
J	Bhatia, S; Frangioni, JV; Hoffman, RM; Iafrate, AJ; Polyak, K				Bhatia, Sangeeta; Frangioni, John V.; Hoffman, Robert M.; Iafrate, A. John; Polyak, Kornelia			The challenges posed by cancer heterogeneity	NATURE BIOTECHNOLOGY			English	Article								A panel of five experts discuss the implications of cancer heterogeneity for diagnostics and therapy.	[Bhatia, Sangeeta] MIT, Cambridge, MA 02139 USA; [Bhatia, Sangeeta] Brigham & Womens Hosp, Boston, MA 02115 USA; [Frangioni, John V.] Beth Israel Deaconess Med Ctr, Boston, MA USA; [Iafrate, A. John] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Polyak, Kornelia] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA	Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California San Diego; Anti Cancer Inc	Bhatia, S (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		li, jie/A-3133-2011; damiani, chiara/R-4256-2016		NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		2011, CANC CELL, V20, P810	1	76	82	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					604	610		10.1038/nbt.2294	http://dx.doi.org/10.1038/nbt.2294			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781679				2022-12-27	WOS:000306293400015
J	Scott, C; Huggett, B				Scott, Christopher; Huggett, Brady			Geron's quixotic fate	NATURE BIOTECHNOLOGY			English	Editorial Material																		Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	1	11	11	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					497	497		10.1038/nbt.2253	http://dx.doi.org/10.1038/nbt.2253			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22678383				2022-12-27	WOS:000305158600015
J	Francisco, M				Francisco, Michael			First-quarter biotech job picture	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					467	467		10.1038/nbt.2212	http://dx.doi.org/10.1038/nbt.2212			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22565977	Bronze			2022-12-27	WOS:000303803200032
J	Polvino, B				Polvino, Bill			A work in progress	NATURE BIOTECHNOLOGY			English	Editorial Material									Veloxis Pharmaceut, Edison, NJ 08837 USA		Polvino, B (corresponding author), Veloxis Pharmaceut, Edison, NJ 08837 USA.	info@veloxis.com							0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					388	389		10.1038/nbt.2178	http://dx.doi.org/10.1038/nbt.2178			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22565957				2022-12-27	WOS:000303803200012
J	Manrao, EA; Derrington, IM; Laszlo, AH; Langford, KW; Hopper, MK; Gillgren, N; Pavlenok, M; Niederweis, M; Gundlach, JH				Manrao, Elizabeth A.; Derrington, Ian M.; Laszlo, Andrew H.; Langford, Kyle W.; Hopper, Matthew K.; Gillgren, Nathaniel; Pavlenok, Mikhail; Niederweis, Michael; Gundlach, Jens H.			Reading DNA at single-nucleotide resolution with a mutant MspA nanopore and phi29 DNA polymerase	NATURE BIOTECHNOLOGY			English	Article							POLYNUCLEOTIDE MOLECULES; PROTEIN NANOPORE; MEMBRANE CHANNEL; DISCRIMINATION; REPLICATION; COMPLEXES; BINDING	Nanopore technologies are being developed for fast and direct sequencing of single DNA molecules through detection of ionic current modulations as DNA passes through a pore's constriction(1,2). Here we demonstrate the ability to resolve changes in current that correspond to a known DNA sequence by combining the high sensitivity of a mutated form of the protein pore Mycobacterium smegmatis porin A (MspA)(3) with phi29 DNA polymerase (DNAP)(4), which controls the rate of DNA translocation through the pore. As phi29 DNAP synthesizes DNA and functions like a motor to pull a single-stranded template through MspA, we observe well-resolved and reproducible ionic current levels with median durations of similar to 28 ms and ionic current differences of up to 40 pA. Using six different DNA sequences with readable regions 42-53 nucleotides long, we record current traces that map to the known DNA sequences. With single-nucleotide resolution and DNA translocation control, this system integrates solutions to two long-standing hurdles to nanopore sequencing(2).	[Manrao, Elizabeth A.; Derrington, Ian M.; Laszlo, Andrew H.; Langford, Kyle W.; Hopper, Matthew K.; Gillgren, Nathaniel; Gundlach, Jens H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Pavlenok, Mikhail; Niederweis, Michael] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham	Gundlach, JH (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	jens@phys.washington.edu		Laszlo, Andrew/0000-0002-7853-0533; Niederweis, Michael/0000-0003-4068-8092; Gundlach, Jens Horst/0000-0002-0773-8038	US National Institutes of Health, National Human Genome Research Institute [R21HG004145, R01HG005115, R01HG006321]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004145, R01HG005115, R01HG006321] Funding Source: NIH RePORTER	US National Institutes of Health, National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Akeson and G. M. Cherf for getting us started with the blocking oligomer phi29 DNAP technique, sharing their CAT DNA and reading the manuscript. We thank J. Bartlett and G. Nayler for their help running experiments and D. Feldman for writing data acquisition code. This work was supported by the US National Institutes of Health, National Human Genome Research Institute $ 1000 Genome Program Grants R21HG004145, R01HG005115 and R01HG006321.	Benner S, 2007, NAT NANOTECHNOL, V2, P718, DOI 10.1038/nnano.2007.344; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Blanco L, 1996, J BIOL CHEM, V271, P8509, DOI 10.1074/jbc.271.15.8509; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107; Durbin R., 2006, BIOL SEQUENCE ANAL; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Gyarfas B, 2009, ACS NANO, V3, P1457, DOI 10.1021/nn900303g; Hurt N, 2009, J AM CHEM SOC, V131, P3772, DOI 10.1021/ja809663f; Ibarra B, 2009, EMBO J, V28, P2794, DOI 10.1038/emboj.2009.219; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Manrao EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025723; Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; Purnell RF, 2008, NANO LETT, V8, P3029, DOI 10.1021/nl802312f; Purnell RF, 2009, ACS NANO, V3, P2533, DOI 10.1021/nn900441x; Salas M, 2008, IUBMB LIFE, V60, P82, DOI 10.1002/iub.19; Stoddart D, 2009, P NATL ACAD SCI USA, V106, P7702, DOI 10.1073/pnas.0901054106; Wallace EVB, 2010, CHEM COMMUN, V46, P8195, DOI 10.1039/c0cc02864a; Wilson NA, 2009, ACS NANO, V3, P995, DOI 10.1021/nn9000897	23	623	735	15	407	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2012	30	4					349	U174		10.1038/nbt.2171	http://dx.doi.org/10.1038/nbt.2171			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	925TR	22446694	Green Accepted			2022-12-27	WOS:000302785000023
J	Mak, HC				Mak, H. Craig			Drug pipeline: Q411	NATURE BIOTECHNOLOGY			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					15	15		10.1038/nbt.2090	http://dx.doi.org/10.1038/nbt.2090			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22231084				2022-12-27	WOS:000299110600007
J	Huggett, B				Huggett, Brady			Biotech's wellspring: the health of private biotech in 2013	NATURE BIOTECHNOLOGY			English	Article																			0	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					428	435		10.1038/nbt.2905	http://dx.doi.org/10.1038/nbt.2905			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24811512				2022-12-27	WOS:000336036100013
J	Patro, R; Mount, SM; Kingsford, C				Patro, Rob; Mount, Stephen M.; Kingsford, Carl			Sailfish enables alignment-free isoform quantification from RNA-seq reads using lightweight algorithms	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIAL EXPRESSION; SEQUENCES	We introduce Sailfish, a computational method for quantifying the abundance of previously annotated RNA isoforms from RNA-seq data. Because Sailfish entirely avoids mapping reads, a time-consuming step in all current methods, it provides quantification estimates much faster than do existing approaches (typically 20 times faster) without loss of accuracy. By facilitating frequent reanalysis of data and reducing the need to optimize parameters, Sailfish exemplifies the potential of lightweight algorithms for efficiently processing sequencing reads.	[Patro, Rob; Kingsford, Carl] Carnegie Mellon Univ, Sch Comp Sci, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Mount, Stephen M.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Mount, Stephen M.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	Carnegie Mellon University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Kingsford, C (corresponding author), Carnegie Mellon Univ, Sch Comp Sci, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.	carlk@cs.cmu.edu		Mount, Steve/0000-0003-2748-8205	US National Science Foundation [CCF-1256087, CCF-1053918, EF-0849899]; US National Institutes of Health [R21AI085376, R21HG006913, R01HG007104]; Division of Computing and Communication Foundations [1319998] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006913, R01HG007104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085376] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been partially funded by the US National Science Foundation (CCF-1256087, CCF-1053918, and EF-0849899) and US National Institutes of Health (R21AI085376, R21HG006913 and R01HG007104). C. K. received support as an Alfred P. Sloan Research Fellow. We would like to thank A. Roberts for helping to diagnose and resolve an artifact in an earlier version of this manuscript pertaining to the synthetic data generated by the Flux Simulator.	Botelho F.C., 2007, P 10 INT WORKSH ALG, P139; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griebel T, 2012, NUCLEIC ACIDS RES, V40, P10073, DOI 10.1093/nar/gks666; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Mortazavi A, NAT METHODS; Nicolae M, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-9; Philippe N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r30; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Roychowdhury S., 2011, SCI TRANS MED; Sacomoto GAT, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S5; Salzman J, 2011, STAT SCI, V26, P62, DOI 10.1214/10-STS343; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Varadhan R, 2008, SCAND J STAT, V35, P335, DOI 10.1111/j.1467-9469.2007.00585.x; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290	21	353	359	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					462	U174		10.1038/nbt.2862	http://dx.doi.org/10.1038/nbt.2862			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24752080	Green Accepted, Green Submitted			2022-12-27	WOS:000336036100021
J	Polak, P; Lawrence, MS; Haugen, E; Stoletzki, N; Stojanov, P; Thurman, RE; Garraway, LA; Mirkin, S; Getz, G; Stamatoyannopoulos, JA; Sunyaev, SR				Polak, Paz; Lawrence, Michael S.; Haugen, Eric; Stoletzki, Nina; Stojanov, Petar; Thurman, Robert E.; Garraway, Levi A.; Mirkin, Sergei; Getz, Gad; Stamatoyannopoulos, John A.; Sunyaev, Shamil R.			Reduced local mutation density in regulatory DNA of cancer genomes is linked to DNA repair	NATURE BIOTECHNOLOGY			English	Article							NUCLEOTIDE EXCISION-REPAIR; NUCLEASE-HYPERSENSITIVE SITES; SOMATIC MUTATIONS; DAMAGE; NUCLEOSOMES; EVOLUTION; YEAST	Carcinogenesis and neoplastic progression are mediated by the accumulation of somatic mutations. Here we report that the local density of somatic mutations in cancer genomes is highly reduced specifically in accessible regulatory DNA defined by DNase I hypersensitive sites. This reduction is independent of any known factors influencing somatic mutation density and is observed in diverse cancer types, suggesting a general mechanism. By analyzing individual cancer genomes(1), we show that the reduced local mutation density within regulatory DNA is linked to intact global genome repair machinery, with nearly complete abrogation of the hypomutation phenomenon in individual cancers that possess mutations in components of the nucleotide excision repair system. Together, our results connect chromatin structure, gene regulation and cancer-associated somatic mutation.	[Polak, Paz; Stoletzki, Nina; Sunyaev, Shamil R.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Polak, Paz; Stoletzki, Nina; Garraway, Levi A.; Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA USA; [Polak, Paz; Lawrence, Michael S.; Stoletzki, Nina; Stojanov, Petar; Garraway, Levi A.; Getz, Gad; Sunyaev, Shamil R.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Haugen, Eric; Thurman, Robert E.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Haugen, Eric; Thurman, Robert E.; Stamatoyannopoulos, John A.] Univ Washington, Dept Med Oncol, Seattle, WA 98195 USA; [Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Mirkin, Sergei] Tufts Univ, Dept Biol, Medford, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Tufts University	Sunyaev, SR (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	jstam@u.washington.edu; ssunyaev@rics.bwh.harvard.edu	Polak, Paz/AAH-9380-2020; Mirkin, Sergei/A-7310-2010; Stojanov, Petar/GQI-4462-2022; Mirkin, Sergei/AAR-7226-2020; Lawrence, Michael/AAC-8202-2020	Stojanov, Petar/0000-0001-7815-776X; Mirkin, Sergei/0000-0003-4576-7582; Haugen, Eric/0000-0001-7444-8981	US National Institutes of Health (NIH) [U54CA143874, RO1MH101244, U54HG004592, HG007010]; NATIONAL CANCER INSTITUTE [U54CA143874] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, U54HG007010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by US National Institutes of Health (NIH) grants U54CA143874 and RO1MH101244 to S. R. S. and U54HG004592 and HG007010 to J.A.S. We thank D. Gordenin for his valuable feedback.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Amouroux R, 2010, NUCLEIC ACIDS RES, V38, P2878, DOI 10.1093/nar/gkp1247; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen XS, 2012, SCIENCE, V335, P1235, DOI 10.1126/science.1217580; CHENG KC, 1992, J BIOL CHEM, V267, P166; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Fei J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001183; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Girard PM, 1997, BIOCHIMIE, V79, P559, DOI 10.1016/S0300-9084(97)82004-4; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hanawalt PC, 2003, MUTAT RES-REV MUTAT, V544, P107, DOI 10.1016/j.mrrev.2003.06.002; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Haruta N, 2012, NUCLEIC ACIDS RES, V40, P8406, DOI 10.1093/nar/gks580; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hodgkinson A, 2012, HUM MUTAT, V33, P136, DOI 10.1002/humu.21616; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kawanishi S, 2006, BIOL CHEM, V387, P365, DOI 10.1515/BC.2006.049; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Laine JP, 2006, EMBO J, V25, P387, DOI 10.1038/sj.emboj.7600933; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Legault J, 1997, MOL CELL BIOL, V17, P5437, DOI 10.1128/MCB.17.9.5437; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Palomera-Sanchez Z, 2011, DNA REPAIR, V10, P119, DOI 10.1016/j.dnarep.2010.10.010; Parker SCJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002871; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Sugasawa K, 2008, CARCINOGENESIS, V29, P455, DOI 10.1093/carcin/bgm282; Thoma F, 2005, DNA REPAIR, V4, P855, DOI 10.1016/j.dnarep.2005.04.005; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Yasuda T, 2005, DNA REPAIR, V4, P389, DOI 10.1016/j.dnarep.2004.10.008	48	83	83	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					71	+		10.1038/nbt.2778	http://dx.doi.org/10.1038/nbt.2778			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24336318	Green Submitted, Bronze, Green Accepted			2022-12-27	WOS:000329513000020
J	Gonzalez-Cordero, A; West, EL; Pearson, RA; Duran, Y; Carvalho, LS; Chu, CJ; Naeem, A; Blackford, SJI; Georgiadis, A; Lakowski, J; Hubank, M; Smith, AJ; Bainbridge, JWB; Sowden, JC; Ali, RR				Gonzalez-Cordero, Anai; West, Emma L.; Pearson, Rachael A.; Duran, Yanai; Carvalho, Livia S.; Chu, Colin J.; Naeem, Arifa; Blackford, Samuel J. I.; Georgiadis, Anastasios; Lakowski, Jorn; Hubank, Mike; Smith, Alexander J.; Bainbridge, James W. B.; Sowden, Jane C.; Ali, Robin R.			Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina	NATURE BIOTECHNOLOGY			English	Article							VESICLE-LIKE STRUCTURES; VISUAL FUNCTION; TRANSPLANTATION; MOUSE; CRX; ROD; GENERATION; GENE; DIFFERENTIATION; RESTORATION	Irreversible blindness caused by loss of photoreceptors may be amenable to cell therapy. We previously demonstrated retinal repair(1) and restoration of vision through transplantation of photoreceptor precursors obtained from postnatal retinas into visually impaired adult mice(2,3). Considerable progress has been made in differentiating embryonic stem cells (ESCs) in vitro toward photoreceptor lineages(4-6). However, the capability of ESC-derived photoreceptors to integrate after transplantation has not been demonstrated unequivocally. Here, to isolate photoreceptor precursors fit for transplantation, we adapted a recently reported three-dimensional (3D) differentiation protocol that generates neuroretina from mouse ESCs6. We show that rod precursors derived by this protocol and selected via a GFP reporter under the control of a Rhodopsin promoter integrate within degenerate retinas of adult mice and mature into outer segment-bearing photoreceptors. Notably, ESC-derived precursors at a developmental stage similar to postnatal days 4-8 integrate more efficiently compared with cells at other stages. This study shows conclusively that ESCs can provide a source of photoreceptors for retinal cell transplantation.	[Gonzalez-Cordero, Anai; West, Emma L.; Pearson, Rachael A.; Duran, Yanai; Carvalho, Livia S.; Chu, Colin J.; Naeem, Arifa; Blackford, Samuel J. I.; Georgiadis, Anastasios; Smith, Alexander J.; Bainbridge, James W. B.; Ali, Robin R.] UCL Inst Ophthalmol, Dept Genet, London, England; [Lakowski, Jorn; Sowden, Jane C.] UCL, Inst Child Hlth, Dev Biol Unit, London, England; [Hubank, Mike] UCL, UCL Genom Inst Child Hlth, London, England; [Ali, Robin R.] UCL, Inst Child Hlth, Mol Immunol Unit, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Ali, RR (corresponding author), UCL Inst Ophthalmol, Dept Genet, London, England.	e.west@ucl.ac.uk; r.ali@ucl.ac.uk	Hubank, Michael JF/C-1837-2008; Lakowski, Jorn/ABD-6613-2020; Smith, Alexander/A-5142-2009; West, Emma L/C-5252-2013; Pearson, Rachael/Y-3339-2018; Georgiadis, Anastasios/G-8777-2012	Hubank, Michael JF/0000-0002-2901-0742; Lakowski, Jorn/0000-0003-4214-7580; Pearson, Rachael/0000-0002-1107-1969; Chu, Colin/0000-0003-2088-8310; Bainbridge, James/0000-0003-1318-8201; Blackford, Samuel/0000-0001-5890-0624; Carvalho, Livia/0000-0002-3909-5778; Gonzalez Cordero, Anai/0000-0002-1818-0375; Ali, Robin/0000-0003-3126-6517; Sowden, Jane/0000-0003-0937-2479; West, Emma/0000-0002-7006-3686; Georgiadis, Anastasios/0000-0001-5079-3588	Medical Research Council UK [mr/j004553/1, G0901550]; RP Fighting Blindness [GR566]; Miller's Trust; Great Ormond Street Hospital Children's Charity; Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; Alcon Research Institute; Medical Research Council [G1100383, G0901550, MR/J004553/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10130, NIHR-RP-011-003] Funding Source: researchfish; Rosetrees Trust [M257] Funding Source: researchfish; Fight for Sight [1351/52, 1371/72] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1257] Funding Source: researchfish; MRC [G0901550, MR/J004553/1, G1100383] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RP Fighting Blindness; Miller's Trust; Great Ormond Street Hospital Children's Charity; Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital(National Institute for Health Research (NIHR)); Alcon Research Institute(Novartis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Fight for Sight; Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council UK (mr/j004553/1, G0901550), RP Fighting Blindness (GR566), The Miller's Trust and Moorfields Eye Charity through a generous private donation. A. G.-C. is a Wellcome Trust PhD student (087256/Z08/Z). R. A. P. is a Royal Society University Research Fellow. J.C.S. is supported by Great Ormond Street Hospital Children's Charity. R. R. A. is partly funded by the Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and Alcon Research Institute. We thank A. Eddaoudi, A. Rose and T. Adejumo for FACS assistance; S. Azam and S. Haria for virus purification; S. Sharma for performing the Affymetrix microarray; and P. Munro for EM assistance. The mouse EK.CCE ESC line<SUP>34</SUP> (129/SvEv) was a kind gift of E. Robertson. The following mouse lines were kind gifts: Gnat1<SUP>-/-</SUP> was provided by J. Lem, Tufts University School of Medicine; Prph2<SUP>rd2/rd2</SUP> by G. Travis, UCLA; Rho<SUP>-/-</SUP> by P. Humphries, Trinity College Dublin and Nrlp.GFP<SUP>+/+</SUP> by A. Swaroop, University of Michigan.	Ali RR, 2011, NATURE, V472, P42, DOI 10.1038/472042a; Barber AC, 2013, P NATL ACAD SCI USA, V110, P354, DOI 10.1073/pnas.1212677110; Bartsch U, 2008, EXP EYE RES, V86, P691, DOI 10.1016/j.exer.2008.01.018; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Davidoff AM, 2004, J VIROL METHODS, V121, P209, DOI 10.1016/j.jviromet.2004.07.001; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gao GP, 2002, MOL THER, V5, P644, DOI 10.1006/mthe.2001.0591; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Hyatt GA, 1996, P NATL ACAD SCI USA, V93, P13298, DOI 10.1073/pnas.93.23.13298; Kelley MW, 1999, NEUROREPORT, V10, P2389, DOI 10.1097/00001756-199908020-00031; Koulen P, 2002, INVEST OPHTH VIS SCI, V43, P1933; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; Lakowski J, 2011, STEM CELLS, V29, P1391, DOI 10.1002/stem.694; Lakowski J, 2010, HUM MOL GENET, V19, P4545, DOI 10.1093/hmg/ddq378; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; LOMBARDINI JB, 1991, BRAIN RES REV, V16, P151, DOI 10.1016/0165-0173(91)90003-Q; Luhmann UFO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035551; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Pearson RA, 2010, CELL TRANSPLANT, V19, P487, DOI 10.3727/096368909X486057; Phillips MJ, 2012, INVEST OPHTH VIS SCI, V53, P2007, DOI 10.1167/iovs.11-9313; Martinez-Morales JR, 2009, CURR OPIN GENET DEV, V19, P511, DOI 10.1016/j.gde.2009.08.003; Singh MS, 2013, P NATL ACAD SCI USA, V110, P1101, DOI 10.1073/pnas.1119416110; Tschernutter M, 2005, GENE THER, V12, P694, DOI 10.1038/sj.gt.3302460; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; West EL, 2012, STEM CELLS, V30, P1424, DOI 10.1002/stem.1123	36	256	274	1	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					741	+		10.1038/nbt.2643	http://dx.doi.org/10.1038/nbt.2643			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23873086	Green Accepted			2022-12-27	WOS:000322911000024
J	Sahay, G; Querbes, W; Alabi, C; Eltoukhy, A; Sarkar, S; Zurenko, C; Karagiannis, E; Love, K; Chen, DL; Zoncu, R; Buganim, Y; Schroeder, A; Langer, R; Anderson, DG				Sahay, Gaurav; Querbes, William; Alabi, Christopher; Eltoukhy, Ahmed; Sarkar, Sovan; Zurenko, Christopher; Karagiannis, Emmanouil; Love, Kevin; Chen, Delai; Zoncu, Roberto; Buganim, Yosef; Schroeder, Avi; Langer, Robert; Anderson, Daniel G.			Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling	NATURE BIOTECHNOLOGY			English	Article							INTRACELLULAR TRAFFICKING; GENE; CYTOSCAPE; MECHANISM; TRANSPORT; TRACKING; REQUIRES; PATHWAY; RNAS	Despite efforts to understand the interactions between nanoparticles and cells, the cellular processes that determine the efficiency of intracellular drug delivery remain unclear. Here we examine cellular uptake of short interfering RNA (siRNA) delivered in lipid nanoparticles (LNPs) using cellular trafficking probes in combination with automated high-throughput confocal microscopy. We also employed defined perturbations of cellular pathways paired with systems biology approaches to uncover protein-protein and protein-small molecule interactions. We show that multiple cell signaling effectors are required for initial cellular entry of LNPs through macropinocytosis, including proton pumps, mTOR and cathepsins. siRNA delivery is substantially reduced as congruent to 70% of the internalized siRNA undergoes exocytosis through egress of LNPs from late endosomes/lysosomes. Niemann-Pick type C1 (NPC1) is shown to be an important regulator of the major recycling pathways of LNP-delivered siRNAs. NPC1-deficient cells show enhanced cellular retention of LNPs inside late endosomes and lysosomes, and increased gene silencing of the target gene. Our data suggest that siRNA delivery efficiency might be improved by designing delivery vehicles that can escape the recycling pathways.	[Sahay, Gaurav; Karagiannis, Emmanouil; Love, Kevin; Chen, Delai; Schroeder, Avi; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Querbes, William; Zurenko, Christopher] Alnylam Pharmaceut, Cambridge, MA USA; [Alabi, Christopher; Eltoukhy, Ahmed; Love, Kevin; Schroeder, Avi; Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Sarkar, Sovan; Zoncu, Roberto; Buganim, Yosef] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Harvard Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] Inst Med Engn & Sci, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Anderson, DG (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dgander@mit.edu	Karagiannis, Emmanouil D./CAA-0759-2022; Sarkar, Sovan/F-8486-2017	Sarkar, Sovan/0000-0002-9456-4362; Sahay, Gaurav/0000-0003-1071-0500; Karagiannis, Emmanouil/0000-0003-0131-6552; Schroeder, Avi/0000-0003-2571-5937	Alnylam Pharmaceuticals [EB000244]; National Heart, Lung, and Blood Institute, US National Institutes of Health, as a Program of Excellence in Nanotechnology (PEN) Award [HHSN268201000045C]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000244, R37EB000244] Funding Source: NIH RePORTER	Alnylam Pharmaceuticals; National Heart, Lung, and Blood Institute, US National Institutes of Health, as a Program of Excellence in Nanotechnology (PEN) Award; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We dedicate this work to the memory of MIT police officer Sean Collier who valiantly gave his life for the protection of the MIT community. We would like to thank P. Lobel and L. Huang from Rutgers University for NPC1 primary and immortalized cell lines. We wish to thank W. Salmon and N. Watson of the Whitehead Institute Core facility at MIT for help with confocal imaging. We would also like to thank D. Brown (Harvard MGH), K. Whitehead, R. Bogorad (MIT) and H. Yin (MIT) for healthy discussion. We would also like to thank J. Maraganore (Alnylam) and M. Invernale (MIT) for critical reading of the manuscript. Special thanks to D. Alakhova at University of Nebraska Medical Center for her help with graphic design. We would also like to thank Alnylam Pharmaceuticals, Control release grant EB000244 for funding. This work was supported by the National Heart, Lung, and Blood Institute, US National Institutes of Health, as a Program of Excellence in Nanotechnology (PEN) Award, Contract #HHSN268201000045C.	Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Alabi CA, 2012, ACS NANO, V6, P6133, DOI 10.1021/nn3013838; Basha G, 2011, MOL THER, V19, P2186, DOI 10.1038/mt.2011.190; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chen DL, 2012, J AM CHEM SOC, V134, P6948, DOI 10.1021/ja301621z; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Nguyen J, 2012, ACCOUNTS CHEM RES, V45, P1153, DOI 10.1021/ar3000162; Juliano RL, 2012, BIOCONJUGATE CHEM, V23, P147, DOI 10.1021/bc200377d; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Koivusalo M, 2007, MOL BIOL CELL, V18, P5113, DOI 10.1091/mbc.E07-04-0330; Lai SK, 2008, J CONTROL RELEASE, V125, P107, DOI 10.1016/j.jconrel.2007.10.015; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Linder MD, 2007, MOL BIOL CELL, V18, P47, DOI 10.1091/mbc.E06-07-0575; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Lu JJ, 2009, MOL PHARMACEUT, V6, P763, DOI 10.1021/mp900023v; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Sarkar S, 2011, MOL CELL, V43, P19, DOI 10.1016/j.molcel.2011.04.029; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheridan C, 2012, NAT BIOTECHNOL, V30, P471, DOI 10.1038/nbt0612-471; Siomi H, 2009, NAT CELL BIOL, V11, P1049, DOI 10.1038/ncb0909-1049; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; Stalder L, 2013, EMBO J, V32, P1115, DOI 10.1038/emboj.2013.52; Stenmark H, 2001, GENOME BIOL, V2; Suh J, 2012, MICROSC RES TECHNIQ, V75, P691, DOI 10.1002/jemt.21113; Wang J, 2011, SMALL, V7, P1919, DOI 10.1002/smll.201100442; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	41	521	550	23	456	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2013	31	7					653	U119		10.1038/nbt.2614	http://dx.doi.org/10.1038/nbt.2614			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	180FS	23792629	Green Submitted, Green Accepted			2022-12-27	WOS:000321579700023
J	Scott, C				Scott, Christopher			CASE STUDY Liquid refreshment	NATURE BIOTECHNOLOGY			English	Editorial Material																		[Anonymous], 2010, MONOCLONAL ANTIBODIE; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295	2	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					115	115		10.1038/nbt.2481	http://dx.doi.org/10.1038/nbt.2481			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23392506	Bronze			2022-12-27	WOS:000315322100016
J	Petsch, B; Schnee, M; Vogel, AB; Lange, E; Hoffmann, B; Voss, D; Schlake, T; Thess, A; Kallen, KJ; Stitz, L; Kramps, T				Petsch, Benjamin; Schnee, Margit; Vogel, Annette B.; Lange, Elke; Hoffmann, Bernd; Voss, Daniel; Schlake, Thomas; Thess, Andreas; Kallen, Karl-Josef; Stitz, Lothar; Kramps, Thomas			Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection	NATURE BIOTECHNOLOGY			English	Article							CYTOTOXIC T-LYMPHOCYTES; LETHAL INFLUENZA; IMMUNITY; VACCINATION; CHALLENGE; IMMUNIZATION; ANTIBODIES; INDUCTION; CORRELATE; A/H1N1	Despite substantial improvements, influenza vaccine production-and availability-remain suboptimal. Influenza vaccines based on mRNA may offer a solution as sequence-matched, clinical-grade material could be produced reliably and rapidly in a scalable process, allowing quick response to the emergence of pandemic strains. Here we show that mRNA vaccines induce balanced, long-lived and protective immunity to influenza A virus infections in even very young and very old mice and that the vaccine remains protective upon thermal stress. This vaccine format elicits B and T cell-dependent protection and targets multiple antigens, including the highly conserved viral nucleoprotein, indicating its usefulness as a cross-protective vaccine. In ferrets and pigs, mRNA vaccines induce immunological correlates of protection and protective effects similar to those of a licensed influenza vaccine in pigs. Thus, mRNA vaccines could address substantial medical need in the area of influenza prophylaxis and the broader realm of anti-infective vaccinology.	[Petsch, Benjamin; Vogel, Annette B.; Stitz, Lothar] Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany; [Schnee, Margit; Voss, Daniel; Schlake, Thomas; Thess, Andreas; Kallen, Karl-Josef; Kramps, Thomas] CureVac GmbH, Tubingen, Germany; [Lange, Elke] Friedrich Loeffler Inst, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany; [Hoffmann, Bernd] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany	Friedrich Loeffler Institute; CureVac N.V.; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Stitz, L (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany.	lothar.stitz@fli.bund.de; karl-josef.kallen@curevac.com	Petsch, Benni/AAL-7767-2020	Petsch, Benni/0000-0001-7431-0683; Vogel, Annette/0000-0002-9940-5379	Federal Ministry for Education and Research (BMBF), Germany (KMU-innovativ) [0315802]; Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany (FSI) [2-43]	Federal Ministry for Education and Research (BMBF), Germany (KMU-innovativ)(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany (FSI)	We thank A. Carnitz, A. Mobes, K. Neumann, M. Queiser, N. Schneck, H. Schneider and E. Zirdum for excellent technical assistance and T. Ketterer, T. Mutzke, A. Schmid and their team for production of mRNA vaccines. We thank the following colleagues for graciously providing virus strains: M. Buttner (A/mallard/Bavaria/1/2006 (H5N1)), J. McCauley (A/Vietnam/1194/2004 (H5N1)), S. Becker (A/Regensburg/D6/2009 (H1N1v); received from M. Beer and T. Mettenleiter), O. Haller and G. Kochs (A/HongKong/1/1968 (H3N2)). We thank R. Zinkernagel and B. Schonfisch for critically reading the manuscript. This work was supported by grants from the Federal Ministry for Education and Research (BMBF), Germany (KMU-innovativ, grant no. 0315802 to T. K.) and by the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany (FSI, project no. 2-43 to L.S.).	Belshe RB, 2007, CLIN PHARMACOL THER, V82, P745, DOI 10.1038/sj.clpt.6100419; Boon ACM, 2010, J VIROL, V84, P7662, DOI 10.1128/JVI.02444-09; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Chaloupka I, 1996, EUR J CLIN MICROBIOL, V15, P121, DOI 10.1007/BF01591484; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Deng YP, 1997, J IMMUNOL, V158, P1507; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Forde GM, 2005, NAT BIOTECHNOL, V23, P1059, DOI 10.1038/nbt0905-1059; Fotin-Mleczek M, 2012, J GENE MED, V14, P428, DOI 10.1002/jgm.2605; Fotin-Mleczek M, 2011, J IMMUNOTHER, V34, P1, DOI 10.1097/CJI.0b013e3181f7dbe8; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Hai R, 2010, J VIROL, V84, P4442, DOI 10.1128/JVI.02717-09; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hoerr I, 2000, EUR J IMMUNOL, V30, P1; Hoffmann B, 2010, BERL MUNCH TIERARZTL, V123, P286, DOI 10.2376/0005-9366-123-286; Johansson DX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029732; Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349; Knipe DM., 2006, FIELDS VIROLOGY, V5th ed; Kubler H, 2011, J CLIN ONCOL, V29; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lange E, 2009, J GEN VIROL, V90, P2119, DOI 10.1099/vir.0.014480-0; Laurent PE, 2007, VACCINE, V25, P8833, DOI 10.1016/j.vaccine.2007.10.020; Lefevre EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032400; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Pascolo Steve, 2008, V183, P221; Pascolo Steve, 2006, V127, P23; Plotkin S.A, 2008, VACCINES EXPERT CONS; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Pyo HM, 2012, VACCINE, V30, P1297, DOI 10.1016/j.vaccine.2011.12.083; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Schlake T, 2012, RNA BIOL IN PRESS; Sebastian M, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.2584; Thalhamer J, 2012, GENE VACCINES, P1, DOI 10.1007/978-3-7091-0439-2; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; Van Reeth K, 2001, VACCINE, V19, P4479, DOI 10.1016/S0264-410X(01)00206-7; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612	47	272	337	4	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1210	+		10.1038/nbt.2436	http://dx.doi.org/10.1038/nbt.2436			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23159882				2022-12-27	WOS:000312092400024
J	Lam, ET; Hastie, A; Lin, C; Ehrlich, D; Das, SK; Austin, MD; Deshpande, P; Cao, H; Nagarajan, N; Xiao, M; Kwok, PY				Lam, Ernest T.; Hastie, Alex; Lin, Chin; Ehrlich, Dean; Das, Somes K.; Austin, Michael D.; Deshpande, Paru; Cao, Han; Nagarajan, Niranjan; Xiao, Ming; Kwok, Pui-Yan			Genome mapping on nanochannel arrays for structural variation analysis and sequence assembly	NATURE BIOTECHNOLOGY			English	Article							SINGLE-MOLECULE DETECTION; HIGH-RESOLUTION; DNA-MOLECULES	We describe genome mapping on nanochannel arrays. In this approach, specific sequence motifs in single DNA molecules are fluorescently labeled, and the DNA molecules are uniformly stretched in thousands of silicon channels on a nanofluidic device. Fluorescence imaging allows the construction of maps of the physical distances between occurrences of the sequence motifs. We demonstrate the analysis, individually and as mixtures, of 95 bacterial artificial chromosome (BAC) clones that cover the 4.7-Mb human major histocompatibility complex region. We obtain accurate, haplotype-resolved, sequence motif maps hundreds of kilobases in length, resulting in a median coverage of 114x for the BACs. The final sequence motif map assembly contains three contigs. With an average distance of 9 kb between labels, we detect 22 haplotype differences. We also use the sequence motif maps to provide scaffolds for de novo assembly of sequencing data. Nanochannel genome mapping should facilitate de novo assembly of sequencing reads from complex regions in diploid organisms, haplotype and structural variation analysis and comparative genomics.	[Hastie, Alex; Das, Somes K.; Austin, Michael D.; Deshpande, Paru; Cao, Han; Xiao, Ming] BioNano Genom, San Diego, CA USA; [Lam, Ernest T.; Lin, Chin; Ehrlich, Dean; Kwok, Pui-Yan] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Nagarajan, Niranjan] Genome Inst Singapore, Singapore, Singapore	University of California System; University of California San Francisco; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Xiao, M (corresponding author), Drexel Univ, Philadelphia, PA 19104 USA.	ming.xiao@drexel.edu; pui.kwok@ucsf.edu	Kwok, Pui-Yan/F-7725-2014; Xiao, Ming/E-7448-2012	Kwok, Pui-Yan/0000-0002-5087-3059; Nagarajan, Niranjan/0000-0003-0850-5604	US National Institutes of Health (NIH) award [R01 HG005946]; NIH Training Grant [T32 GM007175]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007175] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) award; NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank A. Pool and P. Ling-Fung Tang for their assistance in sequencing. O. Hampton and H. VanSteenhouse provided critical comments. This research is supported in part by US National Institutes of Health (NIH) award to P.-Y.K. and M.X. (R01 HG005946). E.T.L. was supported in part by NIH Training Grant T32 GM007175.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Cao H, 2002, APPL PHYS LETT, V81, P3058, DOI 10.1063/1.1515115; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chan EY, 2004, GENOME RES, V14, P1137, DOI 10.1101/gr.1635204; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Das S.K., 2012, NUCLEIC ACIDS RES, V38, pe177; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dervan PB, 1999, CURR OPIN CHEM BIOL, V3, P688, DOI 10.1016/S1367-5931(99)00027-7; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; FELSENFELD G, 1957, BIOCHIM BIOPHYS ACTA, V26, P457, DOI 10.1016/0006-3002(57)90091-4; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jing JP, 1998, P NATL ACAD SCI USA, V95, P8046, DOI 10.1073/pnas.95.14.8046; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Latreille P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-321; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Nielsen P E, 1999, Curr Issues Mol Biol, V1, P89; Proll J, 2011, DNA RES, V18, P201, DOI 10.1093/dnares/dsr008; Reisner W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196101; SAMAD A, 1995, GENOME RES, V5, P1, DOI 10.1101/gr.5.1.1; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Teague B, 2010, P NATL ACAD SCI USA, V107, P10848, DOI 10.1073/pnas.0914638107; Tegenfeldt JO, 2004, P NATL ACAD SCI USA, V101, P10979, DOI 10.1073/pnas.0403849101; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Wu CW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-25; Xiao M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1044; Zhou S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-278; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711	35	412	444	2	175	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					771	776		10.1038/nbt.2303	http://dx.doi.org/10.1038/nbt.2303			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22797562	Green Accepted			2022-12-27	WOS:000307416900020
J	Honeysett, JM; Metheny, R				Honeysett, J. Michael; Metheny, Richard			The importance of matching talented leadership with the growth stage of your life-sciences company	NATURE BIOTECHNOLOGY			English	Editorial Material									[Honeysett, J. Michael; Metheny, Richard] Witt Kieffer, Oak Brook, IL USA		Honeysett, JM (corresponding author), Witt Kieffer, Oak Brook, IL USA.	mhoneysett@wittkieffer.com; rmetheny@wittkieffer.com						Cope F., 1998, HUMAN RESOURCE PLANN, V21, P15; Pickett L, 1998, PUBLIC PERS MANAGE, V27, P103, DOI 10.1177/009102609802700110	2	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					563	565		10.1038/nbt.2267	http://dx.doi.org/10.1038/nbt.2267			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22678402				2022-12-27	WOS:000305158600033
J	Whitehead, TA; Chevalier, A; Song, YF; Dreyfus, C; Fleishman, SJ; De Mattos, C; Myers, CA; Kamisetty, H; Blair, P; Wilson, IA; Baker, D				Whitehead, Timothy A.; Chevalier, Aaron; Song, Yifan; Dreyfus, Cyrille; Fleishman, Sarel J.; De Mattos, Cecilia; Myers, Chris A.; Kamisetty, Hetunandan; Blair, Patrick; Wilson, Ian A.; Baker, David			Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing	NATURE BIOTECHNOLOGY			English	Article							PROTEIN; ANTIBODIES	We show that comprehensive sequence-function maps obtained by deep sequencing can be used to reprogram interaction specificity and to leapfrog over bottlenecks in affinity maturation by combining many individually small contributions not detectable in conventional approaches. We use this approach to optimize two computationally designed inhibitors against H1N1 influenza hemagglutinin and, in both cases, obtain variants with subnanomolar binding affinity. The most potent of these, a 51-residue protein, is broadly cross-reactive against all influenza group 1 hemagglutinins, including human H2, and neutralizes H1N1 viruses with a potency that rivals that of several human monoclonal antibodies, demonstrating that computational design followed by comprehensive energy landscape mapping can generate proteins with potential therapeutic utility.	[Whitehead, Timothy A.; Chevalier, Aaron; Song, Yifan; Fleishman, Sarel J.; Kamisetty, Hetunandan; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Dreyfus, Cyrille; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Dreyfus, Cyrille; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [De Mattos, Cecilia; Myers, Chris A.; Blair, Patrick] USN, Hlth Res Ctr, San Diego, CA 92152 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Scripps Research Institute; Scripps Research Institute; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Fleishman, Sarel/0000-0003-3177-7560	Defense Advanced Research Projects Agency (DARPA); Defense Threat Reduction Agency (DTRA); US National Institutes of Health, National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences [Y1-GM-1104]; National Cancer Institute [Y1-CO-1020]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); US National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank D. Fowler and S. Fields for helpful discussions and use of their in-house software to process sequencing data, C. Lee, J. Shendure and M. Dunham for experimental expertise in DNA prep and sequencing, C. Sitz and C. Santiago for technical help and the Joint Center for Structural Genomics for crystallization using the JCSG/IAVI/TSRI Rigaku Crystalmation system. This work was funded by Defense Advanced Research Projects Agency (DARPA) and the Defense Threat Reduction Agency (DTRA), and US National Institutes of Health, National Institute of Allergy and Infectious Diseases and National Institute of General Medical Sciences. The GM/CA CAT 23-ID-B beamline has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the Advanced Photon Source (APS) was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or the NIH.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Araya CL, 2011, TRENDS BIOTECHNOL, V29, P435, DOI 10.1016/j.tibtech.2011.04.003; Balakrishnan S, 2011, PROTEINS, V79, P1061, DOI 10.1002/prot.22934; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Hietpas RT, 2011, P NATL ACAD SCI USA, V108, P7896, DOI 10.1073/pnas.1016024108; Joughin BA, 2005, PROTEIN SCI, V14, P1363, DOI 10.1110/ps.041283105; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Marshall SA, 2005, PROTEIN SCI, V14, P1293, DOI 10.1110/ps.041259105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Nguyen JT, 2009, ANTIMICROB AGENTS CH, V53, P4115, DOI 10.1128/AAC.00476-09; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Shultzaberger RK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001042; Sitkoff D, 1996, J PHYS CHEM-US, V100, P2744, DOI 10.1021/jp952986i; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532	44	259	278	3	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					543	+		10.1038/nbt.2214	http://dx.doi.org/10.1038/nbt.2214			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22634563	Green Accepted			2022-12-27	WOS:000305158600024
J	Marimuthu, G; Kumari, S; Kandasamy, M; Raghunathan, S; Saberwal, G				Marimuthu, Ganesan; Kumari, Sangita; Kandasamy, Muthukrishnakumar; Raghunathan, Srivatsan; Saberwal, Gayatri			Maintaining patents protecting biologics or small-molecule drugs	NATURE BIOTECHNOLOGY			English	Editorial Material									[Marimuthu, Ganesan; Kumari, Sangita; Kandasamy, Muthukrishnakumar; Raghunathan, Srivatsan; Saberwal, Gayatri] Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India		Marimuthu, G (corresponding author), Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India.	gayatri@ibab.ac.in						Cukier KN, 2006, NAT BIOTECHNOL, V24, P249, DOI 10.1038/nbt0306-249; Johnson L.A., 2011, ASS PRESS       0725; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Lemley MA, 2001, NORTHWEST U LAW REV, V95, P1495; Ouellette Lisa Larrimore, 2010, MICH TELECOMM TECH L, V17, P300; Parida DK, 2008, NAT BIOTECHNOL, V26, P763, DOI 10.1038/nbt0708-763; Putnam J., 1996, 5741 NBER; Quinn G., 2011, IP WATCHDOG     0128; Walsh G, 2006, NAT BIOTECHNOL, V24, P769, DOI 10.1038/nbt0706-769	9	1	1	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					50	53		10.1038/nbt.2082	http://dx.doi.org/10.1038/nbt.2082			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22231094				2022-12-27	WOS:000299110600017
J	Patou, G				Patou, Gary			In vogue with venture	NATURE BIOTECHNOLOGY			English	Editorial Material									MPM Capital, San Francisco, CA 94080 USA		Patou, G (corresponding author), MPM Capital, San Francisco, CA 94080 USA.	gpatou@mpmcapital.com							0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					967	969						3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22175076				2022-12-27	WOS:000296801300010
J	Chan, J; Chang, CJ				Chan, Jefferson; Chang, Christopher J.			Making light of stress	NATURE BIOTECHNOLOGY			English	Editorial Material							CHEMISTRY; BIOLOGY		[Chan, Jefferson; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chan, Jefferson; Chang, Christopher J.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chan, J (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	chrischang@berkeley.educan			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Pu KY, 2014, NAT NANOTECHNOL, V9, P233, DOI [10.1038/nnano.2013.302, 10.1038/NNANO.2013.302]; Shuhendler AJ, 2014, NAT BIOTECHNOL, V32, P373, DOI 10.1038/nbt.2838; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85	5	1	1	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					337	338		10.1038/nbt.2873	http://dx.doi.org/10.1038/nbt.2873			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24714482				2022-12-27	WOS:000334340800016
J	Spits, H				Spits, Hergen			New models of human immunity	NATURE BIOTECHNOLOGY			English	Editorial Material							SYSTEM MICE; CHALLENGES; CELLS		Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Spits, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	hergen.spits@amc.uva.nlis	Spits, Hergen/N-2581-2019	Spits, Hergen/0000-0003-3269-8338				Becker PD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013137; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Lee EC, 2014, NAT BIOTECHNOL, V32, P356, DOI 10.1038/nbt.2825; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Moran N, 2013, NAT BIOTECHNOL, V31, P267, DOI 10.1038/nbt0413-267; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527	11	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					335	336		10.1038/nbt.2871	http://dx.doi.org/10.1038/nbt.2871			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24714481				2022-12-27	WOS:000334340800015
J	Kuleshov, V; Xie, D; Chen, R; Pushkarev, D; Ma, ZH; Blauwkamp, T; Kertesz, M; Snyder, M				Kuleshov, Volodymyr; Xie, Dan; Chen, Rui; Pushkarev, Dmitry; Ma, Zhihai; Blauwkamp, Tim; Kertesz, Michael; Snyder, Michael			Whole-genome haplotyping using long reads and statistical methods	NATURE BIOTECHNOLOGY			English	Article							IMPRINTED GENES; SEQUENCE; AMPLIFICATION; POLYMORPHISM	The rapid growth of sequencing technologies has greatly contributed to our understanding of human genetics. Yet, despite this growth, mainstream technologies have not been fully able to resolve the diploid nature of the human genome. Here we describe statistically aided, long-read haplotyping (SLRH), a rapid, accurate method that uses a statistical algorithm to take advantage of the partially phased information contained in long genomic fragments analyzed by short-read sequencing. For a human sample, as little as 30 Gbp of additional sequencing data are needed to phase genotypes identified by 50x coverage whole-genome sequencing. Using SLRH, we phase 99% of single-nucleotide variants in three human genomes into long haplotype blocks 0.2-1 Mbp in length. We apply our method to determine allele-specific methylation patterns in a human genome and identify hundreds of differentially methylated regions that were previously unknown. SLRH should facilitate population-scale haplotyping of human genomes.	[Kuleshov, Volodymyr] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Kuleshov, Volodymyr; Pushkarev, Dmitry; Blauwkamp, Tim; Kertesz, Michael] Illumina Inc, San Diego, CA USA; [Kuleshov, Volodymyr; Xie, Dan; Chen, Rui; Ma, Zhihai; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Illumina; Stanford University	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	Ma, Zhihai/E-7130-2015	Snyder, Michael/0000-0003-0784-7987	US National Institutes of Health [HL107393-02, HG004558-05]; Genetics Department of Stanford University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK102556] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetics Department of Stanford University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Pan for assistance in coordinating contacts and discussions. This work is funded by US National Institutes of Health grants HL107393-02, HG004558-05, and the Genetics Department of Stanford University.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Daelemans C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-25; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Fong CY, 2010, DEV MED CHILD NEUROL, V52, P489, DOI 10.1111/j.1469-8749.2010.03618.x; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; Kaper F, 2013, P NATL ACAD SCI USA, V110, P5552, DOI 10.1073/pnas.1218696110; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li N, 2003, GENETICS, V165, P2213; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Roach JC, 2011, AM J HUM GENET, V89, P382, DOI 10.1016/j.ajhg.2011.07.023; RUANO G, 1990, P NATL ACAD SCI USA, V87, P6296, DOI 10.1073/pnas.87.16.6296; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Shimizu H, 1999, J AM ACAD DERMATOL, V41, P950, DOI 10.1016/S0190-9622(99)70252-5; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Voskoboynik A, 2013, ELIFE, V2, DOI 10.7554/eLife.00569; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Welch KO, 2007, AM J MED GENET A, V143A, P1567, DOI 10.1002/ajmg.a.31701; Yang H, 2011, P NATL ACAD SCI USA, V108, P12, DOI 10.1073/pnas.1016725108	31	125	132	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					261	266		10.1038/nbt.2833	http://dx.doi.org/10.1038/nbt.2833			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24561555	Green Accepted			2022-12-27	WOS:000332819800024
J	Kurzrock, R; Kantarjian, H; Stewart, DJ				Kurzrock, Razelle; Kantarjian, Hagop; Stewart, David J.			A cancer trial scandal and its regulatory backlash	NATURE BIOTECHNOLOGY			English	Article							CELL LUNG-CANCER; CLINICAL-TRIALS; PHASE-III; GEMCITABINE; CHEMOTHERAPY; METAANALYSIS; CISPLATIN	Regulatory fallout from a scandal surrounding the fabrication of data used to support a molecular test in a Duke University cancer trial is exacting an unjustifiable toll not only on health economics but also on patient lives.	[Kurzrock, Razelle] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Kantarjian, Hagop] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Stewart, David J.] Univ Ottawa, Div Med Oncol, Ottawa, ON, Canada	University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center; University of Ottawa	Kurzrock, R (corresponding author), Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA.	rkurzrock@ucsd.edu	Kurzrock, Razelle/AAU-9782-2020		NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBERTI W, 1995, BRIT MED J, V311, P899; [Anonymous], NONSM CELL LUNG CANC; Beckloff Associates Inc, REG PAR LAB DEV TEST; Behazin N. S., MEDSCAPE; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; D'Addario G, 2005, J CLIN ONCOL, V23, P2926, DOI 10.1200/JCO.2005.03.045; F. Hoffman-La Roche Ltd, 2010, ROCH PROV UPD FDA AP; Hart P.K., 2012, HOUSTON CHRONICLE; Institute of Medicine, 2012, EV TRANSL OM LESS LE; Janku F, 2012, CLIN CANCER RES, V18, P6356, DOI 10.1158/1078-0432.CCR-12-0178; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Laack E, 2004, J CLIN ONCOL, V22, P2348, DOI 10.1200/JCO.2004.10.576; Monnerat C, 2006, ANN ONCOL, V17, pV86, DOI 10.1093/annonc/mdj958; Most clinical trials done abroad, 2009, WALL STREET J; Pujol JL, 2006, LUNG CANCER-J IASLC, V51, P335, DOI 10.1016/j.lungcan.2005.11.001; Rajeswaran A, 2008, LUNG CANCER, V59, P1, DOI 10.1016/j.lungcan.2007.07.012; Schulman K. A., 2010, J INVEST MED, V58, P31; Spigel DR, 2010, J THORAC ONCOL, V5, P841, DOI 10.1097/JTO.0b013e3181d737e3; Stewart DJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-193; Stewart DJ, 2010, J CLIN ONCOL, V28, P2925, DOI 10.1200/JCO.2009.27.5404; Stewart DJ, 2009, J CLIN ONCOL, V27, P328, DOI 10.1200/JCO.2008.18.9621; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; U.S. Food and Drug Administration, FDA APPR NEW TREATM; US Food and Drug Administration, DEV ADV INV DEV EX I; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Westin JR, 2012, MOL CANCER THER, V11, P2549, DOI 10.1158/1535-7163.MCT-12-0473	27	12	12	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					27	31		10.1038/nbt.2792	http://dx.doi.org/10.1038/nbt.2792			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24406925				2022-12-27	WOS:000329513000011
J	Hsu, PD; Scott, DA; Weinstein, JA; Ran, FA; Konermann, S; Agarwala, V; Li, YQ; Fine, EJ; Wu, XB; Shalem, O; Cradick, TJ; Marraffini, LA; Bao, G; Zhang, F				Hsu, Patrick D.; Scott, David A.; Weinstein, Joshua A.; Ran, F. Ann; Konermann, Silvana; Agarwala, Vineeta; Li, Yinqing; Fine, Eli J.; Wu, Xuebing; Shalem, Ophir; Cradick, Thomas J.; Marraffini, Luciano A.; Bao, Gang; Zhang, Feng			DNA targeting specificity of RNA-guided Cas9 nucleases	NATURE BIOTECHNOLOGY			English	Article							DOUBLE-STRAND BREAKS; HUMAN-CELLS; GENOME; GENE; CRISPR; ENDONUCLEASE; GENERATION; SYSTEMS; MICE	The Streptococcus pyogenes Cas9 (SpCas9) nuclease can be efficiently targeted to genomic loci by means of single-guide RNAs (sgRNAs) to enable genome editing(1-10). Here, we characterize SpCas9 targeting specificity in human cells to inform the selection of target sites and avoid off-target effects. Our study evaluates >700 guide RNA variants and SpCas9-induced indel mutation levels at >100 predicted genomic off-target loci in 293T and 293FT cells. We find that SpCas9 tolerates mismatches between guide RNA and target DNA at different positions in a sequence-dependent manner, sensitive to the number, position and distribution of mismatches. We also show that SpCas9-mediated cleavage is unaffected by DNA methylation and that the dosage of SpCas9 and sgRNA can be titrated to minimize off-target modification. To facilitate mammalian genome engineering applications, we provide a web-based software tool to guide the selection and validation of target sequences as well as off-target analyses.	[Hsu, Patrick D.; Scott, David A.; Weinstein, Joshua A.; Ran, F. Ann; Konermann, Silvana; Agarwala, Vineeta; Li, Yinqing; Shalem, Ophir; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA USA; [Hsu, Patrick D.; Scott, David A.; Weinstein, Joshua A.; Ran, F. Ann; Konermann, Silvana; Li, Yinqing; Shalem, Ophir; Zhang, Feng] MIT, Dept Biol Engn, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Hsu, Patrick D.; Ran, F. Ann] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Agarwala, Vineeta] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Agarwala, Vineeta] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Fine, Eli J.; Cradick, Thomas J.; Bao, Gang] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Fine, Eli J.; Cradick, Thomas J.; Bao, Gang] Emory Univ, Atlanta, GA 30322 USA; [Wu, Xuebing] MIT, Koch Inst Integrat Canc Res, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA; [Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10021 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); University System of Georgia; Georgia Institute of Technology; Emory University; Massachusetts Institute of Technology (MIT); Rockefeller University	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.	zhang@broadinstitute.org	Macrae, Rhiannon/AAX-1536-2020; Cradick, Thomas/ABC-3775-2021; Wilson, Matthew H/K-3193-2013; Hsu, Patrick/ABD-5749-2021; Wu, Xuebing/C-9152-2013	Cradick, Thomas/0000-0002-8489-8318; Wu, Xuebing/0000-0003-0369-5269; Hsu, Patrick/0000-0002-9380-2648; Fine, Eli/0000-0002-5745-4498; Shalem, Ophir/0000-0002-2267-0801; Weinstein, Joshua/0000-0002-0103-9738; Li, Yinqing/0000-0002-9096-8482	National Institutes of Health (NIH) [R01-GM34277, R01-CA133404, R01-DK097768]; NIH Nanomedicine Development Center [PN2EY018244]; NIH Director's Pioneer Award [DP1-MH100706]; NATIONAL CANCER INSTITUTE [R01CA133404] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Nanomedicine Development Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Shalek, E. Stamenova and D. Gray for expert help with DNA sequencing, R. Barretto for genome-wide PAM analysis, as well as D. Altshuler, P. A. Sharp, and the entire Zhang Lab for their support and advice. P. D. H. is a James Mills Pierce Fellow. D. A. S. is an National Science Foundation pre-doctoral fellow and J.A.W. is supported by a Life Science Research Foundation Fellowship. X. W. is a Howard Hughes Medical Institute International Student Research Fellow and is supported by National Institutes of Health (NIH) grants R01-GM34277 and R01-CA133404 to P. A. Sharp, X.W.'s thesis advisor. G. B. is supported by an NIH Nanomedicine Development Center Award (PN2EY018244). This work is supported by an NIH Director's Pioneer Award (DP1-MH100706), an NIH Transformative R01 grant (R01-DK097768) to D. Altshuler, the Keck, McKnight, Damon Runyon, Searle Scholars, Klingenstein and Simons Foundations, and Bob Metcalfe and Jane Pauley. The authors wish to dedicate this paper to the memory of Officer Sean Collier, for his caring service to the MIT community and for his sacrifice. Reagents are available to the academic community through Addgene, and associated protocols, support forums and computational tools are available through the Zhang lab website (http://www.genome-engineering.org/).	Bobis-Wozowicz S, 2011, METHODS, V53, P339, DOI 10.1016/j.ymeth.2010.12.019; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hsu PD, 2012, ACS CHEM NEUROSCI, V3, P603, DOI 10.1021/cn300089k; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Michaelis L, 1913, BIOCHEM Z, V49, P333; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773	29	2807	3337	40	1141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					827	+		10.1038/nbt.2647	http://dx.doi.org/10.1038/nbt.2647			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	23873081	Green Accepted, Green Published			2022-12-27	WOS:000324306300023
J	Pattanayak, V; Lin, S; Guilinger, JP; Ma, EB; Doudna, JA; Liu, DR				Pattanayak, Vikram; Lin, Steven; Guilinger, John P.; Ma, Enbo; Doudna, Jennifer A.; Liu, David R.			High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; GENE DISRUPTION; CRISPR; SYSTEMS; CELLS; ENDONUCLEASE; SEQUENCE; IMMUNITY; TALENS	The RNA-programmable Cas9 endonuclease cleaves double-stranded DNA at sites complementary to a 20-base-pair guide RNA. The Cas9 system has been used to modify genomes in multiple cells and organisms, demonstrating its potential as a facile genome-engineering tool. We used in vitro selection and high-throughput sequencing to determine the propensity of eight guide-RNA:Cas9 complexes to cleave each of 10(12) potential off-target DNA sequences. The selection results predicted five off-target sites in the human genome that were confirmed to undergo genome cleavage in HEK293T cells upon expression of one of two guide-RNA:Cas9 complexes. In contrast to previous models, our results show that guide-RNA:Cas9 specificity extends past a 7- to 12-base-pair seed sequence. Our results also suggest a tradeoff between activity and specificity both in vitro and in cells as a shorter, less-active guide RNA is more specific than a longer, more-active guide RNA. High concentrations of guide-RNA:Cas9 complexes can cleave off-target sites containing mutations near or within the PAM that are not cleaved when enzyme concentrations are limiting.	[Pattanayak, Vikram; Guilinger, John P.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Pattanayak, Vikram; Guilinger, John P.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Lin, Steven; Ma, Enbo; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Lin, Steven; Ma, Enbo; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu; drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022; Lin, Steven/G-6142-2019; Lin, Steven/ABD-7821-2021	Lin, Steven/0000-0002-7542-4663; Lin, Steven/0000-0002-7542-4663	DARPA [HR0011-11-2-0003, N66001-12-C-4207]; Howard Hughes Medical Institute; National Institute of General Medical Sciences [T32GM007753]; Howard Hughes Medical Institute (HHMI); US National Institutes of Health [R01GM073794-05]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM073794] Funding Source: NIH RePORTER	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	V.P., J.P.G. and D.R.L. were supported by DARPA HR0011-11-2-0003, DARPA N66001-12-C-4207, and the Howard Hughes Medical Institute. V.P. was supported by award no. T32GM007753 from the National Institute of General Medical Sciences. S.L. and J.A.D. were supported by the Howard Hughes Medical Institute (HHMI); E. M. was supported by US National Institutes of Health grant R01GM073794-05 to J.A.D.; J.A.D. and D.R.L. are HHMI Investigators.	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja057519l; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	21	984	1177	11	352	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					839	+		10.1038/nbt.2673	http://dx.doi.org/10.1038/nbt.2673			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	23934178	Green Submitted, Green Accepted			2022-12-27	WOS:000324306300025
J	Wang, HY; Hu, YC; Markoulaki, S; Welstead, GG; Cheng, AW; Shivalila, CS; Pyntikova, T; Dadon, DB; Voytas, DF; Bogdanove, AJ; Page, DC; Jaenisch, R				Wang, Haoyi; Hu, Yueh-Chiang; Markoulaki, Styliani; Welstead, G. Grant; Cheng, Albert W.; Shivalila, Chikdu S.; Pyntikova, Tatyana; Dadon, Daniel B.; Voytas, Daniel F.; Bogdanove, Adam J.; Page, David C.; Jaenisch, Rudolf			TALEN-mediated editing of the mouse Y chromosome	NATURE BIOTECHNOLOGY			English	Article							GENE; MICE; SRY	The functional study of Y chromosome genes has been hindered by a lack of mouse models with specific Y chromosome mutations. We used transcription activator-like effector nuclease (TALEN)-mediated gene editing in mouse embryonic stem cells (mESCs) to produce mice with targeted gene disruptions and insertions in two Y-linked genes-Sry and Uty. TALEN-mediated gene editing is a useful tool for dissecting the biology of the Y chromosome.	[Wang, Haoyi; Hu, Yueh-Chiang; Markoulaki, Styliani; Welstead, G. Grant; Cheng, Albert W.; Shivalila, Chikdu S.; Pyntikova, Tatyana; Dadon, Daniel B.; Page, David C.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hu, Yueh-Chiang; Page, David C.] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Cheng, Albert W.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Shivalila, Chikdu S.; Dadon, Daniel B.; Page, David C.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA USA; [Voytas, Daniel F.] Univ Minnesota, Dept Genet Cell Biol & Dev, St Paul, MN 55108 USA; [Bogdanove, Adam J.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Minnesota System; University of Minnesota Twin Cities; Cornell University	Page, DC (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dcpage@wi.mit.edu; jaenisch@wi.mit.edu	Bogdanove, Adam/ABE-6252-2020; Hu, Yueh-Chiang/AAX-2370-2020	Voytas, Daniel/0000-0002-4944-1224; Cheng, Albert/0000-0003-2653-5743; Hu, Yueh-Chiang/0000-0002-7992-0525	Croucher scholarship; Howard Hughes Medical Institute; US National Institutes of Health [R37-HD045022, R01-CA084198, R01-HG000257]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098861] Funding Source: NIH RePORTER	Croucher scholarship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Ganz and R. Flannery for support with animal care and experiments. We thank Jaenisch and Page laboratory members for helpful discussions on the manuscript. A.W.C. is supported by a Croucher scholarship. D.C.P. and Y.-C.H. were supported by Howard Hughes Medical Institute. R.J., H.W., S.M., G.G.W., C.S.S. and A.W.C. were supported by US National Institutes of Health grants R37-HD045022 and R01-CA084198. T.P. was supported by US National Institutes of Health grant R01- HG000257.	Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; Mayer A, 2000, NEUROGENETICS, V3, P25, DOI 10.1007/s100480000093; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Pirottin D, 2005, P NATL ACAD SCI USA, V102, P6413, DOI 10.1073/pnas.0502426102; Rohozinski J, 2002, GENESIS, V32, P1, DOI 10.1002/gene.10020; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Washburn LL, 2001, GENETICS, V158, P1675; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109	15	81	106	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					530	532		10.1038/nbt.2595	http://dx.doi.org/10.1038/nbt.2595			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23666012	Green Accepted, Green Submitted			2022-12-27	WOS:000320113200024
J	Choi, HS; Gibbs, SL; Lee, JH; Kim, SH; Ashitate, Y; Liu, FB; Hyun, H; Park, G; Xie, Y; Bae, S; Henary, M; Frangioni, JV				Choi, Hak Soo; Gibbs, Summer L.; Lee, Jeong Heon; Kim, Soon Hee; Ashitate, Yoshitomo; Liu, Fangbing; Hyun, Hoon; Park, GwangLi; Xie, Yang; Bae, Soochan; Henary, Maged; Frangioni, John V.			Targeted zwitterionic near-infrared fluorophores for improved optical imaging	NATURE BIOTECHNOLOGY			English	Article							IN-VIVO; CLINICAL TRANSLATION; RENAL CLEARANCE; DERIVATIVES; NANOPARTICLES; FUNDAMENTALS; ANTIBODIES; PROBES; LIGHT; BODY	The signal-to-background ratio (SBR) is the key determinant of sensitivity, detectability and linearity in optical imaging. As signal strength is often constrained by fundamental limits, background reduction becomes an important approach for improving the SBR. We recently reported that a zwitterionic near-infrared (NIR) fluorophore, ZW800-1, exhibits low background. Here we show that this fluorophore provides a much-improved SBR when targeted to cancer cells or proteins by conjugation with a cyclic RGD peptide, fibrinogen or antibodies. ZW800-1 outperforms the commercially available NIR fluorophores IRDye800-CW and Cy5.5 in vitro for immunocytometry, histopathology and immunoblotting and in vivo for image-guided surgery. In tumor model systems, a tumor-to-background ratio of 17.2 is achieved at 4 h after injection of ZW800-1 conjugated to cRGD compared to ratios of 5.1 with IRDye800-CW and 2.7 with Cy5.5. Our results suggest that introducing zwitterionic properties into targeted fluorophores may be a general strategy for improving the SBR in diagnostic and therapeutic applications.	[Choi, Hak Soo; Gibbs, Summer L.; Lee, Jeong Heon; Kim, Soon Hee; Ashitate, Yoshitomo; Liu, Fangbing; Hyun, Hoon; Park, GwangLi; Xie, Yang; Frangioni, John V.] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA; [Kim, Soon Hee] Chonbuk Natl Univ, Dept BIN Fus Technol, WCU Program, Jeonju, South Korea; [Bae, Soochan] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02215 USA; [Henary, Maged] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Frangioni, John V.] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Jeonbuk National University; Harvard University; Beth Israel Deaconess Medical Center; University System of Georgia; Georgia State University; Harvard University; Beth Israel Deaconess Medical Center	Frangioni, JV (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA.	jfrangio@bidmc.harvard.edu	Kim, Soon Hee/GXF-6736-2022; Choi, Hak Soo/C-9954-2011		US National Institutes of Health: National Cancer Institute Bioengineering Research Partnership [R01-CA-115296]; National Institute of Biomedical Imaging and Bioengineering grant [R01-EB-010022, R01-EB-011523]; Dana Foundation Program in Brain and Immuno-Imaging; WCU Program from the Korea Ministry of Education, Science and Technology (KMEST) [R31-20029]; NATIONAL CANCER INSTITUTE [R01CA115296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010022, R01EB011523] Funding Source: NIH RePORTER	US National Institutes of Health: National Cancer Institute Bioengineering Research Partnership; National Institute of Biomedical Imaging and Bioengineering grant; Dana Foundation Program in Brain and Immuno-Imaging; WCU Program from the Korea Ministry of Education, Science and Technology (KMEST); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank S. Gioux; R. Oketokoun and A. Stockdale for assistance with development of the FLARE (Fluorescence-Assisted Resection and Exploration) imaging system and software. We also thank D. Burrington Jr. for manuscript editing and E. Trabucchi for administrative assistance. This study was supported by the following grants from the US National Institutes of Health: National Cancer Institute Bioengineering Research Partnership grant #R01-CA-115296 (J.V.E) and National Institute of Biomedical Imaging and Bioengineering grants #R01-EB-010022 and #R01-EB-011523 (both to H.S.C. and J.V.F.); this study was also supported by the Dana Foundation Program in Brain and Immuno-Imaging (H.S.C.). S.H.K. was,supported by a WCU Program (R31-20029) from the Korea Ministry of Education, Science and Technology (KMEST).	Achilefu S, 2003, J MED CHEM, V46, P3403, DOI 10.1021/jm030081k; ADAMS JC, 1991, J CELL BIOL, V115, P829, DOI 10.1083/jcb.115.3.829; BALLOU B, 1995, CANCER IMMUNOL IMMUN, V41, P257, DOI 10.1007/s002620050226; Ballou B, 1998, CANCER DETECT PREV, V22, P251, DOI 10.1046/j.1525-1500.1998.0OA25.x; Bourre L, 2009, BRIT J CANCER, V100, P723, DOI 10.1038/sj.bjc.6604928; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Choi HS, 2011, ANGEW CHEM INT EDIT, V50, P6258, DOI 10.1002/anie.201102459; Choi HS, 2010, NAT BIOTECHNOL, V28, P1300, DOI 10.1038/nbt.1696; Choi HS, 2010, MOL IMAGING, V9, P291, DOI 10.2310/7290.2010.00031; Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]; Colton IJ, 1998, ELECTROPHORESIS, V19, P367, DOI 10.1002/elps.1150190303; Frangioni JV, 2008, J CLIN ONCOL, V26, P4012, DOI 10.1200/JCO.2007.14.3065; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Gitlin I, 2006, CHEMBIOCHEM, V7, P1241, DOI 10.1002/cbic.200600191; Humblet V, 2006, CONTRAST MEDIA MOL I, V1, P196, DOI 10.1002/cmmi.106; Hyun H, 2012, CONTRAST MEDIA MOL I, V7, P516, DOI 10.1002/cmmi.1484; KELLEY KW, 1973, J ANIM SCI, V36, P927; Kobayashi H, 2010, CHEM REV, V110, P2620, DOI 10.1021/cr900263j; Kobayashi T, 2007, J AM CHEM SOC, V129, P6696, DOI 10.1021/ja070376d; Lee S, 2008, CHEM COMMUN, P4250, DOI 10.1039/b806854m; Lee S, 2008, ANGEW CHEM INT EDIT, V47, P2804, DOI 10.1002/anie.200705240; Ohnishi S, 2006, SURGERY, V140, P785, DOI 10.1016/j.surg.2006.03.027; RASMUSSEN F, 1983, VET RES COMMUN, V7, P301, DOI 10.1007/BF02228637; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Tanaka E, 2008, SURGERY, V144, P39, DOI 10.1016/j.surg.2008.03.017; te Velde EA, 2010, EJSO-EUR J SURG ONC, V36, P6, DOI 10.1016/j.ejso.2009.10.014; Tung CH, 1999, BIOCONJUGATE CHEM, V10, P892, DOI 10.1021/bc990052h; Urano Y, 2009, NAT MED, V15, P104, DOI 10.1038/nm.1854; Ye YP, 2011, THERANOSTICS, V1, P102, DOI 10.7150/thno/v01p0102; ZWAAL RFA, 1977, NATURE, V268, P358, DOI 10.1038/268358a0	31	380	387	19	338	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					148	153		10.1038/nbt.2468	http://dx.doi.org/10.1038/nbt.2468			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23292608	Green Accepted			2022-12-27	WOS:000315322100026
J	Kloss, CC; Condomines, M; Cartellieri, M; Bachmann, M; Sadelain, M				Kloss, Christopher C.; Condomines, Maud; Cartellieri, Marc; Bachmann, Michael; Sadelain, Michel			Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells	NATURE BIOTECHNOLOGY			English	Article							ADOPTIVE IMMUNOTHERAPY; PROSTATE-CANCER; CD28; PROLIFERATION; EXPRESSION; CD80	Current T-cell engineering approaches redirect patient T cells to tumors by transducing them with antigen-specific T-cell receptors (TCRs) or chimeric antigen receptors (CARs) that target a single antigen(1-3). However, few truly tumor-specific antigens have been identified, and healthy tissues that express the targeted antigen may undergo T cell-mediated damage(4-7). Here we present a strategy to render T cells specific for a tumor in the absence of a truly tumor-restricted antigen. T cells are transduced with both a CAR that provides suboptimal activation upon binding of one antigen and a chimeric costimulatory receptor (CCR) that recognizes a second antigen. Using the prostate tumor antigens PSMA and PSCA, we show that co-transduced T cells destroy tumors that express both antigens but do not affect tumors expressing either antigen alone. This 'tumor-sensing' strategy may help broaden the applicability and avoid some of the side effects of targeted T-cell therapies.	[Kloss, Christopher C.; Condomines, Maud; Sadelain, Michel] MSKCC, Ctr Cell Engn, New York, NY USA; [Kloss, Christopher C.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Biochem Cell & Mol Biol Program, New York, NY 10021 USA; [Cartellieri, Marc; Bachmann, Michael] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany; [Bachmann, Michael] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany; [Sadelain, Michel] MSKCC, Mol Pharmacol & Chem Program, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Memorial Sloan Kettering Cancer Center	Sadelain, M (corresponding author), MSKCC, Ctr Cell Engn, New York, NY USA.	m-sadelain@ski.mskcc.org	Cartellieri, Marc/M-3281-2013; Bachmann, Michael P/E-8850-2010; Cartellieri, Marc/AAL-8197-2020; Bachmann, Michael/AAA-5153-2020	Cartellieri, Marc/0000-0002-4672-3963; Bachmann, Michael P/0000-0002-8029-5755; Bachmann, Michael/0000-0002-8029-5755	Department of Defense Prostate Cancer Training Award [PC101964]; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Major Family Fund for Cancer Research at Memorial Sloan-Kettering; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Department of Defense Prostate Cancer Training Award(United States Department of Defense); Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Major Family Fund for Cancer Research at Memorial Sloan-Kettering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank I. Riviere for reviewing the manuscript and J. Plotkin and G. Gunset for outstanding technical assistance. Our work is supported by Department of Defense Prostate Cancer Training Award PC101964 (C. C. K.), the Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center, the Major Family Fund for Cancer Research at Memorial Sloan-Kettering, the support of Mr. and Mrs. Joel S. Mallah, and Mr. Lewis Sanders.	Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Duong CPM, 2011, IMMUNOTHERAPY-UK, V3, P33, DOI 10.2217/IMT.10.81; Feldmann A, 2012, J IMMUNOL, V189, P3249, DOI 10.4049/jimmunol.1200341; Feldmann A, 2011, PROSTATE, V71, P998, DOI 10.1002/pros.21315; Gade TPF, 2005, CANCER RES, V65, P9080, DOI 10.1158/0008-5472.CAN-05-0436; Ho WY, 2003, CANCER CELL, V3, P431, DOI 10.1016/S1535-6108(03)00113-2; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Krause A, 1998, J EXP MED, V188, P619, DOI 10.1084/jem.188.4.619; Lam JS, 2005, CLIN CANCER RES, V11, P2591, DOI 10.1158/1078-0432.CCR-04-1842; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Liu JC, 2012, P NATL ACAD SCI USA, V109, P5832, DOI 10.1073/pnas.1201105109; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Meyer MJ, 2010, CANCER RES, V70, P4624, DOI 10.1158/0008-5472.CAN-09-3619; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; Saeki N, 2010, CLIN CANCER RES, V16, P3533, DOI 10.1158/1078-0432.CCR-09-3169; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Shih IM, 2009, FUTURE ONCOL, V5, P1641, DOI [10.2217/fon.09.126, 10.2217/FON.09.126]; Shin SM, 2007, J LEUKOCYTE BIOL, V81, P1455, DOI 10.1189/jlb.1006619; Silver DA, 1997, CLIN CANCER RES, V3, P81; Stephan MT, 2007, NAT MED, V13, P1440, DOI 10.1038/nm1676; Strauss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016186; Tammana S, 2010, HUM GENE THER, V21, P75, DOI 10.1089/hum.2009.122; Wang J, 2007, HUM GENE THER, V18, P712, DOI 10.1089/hum.2007.028; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wilkie S, 2012, J CLIN IMMUNOL, V32, P1059, DOI 10.1007/s10875-012-9689-9; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210	34	578	666	4	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					71	+		10.1038/nbt.2459	http://dx.doi.org/10.1038/nbt.2459			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23242161	Green Accepted			2022-12-27	WOS:000313563600024
J	Trapnell, C; Hendrickson, DG; Sauvageau, M; Goff, L; Rinn, JL; Pachter, L				Trapnell, Cole; Hendrickson, David G.; Sauvageau, Martin; Goff, Loyal; Rinn, John L.; Pachter, Lior			Differential analysis of gene regulation at transcript resolution with RNA-seq	NATURE BIOTECHNOLOGY			English	Article							EXPRESSION ANALYSIS; REVEALS; IDENTIFICATION; PLURIPOTENT; PACKAGE	Differential analysis of gene and transcript expression using high-throughput RNA sequencing (RNA-seq) is complicated by several sources of measurement variability and poses numerous statistical challenges. We present Cuffdiff 2, an algorithm that estimates expression at transcript-level resolution and controls for variability evident across replicate libraries. Cuffdiff 2 robustly identifies differentially expressed transcripts and genes and reveals differential splicing and promoter-preference changes. We demonstrate the accuracy of our approach through differential analysis of lung fibroblasts in response to loss of the developmental transcription factor HOXA1, which we show is required for lung fibroblast and HeLa cell cycle progression. Loss of HOXA1 results in significant expression level changes in thousands of individual transcripts, along with isoform switching events in key regulators of the cell cycle. Cuffdiff 2 performs robust differential analysis in RNA-seq experiments at transcript resolution, revealing a layer of regulation not readily observable with other high-throughput technologies.	[Trapnell, Cole; Hendrickson, David G.; Sauvageau, Martin; Goff, Loyal; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Trapnell, Cole; Hendrickson, David G.; Sauvageau, Martin; Goff, Loyal; Rinn, John L.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Goff, Loyal] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pachter, L (corresponding author), Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA.	john_rinn@harvard.edu; lpachter@math.berkeley.edu	Sauvageau, Martin/A-8967-2013	Pachter, Lior/0000-0002-9164-6231; Sauvageau, Martin/0000-0001-9487-5016; Rinn, John/0000-0002-7231-7539; Goff, Loyal/0000-0003-2875-451X	US National Institutes of Health [DP2OD006670, P01GM099117, P50HG006193, RO1ES020260, R01 HG006129, R01 DK094699]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006129, P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006670] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to D. Kelley for a careful reading of the manuscript, and B. Wold for sharing the hESC RNA-seq data. We are also thankful for the ongoing development efforts of A. Roberts, B. Langmead, D. Kim, G. Pertea, H. Pimentel and S. Salzberg. C. T. and D. G. H. are Damon Runyon Postdoctoral Fellows. J.L.R. is a Damon Runyon-Rachleff Inovator fellow. This work was supported by US National Institutes of Health grants DP2OD006670, P01GM099117, P50HG006193 and RO1ES020260 (to J.L.R.) and R01 HG006129 and R01 DK094699 (to L.P.).	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bradley RK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001229; Cabili MN, 2011, GENES DEV; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Dhar SK, 2000, J BIOL CHEM, V275, P34983, DOI 10.1074/jbc.M006069200; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Glaus P, 2012, BIOINFORMATICS, V28, P1721, DOI 10.1093/bioinformatics/bts260; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Guillamot M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00189; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hiller D, 2009, BIOINFORMATICS, V25, P3056, DOI 10.1093/bioinformatics/btp544; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Langmead B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r83; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu SX, 2011, P NATL ACAD SCI USA, V108, P7373, DOI 10.1073/pnas.1013676108; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicolae M, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-9; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang X, 2010, J BIOINF COMPUT BIOL, V8, P177, DOI 10.1142/S0219720010005178; Washkowitz AJ, 2012, WIRES SYST BIOL MED, V4, P273, DOI 10.1002/wsbm.1162; Wilson V, 2002, GENOME BIOL, V3, P30081, DOI [10.1186/gb-2002-3-6-reviews3008, DOI 10.1186/GB-2002-3-6-REVIEWS3008]; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	50	2336	2388	5	491	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					46	+		10.1038/nbt.2450	http://dx.doi.org/10.1038/nbt.2450			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23222703	Green Accepted			2022-12-27	WOS:000313563600021
J	Marks, DS; Hopf, TA; Sander, C				Marks, Debora S.; Hopf, Thomas A.; Sander, Chris			Protein structure prediction from sequence variation	NATURE BIOTECHNOLOGY			English	Review							RESIDUE CONTACTS; SOFTWARE SUITE; CRYSTALLOGRAPHY; COEVOLUTION; INFORMATION; COVARIANCE; PRINCIPLES; FAMILIES; GENOMICS; DESIGN	Genomic sequences contain rich evolutionary information about functional constraints on macromolecules such as proteins. This information can be efficiently mined to detect evolutionary couplings between residues in proteins and address the long-standing challenge to compute protein three-dimensional structures from amino acid sequences. Substantial progress has recently been made on this problem owing to the explosive growth in available sequences and the application of global statistical methods. In addition to three-dimensional structure, the improved understanding of covariation may help identify functional residues involved in ligand binding, protein-complex formation and conformational changes. We expect computation of covariation patterns to complement experimental structural biology in elucidating the full spectrum of protein structures, their functional interactions and evolutionary dynamics.	[Marks, Debora S.; Hopf, Thomas A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA	Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Marks, DS (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	ecreview@hms.harvard.edu; ecreview@hms.harvard.edu			NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; ANFINSEN CB, 1962, COMP BIOCHEM PHYSIOL, V4, P229, DOI 10.1016/0010-406X(62)90007-5; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Ernst A, 2010, MOL BIOSYST, V6, P1782, DOI 10.1039/c0mb00061b; Ezkurdia I, 2009, PROTEINS, V77, P196, DOI 10.1002/prot.22554; Fariselli P, 2001, PROTEINS, P157, DOI 10.1002/prot.1173; Fernandez-Martinez J, 2012, J CELL BIOL, V196, P419, DOI 10.1083/jcb.201109008; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; GEORGES A, 1991, J PHYS A-MATH GEN, V24, P2173, DOI 10.1088/0305-4470/24/9/024; Giraud BG, 1999, PHYS REV E, V59, P4983, DOI 10.1103/PhysRevE.59.4983; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Godzik A, 2011, CURR OPIN STRUC BIOL, V21, P398, DOI 10.1016/j.sbi.2011.03.010; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; HAVEL TF, 1983, J THEOR BIOL, V104, P359, DOI 10.1016/0022-5193(83)90112-1; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; Kinch L, 2011, PROTEINS, V79, P59, DOI 10.1002/prot.23181; Kryshtafovych A, 2011, PROTEINS, V79, P196, DOI 10.1002/prot.23182; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; Lapedes A.B.G., 2012, 29 ARXIV, P29; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lees J, 2012, NUCLEIC ACIDS RES, V40, pD465, DOI 10.1093/nar/gkr1181; Leventhal C, 1969, MOSSBAUER SPECTROSCO, P22; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Liu LC, 1999, MONOGRAPH SERIES I M, P236; Livesay DR, 2012, METHODS MOL BIOL, V796, P385, DOI 10.1007/978-1-61779-334-9_21; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Monastyrskyy B, 2011, PROTEINS, V79, P119, DOI 10.1002/prot.23160; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Newman M. E. J., 1992, THEORY CRITICAL PHEN; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; PLEFKA T, 1982, J PHYS A-MATH GEN, V15, P1971, DOI 10.1088/0305-4470/15/6/035; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109; Taylor WR, 2012, PROTEIN SCI, V21, P299, DOI 10.1002/pro.2002; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341; TIKOCHINSKY Y, 1984, PHYS REV A, V30, P2638, DOI 10.1103/PhysRevA.30.2638; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wright S., 1921, J AGR RES, P29; Wu ST, 2011, STRUCTURE, V19, P1182, DOI 10.1016/j.str.2011.05.004; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	61	399	403	6	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1072	1080		10.1038/nbt.2419	http://dx.doi.org/10.1038/nbt.2419			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138306	Bronze, Green Accepted			2022-12-27	WOS:000311087500026
J	Smith, C; Strauss, S; DeFrancesco, L				Smith, Caitlin; Strauss, Stephen; DeFrancesco, Laura			DNA goes to court	NATURE BIOTECHNOLOGY			English	Article															Canadian Institutes of Health Research, Ottowa, Canada	Canadian Institutes of Health Research, Ottowa, Canada(Canadian Institutes of Health Research (CIHR))	SS received funding from the Canadian Institutes of Health Research, Ottowa, Canada.	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Ackerman MJ, 1999, NEW ENGL J MED, V341, P1121, DOI 10.1056/NEJM199910073411504; Illumina Enters Collaborative Research Agreement with UNTHSC for Next-Generation Sequencing in Forensic DNA Analysis, 2011, ILL ENT COLL RES AGR; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Kayser M, 2011, NAT REV GENET, V12, P179, DOI 10.1038/nrg2952; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; Tester DJ, 2012, MAYO CLIN PROC, V87, P524, DOI 10.1016/j.mayocp.2012.02.017; Thompson W., GENETIC EXPLORATIONS, P227	8	4	4	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1047	1053		10.1038/nbt.2408	http://dx.doi.org/10.1038/nbt.2408			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138297				2022-12-27	WOS:000311087500019
J	Bacchus, W; Lang, M; El-Baba, MD; Weber, W; Stelling, J; Fussenegger, M				Bacchus, William; Lang, Moritz; El-Baba, Marie Daoud; Weber, Wilfried; Stelling, Joerg; Fussenegger, Martin			Synthetic two-way communication between mammalian cells	NATURE BIOTECHNOLOGY			English	Article							GLUCOSE-HOMEOSTASIS; MICE; ANGIOPOIETIN-1; EXPRESSION; CIRCUIT; NETWORKS; LEAKAGE; GROWTH; SWITCH	The design of synthetic biology-inspired control devices enabling entire mammalian cells to receive, process and transfer metabolic information and so communicate with each other via synthetic multichannel networks may provide new insight into the organization of multicellular organisms and future clinical interventions(1). Here we describe communication networks that orchestrate behavior in individual mammalian cells in response to cell-to-cell metabolic signals. We engineered sender, processor and receiver cells that interact with each other in ways that resemble natural intercellular communication networks such as multistep information processing cascades, feed-forward-based signaling loops, and two-way communication. The engineered two-way communication devices mimicking natural control systems in the development of vertebrate extremities(2) and vasculature(3-5) was used to program temporal permeability in vascular endothelial cell layers. These synthetic multicellular communication systems may inspire future therapies or tissue engineering strategies.	[Bacchus, William; Lang, Moritz; Weber, Wilfried; Stelling, Joerg; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [El-Baba, Marie Daoud] IUTA, Dept Genie Biol, Inst Univ Technol, Villeurbanne, France; [Weber, Wilfried] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Weber, Wilfried] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany; [Stelling, Joerg] ETH, Swiss Inst Bioinformat, Zurich, Switzerland; [Fussenegger, Martin] Univ Basel, Fac Sci, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Freiburg; University of Freiburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of Basel	Fussenegger, M (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	joerg.stelling@bsse.ethz.ch; fussenegger@bsse.ethz.ch	Weber, Wilfried/B-4732-2012; Stelling, Joerg/F-7499-2010	Stelling, Joerg/0000-0002-1145-891X; Lang, Moritz/0000-0002-9380-8679; Weber, Wilfried/0000-0003-4340-4446	Swiss National Science Foundation [31003A0-126022]; EC Framework 7 (Persist); Excellence Initiative of the German Federal and State Governments [EXC 294]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EC Framework 7 (Persist)(European Commission); Excellence Initiative of the German Federal and State Governments	We thank M. Tan (pMT1182), M. Ehrbar (pVEGF165pcDNA3), G.Y. Koh (pAng-1) and K. Frei (EA.hy926 cells) for providing reagents and D. Grasso for critical comments on the manuscript. This work was supported by the Swiss National Science Foundation (grant no. 31003A0-126022) and in part by the EC Framework 7 (Persist). Work of W.W. is supported by the Excellence Initiative of the German Federal and State Governments (EXC 294).	Akers JC, 2006, J BACTERIOL, V188, P4236, DOI 10.1128/JB.01660-05; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Chen MT, 2005, NAT BIOTECHNOL, V23, P1551, DOI 10.1038/nbt1162; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; HARTMAN SC, 1988, P NATL ACAD SCI USA, V85, P8047, DOI 10.1073/pnas.85.21.8047; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Lee SW, 2009, INT J MOL MED, V23, P279, DOI 10.3892/ijmm_00000128; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Schlatter S, 2002, GENE, V282, P19, DOI 10.1016/S0378-1119(01)00824-1; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Thurston G, 2002, J ANAT, V200, P575, DOI 10.1046/j.1469-7580.2002.00061.x; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Weber W, 2004, NAT BIOTECHNOL, V22, P1440, DOI 10.1038/nbt1021; Weber W, 2008, P NATL ACAD SCI USA, V105, P9994, DOI 10.1073/pnas.0800663105; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Weber W, 2007, P NATL ACAD SCI USA, V104, P2643, DOI 10.1073/pnas.0606398104; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535	30	71	77	2	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					991	+		10.1038/nbt.2351	http://dx.doi.org/10.1038/nbt.2351			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	22983089				2022-12-27	WOS:000309965500026
J	Sharon, E; Kalma, Y; Sharp, A; Raveh-Sadka, T; Levo, M; Zeevi, D; Keren, L; Yakhini, Z; Weinberger, A; Segal, E				Sharon, Eilon; Kalma, Yael; Sharp, Ayala; Raveh-Sadka, Tali; Levo, Michal; Zeevi, Danny; Keren, Leeat; Yakhini, Zohar; Weinberger, Adina; Segal, Eran			Inferring gene regulatory logic from high-throughput measurements of thousands of systematically designed promoters	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; DNA-BINDING; NUCLEOSOME ORGANIZATION; GLOBAL ANALYSIS; IN-VIVO; YEAST; EXPRESSION; GENOME; LIBRARIES	Despite extensive research, our understanding of the rules according to which cis-regulatory sequences are converted into gene expression is limited. We devised a method for obtaining parallel, highly accurate gene expression measurements from thousands of designed promoters and applied it to measure the effect of systematic changes in the location, number, orientation, affinity and organization of transcription-factor binding sites and nucleosome-disfavoring sequences. Our analyses reveal a clear relationship between expression and binding-site multiplicity, as well as dependencies of expression on the distance between transcription-factor binding sites and gene starts which are transcription-factor specific, including a striking similar to 10-bp periodic relationship between gene expression and binding-site location. We show how this approach can measure transcription-factor sequence specificities and the sensitivity of transcription-factor sites to the surrounding sequence context, and compare the activity of 75 yeast transcription factors. Our method can be used to study both cis and trans effects of genotype on transcriptional, post-transcriptional and translational control.	[Sharon, Eilon; Kalma, Yael; Raveh-Sadka, Tali; Levo, Michal; Zeevi, Danny; Keren, Leeat; Weinberger, Adina; Segal, Eran] Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel; [Sharon, Eilon; Kalma, Yael; Sharp, Ayala; Zeevi, Danny; Keren, Leeat; Weinberger, Adina; Segal, Eran] Weizmann Inst Sci, Dept Mol & Cell Biol, IL-76100 Rehovot, Israel; [Yakhini, Zohar] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Yakhini, Zohar] Agilent Labs, Santa Clara, CA USA	Weizmann Institute of Science; Weizmann Institute of Science; Technion Israel Institute of Technology; Agilent Technologies	Segal, E (corresponding author), Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel.	adina.weinberger@weizmann.ac.il; eran.segal@weizmann.ac.il	Segal, Eran/AAF-4855-2019	Yakhini, Zohar/0000-0002-0420-5412; Segal, Eran/0000-0002-6859-1164; Zeevi, Danny/0000-0002-6901-3737; Sharon, Eilon/0000-0002-1262-350X; Keren, Leeat/0000-0002-6799-6303	European Research Council; US National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA119176] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Widom for assistance and inspiration throughout this project. This work was supported by grants from the European Research Council and the US National Institutes of Health to E. Segal. E. Segal is the incumbent of the Soretta and Henry Shapiro career development chair. We thank S. Lubliner for help with computational analyses. We thank C. Boone (University of Toronto) for kindly giving us the Y8205 strain.	Akache B, 2001, NUCLEIC ACIDS RES, V29, P2181, DOI 10.1093/nar/29.10.2181; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Baliga Nitin S., 2001, Biological Procedures Online, V3, P64, DOI 10.1251/bpo24; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Bulyk ML, 1999, NAT BIOTECHNOL, V17, P573, DOI 10.1038/9878; Canizares JV, 2002, ARCH MICROBIOL, V177, P352, DOI 10.1007/s00203-002-0400-z; Chiang DY, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-16; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; Hanlon SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019060; Hoaglin D.C., 1983, UNDERSTANDING ROBUST; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Kinkhabwala A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002030; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lamb TM, 2003, MOL CELL BIOL, V23, P677, DOI 10.1128/MCB.23.2.677-686.2003; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Ligr M, 2006, GENETICS, V172, P2113, DOI 10.1534/genetics.105.052688; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; Otsuka C, 2002, MUTAT RES-FUND MOL M, V502, P53, DOI 10.1016/S0027-5107(02)00023-4; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Raveh-Sadka T., NAT GENET IN PRESS; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; WOUDT LP, 1986, EMBO J, V5, P1037, DOI 10.1002/j.1460-2075.1986.tb04319.x; Zeevi D, 2011, GENOME RES, V21, P2114, DOI 10.1101/gr.119669.110; Zhao Y, 2006, MOL CELL BIOL, V26, P4853, DOI 10.1128/MCB.02367-05; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	43	289	294	4	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					521	+		10.1038/nbt.2205	http://dx.doi.org/10.1038/nbt.2205			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22609971	Green Accepted			2022-12-27	WOS:000305158600022
J	Holman, CM				Holman, Christopher M.			Debunking the myth that whole-genome sequencing infringes thousands of gene patents	NATURE BIOTECHNOLOGY			English	Editorial Material									Univ Missouri, Kansas City Sch Law, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Holman, CM (corresponding author), Univ Missouri, Kansas City Sch Law, Kansas City, MO 64110 USA.	holmancm@umkc.edu						[Anonymous], US PATENTS ARE FREEL; [Anonymous], 2009, SINGLE MOL REAL TIME; [Anonymous], MORE SPECIFICALLY TH; [Anonymous], QUERY EMPLOYED JENSE; Cook-Deegan R., COMMUNICATION; Cook-Deegan R, 2010, ANNU REV GENOM HUM G, V11, P383, DOI 10.1146/annurev-genom-082509-141811; Davies Kevin, 2010, 1000 GENOME REVOLUTI; Holman C., 2011, HOLMANS BIOTECH 0724; Holman C. M., 2011, IP THEORY, V2, P4; Holman CM, 2008, SCIENCE, V322, P198, DOI 10.1126/science.1160687; Holman CM, 2011, NEW DIRECT PATENT, P260; Huys I, 2009, NAT BIOTECHNOL, V27, P903, DOI 10.1038/nbt1009-903; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Kepler TB, 2010, GENOMICS, V95, P312, DOI 10.1016/j.ygeno.2010.03.003; Moran N, 2012, NAT BIOTECHNOL, V30, P3, DOI 10.1038/nbt0112-3; Price W. N. II, 2012, CARDOZO L REV, V33; Secretary's Advisory Committee for Genetics Health and Society, 2010, GEN PAT LIC PRACT TH; 2001, FED REG         0105, V66, P1092	18	22	23	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					240	244		10.1038/nbt.2146	http://dx.doi.org/10.1038/nbt.2146			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22398617				2022-12-27	WOS:000301303800016
J	Eiben, CB; Siegel, JB; Bale, JB; Cooper, S; Khatib, F; Shen, BW; Players, F; Stoddard, BL; Popovic, Z; Baker, D				Eiben, Christopher B.; Siegel, Justin B.; Bale, Jacob B.; Cooper, Seth; Khatib, Firas; Shen, Betty W.; Players, Foldit; Stoddard, Barry L.; Popovic, Zoran; Baker, David			Increased Diels-Alderase activity through backbone remodeling guided by Foldit players	NATURE BIOTECHNOLOGY			English	Article							COMPUTATIONAL DESIGN; ENZYME; EVOLUTION; MOTIF; LOOP; GAME	Computational enzyme design holds promise for the production of renewable fuels, drugs and chemicals. De novo enzyme design has generated catalysts for several reactions, but with lower catalytic efficiencies than naturally occurring enzymes(1-4). Here we report the use of game-driven crowdsourcing to enhance the activity of a computationally designed enzyme through the functional remodeling of its structure. Players of the online game Foldit(5,6) were challenged to remodel the backbone of a computationally designed bimolecular Diels-Alderase(3) to enable additional interactions with substrates. Several iterations of design and characterization generated a 24-residue helix-turn-helix motif, including a 13-residue insertion, that increased enzyme activity >18-fold. X-ray crystallography showed that the large insertion adopts a helix-turn-helix structure positioned as in the Foldit model. These results demonstrate that human creativity can extend beyond the macroscopic challenges encountered in everyday life to molecular-scale design problems.	[Eiben, Christopher B.; Siegel, Justin B.; Bale, Jacob B.; Khatib, Firas; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Bale, Jacob B.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Cooper, Seth; Popovic, Zoran] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Shen, Betty W.; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Kovanecz, Istvan/H-7386-2014; Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Eiben, Christopher/0000-0002-2816-2277; Bale, Jacob/0000-0003-2444-5875; Kovanecz, Istvan/0000-0002-3514-2338	Center for Game Science at the University of Washington; US Defense Advanced Research Projects Agency (DARPA) [N00173-08-1-G025]; DARPA PDP; Howard Hughes Medical Institute; National Science Foundation [DGE-0718124, 0906026]; Direct For Biological Sciences [0906026] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049857] Funding Source: NIH RePORTER	Center for Game Science at the University of Washington; US Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DARPA PDP; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to acknowledge the members of the Foldit team for their help designing and developing the game and all the Foldit players who volunteered to make this work possible. We would also like to thank J. Thompson for useful scripts, as well as B. Siegel and M. Eiben for helpful comments on the manuscript. This work was supported by the Center for Game Science at the University of Washington, US Defense Advanced Research Projects Agency (DARPA) grant N00173-08-1-G025, the DARPA PDP program, the Howard Hughes Medical Institute (D.B.), a National Science Foundation graduate research fellowship to J.B.B. (grant no. DGE-0718124), and a National Science Foundation grant for F.K. (grant no. 0906026).	[Anonymous], PYMOL MOL GRAPH SYST; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Havranek JJ, 2009, PROTEIN SCI, V18, P1293, DOI 10.1002/pro.142; Hu XZ, 2007, P NATL ACAD SCI USA, V104, P17668, DOI 10.1073/pnas.0707977104; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Khatib F, 2011, NAT STRUCT MOL BIOL, V18, P1175, DOI 10.1038/nsmb.2119; Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Religa TL, 2007, P NATL ACAD SCI USA, V104, P9272, DOI 10.1073/pnas.0703434104; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z	14	183	191	2	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					190	192		10.1038/nbt.2109	http://dx.doi.org/10.1038/nbt.2109			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22267011	Green Accepted			2022-12-27	WOS:000300269100023
J	Kim, K; Zhao, R; Doi, A; Ng, K; Unternaehrer, J; Cahan, P; Huo, HG; Loh, YH; Aryee, MJ; Lensch, MW; Li, H; Collins, JJ; Feinberg, AP; Daley, GQ				Kim, Kitai; Zhao, Rui; Doi, Akiko; Ng, Kitwa; Unternaehrer, Juli; Cahan, Patrick; Huo Hongguang; Loh, Yuin-Han; Aryee, Martin J.; Lensch, M. William; Li, Hu; Collins, James J.; Feinberg, Andrew P.; Daley, George Q.			Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							METHYLATION; MEMORY	We compared bona fide human induced pluripotent stem cells (iPSCs) derived from umbilical cord blood (CB) cells and neonatal keratinocytes (K). As a consequence of both incomplete erasure of tissue-specific methylation and aberrant de novo methylation, CB-iPSCs and K-iPSCs were distinct in genome-wide DNA methylation profiles and differentiation potential. Extended passage of some iPSC clones in culture did not improve their epigenetic resemblance to embryonic stem cells, implying that some human iPSCs retain a residual 'epigenetic memory' of their tissue of origin.	[Kim, Kitai; Zhao, Rui; Ng, Kitwa; Unternaehrer, Juli; Cahan, Patrick; Huo Hongguang; Loh, Yuin-Han; Lensch, M. William; Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA; [Kim, Kitai; Zhao, Rui; Ng, Kitwa; Unternaehrer, Juli; Cahan, Patrick; Huo Hongguang; Loh, Yuin-Han; Lensch, M. William; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kim, Kitai; Zhao, Rui; Unternaehrer, Juli; Cahan, Patrick; Loh, Yuin-Han; Lensch, M. William; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kim, Kitai; Zhao, Rui; Ng, Kitwa; Unternaehrer, Juli; Cahan, Patrick; Huo Hongguang; Loh, Yuin-Han; Lensch, M. William; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA USA; [Doi, Akiko; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD USA; [Doi, Akiko; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Aryee, Martin J.] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Li, Hu; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Boston University; Boston University; Harvard University; Harvard University; Brigham & Women's Hospital	Daley, GQ (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA.	afeinberg@jhu.edu; george.daley@childrens.harvard.edu	Feinberg, Andrew/AAY-7666-2020; Loh, Yuin-Han/E-1096-2014; Aryee, Martin/AAC-8113-2020	Loh, Yuin-Han/0000-0002-4715-6454; Feinberg, Andrew/0000-0002-8364-1991; Unternaehrer-Hamm, Julia/0000-0001-5864-4704; Cahan, Patrick/0000-0003-3652-2540	US National Institutes of Health (NIH) [DK70055, DK59279, RC2-HL102815, K99HL093212-01, R37CA054358, P50HG003233]; Leukemia and Lymphoma Society [3567-07]; Cooley's Anemia Foundation; NATIONAL CANCER INSTITUTE [R37CA054358, R01CA054358] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, RC2HL102815, K99HL093212] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070055, R01DK059279] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Cooley's Anemia Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	G.Q.D. was funded by US National Institutes of Health (NIH) grants DK70055 and DK59279, special funds received by the NIH under the American Recovery and Reinvestment Act (RC2-HL102815). K. K. was supported by NIH (K99HL093212-01), Leukemia and Lymphoma Society (3567-07), and Cooley's Anemia Foundation. A. P. F. was funded by NIH grants R37CA054358 and P50HG003233.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bhattacharya B, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-22; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Metallo CM, 2010, METHODS MOL BIOL, V585, P83, DOI 10.1007/978-1-60761-380-0_7; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Soshnikova N, 2010, DEV CELL, V19, P819, DOI 10.1016/j.devcel.2010.11.009; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017	13	416	437	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1117	1119		10.1038/nbt.2052	http://dx.doi.org/10.1038/nbt.2052			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22119740	Green Accepted			2022-12-27	WOS:000298038700022
J	Gabriel, R; Lombardo, A; Arens, A; Miller, JC; Genovese, P; Kaeppel, C; Nowrouzi, A; Bartholomae, CC; Wang, JB; Friedman, G; Holmes, MC; Gregory, PD; Glimm, H; Schmidt, M; Naldini, L; von Kalle, C				Gabriel, Richard; Lombardo, Angelo; Arens, Anne; Miller, Jeffrey C.; Genovese, Pietro; Kaeppel, Christine; Nowrouzi, Ali; Bartholomae, Cynthia C.; Wang, Jianbin; Friedman, Geoffrey; Holmes, Michael C.; Gregory, Philip D.; Glimm, Hanno; Schmidt, Manfred; Naldini, Luigi; von Kalle, Christof			An unbiased genome-wide analysis of zinc-finger nuclease specificity	NATURE BIOTECHNOLOGY			English	Article							DOUBLE-STRAND BREAKS; MAMMALIAN-CELLS; RESTRICTION ENZYMES; VECTOR INTEGRATION; LENTIVIRAL VECTORS; GENE MODIFICATION; DNA CLEAVAGE; IN-VIVO; KNOCKOUT; SITES	Zinc-finger nucleases (ZFNs) allow gene editing in live cells by inducing a targeted DNA double-strand break (DSB) at a specific genomic locus. However, strategies for characterizing the genome-wide specificity of ZFNs remain limited. We show that nonhomologous end-joining captures integrase-defective lentiviral vectors at DSBs, tagging these transient events. Genome-wide integration site analysis mapped the actual in vivo cleavage activity of four ZFN pairs targeting CCR5 or IL2RG. Ranking loci with repeatedly detectable nuclease activity by deep-sequencing allowed us to monitor the degree of ZFN specificity in vivo at these positions. Cleavage required binding of ZFNs in specific spatial arrangements on DNA bearing high homology to the intended target site and only tolerated mismatches at individual positions of the ZFN binding sites. Whereas the consensus binding sequence derived in vivo closely matched that obtained in biochemical experiments, the ranking of in vivo cleavage sites could not be predicted in silico. Comprehensive mapping of ZFN activity in vivo will facilitate the broad application of these reagents in translational research.	[Lombardo, Angelo; Genovese, Pietro; Naldini, Luigi] Univ Vita Salute San Raffaele, San Raffaele Telethon Inst Gene Therapy HSR TIGET, Milan, Italy; [Gabriel, Richard; Arens, Anne; Kaeppel, Christine; Nowrouzi, Ali; Bartholomae, Cynthia C.; Glimm, Hanno; Schmidt, Manfred; von Kalle, Christof] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, Heidelberg, Germany; [Gabriel, Richard; Arens, Anne; Kaeppel, Christine; Nowrouzi, Ali; Bartholomae, Cynthia C.; Glimm, Hanno; Schmidt, Manfred; von Kalle, Christof] German Canc Res Ctr, Heidelberg, Germany; [Miller, Jeffrey C.; Wang, Jianbin; Friedman, Geoffrey; Holmes, Michael C.; Gregory, Philip D.] Sangamo BioSci Inc, Richmond, CA USA	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Sangamo Therapeutics, Inc.	Naldini, L (corresponding author), Univ Vita Salute San Raffaele, San Raffaele Telethon Inst Gene Therapy HSR TIGET, Milan, Italy.	naldini.luigi@hsr.it; christof.kalle@NCT-Heidelberg.de	Genovese, Pietro/H-3710-2018; lombardo, angelo/J-6241-2016; Naldini, Luigi/E-9083-2012; Wilson, Matthew H/K-3193-2013	Genovese, Pietro/0000-0001-9507-9003; lombardo, angelo/0000-0001-8262-042X; Gregory, Philip/0000-0001-9249-2468; NALDINI, Luigi/0000-0002-7835-527X	Deutsche Forschungsgemeinschaft [SPP1230]; Bundesministerium fur Bildung und Forschung (iGene; European Commission (EC) [FP7-HEALTH-2009-222878, 249845]; European Network for the Advancement of Clinical Gene Transfer and Therapy (CLINIGENE); Persisting Transgenesis (PERSIST); Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer; Telethon	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (iGene(Federal Ministry of Education & Research (BMBF)); European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); European Network for the Advancement of Clinical Gene Transfer and Therapy (CLINIGENE)(European Commission); Persisting Transgenesis (PERSIST); Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer; Telethon(Fondazione Telethon)	We thank U. Abel for fruitful discussions. Funding was provided by the Deutsche Forschungsgemeinschaft (SPP1230, grant of the Tumor Center Heidelberg/Mannheim), by the Bundesministerium fur Bildung und Forschung (iGene), by the VIth + VIIth Framework Programs of the European Commission (EC, European Network for the Advancement of Clinical Gene Transfer and Therapy (CLINIGENE) and Persisting Transgenesis (PERSIST) and by the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer to C.v.K. and M.S. Funding to L.N. was provided by Telethon (TIGET grant), EC (FP7-HEALTH-2009-222878, PERSIST; ERC Advanced Grant FP7, Targeting gene therapy - 249845).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Cornu TI, 2007, MOL THER, V15, P2107, DOI 10.1038/sj.mt.6300345; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Gaur M, 1998, J VIROL, V72, P4678, DOI 10.1128/JVI.72.6.4678-4685.1998; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Handel EM, 2009, MOL THER, V17, P104, DOI 10.1038/mt.2008.233; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Honma M, 2007, DNA REPAIR, V6, P781, DOI 10.1016/j.dnarep.2007.01.004; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Lin YF, 2001, NUCLEIC ACIDS RES, V29, P3975, DOI 10.1093/nar/29.19.3975; Lin YF, 2001, GENETICS, V158, P1665; Liu PQ, 2010, BIOTECHNOL BIOENG, V106, P97, DOI 10.1002/bit.22654; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mani M, 2005, BIOCHEM BIOPH RES CO, V334, P1191, DOI 10.1016/j.bbrc.2005.07.021; Matrai J, 2011, HEPATOLOGY, V53, P1696, DOI 10.1002/hep.24230; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nightingale SJ, 2006, MOL THER, V13, P1121, DOI 10.1016/j.ymthe.2006.01.008; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Petek LM, 2010, MOL THER, V18, P983, DOI 10.1038/mt.2010.35; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vanamee ES, 2001, J MOL BIOL, V309, P69, DOI 10.1006/jmbi.2001.4635; Vargas J, 2004, HUM GENE THER, V15, P361, DOI 10.1089/104303404322959515	45	396	492	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2011	29	9					816	U72		10.1038/nbt.1948	http://dx.doi.org/10.1038/nbt.1948			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	817ZT	21822255				2022-12-27	WOS:000294718400022
J	Bancroft, I; Morgan, C; Fraser, F; Higgins, J; Wells, R; Clissold, L; Baker, D; Long, Y; Meng, JL; Wang, XW; Liu, SY; Trick, M				Bancroft, Ian; Morgan, Colin; Fraser, Fiona; Higgins, Janet; Wells, Rachel; Clissold, Leah; Baker, David; Long, Yan; Meng, Jinling; Wang, Xiaowu; Liu, Shengyi; Trick, Martin			Dissecting the genome of the polyploid crop oilseed rape by transcriptome sequencing	NATURE BIOTECHNOLOGY			English	Article							BRASSICA-NAPUS; SNP DISCOVERY; LINKAGE MAP; SEGMENTS; OLERACEA	Polyploidy complicates genomics-based breeding of many crops, including wheat, potato, cotton, oat and sugarcane. To address this challenge, we sequenced leaf transcriptomes across a mapping population of the polyploid crop oilseed rape (Brassica napus) and representative ancestors of the parents of the population. Analysis of sequence variation(1) and transcript abundance enabled us to construct twin single nucleotide polymorphism linkage maps of B. napus, comprising 23,037 markers. We used these to align the B. napus genome with that of a related species, Arabidopsis thaliana, and to genome sequence assemblies of its progenitor species, Brassica rapa and Brassica oleracea. We also developed methods to detect genome rearrangements and track inheritance of genomic segments, including the outcome of an interspecific cross. By revealing the genetic consequences of breeding, cost-effective, high-resolution dissection of crop genomes by transcriptome sequencing will increase the efficiency of predictive breeding even in the absence of a complete genome sequence.	[Bancroft, Ian; Morgan, Colin; Fraser, Fiona; Higgins, Janet; Wells, Rachel; Clissold, Leah; Trick, Martin] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Baker, David] Genome Anal Ctr, Biotechnol & Biol Sci Res Council, Norwich, Norfolk, England; [Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Wang, Xiaowu] Chinese Acad Agr Sci, Key Lab Hort Crop Genet Improvement, Minist Agr, Beijing 100193, Peoples R China; [Wang, Xiaowu] Chinese Acad Agr Sci, Sino Dutch Joint Lab Hort Genom Technol, Beijing 100193, Peoples R China; [Wang, Xiaowu] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Liu, Shengyi] Chinese Acad Agr Sci, Key Lab Oil Crops Biol, Minist Agr, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; The Genome Analysis Centre (TGAC); Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Bancroft, I (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	ian.bancroft@jic.ac.uk	Bancroft, Ian/AAH-3831-2020; Wang, Xiaowu/L-2579-2019; Liu, Shengyi/S-6772-2016	Bancroft, Ian/0000-0001-7707-1171; Liu, Shengyi/0000-0002-4955-4763	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BBSRC BB/E017363/1, ERAPG08.008]; UK Department for Environment, Food and Rural Affairs (Defra) [Defra IF0144]; China National Basic Research and Development Program [2006CB101600, 2011CB109300]; BBSRC [BB/G024952/1, BB/E017363/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G024952/1, BB/E017363/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); China National Basic Research and Development Program; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank The Genome Analysis Centre for generating Illumina sequence data and the Warwick HRI Genetic Resources Unit for seeds of cultivar Regent. This work was supported by UK Biotechnology and Biological Sciences Research Council (BBSRC BB/E017363/1, ERAPG08.008), UK Department for Environment, Food and Rural Affairs (Defra IF0144) and by China National Basic Research and Development Program (2006CB101600 and 2011CB109300).	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Lagercrantz U, 1996, GENETICS, V144, P1903; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; O'Neill CM, 2000, PLANT J, V23, P233, DOI 10.1046/j.1365-313x.2000.00781.x; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Rounsley S, 2009, RICE, V2, P35, DOI 10.1007/s12284-009-9025-z; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Sharpe AG, 2003, GENOME, V46, P461, DOI 10.1139/G03-031; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Suwabe K, 2008, GENOME, V51, P169, DOI 10.1139/G07-113; The Brassica rapa Genome Sequencing Consortium, NAT GENET IN PRESS; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Trick M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-50; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; U. N., 1935, Japanese Journal of Botany, V7, P389; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59	27	143	148	1	91	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					762	U128		10.1038/nbt.1926	http://dx.doi.org/10.1038/nbt.1926			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21804563				2022-12-27	WOS:000293696500030
J	Grieshammer, U; Shepard, KA; Nigh, EA; Trounson, A				Grieshammer, Uta; Shepard, Kelly A.; Nigh, Elizabeth A.; Trounson, Alan			Finding the niche for human somatic cell nuclear transfer	NATURE BIOTECHNOLOGY			English	Letter							EMBRYONIC STEM-CELLS; BLASTOCYSTS		[Grieshammer, Uta; Shepard, Kelly A.; Trounson, Alan] Calif Inst Regenerat Med, San Francisco, CA USA; [Nigh, Elizabeth A.] Sci Editors, Palo Alto, CA USA		Grieshammer, U (corresponding author), Calif Inst Regenerat Med, San Francisco, CA USA.	ugrieshammer@cirm.ca.gov		Trounson, Alan/0000-0001-5469-0500				Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; California Institute for Regenerative Medicine Medical Research Council, 2010, HUM SOM CELL NUCL TR; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Fan Y., STEM CELLS IN PRESS; French AJ, 2008, STEM CELLS, V26, P485, DOI 10.1634/stemcells.2007-0252; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Halley-Stott RP, 2010, METHODS, V51, P56, DOI 10.1016/j.ymeth.2010.01.035; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Li JY, 2009, CLONING STEM CELLS, V11, P39, DOI 10.1089/clo.2008.0041; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Maruotti J, 2010, STEM CELLS, V28, P743, DOI 10.1002/stem.400; McElroy SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010979; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; Ohtsuka S, 2008, GENE THER, V15, P74, DOI 10.1038/sj.gt.3303065; Panarace M, 2007, THERIOGENOLOGY, V67, P142, DOI 10.1016/j.theriogenology.2006.09.036; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Poulton J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001066; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tecirlioglu RT, 2006, STEM CELL REV, V2, P277, DOI 10.1007/BF02698054; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	32	7	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					701	705		10.1038/nbt.1933	http://dx.doi.org/10.1038/nbt.1933			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21822243				2022-12-27	WOS:000293696500018
J	Sander, JD; Joung, JK				Sander, Jeffry D.; Joung, J. Keith			CRISPR-Cas systems for editing, regulating and targeting genomes	NATURE BIOTECHNOLOGY			English	Review							ZINC-FINGER NUCLEASES; CAENORHABDITIS-ELEGANS; IMMUNE-SYSTEM; HUMAN-CELLS; ENDOGENOUS GENES; DNA RECOGNITION; RNA; ACTIVATION; MUTAGENESIS; TRANSCRIPTION	Targeted genome editing using engineered nucleases has rapidly gone from being a niche technology to a mainstream method used by many biological researchers. This widespread adoption has been largely fueled by the emergence of the clustered, regularly interspaced, short palindromic repeat (CRISPR) technology, an important new approach for generating RNA-guided nucleases, such as Cas9, with customizable specificities. Genome editing mediated by these nucleases has been used to rapidly, easily and efficiently modify endogenous genes in a wide variety of biomedically important cell types and in organisms that have traditionally been challenging to manipulate genetically. Furthermore, a modified version of the CRISPR-Cas9 system has been developed to recruit heterologous domains that can regulate endogenous gene expression or label specific genomic loci in living cells. Although the genome-wide specificities of CRISPR-Cas9 systems remain to be fully defined, the power of these systems to perform targeted, highly efficient alterations of genome sequence and gene expression will undoubtedly transform biological research and spur the development of novel molecular therapeutics for human disease.	[Sander, Jeffry D.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Ctr Computat & Integrat Biol, Mol Pathol Unit, Charlestown, MA 02129 USA; [Sander, Jeffry D.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Joung, JK (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Ctr Computat & Integrat Biol, Mol Pathol Unit, Charlestown, MA 02129 USA.	jjoung@mgh.harvard.edu	Wilson, Matthew H/K-3193-2013		US National Institutes of Health (NIH) [DP1 GM105378, R01 GM088040]; Defense Advanced Research Projects Agency [W911NF-11-2-0056]; The Jim and Ann Orr Massachusetts General Hospital Research Scholar Award; US Army Research Laboratory; US Army Research Office [W911NF-11-2-0056]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378, R01GM088040] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); The Jim and Ann Orr Massachusetts General Hospital Research Scholar Award; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.K.J. is grateful for support from the US National Institutes of Health (NIH) (grants DP1 GM105378 and R01 GM088040), the Defense Advanced Research Projects Agency (grant W911NF-11-2-0056) and The Jim and Ann Orr Massachusetts General Hospital Research Scholar Award. This material is based upon work supported fully or in part by the US Army Research Laboratory and the US Army Research Office under grant number W911NF-11-2-0056.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Carroll D, 2006, NAT PROTOC, V1, P1329, DOI 10.1038/nprot.2006.231; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chiu H, 2013, GENETICS, V195, P1167, DOI 10.1534/genetics.113.155879; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cortes-Ledesma F, 2006, EMBO REP, V7, P919, DOI 10.1038/sj.embor.7400774; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gonzalez B, 2010, NAT PROTOC, V5, P791, DOI 10.1038/nprot.2010.34; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Gupta A, 2012, NAT METHODS, V9, P588, DOI [10.1038/NMETH.1994, 10.1038/nmeth.1994]; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Horii T, 2013, PEERJ, V1, DOI 10.7717/peerj.230; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Katic I, 2013, GENETICS, V195, P1173, DOI 10.1534/genetics.113.155754; Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112; Kim S, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7a; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Tzur YB, 2013, GENETICS, V195, P1181, DOI 10.1534/genetics.113.156075; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JB, 2012, GENOME RES, V22, P1316, DOI 10.1101/gr.122879.111; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	101	1980	2293	86	1454	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					347	355		10.1038/nbt.2842	http://dx.doi.org/10.1038/nbt.2842			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24584096	Green Accepted			2022-12-27	WOS:000334340800019
J	Shuhendler, AJ; Pu, KY; Cui, L; Uetrecht, JP; Rao, JH				Shuhendler, Adam J.; Pu, Kanyi; Cui, Lina; Uetrecht, Jack P.; Rao, Jianghong			Real-time imaging of oxidative and nitrosative stress in the liver of live animals for drug-toxicity testing	NATURE BIOTECHNOLOGY			English	Article							REACTIVE OXYGEN; NITRIC-OXIDE; HEPATOTOXICITY; MICE; BIOACTIVATION; PEROXYNITRITE; MITOCHONDRIAL; MECHANISMS; METABOLITES; TOXICOLOGY	Current drug-safety assays for hepatotoxicity rely on biomarkers with low predictive power. The production of radical species, specifically reactive oxygen species (ROS) and reactive nitrogen species (RNS), has been proposed as an early unifying event linking the bioactivation of drugs to hepatotoxicity and as a more direct and mechanistic indicator of hepatotoxic potential. Here we present a nanosensor for rapid, real-time in vivo imaging of drug-induced ROS and RNS for direct evaluation of acute hepatotoxicity. By combining fluorescence resonance energy transfer (FRET) and chemiluminescence resonance energy transfer (CRET), our semiconducting polymer-based nanosensor simultaneously and differentially detects RNS and ROS using two optically independent channels. We imaged drug-induced hepatotoxicity and its remediation longitudinally in mice after systemic challenge with acetaminophen or isoniazid. We detected dose-dependent ROS and RNS activity in the liver within minutes of drug challenge, which preceded histological changes, protein nitration and DNA double-strand-break induction.	[Shuhendler, Adam J.; Pu, Kanyi; Cui, Lina; Rao, Jianghong] Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA; [Uetrecht, Jack P.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada	Stanford University; University of Toronto	Rao, JH (corresponding author), Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA.	jrao@stanford.edu	Pu, Kanyi/F-2957-2010; Shuhendler, Adam/B-6333-2014	Pu, Kanyi/0000-0002-8064-6009; Shuhendler, Adam/0000-0001-6952-5217	US National Institutes of Health National Cancer Institute (NCI) [R01CA135294, R01DK099800-06A1, R21CA138353A2]; Stanford University NCI CCNE-T [U54CA151459]; In Vivo Cellular and Molecular Imaging Centers [P50CA114747]; Susan G. Komen For The Cure for fellowship; NATIONAL CANCER INSTITUTE [R01CA135294, R21CA138353, U54CA151459, P50CA114747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099800] Funding Source: NIH RePORTER	US National Institutes of Health National Cancer Institute (NCI); Stanford University NCI CCNE-T; In Vivo Cellular and Molecular Imaging Centers; Susan G. Komen For The Cure for fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US National Institutes of Health National Cancer Institute (NCI) grants R01CA135294, R01DK099800-06A1, R21CA138353A2, the Stanford University NCI CCNE-T grant (U54CA151459) and In Vivo Cellular and Molecular Imaging Centers grant (P50CA114747). A.J.S. acknowledges Susan G. Komen For The Cure for fellowship support. We acknowledge the use of the SCi<SUP>3</SUP> Core Facility and the Neuroscience Microscopy Service Facility at Stanford University, P. Chu for her expertise in preparation of histology samples, E.J. McWalter for assistance with MatLab script, and S. Machtaler for assistance with tissue preparation and imaging by confocal microscopy.	Antoine DJ, 2008, EXPERT OPIN DRUG MET, V4, P1415, DOI [10.1517/17425255.4.11.1415, 10.1517/17425255.4.11.1415 ]; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Chowdhury A, 2006, J HEPATOL, V45, P117, DOI 10.1016/j.jhep.2006.01.027; Costa A, 2014, SEMIN CANCER BIOL, V25, P23, DOI 10.1016/j.semcancer.2013.12.007; Cover C, 2005, J PHARMACOL EXP THER, V315, P879, DOI 10.1124/jpet.105.088898; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Guimard NKE, 2009, MACROMOLECULES, V42, P502, DOI 10.1021/ma8019859; Gujral JS, 2002, TOXICOL SCI, V67, P322, DOI 10.1093/toxsci/67.2.322; Herd RM, 1997, DERMATOL CLIN, V15, P355, DOI 10.1016/S0733-8635(05)70446-0; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Holt Michael, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-00663-0_1; Hu YX, 2013, ACS NANO, V7, P5376, DOI 10.1021/nn4012384; Jackson TE, 2000, TOXICOL SCI, V55, P266, DOI 10.1093/toxsci/55.2.266; James LP, 2003, TOXICOL SCI, V75, P458, DOI 10.1093/toxsci/kfg181; Jones CF, 2009, ADV DRUG DELIVER REV, V61, P438, DOI 10.1016/j.addr.2009.03.005; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kramer JA, 2007, NAT REV DRUG DISCOV, V6, P636, DOI 10.1038/nrd2378; LAUTERBURG BH, 1985, J PHARMACOL EXP THER, V235, P566; Lee D, 2007, NAT MATER, V6, P765, DOI 10.1038/nmat1983; Li F, 2013, NAT MED, V19, P418, DOI 10.1038/nm.3104; Li J, 2013, INT J MOL SCI, V14, P24438, DOI 10.3390/ijms141224438; Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029; Maynard AD, 2011, TOXICOL SCI, V120, pS109, DOI 10.1093/toxsci/kfq372; McGill MR, 2013, PHARM RES-DORDR, V30, P2174, DOI 10.1007/s11095-013-1007-6; McGill MR, 2013, TOXICOL APPL PHARM, V269, P240, DOI 10.1016/j.taap.2013.03.026; Metushi IG, 2011, CLIN PHARMACOL THER, V89, P911, DOI 10.1038/clpt.2010.355; Metushi IG, 2012, CHEM RES TOXICOL, V25, P2567, DOI 10.1021/tx300341r; Mourant JR, 1997, APPL OPTICS, V36, P949, DOI 10.1364/AO.36.000949; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; Nasr A, 2011, ADV THER, V28, P842, DOI 10.1007/s12325-011-0059-4; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Oushiki D, 2010, J AM CHEM SOC, V132, P2795, DOI 10.1021/ja910090v; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Park BK, 2005, ANNU REV PHARMACOL, V45, P177, DOI 10.1146/annurev.pharmtox.45.120403.100058; Peet J, 2007, NAT MATER, V6, P497, DOI 10.1038/nmat1928; Pessayre Dominique, 2010, Handb Exp Pharmacol, P311, DOI 10.1007/978-3-642-00663-0_11; Pu KY, 2014, NAT NANOTECHNOL, V9, P233, DOI [10.1038/nnano.2013.302, 10.1038/NNANO.2013.302]; Pu KY, 2013, ANGEW CHEM INT EDIT, V52, P10325, DOI 10.1002/anie.201303420; Russmann S, 2009, CURR MED CHEM, V16, P3041, DOI 10.2174/092986709788803097; Saito C, 2010, HEPATOLOGY, V51, P246, DOI 10.1002/hep.23267; Sakatis MZ, 2012, CHEM RES TOXICOL, V25, P2067, DOI [10.1021/tx300075J, 10.1021/tx300075j]; Saukkonen JJ, 2012, AM J RESP CRIT CARE, V185, P598, DOI 10.1164/rccm.201112-2174ED; Shuhendler AJ, 2011, ACS NANO, V5, P1958, DOI 10.1021/nn103024b; Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326; Sokolov AN, 2012, ACCOUNTS CHEM RES, V45, P361, DOI 10.1021/ar2001233; Srivastava A, 2010, Handb Exp Pharmacol, P165, DOI 10.1007/978-3-642-00663-0_7; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tang W, 2010, DRUG METAB REV, V42, P225, DOI 10.3109/03602530903401658; Tengowski MW, 2005, PROG DRUG RES, V62, P257; Walsh JS, 2011, ANNU REV PHARMACOL, V51, P145, DOI 10.1146/annurev-pharmtox-010510-100514; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Wu CF, 2013, ANGEW CHEM INT EDIT, V52, P3086, DOI 10.1002/anie.201205133; Xiong LQ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2197; Zhang N, 2013, NAT MED, V19, P500, DOI 10.1038/nm.3110	55	421	428	26	484	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					373	U240		10.1038/nbt.2838	http://dx.doi.org/10.1038/nbt.2838			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24658645	Green Accepted			2022-12-27	WOS:000334340800022
J	Newell, EW; Davis, MM				Newell, Evan W.; Davis, Mark M.			Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells	NATURE BIOTECHNOLOGY			English	Review							MASS CYTOMETRY; COMPREHENSIVE ANALYSIS; PARALLEL DETECTION; GENE-EXPRESSION; FLOW-CYTOMETRY; RESPONSES; VIRUS; MEMORY; IMMUNE; REPERTOIRE	Adaptive immune responses often begin with the formation of a molecular complex between a T-cell receptor (TCR) and a peptide antigen bound to a major histocompatibility complex (MHC) molecule. These complexes are highly variable, however, due to the polymorphism of MHC genes, the random, inexact recombination of TCR gene segments, and the vast array of possible self and pathogen peptide antigens. As a result, it has been very difficult to comprehensively study the TCR repertoire or identify and track more than a few antigen-specific T cells in mice or humans. For mouse studies, this had led to a reliance on model antigens and TCR transgenes. The study of limited human clinical samples, in contrast, requires techniques that can simultaneously survey TCR phenotype and function, and TCR reactivity to many T-cell epitopes. Thanks to recent advances in single-cell and cytometry methodologies, as well as high-throughput sequencing of the TCR repertoire, we now have or will soon have the tools needed to comprehensively analyze T-cell responses in health and disease.	[Newell, Evan W.] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Davis, Mark M.] Howard Hughes Med Inst, Dept Microbiol & Immunol, Stanford, CA USA; [Davis, Mark M.] Howard Hughes Med Inst, Inst Immun Transplantat & Infect, Stanford, CA USA; [Davis, Mark M.] Howard Hughes Med Inst, Stanford, CA USA	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Howard Hughes Medical Institute; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Newell, EW (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore.	evan_newell@immunol.a-star.edu.sg; mmdavis@stanford.edu	Newell, Evan W/F-9711-2012	Newell, Evan W/0000-0002-2889-243X; Davis, Mark/0000-0001-6868-657X	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI022511, U19 AI057229] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022511, U19AI057229] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Akram A, 2012, CLIN IMMUNOL, V143, P99, DOI 10.1016/j.clim.2012.01.015; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Andersen RS, 2012, NAT PROTOC, V7, P891, DOI 10.1038/nprot.2012.037; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; Baker ES, 2012, GENOME MED, V4, DOI 10.1186/gm364; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Bjornson ZB, 2013, CURR OPIN IMMUNOL, V25, P484, DOI 10.1016/j.coi.2013.07.004; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Boyd SD, 2013, CURR OPIN IMMUNOL, V25, P511, DOI 10.1016/j.coi.2013.07.007; BRUNNER KT, 1968, IMMUNOLOGY, V14, P181; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Chang CXL, 2011, FRONT BIOSCI-LANDMRK, V16, P3014, DOI 10.2741/3895; Chattopadhyay PK, 2012, METHODS, V57, P251, DOI 10.1016/j.ymeth.2012.02.009; Crawford F, 2006, IMMUNOL REV, V210, P156, DOI 10.1111/j.0105-2896.2006.00365.x; Davis MM, 2011, NAT REV IMMUNOL, V11, P551, DOI 10.1038/nri3020; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Dominguez MH, 2013, J IMMUNOL METHODS, V391, P133, DOI 10.1016/j.jim.2013.03.002; Dziubianau M, 2013, AM J TRANSPLANT, V13, P2842, DOI 10.1111/ajt.12431; Emerson RO, 2013, J PATHOL, V231, P433, DOI 10.1002/path.4260; Finak G, 2014, BIOSTATISTICS, V15, P87, DOI 10.1093/biostatistics/kxt024; Flatz L, 2011, P NATL ACAD SCI USA, V108, P5724, DOI 10.1073/pnas.1013084108; Fortier MH, 2008, J EXP MED, V205, P595, DOI 10.1084/jem.20071985; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Grotenbreg GM, 2008, P NATL ACAD SCI USA, V105, P3831, DOI 10.1073/pnas.0711504105; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Han Q, 2010, LAB CHIP, V10, P1391, DOI 10.1039/b926849a; Harvey CJ, 2013, NAT BIOTECHNOL, V31, P608, DOI 10.1038/nbt.2626; Heemskerk B, 2013, EMBO J, V32, P194, DOI 10.1038/emboj.2012.333; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; Hoof I, 2010, J IMMUNOL, V184, P5383, DOI 10.4049/jimmunol.0903516; HULETT HR, 1969, SCIENCE, V166, P747, DOI 10.1126/science.166.3906.747; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kasuga Kie, 2013, Methods Mol Biol, V1023, P203, DOI 10.1007/978-1-4614-7209-4_14; Kidd BA, 2014, NAT IMMUNOL, V15, P118, DOI 10.1038/ni.2787; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Klarenbeek PL, 2010, IMMUNOL LETT, V133, P42, DOI 10.1016/j.imlet.2010.06.011; La Gruta NL, 2013, CURR OPIN VIROL, V3, P447, DOI 10.1016/j.coviro.2013.06.011; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Maciel M, 2008, VIROLOGY, V378, P105, DOI 10.1016/j.virol.2008.04.043; Makedonas G, 2011, IMMUNOL REV, V239, P109, DOI 10.1111/j.1600-065X.2010.00968.x; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; Ornatsky O, 2006, J IMMUNOL METHODS, V308, P68, DOI 10.1016/j.jim.2005.09.020; Parameswaran P, 2013, CELL HOST MICROBE, V13, P691, DOI 10.1016/j.chom.2013.05.008; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; REAY PA, 1994, J IMMUNOL, V152, P3946; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Rivino L, 2013, J IMMUNOL, V191, P4010, DOI 10.4049/jimmunol.1301507; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Su LF, 2013, IMMUNOL REV, V255, P95, DOI 10.1111/imr.12095; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Turchaninova MA, 2013, EUR J IMMUNOL, V43, P2507, DOI 10.1002/eji.201343453; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Varadarajan N, 2012, P NATL ACAD SCI USA, V109, P3885, DOI 10.1073/pnas.1111205109; Venturi V, 2011, J IMMUNOL, V186, P4285, DOI 10.4049/jimmunol.1003898; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Warren EH, 2013, BLOOD, V122, P19, DOI 10.1182/blood-2013-03-453142; Wee Lawrence Jin Kiat, 2012, Front Biosci (Elite Ed), V4, P311; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; Wen F, 2008, J IMMUNOL METHODS, V336, P37, DOI 10.1016/j.jim.2008.03.008; Wu D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003656; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Yamanaka YJ, 2013, TRENDS IMMUNOL, V34, P59, DOI 10.1016/j.it.2012.10.006; Yang JB, 2006, CLIN IMMUNOL, V120, P21, DOI 10.1016/j.clim.2006.03.008; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110	103	100	104	0	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					149	157		10.1038/nbt.2783	http://dx.doi.org/10.1038/nbt.2783			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24441473	Green Accepted			2022-12-27	WOS:000331074000020
J	Ellefson, JW; Meyer, AJ; Hughes, RA; Cannon, JR; Brodbelt, JS; Ellington, AD				Ellefson, Jared W.; Meyer, Adam J.; Hughes, Randall A.; Cannon, Joe R.; Brodbelt, Jennifer S.; Ellington, Andrew D.			Directed evolution of genetic parts and circuits by compartmentalized partnered replication	NATURE BIOTECHNOLOGY			English	Article							GREEN FLUORESCENT PROTEIN; POLYMERASE-CHAIN-REACTION; TRANSFER-RNA-SYNTHETASE; ESCHERICHIA-COLI; SELF-REPLICATION; DNA FRAGMENTS; SELECTION; SPECIFICITY; MUTAGENESIS; MUTATIONS	Most existing directed evolution methods, both in vivo(1-3) and in vitro(4-6), suffer from inadvertent selective pressures (i.e., altering organism fitness), resulting in the evolution of products with unintended or suboptimal function. To overcome these barriers, here we present compartmentalized partnered replication (CPR). In this approach, synthetic circuits are linked to the production of Taq DNA polymerase so that evolved circuits that most efficiently drive Taq DNA polymerase production are enriched by exponential amplification during a subsequent emulsion PCR step. We apply CPR to evolve a T7 RNA polymerase variant that recognizes an orthogonal promoter and to reengineer the tryptophanyl tRNA-synthetase: suppressor tRNA pair from Saccharomyces cerevisiae(7) to efficiently and site-specifically incorporate an unnatural amino acid into proteins. In both cases, the CPR-evolved parts were more orthogonal and/or more active than variants evolved using other methods. CPR should be useful for evolving any genetic part or circuit that can be linked to Taq DNA polymerase expression.	[Ellefson, Jared W.; Meyer, Adam J.; Hughes, Randall A.; Ellington, Andrew D.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Hughes, Randall A.; Ellington, Andrew D.] Univ Texas Austin, Appl Res Labs, Austin, TX 78713 USA; [Cannon, Joe R.; Brodbelt, Jennifer S.; Ellington, Andrew D.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Ellington, Andrew D.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Ellington, AD (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	andy.ellington@mail.utexas.edu		Cannnon, Joe/0000-0002-3010-0964; Meyer, Adam/0000-0001-5455-3418	National Security Science and Engineering Faculty [FA9550-10-1-0169]; Welch Foundation [F-1654, F-1155]; National Science Foundation [CHE1012622]; Defense Advanced Research Projects Agency [HR-0011-12-C-0066]	National Security Science and Engineering Faculty; Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by the National Security Science and Engineering Faculty (FA9550-10-1-0169) the Welch Foundation (F-1654 to A. D. E. and F-1155 to J.S.B.), the National Science Foundation (CHE1012622 to J.S.B.), and the Defense Advanced Research Projects Agency (HR-0011-12-C-0066). J.S.B. thanks Thermo Fisher Scientific with helping on the modifications to the Orbitrap Elite mass spectrometer to allow UVPD.	BREAKER RR, 1994, P NATL ACAD SCI USA, V91, P6093, DOI 10.1073/pnas.91.13.6093; Bull JJ, 1995, J MOL EVOL, V41, P1160, DOI 10.1007/BF00173197; Chatterjee A, 2013, ANGEW CHEM INT EDIT, V52, P5106, DOI 10.1002/anie.201301094; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Chelliserrykattil J, 2001, BMC Biotechnol, V1, P13, DOI 10.1186/1472-6750-1-13; Collins CH, 2006, NAT BIOTECHNOL, V24, P708, DOI 10.1038/nbt1209; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Davidson EA, 2012, ACS SYNTH BIOL, V1, P190, DOI 10.1021/sb3000113; Dickinson BC, 2013, P NATL ACAD SCI USA, V110, P9007, DOI 10.1073/pnas.1220670110; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Ghadessy FJ, 2007, METH MOL B, V352, P237; Ghadessy FJ, 2001, P NATL ACAD SCI USA, V98, P4552, DOI 10.1073/pnas.071052198; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Goldsmith M, 2009, P NATL ACAD SCI USA, V106, P6197, DOI 10.1073/pnas.0809506106; Han SW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2157; Hughes RA, 2011, METHOD ENZYMOL, V498, P277, DOI 10.1016/B978-0-12-385120-8.00012-7; Hughes RA, 2010, NUCLEIC ACIDS RES, V38, P6813, DOI 10.1093/nar/gkq521; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; KAST P, 1991, J MOL BIOL, V222, P99, DOI 10.1016/0022-2836(91)90740-W; Levy M, 2005, RNA, V11, P1555, DOI 10.1261/rna.2121705; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; RASKIN CA, 1993, P NATL ACAD SCI USA, V90, P3147, DOI 10.1073/pnas.90.8.3147; Shaw JB, 2013, J AM CHEM SOC, V135, P12646, DOI 10.1021/ja4029654; Sinha J, 2010, NAT CHEM BIOL, V6, P464, DOI 10.1038/nchembio.369; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Temme K, 2012, NUCLEIC ACIDS RES, V40, P8773, DOI 10.1093/nar/gks597; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Thyer R, 2013, J AM CHEM SOC, V135, P2, DOI 10.1021/ja3069177; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zhou MY, 2010, NUCLEIC ACIDS RES, V38, P3399, DOI 10.1093/nar/gkp1254	35	93	97	1	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					97	+		10.1038/nbt.2714	http://dx.doi.org/10.1038/nbt.2714			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24185096				2022-12-27	WOS:000329513000024
J	Huang, SXL; Islam, MN; O'Neill, J; Hu, Z; Yang, YG; Chen, YW; Mumau, M; Green, MD; Vunjak-Novakovic, G; Bhattacharya, J; Snoeck, HW				Huang, Sarah X. L.; Islam, Mohammad Naimul; O'Neill, John; Hu, Zheng; Yang, Yong-Guang; Chen, Ya-Wen; Mumau, Melanie; Green, Michael D.; Vunjak-Novakovic, Gordana; Bhattacharya, Jahar; Snoeck, Hans-Willem			Efficient generation of lung and airway epithelial cells from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							GROWTH-FACTOR; DIRECTED DIFFERENTIATION; NODAL ANTAGONISTS; II CELLS; HUMAN ES; ENDODERM; PROGENITORS; RECEPTOR; IDENTITY; FOREGUT	The ability to generate lung and airway epithelial cells from human pluripotent stem cells (hPSCs) would have applications in regenerative medicine, modeling of lung disease, drug screening and studies of human lung development. We have established, based on developmental paradigms, a highly efficient method for directed differentiation of hPSCs into lung and airway epithelial cells. Long-term differentiation of hPSCs in vivo and in vitro yielded basal, goblet, Clara, ciliated, type I and type II alveolar epithelial cells. The type II alveolar epithelial cells were capable of surfactant protein-B uptake and stimulated surfactant release, providing evidence of specific function. Inhibiting or removing retinoic acid, Wnt and BMP-agonists to signaling pathways critical for early lung development in the mouse-recapitulated defects in corresponding genetic mouse knockouts. As this protocol generates most cell types of the respiratory system, it may be useful for deriving patient-specific therapeutic cells.	[Huang, Sarah X. L.; Hu, Zheng; Yang, Yong-Guang; Chen, Ya-Wen; Mumau, Melanie; Green, Michael D.; Snoeck, Hans-Willem] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10027 USA; [Huang, Sarah X. L.; Islam, Mohammad Naimul; Yang, Yong-Guang; Chen, Ya-Wen; Mumau, Melanie; Vunjak-Novakovic, Gordana; Bhattacharya, Jahar; Snoeck, Hans-Willem] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [O'Neill, John; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Bhattacharya, Jahar] Columbia Univ, Med Ctr, Dept Physiol & Cellular Biophys, New York, NY USA; [Snoeck, Hans-Willem] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Snoeck, HW (corresponding author), Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10027 USA.	hs2680@columbia.edu		Islam, Mohammad Naimul/0000-0001-7929-9444; Yang, Yong-Guang/0000-0003-4985-1247; Green, Michael/0000-0003-4951-7118; Vunjak-Novakovic, Gordana/0000-0002-9382-1574; Chen, Ya-Wen/0000-0003-2382-8444	NHLBI NIH HHS [R01 HL120046] Funding Source: Medline; NIAID NIH HHS [R01 AI064569, T32 AI106711] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI106711, R01AI064569] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Barrantes ID, 2003, GENE DEV, V17, P2239, DOI 10.1101/gad.269103; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen F, 2010, J CLIN INVEST, V120, P2040, DOI 10.1172/JCI40253; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Domyan ET, 2011, DEVELOPMENT, V138, P971, DOI 10.1242/dev.053694; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Green MD, 2013, BIOESSAYS, V35, P261, DOI 10.1002/bies.201200090; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Harris-Johnson KS, 2009, P NATL ACAD SCI USA, V106, P16287, DOI 10.1073/pnas.0902274106; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Li Y, 2008, DEV BIOL, V322, P145, DOI 10.1016/j.ydbio.2008.07.021; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Malpel S, 2000, DEVELOPMENT, V127, P3057; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Nostro MC, 2012, SEMIN CELL DEV BIOL, V23, P701, DOI 10.1016/j.semcdb.2012.06.010; O'Neill JD, 2013, ANN THORAC SURG, V96, P1046, DOI 10.1016/j.athoracsur.2013.04.022; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Post M, 1996, DEVELOPMENT, V122, P3107; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rooney SA, 2001, COMP BIOCHEM PHYS A, V129, P233, DOI 10.1016/S1095-6433(01)00320-8; Sanchez-Esteban J, 2001, J APPL PHYSIOL, V91, P589, DOI 10.1152/jappl.2001.91.2.589; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Weaver M, 1999, DEVELOPMENT, V126, P4005; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Wongtrakool C, 2003, J BIOL CHEM, V278, P46911, DOI 10.1074/jbc.M307977200; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	48	352	369	6	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					84	+		10.1038/nbt.2754	http://dx.doi.org/10.1038/nbt.2754			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24291815	Green Accepted			2022-12-27	WOS:000329513000022
J	Der, BS; Kuhlman, B				Der, Bryan S.; Kuhlman, Brian			Cages from coils	NATURE BIOTECHNOLOGY			English	Editorial Material							DESIGN		[Der, Bryan S.; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Kuhlman, Brian] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Der, BS (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	bkuhlman@email.unc.edu						Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Fletcher JM, 2013, SCIENCE, V340, P595, DOI 10.1126/science.1233936; Gradisar H, 2013, NAT CHEM BIOL, V9, P362, DOI 10.1038/nchembio.1248; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Lai YT, 2012, TRENDS CELL BIOL, V22, P653, DOI 10.1016/j.tcb.2012.08.004; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	12	9	9	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					809	810		10.1038/nbt.2670	http://dx.doi.org/10.1038/nbt.2670			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	24022157				2022-12-27	WOS:000324306300018
J	Matthijs, G; Huys, I; Van Overwalle, G; Stoppa-Lyonnet, D				Matthijs, Gert; Huys, Isabelle; Van Overwalle, Geertrui; Stoppa-Lyonnet, Dominique			The European BRCA patent oppositions and appeals: coloring inside the lines	NATURE BIOTECHNOLOGY			English	Editorial Material							CANCER SUSCEPTIBILITY GENE; BREAST-CANCER; FAMILIAL BREAST; OVARIAN-CANCER; MUTATIONS; LINKAGE		[Matthijs, Gert] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Huys, Isabelle] Katholieke Univ Leuven, Fac Pharmaceut Sci, Louvain, Belgium; [Huys, Isabelle] Katholieke Univ Leuven, Ctr Intellectual Property Rights CIR, Louvain, Belgium; [Van Overwalle, Geertrui] Katholieke Univ Leuven, CIR, Louvain, Belgium; [Van Overwalle, Geertrui] Tilburg Univ, Tilburg Inst Law Technol & Soc, NL-5000 LE Tilburg, Netherlands; [Stoppa-Lyonnet, Dominique] Univ Paris 05, Paris, France; [Stoppa-Lyonnet, Dominique] Inst Curie, Serv Genet, Paris, France	KU Leuven; KU Leuven; KU Leuven; KU Leuven; Tilburg University; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Matthijs, G (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium.	gert.matthijs@uzleuven.be; isabelle.huys@pharm.kuleuven.be	Huys, Isabelle/M-8673-2016	Matthijs, Gert/0000-0001-6710-1912				ALBERTSEN H, 1994, AM J HUM GENET, V54, P516; Caux-Moncoutier V, 2011, HUM MUTAT, V32, P325, DOI 10.1002/humu.21414; Cho M, 2010, TRENDS BIOTECHNOL, V28, P548, DOI 10.1016/j.tibtech.2010.08.005; Cook-Deegan R, 2013, EUR J HUM GENET, V21, P585, DOI 10.1038/ejhg.2012.217; Cook-Deegan R, 2010, GENET MED, V12, pS15, DOI 10.1097/GIM.0b013e3181d5a67b; Crichton M., 2008, NEXT, V418-419; Dalpe R, 2003, SCI TECHNOL HUM VAL, V28, P187, DOI 10.1177/0162243902250904; Davies Kevin, 1996, BREAKTHROUGH RACE FI; EASTON DF, 1993, AM J HUM GENET, V52, P678; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gold E. R., 2008, MYRIAD EYE POLICY ST; Graff GD, 2013, NAT BIOTECHNOL, V31, P404, DOI 10.1038/nbt.2568; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hopkins MM, 2012, NAT BIOTECHNOL, V30, P498, DOI 10.1038/nbt.2257; Huys I, 2012, NAT REV GENET, V13, P440, DOI 10.1038/nrg3255; Huys I, 2011, EUR J HUM GENET, V19, P1104, DOI 10.1038/ejhg.2011.76; Huys I, 2009, NAT BIOTECHNOL, V27, P903, DOI 10.1038/nbt1009-903; Lalloo F, 2012, CLIN GENET, V82, P105, DOI 10.1111/j.1399-0004.2012.01859.x; LENOIR GM, 1990, CANCER RES, V50, P4448; Matloff ET, 2010, LANCET, V376, P314, DOI 10.1016/S0140-6736(10)61150-6; Matthijs G, 2006, FAM CANCER, V5, P95, DOI 10.1007/s10689-005-2580-6; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MUNKTELL P, 2004, THESIS U LUND SWEDEN; Myriad, 2012, INT BRACANALYSIS INC; NAROD SA, 1991, LANCET, V338, P82; Rimmer M, 2009, INTELLECTUAL PROPERTY POLICY REFORM: FOSTERING INNOVATION AND DEVELOPMENT, P172; Ripperger T, 2009, EUR J HUM GENET, V17, P722, DOI 10.1038/ejhg.2008.212; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Williams-Jones Bryn, 2002, Health Law J, V10, P123; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	32	12	12	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					704	711		10.1038/nbt.2644	http://dx.doi.org/10.1038/nbt.2644			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23929344	Bronze			2022-12-27	WOS:000322911000016
J	Baccelli, I; Schneeweiss, A; Riethdorf, S; Stenzinger, A; Schillert, A; Vogel, V; Klein, C; Saini, M; Bauerle, T; Wallwiener, M; Holland-Letz, T; Hofner, T; Sprick, M; Scharpff, M; Marme, F; Sinn, HP; Pantel, K; Weichert, W; Trumpp, A				Baccelli, Irene; Schneeweiss, Andreas; Riethdorf, Sabine; Stenzinger, Albrecht; Schillert, Anja; Vogel, Vanessa; Klein, Corinna; Saini, Massimo; Baeuerle, Tobias; Wallwiener, Markus; Holland-Letz, Tim; Hoefner, Thomas; Sprick, Martin; Scharpff, Martina; Marme, Frederik; Sinn, Hans Peter; Pantel, Klaus; Weichert, Wilko; Trumpp, Andreas			Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay	NATURE BIOTECHNOLOGY			English	Article							PROGNOSTIC-SIGNIFICANCE; THERAPEUTIC TARGET; PERIPHERAL-BLOOD; BONE-MARROW; STEM-CELLS; EXPRESSION; SURVIVAL; CD47; MET; DISSEMINATION	It has been hypothesized that carcinoma metastasis is initiated by a subpopulation of circulating tumor cells (CTCs) found in the blood of patients. However, although the presence of CTCs is an indicator of poor prognosis in several carcinoma entities, the existence and phenotype of metastasis-initiating cells (MICs) among CTCs has not been experimentally demonstrated. Here we developed a xenograft assay and used it to show that primary human luminal breast cancer CTCs contain MICs that give rise to bone, lung and liver metastases in mice. These MIC-containing CTC populations expressed EPCAM, CD44, CD47 and MET. In a small cohort of patients with metastases, the number of EPCAM(+)CD44(+)CD47(+)MET(+) CTCs, but not of bulk EPCAM(+) CTCs, correlated with lower overall survival and increased number of metastasic sites. These data describe functional circulating MICs and associated markers, which may aid the design of better tools to diagnose and treat metastatic breast cancer.	[Baccelli, Irene; Schillert, Anja; Vogel, Vanessa; Klein, Corinna; Saini, Massimo; Hoefner, Thomas; Sprick, Martin; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med gGmb, Heidelberg, Germany; [Baccelli, Irene; Schillert, Anja; Vogel, Vanessa; Klein, Corinna; Hoefner, Thomas; Sprick, Martin; Trumpp, Andreas] Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, Heidelberg, Germany; [Schneeweiss, Andreas; Wallwiener, Markus; Scharpff, Martina; Marme, Frederik] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany; [Riethdorf, Sabine; Pantel, Klaus] Univ Klinikum Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany; [Stenzinger, Albrecht; Vogel, Vanessa; Sinn, Hans Peter; Weichert, Wilko] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Baeuerle, Tobias] DKFZ, Dept Med Phys Radiol, Heidelberg, Germany; [Holland-Letz, Tim] DKFZ, Dept Biostat, Heidelberg, Germany; [Trumpp, Andreas] German Canc Consortium, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Trumpp, A (corresponding author), Heidelberg Inst Stem Cell Technol & Expt Med gGmb, Heidelberg, Germany.	a.trumpp@dkfz-heidelberg.de	Sinn, Hans-Peter/C-5661-2008; Schneeweiss, Andreas/HHS-4098-2022; Wallwiener, Markus/AAH-9038-2021; Sprick, Martin R./A-8611-2008; Sprick, Martin R./I-7995-2019; Trumpp, Andreas/Z-2141-2019	Sinn, Hans-Peter/0000-0003-2836-6699; Sprick, Martin R./0000-0001-9691-7574; Sprick, Martin R./0000-0001-9691-7574; Trumpp, Andreas/0000-0002-6212-3466; Saini, Massimo/0000-0002-5916-8516; Wallwiener, Markus/0000-0002-4139-9340; Bauerle, Tobias/0000-0002-0206-6199	BioRN Spitzencluster "Molecular and Cell Based Medicine"; German Bundesministerium fur Bildung und Forschung; EU FP7 Program "EuroSyStem"; Sonderforschungsbereich [SFB-873]; Deutsche Forschungsgemeinschaft; "TIME" consortium Project; Dietmar Hopp Foundation; European Research Council Advanced Investigator Grant DISSECT [269081]	BioRN Spitzencluster "Molecular and Cell Based Medicine"; German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); EU FP7 Program "EuroSyStem"(European Commission); Sonderforschungsbereich(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); "TIME" consortium Project; Dietmar Hopp Foundation; European Research Council Advanced Investigator Grant DISSECT	We thank T. Oskarsson, M. Milsom, H. Medyouf and E. Espinet for helpful discussions, and M. Stoupiec and K. Leotta for technical support, members of the DKFZ FACS core facility, S. Schmitt and K. Hexel for excellent cell sorting, and members of the DKFZ animal facility for animal husbandry. This work was supported by the BioRN Spitzencluster "Molecular and Cell Based Medicine" supported by the German Bundesministerium fur Bildung und Forschung, the EU FP7 Program "EuroSyStem", the Sonderforschungsbereich SFB-873 funded by the Deutsche Forschungsgemeinschaft, the "TIME" consortium Project and the Dietmar Hopp Foundation (all to A.T.) and the European Research Council Advanced Investigator Grant DISSECT (269081 to K.P.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Cohen SJ, 2009, ANN ONCOL, V20, P1223, DOI 10.1093/annonc/mdn786; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kasimir-Bauer S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3099; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kling J, 2012, NAT BIOTECHNOL, V30, P578, DOI 10.1038/nbt.2295; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Nagahara M, 2010, CLIN CANCER RES, V16, P4625, DOI 10.1158/1078-0432.CCR-10-0349; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Powell AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033788; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Riethdorf S, 2010, CLIN CANCER RES, V16, P2634, DOI 10.1158/1078-0432.CCR-09-2042; Shibue T, 2011, SEMIN CANCER BIOL, V21, P99, DOI 10.1016/j.semcancer.2010.12.003; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	43	748	777	11	297	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					539	U143		10.1038/nbt.2576	http://dx.doi.org/10.1038/nbt.2576			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23609047				2022-12-27	WOS:000320113200026
J	Dutkowski, J; Kramer, M; Surma, MA; Balakrishnan, R; Cherry, JM; Krogan, NJ; Ideker, T				Dutkowski, Janusz; Kramer, Michael; Surma, Michal A.; Balakrishnan, Rama; Cherry, J. Michael; Krogan, Nevan J.; Ideker, Trey			A gene ontology inferred from molecular networks	NATURE BIOTECHNOLOGY			English	Article							YEAST; ORGANIZATION; MODULARITY; MAP; DNA; INTERACTOME; PREDICTION; REVEALS; PATHWAY; COMPLEX	Ontologies have proven very useful for capturing knowledge as a hierarchy of terms and their interrelationships. In biology a major challenge has been to construct ontologies of gene function given incomplete biological knowledge and inconsistencies in how this knowledge is manually curated. Here we show that large networks of gene and protein interactions in Saccharomyces cerevisiae can be used to infer an ontology whose coverage and power are equivalent to those of the manually curated Gene Ontology (GO). The network-extracted ontology (NeXO) contains 4,123 biological terms and 5,766 term-term relations, capturing 58% of known cellular components. We also explore robust NeXO terms and term relations that were initially not cataloged in GO, a number of which have now been added based on our analysis. Using quantitative genetic interaction profiling and chemogenomics, we find further support for many of the uncharacterized terms identified by NeXO, including multisubunit structures related to protein trafficking or mitochondrial function. This work enables a shift from using ontologies to evaluate data to using data to construct and evaluate ontologies.	[Dutkowski, Janusz; Kramer, Michael; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Dutkowski, Janusz; Kramer, Michael; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Surma, Michal A.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Surma, Michal A.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Balakrishnan, Rama; Cherry, J. Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA USA; [Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Max Planck Society; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	janusz@ucsd.edu; tideker@ucsd.edu	Surma, Michal/B-1955-2016	Surma, Michal/0000-0001-7833-2214; Ideker, Trey/0000-0002-1708-8454; Kramer, Michael/0000-0003-2544-7266; Cherry, J. Michael/0000-0001-9163-5180	US National Institutes of Health [P41-GM103504, P50-GM085764, R01-GM084448, P50-GM081879]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG002273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, P41GM103504, P50GM081879, T32GM007198, R01GM084448] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Bader and Y. Park for assistance with the HAC-ML software and to I. Lee and E. Marcotte for advice on YeastNet. We would also like to thank D. Botstein, C. Boone, R. Sharan and R. Shamir for constructive advice on the manuscript. This work was generously supported by US National Institutes of Health grants P41-GM103504 and P50-GM085764 (TI) and R01-GM084448 and P50-GM081879 (N.J.K.). N.J.K. is a Searle Scholar and Keck Young Investigator.	Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; Addinall SG, 2008, GENETICS, V180, P2251, DOI 10.1534/genetics.108.092577; Araragi S, 2003, TOXICOLOGY, V184, P1, DOI 10.1016/S0300-483X(02)00443-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Buitelaar P, 2008, FRONT ARTIF INTEL AP, V167, pV; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2010, METHOD ENZYMOL, V470, P205, DOI 10.1016/S0076-6879(10)70009-4; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Coulet A, 2010, J BIOMED INFORM, V43, P1009, DOI 10.1016/j.jbi.2010.08.005; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Dotan-Cohen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005313; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fraser AG, 2004, NAT GENET, V36, P559, DOI 10.1038/ng1370; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gibbons FD, 2002, GENOME RES, V12, P1574, DOI 10.1101/gr.397002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hayes MJ, 2011, TRAFFIC, V12, P260, DOI 10.1111/j.1600-0854.2010.01151.x; Hillenmeyer ME, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r30; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Hubble J, 2009, NUCLEIC ACIDS RES, V37, pD898, DOI 10.1093/nar/gkn786; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jaimovich A, 2010, BIOINFORMATICS, V26, pi228, DOI 10.1093/bioinformatics/btq197; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jean-Mary YR, 2009, J WEB SEMANT, V7, P235, DOI 10.1016/j.websem.2009.04.001; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krallinger M, 2010, METHODS MOL BIOL, V593, P341, DOI 10.1007/978-1-60327-194-3_16; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Leonelli S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-325; Lu PYT, 2009, BIOCHEM CELL BIOL, V87, P799, DOI 10.1139/O09-062; Musen MA, 2012, J AM MED INFORM ASSN, V19, P190, DOI 10.1136/amiajnl-2011-000523; Myers CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r114; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Park Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S44; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Raychaudhuri S, 2002, GENOME RES, V12, P203, DOI 10.1101/gr.199701; Saretzki G, 2009, EXP GERONTOL, V44, P485, DOI 10.1016/j.exger.2009.05.004; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	57	133	135	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					38	+		10.1038/nbt.2463	http://dx.doi.org/10.1038/nbt.2463			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23242164	Green Accepted, Bronze			2022-12-27	WOS:000313563600020
J	Pardey, P; Koo, B; Drew, J; Horwich, J; Nottenburg, C				Pardey, Philip; Koo, Bonwoo; Drew, Jennifer; Horwich, Jeffrey; Nottenburg, Carol			The evolving landscape of plant varietal rights in the United States, 1930-2008	NATURE BIOTECHNOLOGY			English	Editorial Material									[Pardey, Philip; Drew, Jennifer] Univ Minnesota, Dept Appl Econ, Minneapolis, MN 55455 USA; [Koo, Bonwoo] Univ Waterloo, Dept Management Sci, Waterloo, ON N2L 3G1, Canada; [Horwich, Jeffrey] Marketplace Amer Publ Media, Los Angeles, CA USA; [Nottenburg, Carol] Cougar Patent Law, Renton, WA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Waterloo	Pardey, P (corresponding author), Univ Minnesota, Dept Appl Econ, Minneapolis, MN 55455 USA.	ppardey@umn.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004041] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG004041] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Alston JM, 2002, RES POLICY, V31, P527, DOI 10.1016/S0048-7333(01)00123-8; ETC Group, 2008, COMMUNIQUE, P100; Fernandez-Cornejo J., 2004, B USDA, P786; Heald P. J., 2011, LBSS1134; Jones C.A., 2006, EC BRIEF, P7; Kimbrell A., 2002, FATAL HARVEST TRAGED; Louwaars N.P., 2005, IMPACTS STRENGTHENED; Marco AC, 2008, AM J AGR ECON, V90, P133, DOI 10.1111/j.1467-8276.2007.01046.x; Newman M.R., 1931, USDA AGR LIB NOTES, V6, P35; TANSEY G, 2002, FOOD SECURITY BIOTEC; [No title captured]	11	27	30	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					25	29		10.1038/nbt.2467	http://dx.doi.org/10.1038/nbt.2467			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23302928	Green Accepted			2022-12-27	WOS:000313563600014
J	Franzoni, C; Scellato, G; Stephan, P				Franzoni, Chiara; Scellato, Giuseppe; Stephan, Paula			Foreign-born scientists: mobility patterns for 16 countries	NATURE BIOTECHNOLOGY			English	Editorial Material									[Franzoni, Chiara] Politecn Milan, Dept Management Econ & Ind Engn, I-20133 Milan, Italy; [Scellato, Giuseppe] Politecn Torino, Dept Management & Prod Engn, Turin, Italy; [Scellato, Giuseppe] Coll Carlo Alberto, Bur Res Innovat Complex & Knowledge, Moncalieri, Italy; [Stephan, Paula] Georgia State Univ, Andrew Young Sch Policy Studies, Atlanta, GA 30303 USA; [Stephan, Paula] Univ Turin, Dept Econ Cognetti Martiis, Turin, Italy; [Stephan, Paula] Natl Bur Econ Res, Cambridge, MA 02138 USA	Polytechnic University of Milan; Polytechnic University of Turin; Collegio Carlo Alberto; University System of Georgia; Georgia State University; University of Turin; National Bureau of Economic Research	Franzoni, C (corresponding author), Politecn Milan, Dept Management Econ & Ind Engn, I-20133 Milan, Italy.	chiara.franzoni@polimi.it; pstephan@gsu.edu	Franzoni, Chiara/AAH-3119-2019	Franzoni, Chiara/0000-0002-6092-0074; Scellato, Giuseppe/0000-0003-0927-9346				Auriol L., 2007, OECD SCI TECHNOLOGY; Auriol L., 2010, OECD SCI TECHNOLOGY; Hunter RS, 2009, ECON J, V119, pF231, DOI 10.1111/j.1468-0297.2009.02274.x; IDEA Consult, 2010, 3 IDFA CONS MORE; Levin SG, 1999, SCIENCE, V285, P1213, DOI 10.1126/science.285.5431.1213; Sauermann H, 2014, RES POLICY, V43, P32, DOI 10.1016/j.respol.2013.07.006; SCImago, 2010, SJR SCIMAGO J COUNTR; ZUCKER L, 2006, 12172 NBER	8	102	104	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1250	1253		10.1038/nbt.2449	http://dx.doi.org/10.1038/nbt.2449			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222798	Bronze			2022-12-27	WOS:000312092400035
J	Frei, AP; Jeon, OY; Kilcher, S; Moest, H; Henning, LM; Jost, C; Pluckthun, A; Mercer, J; Aebersold, R; Carreira, EM; Wollscheid, B				Frei, Andreas P.; Jeon, Ock-Youm; Kilcher, Samuel; Moest, Hansjoerg; Henning, Lisa M.; Jost, Christian; Plueckthun, Andreas; Mercer, Jason; Aebersold, Ruedi; Carreira, Erick M.; Wollscheid, Bernd			Direct identification of ligand-receptor interactions on living cells and tissues	NATURE BIOTECHNOLOGY			English	Article							PROTEIN INTERACTIONS; VIRUS; PROTEOMICS; ENTRY; MACROPINOCYTOSIS; GLYCOPROTEINS; SULFATE; BINDS	Many cellular responses are triggered by proteins, drugs or pathogens binding to cell-surface receptors, but it can be challenging to identify which receptors are bound by a given ligand. Here we describe TRICEPS, a chemoproteomic reagent with three moieties-one that binds ligands containing an amino group, a second that binds glycosylated receptors on living cells and a biotin tag for purifying the receptor peptides for identification by quantitative mass spectrometry. We validated this ligand-based, receptor-capture (LRC) technology using insulin, transferrin, apelin, epidermal growth factor, the therapeutic antibody trastuzumab and two DARPins targeting ErbB2. In some cases, we could also determine the approximate ligand-binding sites on the receptors. Using TRICEPS to label intact mature vaccinia viruses, we identified the cell surface proteins AXL, M6PR, DAG1, CSPG4 and CDH13 as binding factors on human cells. This technology enables the identification of receptors for many types of ligands under near-physiological conditions and without the need for genetic manipulations.	[Frei, Andreas P.; Moest, Hansjoerg; Henning, Lisa M.; Aebersold, Ruedi; Wollscheid, Bernd] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, Zurich, Switzerland; [Frei, Andreas P.; Moest, Hansjoerg; Henning, Lisa M.; Wollscheid, Bernd] Univ Zurich, NCCR Neuro Ctr Prote, CH-8006 Zurich, Switzerland; [Frei, Andreas P.; Kilcher, Samuel; Jost, Christian] Univ Zurich, PhD Program Mol Life Sci MLS, ETH Zurich, CH-8006 Zurich, Switzerland; [Jeon, Ock-Youm; Carreira, Erick M.] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Organ Chem Lab, Zurich, Switzerland; [Kilcher, Samuel; Mercer, Jason] Swiss Fed Inst Technol, Dept Biol, Inst Biochem, Zurich, Switzerland; [Moest, Hansjoerg] Swiss Fed Inst Technol, Dept Hlth & Technol, Inst Food Nutr & Hlth, Zurich, Switzerland; [Jost, Christian; Plueckthun, Andreas] Univ Zurich, Dept Biochem, CH-8006 Zurich, Switzerland; [Plueckthun, Andreas; Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8006 Zurich, Switzerland; [Aebersold, Ruedi] Competence Ctr Syst Physiol & Metab Dis, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Wollscheid, B (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, Zurich, Switzerland.	bernd.wollscheid@imsb.biol.ethz.ch	Plückthun, Andreas/C-2746-2009; Wollscheid, Bernd/E-8909-2010	Plückthun, Andreas/0000-0003-4191-5306; Wollscheid, Bernd/0000-0002-3923-1610; Carreira, Erick/0000-0003-1472-490X; Jost, Christian/0000-0002-4169-5879; Mercer, Jason/0000-0003-1466-9541	National Center of Competence in Research (NCCR) Neural Plasticity and Repair; Swiss National Science Foundation (SNSF); SystemsX.ch/InfectX; SNSF Ambizione; SystemsX.ch; European Research Council (ERC); ERC	National Center of Competence in Research (NCCR) Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SystemsX.ch/InfectX; SNSF Ambizione; SystemsX.ch; European Research Council (ERC)(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission)	We greatly acknowledge T. Clough and O. Vitek at Purdue University for help with statistical data analysis. We are grateful to A. Hofmann, T. Bock, D. Bausch-Fluck, F. Cerciello, A. Jacobs and A. Leitner for suggestions and support at all stages of the project. We acknowledge S. Dettwiler, P. Schraml, M. Tinguely, H. Moch and the Laboratory for In situ Technologies, University Hospital Zurich, for preparation and staining of breast cancer tissues. This work was supported by funding from National Center of Competence in Research (NCCR) Neural Plasticity and Repair (to B.W.), Swiss National Science Foundation (SNSF) (to B.W.), SystemsX.ch/InfectX (to B.W.), SNSF Ambizione (to J.M.), SystemsX.ch and European Research Council (ERC) (to R.A.) and SystemsX.ch/InfectX and ERC (to S.K. on behalf of A. Helenius). Immortalized murine pre-adipocytes were kindly provided by M. Rosenwald and C. Wolfrum (ETH Zurich). ErbB2-negative breast carcinoma tissue cut into 50 mu m slices was kindly provided by the tissue biobank of the Institute of Surgical Pathology, University Hospital Zurich.	Bantscheff M, 2012, BIOORGAN MED CHEM, V20, P1973, DOI 10.1016/j.bmc.2011.11.003; Barglow KT, 2007, NAT METHODS, V4, P822, DOI 10.1038/NMETH1092; Chiu WL, 2007, J VIROL, V81, P2149, DOI 10.1128/JVI.02302-06; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; Clough T, 2009, J PROTEOME RES, V8, P5275, DOI 10.1021/pr900610q; Elschenbroich S, 2010, EXPERT REV PROTEOMIC, V7, P141, DOI 10.1586/EPR.09.97; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Frei A., 2012, European Patent Application, Patent No. 11000731; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Helbig AO, 2010, J PROTEOMICS, V73, P868, DOI 10.1016/j.jprot.2010.01.005; Hofmann A, 2010, BLOOD, V116, pE26, DOI 10.1182/blood-2010-02-271270; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lenz T, 2011, J PROTEOMICS, V75, P100, DOI 10.1016/j.jprot.2011.07.017; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mercer J, 2010, P NATL ACAD SCI USA, V107, P9346, DOI 10.1073/pnas.1004618107; Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012; Savas JN, 2011, TRENDS BIOCHEM SCI, V36, P388, DOI 10.1016/j.tibs.2011.04.005; Schroeder N, 2012, J VIROL, V86, P4868, DOI 10.1128/JVI.06610-11; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; Steu S, 2008, VIRCHOWS ARCH, V452, P305, DOI 10.1007/s00428-008-0584-y; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Zeng Y, 2009, NAT METHODS, V6, P207, DOI [10.1038/NMETH.1305, 10.1038/nmeth.1305]	28	114	121	1	144	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					997	+		10.1038/nbt.2354	http://dx.doi.org/10.1038/nbt.2354			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	22983091				2022-12-27	WOS:000309965500027
J	Weintraub, A				Weintraub, Arlene			Social networks attempt to spark academic-university collaborations	NATURE BIOTECHNOLOGY			English	News Item																		2008, NAT BIOTECHNOL, V26, P39103	1	3	3	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					901	902		10.1038/nbt1012-901	http://dx.doi.org/10.1038/nbt1012-901			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	23051789				2022-12-27	WOS:000309965500003
J	Singh, M; Ferrara, N				Singh, Mallika; Ferrara, Napoleone			Modeling and predicting clinical efficacy for drugs targeting the tumor milieu	NATURE BIOTECHNOLOGY			English	Review							ENGINEERED MOUSE MODELS; MATRIX-METALLOPROTEINASE INHIBITORS; TRANSLATIONAL PROFILING APPROACH; PHASE-III TRIAL; PANCREATIC NEUROENDOCRINE; ANTIANGIOGENIC THERAPY; CANCER-IMMUNOTHERAPY; LUNG-CANCER; PRECLINICAL MODELS; PROLONGS SURVIVAL	Disappointing results from most late-stage clinical trials of cancer therapeutics indicate a need for improved and more-predictive animal tumor models. This insufficiency of models, combined with the advent of a class of drugs that target the tumor microenvironment rather than the tumor cell, presents new challenges for designing and interpreting preclinical efficacy studies. A comparison of the clinical efficacy of anti-angiogenic drugs with their corresponding preclinical studies over the past two decades offers many lessons that can inform and improve the design of experiments in existing mouse models. In addition, technological and logistical advances in mouse models of human cancer over the past five years have the potential to increase the clinical translatability of animal studies.	[Singh, Mallika] Novartis Inst Biomed Res, Emeryville, CA USA; [Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA	Novartis; Roche Holding; Genentech	Singh, M (corresponding author), Novartis Inst Biomed Res, Emeryville, CA USA.	mallika.singh@novartis.com; nf@gene.com						Allegra CJ, 2011, J CLIN ONCOL, V29, P11, DOI 10.1200/JCO.2010.30.0855; Allen E, 2011, CLIN CANCER RES, V17, P5299, DOI 10.1158/1078-0432.CCR-10-2847; Alley MC, 2004, CANC DRUG DISC DEV, P125; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Becher OJ, 2006, CANCER RES, V66, P3355, DOI 10.1158/0008-5472.CAN-05-3827; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bhargava P, 1999, CLIN CANCER RES, V5, P1989; Boehm JS, 2011, NAT REV GENET, V12, P487, DOI 10.1038/nrg3013; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Bruce D, 2011, EXPERT OPIN INV DRUG, V20, P1413, DOI 10.1517/13543784.2011.611801; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Callahan MK, 2010, SEMIN ONCOL, V37, P473, DOI 10.1053/j.seminoncol.2010.09.001; Cao YH, 2011, INT J DEV BIOL, V55, P557, DOI 10.1387/ijdb.103236yc; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Compagni A, 2000, CANCER RES, V60, P7163; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Crawford Y, 2009, TRENDS PHARMACOL SCI, V30, P624, DOI 10.1016/j.tips.2009.09.004; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; de la Cruz-Merino L, 2008, ONCOLOGIST, V13, P1246, DOI 10.1634/theoncologist.2008-0166; de Vries NA, 2010, CLIN CANCER RES, V16, P3431, DOI 10.1158/1078-0432.CCR-09-3414; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ekins S, 2010, LAB CHIP, V10, P13, DOI 10.1039/b917760b; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Gandhi L, 2009, CANCER PREV RES, V2, P330, DOI 10.1158/1940-6207.CAPR-08-0213; Gerber HP, 2007, P NATL ACAD SCI USA, V104, P3478, DOI 10.1073/pnas.0611492104; Gerber HP, 2005, CANCER RES, V65, P671; Gibbs JP, 2010, AAPS J, V12, P750, DOI 10.1208/s12248-010-9236-7; Gilbert LA, 2011, CANCER RES, V71, P5062, DOI 10.1158/0008-5472.CAN-11-0277; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; Haber DA, 2005, COLD SH Q B, V70, P419, DOI 10.1101/sqb.2005.70.043; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanash SM, 2011, NAT REV CLIN ONCOL, V8, P142, DOI 10.1038/nrclinonc.2010.220; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heyer J, 2010, NAT REV CANCER, V10, P470, DOI 10.1038/nrc2877; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoos A, 2010, SEMIN ONCOL, V37, P533, DOI 10.1053/j.seminoncol.2010.09.015; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Karamouzis MV, 2009, EXPERT OPIN BIOL TH, V9, P641, DOI [10.1517/14712590902882118 , 10.1517/14712590902882118]; Kerbel RS, 2003, CANCER BIOL THER, V2, pS134; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kindler HL, 2011, LANCET ONCOL, V12, P256, DOI 10.1016/S1470-2045(11)70004-3; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Kindler HL, 2005, J CLIN ONCOL, V23, P8033, DOI 10.1200/JCO.2005.01.9661; Kulke MH, 2006, J CLIN ONCOL, V24, P3555, DOI 10.1200/JCO.2006.05.6762; Kwon ED, 1997, P NATL ACAD SCI USA, V94, P8099, DOI 10.1073/pnas.94.15.8099; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; LoRusso PM, 2010, CLIN CANCER RES, V16, P5956, DOI 10.1158/1078-0432.CCR-10-1279; Maxmen A, 2011, NATURE, V478, pS16, DOI 10.1038/478S16a; Maziasz T, 2010, TOXICOL PATHOL, V38, P148, DOI 10.1177/0192623309356448; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mesiano S, 1998, AM J PATHOL, V153, P1249, DOI 10.1016/S0002-9440(10)65669-6; Miles D, 2011, J CLIN ONCOL, V29, P83, DOI 10.1200/JCO.2010.30.2794; Mina LA, 2011, NAT REV CLIN ONCOL, V8, P325, DOI 10.1038/nrclinonc.2011.59; Mokyr MB, 1998, CANCER RES, V58, P5301; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Olson P, 2011, P NATL ACAD SCI USA, V108, pE1275, DOI 10.1073/pnas.1111079108; Olumi AF, 1999, CANCER RES, V59, P5002; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pajic M, 2009, CANCER RES, V69, P6396, DOI 10.1158/0008-5472.CAN-09-0041; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Peterson JK, 2004, EUR J CANCER, V40, P837, DOI 10.1016/j.ejca.2004.01.003; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Pietras K, 2005, J CLIN ONCOL, V23, P939, DOI 10.1200/JCO.2005.07.093; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Politi K, 2010, DIS MODEL MECH, V3, P111, DOI 10.1242/dmm.003681; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Rekhert JM, 2008, DRUG DISCOV TODAY, V13, P30, DOI 10.1016/j.drudis.2007.09.003; Rottenberg S, 2008, DRUG RESIST UPDATE, V11, P51, DOI 10.1016/j.drup.2007.11.002; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Sausville E.A., 2006, CANCER RES, V66; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Scagliotti G, 2010, J CLIN ONCOL, V28, P1835, DOI 10.1200/JCO.2009.26.1321; Scher HI, 2011, CLIN CANCER RES, V17, P6634, DOI 10.1158/1078-0432.CCR-11-1105; Schilsky RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001712; Schreiber SL, 2010, NAT BIOTECHNOL, V28, P904, DOI 10.1038/nbt0910-904; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sharma MR, 2011, JNCI-J NATL CANCER I, V103, P1093, DOI 10.1093/jnci/djr218; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Singh M, 2006, CLIN CANCER RES, V12, P5312, DOI 10.1158/1078-0432.CCR-06-0437; Singh M, 2012, J PATHOL, V227, P417, DOI 10.1002/path.4053; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Taguchi A, 2011, CANCER CELL, V20, P289, DOI 10.1016/j.ccr.2011.08.007; Teicher BA, 2011, BIOCHEM PHARMACOL, V81, P6, DOI 10.1016/j.bcp.2010.09.023; Teicher BA, 2009, TOXICOL PATHOL, V37, P114, DOI 10.1177/0192623308329473; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tuveson DA, 2002, CURR OPIN GENET DEV, V12, P105, DOI 10.1016/S0959-437X(01)00272-6; Van Dyke T, 2010, NAT MED, V16, P976, DOI 10.1038/nm0910-976; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Weber J, 2010, SEMIN ONCOL, V37, P430, DOI 10.1053/j.seminoncol.2010.09.005; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Wong H, 2011, CLIN CANCER RES, V17, P4682, DOI 10.1158/1078-0432.CCR-11-0975; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Yap TA, 2010, NAT REV CANCER, V10, P514, DOI 10.1038/nrc2870; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	130	84	95	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					648	657		10.1038/nbt.2286	http://dx.doi.org/10.1038/nbt.2286			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781694				2022-12-27	WOS:000306293400024
J	Simmons, DP; Wickham, ME				Simmons, David P.; Wickham, Mark E.			Gene patents in Australia: where do we stand?	NATURE BIOTECHNOLOGY			English	Editorial Material								The provision of a patent system that protects innovators and researchers while ensuring reasonable access to emerging technologies and medical treatments are the key objectives of the Australian government's response to three important reports concerning Australia's patent system and gene patents.	[Simmons, David P.; Wickham, Mark E.] Phillips Ormonde Fitzpatrick, Melbourne, Vic, Australia		Simmons, DP (corresponding author), Phillips Ormonde Fitzpatrick, Melbourne, Vic, Australia.	david.simmons@pof.com.au; mark.wickham@pof.com.au	Wickham, Mark/A-1396-2009; Wickham, Mark E/HCI-4959-2022	Wickham, Mark/0000-0002-3473-7196; Wickham, Mark E/0000-0002-3473-7196				*AUSTR LAW REF COM, 2004, GEN ING GEN PAT HUM; Australian Law Reform Commission, 2010, ADV COUNC INT PROP R; Australian Law Reform Commission, 2009, ALRC SEN STAND UNPUB; Myriad Genetics Inc, 1995, AUSTR GOVT RESPONSE, Patent No. 686004; Myriad Genetics Inc, 1995, [No title captured], Patent No. 686004	5	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2012	30	4					323	324		10.1038/nbt.2173	http://dx.doi.org/10.1038/nbt.2173			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	925TR	22491279				2022-12-27	WOS:000302785000014
J	Gruber, B; Walsh, E				Gruber, Bill; Walsh, Emily			Bringing business risk into sharp focus	NATURE BIOTECHNOLOGY			English	Editorial Material									[Gruber, Bill] Solace Therapeut, Framingham, MA 01701 USA; [Walsh, Emily] Halloran Consulting Grp, Waltham, MA USA		Gruber, B (corresponding author), Solace Therapeut, Framingham, MA 01701 USA.	ewalsh@hallorancg.com							0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					30	32		10.1038/nbt.2081	http://dx.doi.org/10.1038/nbt.2081			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22231088				2022-12-27	WOS:000299110600011
J	Yang, W				Yang, Walter			Biotech plummets in 3Q11	NATURE BIOTECHNOLOGY			English	News Item									BioCentury, San Carlos, CA 94070 USA		Yang, W (corresponding author), BioCentury, San Carlos, CA 94070 USA.								0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					962	962		10.1038/nbt.2036	http://dx.doi.org/10.1038/nbt.2036			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22068525	Bronze			2022-12-27	WOS:000296801300008
J	Gaudry, KS				Gaudry, Kate S.			Evergreening: a common practice to protect new drugs	NATURE BIOTECHNOLOGY			English	Editorial Material									Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University	Gaudry, KS (corresponding author), Harvard Univ, Sch Law, Cambridge, MA 02138 USA.	kategaudry@gmail.com						DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; *FDA, DRUG APPR REP; Food and Drug Administration, 2011, OR BOOK APPR DRUG PR; GAUDRY K, 2011, COMMUNICATION   0117; KATE K.T., 1999, COMMERCIAL USE BIODI, V1st, DOI 10.4324/9780429341540; Scherer FM, 2001, HEALTH AFFAIR, V20, P216, DOI 10.1377/hlthaff.20.5.216	6	15	16	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					876	879		10.1038/nbt.1993	http://dx.doi.org/10.1038/nbt.1993			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21997625	Green Submitted			2022-12-27	WOS:000296273000011
J	Gaudry, KS; Cummings, DE				Gaudry, Kate S.; Cummings, Daniel E.			Patent office backlog adds billions to national drug expenditure	NATURE BIOTECHNOLOGY			English	Editorial Material									[Gaudry, Kate S.] Kilpatrick Townsend & Stockton LLP, Washington, DC 20005 USA; [Cummings, Daniel E.] Creighton Univ, Sch Law, Omaha, NE 68178 USA	Creighton University	Gaudry, KS (corresponding author), Kilpatrick Townsend & Stockton LLP, Washington, DC 20005 USA.	kgaudry@kilpatricktownsend.com						Alazraki M., 2011, DAILYFINANCE    0227; Centers for Medicare & Medicaid Services, 2013, NAT HLTH EXP; Dicken J.E., 2012, DRUG PRICING RES SAV; Gaudry K. S., 2014, LOOK RESULTS USPTOS; Gaudry KS, 2011, NAT BIOTECHNOL, V29, P876, DOI 10.1038/nbt.1993; Hemphill CS, 2012, J HEALTH ECON, V31, P327, DOI 10.1016/j.jhealeco.2012.01.004; Hemphill CS, 2011, J EMPIR LEGAL STUD, V8, P613, DOI 10.1111/j.1740-1461.2011.01235.x; Morgan S., 2010, COMMONWEALTH FUND PU, V89, P1408; Office of the Inspector General, 2006, GEN DRUG UT STAT MED; US Department of Health and Human Services, 2013, 1227 ADA HHS; US Patent and Trademark Office, 2012, US DEP COMM MAN PAT; US Patent and Trademark Office, 2013, PRES BUDG SUBM FISC; US Patent and Trademark Office, 2012, PERF ACC REP FISC YE	13	2	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					436	439		10.1038/nbt.2894	http://dx.doi.org/10.1038/nbt.2894			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24811513				2022-12-27	WOS:000336036100015
J	Grunseth, M; Chen, C; Kelly, R; Cook, SB; Megaw, G; Couture, L				Grunseth, Matthew; Chen, Calvin; Kelly, Ryan; Cook, Sangeeta Bardhan; Megaw, George; Couture, Larry			Surveying the best in translation	NATURE BIOTECHNOLOGY			English	Editorial Material									[Grunseth, Matthew; Chen, Calvin; Kelly, Ryan; Cook, Sangeeta Bardhan; Megaw, George; Couture, Larry] Beckman Res Inst City Hope, Ctr Appl Technol Dev, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Grunseth, M (corresponding author), Beckman Res Inst City Hope, Ctr Appl Technol Dev, Duarte, CA 91010 USA.	mgrunseth@coh.org; calchen@coh.org; rykelly@coh.org; scook@coh.org; gmegaw@coh.org; lcouture@coh.org						[Anonymous], 2013, HARVARD MAGAZINE; Kaiser J., 2013, SCIENCEINSIDER  0508; Levinson M., 2010, CIO             0422	3	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					415	418		10.1038/nbt.2887	http://dx.doi.org/10.1038/nbt.2887			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24811508	Bronze			2022-12-27	WOS:000336036100009
J	Im, H; Shao, HL; Park, YI; Peterson, VM; Castro, CM; Weissleder, R; Lee, H				Im, Hyungsoon; Shao, Huilin; Park, Yong Il; Peterson, Vanessa M.; Castro, Cesar M.; Weissleder, Ralph; Lee, Hakho			Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor	NATURE BIOTECHNOLOGY			English	Article							OVARIAN-CANCER; PROTEIN; MARKER; MICROARRAYS; EXPRESSION; KNOWLEDGE; ASCITES; GROWTH; ARRAYS; CD24	Exosomes show potential for cancer diagnostics because they transport molecular contents of the cells from which they originate. Detection and molecular profiling of exosomes is technically challenging and often requires extensive sample purification and labeling. Here we describe a label-free, high-throughput approach for quantitative analysis of exosomes. Our nano-plasmonic exosome (nPLEX) assay is based on transmission surface plasmon resonance through periodic nanohole arrays. Each array is functionalized with antibodies to enable profiling of exosome surface proteins and proteins present in exosome lysates. We show that this approach offers improved sensitivity over previous methods, enables portable operation when integrated with miniaturized optics and allows retrieval of exosomes for further study. Using nPLEX to analyze ascites samples from ovarian cancer patients, we find that exosomes derived from ovarian cancer cells can be identified by their expression of CD24 and EpCAM, suggesting the potential of exosomes for diagnostics.	[Im, Hyungsoon; Shao, Huilin; Park, Yong Il; Peterson, Vanessa M.; Castro, Cesar M.; Weissleder, Ralph; Lee, Hakho] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Weissleder, R (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	rweissleder@mgh.harvard.edu; hlee@mgh.harvard.edu	Im, Hyungsoon/A-3178-2009; Park, Yong Il/AAI-1187-2019	Im, Hyungsoon/0000-0002-0626-1346; Park, Yong Il/0000-0003-3167-4908; /0000-0003-0828-4143	US National Institutes of Health (NIH) [R01-HL113156, R01-EB010011, R01-EB00462605A1, T32CA79443, K12CA087723-11A1]; National Heart, Lung, and Blood Institute [HHSN268201000044C]; Center for Nanoscale Systems (CNS) at Harvard University (National Science Foundation award) [ECS-0335765]; NATIONAL CANCER INSTITUTE [P01CA069246, T32CA079443, R01CA204019, K12CA087723] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010011, R01EB004626, R01EB000462] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Nanoscale Systems (CNS) at Harvard University (National Science Foundation award); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank S. Skates (Massachusetts General Hospital) for helpful discussion on statistical analyses; M. Birrer for facilitating sample collection; K. Joyes for reviewing the manuscript. This work was supported in part by US National Institutes of Health (NIH) grants R01-HL113156 (H.L.), R01-EB010011 (R.W.), R01-EB00462605A1 (R.W.), T32CA79443 (R.W.), K12CA087723-11A1 (C.M.C) and National Heart, Lung, and Blood Institute contract HHSN268201000044C (R.W.). The device was fabricated using the facilities at the Center for Nanoscale Systems (CNS) at Harvard University (National Science Foundation award ECS-0335765).	Aldovini D, 2006, INT J CANCER, V119, P1920, DOI 10.1002/ijc.22082; Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]; Bast RC, 1998, INT J BIOL MARKER, V13, P179, DOI 10.1177/172460089801300402; Brolo AG, 2012, NAT PHOTONICS, V6, P709, DOI 10.1038/nphoton.2012.266; Campbell M, 2000, NATURE, V404, P53, DOI 10.1038/35003523; CANNEY PA, 1985, BRIT J CANCER, V52, P131, DOI 10.1038/bjc.1985.161; Carey MS, 2010, CLIN CANCER RES, V16, P2852, DOI 10.1158/1078-0432.CCR-09-2502; Chu AY, 2005, MODERN PATHOL, V18, P105, DOI 10.1038/modpathol.3800259; Escobedo C, 2013, LAB CHIP, V13, P2445, DOI 10.1039/c3lc50107h; Gordon R, 2008, ACCOUNTS CHEM RES, V41, P1049, DOI 10.1021/ar800074d; Hill HD, 2006, NAT PROTOC, V1, P324, DOI 10.1038/nprot.2006.51; Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d; Im H, 2010, CHEM SCI, V1, P688, DOI 10.1039/c0sc00365d; Im H, 2009, ANAL CHEM, V81, P2854, DOI 10.1021/ac802276x; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Lee HJ, 2006, ANAL CHEM, V78, P6504, DOI 10.1021/ac060881d; Li JH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-244; MacBeath G, 2000, SCIENCE, V289, P1760; Meden H, 1997, EUR J OBSTET GYN R B, V71, P173, DOI 10.1016/S0301-2115(96)02630-9; Mudanyali O, 2010, LAB CHIP, V10, P1417, DOI 10.1039/c000453g; Palik E, 1998, HDB OPTICAL CONSTANT, V2; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Psyrri A, 2005, CLIN CANCER RES, V11, P8637, DOI 10.1158/1078-0432.CCR-05-1436; Runz S, 2007, GYNECOL ONCOL, V107, P563, DOI 10.1016/j.ygyno.2007.08.064; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tassa C, 2010, BIOCONJUGATE CHEM, V21, P14, DOI 10.1021/bc900438a; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Yanik AA, 2011, P NATL ACAD SCI USA, V108, P11784, DOI 10.1073/pnas.1101910108; Yuan HK, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/7/075102	36	831	847	36	761	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					490	U219		10.1038/nbt.2886	http://dx.doi.org/10.1038/nbt.2886			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24752081	Green Accepted			2022-12-27	WOS:000336036100026
J	Rajagopala, SV; Sikorski, P; Kumar, A; Mosca, R; Vlasblom, J; Arnold, R; Franca-Koh, J; Pakala, SB; Phanse, S; Ceol, A; Hauser, R; Siszler, G; Wuchty, S; Emili, A; Babu, M; Aloy, P; Pieper, R; Uetz, P				Rajagopala, Seesandra V.; Sikorski, Patricia; Kumar, Ashwani; Mosca, Roberto; Vlasblom, James; Arnold, Roland; Franca-Koh, Jonathan; Pakala, Suman B.; Phanse, Sadhna; Ceol, Arnaud; Haeuser, Roman; Siszler, Gabriella; Wuchty, Stefan; Emili, Andrew; Babu, Mohan; Aloy, Patrick; Pieper, Rembert; Uetz, Peter			The binary protein-protein interaction landscape of Escherichia coli	NATURE BIOTECHNOLOGY			English	Article							COLI; COMPLEXES; NETWORKS; IDENTIFICATION; MAP	Efforts to map the Escherichia coli interactome have identified several hundred macromolecular complexes, but direct binary protein-protein interactions (PPIs) have not been surveyed on a large scale. Here we performed yeast two-hybrid screens of 3,305 baits against 3,606 preys (similar to 70% of the E. coli proteome) in duplicate to generate a map of 2,234 interactions, which approximately doubles the number of known binary PPIs in E. coli. Integration of binary PPI and genetic-interaction data revealed functional dependencies among components involved in cellular processes, including envelope integrity, flagellum assembly and protein quality control. Many of the binary interactions that we could map in multiprotein complexes were informative regarding internal topology of complexes and indicated that interactions in complexes are substantially more conserved than those interactions connecting different complexes. This resource will be useful for inferring bacterial gene function and provides a draft reference of the basic physical wiring network of this evolutionarily important model microbe.	[Rajagopala, Seesandra V.; Sikorski, Patricia; Franca-Koh, Jonathan; Pakala, Suman B.; Pieper, Rembert] J Craig Venter Inst, Rockville, MD USA; [Kumar, Ashwani; Vlasblom, James; Phanse, Sadhna; Babu, Mohan] Univ Regina, Res & Innovat Ctr, Dept Biochem, Regina, SK S4S 0A2, Canada; [Mosca, Roberto; Ceol, Arnaud; Aloy, Patrick] Inst Res Biomed IRB Barcelona, Joint IRB BSC Program Computat Biol, Barcelona, Spain; [Arnold, Roland; Emili, Andrew] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr, Toronto, ON, Canada; [Haeuser, Roman; Siszler, Gabriella] German Canc Res Ctr, Heidelberg, Germany; [Wuchty, Stefan] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Aloy, Patrick] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Uetz, Peter] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	J. Craig Venter Institute; University of Regina; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; ICREA; Virginia Commonwealth University	Rajagopala, SV (corresponding author), J Craig Venter Inst, Rockville, MD USA.	raja@jcvi.org; mohan.babu@uregina.ca	Arnold, Roland/AAC-5256-2022; Mohan, Babu P./I-7362-2019; Uetz, Peter/A-7119-2012; Aloy, Patrick/AAB-3538-2019; Ceol, Arnaud/H-3386-2012	Arnold, Roland/0000-0002-7496-7578; Uetz, Peter/0000-0001-6194-4927; Ceol, Arnaud/0000-0001-9533-4246; Pakala, Suman/0000-0001-5156-0823; Sikorski, Patricia/0000-0003-4609-1174; Aloy, Patrick/0000-0002-3557-0236; Rajagopala, Seesandra/0000-0001-7176-5770; Mosca, Roberto/0000-0002-3244-1885; Phanse, Sadhna/0000-0001-6306-0551	US National Institutes of Health [GM079710]; Seventh Research Framework Programme of the European Union (AntiPathoGN; EU) [HEALTH-F3-2009-223101]; Natural Sciences and Engineering Research Council [DG-20234]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079710] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seventh Research Framework Programme of the European Union (AntiPathoGN; EU); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); ICREA(ICREA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.V.R. and P.U. were supported by US National Institutes of Health grant GM079710. P.U., R.H. and P.A. were supported by the Seventh Research Framework Programme of the European Union (AntiPathoGN; EU grant HEALTH-F3-2009-223101). M.B. was supported by the Discovery Grant from the Natural Sciences and Engineering Research Council (DG-20234). We thank X. De Bolle (University of Namur, Belgium) for providing pRH016 and pRH018 vectors.	Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Babu M., PLOS GENET; Babu M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002377; Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bershtein S, 2013, MOL CELL, V49, P133, DOI 10.1016/j.molcel.2012.11.004; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Chen YC, 2010, NAT METHODS, V7, P667, DOI 10.1038/nmeth0910-667; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Goll J, 2008, BIOINFORMATICS, V24, P1743, DOI 10.1093/bioinformatics/btn285; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Lasker K, 2010, MOL CELL PROTEOMICS, V9, P1689, DOI 10.1074/mcp.R110.000067; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; Rajagopala SV, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100166; Rajagopala SV, 2012, METHODS, V58, P392, DOI 10.1016/j.ymeth.2012.07.015; Rajagopala SV, 2011, METHODS MOL BIOL, V781, P1, DOI 10.1007/978-1-61779-276-2_1; Rajagopala SV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-470; Rajagopala SV, 2008, BIOINFORMATICS, V24, P2622, DOI 10.1093/bioinformatics/btn481; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Titz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002292; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	40	137	141	4	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					285	290		10.1038/nbt.2831	http://dx.doi.org/10.1038/nbt.2831			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24561554	Green Accepted			2022-12-27	WOS:000332819800028
J	Maeder, ML; Angstman, JF; Richardson, ME; Linder, SJ; Cascio, VM; Tsai, SQ; Ho, QH; Sander, JD; Reyon, D; Bernstein, BE; Costello, JF; Wilkinson, MF; Joung, JK				Maeder, Morgan L.; Angstman, James F.; Richardson, Marcy E.; Linder, Samantha J.; Cascio, Vincent M.; Tsai, Shengdar Q.; Ho, Quan H.; Sander, Jeffry D.; Reyon, Deepak; Bernstein, Bradley E.; Costello, Joseph F.; Wilkinson, Miles F.; Joung, J. Keith			Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins	NATURE BIOTECHNOLOGY			English	Article							IN-VIVO; MAMMALIAN DEVELOPMENT; CYTOSINE METHYLATION; TET PROTEINS; CELLS; 5-CARBOXYLCYTOSINE; 5-METHYLCYTOSINE; SEQUENCES; METHYLTRANSFERASES; 5-FORMYLCYTOSINE	Genome-wide studies have defined cell type-specific patterns of DNA methylation(1) that are important for regulating gene expression in both normal development(2) and disease(3). However, determining the functional significance of specific methylation events remains challenging, owing to the lack of methods for removing such modifications in a targeted manner. Here we describe an approach for efficient targeted demethylation of specific CpGs in human cells using fusions of engineered transcription activator-like effector (TALE) repeat arrays and the TET1 hydroxylase catalytic domain. Using these TALE-TET1 fusions, we demonstrate that modification of critical methylated promoter CpG positions can lead to substantial increases in the expression of endogenous human genes. Our results delineate a strategy for understanding the functional significance of specific CpG methylation marks in the context of endogenous gene loci and validate programmable DNA demethylation reagents with potential utility for research and therapeutic applications.	[Maeder, Morgan L.; Angstman, James F.; Linder, Samantha J.; Cascio, Vincent M.; Tsai, Shengdar Q.; Ho, Quan H.; Sander, Jeffry D.; Reyon, Deepak; Bernstein, Bradley E.; Joung, J. Keith] Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA USA; [Maeder, Morgan L.; Angstman, James F.; Linder, Samantha J.; Cascio, Vincent M.; Tsai, Shengdar Q.; Ho, Quan H.; Sander, Jeffry D.; Reyon, Deepak; Bernstein, Bradley E.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Maeder, Morgan L.; Angstman, James F.; Linder, Samantha J.; Cascio, Vincent M.; Tsai, Shengdar Q.; Sander, Jeffry D.; Reyon, Deepak; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Maeder, Morgan L.; Joung, J. Keith] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA USA; [Angstman, James F.] Harvard Univ, Dept Mol & Cellular Biol, Grad Program Mol Cells & Organisms, Cambridge, MA 02138 USA; [Richardson, Marcy E.; Wilkinson, Miles F.] Univ Calif San Diego, Sch Med, Dept Reprod Med, San Diego, CA 92103 USA; [Tsai, Shengdar Q.; Sander, Jeffry D.; Reyon, Deepak; Bernstein, Bradley E.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Bernstein, Bradley E.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Costello, Joseph F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Wilkinson, Miles F.] Univ Calif San Diego, Inst Genom Med, San Diego, CA 92103 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Francisco; University of California System; University of California San Diego	Joung, JK (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA USA.	jjoung@partners.org	Tsai, Shengdar Q./G-4600-2012; Reyon, Deepak/HCH-3183-2022	Tsai, Shengdar Q./0000-0001-9161-3993; 	National Institutes of Health (NIH) [DP1 GM105378, P50 HG005550, R01 HD053808, R01 HD045595, R01 CA169316, F32 GM105189, P30 NS45776]; Defense Advanced Research Projects Agency (DARPA) [W911NF-11-2-0056]; Karen Osney Brownstein Endowed Chair; Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; US National Science Foundation Graduate Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045595] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053808] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA169316] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM105189, DP1GM105378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Karen Osney Brownstein Endowed Chair; Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institutes of Health (NIH) Director's Pioneer Award DP1 GM105378 (to J.K.J.), NIH P50 HG005550 (to J.K.J.), NIH R01 HD053808 (to M.F.W.), NIH R01 HD045595 (to M.F.W.), NIH R01 CA169316 (to J.F.C.), NIH F32 GM105189 (to S.Q.T.), Defense Advanced Research Projects Agency (DARPA) W911NF-11-2-0056 (to J.K.J.), the Karen Osney Brownstein Endowed Chair (to J.F.C.), the Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award (to J.K.J.) and a US National Science Foundation Graduate Research Fellowship (to M. L. M.). We thank the MGH Nucleic Acid Quantitation Core (supported by NIH P30 NS45776) for use of their real-time PCR machine.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brena RM, 2007, HUM MOL GENET, V16, pR96, DOI 10.1093/hmg/ddm073; Carvin CD, 2003, NUCLEIC ACIDS RES, V31, P6493, DOI 10.1093/nar/gkg853; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Mabaera R, 2007, BLOOD, V110, P1343, DOI 10.1182/blood-2007-01-068635; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; McNamara AR, 2002, NUCLEIC ACIDS RES, V30, P3818, DOI 10.1093/nar/gkf501; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nomura W, 2007, J AM CHEM SOC, V129, P8676, DOI 10.1021/ja0705588; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Siddique A, 2013, J MOL BIOL, V425, P479, DOI 10.1016/j.jmb.2012.11.038; Smith AE, 2007, NUCLEIC ACIDS RES, V35, P740, DOI 10.1093/nar/gkl1053; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Song HW, 2013, HUM REPROD, V28, P1635, DOI 10.1093/humrep/det043; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan SY, 2003, P NATL ACAD SCI USA, V100, P11997, DOI 10.1073/pnas.2035056100; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005	32	329	370	2	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1137	+		10.1038/nbt.2726	http://dx.doi.org/10.1038/nbt.2726			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24108092	Green Accepted, Green Submitted			2022-12-27	WOS:000328251900028
J	Dahl, RH; Zhang, F; Alonso-Gutierrez, J; Baidoo, E; Batth, TS; Redding-Johanson, AM; Petzold, CJ; Mukhopadhyay, A; Lee, TS; Adams, PD; Keasling, JD				Dahl, Robert H.; Zhang, Fuzhong; Alonso-Gutierrez, Jorge; Baidoo, Edward; Batth, Tanveer S.; Redding-Johanson, Alyssa M.; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Lee, Taek Soon; Adams, Paul D.; Keasling, Jay D.			Engineering dynamic pathway regulation using stress-response promoters	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; MICROBIAL-PRODUCTION; MEVALONATE PATHWAY; ISOPRENOID PATHWAY; ACID; OPTIMIZATION; DESIGN; SYSTEM; IDENTIFICATION	Heterologous pathways used in metabolic engineering may produce intermediates toxic to the cell. Dynamic control of pathway enzymes could prevent the accumulation of these metabolites, but such a strategy requires sensors, which are largely unknown, that can detect and respond to the metabolite. Here we applied whole-genome transcript arrays to identify promoters that respond to the accumulation of toxic intermediates, and then used these promoters to control accumulation of the intermediate and improve the final titers of a desired product. We apply this approach to regulate farnesyl pyrophosphate (FPP) production in the isoprenoid biosynthetic pathway in Escherichia coli. This strategy improved production of amorphadiene, the final product, by twofold over that from inducible or constitutive promoters, eliminated the need for expensive inducers, reduced acetate accumulation and improved growth. We extended this approach to another toxic intermediate to demonstrate the broad utility of identifying novel sensor-regulator systems for dynamic regulation.	[Dahl, Robert H.; Zhang, Fuzhong; Alonso-Gutierrez, Jorge; Baidoo, Edward; Batth, Tanveer S.; Redding-Johanson, Alyssa M.; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Lee, Taek Soon; Adams, Paul D.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Dahl, Robert H.; Zhang, Fuzhong; Alonso-Gutierrez, Jorge; Baidoo, Edward; Batth, Tanveer S.; Redding-Johanson, Alyssa M.; Petzold, Christopher J.; Mukhopadhyay, Aindrila; Lee, Taek Soon; Adams, Paul D.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Dahl, Robert H.; Zhang, Fuzhong; Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Adams, Paul D.; Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Joint BioEnergy Inst, Emeryville, CA USA.	keasling@berkeley.edu	Mukhopadhyay, Aindrila/AAW-7257-2021; Keasling, Jay D/J-9162-2012; Adams, Paul David/A-1977-2013	Keasling, Jay D/0000-0003-4170-6088; Adams, Paul David/0000-0001-9333-8219; Zhang, Fuzhong/0000-0001-6979-7909; Batth, Tanveer Singh/0000-0001-5346-4544; Petzold, Christopher/0000-0002-8270-5228	US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	US Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	The authors thank D.Pitera for the pADSmut plasmid and W.Holtz for the BglBrick plasmids with the lacUV5 promoter and LacI<SUP>Q</SUP> removed. J.A.-G. thanks Fundacion Ramon Areces for his PostDoc fellowship. This work was part of the Department of Energy Joint BioEnergy Institute (http://www.jbei.org/) supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US Department of Energy.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; CHEN AJ, 1994, PROTEIN SCI, V3, P600; Chen CY, 2000, PLANT PHYSIOL, V123, P853, DOI 10.1104/pp.123.3.853; Chin CS, 2008, PLOS BIOL, V6, P1343, DOI 10.1371/journal.pbio.0060146; Colantuoni C, 2002, BIOINFORMATICS, V18, P1540, DOI 10.1093/bioinformatics/18.11.1540; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; De Mey M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-26; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Dietrich JA, 2013, ACS SYNTH BIOL, V2, P47, DOI 10.1021/sb300091d; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Dunlop Mary J, 2010, Syst Synth Biol, V4, P95, DOI 10.1007/s11693-010-9052-5; Fazelinia H, 2007, BIOPHYS J, V92, P2120, DOI 10.1529/biophysj.106.096016; Ferrandez A, 2000, J BIOL CHEM, V275, P12214, DOI 10.1074/jbc.275.16.12214; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; Hammer K, 2006, TRENDS BIOTECHNOL, V24, P53, DOI 10.1016/j.tibtech.2005.12.003; Hinson DD, 1997, J LIPID RES, V38, P2216; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Hommais F, 2004, MICROBIOL-SGM, V150, P61, DOI 10.1099/mic.0.26659-0; Kang Z, 2008, APPL MICROBIOL BIOT, V79, P203, DOI 10.1007/s00253-008-1428-z; Karig D, 2005, BIOTECHNOL BIOENG, V89, P709, DOI 10.1002/bit.20371; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Krings U, 1998, APPL MICROBIOL BIOT, V49, P1, DOI 10.1007/s002530051129; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Mahmoud SS, 2001, P NATL ACAD SCI USA, V98, P8915, DOI 10.1073/pnas.141237298; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Martin VJJ, 2001, BIOTECHNOL BIOENG, V75, P497, DOI 10.1002/bit.10037; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Miksch G, 2005, J BIOTECHNOL, V120, P25, DOI 10.1016/j.jbiotec.2005.04.027; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Reiling KK, 2004, BIOTECHNOL BIOENG, V87, P200, DOI 10.1002/bit.20128; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sayed AK, 2009, MOL MICROBIOL, V71, P1435, DOI 10.1111/j.1365-2958.2009.06614.x; Shamah SM, 2008, ACCOUNTS CHEM RES, V41, P130, DOI 10.1021/ar700142z; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Smolke CD, 2001, METAB ENG, V3, P313, DOI 10.1006/mben.2001.0194; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Withers ST, 2007, APPL ENVIRON MICROB, V73, P6277, DOI 10.1128/AEM.00861-07; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106	54	314	346	20	261	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					1039	+		10.1038/nbt.2689	http://dx.doi.org/10.1038/nbt.2689			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24142050				2022-12-27	WOS:000326921200027
J	Kamb, A; Harper, S; Stefansson, K				Kamb, Alexander; Harper, Sean; Stefansson, Kari			Human genetics as a foundation for innovative drug development	NATURE BIOTECHNOLOGY			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN; CHOLESTEROL LEVELS; MYOCARDIAL-INFARCTION; SERUM-CHOLESTEROL; LDL CHOLESTEROL; STATIN THERAPY; HIGH-RISK; PCSK9; RECEPTOR		[Kamb, Alexander; Harper, Sean] Amgen Inc, Thousand Oaks, CA USA; [Stefansson, Kari] deCODE Genet Amgen, Reykjavik, Iceland	Amgen	Kamb, A (corresponding author), Amgen Inc, Thousand Oaks, CA USA.	akamb@amgen.com	Stefansson, Kari/AAE-7187-2019					Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Benn M, 2010, J AM COLL CARDIOL, V55, P2833, DOI 10.1016/j.jacc.2010.02.044; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Fishman MC, 2005, NATURE, V437, P491, DOI 10.1038/437491a; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gudmundsson J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001513; Haddad L, 1999, J LIPID RES, V40, P1113; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kannel W B, 1972, Med Times, V100, P173; Kolodgie FD, 2004, HEART, V90, P1385, DOI 10.1136/hrt.2004.041798; Lambert G, 2012, J LIPID RES, V53, P2515, DOI 10.1194/jlr.R026658; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Laurie SA, 2013, J CLIN ONCOL, V31, P1061, DOI 10.1200/JCO.2012.43.4522; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Moller M, 2012, MCKINSEY PERSPECTIVE, P2; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; PEKKANEN J, 1990, NEW ENGL J MED, V322, P1700, DOI 10.1056/NEJM199006143222403; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; ROSSOUW JE, 1990, NEW ENGL J MED, V323, P1112, DOI 10.1056/NEJM199010183231606; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Steinberg D, 2009, P NATL ACAD SCI USA, V106, P9546, DOI 10.1073/pnas.0904560106; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WONG ND, 1991, ANN INTERN MED, V115, P687, DOI 10.7326/0003-4819-115-9-687; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	40	34	34	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					975	978		10.1038/nbt.2732	http://dx.doi.org/10.1038/nbt.2732			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24213769				2022-12-27	WOS:000326921200014
J	Zangi, L; Lui, KO; von Gise, A; Ma, Q; Ebina, W; Ptaszek, LM; Spater, D; Xu, HS; Tabebordbar, M; Gorbatov, R; Sena, B; Nahrendorf, M; Briscoe, DM; Li, RA; Wagers, AJ; Rossi, DJ; Pu, WT; Chien, KR				Zangi, Lior; Lui, Kathy O.; von Gise, Alexander; Ma, Qing; Ebina, Wataru; Ptaszek, Leon M.; Spater, Daniela; Xu, Huansheng; Tabebordbar, Mohammadsharif; Gorbatov, Rostic; Sena, Brena; Nahrendorf, Matthias; Briscoe, David M.; Li, Ronald A.; Wagers, Amy J.; Rossi, Derrick J.; Pu, William T.; Chien, Kenneth R.			Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction	NATURE BIOTECHNOLOGY			English	Article							ENDOTHELIAL GROWTH-FACTOR; ADENOASSOCIATED VIRUS VECTORS; ADULT NEOVASCULARIZATION; EPICARDIAL PROGENITORS; HIGHLY EFFICIENT; SKELETAL-MUSCLE; GENE DELIVERY; SMOOTH-MUSCLE; CYTOSOLIC DNA; BETA-CATENIN	In a cell-free approach to regenerative therapeutics, transient application of paracrine factors in vivo could be used to alter the behavior and fate of progenitor cells to achieve sustained clinical benefits. Here we show that intramyocardial injection of synthetic modified RNA (modRNA) encoding human vascular endothelial growth factor-A (VEGF-A) results in the expansion and directed differentiation of endogenous heart progenitors in a mouse myocardial infarction model. VEGF-A modRNA markedly improved heart function and enhanced long-term survival of recipients. This improvement was in part due to mobilization of epicardial progenitor cells and redirection of their differentiation toward cardiovascular cell types. Direct in vivo comparison with DNA vectors and temporal control with VEGF inhibitors revealed the greatly increased efficacy of pulse-like delivery of VEGF-A. Our results suggest that modRNA is a versatile approach for expressing paracrine factors as cell fate switches to control progenitor cell fate and thereby enhance long-term organ repair.	[Zangi, Lior; Lui, Kathy O.; Ebina, Wataru; Ptaszek, Leon M.; Spater, Daniela; Xu, Huansheng; Tabebordbar, Mohammadsharif; Wagers, Amy J.; Rossi, Derrick J.; Chien, Kenneth R.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Zangi, Lior; Lui, Kathy O.; Ptaszek, Leon M.; Spater, Daniela; Xu, Huansheng; Chien, Kenneth R.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Zangi, Lior; von Gise, Alexander; Ma, Qing; Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Zangi, Lior; Ebina, Wataru; Rossi, Derrick J.] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Zangi, Lior; Ebina, Wataru; Rossi, Derrick J.] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Zangi, Lior; von Gise, Alexander; Ma, Qing; Pu, William T.] Boston & Harvard Stem Cell Inst, Cambridge, MA USA; [Zangi, Lior; von Gise, Alexander; Ma, Qing; Pu, William T.] Univ Hong Kong, LKS Fac Med, Pokfulam, Hong Kong, Peoples R China; [Lui, Kathy O.; Xu, Huansheng; Li, Ronald A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ptaszek, Leon M.] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Boston, MA USA; [Tabebordbar, Mohammadsharif] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Gorbatov, Rostic; Sena, Brena; Nahrendorf, Matthias] Harvard Univ, Sch Med, Boston, MA USA; [Briscoe, David M.] Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Li, Ronald A.] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA; [Wagers, Amy J.] Howard Hughes Med Inst, Cambridge, MA USA; [Chien, Kenneth R.] Karolinska Inst, Dept Cell & Mol Biol & Med, Stockholm, Sweden	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Hong Kong; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; Karolinska Institutet	Chien, KR (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	wpu@enders.tch.harvard.edu; kenneth.chien@ki.se	von Gise, Alexander/C-3997-2016; Lui, Kathy O./E-4883-2015; Lui, Kathy/AAC-8303-2020; Pu, William/AAJ-8301-2020	von Gise, Alexander/0000-0001-7886-3031; Lui, Kathy O./0000-0002-1616-3643; Lui, Kathy/0000-0002-1616-3643; Pu, William/0000-0002-4551-8079; Briscoe, David/0000-0003-4135-5417	US National Institutes of Health [U01H100408, U01HL098166, U01JL100401, R01HL094683, RC1HL099618, UO1HL100402]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099618, R21HL104602, R01HL094683, U01HL100401, U01HL098166, U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092305] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by US National Institutes of Health U01H100408 (K.R.C.), U01HL098166 (K.R.C.), U01JL100401 (W.T.P.), R01HL094683 (W.T.P.), RC1HL099618 (K.R.C., W.T.P.) and UO1HL100402 (A.J.W.). K.O.L. held a Croucher Foundation Fellowship and A.J.W. is an Early Career Scientist of the Howard Hughes Medical Institute. We thank R. Liao, J. Guan, J. Truelove, L. Bu, M. Stachel, K. Buac, V. Priestly, R. Gazit, K. Ketman, N. Barteneva, A. He, S. Stevens, B. Zhou and L. Warren for all their help in this project. Adult cardiomyocytes were a kind gift from R. Liao (Biological and Biomaterial Science, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School).	Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Choi MK, 2009, P NATL ACAD SCI USA, V106, P17870, DOI 10.1073/pnas.0909545106; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Djurovic S, 2004, MOL BIOTECHNOL, V28, P21, DOI 10.1385/MB:28:1:21; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Eppler SM, 2002, CLIN PHARMACOL THER, V72, P20, DOI 10.1067/mcp.2002.126179; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hao XJ, 2007, CARDIOVASC RES, V73, P481, DOI 10.1016/j.cardiores.2006.10.011; Hoshijima M, 2002, NAT MED, V8, P864, DOI 10.1038/nm739; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2012, MOL THER, V20, P948, DOI 10.1038/mt.2012.7; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Kruithof BPT, 2006, DEV BIOL, V295, P507, DOI 10.1016/j.ydbio.2006.03.033; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee RJ, 2000, CIRCULATION, V102, P898; Lee WW, 2012, J AM COLL CARDIOL, V59, P153, DOI 10.1016/j.jacc.2011.08.066; Liao Ronglih, 2007, V139, P251; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Lui KO, 2013, CELL RES, V23, P1172, DOI 10.1038/cr.2013.112; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; Mays LE, 2013, J CLIN INVEST, V123, P1216, DOI 10.1172/JCI65351; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagy JA, 2006, LAB INVEST, V86, P767, DOI 10.1038/labinvest.3700436; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Patterson C, 2000, CIRCULATION, V102, P940, DOI 10.1161/01.CIR.102.9.940; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; Shen BQ, 1998, J BIOL CHEM, V273, P29979, DOI 10.1074/jbc.273.45.29979; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spilsbury K, 2000, AM J PATHOL, V157, P135, DOI 10.1016/S0002-9440(10)64525-7; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Su H, 2009, INT J CARDIOL, V133, P191, DOI 10.1016/j.ijcard.2007.12.034; Svensson EC, 1999, CIRCULATION, V99, P201, DOI 10.1161/01.CIR.99.2.201; Tafuro S, 2009, CARDIOVASC RES, V83, P663, DOI 10.1093/cvr/cvp152; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wessels A, 2012, DEV BIOL, V366, P111, DOI 10.1016/j.ydbio.2012.04.020; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Yuan MJ, 2012, REGUL PEPTIDES, V179, P39, DOI 10.1016/j.regpep.2012.08.013; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2012, CIRC RES, V111, pE276, DOI 10.1161/CIRCRESAHA.112.275784; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	55	419	465	5	119	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2013	31	10					898	+		10.1038/nbt.2682	http://dx.doi.org/10.1038/nbt.2682			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233CA	24013197	Green Accepted			2022-12-27	WOS:000325541300018
J	Tabashnik, BE; Brevault, T; Carriere, Y				Tabashnik, Bruce E.; Brevault, Thierry; Carriere, Yves			Insect resistance to Bt crops: lessons from the first billion acres	NATURE BIOTECHNOLOGY			English	Review							EUROPEAN CORN-BORER; FIELD-EVOLVED RESISTANCE; HELICOVERPA-ARMIGERA LEPIDOPTERA; BACILLUS-THURINGIENSIS TOXINS; TOBACCO BUDWORM LEPIDOPTERA; TRANSGENIC COTTON; OSTRINIA-NUBILALIS; DIAMONDBACK MOTH; PINK-BOLLWORM; HELIOTHIS-VIRESCENS	Evolution of resistance in pests can reduce the effectiveness of insecticidal proteins from Bacillus thuringiensis (Bt) produced by transgenic crops. We analyzed results of 77 studies from five continents reporting field monitoring data for resistance to Bt crops, empirical evaluation of factors affecting resistance or both. Although most pest populations remained susceptible, reduced efficacy of Bt crops caused by field-evolved resistance has been reported now for some populations of 5 of 13 major pest species examined, compared with resistant populations of only one pest species in 2005. Field outcomes support theoretical predictions that factors delaying resistance include recessive inheritance of resistance, low initial frequency of resistance alleles, abundant refuges of non-Bt host plants and two-toxin Bt crops deployed separately from one-toxin Bt crops. The results imply that proactive evaluation of the inheritance and initial frequency of resistance are useful for predicting the risk of resistance and improving strategies to sustain the effectiveness of Bt crops.	[Tabashnik, Bruce E.; Carriere, Yves] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Brevault, Thierry] Ctr Cooperat Int Rech Agron Dev, UPR 102, Montpellier, France	University of Arizona; CIRAD	Tabashnik, BE (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	brucet@cals.arizona.edu	Brévault, Thierry/AAV-5990-2021; Brevault, Thierry/R-9757-2019; Brevault, Thierry/F-2653-2011	Brévault, Thierry/0000-0003-0159-3509; Brevault, Thierry/0000-0003-0159-3509; Brevault, Thierry/0000-0003-0159-3509	US Department of Agriculture (USDA) Agriculture and Food Research Initiative [2008-35302-0390]; USDA Biotechnology Risk Assessment [2011-33522-30729]	US Department of Agriculture (USDA) Agriculture and Food Research Initiative; USDA Biotechnology Risk Assessment	We thank A. Yelich for assistance with figures, and D. Crowder, L. Masson and M. Sisterson for providing comments. This work was supported by US Department of Agriculture (USDA) Agriculture and Food Research Initiative Grant 2008-35302-0390 and USDA Biotechnology Risk Assessment Grant 2011-33522-30729.	Alcantara E, 2011, CROP PROT, V30, P554, DOI 10.1016/j.cropro.2010.12.019; Ali MI, 2007, J ECON ENTOMOL, V100, P921, DOI 10.1603/0022-0493(2007)100[921:SOBATB]2.0.CO;2; Ali MI, 2006, J ECON ENTOMOL, V99, P164, DOI 10.1603/0022-0493(2006)099[0164:SOHZAH]2.0.CO;2; Alyokhin A, 2011, NAT BIOTECHNOL, V29, P577, DOI 10.1038/nbt.1911; Andow DA, 2000, J ECON ENTOMOL, V93, P26, DOI 10.1603/0022-0493-93.1.26; [Anonymous], ARTHR PEST RES DAT; [Anonymous], FISC YEARS 1996 2009; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Baker GH, 2008, AUST J AGR RES, V59, P723, DOI 10.1071/AR07421; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bird LJ, 2005, J ECON ENTOMOL, V98, P1311, DOI 10.1603/0022-0493-98.4.1311; Bird LJ, 2004, J ECON ENTOMOL, V97, P1699, DOI 10.1603/0022-0493-97.5.1699; Blanco CA, 2010, SOUTHWEST ENTOMOL, V35, P409, DOI 10.3958/059.035.0325; Blanco CA, 2009, J ECON ENTOMOL, V102, P381, DOI 10.1603/029.102.0149; Bourguet D, 2003, THEOR APPL GENET, V106, P1225, DOI 10.1007/s00122-002-1172-1; Brent K., 1986, PESTICIDE RESISTANCE, P298; Brevault T, 2013, P NATL ACAD SCI USA, V110, P5806, DOI 10.1073/pnas.1216719110; Brevault T, 2012, EVOL APPL, V5, P53, DOI 10.1111/j.1752-4571.2011.00207.x; Carpenter JE, 2010, NAT BIOTECHNOL, V28, P319, DOI 10.1038/nbt0410-319; Carriere Y, 2005, PEST MANAG SCI, V61, P327, DOI 10.1002/ps.1039; Carriere Y, 2001, P ROY SOC B-BIOL SCI, V268, P1475, DOI 10.1098/rspb.2001.1689; Carriere Y, 2012, P NATL ACAD SCI USA, V109, P775, DOI 10.1073/pnas.1117851109; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Center for Environmental Risk Assessment, GM CROP DAT EV NAM M; Choudhary B., 2013, BT COTTON INDIA COUN; Cotton CRC Extension Team, 2009, COTT PEST MAN GUID 2; Crespo ALB, 2009, PEST MANAG SCI, V65, P1071, DOI 10.1002/ps.1793; Dhurua S., 2011, PEST MANAG SCI; Downes Sharon, 2012, GM Crops Food, V3, P228, DOI 10.4161/gmcr.20194; Downes S, 2012, J INVERTEBR PATHOL, V110, P281, DOI 10.1016/j.jip.2012.04.005; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Edgerton MD, 2012, NAT BIOTECHNOL, V30, P493, DOI 10.1038/nbt.2259; EPA], 2001, BT PLANT INC PROT BI; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gassmann Aaron J, 2012, GM Crops Food, V3, P235, DOI 10.4161/gmcr.20744; Gassmann AJ, 2012, J INVERTEBR PATHOL, V110, P287, DOI 10.1016/j.jip.2012.04.006; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Genetic Engineering Approval Committee, 2010, DEC TAK 100 M GEN EN; GEORGHIOU GP, 1977, J ECON ENTOMOL, V70, P319, DOI 10.1093/jee/70.3.319; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; Gould F, 2006, J ECON ENTOMOL, V99, P2091, DOI 10.1603/0022-0493-99.6.2091; Gustafson DI, 2006, J ECON ENTOMOL, V99, P2116, DOI 10.1603/0022-0493-99.6.2116; Head G, 2010, J APPL ECOL, V47, P583, DOI 10.1111/j.1365-2664.2010.01796.x; Heckel DG, 2012, SCIENCE, V337, P1613, DOI 10.1126/science.1226994; Herring RJ, 2007, J DEV STUD, V43, P130, DOI 10.1080/00220380601055601; Huang Fangneng, 2012, GM Crops Food, V3, P245, DOI 10.4161/gmcr.20539; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Huang FN, 2009, CROP PROT, V28, P174, DOI 10.1016/j.cropro.2008.10.002; Huffman M, 2007, P 2007 BELTW COTT C, P1073; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jackson RE, 2006, J ECON ENTOMOL, V99, P1790, DOI 10.1603/0022-0493-99.5.1790; Jackson R. E., 2011, P 2011 BELTW COTT C, P893; Jackson RE, 2004, J ECON ENTOMOL, V97, P1719, DOI 10.1603/0022-0493-97.5.1719; James C, 2011, ISAAA BRIEFS, V43; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; Kruger M, 2011, ENVIRON ENTOMOL, V40, P477, DOI 10.1603/EN09220; Kruger M, 2012, J APPL ENTOMOL, V136, P38, DOI 10.1111/j.1439-0418.2011.01616.x; Kruger M, 2009, CROP PROT, V28, P684, DOI 10.1016/j.cropro.2009.04.001; Lalitha N, 2009, ROUTL EXPLOR ENVIRON, V19, P135; Liu YB, 1996, J ECON ENTOMOL, V89, P798, DOI 10.1093/jee/89.4.798; Liu YB, 1997, APPL ENVIRON MICROB, V63, P2218, DOI 10.1128/AEM.63.6.2218-2223.1997; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Luttrell R., 2004, P 2004 BELTW COTT C, V2004, P1373; Luttrell Randall G, 2012, GM Crops Food, V3, P213, DOI 10.4161/gmcr.20742; Luttrell RG, 1999, J ECON ENTOMOL, V92, P21, DOI 10.1093/jee/92.1.21; Mahon RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039192; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; McCaffery AR, 1998, PHILOS T R SOC B, V353, P1735, DOI 10.1098/rstb.1998.0326; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Moar W, 2008, NAT BIOTECHNOL, V26, P1072, DOI 10.1038/nbt1008-1072; *NAT RES COUNC, 1986, PEST RES STRAT TACT; National Agricultural Statistics Service, ACR; National Research Council, 2010, IMP GEN ENG CROPS FA; O'Rourke ME, 2010, ECOL APPL, V20, P1228, DOI 10.1890/09-0067.1; Onstad D, 2008, ISNECT RESISTANCE MA; Pan ZQ, 2011, ENVIRON ENTOMOL, V40, P964, DOI 10.1603/EN10305; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Pittendrigh BR, 2004, J THEOR BIOL, V231, P461, DOI 10.1016/j.jtbi.2004.05.023; Roush RT, 1997, PESTIC SCI, V51, P328, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;328::AID-PS650&gt;3.0.CO;2-B; ROUSH RT, 1994, BIOCONTROL SCI TECHN, V4, P501, DOI 10.1080/09583159409355364; Sainsbury F, 2012, TOXINS, V4, P455, DOI 10.3390/toxins4060455; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Showalter AM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.2201; Stodola TJ, 2006, J ECON ENTOMOL, V99, P502, DOI 10.1603/0022-0493-99.2.502; Stone GD, 2004, HUM ORGAN, V63, P127, DOI 10.17730/humo.63.2.jgvu7rlfafk9jwf9; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; TABASHNIK BE, 1982, ENVIRON ENTOMOL, V11, P1137, DOI 10.1093/ee/11.6.1137; Tabashnik BE, 2004, J EVOLUTION BIOL, V17, P904, DOI 10.1111/j.1420-9101.2004.00695.x; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P1074, DOI 10.1038/nbt1008-1074; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; Tabashnik Bruce E., 2012, P341; Tabashnik Bruce E, 2012, GM Crops Food, V3, P194, DOI 10.4161/gmcr.20329; Tabashnik BE, 2012, J ECON ENTOMOL, V105, P767, DOI 10.1603/EC12080; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2010, SOUTHWEST ENTOMOL, V35, P417, DOI 10.3958/059.035.0326; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2008, P NATL ACAD SCI USA, V105, P19029, DOI 10.1073/pnas.0810763106; Tabashnik Bruce E., 1999, P673, DOI 10.1016/B978-012257305-7/50071-0; Tang JD, 1996, APPL ENVIRON MICROB, V62, P564, DOI 10.1128/AEM.62.2.564-569.1996; US Department of Agriculture Economic Research Service, AD GEN ENG CROPS US; US Environmental Protection Agency, 2007, PEST NEWS STOR EPA A; US Environmental Protection Agency, 1998, FIN REP SUBP BAC THU; US Environmental Protection Agency, 2011, CURR PREV REG SECT 3; (US EPA) U. S. Environmental Protection Agency, 1998, ENV PROT AG WHIT PAP; USDA Agricultural Marketing Service, COTT VAR PLANT 2012; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Whalon ME, 2008, GLOBAL PESTICIDE RESISTANCE IN ARTHROPODS, P1, DOI 10.1079/9781845933531.0000; Williams M. R., 2012, P 2012 BELTW COTT C, P1001; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874; Zhao JZ, 2005, P NATL ACAD SCI USA, V102, P8426, DOI 10.1073/pnas.0409324102	121	637	690	16	518	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					510	521		10.1038/nbt.2597	http://dx.doi.org/10.1038/nbt.2597			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23752438				2022-12-27	WOS:000320113200022
J	Nivala, J; Marks, DB; Akeson, M				Nivala, Jeff; Marks, Douglas B.; Akeson, Mark			Unfoldase-mediated protein translocation through an alpha-hemolysin nanopore	NATURE BIOTECHNOLOGY			English	Article							DNA; CLPXP	Using nanopores to sequence biopolymers was proposed more than a decade ago(1). Recent advances in enzyme-based control of DNA translocation(2) and in DNA nucleotide resolution using modified biological pores(3) have satisfied two technical requirements of a functional nanopore DNA sequencing device. Nanopore sequencing of proteins was also envisioned(1). Although proteins have been shown to move through nanopores(4-6), a technique to unfold proteins for processive translocation has yet to be demonstrated. Here we describe controlled unfolding and translocation of proteins through the alpha-hemolysin (alpha-HL) pore using the AAA+ unfoldase CIpX. Sequence-dependent features of individual engineered proteins were detected during translocation. These results demonstrate that molecular motors can reproducibly drive proteins through a model nanopore-a feature required for protein sequence analysis using this single-molecule technology.	[Nivala, Jeff; Marks, Douglas B.; Akeson, Mark] Univ Calif Santa Cruz, Dept Biomol Engn, Nanopore Grp, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Akeson, M (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Nanopore Grp, Santa Cruz, CA 95064 USA.	makeson@soe.ucsc.edu	Akeson, Mark/HCH-3046-2022	Nivala, Jeff/0000-0002-8210-5417	UC startup grant; National Human Genome Research Institute [R01HG006321]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006321] Funding Source: NIH RePORTER	UC startup grant; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank Oxford Nanopore Technologies (Oxford, UK) for supplying alpha-HL heptamers, and A. Martin (UC Berkeley) for supplying ClpX-related expression plasmids and for helpful discussions on their use. R. Abu-Shumays, D. Bernick, K. Lieberman and H. Olsen commented on drafts of the manuscript. This work was supported by a UC startup grant to MA., and by equipment purchased previously using National Human Genome Research Institute grant R01HG006321. The C1pX-Delta N<INF>3</INF> BLR expression strain was obtained from A. Martin (UC Berkeley), as was a his-tagged ClpP expression strain.	Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Christensen C, 2011, J PEPT SCI, V17, P726, DOI 10.1002/psc.1393; Church G, 1998, US Patent, Patent No. [5,795,782, 5795782]; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Merstorf C, 2012, ACS CHEM BIOL, V7, P652, DOI 10.1021/cb2004737; Mohammad MM, 2008, J AM CHEM SOC, V130, P4081, DOI 10.1021/ja710787a; Movileanu L, 2009, TRENDS BIOTECHNOL, V27, P333, DOI 10.1016/j.tibtech.2009.02.008; Olasagasti F, 2010, NAT NANOTECHNOL, V5, P798, DOI [10.1038/nnano.2010.177, 10.1038/NNANO.2010.177]; Oukhaled G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158101; Sheng WY, 2002, PROTEIN SCI, V11, P1482, DOI 10.1110/ps.0201602; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Talaga DS, 2009, J AM CHEM SOC, V131, P9287, DOI 10.1021/ja901088b	18	227	248	5	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					247	250		10.1038/nbt.2503	http://dx.doi.org/10.1038/nbt.2503			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23376966	Green Accepted			2022-12-27	WOS:000316439500020
J	Zhong, SL; Fei, ZJ; Chen, YR; Zheng, Y; Huang, MY; Vrebalov, J; McQuinn, R; Gapper, N; Liu, B; Xiang, J; Shao, Y; Giovannoni, JJ				Zhong, Silin; Fei, Zhangjun; Chen, Yun-Ru; Zheng, Yi; Huang, Mingyun; Vrebalov, Julia; McQuinn, Ryan; Gapper, Nigel; Liu, Bao; Xiang, Jenny; Shao, Ying; Giovannoni, James J.			Single-base resolution methylomes of tomato fruit development reveal epigenome modifications associated with ripening	NATURE BIOTECHNOLOGY			English	Article							EPIGENETIC MUTATION; REGULATORY REGIONS; GENE-EXPRESSION; DNA; ETHYLENE; METHYLATION; TRANSCRIPTION; ARABIDOPSIS; GENOME; PLANTS	Ripening of tomato fruits is triggered by the plant hormone ethylene, but its effect is restricted by an unknown developmental cue to mature fruits containing viable seeds. To determine whether this cue involves epigenetic remodeling, we expose tomatoes to the methyltransferase inhibitor 5-azacytidine and find that they ripen prematurely. We performed whole-genome bisulfite sequencing on fruit in four stages of development, from immature to ripe. We identified 52,095 differentially methylated regions (representing 1% of the genome) in the 90% of the genome covered by our analysis. Furthermore, binding sites for RIN, one of the main ripening transcription factors, are frequently localized in the demethylated regions of the promoters of numerous ripening genes, and binding occurs in concert with demethylation. Our data show that the epigenome is not static during development and may have been selected to ensure the fidelity of developmental processes such as ripening. Crop-improvement strategies could benefit by taking into account not only DNA sequence variation among plant lines, but also the information encoded in the epigenome.	[Zhong, Silin; Fei, Zhangjun; Chen, Yun-Ru; Zheng, Yi; Huang, Mingyun; Vrebalov, Julia; McQuinn, Ryan; Gapper, Nigel; Giovannoni, James J.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Zhong, Silin; Liu, Bao] NE Normal Univ, Minist Educ, Key Labs Mol Epigenet, Changchun, Peoples R China; [Fei, Zhangjun; Giovannoni, James J.] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Xiang, Jenny; Shao, Ying] Cornell Univ, Weill Med Coll, Genom Resource Core Facil, New York, NY 10021 USA	Cornell University; Boyce Thompson Institute for Plant Research; Northeast Normal University - China; United States Department of Agriculture (USDA); Cornell University	Giovannoni, JJ (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	sz284@cornell.edu; zf25@cornell.edu; jjg33@cornell.edu	Fei, Zhangjun/H-5152-2012; Zheng, Yi/F-6150-2016; zhong, silin/O-7029-2015	Zheng, Yi/0000-0002-8042-7770; zhong, silin/0000-0002-0198-7383; Liu, Bao/0000-0001-5481-1675; McQuinn, Ryan/0000-0002-5549-5181; Fei, Zhangjun/0000-0001-9684-1450; zakaria, seyed moein/0000-0002-0086-1279	United States Department of Agriculture - Agricultural Research Service, National Science Foundation [IOS-0606595, IOS-0923312, DBI-0820612]; National Natural Science Foundation of China [30900783, 3090243]; Human Frontier Science Program [LTF000076/2009]	United States Department of Agriculture - Agricultural Research Service, National Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Human Frontier Science Program(Human Frontier Science Program)	We thank E. Richards, R. Schmitz and J. Ecker for discussion and thoughtful advice in preparing this manuscript, and R. White, Y. Xu and Z. Li for technical assistance. This project was supported by the United States Department of Agriculture - Agricultural Research Service, National Science Foundation IOS-0606595 and IOS-0923312 to J.J.G. and Z.F., DBI-0820612 to J.J.G., National Natural Science Foundation of China 30900783 and 3090243 to S.Z. and B.L. and the Human Frontier Science Program LTF000076/2009 to S.Z.	Barry CS, 2000, PLANT PHYSIOL, V123, P979, DOI 10.1104/pp.123.3.979; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; BURG SP, 1965, SCIENCE, V148, P1190, DOI 10.1126/science.148.3674.1190; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; DEIKMAN J, 1992, PLANT PHYSIOL, V100, P2013, DOI 10.1104/pp.100.4.2013; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fujisawa M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-26; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; KING GN, 1947, PLANT PHYSIOL, V22, P572, DOI 10.1104/pp.22.4.572; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; MCMURCHIE EJ, 1972, NATURE, V237, P235, DOI 10.1038/237235a0; MESSEGUER R, 1991, PLANT MOL BIOL, V16, P753, DOI 10.1007/BF00015069; NICHOLASS FJ, 1995, PLANT MOL BIOL, V28, P423, DOI 10.1007/BF00020391; OELLER PW, 1991, SCIENCE, V254, P437, DOI 10.1126/science.1925603; PATTERSON GI, 1993, GENETICS, V135, P881; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Seymour G, 2008, CURR OPIN PLANT BIOL, V11, P58, DOI 10.1016/j.pbi.2007.09.003; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang H, 2009, PLANT CELL, V21, P1428, DOI 10.1105/tpc.108.060830; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107	30	483	513	22	351	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					154	159		10.1038/nbt.2462	http://dx.doi.org/10.1038/nbt.2462			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23354102				2022-12-27	WOS:000315322100027
J	Schmid-Burgk, JL; Schmidt, T; Kaiser, V; Honing, K; Hornung, V				Schmid-Burgk, Jonathan L.; Schmidt, Tobias; Kaiser, Vera; Hoening, Klara; Hornung, Veit			A ligation-independent cloning technique for high-throughput assembly of transcription activator-like effector genes	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; TAL EFFECTORS; III EFFECTORS; PCR PRODUCTS; GENOME; EFFICIENT; CELLS; KNOCKOUT	Transcription activator-like (TAL) effector proteins derived from Xanthomonas species have emerged as versatile scaffolds for engineering DNA-binding proteins of user-defined specificity and functionality. Here we describe a rapid, simple, ligation-independent cloning (LIC) technique for synthesis of TAL effector genes. Our approach is based on a library of DNA constructs encoding individual TAL effector repeat unit combinations that can be processed to contain long, unique single-stranded DNA overhangs suitable for LIC. Assembly of TAL effector arrays requires only the combinatorial mixing of fluids and has exceptional fidelity. TAL effector nucleases (TALENs) produced by this method had high genome-editing activity at endogenous loci in HEK 293T cells (64% were active). To maximize throughput, we generated a comprehensive 5-mer TAL effector repeat unit fragment library that allows automated assembly of >600 TALEN genes in a single day. Given its simplicity, throughput and fidelity, LIC assembly will permit the generation of TAL effector gene libraries for large-scale functional genomics studies.	[Schmid-Burgk, Jonathan L.; Schmidt, Tobias; Kaiser, Vera; Hoening, Klara; Hornung, Veit] Univ Bonn, Univ Hosp, Unit Clin Biochem, Inst Clin Chem & Clin Pharmacol, Bonn, Germany	University of Bonn	Hornung, V (corresponding author), Univ Bonn, Univ Hosp, Unit Clin Biochem, Inst Clin Chem & Clin Pharmacol, Bonn, Germany.	veit.hornung@uni-bonn.de	Hornung, Veit/C-3565-2012; Schmid-Burgk, Jonathan/GSN-3512-2022	Hornung, Veit/0000-0002-4150-194X; Schmidt, Tobias/0000-0003-3102-3515; Schmid-Burgk, Jonathan/0000-0003-0988-2487	German Research Foundation [SFB704, SFB670]; European Research Council [ERC-2009-StG 243046]	German Research Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	We thank T. Cathomen for technical advice with the T7EI assay and M. Holzel for helpful discussion. V. H. is member of the excellence cluster ImmunoSensation and supported by grants from the German Research Foundation (SFB704 and SFB670) and the European Research Council (ERC-2009-StG 243046).	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Schmid-Burgk JL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks236; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Watanabe T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2020; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	27	165	189	1	120	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					76	+		10.1038/nbt.2460	http://dx.doi.org/10.1038/nbt.2460			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23242165	Green Accepted			2022-12-27	WOS:000313563600025
J	Giusti, K				Giusti, Kathy			The Multiple Myeloma Research Foundation's evolving focus on drug R&D	NATURE BIOTECHNOLOGY			English	Letter								The Multiple Myeloma Research Foundation (MMRF) has developed innovative, collaborative business models to reshape the R&D enterprise with the single-minded focus of accelerating the development of new treatments for patients to extend their lives and lead to a cure.	Multiple Myeloma Res Fdn, Norwalk, CT USA		Giusti, K (corresponding author), Multiple Myeloma Res Fdn, Norwalk, CT USA.	giustik@themmrf.org						Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Dilts DM, 2006, J CLIN ONCOL, V24, P4545, DOI 10.1200/JCO.2005.05.0104; Wear S., 2011, P AM SOC HEM SAN DIE	3	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					600	603		10.1038/nbt.2297	http://dx.doi.org/10.1038/nbt.2297			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781678				2022-12-27	WOS:000306293400014
J	Hopkins, MM; Hogarth, S				Hopkins, Michael M.; Hogarth, Stuart			Biomarker patents for diagnostics: problem or solution?	NATURE BIOTECHNOLOGY			English	Editorial Material							PHARMACOGENETICS; GENE		[Hopkins, Michael M.] Univ Sussex, SPRU Sci & Technol Policy Res, Brighton, E Sussex, England; [Hogarth, Stuart] Kings Coll London, Dept Social Sci Hlth & Med, London WC2R 2LS, England	University of Sussex; University of London; King's College London	Hopkins, MM (corresponding author), Univ Sussex, SPRU Sci & Technol Policy Res, Brighton, E Sussex, England.	m.m.hopkins@sussex.ac.uk; stuart.hogarth@kcl.ac.uk		Hogarth, Stuart/0000-0001-6796-8815	Economic and Social Research Council [ES/J012521/1] Funding Source: researchfish; ESRC [ES/J012521/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		*ASS U TECHN MAN, 2007, PUBL INT 9 POINTS CO; Baker M, 2006, NAT BIOTECHNOL, V24, P931, DOI 10.1038/nbt0806-931; Carbone J, 2010, NAT BIOTECHNOL, V28, P784, DOI 10.1038/nbt0810-784; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Cornish W.R., 2003, INTELLECTUAL PROPERT; Digene Corp, 2003, ANN REP DIG CORP; Gaisser S, 2009, NATURE, V458, P407, DOI 10.1038/458407a; Garrison LP, 2006, HEALTH AFFAIR, V25, P1281, DOI 10.1377/hlthaff.25.5.1281; Hogarth S, 2012, SOCIOL HEALTH ILL, V34, P234, DOI 10.1111/j.1467-9566.2011.01411.x; Hopkins MM, 2006, NAT BIOTECHNOL, V24, P403, DOI 10.1038/nbt0406-403; Human Genetics Commission, 2011, INT PROP DNA DIAGN; Huys I, 2011, EUR J HUM GENET, V19, P1104, DOI 10.1038/ejhg.2011.76; Huys I, 2009, NAT BIOTECHNOL, V27, P903, DOI 10.1038/nbt1009-903; Liddell K, 2008, INTELLECTUAL PROPERT, V3, P286; Malik NN, 2011, NAT BIOTECHNOL, V29, P390, DOI 10.1038/nbt.1869; Matthijs G, 2004, BRIT MED J, V329, P1358, DOI 10.1136/bmj.329.7479.1358; NASS SJ, 2007, CANC BIOMARKERS PROM; National Endowment for Science Technology and the Arts, 2006, INN GAP, P24; *NUFF COUNC BIOETH, 2002, ETH PAT DNA; Organisation for Economic Cooperation and Development, 2006, GUID LIC GEN INV; Secretary's Advisory Committee for Genetics Health and Society, 2010, GEN PAT LIC PRACT TH; Stiglitz JE, 2006, BMJ-BRIT MED J, V333, P1279, DOI 10.1136/bmj.39048.428380.80; Thompson M, 2011, BRIT MED J, V342, pd2973	23	12	12	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					498	501		10.1038/nbt.2257	http://dx.doi.org/10.1038/nbt.2257			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22678384	Bronze			2022-12-27	WOS:000305158600016
J	Carter, SL; Cibulskis, K; Helman, E; McKenna, A; Shen, H; Zack, T; Laird, PW; Onofrio, RC; Winckler, W; Weir, BA; Beroukhim, R; Pellman, D; Levine, DA; Lander, ES; Meyerson, M; Getz, G				Carter, Scott L.; Cibulskis, Kristian; Helman, Elena; McKenna, Aaron; Shen, Hui; Zack, Travis; Laird, Peter W.; Onofrio, Robert C.; Winckler, Wendy; Weir, Barbara A.; Beroukhim, Rameen; Pellman, David; Levine, Douglas A.; Lander, Eric S.; Meyerson, Matthew; Getz, Gad			Absolute quantification of somatic DNA alterations in human cancer	NATURE BIOTECHNOLOGY			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COPY-NUMBER ALTERATION; NUCLEOTIDE POLYMORPHISM ARRAYS; HIGH-RESOLUTION ANALYSIS; ACUTE MYELOID-LEUKEMIA; CHROMOSOMAL INSTABILITY; GENETIC EVOLUTION; PROSTATE-CANCER; TUMOR SAMPLES; SOLID TUMORS	We describe a computational method that infers tumor purity and malignant cell ploidy directly from analysis of somatic DNA alterations. The method, named ABSOLUTE, can detect subclonal heterogeneity and somatic homozygosity, and it can calculate statistical sensitivity for detection of specific aberrations. We used ABSOLUTE to analyze exome sequencing data from 214 ovarian carcinoma tumor-normal pairs. This analysis identified both pervasive subclonal somatic point-mutations and a small subset of predominantly clonal and homozygous mutations, which were overrepresented in the tumor suppressor genes TP53 and NF1 and in a candidate tumor suppressor gene CDK12. We also used ABSOLUTE to infer absolute allelic copy-number profiles from 3,155 diverse cancer specimens, revealing that genome-doubling events are common in human cancer, likely occur in cells that are already aneuploid, and influence pathways of tumor progression (for example, with recessive inactivation of NF1 being less common after genome doubling). ABSOLUTE will facilitate the design of clinical sequencing studies and studies of cancer genome evolution and intra-tumor heterogeneity.	[Carter, Scott L.; Cibulskis, Kristian; Helman, Elena; McKenna, Aaron; Onofrio, Robert C.; Winckler, Wendy; Weir, Barbara A.; Beroukhim, Rameen; Lander, Eric S.; Meyerson, Matthew; Getz, Gad] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Carter, Scott L.; Helman, Elena] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Shen, Hui; Laird, Peter W.] Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Zack, Travis] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA; [Zack, Travis; Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; [Zack, Travis; Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Div Canc Biol, Boston, MA 02115 USA; [Zack, Travis; Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Beroukhim, Rameen] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Pellman, David] Harvard Univ, Childrens Hosp, Dana Farber Canc Inst,Dept Cell Biol, Howard Hughes Med Inst,Dept Pediat Oncol,Sch Med, Boston, MA 02115 USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Southern California; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Getz, G (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	gadgetz@broadinstitute.org	Shen, Hui/AAO-4387-2020; Cibulskis, Kristian/AAC-7380-2019; Laird, Peter W/G-8683-2012; Meyerson, Matthew L/E-7123-2012	Laird, Peter W/0000-0001-9117-3641; Levine, Douglas/0000-0003-1038-8232; Cibulskis, Kristian/0000-0003-1343-1582; Meyerson, Matthew/0000-0002-9133-8108; Shen, Hui/0000-0001-9767-4084	National Cancer Institute [U24CA126546, U24CA143867, U24CA143845]; National Human Genome Research Institute [T32 HG002295]; US National Institutes of Health (NIH) [5R01 GM083299-14]; Department of Defense [W81XWH-10-1-0222]; NIH/National Institute of General Medical Sciences [5 T32 GM008313]; NIH [K08CA122833, U54CA14379]; National Research Service Award [F32CA113126]; NATIONAL CANCER INSTITUTE [U24CA143867, U24CA143882, U24CA126546, K08CA122833, U24CA143845, F32CA113126, U54CA143798] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, R01GM083299] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Cancer Institute as part of The Cancer Genome Atlas project: U24CA126546 (M.M.), U24CA143867 (M.M.), and U24CA143845 (G.G.). S.L.C. and E.H. were supported by training grant T32 HG002295 from the National Human Genome Research Institute. In addition, D.P. was supported by the US National Institutes of Health (NIH) - 5R01 GM083299-14; D.A.L. by Department of Defense W81XWH-10-1-0222; T.Z. by NIH/National Institute of General Medical Sciences 5 T32 GM008313; R.B. by NIH K08CA122833 and U54CA143798. B.A.W. was supported by National Research Service Award grant F32CA113126.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Attiyeh EF, 2009, GENOME RES, V19, P276, DOI 10.1101/gr.075671.107; Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bazeley PS, 2011, CELL PROLIFERAT, V44, P212, DOI 10.1111/j.1365-2184.2011.00746.x; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carter S.L, 2011, ACCURATE ESTIMATION; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; DUTRILLAUX B, 1991, BREAST CANCER RES TR, V19, P245, DOI 10.1007/BF01961161; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Hicks J, 2005, COLD SH Q B, V70, P51, DOI 10.1101/sqb.2005.70.055; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Li A, 2011, NUCLEIC ACIDS RES, V39, P4928, DOI 10.1093/nar/gkr014; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Lyng H, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r86; Mei R, 2000, GENOME RES, V10, P1126, DOI 10.1101/gr.10.8.1126; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mitelman F, 2000, MUTAT RES-REV MUTAT, V462, P247, DOI 10.1016/S1383-5742(00)00006-5; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Roschke AV, 2003, CANCER RES, V63, P8634; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yau C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r92; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	60	1206	1239	4	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					413	+		10.1038/nbt.2203	http://dx.doi.org/10.1038/nbt.2203			14	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22544022	Bronze, Green Accepted, Green Submitted			2022-12-27	WOS:000303803200021
J	Wu, LC; Wu, LH				Wu, Liangchuan; Wu, Lianghong			Pharmaceutical patent evaluation and licensing using a stochastic model and Monte Carlo simulations	NATURE BIOTECHNOLOGY			English	Editorial Material							OPTIONS; INVESTMENT; FIRM; REAL		[Wu, Lianghong] Natl Cent Univ, Chungli 32054, Taiwan; [Wu, Liangchuan] Natl Chung Hsing Univ, Taichung 40227, Taiwan	National Central University; National Chung Hsing University	Wu, LH (corresponding author), Natl Cent Univ, Chungli 32054, Taiwan.	wlh@mgt.ncu.edu.tw	Wu, Lianghong/AAM-8081-2021	Wu, Liang-Hong/0000-0002-6665-1709				[Anonymous], 2010, PHARM LICENSING OVER; Baudry M, 2006, REV IND ORGAN, V28, P41, DOI 10.1007/s11151-006-0001-0; Burgess P, 2010, NAT BIOTECHNOL, V28, P1267, DOI 10.1038/nbt.1725; David E, 2009, NAT REV DRUG DISCOV, V8, P609, DOI 10.1038/nrd2948; Dixit A.K., 1994, INVESTMENT UNCERTAIN, DOI DOI 10.1515/9781400830176; Kellogg D., 2000, FINANCIAL ANAL J, V56, P76, DOI DOI 10.2469/FAJ.V56.N3.2362; Kulatilaka N, 1998, MANAGE SCI, V44, P1021, DOI 10.1287/mnsc.44.8.1021; MYERS SC, 1974, J FINANC, V29, P1, DOI 10.2307/2978211; Myers SC., 1997, LIFE CYCLE FINANCIAL; PINDYCK RS, 1988, AM ECON REV, V78, P969; Schwartz E., 2004, ECON NOTES, V33, P23, DOI [https://doi.org/10.1111/j.0391-5026.2004.00124.x, DOI 10.1111/J.0391-5026.2004.00124.X]; Stewart JJ, 2001, NAT BIOTECHNOL, V19, P813, DOI 10.1038/nbt0901-813; Villiger R, 2005, NAT BIOTECHNOL, V23, P423, DOI 10.1038/nbt0405-423; Wu MC, 2006, APPL ECON LETT, V13, P313, DOI 10.1080/13504850500393477; 2006, PHARM LICENSING STRA	15	2	2	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2011	29	9					798	802		10.1038/nbt.1963	http://dx.doi.org/10.1038/nbt.1963			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	817ZT	21904321				2022-12-27	WOS:000294718400017
J	Van Eenennaam, AL; Muir, WM				Van Eenennaam, Alison L.; Muir, William M.			Transgenic salmon: a final leap to the grocery shelf?	NATURE BIOTECHNOLOGY			English	Letter							POSSIBLE ECOLOGICAL RISKS; FISH; ALLERGEN; PARVALBUMIN; STORAGE		[Van Eenennaam, Alison L.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Muir, William M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	University of California System; University of California Davis; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Van Eenennaam, AL (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	alvaneenennaam@ucdavis.edu	Van Eenennaam, Alison L/G-3481-2011	Van Eenennaam, Alison L/0000-0003-1562-162X				AquaBounty Technologies Inc, 2010, ENV ASS ADQADVANTAGE; Conko G, 2010, NAT BIOTECHNOL, V28, P1256, DOI 10.1038/nbt.1730; Goodman RE, 2008, NAT BIOTECHNOL, V26, P73, DOI 10.1038/nbt1343; Kuehn A, 2010, INT ARCH ALLERGY IMM, V153, P359, DOI 10.1159/000316346; Lindstrom CDV, 1996, SCAND J IMMUNOL, V44, P335, DOI 10.1046/j.1365-3083.1996.d01-314.x; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; Lynch M, 2001, CONSERV GENET, V2, P363, DOI 10.1023/A:1012550620717; Marzban G., 2005, PLANT SCI, V169, P387; Moreau D.T.R.Conway, 2011, EVOL APPL        JUL, DOI [10.1111/j.1752-4571.2011.00196.x, DOI 10.1111/J.1752-4571.2011.00196.X]; Muir W.M., 2001, AM NAT, V158, P1; Muir WM, 2004, EMBO REP, V5, P654, DOI 10.1038/sj.embor.7400197; Muir WM, 2002, TRANSGENIC RES, V11, P101, DOI 10.1023/A:1015203812200; Muir WM, 1999, P NATL ACAD SCI USA, V96, P13853, DOI 10.1073/pnas.96.24.13853; National Research Council, 2002, COMM DEF SCI BAS CON; Nordlee JA, 1996, NEW ENGL J MED, V334, P688, DOI 10.1056/NEJM199603143341103; Pollack A., 2010, NY TIMES        0903; Sancho AI, 2006, J AGR FOOD CHEM, V54, P5098, DOI 10.1021/jf0530446; Sancho AI, 2006, J AGR FOOD CHEM, V54, P5917, DOI 10.1021/jf060880m; Schiermeier Q, 2003, NATURE, V425, P753, DOI 10.1038/425753a; Sten E, 2004, APMIS, V112, P21, DOI 10.1111/j.1600-0463.2004.apm1120104.x; United Nations Food and Agriculture Organization and World Health Organization, 2008, GUID COND FOOD SAF A; . US Food and Drug Administration, 2009, FDA FIN GUID IND 187; US Food and Drug Administration, 2010, FDA VET MED ADV COMM; Wild LG, 2005, CURR ALLERGY ASTHM R, V5, P74, DOI 10.1007/s11882-005-0059-z; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Young D., 2011, REP YOUNGS FRANKENFI	26	42	45	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					706	710		10.1038/nbt.1938	http://dx.doi.org/10.1038/nbt.1938			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21822244				2022-12-27	WOS:000293696500019
J	Benson, JM; Sachs, CW; Treacy, G; Zhou, HH; Pendley, CE; Brodmerkel, CM; Shankar, G; Mascelli, MA				Benson, Jacqueline M.; Sachs, Clifford W.; Treacy, George; Zhou, Honghui; Pendley, Charles E.; Brodmerkel, Carrie M.; Shankar, Gopi; Mascelli, Mary A.			Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab	NATURE BIOTECHNOLOGY			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELL POPULATION; IFN-GAMMA; DOUBLE-BLIND; PHASE-I; MULTIPLE-SCLEROSIS; SEVERE PSORIASIS; CYTOKINE; IL-23	Preclinical and clinical studies conducted in the mid-1990s reported strong association and causality between the T-cell helper (T-H) 1 inductor cytokine interleukin (IL)-12 and numerous immune-mediated disorders, which spurred the development of therapeutic agents targeting IL-12 function. One of the first to enter the clinic, ustekinumab, is a human monoclonal antibody (mAb) that binds to the p40 subunit of IL-12. Subsequent to the generation of ustekinumab, it was discovered that IL-23 also contains the p40 subunit. Thus, although ustekinumab was designed to target IL-12, it also modulates IL-23, a cytokine important to the development and/or maintenance of T(H)17 cells. Clinical observations established that IL-12/23p40 is integral to the pathologies of psoriasis, psoriatic arthritis and Crohn's disease. The molecular and cellular evaluations conducted in ustekinumab clinical programs have provided numerous insights into the pathologic processes of these disorders, illustrating how a novel molecular entity can contribute to our understanding of disease. The individual contributions of these cytokines to specific pathologies require investigation and clinical evaluation of the role of IL-12-and IL-23-specific inhibitors.	[Benson, Jacqueline M.; Sachs, Clifford W.; Treacy, George; Zhou, Honghui; Pendley, Charles E.; Brodmerkel, Carrie M.; Shankar, Gopi] Centocor Res & Dev Inc, Malvern, PA USA; [Mascelli, Mary A.] Biopharmaceut Consultant LLC, Ambler, PA USA	Johnson & Johnson; Johnson & Johnson USA	Benson, JM (corresponding author), Centocor Res & Dev Inc, Malvern, PA USA.	jbenson4@its.jnj.com						Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Airoldi I, 2005, BLOOD, V106, P3846, DOI 10.1182/blood-2005-05-2034; Berrebi D, 1998, AM J PATHOL, V152, P667; Bowman EP, 2006, CURR OPIN INFECT DIS, V19, P245, DOI 10.1097/01.qco.0000224818.42729.67; Brodmerkel C, 2010, J DRUGS DERMATOL, V9, P677; Buse E, 2003, TOXICOLOGY, V185, P221, DOI 10.1016/S0300-483X(02)00614-5; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cardenes M, 2010, J MED GENET, V47, P635, DOI 10.1136/jmg.2009.071910; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Curtis MM, 2009, J IMMUNOL, V183, P381, DOI 10.4049/jimmunol.0900939; Davidson NJ, 1998, J IMMUNOL, V161, P3143; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; DILLON SB, 2010, DRUG DISC WORLD  FAL, P87; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fassbender K, 1998, NEUROLOGY, V51, P753, DOI 10.1212/WNL.51.3.753; Fieschi C, 2003, EUR J IMMUNOL, V33, P1461, DOI 10.1002/eji.200324038; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fishwild DM, 1996, NAT BIOTECHNOL, V14, P845, DOI 10.1038/nbt0796-845; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Ghetie V, 2002, IMMUNOL RES, V25, P97, DOI 10.1385/IR:25:2:097; Gottlieb A, 2010, LANCET, V376, P1542; Gottlieb AB, 2007, CURR MED RES OPIN, V23, P1081, DOI 10.1185/030079907X182112; Gottlieb AB, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.06.021; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Hong K, 1999, J IMMUNOL, V162, P7480; JUDSON M, J AM ACAD D IN PRESS; Kasper LH, 2006, CURR MED RES OPIN, V22, P1671, DOI 10.1185/030079906X120931; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, NAT IMMUNOL, V8, P903, DOI 10.1038/ni0907-903; Leonard JP, 1997, BLOOD, V90, P2541; LEONARD JP, 1995, J EXP MED, V181, P381, DOI 10.1084/jem.181.1.381; Leonardi CL, 2008, LANCET, V371, P1838; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Looney RJ, 2007, CLIN IMMUNOL, V123, P235, DOI 10.1016/j.clim.2007.01.001; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Luo JQ, 2010, J MOL BIOL, V402, P797, DOI 10.1016/j.jmb.2010.07.046; Malfait AM, 1998, CLIN EXP IMMUNOL, V111, P377; MARTIN PL, 2010, BIRTH DEFECTS RES, V83, P1; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Naz RK, 1998, J ANDROL, V19, P302; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nicoletti F, 1996, J NEUROIMMUNOL, V70, P87, DOI 10.1016/S0165-5728(96)00101-4; Novelli F, 2004, CYTOKINE GROWTH F R, V15, P367, DOI 10.1016/j.cytogfr.2004.03.009; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Portielje JEA, 1999, CLIN CANCER RES, V5, P3983; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Reddy M, 2010, J DERMATOL, V37, P413, DOI 10.1111/j.1346-8138.2010.00802.x; SACHS C, 2008, TOXICOLOGIST, V102; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Shigehara K, 2001, J IMMUNOL, V166, P642, DOI 10.4049/jimmunol.166.1.642; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Toichi E, 2006, J IMMUNOL, V177, P4917, DOI 10.4049/jimmunol.177.7.4917; Torti DC, 2007, J AM ACAD DERMATOL, V57, P1059, DOI 10.1016/j.jaad.2007.07.016; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; van Boxel-Dezaire AHH, 1999, ANN NEUROL, V45, P695, DOI 10.1002/1531-8249(199906)45:6<695::AID-ANA3>3.0.CO;2-R; van de Wetering D, 2009, INT IMMUNOL, V21, P145, DOI 10.1093/intimm/dxn132; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; WINDHAGEN A, 1995, J EXP MED, V182, P1985, DOI 10.1084/jem.182.6.1985; Yawalkar N, 1998, J INVEST DERMATOL, V111, P1053, DOI 10.1046/j.1523-1747.1998.00446.x; Zhou HH, 2006, J CLIN PHARMACOL, V46, P1268, DOI 10.1177/0091270006294278; Zhou HH, 2010, J CLIN PHARMACOL, V50, P257, DOI 10.1177/0091270009343695; Zhou HH, 2009, DRUG DISCOV TODAY, V14, P891, DOI 10.1016/j.drudis.2009.05.014; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu YW, 2010, INT J CLIN PHARM TH, V48, P830; Zhu YW, 2007, J CLIN PHARMACOL, V47, P1203; Zhu YW, 2009, J CLIN PHARMACOL, V49, P162, DOI 10.1177/0091270008329556	84	104	107	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2011	29	7					615	624		10.1038/nbt.1903	http://dx.doi.org/10.1038/nbt.1903			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	790NM	21747388				2022-12-27	WOS:000292595200020
J	Rongvaux, A; Willinger, T; Martinek, J; Strowig, T; Gearty, SV; Teichmann, LL; Saito, Y; Marches, F; Halene, S; Palucka, AK; Manz, MG; Flavell, RA				Rongvaux, Anthony; Willinger, Tim; Martinek, Jan; Strowig, Till; Gearty, Sofia V.; Teichmann, Lino L.; Saito, Yasuyuki; Marches, Florentina; Halene, Stephanie; Palucka, A. Karolina; Manz, Markus G.; Flavell, Richard A.			Development and function of human innate immune cells in a humanized mouse model	NATURE BIOTECHNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; TUMOR-ASSOCIATED MACROPHAGES; REGULATORY PROTEIN ALPHA; LYMPHOID-SYSTEM MICE; NATURAL-KILLER-CELLS; IN-VIVO; TRANSGENIC EXPRESSION; RECONSTITUTION; ENGRAFTMENT; HOMEOSTASIS	Mice repopulated with human hematopoietic cells are a powerful tool for the study of human hematopoiesis and immune function in vivo. However, existing humanized mouse models cannot support development of human innate immune cells, including myeloid cells and natural killer (NK) cells. Here we describe two mouse strains called MITRG and MISTRG, in which human versions of four genes encoding cytokines important for innate immune cell development are knocked into their respective mouse loci. The human cytokines support the development and function of monocytes, macrophages and NK cells derived from human fetal liver or adult CD34(+) progenitor cells injected into the mice. Human macrophages infiltrated a human tumor xenograft in MITRG and MISTRG mice in a manner resembling that observed in tumors obtained from human patients. This humanized mouse model may be used to model the human immune system in scenarios of health and pathology, and may enable evaluation of therapeutic candidates in an in vivo setting relevant to human physiology.	[Rongvaux, Anthony; Willinger, Tim; Strowig, Till; Gearty, Sofia V.; Flavell, Richard A.] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA; [Martinek, Jan; Marches, Florentina; Palucka, A. Karolina] Baylor Inst Immunol Res, Dallas, TX USA; [Martinek, Jan] Baylor Univ, Biomed Studies Program, Waco, TX 76798 USA; [Teichmann, Lino L.] Yale Univ, Dept Lab Med, New Haven, CT USA; [Teichmann, Lino L.] Univ Hosp Bonn, Dept Med 3, Bonn, Germany; [Saito, Yasuyuki] Univ Zurich Hosp, Div Hematol, CH-8091 Zurich, Switzerland; [Halene, Stephanie] Yale Univ, Dept Internal Med, Sect Hematol, New Haven, CT USA; [Halene, Stephanie] Yale Univ, Yale Comprehens Canc Ctr, New Haven, CT USA; [Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA	Yale University; Baylor Scott & White Health; Baylor University; Yale University; University of Bonn; University of Zurich; University Zurich Hospital; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA.	markus.manz@usz.ch; richard.flavell@yale.edu	Saito, Yasuyuki/AAD-1436-2019; Saito, Yasuyuki/C-2541-2015; Teichmann, Lino/GQA-4636-2022	Saito, Yasuyuki/0000-0002-9291-1383; Saito, Yasuyuki/0000-0002-9291-1383; Strowig, Till/0000-0003-0185-1459; Willinger, TIM/0000-0002-8720-7199; Manz, Markus/0000-0002-4676-7931; Teichmann, Lino/0000-0001-9489-7282; Gearty, Sofia/0000-0001-8633-3663	Bill and Melinda Gates Foundation; US National Institutes of Health [CA156689, CA129350, CA84512, CA140602]; University of Zurich Clinical Research Program; Juvenile Diabetes Research Foundation; Connecticut Stem Cell Research Grants Program; Baylor Health Care System Foundation; American Cancer Society [58-012-54]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA140602, R01CA129350, R01CA156689, P01CA084512] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Zurich Clinical Research Program; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Connecticut Stem Cell Research Grants Program; Baylor Health Care System Foundation; American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Yancopoulos, D. Valenzuela, A. Murphy and W. Auerbach at Regeneron Pharmaceuticals who generated, in collaboration with our groups, the individual knock-in alleles combined in MISTRG, J. Alderman for managerial support, A.M. Franco, P. Ranney, C. Weibel, S. Patel and M. Santhanakrishnan for technical assistance, G. Lyon for cell sorting and C. Lieber for manuscript submission. This work was supported by the Bill and Melinda Gates Foundation and US National Institutes of Health CA156689 (to R. A. F. and M.G.M.), CA129350, CA84512, CA140602 (to A.K.P.); the University of Zurich Clinical Research Program (to M.G.M.); the Juvenile Diabetes Research Foundation and the Connecticut Stem Cell Research Grants Program (to R.A.F.); the Baylor Health Care System Foundation (to A.K.P.); and an Institutional Research Grant 58-012-54 from the American Cancer Society (to S.H.). T.S. was supported by the Leukemia and Lymphoma Society. The Me290 cell line was established at the Ludwig Cancer Institute in Lausanne.	Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Brehm MA, 2012, BLOOD, V119, P2778, DOI 10.1182/blood-2011-05-353243; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Chow A, 2011, NAT REV IMMUNOL, V11, P788, DOI 10.1038/nri3087; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Drake AC, 2012, CELL MOL IMMUNOL, V9, P215, DOI 10.1038/cmi.2012.6; Gille C, 2012, HUM IMMUNOL, V73, P346, DOI 10.1016/j.humimm.2012.01.006; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Ito R, 2013, J IMMUNOL, V191, P2890, DOI 10.4049/jimmunol.1203543; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Kandalaft LE, 2011, CURR TOP MICROBIOL, V344, P129, DOI 10.1007/82_2010_95; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Lang JL, 2013, J IMMUNOL, V190, P2090, DOI 10.4049/jimmunol.1202810; Legrand N, 2011, P NATL ACAD SCI USA, V108, P13224, DOI 10.1073/pnas.1101398108; Li Y, 2013, J IMMUNOL, V191, P3192, DOI 10.4049/jimmunol.1300742; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Nicolini FE, 2004, LEUKEMIA, V18, P341, DOI 10.1038/sj.leu.2403222; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Rathinam C, 2011, BLOOD, V118, P3119, DOI 10.1182/blood-2010-12-326926; Raulet DH, 2006, SEMIN IMMUNOL, V18, P145, DOI 10.1016/j.smim.2006.03.003; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Rongvaux A, 2011, P NATL ACAD SCI USA, V108, P2378, DOI 10.1073/pnas.1019524108; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soderquest K, 2011, BLOOD, V117, P4511, DOI 10.1182/blood-2010-10-312264; Strowig T, 2011, P NATL ACAD SCI USA, V108, P13218, DOI 10.1073/pnas.1109769108; Strowig T, 2010, BLOOD, V116, P4158, DOI 10.1182/blood-2010-02-270678; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tanaka S, 2012, J IMMUNOL, V188, P6145, DOI 10.4049/jimmunol.1103660; Thanopoulou E, 2004, BLOOD, V103, P4285, DOI 10.1182/blood-2003-09-3192; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Valmori D, 1998, J IMMUNOL, V160, P1750; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wang XL, 2012, J CLIN INVEST, V122, P3888, DOI 10.1172/JCI64397; Willinger T, 2011, TRENDS IMMUNOL, V32, P321, DOI 10.1016/j.it.2011.04.005; Willinger T, 2011, P NATL ACAD SCI USA, V108, P2390, DOI 10.1073/pnas.1019682108; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3	50	452	472	8	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					364	U230		10.1038/nbt.2858	http://dx.doi.org/10.1038/nbt.2858			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24633240	Green Accepted			2022-12-27	WOS:000334340800021
J	Fu, YF; Sander, JD; Reyon, D; Cascio, VM; Joung, JK				Fu, Yanfang; Sander, Jeffry D.; Reyon, Deepak; Cascio, Vincent M.; Joung, J. Keith			Improving CRISPR-Cas nuclease specificity using truncated guide RNAs	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER TARGETER; HUMAN-CELLS; TRANSCRIPTION FACTORS; HUMAN GENOME; TOOL; NICKASES; SYSTEMS; NICKING; GENES; ZIFIT	Clustered, regularly interspaced, short palindromic repeat (CRISPR) RNA-guided nucleases (RGNs) are highly efficient genome editing tools(1-3). CRISPR-associated 9 (Cas9) RGNs are directed to genomic loci by guide RNAs (gRNAs) containing 20 nucleotides that are complementary to a target DNA sequence. However, RGNs can induce mutations at sites that differ by as many as five nucleotides from the intended target(4-6). Here we report that truncated gRNAs, with shorter regions of target complementarity <20 nucleotides in length, can decrease undesired mutagenesis at some off-target sites by 5,000-fold or more without sacrificing on-target genome editing efficiencies. In addition, use of truncated gRNAs can further reduce off-target effects induced by pairs of Cas9 variants that nick DNA (paired nickases). Our results delineate a simple, effective strategy to improve the specificities of Cas9 nucleases or paired nickases.	[Fu, Yanfang; Sander, Jeffry D.; Reyon, Deepak; Cascio, Vincent M.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Fu, Yanfang; Sander, Jeffry D.; Reyon, Deepak; Cascio, Vincent M.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Fu, Yanfang; Sander, Jeffry D.; Reyon, Deepak; Cascio, Vincent M.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Fu, Yanfang; Sander, Jeffry D.; Reyon, Deepak; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	jsander@alumni.iastate.edu; jjoung@mgh.harvard.edu	Reyon, Deepak/HCH-3183-2022		National Institutes of Health (NIH) Director's Pioneer Award [DP1 GM105378]; NIH [R01 GM088040, NIH P50 HG005550]; Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; US Army Research Laboratory; US Army-Research Office [W911NF-11-2-0056]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088040, DP1GM105378] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Director's Pioneer Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army-Research Office; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Maeder, S. Tsai and J. Angstman for helpful discussions and comments on the manuscript and J. Foden for technical assistance. This work was funded by a National Institutes of Health (NIH) Director's Pioneer Award (DP1 GM105378), NIH R01 GM088040, NIH P50 HG005550, and the Jim and Ann Orr Massachusetts General Hospital (MGH) Research Scholar Award. This material is based upon work supported by, or in part by, the US Army Research Laboratory and the US Army-Research Office under grant number W911NF-11-2-0056.	Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Charpentier E, 2013, NATURE, V495, P50, DOI 10.1038/495050a; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	28	1271	1550	13	468	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					279	284		10.1038/nbt.2808	http://dx.doi.org/10.1038/nbt.2808			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24463574	Green Accepted, Green Submitted			2022-12-27	WOS:000332819800027
J	Jarchum, I				Jarchum, Irene			A one-two punch knocks out biofilms	NATURE BIOTECHNOLOGY			English	Editorial Material																		Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790	2	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					142	142		10.1038/nbt.2813	http://dx.doi.org/10.1038/nbt.2813			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24509763	Bronze			2022-12-27	WOS:000331074000017
J	Bonning, BC; Pal, N; Liu, SJ; Wang, ZH; Sivakumar, S; Dixon, PM; King, GF; Miller, WA				Bonning, Bryony C.; Pal, Narinder; Liu, Sijun; Wang, Zhaohui; Sivakumar, S.; Dixon, Philip M.; King, Glenn F.; Miller, W. Allen			Toxin delivery by the coat protein of an aphid-vectored plant virus provides plant resistance to aphids	NATURE BIOTECHNOLOGY			English	Article							INSECTICIDAL NEUROTOXIN; BACILLUS-THURINGIENSIS; BT COTTON; TRANSMISSION; LUTEOVIRUSES; BACULOVIRUS; EXPRESSION; PARTICLES; VENOM; GENE	The sap-sucking insects (order Hemiptera), including aphids, planthoppers, whiteflies and stink bugs, present one of the greatest challenges for pest management in global agriculture. Insect neurotoxins offer an alternative to chemical insecticides for controlling these pests, but require delivery into the insect hemocoel. Here we use the coat protein of a luteovirus, an aphid-vectored plant virus, to deliver a spider-derived, insect-specific toxin that acts within the hemocoel. The luteovirid coat protein is sufficient for delivery of fused proteins into the hemocoel of pea aphids, Acyrthosiphon pisum, without virion assembly. We show that when four aphid pest species-A. pisum, Rhopalosiphum padi, Aphis glycines and Myzus persicae-feed on a recombinant coat protein-toxin fusion, either in an experimental membrane sachet or in transgenic Arabidopsis plants, they experience significant mortality. Aphids fed on these fusion proteins showed signs of neurotoxin-induced paralysis. Luteovirid coat protein-insect neurotoxin fusions represent a promising strategy for transgenic control of aphids and potentially other hemipteran pests.	[Bonning, Bryony C.; Pal, Narinder; Liu, Sijun; Sivakumar, S.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; [Wang, Zhaohui; Miller, W. Allen] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Dixon, Philip M.] Iowa State Univ, Dept Stat, Ames, IA USA; [King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	Iowa State University; Iowa State University; Iowa State University; University of Queensland	Bonning, BC (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.	bbonning@iastate.edu; wamiller@iastate.edu	Dixon, Philip Michael/I-4843-2019; King, Glenn F/J-5059-2012	Dixon, Philip Michael/0000-0002-1778-0686; King, Glenn F/0000-0002-2308-2200; Swaminathan, Sivakumar/0000-0003-3931-275X	USDA North Central Biotechnology Initiative [97-34340-3987]; USDA National Research Initiative [02-01280]; Australian Research Council [DP0774245]; Bayer Crop Science; Syngenta; DuPont Pioneer; Grow Iowa Values Funds; Iowa State University Plant Sciences Institute; Hatch Act; State of Iowa	USDA North Central Biotechnology Initiative; USDA National Research Initiative(United States Department of Agriculture (USDA)); Australian Research Council(Australian Research Council); Bayer Crop Science(Bayer AG); Syngenta(Syngenta); DuPont Pioneer; Grow Iowa Values Funds; Iowa State University Plant Sciences Institute; Hatch Act(United States Department of Agriculture (USDA)); State of Iowa	We thank R. Harrison, US Department of Agriculture (USDA), Beltsville, Maryland, for construction of the baculovirus expressing CP-GFP and for production of the PEMV coat protein antiserum. This work was supported by the USDA North Central Biotechnology Initiative grant number 97-34340-3987, USDA National Research Initiative grant number 02-01280, Australian Research Council Discovery Grant DP0774245, Bayer Crop Science, Syngenta, DuPont Pioneer, Grow Iowa Values Funds, Iowa State University Plant Sciences Institute, and by Hatch Act and State of Iowa funds. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the US Department of Agriculture.	[Anonymous], 2013, Science, V341, P730, DOI 10.1126/science.341.6147.730; Bonning B.C., 2013, TRENDS BIOT IN PRESS; Chougule NP, 2012, TOXINS, V4, P405, DOI 10.3390/toxins4060405; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Crossley A.C., 1985, P487; Demler SA, 1997, J GEN VIROL, V78, P511, DOI 10.1099/0022-1317-78-3-511; FEBVAY G, 1988, CAN J ZOOL, V66, P2449, DOI 10.1139/z88-362; Fitches EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039389; Fitches EC, 2010, PEST MANAG SCI, V66, P74, DOI 10.1002/ps.1833; Fletcher JI, 1997, NAT STRUCT BIOL, V4, P559, DOI 10.1038/nsb0797-559; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Gray S, 2003, ANNU REV PHYTOPATHOL, V41, P539, DOI 10.1146/annurev.phyto.41.012203.105815; Gray SM, 1999, MICROBIOL MOL BIOL R, V63, P128, DOI 10.1128/MMBR.63.1.128-148.1999; HUGHES PR, 1986, J INVERTEBR PATHOL, V48, P187, DOI 10.1016/0022-2011(86)90122-9; Jeffers LA, 2008, J INSECT PHYSIOL, V54, P319, DOI 10.1016/j.jinsphys.2007.10.009; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Lamb JW, 1996, J GEN VIROL, V77, P1349, DOI 10.1099/0022-1317-77-7-1349; *LEORA SOFTW POLO, 1987, US GUID PROB LOG AN; Li GP, 2010, ENVIRON ENTOMOL, V39, P1378, DOI 10.1603/EN09223; Li HR, 2011, J INVERTEBR PATHOL, V107, P69, DOI 10.1016/j.jip.2011.02.001; Liu SJ, 2009, ARCH VIROL, V154, P469, DOI 10.1007/s00705-009-0327-7; Liu SJ, 2006, J VIROL METHODS, V132, P174, DOI 10.1016/j.jviromet.2005.10.015; Locke M, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P687; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Maiti IB, 2003, PLANT BIOTECHNOL J, V1, P209, DOI 10.1046/j.1467-7652.2003.00019.x; Pal N, 2013, TOXICON, V70, P114, DOI 10.1016/j.toxicon.2013.04.015; Pennacchio F, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P269, DOI 10.1016/B978-0-12-384858-1.00022-9; Reavy B, 2002, ADV BOT RES, V36, P21, DOI 10.1016/S0065-2296(02)36057-9; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; SAS Institute, 2013, SAS STAT R 9 3 US GU; Schmidt N.R., 2010, MOL BIOL GENETICS LE, P307; Sivakumar S, 2009, VIRUS RES, V139, P54, DOI 10.1016/j.virusres.2008.10.002; Tedford HW, 2004, J BIOL CHEM, V279, P44133, DOI 10.1074/jbc.M404006200; Tedford HW, 2001, J BIOL CHEM, V276, P26568, DOI 10.1074/jbc.M102199200; Tortiglione C, 2002, MOL BREEDING, V9, P159, DOI 10.1023/A:1019785914424; Wang XH, 1999, EUR J BIOCHEM, V264, P488, DOI 10.1046/j.1432-1327.1999.00646.x	37	48	49	0	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					102	+		10.1038/nbt.2753	http://dx.doi.org/10.1038/nbt.2753			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24316580				2022-12-27	WOS:000329513000025
J	Hu, RF; Wang, XB; Huang, JK; Cai, JY				Hu, Ruifa; Wang, Xiaobing; Huang, Jikun; Cai, Jinyang			Patents and China's research and development in agricultural biotechnology	NATURE BIOTECHNOLOGY			English	Editorial Material							INTELLECTUAL PROPERTY; BIOMEDICAL-RESEARCH; PRODUCTIVITY; SCIENCE; COTTON		[Hu, Ruifa; Cai, Jinyang] Beijing Inst Technol, Sch Management & Econ, Beijing 100081, Peoples R China; [Hu, Ruifa; Wang, Xiaobing; Huang, Jikun; Cai, Jinyang] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Ctr Chinese Agr Policy, Beijing, Peoples R China	Beijing Institute of Technology; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Hu, RF (corresponding author), Beijing Inst Technol, Sch Management & Econ, Beijing 100081, Peoples R China.	jkhuang.ccap@igsnrr.ac.cn						Andrews L, 2006, SCIENCE, V314, P1395, DOI 10.1126/science.1135872; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Hu RF, 2012, NAT BIOTECHNOL, V30, P749, DOI 10.1038/nbt.2323; Huang JK, 2012, NAT BIOTECHNOL, V30, P1007, DOI 10.1038/nbt.2386; Huang JK, 2004, J DEV ECON, V75, P27, DOI 10.1016/j.jdeveco.2003.07.005; Huang JK, 2002, AUST J AGR RESOUR EC, V46, P367, DOI 10.1079/9780851996189.0393; James C., 2004, GLOBAL STATUS COMMER; Lei Z, 2009, NAT BIOTECHNOL, V27, P36, DOI 10.1038/nbt0109-36; Pray C, 2001, WORLD DEV, V29, P813, DOI 10.1016/S0305-750X(01)00010-9; Shapiro C, 2001, INNOVATION POLICY EC, P121; Walsh JP, 2007, RES POLICY, V36, P1184, DOI 10.1016/j.respol.2007.04.006; Walsh JP, 2005, SCIENCE, V309, P2002, DOI 10.1126/science.1115813; Walsh JP, 2003, SCIENCE, V299, P1021, DOI 10.1126/science.299.5609.1021	13	1	1	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					986	989		10.1038/nbt.2730	http://dx.doi.org/10.1038/nbt.2730			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	251IM	24213771				2022-12-27	WOS:000326921200016
J	Langille, MGI; Zaneveld, J; Caporaso, JG; McDonald, D; Knights, D; Reyes, JA; Clemente, JC; Burkepile, DE; Thurber, RLV; Knight, R; Beiko, RG; Huttenhower, C				Langille, Morgan G. I.; Zaneveld, Jesse; Caporaso, J. Gregory; McDonald, Daniel; Knights, Dan; Reyes, Joshua A.; Clemente, Jose C.; Burkepile, Deron E.; Thurber, Rebecca L. Vega; Knight, Rob; Beiko, Robert G.; Huttenhower, Curtis			Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences	NATURE BIOTECHNOLOGY			English	Article							GLOBAL-NETWORK; EVOLUTION; GENOME; METAGENOMICS; BACTERIA; GREENGENES; PHYLOGENY; TAXONOMY; INSIGHTS; DATABASE	Profiling phylogenetic marker genes, such as the 16S rRNA gene, is a key tool for studies of microbial communities but does not provide direct evidence of a community's functional capabilities. Here we describe PICRUSt (phylogenetic investigation of communities by reconstruction of unobserved states), a computational approach to predict the functional composition of a metagenome using marker gene data and a database of reference genomes. PICRUSt uses an extended ancestral-state reconstruction algorithm to predict which gene families are present and then combines gene families to estimate the composite metagenome. Using 16S information, PICRUSt recaptures key findings from the Human Microbiome Project and accurately predicts the abundance of gene families in host-associated and environmental communities, with quantifiable uncertainty. Our results demonstrate that phylogeny and function are sufficiently linked that this 'predictive metagenomic' approach should provide useful insights into the thousands of uncultivated microbial communities for which only marker gene surveys are currently available.	[Langille, Morgan G. I.; Beiko, Robert G.] Dalhousie Univ, Fac Comp Sci, Halifax, NS, Canada; [Zaneveld, Jesse; Thurber, Rebecca L. Vega] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Caporaso, J. Gregory] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Caporaso, J. Gregory] Argonne Natl Lab, Inst Genom & Syst Biol, Lemont, IL USA; [McDonald, Daniel] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [McDonald, Daniel] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Knights, Dan] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Knights, Dan] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Reyes, Joshua A.; Huttenhower, Curtis] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Clemente, Jose C.; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Burkepile, Deron E.] Florida Int Univ, Dept Biol Sci, Miami Beach, FL USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Huttenhower, Curtis] Broad Inst MIT & Harvard, Cambridge, MA USA	Dalhousie University; Oregon State University; Northern Arizona University; United States Department of Energy (DOE); Argonne National Laboratory; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard T.H. Chan School of Public Health; University of Colorado System; University of Colorado Boulder; State University System of Florida; Florida International University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Huttenhower, C (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	chuttenh@hsph.harvard.edu	Knight, Rob/D-1299-2010	Langille, Morgan/0000-0002-6604-3009; Caporaso, Greg/0000-0002-8865-1670; Huttenhower, Curtis/0000-0002-1110-0096; Knight, Rob/0000-0002-0975-9019	Canadian Institutes of Health Research; Canada Research Chairs program; US National Science Foundation (NSF) [1130786]; Howard Hughes Medical Institute; US National Institutes of Health (NIH) [P01DK078669, U01HG004866, R01HG004872]; Crohn's and Colitis Foundation of America; Sloan Foundation; NSF [CAREER DBI1053486]; ARO [W911NF-11-1-0473];  [NIH 1R01HG005969]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872, R01HG005969, U01HG004866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080177, T32GM008759] Funding Source: NIH RePORTER; Directorate For Geosciences [1130786] Funding Source: National Science Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); US National Science Foundation (NSF)(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Sloan Foundation(Alfred P. Sloan Foundation); NSF(National Science Foundation (NSF)); ARO; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We would like to thank A. Robbins-Pianka and N. Segata, along with all members of the Knight, Beiko, Vega Thurber, Caporaso and Huttenhower laboratories, for their assistance during PICRUSt conception and development. This work was supported in part by the Canadian Institutes of Health Research (M. G. I. L., R. G. B.), the Canada Research Chairs program (R. G. B.), US National Science Foundation (NSF) OCE #1130786 (R. V. T., D. B.), the Howard Hughes Medical Institute (R. K.), US National Institutes of Health (NIH) P01DK078669, U01HG004866, R01HG004872 (R. K.), the Crohn's and Colitis Foundation of America (R. K.), the Sloan Foundation (R. K.), NIH 1R01HG005969 (C. H.), NSF CAREER DBI1053486 (C. H.) and ARO W911NF-11-1-0473 (C.H.).	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Collins RE, 2012, MOL BIOL EVOL, V29, P3413, DOI 10.1093/molbev/mss163; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Csuros M, 2010, BIOINFORMATICS, V26, P1910, DOI 10.1093/bioinformatics/btq315; Daniluk T, 2006, Adv Med Sci, V51 Suppl 1, P81; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Harris JK, 2013, ISME J, V7, P50, DOI 10.1038/ismej.2012.79; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kunin Victor, 2008, Mol Syst Biol, V4, P198, DOI 10.1038/msb.2008.35; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McHardy AC, 2007, CURR OPIN MICROBIOL, V10, P499, DOI 10.1016/j.mib.2007.08.004; Meehan CJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-248; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parks DH, 2013, ISME J, V7, P173, DOI 10.1038/ismej.2012.88; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Patel PV, 2010, GENOME RES, V20, P960, DOI 10.1101/gr.102814.109; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Segata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024704; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Zaneveld JR, 2010, NUCLEIC ACIDS RES, V38, P3869, DOI 10.1093/nar/gkq066; Zuniga M, 2005, MOL BIOL EVOL, V22, P1673, DOI 10.1093/molbev/msi163	49	5551	5785	161	1496	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					814	+		10.1038/nbt.2676	http://dx.doi.org/10.1038/nbt.2676			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	23975157	Green Submitted, Bronze, Green Accepted			2022-12-27	WOS:000324306300021
J	Grainger, DW				Grainger, David W.			All charged up about implanted biomaterials	NATURE BIOTECHNOLOGY			English	Editorial Material							ZWITTERIONIC HYDROGELS		[Grainger, David W.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA; [Grainger, David W.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Grainger, DW (corresponding author), Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.	david.grainger@utah.edu						Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Holt D, 2011, INTRO BIOMATERIALS, P63; Ishihara K., 2012, ENCY POLYM SCI TECHN; Smith RS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004120; Tian WM, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015010; Ward W Kenneth, 2004, Diabetes Technol Ther, V6, P137, DOI 10.1089/152091504773731320; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031; Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580; Zhang Z, 2009, J BIOMAT SCI-POLYM E, V20, P1845, DOI 10.1163/156856208X386444	10	111	116	5	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					507	509		10.1038/nbt.2600	http://dx.doi.org/10.1038/nbt.2600			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23752436				2022-12-27	WOS:000320113200021
J	Olle, B				Olle, Bernat			Medicines from microbiota	NATURE BIOTECHNOLOGY			English	Article							INTESTINAL MICROBIOTA; GUT MICROBIOME; CLOSTRIDIUM		[Olle, Bernat] PureTech Ventures, Boston, MA 02116 USA; [Olle, Bernat] Vedanta Biosci, Boston, MA USA		Olle, B (corresponding author), PureTech Ventures, Boston, MA 02116 USA.	bolle@puretechventures.com						Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Britton RA, 2012, TRENDS MICROBIOL, V20, P313, DOI 10.1016/j.tim.2012.04.001; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kachrimanidou M, 2011, CRIT REV MICROBIOL, V37, P178, DOI 10.3109/1040841X.2011.556598; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Tannock GW, 2010, MICROBIOL-SGM, V156, P3354, DOI 10.1099/mic.0.042010-0; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	20	103	123	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2013	31	4					309	315		10.1038/nbt.2548	http://dx.doi.org/10.1038/nbt.2548			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	120TI	23563425				2022-12-27	WOS:000317195500020
J	Kim, Y; Kweon, J; Kim, A; Chon, JK; Yoo, JY; Kim, HJ; Kim, S; Lee, C; Jeong, E; Chung, E; Kim, D; Lee, MS; Go, EM; Song, HJ; Kim, H; Cho, N; Bang, D; Kim, S; Kim, JS				Kim, Yongsub; Kweon, Jiyeon; Kim, Annie; Chon, Jae Kyung; Yoo, Ji Yeon; Kim, Hye Joo; Kim, Sojung; Lee, Choongil; Jeong, Euihwan; Chung, Eugene; Kim, Doyoung; Lee, Mi Seon; Go, Eun Mi; Song, Hye Jung; Kim, Hwangbeom; Cho, Namjin; Bang, Duhee; Kim, Seokjoong; Kim, Jin-Soo			A library of TAL effector nucleases spanning the human genome	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; NF-KAPPA-B; DNA-BINDING SPECIFICITY; TARGETED GENE KNOCKOUT; HOMOLOGOUS RECOMBINATION; CELLS; ACTIVATION; TRANSCRIPTION; CONSTRUCTION; RECOGNITION	Transcription activator-like (TAL) effector nucleases (TALENs) can be readily engineered to bind specific genomic loci, enabling the introduction of precise genetic modifications such as gene knockouts and additions. Here we present a genome-scale collection of TALENs for efficient and scalable gene targeting in human cells. We chose target sites that did not have highly similar sequences elsewhere in the genome to avoid off-target mutations and assembled TALEN plasmids for 18,740 protein-coding genes using a high-throughput Golden-Gate cloning system. A pilot test involving 124 genes showed that all TALENs were active and disrupted their target genes at high frequencies, although two of these TALENs became active only after their target sites were partially demethylated using an inhibitor of DNA methyltransferase. We used our TALEN library to generate single- and double-gene-knockout cells in which NF-kappa B signaling pathways were disrupted. Compared with cells treated with short interfering RNAs, these cells showed unambiguous suppression of signal transduction.	[Kim, Yongsub; Kweon, Jiyeon; Kim, Annie; Kim, Hye Joo; Kim, Sojung; Lee, Choongil; Jeong, Euihwan; Chung, Eugene; Kim, Doyoung; Kim, Jin-Soo] Seoul Natl Univ, Natl Creat Initiat Res Ctr Genome Engn, Seoul, South Korea; [Kim, Yongsub; Kweon, Jiyeon; Kim, Annie; Kim, Hye Joo; Kim, Sojung; Lee, Choongil; Jeong, Euihwan; Chung, Eugene; Kim, Doyoung; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Chon, Jae Kyung] Seoul Natl Univ, Dept Interdisciplinary Program Bioinformat, Seoul, South Korea; [Yoo, Ji Yeon; Lee, Mi Seon; Go, Eun Mi; Song, Hye Jung; Kim, Seokjoong] ToolGen Inc, Seoul, South Korea; [Kim, Hwangbeom; Cho, Namjin; Bang, Duhee] Yonsei Univ, Dept Chem, Seoul 120749, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Yonsei University	Kim, JS (corresponding author), Seoul Natl Univ, Natl Creat Initiat Res Ctr Genome Engn, Seoul, South Korea.	sj.kim@toolgen.com; jskim01@snu.ac.kr	KIM, Jin-Soo/M-6918-2013	KIM, Jin-Soo/0000-0003-4847-1306; Kim, Yongsub/0000-0002-9334-4333	National Research Foundation of Korea [2012-0001225]; Intelligent Synthetic Biology Center of the Global Frontier Project; Ministry of Education, Science and Technology, Korea [2011-0031956]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries [311062-04-2-sb1010]; Plant Molecular Breeding Center of Next-Generation BioGreen 21 Program [PJ009081]	National Research Foundation of Korea(National Research Foundation of Korea); Intelligent Synthetic Biology Center of the Global Frontier Project; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries(Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, & Fisheries (iPET), Republic of Korea); Plant Molecular Breeding Center of Next-Generation BioGreen 21 Program	This work was supported by the National Research Foundation of Korea (J.-S.K., 2012-0001225), the Intelligent Synthetic Biology Center of the Global Frontier Project funded by the Ministry of Education, Science and Technology, Korea (D.B., 2011-0031956), Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (S.K., 311062-04-2-sb1010), and Plant Molecular Breeding Center of Next-Generation BioGreen 21 Program (S.K., PJ009081).	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Bylund L, 2004, CYTOGENET GENOME RES, V106, P28, DOI 10.1159/000078556; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Deng D, 2012, CELL RES, V22, P1502, DOI 10.1038/cr.2012.127; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gewurz BE, 2012, P NATL ACAD SCI USA, V109, P2467, DOI 10.1073/pnas.1120542109; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Gupta A, 2012, NAT METHODS, V9, P588, DOI [10.1038/NMETH.1994, 10.1038/nmeth.1994]; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim JS, 2010, NAT METHODS, V7, P91, DOI 10.1038/nmeth0210-91a; Kim S, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7a; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kruger U, 2007, OLIGONUCLEOTIDES, V17, P237, DOI 10.1089/oli.2006.0065; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; Macville M, 1999, CANCER RES, V59, P141; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Volcic M, 2012, NUCLEIC ACIDS RES, V40, P181, DOI 10.1093/nar/gkr687; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	57	261	305	5	138	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					251	258		10.1038/nbt.2517	http://dx.doi.org/10.1038/nbt.2517			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23417094				2022-12-27	WOS:000316439500021
J	Lee, G; Ramirez, CN; Kim, H; Zeltner, N; Liu, B; Radu, C; Bhinder, B; Kim, YJ; Choi, IY; Mukherjee-Clavin, B; Djaballah, H; Studer, L				Lee, Gabsang; Ramirez, Christina N.; Kim, Hyesoo; Zeltner, Nadja; Liu, Becky; Radu, Constantin; Bhinder, Bhavneet; Kim, Yong Jun; Choi, In Young; Mukherjee-Clavin, Bipasha; Djaballah, Hakim; Studer, Lorenz			Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression	NATURE BIOTECHNOLOGY			English	Article							INHIBITORS; MODELS; ASSAY	Patient-specific induced pluripotent stem cells (iPSCs) represent a novel system for modeling human genetic disease and could provide a source of cells for large-scale drug-discovery screens. Here we demonstrate the feasibility of performing a primary screen in neural crest precursors derived from iPSCs that were generated from individuals with familial dysautonomia (FD), a rare, fatal genetic disorder affecting neural crest lineages. We tested 6,912 small-molecule compounds and characterized eight that rescued expression of IKBKAP, the gene responsible for FD. One of the hits, SKF-86466, was found to induce IKBKAP transcription through modulation of intracellular cAMP levels and PKA-dependent CREB phosphorylation. SKF-86466 also rescued IKAP protein expression and the disease-specific loss of autonomic neuronal marker expression. Our data implicate alpha-2 adrenergic receptor activity in regulating IKBKAP expression and demonstrate that small-molecule discovery using an iPSC-based disease model can identify candidate drugs for potential therapeutic intervention.	[Lee, Gabsang; Kim, Hyesoo; Zeltner, Nadja; Liu, Becky; Studer, Lorenz] Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY USA; [Lee, Gabsang; Kim, Hyesoo; Zeltner, Nadja; Liu, Becky; Studer, Lorenz] Sloan Kettering Inst Canc Res, Dev Biol Program, New York, NY USA; [Kim, Hyesoo] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Neurol & Neurosci,Stem Cell Core Facil, Baltimore, MD USA; [Ramirez, Christina N.; Radu, Constantin; Bhinder, Bhavneet; Djaballah, Hakim] Sloan Kettering Inst Canc Res, HTS Core Facil, New York, NY USA; [Djaballah, Hakim] Sloan Kettering Inst Canc Res, Mol Pharmacol & Chem Program, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Studer, L (corresponding author), Sloan Kettering Inst Canc Res, Ctr Stem Cell Biol, New York, NY USA.	glee48@jhmi.edu; studerl@mskcc.org	Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Lee, Gabsang/0000-0002-5052-5927; Djaballah, Hakim/0000-0002-6039-0181; Kim, Yong Jun/0000-0002-5374-712X	NYSTEM; New York Stem Cell Foundation; Maryland Stem Cell Research Funding; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center at MSKCC; W.R. Hearst Fund in Experimental Therapeutics; L.S. Wells Foundation; National Institutes of Health National Cancer Institute [5 P30 CA008748-44]; W.H. Goodwin; A. Goodwin; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053655] Funding Source: NIH RePORTER	NYSTEM; New York Stem Cell Foundation; Maryland Stem Cell Research Funding; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center at MSKCC; W.R. Hearst Fund in Experimental Therapeutics; L.S. Wells Foundation; National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); W.H. Goodwin; A. Goodwin; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank members of the Studer lab for valuable discussions on the manuscript and the members of the HTS Core Facility for their help during the course of this study. We also thank J. Hendrikx and P. Anderson for technical help in flow cytometry assays. Work in the Studer lab was supported by grants from NYSTEM (L. S.) and Druckenmiller Fellowship from New York Stem Cell Foundation (G. L.). Robertson Investigator Award from New York Stem Cell Foundation (G. L.) and Maryland Stem Cell Research Funding (G. L.) supported experiments in the Lee lab. Work of the HTS Core Facility was supported by W.H. Goodwin and A. Goodwin and the Commonwealth Foundation for Cancer Research, the Experimental Therapeutics Center at MSKCC, the W.R. Hearst Fund in Experimental Therapeutics, the L.S. Wells Foundation, and by grant 5 P30 CA008748-44 from National Institutes of Health National Cancer Institute.	Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Hims MM, 2007, GENOMICS, V90, P389, DOI 10.1016/j.ygeno.2007.05.012; Hims MM, 2007, J MOL MED, V85, P149, DOI 10.1007/s00109-006-0137-2; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Ooi YH, 2009, INVEST OPHTH VIS SCI, V50, P4237, DOI 10.1167/iovs.08-2312; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pauwels PJ, 2000, J PHARMACOL EXP THER, V292, P654; Pfenning AR, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-20; Rodriguez Luis G., 2004, V294, P23; Shum D, 2010, ASSAY DRUG DEV TECHN, V8, P553, DOI 10.1089/adt.2010.0321; Slaugenhaupt SA, 2004, HUM MOL GENET, V13, P429, DOI 10.1093/hmg/ddh046; Trendelenburg AU, 1996, N-S ARCH PHARMACOL, V353, P245, DOI 10.1007/BF00168625; Yahata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025788; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	23	166	173	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1244	+		10.1038/nbt.2435	http://dx.doi.org/10.1038/nbt.2435			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23159879	Green Accepted			2022-12-27	WOS:000312092400029
J	Bashir, A; Klammer, AA; Robins, WP; Chin, CS; Webster, D; Paxinos, E; Hsu, D; Ashby, M; Wang, S; Peluso, P; Sebra, R; Sorenson, J; Bullard, J; Yen, J; Valdovino, M; Mollova, E; Luong, K; Lin, S; Lamay, B; Joshi, A; Rowe, L; Frace, M; Tarr, CL; Turnsek, M; Davis, BM; Kasarskis, A; Mekalanos, JJ; Waldor, MK; Schadt, EE				Bashir, Ali; Klammer, Aaron A.; Robins, William P.; Chin, Chen-Shan; Webster, Dale; Paxinos, Ellen; Hsu, David; Ashby, Meredith; Wang, Susana; Peluso, Paul; Sebra, Robert; Sorenson, Jon; Bullard, James; Yen, Jackie; Valdovino, Marie; Mollova, Emilia; Luong, Khai; Lin, Steven; Lamay, Brianna; Joshi, Amruta; Rowe, Lori; Frace, Michael; Tarr, Cheryl L.; Turnsek, Maryann; Davis, Brigid M.; Kasarskis, Andrew; Mekalanos, John J.; Waldor, Matthew K.; Schadt, Eric E.			A hybrid approach for the automated finishing of bacterial genomes	NATURE BIOTECHNOLOGY			English	Article							READ SEQUENCE DATA; VIBRIO-CHOLERAE; STRUCTURAL VARIATION; ORIGIN; GENERATION; INTEGRONS; ASSEMBLER; OUTBREAK; STRAIN; HAITI	Advances in DNA sequencing technology have improved our ability to characterize most genomic diversity. However, accurate resolution of large structural events is challenging because of the short read lengths of second-generation technologies. Third-generation sequencing technologies, which can yield longer multikilobase reads, have the potential to address limitations associated with genome assembly. Here we combine sequencing data from second- and third-generation DNA sequencing technologies to assemble the two-chromosome genome of a recent Haitian cholera outbreak strain into two nearly finished contigs at >99.9% accuracy. Complex regions with clinically relevant structure were completely resolved. In separate control assemblies on experimental and simulated data for the canonical N16961 cholera reference strain, we obtained 14 scaffolds of greater than 1 kb for the experimental data and 8 scaffolds of greater than 1 kb for the simulated data, which allowed us to correct several errors in contigs assembled from the short-read data alone. This work provides a blueprint for the next generation of rapid microbial identification and full-genome assembly.	[Bashir, Ali; Klammer, Aaron A.; Chin, Chen-Shan; Webster, Dale; Paxinos, Ellen; Hsu, David; Ashby, Meredith; Wang, Susana; Peluso, Paul; Sebra, Robert; Sorenson, Jon; Bullard, James; Yen, Jackie; Valdovino, Marie; Mollova, Emilia; Luong, Khai; Lin, Steven; Lamay, Brianna; Joshi, Amruta; Kasarskis, Andrew; Schadt, Eric E.] Pacific Biosci, Menlo Pk, CA USA; [Bashir, Ali; Schadt, Eric E.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Robins, William P.; Mekalanos, John J.; Waldor, Matthew K.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Rowe, Lori; Frace, Michael; Tarr, Cheryl L.; Turnsek, Maryann] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Davis, Brigid M.; Waldor, Matthew K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Davis, Brigid M.; Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA	Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Centers for Disease Control & Prevention - USA; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Schadt, EE (corresponding author), Pacific Biosci, Menlo Pk, CA USA.	eschadt@pacificbiosciences.com	Paxinos, Ellen/AAG-2907-2019	Paxinos, Ellen/0000-0002-1710-8064; Sorenson, Jon/0000-0002-5301-8306; Ashby, Meredith/0000-0002-4385-9486; Waldor, Matthew/0000-0003-1843-7000; Bashir, Ali/0000-0002-5240-9604	US National Institutes of Health National Institute of General Medical Sciences [R01GM068851]; NIH [R37 AI-42347]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347, T32AI007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068851] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by the US National Institutes of Health National Institute of General Medical Sciences grant R01GM068851 (J.J.M. and W.P.R.), NIH R37 AI-42347 (B.M.D. and M.K.W.) and the Howard Hughes Medical Institute (B.M.D. and M.K.W.).	Ali A, 2011, EMERG INFECT DIS, V17, P699, DOI 10.3201/eid1704.101973; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Chaisson M, 2004, BIOINFORMATICS, V20, P2067, DOI 10.1093/bioinformatics/bth205; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Davis BM, 2000, P NATL ACAD SCI USA, V97, P8572, DOI 10.1073/pnas.140109997; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Frerichs RR, 2012, CLIN MICROBIOL INFEC, V18, pE158, DOI 10.1111/j.1469-0691.2012.03841.x; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Grim CJ, 2010, J BACTERIOL, V192, P3524, DOI 10.1128/JB.00040-10; Hassan F, 2010, NATURE, V467, P982, DOI 10.1038/nature09469; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2006, NATURE, V441, P120, DOI 10.1038/nature04726; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Medvedev P, 2009, J COMPUT BIOL, V16, P1101, DOI 10.1089/cmb.2009.0047; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pop M, 2004, GENOME RES, V14, P149; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Reimer AR, 2011, EMERG INFECT DIS, V17, P2113, DOI 10.3201/eid1711.110794; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Ritz A, 2010, BIOINFORMATICS, V26, P1291, DOI 10.1093/bioinformatics/btq153; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Rowe-Magnus DA, 1999, RES MICROBIOL, V150, P641, DOI 10.1016/S0923-2508(99)00127-8; Rubin EJ, 1998, MOL MICROBIOL, V28, P1247, DOI 10.1046/j.1365-2958.1998.00889.x; Schadt EE, 2011, HUM MOL GENET, V20, P853, DOI 10.1093/hmg/ddq481; Schadt EE, 2010, HUM MOL GENET, V19, pR227, DOI 10.1093/hmg/ddq416; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	49	130	134	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					701	+		10.1038/nbt.2288	http://dx.doi.org/10.1038/nbt.2288			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22750883	Green Accepted			2022-12-27	WOS:000306293400029
J	Shen, BQ; Xu, KY; Liu, LN; Raab, H; Bhakta, S; Kenrick, M; Parsons-Reponte, KL; Tien, J; Yu, SF; Mai, E; Li, DW; Tibbitts, J; Baudys, J; Saadi, OM; Scales, SJ; McDonald, PJ; Hass, PE; Eigenbrot, C; Nguyen, T; Solis, WA; Fuji, RN; Flagella, KM; Patel, D; Spencer, SD; Khawlil, LA; Ebens, A; Wong, WL; Vandlen, R; Kaur, S; Sliwkowski, MX; Scheller, RH; Polakis, P; Junutula, JR				Shen, Ben-Quan; Xu, Keyang; Liu, Luna; Raab, Helga; Bhakta, Sunil; Kenrick, Margaret; Parsons-Reponte, Kathryn L.; Tien, Janet; Yu, Shang-Fan; Mai, Elaine; Li, Dongwei; Tibbitts, Jay; Baudys, Jakub; Saadi, Ola M.; Scales, Suzie J.; McDonald, Paul J.; Hass, Philip E.; Eigenbrot, Charles; Trung Nguyen; Solis, Willy A.; Fuji, Reina N.; Flagella, Kelly M.; Patel, Darshana; Spencer, Susan D.; Khawlil, Leslie A.; Ebens, Allen; Wong, Wai Lee; Vandlen, Richard; Kaur, Surinder; Sliwkowski, Mark X.; Scheller, Richard H.; Polakis, Paul; Junutula, Jagath R.			Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates	NATURE BIOTECHNOLOGY			English	Article							TARGETED CANCER-THERAPY; ARMING ANTIBODIES; CYTOTOXIC DRUG; BREAST-CANCER; HYDROLYSIS; MALEIMIDE; ADDUCTS; INDEX	The reactive thiol in cysteine is used for coupling maleimide linkers in the generation of antibody conjugates. To assess the impact of the conjugation site, we engineered cysteines into a therapeutic HER2/neu antibody at three sites differing in solvent accessibility and local charge. The highly solvent-accessible site rapidly lost conjugated thiol-reactive linkers in plasma owing to maleimide exchange with reactive thiols in albumin, free cysteine or glutathione. In contrast, a partially accessible site with a positively charged environment promoted hydrolysis of the succinimide ring in the linker, thereby preventing this exchange reaction. The site with partial solvent-accessibility and neutral charge displayed both properties. In a mouse mammary tumor model, the stability and therapeutic activity of the antibody conjugate were affected positively by succinimide ring hydrolysis and negatively by maleimide exchange with thiol-reactive constituents in plasma. Thus, the chemical and structural dynamics of the conjugation site can influence antibody conjugate performance by modulating the stability of the antibody-linker interface.	[Shen, Ben-Quan; Xu, Keyang; Liu, Luna; Raab, Helga; Bhakta, Sunil; Kenrick, Margaret; Parsons-Reponte, Kathryn L.; Tien, Janet; Yu, Shang-Fan; Mai, Elaine; Li, Dongwei; Tibbitts, Jay; Baudys, Jakub; Saadi, Ola M.; Scales, Suzie J.; McDonald, Paul J.; Hass, Philip E.; Eigenbrot, Charles; Trung Nguyen; Solis, Willy A.; Fuji, Reina N.; Flagella, Kelly M.; Patel, Darshana; Spencer, Susan D.; Khawlil, Leslie A.; Ebens, Allen; Wong, Wai Lee; Vandlen, Richard; Kaur, Surinder; Sliwkowski, Mark X.; Scheller, Richard H.; Polakis, Paul; Junutula, Jagath R.] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Junutula, JR (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	jagath@gene.com	Junutula, Jagath Reddy/ABD-4753-2020; Scales, Suzie J./H-4507-2019	Junutula, Jagath Reddy/0000-0002-5942-4428; Scales, Suzie J./0000-0003-2544-0283; BHAKTA, SUNIL/0000-0002-1554-7098; Saad, Ola/0000-0002-2607-8901				Alley SC, 2008, BIOCONJUGATE CHEM, V19, P759, DOI 10.1021/bc7004329; Carter PJ, 2008, CANCER J, V14, P154, DOI 10.1097/PPO.0b013e318172d704; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Junutula JR, 2010, CLIN CANCER RES, V16, P4769, DOI 10.1158/1078-0432.CCR-10-0987; Kalia J, 2007, BIOORG MED CHEM LETT, V17, P6286, DOI 10.1016/j.bmcl.2007.09.002; KHAN MN, 1984, J PHARM SCI, V73, P1767, DOI 10.1002/jps.2600731227; KNIGHT P, 1979, BIOCHEM J, V179, P191, DOI 10.1042/bj1790191; Kreitman RJ, 1998, ADV DRUG DELIVER REV, V31, P53, DOI 10.1016/S0169-409X(97)00094-X; Lin D, 2008, CHEM RES TOXICOL, V21, P2361, DOI 10.1021/tx800248x; Marik J, 2011, CURR DRUG DELIV, V8, P70, DOI 10.2174/156720111793663589; McCarron PA, 2005, MOL INTERV, V5, P368, DOI 10.1124/mi.5.6.9; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Polakis P, 2005, CURR OPIN PHARMACOL, V5, P382, DOI 10.1016/j.coph.2005.04.008; Polson AG, 2009, CANCER RES, V69, P2358, DOI 10.1158/0008-5472.CAN-08-2250; Ryan SM, 2008, EXPERT OPIN DRUG DEL, V5, P371, DOI [10.1517/17425247.5.4.371, 10.1517/17425247.5.4.371 ]; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Xu K, 2011, ANAL BIOCHEM, V412, P56, DOI 10.1016/j.ab.2011.01.004	22	672	757	23	348	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					184	189		10.1038/nbt.2108	http://dx.doi.org/10.1038/nbt.2108			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22267010				2022-12-27	WOS:000300269100022
J	Qiu, P; Simonds, EF; Bendall, SC; Gibbs, KD; Bruggner, RV; Linderman, MD; Sachs, K; Nolan, GP; Plevritis, SK				Qiu, Peng; Simonds, Erin F.; Bendall, Sean C.; Gibbs, Kenneth D., Jr.; Bruggner, Robert V.; Linderman, Michael D.; Sachs, Karen; Nolan, Garry P.; Plevritis, Sylvia K.			Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE	NATURE BIOTECHNOLOGY			English	Article							FLOW-CYTOMETRY; MASS CYTOMETRY; STEM-CELL; IDENTIFICATION; IMMUNE	The ability to analyze multiple single-cell parameters is critical for understanding cellular heterogeneity. Despite recent advances in measurement technology, methods for analyzing high-dimensional single-cell data are often subjective, labor intensive and require prior knowledge of the biological system. To objectively uncover cellular heterogeneity from single-cell measurements, we present a versatile computational approach, spanning-tree progression analysis of density-normalized events (SPADE). We applied SPADE to flow cytometry data of mouse bone marrow and to mass cytometry data of human bone marrow. In both cases, SPADE organized cells in a hierarchy of related phenotypes that partially recapitulated well-described patterns of hematopoiesis. We demonstrate that SPADE is robust to measurement noise and to the choice of cellular markers. SPADE facilitates the analysis of cellular heterogeneity, the identification of cell types and comparison of functional markers in response to perturbations.	[Qiu, Peng; Plevritis, Sylvia K.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Qiu, Peng] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Simonds, Erin F.; Bendall, Sean C.; Gibbs, Kenneth D., Jr.; Bruggner, Robert V.; Sachs, Karen; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Linderman, Michael D.] Stanford Univ, Comp Syst Lab, Stanford, CA 94305 USA	Stanford University; University of Texas System; UTMD Anderson Cancer Center; Stanford University; Stanford University	Qiu, P (corresponding author), Stanford Univ, Dept Radiol, Stanford, CA 94305 USA.	pqiu@mdanderson.org	Nolan, Garry/AAE-7903-2019; Bendall, Sean/AGG-0126-2022	Gibbs, Kenneth/0000-0002-3532-5396; Bendall, Sean/0000-0003-1341-2453; Nolan, Garry/0000-0002-8862-9043; Simonds, Erin/0000-0002-3497-4861	National Cancer Institute [U56CA112973, U54CA149145]; A Damon Runyon Cancer Research Foundation; National Science Foundation; Stanford DARE; US National Institutes of Health [U19 AI057229, P01 CA034233, HHSN272200700038C, 1R01CA130826, 5U54 CA143907, RB2-01592, PN2EY018228, N01-HV-00242]; European Commission [HEALTH.2010.1.2-1]; California Institute for Regenerative Medicine [DR1-01477]; NATIONAL CANCER INSTITUTE [R01CA130826, U54CA143907, P01CA034233, U54CA149145, U56CA112973] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); A Damon Runyon Cancer Research Foundation; National Science Foundation(National Science Foundation (NSF)); Stanford DARE; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors gratefully acknowledge funding from National Cancer Institute Integrative Cancer Biology Program (ICBP), grants U56CA112973 and U54CA149145 to S.K.P. A Damon Runyon Cancer Research Foundation Fellowship supports S.C.B. National Science Foundation Graduate Research Fellowship and Stanford DARE Fellowship support K. D. G. This work is also supported by US National Institutes of Health grants U19 AI057229, P01 CA034233, HHSN272200700038C, 1R01CA130826, 5U54 CA143907, RB2-01592, PN2EY018228, N01-HV-00242, HEALTH.2010.1.2-1 (European Commission), as well as the California Institute for Regenerative Medicine (DR1-01477) to G.P.N.	Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bagwell CB, 2010, U.S. Patent, Patent No. [7653509, 7,653,509]; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Boedigheimer MJ, 2008, CYTOM PART A, V73A, P421, DOI 10.1002/cyto.a.20553; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Chan C, 2008, CYTOM PART A, V73A, P693, DOI 10.1002/cyto.a.20583; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; Chen W, 2004, BLOOD, V103, P2547, DOI 10.1182/blood-2003-09-3058; Ellis B., 2018, FLOWCORE BASIC STRUC; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; KOTECHA N, 2010, CURR PROT CYTOM, V53; Lo K, 2008, CYTOM PART A, V73A, P321, DOI 10.1002/cyto.a.20531; MURPHY RF, 1985, CYTOMETRY, V6, P302, DOI 10.1002/cyto.990060405; Pettie S., 1999, J ACM, V49, P49; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Qiu P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001123; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; Walther Guenther, 2009, Advances in Bioinformatics, V2009, P686759, DOI 10.1155/2009/686759; Zare H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-403	23	651	661	3	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					886	U181		10.1038/nbt.1991	http://dx.doi.org/10.1038/nbt.1991			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21964415	Green Accepted			2022-12-27	WOS:000296273000015
J	Capoulade, J; Wachsmuth, M; Hufnagel, L; Knop, M				Capoulade, Jeremie; Wachsmuth, Malte; Hufnagel, Lars; Knop, Michael			Quantitative fluorescence imaging of protein diffusion and interaction in living cells	NATURE BIOTECHNOLOGY			English	Article							PLANE ILLUMINATION MICROSCOPY; CORRELATION SPECTROSCOPY; HETEROCHROMATIN PROTEIN-1; DYNAMICS; YEAST; MECHANISM; PROBES; HP1	Diffusion processes and local dynamic equilibria inside cells lead to nonuniform spatial distributions of molecules, which are essential for processes such as nuclear organization and signaling in cell division, differentiation and migration(1). To understand these mechanisms, spatially resolved quantitative measurements of protein abundance, mobilities and interactions are needed, but current methods have limited capabilities to study dynamic parameters. Here we describe a microscope based on light-sheet illumination(2) that allows massively parallel fluorescence correlation spectroscopy (FCS)(3) measurements and use it to visualize the diffusion and interactions of proteins in mammalian cells and in isolated fly tissue. Imaging the mobility of heterochromatin protein HP1 alpha (ref. 4) in cell nuclei we could provide high-resolution diffusion maps that reveal euchromatin areas with heterochromatin-like HP1 alpha-chromatin interactions. We expect that FCS imaging will become a useful method for the precise characterization of cellular reaction-diffusion processes.	[Capoulade, Jeremie; Wachsmuth, Malte; Hufnagel, Lars; Knop, Michael] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Wachsmuth, M (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany.	malte.wachsmuth@embl.de; m.knop@zmbh.uni-heidelberg.de		Capoulade, Jeremie/0000-0002-4305-9534; Capoulade, Jeremie/0000-0003-3840-912X	Leica Microsystems; Advanced Light Microscopy Facility of EMBL; center for modeling and simulation in the biosciences (BioMS); EMBL; BMBF [0315502C]	Leica Microsystems; Advanced Light Microscopy Facility of EMBL; center for modeling and simulation in the biosciences (BioMS); EMBL; BMBF(Federal Ministry of Education & Research (BMBF))	We thank the mechanical and the electronics workshop of the European Molecular Biology Laboratory (EMBL) for custom hardware, M. Meurer for yeast cell culture, D. Holzer for mammalian cell culture, T. Weimbs for providing the MDCK II cells, A. Ephrussi for providing the flies expressing Ubi-GFP-NLS and K. Rippe for providing 3T3 cells expressing HP1 alpha-EGFP. We would like to thank Leica Microsystems as well as R. Pepperkok, J. Ellenberg and the Advanced Light Microscopy Facility of EMBL for support. A. Aulehla, P. Keller and A. Khmelinskii are kindly acknowledged for helpful comments, as are many other colleagues for discussions. L.H. was supported by the center for modeling and simulation in the biosciences (BioMS). We are grateful for financial support from EMBL and from the EpiSys project within the BMBF SysTec program (grant no. 0315502C to M.W.).	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bestvater F, 2010, OPT EXPRESS, V18, P23818, DOI 10.1364/OE.18.023818; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Dertinger T, 2007, CHEMPHYSCHEM, V8, P433, DOI 10.1002/cphc.200600638; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Gregor I, 2005, CHEMPHYSCHEM, V6, P164, DOI 10.1002/cphc.200400319; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Groner N, 2010, OPT EXPRESS, V18, P21225, DOI 10.1364/OE.18.021225; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Heuvelman G, 2009, EUR BIOPHYS J BIOPHY, V38, P813, DOI 10.1007/s00249-009-0499-9; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; Im KB, 2010, OPT EXPRESS, V18, P26905, DOI 10.1364/OE.18.026905; Kannan B, 2007, ANAL CHEM, V79, P4463, DOI 10.1021/ac0624546; Kawai-Noma S, 2006, GENES CELLS, V11, P1085, DOI 10.1111/j.1365-2443.2006.01004.x; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; Kinkhabwala A, 2010, CURR OPIN GENET DEV, V20, P31, DOI 10.1016/j.gde.2009.12.006; Kwon SH, 2008, MOL CELLS, V26, P217; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Muller KP, 2009, BIOPHYS J, V97, P2876, DOI 10.1016/j.bpj.2009.08.057; Needleman DJ, 2009, BIOPHYS J, V96, P5050, DOI 10.1016/j.bpj.2009.03.023; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Ritter JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011639; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schmidt U, 2009, RNA, V15, P862, DOI 10.1261/rna.1387009; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wohland T, 2010, OPT EXPRESS, V18, P10627, DOI 10.1364/OE.18.010627; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	37	128	134	0	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2011	29	9					835	842		10.1038/nbt.1928	http://dx.doi.org/10.1038/nbt.1928			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	817ZT	21822256				2022-12-27	WOS:000294718400025
J	Mills, AE; Tereskerz, P				Mills, Ann E.; Tereskerz, Patti			Human DNA patent renewals on the decline	NATURE BIOTECHNOLOGY			English	Editorial Material							HUMAN GENOME		[Mills, Ann E.; Tereskerz, Patti] Univ Virginia, Ctr Biomed Eth, Charlottesville, VA 22903 USA	University of Virginia	Mills, AE (corresponding author), Univ Virginia, Ctr Biomed Eth, Charlottesville, VA 22903 USA.	amh2r@virginia.edu						*BRIEF DEP JUST AM, 2010, ASS MOL PATH, P185; *BRIF BIOT IND ORG, 2010, ASS MOL PATH, P185; Carbone J, 2010, NAT BIOTECHNOL, V28, P784, DOI 10.1038/nbt0810-784; CRICHTON M, 2007, NY TIMES        0213; DUNCAN DE, 2010, DNA PATENT DEAD FORT; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Kean S, 2011, SCIENCE, V331, P530, DOI 10.1126/science.331.6017.530; Lemley MA, 2001, NORTHWEST U LAW REV, V95, P1495; Mills AE, 2008, NAT BIOTECHNOL, V26, P993, DOI 10.1038/nbt0908-993; Secretary's Advisory Committee on Genetics Health and Society, 2010, REP GEN PAT LIC PRAC	10	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					711	714		10.1038/nbt.1930	http://dx.doi.org/10.1038/nbt.1930			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21822245				2022-12-27	WOS:000293696500020
J	Yin, H; Xue, W; Chen, S; Bogorad, RL; Benedetti, E; Grompe, M; Koteliansky, V; Sharp, PA; Jacks, T; Anderson, DG				Yin, Hao; Xue, Wen; Chen, Sidi; Bogorad, Roman L.; Benedetti, Eric; Grompe, Markus; Koteliansky, Victor; Sharp, Phillip A.; Jacks, Tyler; Anderson, Daniel G.			Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype	NATURE BIOTECHNOLOGY			English	Article							MOUSE MODEL; HUMAN-CELLS; IN-VIVO; SPECIFICITY; NUCLEASES; REPAIR; GENE; DNA	We demonstrate CRISPR-Cas9-mediated correction of a Fah mutation in hepatocytes in a mouse model of the human disease hereditary tyrosinemia. Delivery of components of the CRISPR-Cas9 system by hydrodynamic injection resulted in initial expression of the wild-type Fah protein in similar to 1/250 liver cells. Expansion of Fah-positive hepatocytes rescued the body weight loss phenotype. Our study indicates that CRISPR-Cas9-mediated genome editing is possible in adult animals and has potential for correction of human genetic diseases.	[Yin, Hao; Xue, Wen; Chen, Sidi; Bogorad, Roman L.; Sharp, Phillip A.; Jacks, Tyler; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Benedetti, Eric; Grompe, Markus] Oregon Hlth & Sci Univ, Dept Pediat, Oregon Stem Cell Ctr, Portland, OR 97201 USA; [Koteliansky, Victor] Skolkovo Inst Sci & Technol, Skolkovo, Russia; [Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Anderson, Daniel G.] Harvard MIT, Div Hlth Sci & Technol, Cambridge, MA USA; [Anderson, Daniel G.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Oregon Health & Science University; Skolkovo Institute of Science & Technology; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Anderson, DG (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dgander@mit.edu	CHEN, SIDI/D-8284-2016	CHEN, SIDI/0000-0002-3819-5005; Grompe, Markus/0000-0002-6616-4345	National Cancer Institute [2-PO1-CA42063, P30-CA14051]; National Institutes of Health (NIH) [R01-CA133404]; Howard Hughes Investigator; NIH Centers for Cancer Nanotechnology Excellence and the Harvard-MIT Center of Cancer Nanotechnology Excellence [5-U51-CA151884-04]; Damon Runyon Fellow [DRG2117- 12];  [1K99CA169512]; NATIONAL CANCER INSTITUTE [U54CA151884, P01CA042063, R00CA169512, P30CA014051, K99CA169512, R01CA133404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048252] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Investigator(Howard Hughes Medical Institute); NIH Centers for Cancer Nanotechnology Excellence and the Harvard-MIT Center of Cancer Nanotechnology Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Fellow; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank I. Zhuang and W.Cai for technical assistance, F.Zhang for sharing pX330 CRISPR vectors, and D.Crowley and K. Cormier for histology. This work was supported in part by grants 2-PO1-CA42063 to P.A.S. and T.J. and core grant P30-CA14051 from the National Cancer Institute. This work was supported in part by National Institutes of Health (NIH) Grant R01-CA133404 and the Marie-D. & Pierre Casimir-Lambert Fund to P.A.S.T.J. is a Howard Hughes Investigator, the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar. H.Y. and S.C. are supported by 5-U51-CA151884-04 NIH Centers for Cancer Nanotechnology Excellence and the Harvard-MIT Center of Cancer Nanotechnology Excellence. W.X. is supported by grant 1K99CA169512. S.C. is a Damon Runyon Fellow (DRG2117- 12). The authors acknowledge the service of the late Sean Collier to the MIT community. We thank the Swanson Biotechnology Center for technical support.	Aponte JL, 2001, P NATL ACAD SCI USA, V98, P641, DOI 10.1073/pnas.98.2.641; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nielsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037558; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016	15	641	763	11	415	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2014	32	6					551	553		10.1038/nbt.2884	http://dx.doi.org/10.1038/nbt.2884			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AI9EV	24681508	Green Accepted, Green Published			2022-12-27	WOS:000337233800017
J	Rychlik, B				Rychlik, Bruce			Pay increases still healthy for nonfounder executives at private life sciences companies	NATURE BIOTECHNOLOGY			English	Editorial Material								Executive cash compensation data for nonfounders revealed a 3% year-over-year rise.	Pk Sq Execut Search LLC, Cambridge, MA 02140 USA		Rychlik, B (corresponding author), Pk Sq Execut Search LLC, Cambridge, MA 02140 USA.	bruce@parksquare.com							0	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					393	395		10.1038/nbt.2878	http://dx.doi.org/10.1038/nbt.2878			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24714485				2022-12-27	WOS:000334340800025
J	Ding, L; Wendl, MC				Ding, Li; Wendl, Michael C.			Differences that matter in cancer genomics	NATURE BIOTECHNOLOGY			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; GENES; LANDSCAPE	Correcting for mutational heterogeneity within and between tumor samples improves cancer genome analyses.	[Ding, Li; Wendl, Michael C.] Washington Univ, Genome Inst, St Louis, MO 63130 USA; [Ding, Li; Wendl, Michael C.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Ding, Li] Washington Univ, Dept Med, St Louis, MO USA; [Ding, Li] Washington Univ, Siteman Canc Ctr, St Louis, MO USA; [Wendl, Michael C.] Washington Univ, Dept Math, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Ding, L (corresponding author), Washington Univ, Genome Inst, St Louis, MO 63130 USA.	lding@genome.wustl.edu			NATIONAL CANCER INSTITUTE [R01CA180006] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006517] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA180006] Funding Source: Medline; NHGRI NIH HHS [U01 HG006517] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fisher R.A., 1948, AM STAT, V2, P2; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; LAWRENCE, NATURE; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023	11	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2013	31	10					892	893		10.1038/nbt.2715	http://dx.doi.org/10.1038/nbt.2715			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233CA	24104755				2022-12-27	WOS:000325541300016
J	Koerber, JT; Thomsen, ND; Hannigan, BT; Degrado, WF; Wells, JA				Koerber, James T.; Thomsen, Nathan D.; Hannigan, Brett T.; Degrado, William F.; Wells, James A.			Nature-inspired design of motif-specific antibody scaffolds	NATURE BIOTECHNOLOGY			English	Article							SIGNALING NETWORKS; PHAGE; LIBRARIES; RECOGNITION; DOMAINS; PHOSPHOSITE; VALIDATION; SELECTION; PROTEINS; RECEPTOR	Aberrant changes in post-translational modifications (PTMs) such as phosphate groups underlie a majority of human diseases. However, detection and quantification of PTMs for diagnostic or biomarker applications often require PTM-specific monoclonal antibodies (mAbs), which are challenging to generate using traditional antibody-selection methods. Here we outline a general strategy for producing synthetic, PTM-specific mAbs by engineering a motif-specific 'hot spot' into an antibody scaffold. Inspired by a natural phosphate-binding motif, we designed and selected mAb scaffolds with hot spots specific for phosphoserine, phosphothreonine or phosphotyrosine. Crystal structures of the phospho-specific mAbs revealed two distinct modes of phosphoresidue recognition. Our data suggest that each hot spot functions independently of the surrounding scaffold, as phage display antibody libraries using these scaffolds yielded >50 phospho-and target-specific mAbs against 70% of target peptides. Our motif-specific scaffold strategy may provide a general solution for rapid, robust development of anti-PTM mAbs for signaling, diagnostic and therapeutic applications.	[Koerber, James T.; Thomsen, Nathan D.; Degrado, William F.; Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Hannigan, Brett T.] Univ Penn, Sch Med, Grad Grp Genom & Computat Biol GCB, Philadelphia, PA 19104 USA; [Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Pennsylvania; University of California System; University of California San Francisco	Wells, JA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA.	jim.wells@ucsf.edu	Wells, Jim A/O-9854-2016		US National Institutes of Heath [R01 CA154802, GM54616]; NATIONAL CANCER INSTITUTE [R01CA154802] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054616, R01GM054616] Funding Source: NIH RePORTER	US National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Wells laboratory for helpful discussions regarding this manuscript and S. Pfaff for assistance with Biacore experiments. We thank C. Waddling at the UCSF X-ray facility for assistance with generating protein crystals and J. Holton, G. Meigs and J. Tanamachi at the Advanced Light Source beam line 8.3.1 at the Lawrence Berkeley National Laboratory for help with collection of diffraction data. We thank the Court laboratory at the National Institutes of Health for generously providing the recombineering vectors. J.T.K. is a Fellow of the Life Sciences Research Foundation and N.D.T. is the Suzanne and Bob Wright Fellow of the Damon Runyon Cancer Research Foundation. This work was supported by grants from the US National Institutes of Heath (R01 CA154802 to J.A.W. and GM54616 to W.F.D.). J.T.K., J.A.W. and W.F.D. have filed a provisional patent on the technology described in this manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALVING CR, 1986, CHEM PHYS LIPIDS, V40, P303, DOI 10.1016/0009-3084(86)90075-7; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Brumbaugh K, 2011, METHODS MOL BIOL, V717, P3, DOI 10.1007/978-1-61779-024-9_1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cobaugh CW, 2008, J MOL BIOL, V378, P622, DOI 10.1016/j.jmb.2008.02.037; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; DIGIOVANNA MP, 1995, CANCER RES, V55, P1946; Dopfer EP, 2010, IMMUNOL LETT, V130, P43, DOI 10.1016/j.imlet.2009.12.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanes J, 2000, NAT BIOTECHNOL, V18, P1287, DOI 10.1038/82407; Hollingsworth Scott A, 2010, Biomol Concepts, V1, P271, DOI 10.1515/BMC.2010.022; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Kaneko T, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-32; Kaneko T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003021; KANG AS, 1991, P NATL ACAD SCI USA, V88, P4363, DOI 10.1073/pnas.88.10.4363; Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Landry RC, 2001, J MOL BIOL, V308, P883, DOI 10.1006/jmbi.2001.4628; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Luft JR, 1999, ACTA CRYSTALLOGR D, V55, P988, DOI 10.1107/S0907444999002085; Malabarba MG, 2001, ONCOGENE, V20, P5186, DOI 10.1038/sj.onc.1204654; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Mersmann M, 2010, NEW BIOTECHNOL, V27, P118, DOI 10.1016/j.nbt.2009.10.007; Nita-Lazar A, 2008, PROTEOMICS, V8, P4433, DOI 10.1002/pmic.200800231; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pershad K, 2012, J MOL BIOL, V424, P88, DOI 10.1016/j.jmb.2012.09.006; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shih HH, 2012, J BIOL CHEM, V287, P44425, DOI 10.1074/jbc.M112.415935; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Thomsen ND, 2013, P NATL ACAD SCI USA, V110, P8477, DOI 10.1073/pnas.1306759110; Vielemeyer O, 2009, J BIOL CHEM, V284, P20791, DOI 10.1074/jbc.M109.008730; Watson JD, 2002, J MOL BIOL, V315, P171, DOI 10.1006/jmbi.2001.5227; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9; Zhou HL, 2001, NAT BIOTECHNOL, V19, P375, DOI 10.1038/86777	49	49	49	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2013	31	10					916	+		10.1038/nbt.2672	http://dx.doi.org/10.1038/nbt.2672			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233CA	23955275	Green Submitted, Green Accepted			2022-12-27	WOS:000325541300020
J	Huggett, B				Huggett, Brady			The rarest of bounties	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					696	696		10.1038/nbt.2649	http://dx.doi.org/10.1038/nbt.2649			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23929342	Bronze			2022-12-27	WOS:000322911000014
J	Link, H; Kochanowski, K; Sauer, U				Link, Hannes; Kochanowski, Karl; Sauer, Uwe			Systematic identification of allosteric protein-metabolite interactions that control enzyme activity in vivo	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; SITE; PHOSPHOFRUCTOKINASE; ACTIVATION	Recent data suggest that the majority of proteins bind specific metabolites(1,2) and that such interactions are relevant to metabolic and gene regulation(3-5). However, there are no methods to systematically identify functional allosteric protein-metabolite interactions(4,6). Here we present an experimental and computational approach for using dynamic metabolite data to discover allosteric regulation that is relevant in vivo. By switching the culture conditions of Escherichia coli every 30 s between medium containing either pyruvate or C-13-labeled fructose or glucose, we measured the reversal of flux through glycolysis pathways and observed rapid changes in metabolite concentration. We fit these data to a kinetic model of glycolysis and systematically tested the consequences of 126 putative allosteric interactions on metabolite dynamics. We identified allosteric interactions that govern the reversible switch between gluconeogenesis and glycolysis, including one by which pyruvate activates fructose-1,6-bisphosphatase. Thus, from large sets of putative allosteric interactions, our approach can identify the most likely ones and provide hypotheses about their function.	[Link, Hannes; Kochanowski, Karl; Sauer, Uwe] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Kochanowski, Karl] Life Sci Zurich PhD Program Syst Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Sauer, U (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.	sauer@imsb.biol.ethz.ch	Kochanowski, Karl/ABE-7236-2021; Sauer, Uwe/Y-3556-2019; Link, Hannes/K-1932-2015		Deutsche Forschungsgemeinschaft [Li 1993/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank E. Zamora-Sillero, L. Gerosa, M. Zampieri and R. Milo for discussions. This work was supported by Deutsche Forschungsgemeinschaft grant Li 1993/1-1.	Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Curien G, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.29; Gallego O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.87; Gerosa L, 2011, CURR OPIN BIOTECH, V22, P566, DOI 10.1016/j.copbio.2011.04.016; Goyal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000802; Grimbs S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100186; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; Hilser VJ, 2010, SCIENCE, V327, P653, DOI 10.1126/science.1186121; Hines JK, 2006, J BIOL CHEM, V281, P18386, DOI 10.1074/jbc.M602553200; JOHNSON JL, 1992, BIOCHEMISTRY-US, V31, P11510, DOI 10.1021/bi00161a032; Kremling A, 2008, BIOINFORMATICS, V24, P704, DOI 10.1093/bioinformatics/btn010; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Kuepfer L, 2007, NAT BIOTECHNOL, V25, P1001, DOI 10.1038/nbt1330; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Lindsley JE, 2006, P NATL ACAD SCI USA, V103, P10533, DOI 10.1073/pnas.0604452103; Orsak T, 2012, BIOCHEMISTRY-US, V51, P225, DOI 10.1021/bi201313s; Petschnigg J, 2011, CURR OPIN BIOTECH, V22, P50, DOI 10.1016/j.copbio.2010.09.001; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Ruhl M, 2012, BIOTECHNOL BIOENG, V109, P763, DOI 10.1002/bit.24344; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Turkheimer FE, 2003, J CEREBR BLOOD F MET, V23, P490, DOI 10.1097/01.WCB.0000050065.57184.BB; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; WOHL RC, 1972, J BIOL CHEM, V247, P5785; Xu YF, 2012, NAT CHEM BIOL, V8, P562, DOI [10.1038/NCHEMBIO.941, 10.1038/nchembio.941]; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131	28	156	157	1	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2013	31	4					357	+		10.1038/nbt.2489	http://dx.doi.org/10.1038/nbt.2489			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	120TI	23455438				2022-12-27	WOS:000317195500030
J	Dong, Y; Xie, M; Jiang, Y; Xiao, NQ; Du, XY; Zhang, WG; Tosser-Klopp, G; Wang, JH; Yang, S; Liang, J; Chen, WB; Chen, J; Zeng, P; Hou, Y; Bian, C; Pan, SK; Li, YX; Liu, X; Wang, WL; Servin, B; Sayre, B; Zhu, B; Sweeney, D; Moore, R; Nie, WH; Shen, YY; Zhao, RP; Zhang, GJ; Li, JQ; Faraut, T; Womack, J; Zhang, YP; Kijas, J; Cockett, N; Xu, X; Zhao, SH; Wang, J; Wang, W				Dong, Yang; Xie, Min; Jiang, Yu; Xiao, Nianqing; Du, Xiaoyong; Zhang, Wenguang; Tosser-Klopp, Gwenola; Wang, Jinhuan; Yang, Shuang; Liang, Jie; Chen, Wenbin; Chen, Jing; Zeng, Peng; Hou, Yong; Bian, Chao; Pan, Shengkai; Li, Yuxiang; Liu, Xin; Wang, Wenliang; Servin, Bertrand; Sayre, Brian; Zhu, Bin; Sweeney, Deacon; Moore, Rich; Nie, Wenhui; Shen, Yongyi; Zhao, Ruoping; Zhang, Guojie; Li, Jinquan; Faraut, Thomas; Womack, James; Zhang, Yaping; Kijas, James; Cockett, Noelle; Xu, Xun; Zhao, Shuhong; Wang, Jun; Wang, Wen			Sequencing and automated whole-genome optical mapping of the genome of a domestic goat (Capra hircus)	NATURE BIOTECHNOLOGY			English	Article							RETINOIC ACID; HAIR; CHROMOSOME; EVOLUTION; VALIDATION; ORIGINS; GROWTH; MILK; MAPS	We report the similar to 2.66-Gb genome sequence of a female Yunnan black goat. The sequence was obtained by combining short-read sequencing data and optical mapping data from a high-throughput whole-genome mapping instrument. The whole-genome mapping data facilitated the assembly of super-scaffolds >5x longer by the N50 metric than scaffolds augmented by fosmid end sequencing (scaffold N50 = 3.06 Mb, super-scaffold N50 = 16.3 Mb). Super-scaffolds are anchored on chromosomes based on conserved synteny with cattle, and the assembly is well supported by two radiation hybrid maps of chromosome 1. We annotate 22,175 protein-coding genes, most of which were recovered in the RNA-seq data of ten tissues. Comparative transcriptomic analysis of the primary and secondary follicles of a cashmere goat reveal 51 genes that are differentially expressed between the two types of hair follicles. This study, whose results will facilitate goat genomics, shows that whole-genome mapping technology can be used for the de novo assembly of large genomes.	[Dong, Yang; Jiang, Yu; Zhang, Wenguang; Wang, Jinhuan; Nie, Wenhui; Shen, Yongyi; Zhao, Ruoping; Zhang, Yaping; Xu, Xun; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Dong, Yang; Shen, Yongyi; Xu, Xun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xie, Min; Yang, Shuang; Liang, Jie; Chen, Wenbin; Chen, Jing; Zeng, Peng; Hou, Yong; Bian, Chao; Pan, Shengkai; Li, Yuxiang; Liu, Xin; Wang, Wenliang; Zhang, Guojie; Xu, Xun; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Du, Xiaoyong; Zhao, Shuhong] Huazhong Agr Univ, Wuhan, Peoples R China; [Jiang, Yu; Kijas, James] CSIRO Livestock Ind, St Lucia, Qld, Australia; [Zhang, Wenguang; Li, Jinquan] Inner Mongolia Agr Univ, Hohhot, Peoples R China; [Tosser-Klopp, Gwenola; Servin, Bertrand; Faraut, Thomas] INRA, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France; [Cockett, Noelle] Utah State Univ, Logan, UT 84322 USA; [Womack, James] Texas A&M Univ, College Stn, TX USA; [Xiao, Nianqing; Zhu, Bin; Sweeney, Deacon; Moore, Rich] OpGen Inc, Gaithersburg, MD USA; [Sayre, Brian] Virginia State Univ, Petersburg, VA 23806 USA	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI); Huazhong Agricultural University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Inner Mongolia Agricultural University; INRAE; Utah System of Higher Education; Utah State University; Texas A&M University System; Texas A&M University College Station; Virginia State University	Wang, W (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	xuxun@genomics.cn; shzhao@mail.hzau.edu.cn; wangj@genomics.cn; wwang@mail.kiz.ac.cn	Shen, Yongyi/GWU-8031-2022; Zhang, Guojie/J-7273-2019; Zhang, Guojie/B-6188-2014; Sayre, Brian/V-7889-2019; Servin, Bertrand/B-2206-2008; Jiang, Yu/O-5114-2015; XIE, MIN/P-8062-2019; Wang, Wen/AAP-9873-2020; Li, yu/HHZ-5236-2022; Kijas, James W/A-4656-2011; Xu, Xun/AAI-6763-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Servin, Bertrand/0000-0001-5141-0913; Jiang, Yu/0000-0003-4821-3585; XIE, MIN/0000-0002-5652-5039; Kijas, James W/0000-0002-1417-8278; Xu, Xun/0000-0002-5338-5173; hou, yong/0000-0002-0420-0726; Wang, Jun/0000-0002-8540-8931; Shen, Yongyi/0000-0001-7660-5522; Bian, Chao/0000-0001-9904-721X; Liu, Xin/0000-0003-3256-2940; TOSSER-KLOPP, GWENOLA/0000-0003-0550-4673; Wang, Wen/0000-0002-7801-2066; Wang, Jun/0000-0002-2113-5874	CAS [KSZD-EW-Z-005]; Chinese 973 programs [2007CB815700]; National Natural Science Foundation of China [30960246, 31260538]; Shenzhen Municipal Government; Yantian District local government of Shenzhen; CAS-Max Planck Society Fellowship; CAS	CAS(Chinese Academy of Sciences); Chinese 973 programs(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government; Yantian District local government of Shenzhen; CAS-Max Planck Society Fellowship(Max Planck Society); CAS(Chinese Academy of Sciences)	This work was supported by the key project of CAS (KSZD-EW-Z-005), Chinese 973 programs (2007CB815700), the National Natural Science Foundation of China (30960246 and 31260538), the Shenzhen Municipal Government and the Yantian District local government of Shenzhen, and a CAS-Max Planck Society Fellowship and the 100 talent program of CAS to W.W. and Jun W.	Adelson DL, 2009, P NATL ACAD SCI USA, V106, P12855, DOI 10.1073/pnas.0901282106; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Anantharaman T, 1999, Proc Int Conf Intell Syst Mol Biol, P18; Chen Q, 2006, MICROBIOL-SGM, V152, P1041, DOI 10.1099/mic.0.28648-0; EBERT KM, 1991, BIO-TECHNOL, V9, P835, DOI 10.1038/nbt0991-835; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Gao JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-466; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Hanakawa Y, 2004, J INVEST DERMATOL, V123, P817, DOI 10.1111/j.0022-202X.2004.23479.x; Handwerger S, 2000, J PEDIATR ENDOCR MET, V13, P343, DOI 10.1515/JPEM.2000.13.4.343; Iannuzzi L, 2009, CYTOGENET GENOME RES, V126, P49, DOI 10.1159/000245906; IBRAHEEM M, 1994, J ANAT, V185, P135; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Ko JH, 2000, TRANSGENIC RES, V9, P215, DOI 10.1023/A:1008972010351; LEFEBVRE PP, 1993, SCIENCE, V260, P692, DOI 10.1126/science.8480180; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lim A, 2001, GENOME RES, V11, P1584, DOI 10.1101/gr.172101; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; MacHugh DE, 2001, P NATL ACAD SCI USA, V98, P5382, DOI 10.1073/pnas.111163198; Mariat D, 2001, CYTOGENET CELL GENET, V92, P144, DOI 10.1159/000056886; Nagarajan N, 2008, BIOINFORMATICS, V24, P1229, DOI 10.1093/bioinformatics/btn102; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Rogers MA, 2005, J INVEST DERMATOL, V124, pVII, DOI 10.1111/j.0022-202X.2005.23728.x; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Schlake T, 2005, DEVELOPMENT, V132, P2981, DOI 10.1242/dev.01873; SUN TT, 1983, J INVEST DERMATOL, V81, pS109, DOI 10.1111/1523-1747.ep12540831; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; VIALLET JP, 1994, DEV BIOL, V166, P277, DOI 10.1006/dbio.1994.1314; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; WEI FS, 2009, PLOS GENET, V5; White C., 1840, CASHMERE SHAWL E FIC, V1; Wu CW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-25; WURSTER DH, 1968, CHROMOSOMA, V25, P152, DOI 10.1007/BF00327175; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zhang Dongliang, 2011, Indian J Dermatol, V56, P14, DOI 10.4103/0019-5154.77544; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhou S., 2009, PLOS GENET, V5; Zhou S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-278	42	329	365	8	169	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					135	141		10.1038/nbt.2478	http://dx.doi.org/10.1038/nbt.2478			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23263233	hybrid			2022-12-27	WOS:000315322100024
J	Saberwal, G				Saberwal, Gayatri			Giving voice to India's entrepreneurs	NATURE BIOTECHNOLOGY			English	Editorial Material									NEN Wadhwani Ctr Excellence Entrepreneurship Educ, Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India		Saberwal, G (corresponding author), NEN Wadhwani Ctr Excellence Entrepreneurship Educ, Inst Bioinformat & Appl Biotechnol, Biotech Pk,Elect City Phase I, Bangalore, Karnataka, India.	gayatri@ibab.ac.in			Institut Merieux	Institut Merieux	I would like to sincerely thank all the interviewees who were so generous with their time and their insights. The work presented here has been entirely funded by the Institut Merieux as part of a larger grant supporting my work, for which I am very grateful.	2010, NAT BIOTECHNOL, V28, P917; 2006, NAT BIOTECHNOL, V24, P499; 2007, NAT BIOTECHNOL, V25, P403	3	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2013	31	2					104	107		10.1038/nbt.2493	http://dx.doi.org/10.1038/nbt.2493			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	095GG	23392503	Bronze			2022-12-27	WOS:000315322100013
J	Varshney, RK; Ribaut, JM; Buckler, ES; Tuberosa, R; Rafalski, JA; Langridge, P				Varshney, Rajeev K.; Ribaut, Jean-Marcel; Buckler, Edward S.; Tuberosa, Roberto; Rafalski, J. Antoni; Langridge, Peter			Can genomics boost productivity of orphan crops?	NATURE BIOTECHNOLOGY			English	Letter							MIXED-MODEL APPROACH; WIDE ASSOCIATION; GENETIC ARCHITECTURE; COMPLEX TRAITS; SELECTION; OPPORTUNITIES; TECHNOLOGIES		[Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, CEG, Hyderabad, Andhra Pradesh, India; [Varshney, Rajeev K.; Ribaut, Jean-Marcel] Int Maize & Wheat Improvement Ctr CIMMYT, CGIAR Generat Challenge Programme GCP, Mexico City, DF, Mexico; [Varshney, Rajeev K.] UWA, Sch Plant Biol M084, Fac Nat & Agr Sci, Crawley, WA, Australia; [Buckler, Edward S.] ARS, USDA, Ithaca, NY USA; [Buckler, Edward S.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Tuberosa, Roberto] Univ Bologna, Dept Agroenvironm Sci & Technol, Bologna, Italy; [Rafalski, J. Antoni] DuPont Pioneer, Wilmington, DE USA; [Langridge, Peter] Univ Adelaide, ACPFG, Adelaide, SA, Australia	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of Western Australia; United States Department of Agriculture (USDA); Cornell University; University of Bologna; DuPont; University of Adelaide	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, CEG, Hyderabad, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Varshney, Rajeev K/C-5295-2014; Buckler, Edward/L-7651-2019; Langridge, Peter/G-5864-2010; Buckler, Edward/GPS-4932-2022; Tuberosa, Roberto/A-2781-2016	Varshney, Rajeev K/0000-0002-4562-9131; Buckler, Edward/0000-0002-3100-371X; Langridge, Peter/0000-0001-9494-400X; Tuberosa, Roberto/0000-0001-9143-9569				Belo A, 2008, MOL GENET GENOMICS, V279, P1, DOI 10.1007/s00438-007-0289-y; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Eathington SR, 2007, CROP SCI, V47, pS154, DOI 10.2135/cropsci2007.04.0015IPBS; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Ribaut JM, 2010, CURR OPIN PLANT BIOL, V13, P213, DOI 10.1016/j.pbi.2009.12.011; Ribaut JM, 1998, TRENDS PLANT SCI, V3, P236, DOI 10.1016/S1360-1385(98)01240-0; Salekdeh GH, 2009, TRENDS PLANT SCI, V14, P488, DOI 10.1016/j.tplants.2009.07.007; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Septiningsih EM, 2009, ANN BOT-LONDON, V103, P151, DOI 10.1093/aob/mcn206; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Varshney RK, 2006, TRENDS BIOTECHNOL, V24, P490, DOI 10.1016/j.tibtech.2006.08.006; Varshney RK, 2012, BRIEF FUNCT GENOMICS, V11, P1, DOI 10.1093/bfgp/els001; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Varshney RK, 2009, CURR OPIN PLANT BIOL, V12, P202, DOI 10.1016/j.pbi.2008.12.004; Varshney RK, 2005, TRENDS PLANT SCI, V10, P621, DOI 10.1016/j.tplants.2005.10.004; Walter A, 2012, ANN BOT-LONDON, V110, P1271, DOI 10.1093/aob/mcs026; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	40	158	163	2	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1172	1176		10.1038/nbt.2440	http://dx.doi.org/10.1038/nbt.2440			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222781	Green Accepted			2022-12-27	WOS:000312092400014
J	Holman, CM				Holman, Christopher M.			Advances in DNA sequencing lead to patent disputes	NATURE BIOTECHNOLOGY			English	Editorial Material									Univ Missouri Kansas City, Sch Med, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Holman, CM (corresponding author), Univ Missouri Kansas City, Sch Med, Kansas City, MO 64110 USA.	holmancm@umkc.edu						[Anonymous], 2012, P GROSSMAN STORY 2; Cook-Deegan R, 2010, ANNU REV GENOM HUM G, V11, P383, DOI 10.1146/annurev-genom-082509-141811; Holman CM, 2012, NAT BIOTECHNOL, V30, P240, DOI 10.1038/nbt.2146; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nottenburg C., 2004, ANAL JUNK DNA PATENT; Rusert B. M., 2005, PATENTED DNA SEQUENC, V4	7	6	6	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1054	1059		10.1038/nbt.2407	http://dx.doi.org/10.1038/nbt.2407			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138298				2022-12-27	WOS:000311087500020
J	Lopez-Arredondo, DL; Herrera-Estrella, L				Lizbeth Lopez-Arredondo, Damar; Herrera-Estrella, Luis			Engineering phosphorus metabolism in plants to produce a dual fertilization and weed control system	NATURE BIOTECHNOLOGY			English	Article							PHOSPHATE STARVATION RESPONSES; REDUCED PHOSPHORUS; ENVIRONMENT; EXPRESSION; GENES; ROOT	High crop yields depend on the continuous input of orthophosphate (PO4-3)-based fertilizers and herbicides(1,2). Two major challenges for agriculture are that phosphorus is a nonrenewable resource and that weeds have developed broad herbicide resistance(3-5). One strategy to overcome both problems is to engineer plants to outcompete weeds and microorganisms for limiting resources, thereby reducing the requirement for both fertilizers and herbicides. Plants and most microorganisms are unable to metabolize phosphite (PO3-3), so we developed a dual fertilization and weed control system by generating transgenic plants that can use phosphite as a sole phosphorus source. Under greenhouse conditions, these transgenic plants require 30-50% less phosphorus input when fertilized with phosphite to achieve similar productivity to that obtained by the same plants using orthophosphate fertilizer and, when in competition with weeds, accumulate 2-10 times greater biomass than when fertilized with orthophosphate.	[Lizbeth Lopez-Arredondo, Damar; Herrera-Estrella, Luis] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Herrera-Estrella, L (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico.	lherrera@langebio.cinvestav.mx	Herrera-Estrella, Luis/AAL-2472-2020; Estrella, Luis R Herrera/G-7351-2011; Herrera-Estrella, Luis/ABC-7431-2020	Herrera-Estrella, Luis/0000-0001-7936-3856; Estrella, Luis R Herrera/0000-0001-7936-3856; LOPEZ ARREDONDO, DAMAR/0000-0001-7389-3143	Howard Hughes Medical Institute [55005946]; CONACyT, Mexico [207308]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We thank O. Martinez for advice in statistical analysis; M. A. Leyva, A. Vera and J.L. Cabrera for technical support; K. Wrobel and K. Wrobel for the phosphite detection method; V. Limones for assistance in Tobacco transformation and C. Castro and E. Alva in Arabidopsis greenhouse experiments. We are grateful to A. Estrada, J.D. Frier and Universidad Autonoma Chapingo for providing Brachypodium distachyon, Amaranthus hybridus and Ipomoea purpurea and Brachiaria plantaginea seeds, respectively; and C. Morales for assistance in photosynthesis measurements. We thank S. Gillmore and V. Albert for critical reading this manuscript. This work was supported in part by grant from the Howard Hughes Medical Institute (grant 55005946) to L.H.-E. D.L.L.-A. is indebted to CONACyT, Mexico, for a PhD fellowship (no. 207308). pWM302 was a gift from W. W. Metcalf.	Abelson PH, 1999, SCIENCE, V283, P2015, DOI 10.1126/science.283.5410.2015; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Cakmak I, 2002, PLANT SOIL, V247, P3, DOI 10.1023/A:1021194511492; Carpenter SR, 2008, P NATL ACAD SCI USA, V105, P11039, DOI 10.1073/pnas.0806112105; Carswell C, 1996, PLANT PHYSIOL, V110, P105, DOI 10.1104/pp.110.1.105; Carswell MC, 1997, PLANTA, V203, P67, DOI 10.1007/s004250050166; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Costas AMG, 2001, J BIOL CHEM, V276, P17429, DOI 10.1074/jbc.M011764200; Dawson CJ, 2011, FOOD POLICY, V36, pS14, DOI 10.1016/j.foodpol.2010.11.012; Downing JA, 2001, CAN J FISH AQUAT SCI, V58, P1905, DOI 10.1139/cjfas-58-10-1905; Forster H, 1998, PLANT DIS, V82, P1165, DOI 10.1094/PDIS.1998.82.10.1165; Gianessi LP, 2007, WEED TECHNOL, V21, P559, DOI 10.1614/WT-06-130.1; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Hesse P.R., 1971, AUST J SOIL RES, V35, P227; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Lee TM, 2005, J PHYCOL, V41, P975, DOI 10.1111/j.1529-8817.2005.00119.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Trujillo M, 2004, PLANT MOL BIOL REP, V22, P63, DOI 10.1007/BF02773350; McDonald AE, 2001, J PLANT NUTR, V24, P1505, DOI 10.1081/PLN-100106017; Metcalf WW, 1998, J BACTERIOL, V180, P5547, DOI 10.1128/JB.180.21.5547-5558.1998; Morton SC, 2005, ENVIRON SCI TECHNOL, V39, P4369, DOI 10.1021/es0401038; OUIMETTE DG, 1989, PLANT DIS, V73, P212, DOI 10.1094/PD-73-0212; Pasek MA, 2008, P NATL ACAD SCI USA, V105, P853, DOI 10.1073/pnas.0708205105; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; RAO IM, 1989, PLANT PHYSIOL, V90, P820, DOI 10.1104/pp.90.3.820; Ruthbaum HP, 1964, NZ J SCI, V7, P446; SAINDRENAN P, 1988, PLANT SCI, V58, P245, DOI 10.1016/0168-9452(88)90015-5; Sambrook J., 2001, MOL CLONING LAB MANU; Schroetter S, 2006, LANDBAUFORSCH VOLK, V56, P87; Syers J.K., 2008, FAO FERTILIZER PLANT, V18; Ticconi CA, 2001, PLANT PHYSIOL, V127, P963, DOI 10.1104/pp.010396; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Varadarajan DK, 2002, PLANT PHYSIOL, V129, P1232, DOI 10.1104/pp.010835; White AK, 2007, ANNU REV MICROBIOL, V61, P379, DOI 10.1146/annurev.micro.61.080706.093357; Wrobel K, 2010, J CHROMATOGR B, V878, P609, DOI 10.1016/j.jchromb.2010.01.008	36	77	84	2	106	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					889	U123		10.1038/nbt.2346	http://dx.doi.org/10.1038/nbt.2346			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22922674				2022-12-27	WOS:000308705700024
J	Tautenhahn, R; Cho, K; Uritboonthai, W; Zhu, ZJ; Patti, GJ; Siuzdak, G				Tautenhahn, Ralf; Cho, Kevin; Uritboonthai, Winnie; Zhu, Zhengjiang; Patti, Gary J.; Siuzdak, Gary			An accelerated workflow for untargeted metabolomics using the METLIN database	NATURE BIOTECHNOLOGY			English	Letter									[Tautenhahn, Ralf; Cho, Kevin; Uritboonthai, Winnie; Zhu, Zhengjiang; Siuzdak, Gary] Scripps Res Inst, Dept Chem, Ctr Metabol, La Jolla, CA 92037 USA; [Tautenhahn, Ralf; Cho, Kevin; Uritboonthai, Winnie; Zhu, Zhengjiang; Siuzdak, Gary] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Patti, Gary J.] Washington Univ, Dept Chem, Sch Med, St Louis, MO 63130 USA; [Patti, Gary J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Patti, Gary J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Scripps Research Institute; Scripps Research Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Tautenhahn, R (corresponding author), Scripps Res Inst, Dept Chem, Ctr Metabol, La Jolla, CA 92037 USA.	gjpattij@wustl.edu; siuzdak@scripps.edu	Zhu, Zheng-Jiang/C-5306-2011	Zhu, Zheng-Jiang/0000-0002-3272-3567; Siuzdak, Gary/0000-0002-4749-0014; Cho, Kevin/0000-0002-3041-3506	NATIONAL CANCER INSTITUTE [R01CA170737] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY017540] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL101034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA026146] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA170737] Funding Source: Medline; NEI NIH HHS [R24 EY017540] Funding Source: Medline; NHLBI NIH HHS [RC1 HL101034] Funding Source: Medline; NIA NIH HHS [L30 AG038036, L30 AG0 038036] Funding Source: Medline; NIDA NIH HHS [P01 DA026146] Funding Source: Medline; NIEHS NIH HHS [R01 ES022181] Funding Source: Medline; NIMH NIH HHS [P30 MH062261] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Mylonas R, 2009, ANAL CHEM, V81, P7604, DOI 10.1021/ac900954d; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Yanes O, 2011, ANAL CHEM, V83, P2152, DOI 10.1021/ac102981k; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364	9	352	365	6	198	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					826	828		10.1038/nbt.2348	http://dx.doi.org/10.1038/nbt.2348			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22965049	Green Accepted, Green Submitted			2022-12-27	WOS:000308705700012
J	Russell, SJ; Peng, KW; Bell, JC				Russell, Stephen J.; Peng, Kah-Whye; Bell, John C.			Oncolytic virotherapy	NATURE BIOTECHNOLOGY			English	Review							VESICULAR STOMATITIS-VIRUS; HERPES-SIMPLEX-VIRUS; MEDIATED GENE-EXPRESSION; NONLINEAR DOSE-RESPONSE; MESENCHYMAL STEM-CELLS; TUMOR-SPECIFIC DEFECTS; MEASLES-VIRUS; INTRATUMORAL SPREAD; T-CELLS; PHASE-I	Oncolytic virotherapy is an emerging treatment modality that uses replication-competent viruses to destroy cancers. Recent advances include preclinical proof of feasibility for a single-shot virotherapy cure, identification of drugs that accelerate intratumoral virus propagation, strategies to maximize the immunotherapeutic action of oncolytic viruses and clinical confirmation of a critical viremic threshold for vascular delivery and intratumoral virus replication. The primary clinical milestone has been completion of accrual in a phase 3 trial of intratumoral herpes simplex virus therapy using talimogene laherparepvec for metastatic melanoma. Key challenges for the field are to select 'winners' from a burgeoning number of oncolytic platforms and engineered derivatives, to transiently suppress but then unleash the power of the immune system to maximize both virus spread and anticancer immunity, to develop more meaningful preclinical virotherapy models and to manufacture viruses with orders-of-magnitude higher yields than is currently possible.	[Russell, Stephen J.; Peng, Kah-Whye] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Bell, John C.] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Bell, John C.] Jennerex Biotherapeut, San Francisco, CA USA	Mayo Clinic; University of Ottawa; Ottawa Hospital Research Institute	Russell, SJ (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	sjr@mayo.edu	Kostov, Daniel/J-4106-2017	Kostov, Daniel/0000-0002-9721-320X; Russell, Stephen/0000-0002-0799-6432	Mayo Foundation; Mayo Clinic Comprehensive Cancer Center [CA15083]; National Cancer Institute [CA100634, CA129966, CA118488, CA129193, CA136547, CA136393]; Richard M. Schulze Family Foundation; Ontario Institute for Cancer Research; Terry Fox Foundation; Ottawa Regional Cancer Foundation; US National Institutes of Health; Al and Mary Agnes McQuinn and Minnesota Partnership for Biotechnology; NATIONAL CANCER INSTITUTE [R01CA100634, P30CA015083, R01CA129193, P50CA136393, R01CA118488, R01CA129966, R01CA136547, R01CA168719] Funding Source: NIH RePORTER	Mayo Foundation; Mayo Clinic Comprehensive Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Richard M. Schulze Family Foundation; Ontario Institute for Cancer Research; Terry Fox Foundation; Ottawa Regional Cancer Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Al and Mary Agnes McQuinn and Minnesota Partnership for Biotechnology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	S.J.R. and K.-W.P. acknowledge funding support from the Mayo Foundation, Mayo Clinic Comprehensive Cancer Center (CA15083), US National Institutes of Health and National Cancer Institute (CA100634, CA129966, CA118488, CA129193, CA136547 and CA136393), Richard M. Schulze Family Foundation, Al and Mary Agnes McQuinn and Minnesota Partnership for Biotechnology. J.C.B. is supported by the Ontario Institute for Cancer Research, the Terry Fox Foundation and the Ottawa Regional Cancer Foundation.	Alain T, 2010, P NATL ACAD SCI USA, V107, P1576, DOI 10.1073/pnas.0912344107; Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Altomonte J, 2008, MOL THER, V16, P146, DOI 10.1038/sj.mt.6300343; ASADA T, 1974, CANCER, V34, P1907, DOI 10.1002/1097-0142(197412)34:6<1907::AID-CNCR2820340609>3.0.CO;2-4; Au GG, 2005, INT J ONCOL, V26, P1471; Ayala-Breton C, 2012, HUM GENE THER, V23, P484, DOI 10.1089/hum.2011.146; Bachtarzi H, 2011, J CONTROL RELEASE, V150, P196, DOI 10.1016/j.jconrel.2010.10.011; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Barnett FH, 1999, CANCER GENE THER, V6, P14, DOI 10.1038/sj.cgt.7700003; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; Bessis N, 2004, GENE THER, V11, pS10, DOI 10.1038/sj.gt.3302364; Breitbach CJ, 2011, NATURE, V477, P99, DOI 10.1038/nature10358; Breitbach CJ, 2011, MOL THER, V19, P886, DOI 10.1038/mt.2011.26; Bridle BW, 2010, CYTOKINE GROWTH F R, V21, P143, DOI 10.1016/j.cytogfr.2010.02.009; Brown CW, 2009, J VIROL, V83, P552, DOI 10.1128/JVI.01921-08; Byrnes AP, 2000, J VIROL, V74, P644, DOI 10.1128/JVI.74.2.644-651.2000; Cattaneo R, 2008, NAT REV MICROBIOL, V6, P529, DOI 10.1038/nrmicro1927; Cawood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016152; Cawood R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000440; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Chen HH, 2011, MOL THER, V19, P67, DOI 10.1038/mt.2010.209; Chen NH, 2011, VIROLOGY, V409, P328, DOI 10.1016/j.virol.2010.10.021; Chiocca EA, 2008, CURR OPIN MOL THER, V10, P38; Croyle MA, 2004, J VIROL, V78, P912, DOI 10.1128/JVI.78.2.912-921.2004; Diallo JS, 2010, MOL THER, V18, P1123, DOI 10.1038/mt.2010.67; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Dingli D, 2004, BLOOD, V103, P1641, DOI 10.1182/blood-2003-07-2233; Dingli D, 2003, J CELL BIOCHEM, V90, P1079, DOI 10.1002/jcb.10714; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; Dorer DE, 2009, ADV DRUG DELIVER REV, V61, P554, DOI 10.1016/j.addr.2009.03.013; Doronin K, 2000, J VIROL, V74, P6147, DOI 10.1128/JVI.74.13.6147-6155.2000; Doronin K, 2009, HUM GENE THER, V20, P975, DOI 10.1089/hum.2009.028; Driessen WHP, 2009, ADV GENET, V67, P103, DOI 10.1016/S0065-2660(09)67004-8; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Dwyer RM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt25; Eager RM, 2011, CANCER GENE THER, V18, P305, DOI 10.1038/cgt.2011.7; Edge RE, 2008, MOL THER, V16, P1437, DOI 10.1038/mt.2008.130; Eto Y, 2008, INT J PHARM, V354, P3, DOI 10.1016/j.ijpharm.2007.08.025; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Fisher KD, 2010, ADV DRUG DELIVER REV, V62, P240, DOI 10.1016/j.addr.2009.12.003; Foka P, 2010, J GENE MED, V12, P956, DOI 10.1002/jgm.1519; Fox ME, 2009, ACCOUNTS CHEM RES, V42, P1141, DOI 10.1021/ar900035f; Galanis E, 2010, CANCER RES, V70, P875, DOI 10.1158/0008-5472.CAN-09-2762; Ganesh S, 2008, CLIN CANCER RES, V14, P3933, DOI 10.1158/1078-0432.CCR-07-4732; Garcia-Castro J, 2010, CANCER GENE THER, V17, P476, DOI 10.1038/cgt.2010.4; Glass M, 2009, NAT METHODS, V6, P577, DOI 10.1038/nmeth.1346; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Guedan S, 2010, MOL THER, V18, P1275, DOI 10.1038/mt.2010.79; Haisma HJ, 2011, MOL PHARMACEUT, V8, P50, DOI 10.1021/mp100310h; Haisma HJ, 2009, MOL PHARMACEUT, V6, P366, DOI 10.1021/mp8000974; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haralambieva I, 2007, MOL THER, V15, P588, DOI 10.1038/sj.mt.6300076; Harrington KJ, 2010, CYTOKINE GROWTH F R, V21, P91, DOI 10.1016/j.cytogfr.2010.02.006; Harrington KJ, 2010, CLIN CANCER RES, V16, P4005, DOI 10.1158/1078-0432.CCR-10-0196; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Heo J, 2011, MOL THER, V19, P1170, DOI 10.1038/mt.2011.39; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hoffmann D, 2006, MOL CANCER THER, V5, P2013, DOI 10.1158/1535-7163.MCT-06-0128; Ikeda K, 1999, NAT MED, V5, P881, DOI 10.1038/11320; Ikeda K, 2000, J VIROL, V74, P4765, DOI 10.1128/JVI.74.10.4765-4775.2000; Ilett EJ, 2009, GENE THER, V16, P689, DOI 10.1038/gt.2009.29; Ilett EJ, 2011, CLIN CANCER RES, V17, P2767, DOI 10.1158/1078-0432.CCR-10-3266; Israyelyan A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-68; Jacobs A, 2001, LANCET, V358, P727, DOI 10.1016/S0140-6736(01)05904-9; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Jing YQ, 2009, CANCER RES, V69, P1459, DOI 10.1158/0008-5472.CAN-08-2628; Kanai R, 2010, FUTURE ONCOL, V6, P619, DOI [10.2217/fon.10.18, 10.2217/FON.10.18]; Kelly E, 2007, MOL THER, V15, P651, DOI 10.1038/sj.mt.6300108; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Kelly EJ, 2010, J VIROL, V84, P1550, DOI 10.1128/JVI.01788-09; Kelly EJ, 2009, MOL THER, V17, P409, DOI 10.1038/mt.2008.288; Kim JH, 2006, JNCI-J NATL CANCER I, V98, P1482, DOI 10.1093/jnci/djj397; Kirn DH, 2008, CANCER RES, V68, P2071, DOI 10.1158/0008-5472.CAN-07-6515; Kirn DH, 2009, NAT REV CANCER, V9, P64, DOI 10.1038/nrc2545; Knop DR, 2007, BIOTECHNOL PROGR, V23, P715, DOI 10.1021/bp060373p; Koski A, 2009, J GENE MED, V11, P966, DOI 10.1002/jgm.1373; Kottke T, 2008, MOL THER, V16, P1217, DOI 10.1038/mt.2008.83; Kottke T, 2011, NAT MED, V17, P854, DOI 10.1038/nm.2390; Kottke T, 2010, J CLIN INVEST, V120, P1551, DOI 10.1172/JCI41431; Kottke T, 2008, MOL THER, V16, P1910, DOI 10.1038/mt.2008.212; Kottke T, 2009, CLIN CANCER RES, V15, P561, DOI 10.1158/1078-0432.CCR-08-1688; Kuhn I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002409; Kumar CC, 1997, J PHARMACOL EXP THER, V283, P843; Kurozumi K, 2007, JNCI-J NATL CANCER I, V99, P1768, DOI 10.1093/jnci/djm229; Le Boeuf F, 2010, MOL THER, V18, P888, DOI 10.1038/mt.2010.44; Leber MF, 2011, MOL THER, V19, P1097, DOI 10.1038/mt.2011.55; Lee CYF, 2010, MOL THER, V18, P929, DOI 10.1038/mt.2010.26; Lee PY, 2002, J VIROL, V76, P6302, DOI 10.1128/JVI.76.12.6302-631-.2002; Lewis J.A., 2006, DEV BIOL BASEL, V123, P183; Lewis JA, 2006, DEV BIOLOGICALS, V123, P165; Ling XY, 2010, CANCER MICROENVIRON, V3, P83, DOI 10.1007/s12307-010-0041-8; Liu CS, 2010, MOL THER, V18, P1155, DOI 10.1038/mt.2010.43; Liu TC, 2007, NAT CLIN PRACT ONCOL, V4, P101, DOI 10.1038/ncponc0736; Lu MY, 2011, CELL DEATH DIFFER, V18, P925, DOI 10.1038/cdd.2010.160; Lun XQ, 2007, CANCER RES, V67, P8818, DOI 10.1158/0008-5472.CAN-07-1214; Lun XQ, 2010, CANCER RES, V70, P598, DOI 10.1158/0008-5472.CAN-09-1510; MacTavish H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014462; Mader EK, 2009, CLIN CANCER RES, V15, P7246, DOI 10.1158/1078-0432.CCR-09-1292; Manickan E, 2006, MOL THER, V13, P108, DOI 10.1016/j.ymthe.2005.08.007; MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332; Mastrangelo MJ, 2000, ADV EXP MED BIOL, V465, P391; Mastrangelo MJ, 1999, CANCER GENE THER, V6, P409, DOI 10.1038/sj.cgt.7700066; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Melcher A, 2011, MOL THER, V19, P1008, DOI 10.1038/mt.2011.65; Miyatake S, 1997, J VIROL, V71, P5124, DOI 10.1128/JVI.71.7.5124-5132.1997; Morrison J, 2008, MOL THER, V16, P244, DOI 10.1038/sj.mt.6300363; Morrison J, 2009, HUM GENE THER, V20, P239, DOI 10.1089/hum.2008.167; Muik A, 2011, J VIROL, V85, P5679, DOI 10.1128/JVI.02511-10; Muthana M, 2011, CANCER RES, V71, P1805, DOI 10.1158/0008-5472.CAN-10-2349; Naik S, 2012, LEUKEMIA, V26, P1870, DOI 10.1038/leu.2012.70; Naik S, 2009, EXPERT OPIN BIOL TH, V9, P1163, DOI 10.1517/14712590903170653; Nakamura T, 2005, NAT BIOTECHNOL, V23, P209, DOI 10.1038/nbt1060; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Nguyen TLA, 2008, P NATL ACAD SCI USA, V105, P14981, DOI 10.1073/pnas.0803988105; Oliere S, 2008, J VIROL, V82, P5735, DOI 10.1128/JVI.02601-07; Ong HT, 2007, GENE THER, V14, P324, DOI 10.1038/sj.gt.3302880; Ong HT, 2009, MOL THER, V17, P1012, DOI 10.1038/mt.2009.39; Otsuki A, 2008, MOL THER, V16, P1546, DOI 10.1038/mt.2008.155; Palumbo A, 2011, BRIT J CANCER, V104, P1106, DOI 10.1038/bjc.2011.78; Park BH, 2008, LANCET ONCOL, V9, P533, DOI 10.1016/S1470-2045(08)70107-4; Passer BJ, 2010, CANCER RES, V70, P3890, DOI 10.1158/0008-5472.CAN-10-0155; Patel B, 2011, MOL THER, V19, P1034, DOI 10.1038/mt.2011.44; Peng KW, 2013, GENE THER, V20, P255, DOI 10.1038/gt.2012.31; Peng KW, 2002, NAT MED, V8, P527, DOI 10.1038/nm0502-527; Power AT, 2008, GENE THER, V15, P772, DOI 10.1038/gt.2008.40; Pulido J, 2012, NAT BIOTECHNOL, V30, P336, DOI 10.1038/nbt.2157; Qiao J, 2008, GENE THER, V15, P604, DOI 10.1038/sj.gt.3303098; Qiao J, 2008, CLIN CANCER RES, V14, P259, DOI 10.1158/1078-0432.CCR-07-1510; Reeves PM, 2011, J VIROL, V85, P21, DOI 10.1128/JVI.01814-10; Rodriguez R, 1997, CANCER RES, V57, P2559; Roos FC, 2010, EMBO MOL MED, V2, P275, DOI 10.1002/emmm.201000081; Rudin CM, 2011, CLIN CANCER RES, V17, P888, DOI 10.1158/1078-0432.CCR-10-1706; Russell SJ, 2009, CURR TOP MICROBIOL, V330, P213; RUSSELL SJ, 1994, SEMIN CANCER BIOL, V5, P437; Russell SJ, 2007, TRENDS PHARMACOL SCI, V28, P326, DOI 10.1016/j.tips.2007.05.005; Sanz L, 2002, GENE THER, V9, P1049, DOI 10.1038/sj.gt.3301725; Sauthoff H, 2003, HUM GENE THER, V14, P425, DOI 10.1089/104303403321467199; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schoofs G, 1998, CYTOTECHNOLOGY, V28, P81, DOI 10.1023/A:1008021428969; Senac JS, 2010, HUM GENE THER, V21, P179, DOI 10.1089/hum.2009.082; Senzer NN, 2009, J CLIN ONCOL, V27, P5763, DOI 10.1200/JCO.2009.24.3675; Serganova I, 2007, NUCL MED BIOL, V34, P791, DOI 10.1016/j.nucmedbio.2007.05.009; Shashkova EV, 2008, CANCER RES, V68, P5896, DOI 10.1158/0008-5472.CAN-08-0488; Shashkova EV, 2009, MOL THER, V17, P2121, DOI 10.1038/mt.2009.217; SOUTHAM CHESTER M., 1960, TRANS NEW YORK ACAD SCI, V22, P657; Stepkowski S M, 2000, Expert Rev Mol Med, V2, P1, DOI 10.1017/S1462399400001769; Stoff-Khalili MA, 2008, BREAST CANCER RES TR, V108, P43, DOI 10.1007/s10549-007-9587-7; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Sugio K, 2011, CLIN CANCER RES, V17, P2807, DOI 10.1158/1078-0432.CCR-10-2008; Tai CK, 2008, FRONT BIOSCI-LANDMRK, V13, P3083, DOI 10.2741/2910; Tao NJ, 2001, MOL THER, V3, P28, DOI 10.1006/mthe.2000.0227; Thorne SH, 2006, SCIENCE, V311, P1780, DOI 10.1126/science.1121411; Thorne SH, 2007, J CLIN INVEST, V117, P3350, DOI 10.1172/JCI32727; Toth K, 2010, EXPERT OPIN BIOL TH, V10, P353, DOI 10.1517/14712590903559822; Tseng JC, 2010, CANCER GENE THER, V17, P244, DOI 10.1038/cgt.2009.70; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vandevenne P, 2010, BIOCHEM PHARMACOL, V80, P1955, DOI 10.1016/j.bcp.2010.07.001; Virgin S., 2007, FIELDS VIROLOGY, V1; Wakimoto H, 2002, MOL THER, V5, P275, DOI 10.1006/mthe.2002.0547; Wong RJ, 2001, HUM GENE THER, V12, P253, DOI 10.1089/10430340150218396; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yang XY, 2009, J VIROL METHODS, V155, P44, DOI 10.1016/j.jviromet.2008.09.020; Yun CO, 2008, CURR OPIN MOL THER, V10, P356; Zhang XD, 2011, ONCOL REP, V26, P637, DOI 10.3892/or.2011.1306; Ziegler RJ, 2002, HUM GENE THER, V13, P935, DOI 10.1089/10430340252939041	168	913	981	23	444	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					658	670		10.1038/nbt.2287	http://dx.doi.org/10.1038/nbt.2287			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781695	Green Accepted			2022-12-27	WOS:000306293400025
J	Ivanciu, L; Toso, R; Margaritis, P; Pavani, G; Kim, H; Schlachterman, A; Liu, JH; Clerin, V; Pittman, DD; Rose-Miranda, R; Shields, KM; Erbe, DV; Tobin, JF; Arruda, VR; Camire, RM				Ivanciu, Lacramioara; Toso, Raffaella; Margaritis, Paris; Pavani, Giulia; Kim, Haein; Schlachterman, Alexander; Liu, Jian-Hua; Clerin, Valerie; Pittman, Debra D.; Rose-Miranda, Rosalind; Shields, Kathleen M.; Erbe, David V.; Tobin, James F.; Arruda, Valder R.; Camire, Rodney M.			A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia	NATURE BIOTECHNOLOGY			English	Article							FACTOR VIIA; THROMBIN GENERATION; TISSUE FACTOR; FACTOR-V; RECOMBINANT FVIIA; HUMAN-PLASMA; MOUSE MODEL; HEMOSTASIS; PLATELETS; INHIBITOR	Effective therapies are needed to control excessive bleeding in a range of clinical conditions. We improve hemostasis in vivo using a conformationally pliant variant of coagulation factor Xa (FXa(I16L)) rendered partially inactive by a defect in the transition from zymogen to active protease(1,2). Using mouse models of hemophilia, we show that FXa(I16L) has a longer half-life than wild-type FXa and does not cause excessive activation of coagulation. Once clotting mechanisms are activated to produce its cofactor FVa, FXa(I16L) is driven to the protease state and restores hemostasis in hemophilic animals upon vascular injury. Moreover, using human or murine analogs, we show that FXa(I16L) is more efficacious than FVIIa, which is used to treat bleeding in hemophilia inhibitor patients(3). FXa(I16L) may provide an effective strategy to enhance blood clot formation and act as a rapid pan-hemostatic agent for the treatment of bleeding conditions.	[Ivanciu, Lacramioara; Toso, Raffaella; Margaritis, Paris; Pavani, Giulia; Kim, Haein; Schlachterman, Alexander; Liu, Jian-Hua; Arruda, Valder R.; Camire, Rodney M.] Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA; [Margaritis, Paris; Arruda, Valder R.; Camire, Rodney M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Clerin, Valerie; Pittman, Debra D.; Rose-Miranda, Rosalind; Shields, Kathleen M.; Erbe, David V.; Tobin, James F.] Pfizer Inc, Cambridge, MA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Pfizer	Camire, RM (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA.	rcamire@mail.med.upenn.edu	Pavani, Giulia/I-3612-2012; Toso, Raffaella/I-5202-2012	Pavani, Giulia/0000-0002-2522-2684; 	US National Institutes of Health [P01 HL-74124]; Pfizer; National Hemophilia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); National Hemophilia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by US National Institutes of Health grant P01 HL-74124, Project 2; research funding from Pfizer (to R.M.C.); and the Judith Graham Pool Postdoctoral Research Fellowship, National Hemophilia Foundation (to L.I.). We would like to thank L. Albert and B. Carito (Pfizer), and A. Hannan (Children's Hospital of Philadelphia) for their technical assistance. We are also grateful to S. Krishnaswamy (Children's Hospital of Philadelphia/University of Pennsylvania) for useful suggestions and critical review of the manuscript.	Aijarnali MN, 2008, J CLIN INVEST, V118, P1825, DOI 10.1172/JCI32878; Berntorp E, 2009, HAEMOPHILIA, V15, P3, DOI 10.1111/j.1365-2516.2008.01931.x; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Bunce MW, 2011, BLOOD, V117, P290, DOI 10.1182/blood-2010-08-300756; Butenas S, 2003, J THROMB HAEMOST, V1, P1158, DOI 10.1046/j.1538-7836.2003.00181.x; Darby SC, 2004, J THROMB HAEMOST, V2, P1047, DOI 10.1046/j.1538-7836.2004.00710.x; DiMichele D, 2007, BRIT J HAEMATOL, V138, P305, DOI 10.1111/j.1365-2141.2007.06657.x; Escobar MA, 2010, HAEMOPHILIA, V16, P29, DOI 10.1111/j.1365-2516.2010.02257.x; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; GILES AR, 1988, BRIT J HAEMATOL, V69, P491, DOI 10.1111/j.1365-2141.1988.tb02405.x; GILES AR, 1984, J CLIN INVEST, V74, P2219, DOI 10.1172/JCI111648; GITEL SN, 1984, J BIOL CHEM, V259, P6890; Hedner U, 2006, J BIOTECHNOL, V124, P747, DOI 10.1016/j.jbiotec.2006.03.042; Khan AR, 1998, PROTEIN SCI, V7, P815; Kung SH, 1998, BLOOD, V91, P784, DOI 10.1182/blood.V91.3.784.784_784_790; Lin HF, 1997, BLOOD, V90, P3962, DOI 10.1182/blood.V90.10.3962; MANN KG, 1990, BLOOD, V76, P1; Mannucci PM, 2008, HAEMOPHILIA, V14, P10, DOI 10.1111/j.1365-2516.2008.01708.x; Margaritis P, 2004, J CLIN INVEST, V113, P1025, DOI 10.1172/JCI200420106; Margaritis P, 2011, BLOOD, V117, P3974, DOI 10.1182/blood-2010-09-309732; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; Monroe DM, 1997, BRIT J HAEMATOL, V99, P542, DOI 10.1046/j.1365-2141.1997.4463256.x; Moss J, 2009, J THROMB HAEMOST, V7, P299, DOI 10.1111/j.1538-7836.2008.03253.x; Neyman M, 2008, BLOOD, V112, P1101, DOI 10.1182/blood-2008-04-152959; Petersen LC, 2005, THROMB RES, V116, P75, DOI 10.1016/j.thromres.2004.11.003; Roberts HR, 2006, HEMOSTASIS THROMBOSI, P877; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Schlachterman A, 2005, J THROMB HAEMOST, V3, P2730, DOI 10.1111/j.1538-7836.2005.01639.x; Tchaikovski SN, 2007, J THROMB HAEMOST, V5, P2079, DOI 10.1111/j.1538-7836.2007.02719.x; Toso R, 2008, J BIOL CHEM, V283, P18627, DOI 10.1074/jbc.M802205200; TRACY PB, 1982, BLOOD, V60, P59; Tranholm M, 2003, BLOOD, V102, P3615, DOI 10.1182/blood-2003-05-1369; Turecek PL, 2004, HAEMOPHILIA, V10, P3, DOI 10.1111/j.1365-2516.2004.00934.x; Turecek PL, 2003, PATHOPHYSIOL HAEMO T, V33, P16, DOI 10.1159/000071637; Weeterings C, 2008, SEMIN HEMATOL, V45, pS12, DOI 10.1053/j.seminhematol.2008.03.018; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006	36	61	69	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1028	U103		10.1038/nbt.1995	http://dx.doi.org/10.1038/nbt.1995			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22020385	Green Accepted			2022-12-27	WOS:000296801300025
J	Vierbuchen, T; Wernig, M				Vierbuchen, Thomas; Wernig, Marius			Direct lineage conversions: unnatural but useful?	NATURE BIOTECHNOLOGY			English	Review							PLURIPOTENT STEM-CELLS; INSULIN GENE-TRANSCRIPTION; CHROMATIN REMODELING COMPLEXES; PANCREATIC BETA-CELLS; DNA-BINDING PROTEIN; HUMAN SOMATIC-CELLS; RADIAL GLIAL-CELLS; HUMAN FIBROBLASTS; NUCLEAR TRANSFER; SKELETAL-MUSCLE	Classic experiments such as somatic cell nuclear transfer into oocytes and cell fusion demonstrated that differentiated cells are not irreversibly committed to their fate. More recent work has built on these conclusions and discovered defined factors that directly induce one specific cell type from another, which may be as distantly related as cells from different germ layers. This suggests the possibility that any specific cell type may be directly converted into any other if the appropriate reprogramming factors are known. Direct lineage conversion could provide important new sources of human cells for modeling disease processes or for cellular-replacement therapies. For future applications, it will be critical to carefully determine the fidelity of reprogramming and to develop methods for robustly and efficiently generating human cell types of interest.	[Wernig, Marius] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University	Wernig, M (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	wernig@standford.edu		Vierbuchen, Thomas/0000-0002-5690-5680	US National Institutes of Health; Department of Defense; California Institute of Regenerative Medicine; BioX program at Stanford; Baxter Foundation; Stinehart-Reed Foundation; Ruth and Robert Halperin Stanford Graduate Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS073015] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); BioX program at Stanford; Baxter Foundation; Stinehart-Reed Foundation; Ruth and Robert Halperin Stanford Graduate Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the many colleagues who have contributed to this work through many insightful discussions on the topic over the last year. These include T. Graf, F. Guillemot, M. Gotz, J. Crabtree, A. Smith, R. Jaenisch, J. Wysocka, H. Blau, H. Chang, A. Kriegstein and I. Weissman. M. W. is a New York Stem Cell Foundation (NYSCF) Robertson Investigator, and our research is also supported by grants from the US National Institutes of Health, the Department of Defense, the California Institute of Regenerative Medicine, the BioX program at Stanford, the Baxter Foundation and the Stinehart-Reed Foundation. T. V. is supported by the Ruth and Robert Halperin Stanford Graduate Fellowship. We apologize to numerous authors whose valuable contributions we were unable to cite due to space constraints.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Albini S, 2010, EXP CELL RES, V316, P3073, DOI 10.1016/j.yexcr.2010.05.023; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Angel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011756; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; ARMSTRONG RC, 1995, GLIA, V14, P303, DOI 10.1002/glia.440140407; Artner I, 2008, J ENDOCRINOL, V198, P271, DOI 10.1677/JOE-08-0063; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Biddle A, 2009, DEVELOPMENT, V136, P2695, DOI 10.1242/dev.036327; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Blau HM, 1999, SEMIN CELL DEV BIOL, V10, P267, DOI 10.1006/scdb.1999.0311; Blum R, 2011, CEREB CORTEX, V21, P413, DOI 10.1093/cercor/bhq107; Bonal C, 2008, INT J DEV BIOL, V52, P823, DOI 10.1387/ijdb.072444cb; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Casarosa S, 1999, DEVELOPMENT, V126, P525; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; CHIU CP, 1985, CELL, V40, P417, DOI 10.1016/0092-8674(85)90155-2; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; CORCORAN LM, 1993, GENE DEV, V7, P570, DOI 10.1101/gad.7.4.570; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Davidson EH, 2006, REG GEN GEN REG; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Desgraz R, 2009, DEVELOPMENT, V136, P3567, DOI 10.1242/dev.039214; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Farah MH, 2000, DEVELOPMENT, V127, P693; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Fode C, 2000, GENE DEV, V14, P67; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Gasa R, 2008, DIFFERENTIATION, V76, P381, DOI 10.1111/j.1432-0436.2007.00228.x; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gaspard N, 2010, CURR OPIN NEUROBIOL, V20, P37, DOI 10.1016/j.conb.2009.12.001; Gaspard N, 2009, CELL CYCLE, V8, P2491, DOI 10.4161/cc.8.16.9276; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gotz M, 2010, NAT NEUROSCI, V13, P1308, DOI 10.1038/nn1110-1308; GOLDSMITH MA, 1989, J BIOL CHEM, V264, P17190; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gu GQ, 2002, DEVELOPMENT, V129, P2447; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; HA K, 1984, CANCER RES, V44, P4658; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hobert O, 2010, TRENDS NEUROSCI, V33, P435, DOI 10.1016/j.tins.2010.05.006; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jan Yuh Nung, 1994, Current Opinion in Neurobiology, V4, P8, DOI 10.1016/0959-4388(94)90025-6; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Kaneto H, 2005, DIABETES, V54, P1009, DOI 10.2337/diabetes.54.4.1009; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kataoka K, 2002, J BIOL CHEM, V277, P36825, DOI 10.1074/jbc.M206756200; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kondo T, 2000, DEVELOPMENT, V127, P2989; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lin W, 2009, DEV BIOL, V333, P386, DOI 10.1016/j.ydbio.2009.07.006; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; MILLER RA, 1976, CELL, V9, P45, DOI 10.1016/0092-8674(76)90051-9; Miyatsuka T, 2003, BIOCHEM BIOPH RES CO, V310, P1017, DOI 10.1016/j.bbrc.2003.09.108; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Ng RK, 2005, P NATL ACAD SCI USA, V102, P1957, DOI 10.1073/pnas.0409813102; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nishimura W, 2009, DEV BIOL, V333, P108, DOI 10.1016/j.ydbio.2009.06.029; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Omodei D, 2008, DEVELOPMENT, V135, P3459, DOI 10.1242/dev.027003; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; PALUMBO A, 1984, BLOOD, V64, P1059; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Parras CM, 2007, J NEUROSCI, V27, P4233, DOI 10.1523/JNEUROSCI.0126-07.2007; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; PAVLATH GK, 1989, NATURE, V337, P570, DOI 10.1038/337570a0; Perez SE, 1999, DEVELOPMENT, V126, P1715; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Pomerantz JH, 2009, J CELL SCI, V122, P1045, DOI 10.1242/jcs.041376; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; PTASHNE M, 2002, GENES SIGNALS; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Puri S, 2010, DEV CELL, V18, P342, DOI 10.1016/j.devcel.2010.02.005; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; ROVIGATTI U, 1984, BLOOD, V63, P1023; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; SCHAFER BW, 1990, NATURE, V344, P454, DOI 10.1038/344454a0; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sebastiano V, 2010, DEVELOPMENT, V137, P3551, DOI 10.1242/dev.047027; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Smale ST, 2010, CURR OPIN GENET DEV, V20, P519, DOI 10.1016/j.gde.2010.06.010; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Sugimori M, 2008, DEVELOPMENT, V135, P1271, DOI 10.1242/dev.015370; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Taberlay PC, 2011, PROG DRUG RES, V67, P1, DOI 10.1007/978-3-7643-8989-5_1; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; VISVADER JE, 1992, EMBO J, V11, P4557, DOI 10.1002/j.1460-2075.1992.tb05557.x; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; WALL L, 1988, GENE DEV, V2, P1089, DOI 10.1101/gad.2.9.1089; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Watada H, 1996, DIABETES, V45, P1478, DOI 10.2337/diabetes.45.11.1478; Weiner JA, 1997, J COMP NEUROL, V381, P130, DOI 10.1002/(SICI)1096-9861(19970505)381:2<130::AID-CNE2>3.0.CO;2-4; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; WITTA SE, 1995, DEVELOPMENT, V121, P721; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; WRIGHT WE, 1984, J CELL BIOL, V98, P427, DOI 10.1083/jcb.98.2.427; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zaret KS, 2010, NATURE, V464, P1132, DOI 10.1038/4641132a; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	272	189	203	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					892	907		10.1038/nbt.1946	http://dx.doi.org/10.1038/nbt.1946			16	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21997635	Green Accepted			2022-12-27	WOS:000296273000016
J	Prensner, JR; Iyer, MK; Balbin, OA; Dhanasekaran, SM; Cao, Q; Brenner, JC; Laxman, B; Asangani, IA; Grasso, CS; Kominsky, HD; Cao, XH; Jing, XJ; Wang, XJ; Siddiqui, J; Wei, JT; Robinson, D; Iyer, HK; Palanisamy, N; Maher, CA; Chinnaiyan, AM				Prensner, John R.; Iyer, Matthew K.; Balbin, O. Alejandro; Dhanasekaran, Saravana M.; Cao, Qi; Brenner, J. Chad; Laxman, Bharathi; Asangani, Irfan A.; Grasso, Catherine S.; Kominsky, Hal D.; Cao, Xuhong; Jing, Xiaojun; Wang, Xiaoju; Siddiqui, Javed; Wei, John T.; Robinson, Daniel; Iyer, Hari K.; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.			Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression	NATURE BIOTECHNOLOGY			English	Article							LONG NONCODING RNA; GENE FUSIONS; HUMAN GENOME; POLYCOMB; REVEALS; BREAST; LOCI; BIOMARKER; ELEMENTS; MARKER	Noncoding RNAs (ncRNAs) are emerging as key molecules in human cancer, with the potential to serve as novel markers of disease and to reveal uncharacterized aspects of tumor biology. Here we discover 121 unannotated prostate cancer-associated ncRNA transcripts (PCATs) by ab initio assembly of high-throughput sequencing of polyA(+) RNA (RNA-Seq) from a cohort of 102 prostate tissues and cells lines. We characterized one ncRNA, PCAT-1, as a prostate-specific regulator of cell proliferation and show that it is a target of the Polycomb Repressive Complex 2 (PRC2). We further found that patterns of PCAT-1 and PRC2 expression stratified patient tissues into molecular subtypes distinguished by expression signatures of PCAT-1-repressed target genes. Taken together, our findings suggest that PCAT-1 is a transcriptional repressor implicated in a subset of prostate cancer patients. These findings establish the utility of RNA-Seq to identify disease-associated ncRNAs that may improve the stratification of cancer subtypes.	[Prensner, John R.; Iyer, Matthew K.; Balbin, O. Alejandro; Dhanasekaran, Saravana M.; Cao, Qi; Brenner, J. Chad; Asangani, Irfan A.; Grasso, Catherine S.; Kominsky, Hal D.; Cao, Xuhong; Jing, Xiaojun; Wang, Xiaoju; Siddiqui, Javed; Robinson, Daniel; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Dhanasekaran, Saravana M.; Palanisamy, Nallasivam; Maher, Christopher A.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Laxman, Bharathi] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Wei, John T.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Iyer, Hari K.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Chicago; University of Michigan System; University of Michigan; Colorado State University; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Palanisamy, Nallasivam/ABC-8844-2020; Cao, Qi/A-5517-2010; Wei, John T/E-8967-2012	Palanisamy, Nallasivam/0000-0002-0633-9772; Cao, Qi/0000-0002-5140-3681; Prensner, John/0000-0002-7024-636X; Dhanasekaran, saravana mohan/0000-0002-0489-2224; asangani, irfan/0000-0001-5381-1702	US National Institutes of Health (NIH) [P50CA69568]; Early Detection Research Network [UO1 CA111275]; NIH [R01CA132874-01A1, CA009676-18]; Department of Defense [W81XWH-10-0652, W81XWH-11-1-0337, PC094725, W81XWH-10-1-0551, W81XWH-11-1-0136]; Doris Duke Charitable Foundation; Burroughs Wellcome Foundation; Prostate Cancer Foundation; University of Michigan; American Association of Cancer Research; Canary Foundation; American Cancer Society; NATIONAL CANCER INSTITUTE [U01CA111275, P50CA069568, T32CA009676, R01CA132874] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Prostate Cancer Foundation; University of Michigan(University of Michigan System); American Association of Cancer Research; Canary Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Ramnarayanan and R. Morey for technical assistance with next generation sequencing. We thank R.J. Lonigro, S. Kaylana-Sundaram, T. Barrette, and M. Quist for help with sequencing data analysis, and R. Mehra, B. Han and K. Suleman for prostate tissue specimens. We thank C. Trapnell and G. Pertea for assistance with computational analyses. We thank S. Tomlins, Y.-M. Wu, S. Roychowdhury and members of the Chinnaiyan laboratory for advice and discussions. We thank R. Beroukhim for guidance. This work was supported in part by the US National Institutes of Health (NIH) Prostate Specialized Program of Research Excellence grant P50CA69568, the Early Detection Research Network grant UO1 CA111275 (to A.M.C.), the NIH R01CA132874-01A1 (to A.M.C.), the Department of Defense grant W81XWH-10-0652 and W81XWH-11-1-0337 (to A.M.C.) and the National Center for Functional Genomics supported by the Department of Defense (to A.M.C.). A.M.C. is supported by the Doris Duke Charitable Foundation Clinical Scientist Award, a Burroughs Wellcome Foundation Award in Clinical Translational Research and the Prostate Cancer Foundation. A.M.C. is an American Cancer Society Research Professor. N.P. was supported by a University of Michigan Prostate SPORE Career Development Award. C. A. M. was supported by the American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research, the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship, and a Prostate Cancer Foundation Young Investigator Award. Q. C. was supported by a Department of Defense Postdoctoral Fellowship grant PC094725. J.R.P. was supported by the NIH Cancer Biology Training grant CA009676-18 and the Department of Defense Predoctoral Fellowship W81XWH-10-1-0551. M. K. I. was supported by the Department of Defense Predoctoral Fellowship W81XWH-11-1-0136. J.R.P. and M. K. I. are Fellows of the University of Michigan Medical Scientist Training Program.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bjartell AS, 2007, CLIN CANCER RES, V13, P4130, DOI 10.1158/1078-0432.CCR-06-3031; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Day DS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r69; de Kok JB, 2002, CANCER RES, V62, P2695; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hessels D, 2003, EUR UROL, V44, P8, DOI 10.1016/S0302-2838(03)00201-X; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Laxman B, 2008, CANCER RES, V68, P645, DOI 10.1158/0008-5472.CAN-07-3224; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; OOSUMI T, 1995, NATURE, V378, P672, DOI 10.1038/378672a0; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Prensner JR, 2009, CURR OPIN GENET DEV, V19, P82, DOI 10.1016/j.gde.2008.11.008; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robertson HM, 1996, NAT GENET, V12, P360, DOI 10.1038/ng0496-360; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	48	776	837	0	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					742	U134		10.1038/nbt.1914	http://dx.doi.org/10.1038/nbt.1914			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21804560	Green Accepted			2022-12-27	WOS:000293696500027
J	Grimaldi, A				Grimaldi, Annette			The outlook for biotech exits	NATURE BIOTECHNOLOGY			English	Article									BMO Capital Markets, New York, NY USA		Grimaldi, A (corresponding author), BMO Capital Markets, New York, NY USA.	annette.grimaldi@bmo.com							0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					227	228		10.1038/nbt.2852	http://dx.doi.org/10.1038/nbt.2852			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24727772				2022-12-27	WOS:000332819800017
J	Lanier, LL				Lanier, Lewis L.			Of snowflakes and natural killer cell subsets	NATURE BIOTECHNOLOGY			English	Editorial Material							3-COLOR IMMUNOFLUORESCENCE; LYMPHOCYTE SUBPOPULATIONS; FLOW-CYTOMETRY; EXPRESSION; CONTINUUM		[Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Lanier, Lewis L.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lewis.lanier@ucsf.edu	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952	NIAID NIH HHS [R37 AI066897, R01 AI068129, AI068129, AI066897] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068129, R37AI066897] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Chng WJ, 2004, CLIN DIAGN LAB IMMUN, V11, P168, DOI 10.1128/CDLI.11.1.168-173.2004; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; LANIER LL, 1984, J IMMUNOL, V132, P151; LOKEN MR, 1977, J HISTOCHEM CYTOCHEM, V25, P899, DOI 10.1177/25.7.330738; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; PARKS DR, 1984, CYTOMETRY, V5, P159, DOI 10.1002/cyto.990050210	8	10	10	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					140	142		10.1038/nbt.2810	http://dx.doi.org/10.1038/nbt.2810			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24509762	Green Published			2022-12-27	WOS:000331074000016
J	Behr, J; Murray, P				Behr, Jonathan; Murray, Phil			In search of dry powder	NATURE BIOTECHNOLOGY			English	Editorial Material									[Behr, Jonathan; Murray, Phil] PureTech, Boston, MA USA; [Behr, Jonathan] Enlight Biosci, New Ventures, Boston, MA USA		Behr, J (corresponding author), PureTech, Boston, MA USA.	jbehr@enlightbio.com; pmurray@puretechventures.com						Petty JS, 2011, J BUS VENTURING, V26, P172, DOI 10.1016/j.jbusvent.2009.07.002	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					961	964		10.1038/nbt.2729	http://dx.doi.org/10.1038/nbt.2729			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24213762	Bronze			2022-12-27	WOS:000326921200007
J	Francisco, M				Francisco, Michael			Second-quarter biotech job picture	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					766	766		10.1038/nbt.2660	http://dx.doi.org/10.1038/nbt.2660			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23929351	Bronze			2022-12-27	WOS:000322911000028
J	Graff, GD; Phillips, D; Lei, Z; Oh, S; Nottenburg, C; Pardey, PG				Graff, Gregory D.; Phillips, Devon; Lei, Zhen; Oh, Sooyoung; Nottenburg, Carol; Pardey, Philip G.			Not quite a myriad of gene patents	NATURE BIOTECHNOLOGY			English	Editorial Material							INTELLECTUAL PROPERTY; HUMAN GENOME; DEBATE	A new study assesses the impact of recent US Supreme Court rulings on the changing landscape of US patents claiming nucleic acids.	[Graff, Gregory D.] Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA; [Phillips, Devon; Pardey, Philip G.] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Lei, Zhen] Penn State Univ, Dept Energy & Mineral Engn, University Pk, PA 16802 USA; [Lei, Zhen] Penn State Univ, EMS Energy Inst, University Pk, PA 16802 USA; [Oh, Sooyoung] Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; [Nottenburg, Carol] Cougar Patent Law, Renton, WA USA; [Graff, Gregory D.; Lei, Zhen; Nottenburg, Carol; Pardey, Philip G.] Univ Minnesota, Dept Appl Econ, Int Sci & Technol Practice & Policy InSTePP Ctr, St Paul, MN 55108 USA	Colorado State University; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Minnesota System; University of Minnesota Twin Cities	Graff, GD (corresponding author), Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA.	gregory.graff@colostate.edu		Graff, Gregory/0000-0002-9140-0901	US National Institutes of Health [5 R01 HG004041-03]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004041] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors sincerely thank E. Hicks, K. Lee and C. Pratt for capable research assistance, and K. Silverstein for helpful advice. This research was supported by the US National Institutes of Health grant number 5 R01 HG004041-03.	[Anonymous], 2012, DERWENT WORLD PATENT; [Anonymous], 1999, FED REGISTER, V64, P71440; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Caulfield T, 2000, NAT REV GENET, V1, P227, DOI 10.1038/35042087; Cook-Deegan R, 2012, SCIENCE, V338, P745, DOI 10.1126/science.1229854; Fowler C., 1994, UNNATURAL SELECTION; Gold ER, 2000, NAT BIOTECHNOL, V18, P1217, DOI 10.1038/81233; Goldfarb B, 2007, J FINANC ECON, V86, P100, DOI 10.1016/j.jfineco.2006.03.009; Graff GD, 2003, NAT BIOTECHNOL, V21, P989, DOI 10.1038/nbt0903-989; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; HOLMAN CM, 2007, UMKC L REV, V76, P295; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Kling J, 2005, EMBO REP, V6, P1012, DOI 10.1038/sj.embor.7400553; National Research Council, 2006, REAP BEN GEN PROT RE; Nuffield Council on Bioethics, 2002, ETH PAT DNA DISC PAP; Pressman L, 2006, NAT BIOTECHNOL, V24, P31, DOI 10.1038/nbt0106-31; Resnik David, 2004, OWNING GENOME MORAL; Rogers E. J., 2010, J PAT TRADEMARK OFF, V93, P19; Schauinger S., 2012, HUMAN GENE PATENT RE; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; 2001, FED REG, V66, P1092; 5837492; 5747282; 5693473	24	36	36	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					404	411		10.1038/nbt.2568	http://dx.doi.org/10.1038/nbt.2568			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23657391				2022-12-27	WOS:000318589600016
J	Eichelbaum, K; Winter, M; Diaz, MB; Herzig, S; Krijgsveld, J				Eichelbaum, Katrin; Winter, Markus; Diaz, Mauricio Berriel; Herzig, Stephan; Krijgsveld, Jeroen			Selective enrichment of newly synthesized proteins for quantitative secretome analysis	NATURE BIOTECHNOLOGY			English	Article							SERUM STARVATION; CELL-LINES; IDENTIFICATION; PHOSPHORYLATION; EXPRESSION; BIOMARKERS; DISCOVERY; PEPTIDES; PROTEOME; BIOLOGY	Secreted proteins constitute a large and biologically important subset of proteins that are involved in cellular communication, adhesion and migration. Yet secretomes are understudied because of technical limitations in the detection of low-abundance proteins against a background of serum-containing media. Here we introduce a method that combines click chemistry and pulsed stable isotope labeling with amino acids in cell culture to selectively enrich and quantify secreted proteins. The combination of these two labeling approaches allows cells to be studied irrespective of the complexity of the background proteins. We provide an in-depth and differential secretome analysis of various cell lines and primary cells, quantifying secreted factors, including cytokines, chemokines and growth factors. In addition, we reveal that serum starvation has a marked effect on secretome composition. We also analyze the kinetics of protein secretion by macrophages in response to lipopolysaccharides.	[Eichelbaum, Katrin; Winter, Markus; Krijgsveld, Jeroen] EMBL, Genome Biol Unit, Heidelberg, Germany; [Diaz, Mauricio Berriel; Herzig, Stephan] Univ Heidelberg Hosp, Joint Div Mol Metab Control, DKFZ ZMBH Alliance, Ctr Mol Biol ZMBH, Heidelberg, Germany; [Diaz, Mauricio Berriel; Herzig, Stephan] German Canc Res Ctr, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Krijgsveld, J (corresponding author), EMBL, Genome Biol Unit, Heidelberg, Germany.	jeroen.krijgsveld@embl.de	Diaz, Mauricio Berriel/AAF-8285-2021; Krijgsveld, Jeroen/F-5974-2011	Krijgsveld, Jeroen/0000-0001-7549-9326; Berriel Diaz, Mauricio/0000-0003-4670-919X; Herzig, Stephan/0000-0003-3950-3652	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We gratefully acknowledge the EMBL Proteomics Core Facility for expert technical assistance. This study was supported by the Netherlands Organisation for Scientific Research (NWO).	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Bailey MJ, 2011, IMMUNOL CELL BIOL, V89, P283, DOI 10.1038/icb.2010.92; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Burghoff S, 2011, J PROTEOME RES, V10, P1160, DOI 10.1021/pr100937a; Caccia D, 2011, J PROTEOME RES, V10, P4196, DOI 10.1021/pr200344n; Colzani M, 2009, J PROTEOME RES, V8, P4779, DOI 10.1021/pr900476b; Cooper S, 2003, FASEB J, V17, P333, DOI 10.1096/fj.02-0352rev; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Dowling P, 2011, PROTEOMICS, V11, P794, DOI 10.1002/pmic.201000530; Finoulst I, 2011, J PROTEOMICS, V75, P23, DOI 10.1016/j.jprot.2011.03.034; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hasan NM, 1999, INT J CANCER, V80, P400, DOI 10.1002/(SICI)1097-0215(19990129)80:3<400::AID-IJC11>3.0.CO;2-U; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; Levin VA, 2010, J PROTEOME RES, V9, P179, DOI 10.1021/pr900392b; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; Manderson AP, 2007, J CELL BIOL, V178, P57, DOI 10.1083/jcb.200612131; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Nikolsky Y, 2005, TOXICOL LETT, V158, P20, DOI 10.1016/j.toxlet.2005.02.004; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sardana G, 2008, J PROTEOME RES, V7, P3329, DOI 10.1021/pr8003216; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stow JL, 2009, IMMUNOBIOLOGY, V214, P601, DOI 10.1016/j.imbio.2008.11.005; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; YAN XQ, 1993, J IMMUNOL, V150, P2440; Zhu XC, 2006, J IMMUNOL, V177, P4299, DOI 10.4049/jimmunol.177.7.4299	44	173	176	2	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					984	+		10.1038/nbt.2356	http://dx.doi.org/10.1038/nbt.2356			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	23000932				2022-12-27	WOS:000309965500025
J	Qi, L; Haurwitz, RE; Shao, WJ; Doudna, JA; Arkin, AP				Qi, Lei; Haurwitz, Rachel E.; Shao, Wenjun; Doudna, Jennifer A.; Arkin, Adam P.			RNA processing enables predictable programming of gene expression	NATURE BIOTECHNOLOGY			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; ANTIVIRAL DEFENSE; CRISPR RNA; NETWORKS; BACTERIA; PATHWAY; PROKARYOTES; MATURATION; REGULATORS	Complex interactions among genetic components often result in variable systemic performance in designed multigene systems(1,2). Using the bacterial clustered regularly interspaced short palindromic repeat (CRISPR) pathway(3,4) we develop a synthetic RNA-processing platform, and show that efficient and specific cleavage of precursor mRNA enables reliable and predictable regulation of multigene operons. Physical separation of linked genetic elements by CRISPR-mediated cleavage is an effective strategy to achieve assembly of promoters, ribosome binding sites, cis-regulatory elements, and riboregulators into single- and multigene operons with predictable functions in bacteria. We also demonstrate that CRISPR-based RNA cleavage is effective for regulation in bacteria, archaea and eukaryotes. Programmable RNA processing using CRISPR offers a general approach for creating context-free genetic elements and can be readily used in the bottom-up construction of increasingly complex biological systems in a plug-and-play manner.	[Qi, Lei; Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Haurwitz, Rachel E.; Shao, Wenjun; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Arkin, Adam P.] Calif Inst Quantitat Biosci QB3, Berkeley, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Arkin, AP (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	aparkin@lbl.gov	Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008; Qi, Lei S/AAC-5088-2019	Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931; Qi, Lei S/0000-0002-3965-3223	US National Science Foundation (SynBERC); Department of Energy through Laboratory Directed Research and Development [DE-AC02-05CH11231d]; Howard Hughes Medical Institute	US National Science Foundation (SynBERC); Department of Energy through Laboratory Directed Research and Development; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank members of BIOFAB, International Open Facility Advancing Biotechnology, for distributing genetic parts, and J. Dueber, M. Lee and H. Lee (University of California, Berkeley) for providing the yeast vector. This work was supported by the US National Science Foundation (SynBERC, NSFEEC-0540879, L.Q. and A.P.A.), Department of Energy through Laboratory Directed Research and Development (DE-AC02-05CH11231d, L.Q., W.S. and A.P.A.) and Howard Hughes Medical Institute (R.E.H. and J.A.D.).	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; DAROS JA, 1994, P NATL ACAD SCI USA, V91, P12813, DOI 10.1073/pnas.91.26.12813; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; DUNN JJ, 1973, P NATL ACAD SCI USA, V70, P3296, DOI 10.1073/pnas.70.12.3296; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Espeli O, 2001, J MOL BIOL, V314, P375, DOI 10.1006/jmbi.2001.5150; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; HAMPEL A, 1989, BIOCHEMISTRY-US, V28, P4929, DOI 10.1021/bi00438a002; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Leveau JHJ, 2001, J BACTERIOL, V183, P6752, DOI 10.1128/JB.183.23.6752-6762.2001; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mutalik VK, 2012, NAT CHEM BIOL, V8, P447, DOI [10.1038/NCHEMBIO.919, 10.1038/nchembio.919]; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WEK RC, 1987, J BIOL CHEM, V262, P15256; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zaslaver A, 2011, CELL, V145, P981, DOI 10.1016/j.cell.2011.05.013	34	142	170	4	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					1002	+		10.1038/nbt.2355	http://dx.doi.org/10.1038/nbt.2355			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	22983090				2022-12-27	WOS:000309965500028
J	Waltz, E				Waltz, Emily			Industry cautiously welcomes Supreme Court decision on healthcare overhaul	NATURE BIOTECHNOLOGY			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					812	813		10.1038/nbt0912-812b	http://dx.doi.org/10.1038/nbt0912-812b			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22965034				2022-12-27	WOS:000308705700005
J	Harper, AL; Trick, M; Higgins, J; Fraser, F; Clissold, L; Wells, R; Hattori, C; Werner, P; Bancroft, I				Harper, Andrea L.; Trick, Martin; Higgins, Janet; Fraser, Fiona; Clissold, Leah; Wells, Rachel; Hattori, Chie; Werner, Peter; Bancroft, Ian			Associative transcriptomics of traits in the polyploid crop species Brassica napus	NATURE BIOTECHNOLOGY			English	Article							GENOME-WIDE ASSOCIATION; OILSEED RAPE; RNA-SEQ; GENE; ARCHITECTURE; PATTERNS; SEGMENTS; OLERACEA; REVEALS	Association genetics can quickly and efficiently delineate regions of the genome that control traits and provide markers to accelerate breeding by marker-assisted selection. But most crops are polyploid, making it difficult to identify the required markers and to assemble a genome sequence to order those markers. To circumvent this difficulty, we developed associative transcriptomics, which uses transcriptome sequencing to identify and score molecular markers representing variation in both gene sequences and gene expression, and correlate this with trait variation. Applying the method in the recently formed tetraploid crop Brassica napus, we identified genomic deletions that underlie two quantitative trait loci for glucosinolate content of seeds. The deleted regions contained orthologs of the transcription factor HAG1 (At5g61420), which controls aliphatic glucosinolate biosynthesis in Arabidopsis thaliana. This approach facilitates the application of association genetics in a broad range of crops, even those with complex genomes.	[Harper, Andrea L.; Trick, Martin; Higgins, Janet; Fraser, Fiona; Clissold, Leah; Wells, Rachel; Hattori, Chie; Bancroft, Ian] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Werner, Peter] KWS UK Ltd, Thriplow, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bancroft, I (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	ian.bancroft@jic.ac.uk	Bancroft, Ian/AAH-3831-2020	Harper, Andrea/0000-0003-3859-1152; Bancroft, Ian/0000-0001-7707-1171	UK Biotechnology and Biological Sciences Research Council [BBSRC BB/H004351/1, BB/E017363/1, ERAPG08.008]; UK Department for Environment, Food and Rural Affairs [Defra IF0144]; BBSRC [BBS/E/T/000PR6193, BB/E017363/1, BB/H004351/1, BB/G024952/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E017363/1, BB/H004351/1, BBS/E/T/000PR6193, BB/G024952/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank The Genome Analysis Centre for generating Illumina sequence data. This work was supported by UK Biotechnology and Biological Sciences Research Council (BBSRC BB/H004351/1 (IBTI Club), BB/E017363/1, ERAPG08.008) and UK Department for Environment, Food and Rural Affairs (Defra IF0144). We would like to thank R. Snowdon, J. Barker and G. Teakle for providing germplasm. We would like to thank D. Manning and M. Turner of KWS-UK and P. Tillmann of Verband Deutscher Landwirtschaftlicher Untersuchungs und Forschungsanstalten (VDLUFA) Qualitatssicherung NIRS/NIT, Kassel, Germany, for their assistance with NIRS measurements.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Ecke W, 2010, THEOR APPL GENET, V120, P921, DOI 10.1007/s00122-009-1221-0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fourmann M, 1998, THEOR APPL GENET, V96, P852, DOI 10.1007/s001220050812; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hasan M, 2006, GENET RESOUR CROP EV, V53, P793, DOI 10.1007/s10722-004-5541-2; Higgins J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-247; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Howell PM, 2003, GENOME, V46, P454, DOI 10.1139/G03-028; JAMES DW, 1995, PLANT CELL, V7, P309, DOI 10.2307/3869853; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; O'Neill CM, 2000, PLANT J, V23, P233, DOI 10.1046/j.1365-313x.2000.00781.x; Parkin IAP, 2003, GENOME, V46, P291, DOI [10.1139/g03-006, 10.1139/G03-006]; Pires JC, 2004, BIOL J LINN SOC, V82, P675, DOI 10.1111/j.1095-8312.2004.00350.x; Schmidt R, 2011, PLANT GENET GENOMICS, V9, P1, DOI 10.1007/978-1-4419-7118-0; Stokes D, 2010, MOL BREEDING, V26, P91, DOI 10.1007/s11032-009-9379-3; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	29	207	231	1	157	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					798	802		10.1038/nbt.2302	http://dx.doi.org/10.1038/nbt.2302			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22820317				2022-12-27	WOS:000307416900024
J	Huggett, B; Lahteenmaki, R				Huggett, Brady; Lahteenmaki, Riku			Public biotech 2011-the numbers	NATURE BIOTECHNOLOGY			English	Article																			0	9	9	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					751	757		10.1038/nbt.2320	http://dx.doi.org/10.1038/nbt.2320			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22871710				2022-12-27	WOS:000307416900015
J	Loh, PR; Baym, M; Berger, B				Loh, Po-Ru; Baym, Michael; Berger, Bonnie			Compressive genomics	NATURE BIOTECHNOLOGY			English	Article							SEQUENCE; ALIGNMENT; RETRIEVAL; STORAGE; TOOL	Algorithms that compute directly on compressed genomic data allow analyses to keep pace with data generation.	[Loh, Po-Ru; Baym, Michael; Berger, Bonnie] MIT, Dept Math & Comp Sci, Cambridge, MA 02139 USA; [Loh, Po-Ru; Baym, Michael; Berger, Bonnie] MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Baym, Michael] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Loh, PR (corresponding author), MIT, Dept Math & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bab@mit.edu; baym@mit.edu		Berger, Bonnie/0000-0002-2724-7228; Baym, Michael/0000-0003-1303-5598	Direct For Mathematical & Physical Scien [0903013] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brandon MC, 2009, BIOINFORMATICS, V25, P1731, DOI 10.1093/bioinformatics/btp319; CARTER DM, 2005, SACCHAROMYCES GENOME; Chen X, 2002, BIOINFORMATICS, V18, P1696, DOI 10.1093/bioinformatics/18.12.1696; Christley S, 2009, BIOINFORMATICS, V25, P274, DOI 10.1093/bioinformatics/btn582; Fritz MHY, 2011, GENOME RES, V21, P734, DOI 10.1101/gr.114819.110; Gross M, 2011, CURR BIOL, V21, pR204, DOI 10.1016/j.cub.2011.03.009; Grumbach S., 1994, J INFORM PROCESSING, V30, P875; Huttenhower C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000779; Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Kozanitis C, 2010, LECT N BIOINFORMAT, V6044, P310, DOI 10.1007/978-3-642-12683-3_20; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Makinen V, 2009, LECT NOTES COMPUT SC, V5541, P121, DOI 10.1007/978-3-642-02008-7_9; Schatz MC, 2010, NAT BIOTECHNOL, V28, P691, DOI 10.1038/nbt0710-691; Stratton M, 2008, NAT BIOTECHNOL, V26, P65, DOI 10.1038/nbt0108-65; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	24	78	78	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					627	630		10.1038/nbt.2241	http://dx.doi.org/10.1038/nbt.2241			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781691	Bronze			2022-12-27	WOS:000306293400021
J	Filonov, GS; Piatkevich, KD; Ting, LM; Zhang, JH; Kim, K; Verkhusha, VV				Filonov, Grigory S.; Piatkevich, Kiryl D.; Ting, Li-Min; Zhang, Jinghang; Kim, Kami; Verkhusha, Vladislav V.			Bright and stable near-infrared fluorescent protein for in vivo imaging	NATURE BIOTECHNOLOGY			English	Article							ELECTROSTATIC INTERACTIONS; PHYTOCHROME; BACTERIOPHYTOCHROME; STABILITY; EXPRESSION; BACTERIA; CELLS; CHAIN	Imaging biological processes in mammalian tissues will be facilitated by fluorescent probes with excitation and emission bands within the near-infrared optical window of high transparency(1). Here we report a phytochrome-based near-infrared fluorescent protein (iRFP) with excitation and emission maxima at 690 nm and 713 nm, respectively. iRFP does not require an exogenous supply of the chromophore biliverdin and has higher effective brightness, intracellular stability and photostability than earlier phytochrome-derived fluorescent probes. Compared with far-red GFP-like proteins, iRFP has a substantially higher signal-to-background ratio in a mouse model due to its infrared-shifted spectra.	[Filonov, Grigory S.; Piatkevich, Kiryl D.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Filonov, Grigory S.; Piatkevich, Kiryl D.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA; [Ting, Li-Min; Kim, Kami] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Ting, Li-Min; Kim, Kami] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Zhang, Jinghang] Albert Einstein Coll Med, Flow Cytometry Core Facil, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Verkhusha, VV (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.	vladislav.verkhusha@einstein.yu.edu	Verkhusha, Vladislav/AAU-7784-2020	Verkhusha, Vladislav/0000-0002-2083-8121; Kim, Kami/0000-0003-3384-152X	US National Institutes of Health [AI046985, AI087625, GM073913, S10RR027308]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087625, R01AI046985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073913] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Giraud (Institute for Research and Development, France) for the plasmid encoding bacteriophytochrome from R. palustris, A. Ulijasz and R. Vierstra (both from University of Wisconsin) for the plasmid encoding the heme-oxygenase from Synechocystis sp. PCC6803 and B. Glick (University of Chicago), D. Chudakov and K. Lukyanov (both from Institute of Bioorganic Chemistry, Russia) for the plasmids encoding GFP-like far-red fluorescent proteins. We are grateful to D. Entenberg for the help with two-photon excitation measurements, A. Muesch and D. Cohen for the assistance with virus purification and providing GFP-encoding adenoviruses and R. Zheng for the help with size-exclusion chromatography (all from Albert Einstein College of Medicine). This work was supported by grants from the US National Institutes of Health, AI046985 and AI087625 to K.K., GM073913 to V.V.V. and S10RR027308 for purchase of the IVIS imager.	Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kuo C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717898; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; LI LM, 1995, BIOCHEMISTRY-US, V34, P7923, DOI 10.1021/bi00024a017; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Muller L, 2010, MOL BIOL CELL, V21, P691, DOI 10.1091/mbc.E09-08-0730; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; SALI D, 1991, J MOL BIOL, V220, P779, DOI 10.1016/0022-2836(91)90117-O; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SENS R, 1981, J LUMIN, V24-5, P709, DOI 10.1016/0022-2313(81)90075-2; Sharrock RA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-230; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Stepartenko OV, 2008, PROTEINS, V73, P539, DOI 10.1002/prot.22089; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Subramanian S, 1996, J BIOTECHNOL, V49, P137, DOI 10.1016/0168-1656(96)01536-2; Ulijasz AT, 2008, J BIOL CHEM, V283, P21251, DOI 10.1074/jbc.M801592200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Xu H, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3258838	34	511	533	10	264	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					757	U133		10.1038/nbt.1918	http://dx.doi.org/10.1038/nbt.1918			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21765402	Green Accepted			2022-12-27	WOS:000293696500029
J	Zhao, WX; Pollack, JL; Blagev, DP; Zaitlen, N; McManus, MT; Erle, DJ				Zhao, Wenxue; Pollack, Joshua L.; Blagev, Denitza P.; Zaitlen, Noah; McManus, Michael T.; Erle, David J.			Massively parallel functional annotation of 3 ' untranslated regions	NATURE BIOTECHNOLOGY			English	Article							MICRORNA TARGET SITES; MESSENGER-RNA DECAY; SYSTEMATIC DISCOVERY; MAMMALIAN-CELLS; RICH ELEMENTS; STABILITY; PROMOTERS; MOTIFS; POLYADENYLATION; TRANSLATION	Functional characterization of noncoding sequences is crucial for understanding the human genome and learning how genetic variation contributes to disease. 3' untranslated regions (UTRs) are an important class of noncoding sequences, but their functions remain largely uncharacterized(1). We developed a method for massively parallel functional annotation of sequences from 3' UTRs (fast-UTR) and used this approach to measure the effects of a total of >450 kilobases of 3' UTR sequences from >2,000 human genes on steady-state mRNA abundance, mRNA stability and protein production. We found widespread regulatory effects on mRNA that were coupled to effects on mRNA stability and protein production. Furthermore, we discovered 87 novel cis-regulatory elements and measured the effects of genetic variation within known and novel 3' UTR motifs. This work shows how massively parallel approaches can improve the functional annotation of noncoding sequences, advance our understanding of cis-regulatory mechanisms and quantify the effects of human genetic variation.	[Zhao, Wenxue; Pollack, Joshua L.; Blagev, Denitza P.; Zaitlen, Noah; Erle, David J.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [McManus, Michael T.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Erle, DJ (corresponding author), Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA.	david.erle@ucsf.edu	mcmanus, michael/AAB-1239-2020; Zhao, Wenxue/I-7721-2013	mcmanus, michael/0000-0003-3013-6569; Erle, David/0000-0002-2171-0648; Zhao, Wenxue/0000-0001-5380-1176	US National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL108596] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. M. Ansel, R. Barbeau, A. Barczak, S. E. Brenner, K. Chin, C. Eisley, E. Ostrin, S.-W. Park, A. Sayce, T. Wang and G. Zhang for advice and technical assistance. We thank A. Shyu (University of Texas Health Science Center at Houston) for providing BEAS-2B tTA cells. This work was supported by research grants (D.J.E.) and a training grant (D.P.B.) from the US National Institutes of Health.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Chen CYA, 2007, RNA, V13, P1775, DOI 10.1261/rna.663507; Chen CY, 1995, TRENDS BIOCHEM SCI, V11, P465, DOI DOI 10.1016/S0968-0004(00)89102-1.PUBMED:8578590; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Holcik M, 1997, P NATL ACAD SCI USA, V94, P2410, DOI 10.1073/pnas.94.6.2410; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Numahata K, 2003, J CELL BIOCHEM, V90, P976, DOI 10.1002/jcb.10710; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Spies N, 2013, GENOME RES, V23, P2078, DOI 10.1101/gr.156919.113; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Wang SB, 2006, NUCLEIC ACIDS RES, V34, P3044, DOI 10.1093/nar/gkl386; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao Wenxue, 2011, Proc Am Thorac Soc, V8, P163, DOI 10.1513/pats.201007-054MS	40	62	63	3	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					387	U259		10.1038/nbt.2851	http://dx.doi.org/10.1038/nbt.2851			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24633241	Green Accepted, Green Submitted			2022-12-27	WOS:000334340800024
J	Rooswinkel, R; Mulder, GJ; van Deventer, S				Rooswinkel, Rogier; Mulder, Geert-Jan; van Deventer, Sander			Acquiring orphans	NATURE BIOTECHNOLOGY			English	Editorial Material									[Rooswinkel, Rogier; Mulder, Geert-Jan; van Deventer, Sander] Forb Capital Partners, Naarden, Netherlands; [van Deventer, Sander] Leiden Univ, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rooswinkel, R (corresponding author), Forb Capital Partners, Naarden, Netherlands.	Sander.van.Deventer@forbion.com						Giniatullina A, 2013, NAT BIOTECHNOL, V31, pA1, DOI 10.1038/nbt.2533; HBM Partners, 2013, HBM PHARM BIOT M A R; Meekings KN, 2012, DRUG DISCOV TODAY, V17, P660, DOI 10.1016/j.drudis.2012.02.005; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P87, DOI 10.1038/nrd3946; Novartis Institutes for BioMedical Research, 2009, PROOF OF CONC INN NO; O'Sullivan BP, 2013, JAMA-J AM MED ASSOC, V310, P1343, DOI 10.1001/jama.2013.278129; Sasinowski FJ, 2012, DRUG INF J, V46, P238, DOI 10.1177/0092861511435906; Wellman-Labadie O, 2010, HEALTH POLICY, V95, P216, DOI 10.1016/j.healthpol.2009.12.001	8	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					213	216		10.1038/nbt.2836	http://dx.doi.org/10.1038/nbt.2836			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24727767	Green Published, Bronze			2022-12-27	WOS:000332819800013
J	Zook, JM; Chapman, B; Wang, J; Mittelman, D; Hofmann, O; Hide, W; Salit, M				Zook, Justin M.; Chapman, Brad; Wang, Jason; Mittelman, David; Hofmann, Oliver; Hide, Winston; Salit, Marc			Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls	NATURE BIOTECHNOLOGY			English	Article							GENOME; CANCER; MUTATIONS; FRAMEWORK; EXOME; MAP	Clinical adoption of human genome sequencing requires methods that output genotypes with known accuracy at millions or billions of positions across a genome. Because of substantial discordance among calls made by existing sequencing methods and algorithms, there is a need for a highly accurate set of genotypes across a genome that can be used as a benchmark. Here we present methods to make high-confidence, single-nucleotide polymorphism (SNP), indel and homozygous reference genotype calls for NA12878, the pilot genome for the Genome in a Bottle Consortium. We minimize bias toward any method by integrating and arbitrating between 14 data sets from five sequencing technologies, seven read mappers and three variant callers. We identify regions for which no confident genotype call could be made, and classify them into different categories based on reasons for uncertainty. Our genotype calls are publicly available on the Genome Comparison and Analytic Testing website to enable real-time benchmarking of any method.	[Zook, Justin M.; Salit, Marc] NIST, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA; [Chapman, Brad; Hofmann, Oliver; Hide, Winston] Harvard Univ, Sch Publ Hlth, Dept Biostat, Bioinformat Core, Cambridge, MA 02138 USA; [Wang, Jason; Mittelman, David] Arpeggi Inc, Austin, TX USA; [Mittelman, David] Virginia Bioinformat Inst, Blacksburg, VA USA; [Mittelman, David] Dept Biol Sci, Blacksburg, VA USA	National Institute of Standards & Technology (NIST) - USA; Harvard University; Harvard T.H. Chan School of Public Health	Zook, JM (corresponding author), NIST, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA.	jzook@nist.gov	Zook, Justin/B-7000-2008; Hide, Winston/R-3815-2019; Hide, Winston Hide/C-7217-2009; Hide, Winston A/V-2727-2017; Hofmann, Oliver/F-1800-2013	Zook, Justin/0000-0003-2309-8402; Hide, Winston/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271; Hofmann, Oliver/0000-0002-7738-1513	US Food and Drug Administration High Performance Computing; Archon Genomics X PRIZE	US Food and Drug Administration High Performance Computing; Archon Genomics X PRIZE	We thank J. Johnson and A. Varadarajan from the Archon Genomics X Prize and EdgeBio for contributing their whole-genome sequencing data from SOLiD and Illumina, Complete Genomics and Life Technologies for providing bam files for NAl2878, and the Broad Institute and 1000 Genomes Project for making publicly available barn and VCF files for NAl2878. The Illumina exome data on GCAT were given to the Mittelman laboratory by M. Linderman at Icahn Institute of Genomics and Multiscale Biology of the Icahn School of Medicine at Mount Sinai. We thank the US Food and Drug Administration High Performance Computing staff for their support in running the bioinformatics analyses. Harvard School of Public Health contributions were funded by the Archon Genomics X PRIZE. Certain commercial equipment, instruments or materials are identified in this document. Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the products identified are necessarily the best available for the purpose.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Author A., 1975, PLASMA PROTEINS STRU; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Blum A., 1998, Proceedings of the Eleventh Annual Conference on Computational Learning Theory, P92, DOI 10.1145/279943.279962; Boland JF, 2013, HUM GENET, V132, P1153, DOI 10.1007/s00439-013-1321-4; Collins FS, 2013, NEW ENGL J MED, V369, P2369, DOI 10.1056/NEJMp1314561; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Garrison E., 2012, PREPRINT; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lee H, 2012, BIOINFORMATICS, V28, P2097, DOI 10.1093/bioinformatics/bts330; Li H., 2013, PREPRINT, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Rieber N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066621; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Zook JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041356	25	461	469	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					246	251		10.1038/nbt.2835	http://dx.doi.org/10.1038/nbt.2835			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24531798	Green Submitted, Bronze			2022-12-27	WOS:000332819800022
J	Kessel, M				Kessel, Mark			Do you really want to be a biotech board member?	NATURE BIOTECHNOLOGY			English	Editorial Material								There are many advantages to becoming a company advisor, but academics should think carefully about the legal and personal implications before accepting a seat on the board.	Shearman & Sterling LLP, New York, NY USA		Kessel, M (corresponding author), Shearman & Sterling LLP, New York, NY USA.	mark.kessel@shearman.com							0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1072	1074		10.1038/nbt.2763	http://dx.doi.org/10.1038/nbt.2763			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24316635	Bronze			2022-12-27	WOS:000328251900011
J	Zhang, L; Cao, ZQ; Bai, T; Carr, L; Ella-Menye, JR; Irvin, C; Ratner, BD; Jiang, SY				Zhang, Lei; Cao, Zhiqiang; Bai, Tao; Carr, Louisa; Ella-Menye, Jean-Rene; Irvin, Colleen; Ratner, Buddy D.; Jiang, Shaoyi			Zwitterionic hydrogels implanted in mice resist the foreign-body reaction	NATURE BIOTECHNOLOGY			English	Article							PROTEIN ADSORPTION; IN-VITRO; CHALLENGES; THICKNESS; SURFACES; PLASMA	The performance of implantable biomedical devices is impeded by the foreign-body reaction, which results in formation of a dense collagenous capsule that blocks mass transport and/or electric communication between the implant and the body. No known materials or coatings can completely prevent capsule formation. Here we demonstrate that ultra-low-fouling zwitterionic hydrogels can resist the formation of a capsule for at least 3 months after subcutaneous implantation in mice. Zwitterionic hydrogels also promote angiogenesis in surrounding tissue, perhaps owing to the presence of macrophages exhibiting phenotypes associated with anti-inflammatory, pro-healing functions. Thus, zwitterionic hydrogels may be useful in a broad range of applications, including generation of biocompatible implantable medical devices and tissue scaffolds.	[Zhang, Lei; Cao, Zhiqiang; Bai, Tao; Carr, Louisa; Ella-Menye, Jean-Rene; Ratner, Buddy D.; Jiang, Shaoyi] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA; [Irvin, Colleen; Ratner, Buddy D.; Jiang, Shaoyi] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jiang, SY (corresponding author), Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.	sjiang@uw.edu	Bai, Tao/U-6513-2017; Zhang, Lei/H-5729-2013	Zhang, Lei/0000-0003-3638-6219; Bai, Tao/0000-0002-7597-9853	Office of Naval Research [N000140910137]; University of Washington; Boeing-Roundhill Professorship	Office of Naval Research(Office of Naval Research); University of Washington(University of Washington); Boeing-Roundhill Professorship	We thank E. Sussman, M. Takeno, H. Ma and K. Hauch in Bioengineering Department at the University of Washington for their help with histological staining and image analysis. This work was supported by the Office of Naval Research (N000140910137), University of Washington and Boeing-Roundhill Professorship.	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Campioni EG, 1998, BIOMATERIALS, V19, P829, DOI 10.1016/S0142-9612(97)00241-X; Carr L, 2010, LANGMUIR, V26, P14793, DOI 10.1021/la1028004; Carr LR, 2011, BIOMATERIALS, V32, P6893, DOI 10.1016/j.biomaterials.2011.06.006; Carr LR, 2011, BIOMATERIALS, V32, P961, DOI 10.1016/j.biomaterials.2010.09.067; HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4; Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036; ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107; Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407; Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768; Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589; Liu LY, 2008, J BIOMAT SCI-POLYM E, V19, P821, DOI 10.1163/156856208784522083; Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595; Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107; Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; Ratner, 2012, BIOMATERIALS SCI; Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8; Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910; Smith RS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004120; Tsai AT, 2005, BIOMATERIALS, V26, P5835, DOI 10.1016/j.biomaterials.2005.03.003; Ueland PM, 2005, CLIN CHEM LAB MED, V43, P1069, DOI 10.1515/CCLM.2005.187; Ward WK, 2002, BIOMATERIALS, V23, P4185, DOI 10.1016/S0142-9612(02)00160-6; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027; Zhang Z, 2009, J BIOMAT SCI-POLYM E, V20, P1845, DOI 10.1163/156856208X386444	28	627	641	39	763	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					553	+		10.1038/nbt.2580	http://dx.doi.org/10.1038/nbt.2580			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23666011				2022-12-27	WOS:000320113200028
J	Sandercock, CG; Storz, U				Sandercock, Colin G.; Storz, Ulrich			Antibody specification beyond the target: claiming a later-generation therapeutic antibody by its target epitope	NATURE BIOTECHNOLOGY			English	Editorial Material								It may be possible to patent both antibodies to new targets and later-developed antibodies to known targets.	[Sandercock, Colin G.] Perkins Coie LLP, Washington, DC USA; [Storz, Ulrich] Michalski Huttermann Patent Attorneys, Dusseldorf, Germany		Sandercock, CG (corresponding author), Perkins Coie LLP, Washington, DC USA.	csandercock@perkinscoie.com; st@mhpatent.de						[Anonymous], 1999, T054295 EUR PAT OFF; [Anonymous], 2004, 355F3D1343 US; [Anonymous], 2011, 10CV00608 BEN US DIS; Storz U, 2012, SPRINGERBRIEFS BIOTE	4	11	11	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					615	619		10.1038/nbt.2291	http://dx.doi.org/10.1038/nbt.2291			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781681				2022-12-27	WOS:000306293400017
J	Vanderford, NL				Vanderford, Nathan L.			Broadening PhD curricula	NATURE BIOTECHNOLOGY			English	Editorial Material									Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky	Vanderford, NL (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA.	nathan.vanderford@uky.edu						Andreson J, 2006, FASEB J, V20, P1761, DOI 10.1096/fj.06-0903ufm; [Anonymous], 2006, NAT IMMUNOL, V7, P535; [Anonymous], 2001, NAT STRUCT MOL BIOL, V8, P567; [Anonymous], 2010, NAT CELL BIOL, V12, P1123; Gewin V, 2009, NATURE, V461, P299; KERR E, 1995, NAT MED, V1, P14, DOI 10.1038/nm0195-14; Schuster SM, 2011, BIOCHEM MOL BIOL EDU, V39, P61, DOI 10.1002/bmb.20475; Schuster SM, 2009, BIOCHEM MOL BIOL EDU, V37, P381, DOI 10.1002/bmb.20337; Vanderford N.L, 2010, SCI NEWS        0928; Vanderford N.L., 2010, SCI NEWS        0317	10	5	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					113	114		10.1038/nbt.2091	http://dx.doi.org/10.1038/nbt.2091			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22231111				2022-12-27	WOS:000299110600034
J	Huggett, B; Hodgson, J; Lahteenmaki, R				Huggett, Brady; Hodgson, John; Lahteenmaki, Riku			Public biotech 2010-the numbers	NATURE BIOTECHNOLOGY			English	Article																			0	12	12	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2011	29	7					585	591		10.1038/nbt.1913	http://dx.doi.org/10.1038/nbt.1913			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	790NM	21747381				2022-12-27	WOS:000292595200014
J	Meuris, L; Santens, F; Elson, G; Festjens, N; Boone, M; Dos Santos, A; Devos, S; Rousseau, F; Plets, E; Houthuys, E; Malinge, P; Magistrelli, G; Cons, L; Chatel, L; Devreese, B; Callewaert, N				Meuris, Leander; Santens, Francis; Elson, Greg; Festjens, Nele; Boone, Morgane; Dos Santos, Anaelle; Devos, Simon; Rousseau, Francois; Plets, Evelyn; Houthuys, Erica; Malinge, Pauline; Magistrelli, Giovanni; Cons, Laura; Chatel, Laurence; Devreese, Bart; Callewaert, Nico			GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins	NATURE BIOTECHNOLOGY			English	Article							COLONY-STIMULATING FACTOR; IGG BINDING; ANTIBODY; EXPRESSION; ENZYME; CDNA; FCRN	Heterogeneity in the N-glycans on therapeutic proteins causes difficulties for protein purification and process reproducibility and can lead to variable therapeutic efficacy. This heterogeneity arises from the multistep process of mammalian complex-type N-glycan synthesis. Here we report a glycoengineering strategy-which we call GlycoDelete-that shortens the Golgi N-glycosylation pathway in mammalian cells. This shortening results in the expression of proteins with small, sialylated trisaccharide N-glycans and reduced complexity compared to native mammalian cell glycoproteins. GlycoDelete engineering does not interfere with the functioning of N-glycans in protein folding, and the physiology of cells modified by GlycoDelete is similar to that of wild-type cells. A therapeutic human IgG expressed in GlycoDelete cells had properties, such as reduced initial clearance, that might be beneficial when the therapeutic goal is antigen neutralization. This strategy for reducing N-glycan heterogeneity on mammalian proteins could lead to more consistent performance of therapeutic proteins and modulation of biopharmaceutical functions.	[Meuris, Leander; Santens, Francis; Festjens, Nele; Boone, Morgane; Plets, Evelyn; Houthuys, Erica; Callewaert, Nico] VIB, Unit Med Biotechnol, IRC, Ghent, Belgium; [Meuris, Leander; Santens, Francis; Festjens, Nele; Boone, Morgane; Devos, Simon; Plets, Evelyn; Houthuys, Erica; Devreese, Bart; Callewaert, Nico] Univ Ghent, Dept Biochem & Microbiol, Lab Prot Biochem & Biomol Engn, B-9000 Ghent, Belgium; [Elson, Greg; Dos Santos, Anaelle; Rousseau, Francois; Malinge, Pauline; Magistrelli, Giovanni; Cons, Laura; Chatel, Laurence] NovImmune SA, Geneva, Switzerland	Flanders Institute for Biotechnology (VIB); Ghent University; NovImmune SA	Callewaert, N (corresponding author), VIB, Unit Med Biotechnol, IRC, Ghent, Belgium.	nico.callewaert@irc.vib-ugent.be	Festjens, Nele/C-2093-2009; Boone, Morgane/ABF-7205-2021; Devreese, Bart/B-2011-2009; Meuris, Leander/B-6988-2015; Devreese, Bart/K-2841-2019	Festjens, Nele/0000-0002-3429-5463; Boone, Morgane/0000-0002-7807-5542; Devreese, Bart/0000-0002-9764-2581; Meuris, Leander/0000-0001-8940-3022; Devreese, Bart/0000-0002-9764-2581; Callewaert, Nico/0000-0003-2069-6917; Devos, Simon/0000-0002-0623-433X; Santens, Francis/0000-0001-9521-9846; Plets, Evelyn/0000-0001-7312-8804	Fund for Scientific Research-Flanders (FWO); predoctoral fellowships of agentschap voor Innovatie door Wetenschap en Technologie (IWT) Flanders (Strategic Basic Research fellowship) [101456, 111252]; VIB; Ghent University Industrial Research Fund (UGent-IOF) [041]; Hercules Foundation [AUGE019]; FWO research project [G.0.541.08.N.10]	Fund for Scientific Research-Flanders (FWO)(FWO); predoctoral fellowships of agentschap voor Innovatie door Wetenschap en Technologie (IWT) Flanders (Strategic Basic Research fellowship); VIB; Ghent University Industrial Research Fund (UGent-IOF); Hercules Foundation; FWO research project(FWO)	We thank G. Pontini, Y. Poitevin, L. Bernasconi, D. Schrag and S. Raimondi (NovImmune) for their help with anti-CD20 generation and characterization; S. Savvides (Ghent University) for providing the 293SGnTI(-) clone expressing the Flt3 receptor extracellular domain; E. Van Damme (Ghent University) for providing ConA; and E. Dirksen and K. Nooijen (Merck) for the LC-MS analysis of anti-CD20. L.M. and M.B. are supported by predoctoral fellowships, and N.F. by a postdoctoral fellowship, of the Fund for Scientific Research-Flanders (FWO). F.S. and S.D. are supported by predoctoral fellowships of agentschap voor Innovatie door Wetenschap en Technologie (IWT) Flanders (Strategic Basic Research fellowship nos. 101456 and 111252). This research was supported by VIB, Ghent University Industrial Research Fund (UGent-IOF) Advanced Grant no. 041 (N.C.), FWO research project grant no. G.0.541.08.N.10 (N.C.) and Hercules Foundation grant no. AUGE019 (B.D.).	Allhorn M, 2009, ANN NY ACAD SCI, V1173, P664, DOI 10.1111/j.1749-6632.2009.04739.x; Beck A, 2011, MABS-AUSTIN, V3, P107, DOI 10.4161/mabs.3.2.14785; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Crispin M, 2006, GLYCOBIOLOGY, V16, P748, DOI 10.1093/glycob/cwj119; Elliott S, 2004, EXP HEMATOL, V32, P1146, DOI 10.1016/j.exphem.2004.08.004; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777; Forno G, 2004, EUR J BIOCHEM, V271, P907, DOI 10.1111/j.1432-1033.2004.03993.x; GRUNDMANN U, 1990, NUCLEIC ACIDS RES, V18, P667, DOI 10.1093/nar/18.3.667; HAMBLIN MW, 1991, MOL PHARMACOL, V40, P143; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Herter S, 2013, MOL CANCER THER, V12, P2031, DOI 10.1158/1535-7163.MCT-12-1182; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Kanda Y, 2006, BIOTECHNOL BIOENG, V94, P680, DOI 10.1002/bit.20880; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; LEE F, 1985, P NATL ACAD SCI USA, V82, P4360, DOI 10.1073/pnas.82.13.4360; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Magistrelli G, 2012, J IMMUNOL METHODS, V375, P20, DOI 10.1016/j.jim.2011.09.002; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; Nallet S, 2012, NEW BIOTECHNOL, V29, P471, DOI 10.1016/j.nbt.2012.02.003; Nandakumar KS, 2013, P NATL ACAD SCI USA, V110, P10252, DOI 10.1073/pnas.1301480110; Ramsland PA, 2011, J IMMUNOL, V187, P3208, DOI 10.4049/jimmunol.1101467; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Stals I, 2010, FEMS MICROBIOL LETT, V303, P9, DOI 10.1111/j.1574-6968.2009.01849.x; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Tradtrantip L, 2013, ANN NEUROL, V73, P77, DOI 10.1002/ana.23741; Verstraete K, 2011, BLOOD, V118, P60, DOI 10.1182/blood-2011-01-329532	30	100	107	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					485	U210		10.1038/nbt.2885	http://dx.doi.org/10.1038/nbt.2885			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24752077	Green Accepted			2022-12-27	WOS:000336036100025
J	Cheng, Z; Yi, PS; Wang, XM; Chai, YP; Feng, GX; Yang, YH; Liang, X; Zhu, ZW; Li, W; Ou, GS				Cheng, Ze; Yi, Peishan; Wang, Xiangming; Chai, Yongping; Feng, Guoxin; Yang, Yihong; Liang, Xing; Zhu, Zhiwen; Li, Wei; Ou, Guangshuo			Conditional targeted genome editing using somatically expressed TALELENs in C. elegans	NATURE BIOTECHNOLOGY			English	Article							CAENORHABDITIS-ELEGANS; REGULATOR; TALENS	We have developed a method for the generation of conditional knockouts in Caenorhabditis elegans by expressing transcription activator-like effector nucleases (TALENs) in somatic cells. Using germline transformation with plasmids encoding TALENs under the control of an inducible or tissue-specific promoter, we observed effective gene modifications and resulting phenotypes in specific developmental stages and tissues. We further used this method to bypass the embryonic requirement of cor-1, which encodes the homolog of human severe combined immunodeficiency (SCID) protein coronin, and we determined its essential role in cell migration in larval Q-cell lineages. Our results show that TALENs expressed in the somatic cells of model organisms provide a versatile tool for functional genomics.	[Cheng, Ze; Yi, Peishan; Wang, Xiangming; Chai, Yongping; Feng, Guoxin; Yang, Yihong; Liang, Xing; Zhu, Zhiwen; Li, Wei; Ou, Guangshuo] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Cheng, Ze] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Peking University	Ou, GS (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	weili.oulab@gmail.com; guangshuo.ou@gmail.com	Liang, Xing-Jie/U-7657-2019; Liang, Xing/AAT-4144-2021; Yi, Peishan/AAR-6628-2020	Liang, Xing/0000-0002-8298-1214; Yi, Peishan/0000-0003-4710-8089	National Basic Research Program of China (973 Program) [2012CB966800, 2012CB945002, 2013CB945600]; National Natural Science Foundation of China [31201009, 31201048, 31222035, 31101002, 31100972, 31171295, 31190063]; Natural Science Foundation of Beijing [5123045]; Chinese Academy of Sciences; Junior Thousand Talents Program of China	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences); Junior Thousand Talents Program of China	We thank B. Zhang and R. Jiao for TALEN reagents and W. Zhong, D. Huangfu, L. Cai and P. Gonczy for the helpful discussion. This work was supported by National Basic Research Program of China to W.L. and G.O. (973 Program, 2012CB966800, 2012CB945002 and 2013CB945600), the National Natural Science Foundation of China to G.O., X.W., Y.C., Y.Y. and W.L. (31201009, 31201048, 31222035, 31101002, 31100972, 31171295 and 31190063), the Natural Science Foundation of Beijing to X.W. (5123045), Chinese Academy of Sciences and the Junior Thousand Talents Program of China to G.O.	Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Chai YP, 2012, NAT PROTOC, V7, P2090, DOI 10.1038/nprot.2012.128; Chan KT, 2011, TRENDS CELL BIOL, V21, P481, DOI 10.1016/j.tcb.2011.04.004; Davis MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000028; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Frokjaer-Jensen C, 2010, NAT METHODS, V7, P451, DOI [10.1038/NMETH.1454, 10.1038/nmeth.1454]; Garrison JL, 2012, SCIENCE, V338, P540, DOI 10.1126/science.1226201; Gumienny TL, 2007, CURR BIOL, V17, P159, DOI 10.1016/j.cub.2006.11.065; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; KENYON C, 1986, CELL, V46, P477, DOI 10.1016/0092-8674(86)90668-9; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mueller P, 2011, J IMMUNOL, V186, P4039, DOI 10.4049/jimmunol.1003352; O'Rourke SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016644; Pastrana E, 2010, NAT METHODS, V7, P488, DOI 10.1038/nmeth0710-488a; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Thacker C, 2006, CELL MOL LIFE SCI, V63, P1193, DOI 10.1007/s00018-006-6012-z; The C. elegans Deletion Mutant Consortium, 2012, G3 BETHESDA, V2, P1415; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773	23	30	38	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2013	31	10					934	+		10.1038/nbt.2674	http://dx.doi.org/10.1038/nbt.2674			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233CA	23955274				2022-12-27	WOS:000325541300023
J	Simmons, WJ				Simmons, William J.			Bowman v. Monsanto and the protection of patented replicative biologic technologies	NATURE BIOTECHNOLOGY			English	Editorial Material									Sughrue Mion, Washington, DC 20037 USA		Simmons, WJ (corresponding author), Sughrue Mion, Washington, DC 20037 USA.	wsimmons@sughrue.com						Baumann K, 2013, NAT REV MOL CELL BIO, V14, P266, DOI 10.1038/nrm3561; Burchfiel K.J., 2012, BIOTECHNOLOGY FEDERA; Engelman A, 2012, NAT REV MICROBIOL, V10, P279, DOI 10.1038/nrmicro2747; Francisco M., 2013, NAT BIOTECHNOL, V31, P268; Ledford H., 2013, NATURE NEWS BLO 0415; Lee DH, 1996, NATURE, V382, P525, DOI 10.1038/382525a0; Mears Bill, 2013, CNN HLTH        0417; Pardey P, 2013, NAT BIOTECHNOL, V31, P25, DOI 10.1038/nbt.2467; Singh P, 2008, COMPR REV FOOD SCI F, V7, P14, DOI 10.1111/j.1541-4337.2007.00025.x; USDA Economic Research Service, 2013, SOYB OIL CROPS BACKG; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274	11	2	3	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2013	31	7					602	607		10.1038/nbt.2625	http://dx.doi.org/10.1038/nbt.2625			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	180FS	23839143				2022-12-27	WOS:000321579700014
J	Amir, ED; Davis, KL; Tadmor, MD; Simonds, EF; Levine, JH; Bendall, SC; Shenfeld, DK; Krishnaswamy, S; Nolan, GP; Pe'er, D				Amir, El-ad David; Davis, Kara L.; Tadmor, Michelle D.; Simonds, Erin F.; Levine, Jacob H.; Bendall, Sean C.; Shenfeld, Daniel K.; Krishnaswamy, Smita; Nolan, Garry P.; Pe'er, Dana			viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia	NATURE BIOTECHNOLOGY			English	Article							MINIMAL RESIDUAL DISEASE; FLOW-CYTOMETRY; MASS CYTOMETRY; STEM-CELLS; PROGENITORS; HIERARCHY; NETWORKS; BIOLOGY; GUIDE	New high-dimensional, single-cell technologies offer unprecedented resolution in the analysis of heterogeneous tissues. However, because these technologies can measure dozens of parameters simultaneously in individual cells, data interpretation can be challenging. Here we present viSNE, a tool that allows one to map high-dimensional cytometry data onto two dimensions, yet conserve the high-dimensional structure of the data. viSNE plots individual cells in a visual similar to a scatter plot, while using all pairwise distances in high dimension to determine each cell's location in the plot. We integrated mass cytometry with viSNE to map healthy and cancerous bone marrow samples. Healthy bone marrow automatically maps into a consistent shape, whereas leukemia samples map into malformed shapes that are distinct from healthy bone marrow and from each other. We also use viSNE and mass cytometry to compare leukemia diagnosis and relapse samples, and to identify a rare leukemia population reminiscent of minimal residual disease. viSNE can be applied to any multi-dimensional single-cell technology.	[Amir, El-ad David; Tadmor, Michelle D.; Levine, Jacob H.; Shenfeld, Daniel K.; Krishnaswamy, Smita; Pe'er, Dana] Columbia Univ, Dept Biol Sci, Columbia Initiat Syst Biol, New York, NY 10027 USA; [Davis, Kara L.; Simonds, Erin F.; Bendall, Sean C.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA	Columbia University; Stanford University	Pe'er, D (corresponding author), Columbia Univ, Dept Biol Sci, Columbia Initiat Syst Biol, New York, NY 10027 USA.	dpeer@biology.columbia.edu	Krishnaswamy, Smita/D-8089-2016; Bendall, Sean/AGG-0126-2022; Nolan, Garry/AAE-7903-2019	Krishnaswamy, Smita/0000-0001-5823-1985; Pe'er, Dana/0000-0002-9259-8817; Nolan, Garry/0000-0002-8862-9043; Simonds, Erin/0000-0002-3497-4861; Bendall, Sean/0000-0003-1341-2453	National Science Foundation CAREER award [MCB-1149728]; National Institutes of Health Roadmap Initiative; NIH Director's New Innovator Award Program [1-DP2-OD002414-01]; National Centers for Biomedical Computing [1U54CA121852-01A1]; Alex's Lemonade Fund Young Investigator Award; St. Baldrick's Foundation Scholar Award; Damon Runyon Cancer Research Foundation Fellowship [DRG-2017-09]; Rachford and Carlota A. Harris Endowed Professorship; European Commission HEALTH [2010.1.2-1]; Bill and Melinda Gates Foundation [GF12141-137101];  [U19 AI057229];  [P01 CA034233];  [HHSN272200700038C];  [1R01CA130826];  [CIRM DR1-01477];  [RB2-01592];  [NCI RFA CA 09-011];  [NHLBIHV-10-05(2)]; Div Of Molecular and Cellular Bioscience [1149728] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA130826, P01CA034233, F32CA009011, R01CA164729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, U19AI100627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002414] Funding Source: NIH RePORTER	National Science Foundation CAREER award(National Science Foundation (NSF)); National Institutes of Health Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award Program; National Centers for Biomedical Computing; Alex's Lemonade Fund Young Investigator Award; St. Baldrick's Foundation Scholar Award; Damon Runyon Cancer Research Foundation Fellowship; Rachford and Carlota A. Harris Endowed Professorship; European Commission HEALTH; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); ; ; ; ; ; ; ; ; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank N. Friedman, I. Pe'er and O. Litvin for valuable comments. The authors would also like to thank M. Minden (Princess Margaret Hospital), C. Mullighan, J. Downing and I. Radtke (St. Jude Children's Hospital) for generously providing leukemia samples for mass cytometry analysis. This research was supported by the National Science Foundation CAREER award through grant number MCB-1149728, National Institutes of Health Roadmap Initiative, NIH Director's New Innovator Award Program through grant number 1-DP2-OD002414-01 and National Centers for Biomedical Computing Grant 1U54CA121852-01A1. E.D.A. is a Howard Hughes Medical Institute International Student Research Fellow. K.L.D. is supported by Alex's Lemonade Fund Young Investigator Award and St. Baldrick's Foundation Scholar Award. S.C.B. is supported by the Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09). G.P.N. is supported by the Rachford and Carlota A. Harris Endowed Professorship and grants from U19 AI057229, P01 CA034233, HHSN272200700038C, 1R01CA130826, CIRM DR1-01477 and RB2-01592, NCI RFA CA 09-011, NHLBIHV-10-05(2), European Commission HEALTH. 2010.1.2-1, and the Bill and Melinda Gates Foundation (GF12141-137101). D.P. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and Packard Fellowship for Science and Engineering.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bendall SC, 2012, NAT BIOTECHNOL, V30, P639, DOI 10.1038/nbt.2283; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Benoist C, 2011, SCIENCE, V332, P677, DOI 10.1126/science.1206351; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Campana D, 2008, BRIT J HAEMATOL, V143, P481, DOI 10.1111/j.1365-2141.2008.07350.x; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Loken MR, 2012, BLOOD, V120, P1581, DOI 10.1182/blood-2012-02-408336; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Ossenkoppele GJ, 2011, BRIT J HAEMATOL, V153, P421, DOI 10.1111/j.1365-2141.2011.08595.x; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Qian Y, 2010, FRONT ENVIRON SCI EN, V4, P1, DOI 10.1007/s11783-010-1000-9; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Tarnok A, 2010, CYTOM PART A, V77A, P6, DOI 10.1002/cyto.a.20844; Van Der Maaten L., 2009, J MACH LEARN RES, V10, P13, DOI [10.1080/ 135062804440 0 0102, DOI 10.1080/13506280444000102]; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; Wakita S, 2013, LEUKEMIA, V27, P1044, DOI 10.1038/leu.2012.317; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	33	1046	1065	7	155	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					545	+		10.1038/nbt.2594	http://dx.doi.org/10.1038/nbt.2594			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23685480	Green Accepted			2022-12-27	WOS:000320113200027
J	Marx, H; Lemeer, S; Schliep, JE; Matheron, L; Mohammed, S; Cox, J; Mann, M; Heck, AJR; Kuster, B				Marx, Harald; Lemeer, Simone; Schliep, Jan Erik; Matheron, Lucrece; Mohammed, Shabaz; Cox, Juergen; Mann, Matthias; Heck, Albert J. R.; Kuster, Bernhard			A large synthetic peptide and phosphopeptide reference library for mass spectrometry-based proteomics	NATURE BIOTECHNOLOGY			English	Article							PHOSPHORYLATION SITE LOCALIZATION; PROTEIN IDENTIFICATION; SHOTGUN PROTEOMICS; STATISTICAL-MODEL; MS/MS; FRAGMENTATION; SPECTRA; PHOSPHOPROTEOMICS; PREDICTION; SEARCH	We present a peptide library and data resource of > 100,000 synthetic, unmodified peptides and their phosphorylated counterparts with known sequences and phosphorylation sites. Analysis of the library by mass spectrometry yielded a data set that we used to evaluate the merits of different search engines (Mascot and Andromeda) and fragmentation methods (beam-type collision-induced dissociation (HCD) and electron transfer dissociation (ETD)) for peptide identification. We also compared the sensitivities and accuracies of phosphorylation-site localization tools (Mascot Delta Score, PTM score and phosphoRS), and we characterized the chromatographic behavior of peptides in the library. We found that HCD identified more peptides and phosphopeptides than did ETD, that phosphopeptides generally eluted later from reversed-phase columns and were easier to identify than unmodified peptides and that current computational tools for proteomics can still be substantially improved. These peptides and spectra will facilitate the development, evaluation and improvement of experimental and computational proteomic strategies, such as separation techniques and the prediction of retention times and fragmentation patterns.	[Marx, Harald; Lemeer, Simone; Schliep, Jan Erik; Kuster, Bernhard] Tech Univ Munich, Chair Prote & Bioanalyt, Freising Weihenstephan, Germany; [Matheron, Lucrece; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Matheron, Lucrece; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Cox, Juergen; Mann, Matthias] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Kuster, Bernhard] Ctr Integrated Prot Sci, Munich, Germany	Technical University of Munich; Utrecht University; Utrecht University; Max Planck Society; University of Munich	Kuster, B (corresponding author), Tech Univ Munich, Chair Prote & Bioanalyt, Freising Weihenstephan, Germany.	kuster@tum.de	Cox, Jurgen/B-9481-2008; Mohammed, Shabaz/D-1042-2010; Mohammed, Shabaz/AAY-6313-2020; Heck, Albert/D-7098-2011; Mann, Matthias/A-3454-2013; Schliep, Erik/AAC-1327-2020; Lemeer, Simone/I-4363-2016; Kuster, Bernhard/Q-6031-2016	Cox, Jurgen/0000-0001-8597-205X; Mohammed, Shabaz/0000-0003-2640-9560; Mohammed, Shabaz/0000-0003-2640-9560; Heck, Albert/0000-0002-2405-4404; Mann, Matthias/0000-0003-1292-4799; Schliep, Erik/0000-0001-7103-5954; Kuster, Bernhard/0000-0002-9094-1677	Deutsche Forschungsgemeinschaft International Research Training Group 'Regulation and Evolution of Cellular Systems' (RECESS) [GRK 1563]; PRIME-XS project [262067]; European Union 7th Framework Program; Graduate School at the Technische Universitat Munchen	Deutsche Forschungsgemeinschaft International Research Training Group 'Regulation and Evolution of Cellular Systems' (RECESS); PRIME-XS project; European Union 7th Framework Program(European Commission); Graduate School at the Technische Universitat Munchen	This research was supported in part by the Deutsche Forschungsgemeinschaft International Research Training Group 'Regulation and Evolution of Cellular Systems' (RECESS, GRK 1563) and in part by the PRIME-XS project with the grant agreement number 262067 funded by the European Union 7th Framework Program. H.M. acknowledges the support of the Graduate School at the Technische Universitat Munchen, and the authors thank A. Hubauer for expert technical assistance.	Bailey CM, 2009, J PROTEOME RES, V8, P1965, DOI 10.1021/pr800917p; Baker PR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008078; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Boersema PJ, 2009, J MASS SPECTROM, V44, P861, DOI 10.1002/jms.1599; Bohrer BC, 2010, ANAL CHEM, V82, P6559, DOI 10.1021/ac100910a; Chalkley RJ, 2012, MOL CELL PROTEOMICS, V11, P3, DOI 10.1074/mcp.R111.015305; Chen Y, 2005, J PROTEOME RES, V4, P998, DOI 10.1021/pr049754t; Chen Y, 2009, J PROTEOME RES, V8, P3141, DOI 10.1021/pr900172v; Conrads TP, 2000, ANAL CHEM, V72, P3349, DOI 10.1021/ac0002386; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Frank AM, 2011, NAT METHODS, V8, P587, DOI [10.1038/NMETH.1609, 10.1038/nmeth.1609]; Frese CK, 2011, J PROTEOME RES, V10, P2377, DOI 10.1021/pr1011729; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Hoadlund-Hyzer CS, 2000, ANAL CHEM, V72, P2737; Huang YY, 2008, J PROTEOME RES, V7, P70, DOI 10.1021/pr070106u; Jedrychowski MP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009910; Kapp EA, 2005, PROTEOMICS, V5, P3475, DOI 10.1002/pmic.200500126; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller Andrew, 2002, OMICS A Journal of Integrative Biology, V6, P207, DOI 10.1089/153623102760092805; Kelstrup CD, 2011, J PROTEOME RES, V10, P2937, DOI 10.1021/pr200154t; Klimek J, 2008, J PROTEOME RES, V7, P96, DOI 10.1021/pr070244j; Krokhin OV, 2006, ANAL CHEM, V78, P7785, DOI 10.1021/ac060777w; Krokhin OV, 2009, ANAL CHEM, V81, P9522, DOI 10.1021/ac9016693; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lemeer S, 2012, ANAL BIOANAL CHEM, V402, P249, DOI 10.1007/s00216-011-5469-2; Lemeer S, 2009, CURR OPIN CHEM BIOL, V13, P414, DOI 10.1016/j.cbpa.2009.06.022; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Mallick P, 2010, NAT BIOTECHNOL, V28, P695, DOI 10.1038/nbt.1658; Moruz L, 2012, PROTEOMICS, V12, P1151, DOI 10.1002/pmic.201100386; Moruz L, 2010, J PROTEOME RES, V9, P5209, DOI 10.1021/pr1005058; Nagaraj N, 2010, J PROTEOME RES, V9, P6786, DOI 10.1021/pr100637q; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rudnick PA, 2005, J PROTEOME RES, V4, P1353, DOI 10.1021/pr0500509; Savitski MM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003830; Shteynberg D, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007690; Steen H, 2006, MOL CELL PROTEOMICS, V5, P172, DOI 10.1074/mcp.M500135-MCP200; Swaney DL, 2008, NAT METHODS, V5, P959, DOI 10.1038/nmeth.1260; Swaney DL, 2009, P NATL ACAD SCI USA, V106, P995, DOI 10.1073/pnas.0811964106; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Thingholm TE, 2009, PROTEOMICS, V9, P1451, DOI 10.1002/pmic.200800454; Zhou HJ, 2013, NAT PROTOC, V8, P461, DOI 10.1038/nprot.2013.010; Zhou HJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006452	48	134	135	1	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					557	+		10.1038/nbt.2585	http://dx.doi.org/10.1038/nbt.2585			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23685481				2022-12-27	WOS:000320113200029
J	Gat-Viks, I; Chevrier, N; Wilentzik, R; Eisenhaure, T; Raychowdhury, R; Steuerman, Y; Shalek, AK; Hacohen, N; Amit, I; Regev, A				Gat-Viks, Irit; Chevrier, Nicolas; Wilentzik, Roni; Eisenhaure, Thomas; Raychowdhury, Raktima; Steuerman, Yael; Shalek, Alex K.; Hacohen, Nir; Amit, Ido; Regev, Aviv			Deciphering molecular circuits from genetic variation underlying transcriptional responsiveness to stimuli	NATURE BIOTECHNOLOGY			English	Article							QUANTITATIVE TRAIT LOCI; RIG-I; EXPRESSION; CELLS; RECOGNITION; RESPONSES; IMMUNE; IDENTIFICATION; REGULATORS; RECEPTORS	Individual genetic variation affects gene responsiveness to stimuli, often by influencing complex molecular circuits. Here we combine genomic and intermediate-scale transcriptional profiling with computational methods to identify variants that affect the responsiveness of genes to stimuli (responsiveness quantitative trait loci or reQTLs) and to position these variants in molecular circuit diagrams. We apply this approach to study variation in transcriptional responsiveness to pathogen components in dendritic cells from recombinant inbred mouse strains. We identify reQTLs that correlate with particular stimuli and position them in known pathways. For example, in response to a virus-like stimulus, a trans-acting variant responds as an activator of the antiviral response; using RNA interference, we identify Rgs16 as the likely causal gene. Our approach charts an experimental and analytic path to decipher the mechanisms underlying genetic variation in circuits that control responses to stimuli.	[Gat-Viks, Irit; Chevrier, Nicolas; Eisenhaure, Thomas; Raychowdhury, Raktima; Hacohen, Nir; Amit, Ido; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gat-Viks, Irit; Wilentzik, Roni; Steuerman, Yael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Chevrier, Nicolas] Harvard Univ, Sch Med, Div Med Sci, Grad Program Immunol, Boston, MA USA; [Chevrier, Nicolas] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Eisenhaure, Thomas; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA; [Shalek, Alex K.] Harvard Univ, Dept Chem, Cambridge, MA 02138 USA; [Shalek, Alex K.] Harvard Univ, Dept Biol Chem, Cambridge, MA 02138 USA; [Shalek, Alex K.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Hacohen, Nir] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tel Aviv University; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University; Harvard Medical School; Weizmann Institute of Science; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Gat-Viks, I (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	iritgv@post.tau.ac.il; ido.amit@weizmann.ac.il; aregev@broad.mit.edu	Shalek, Alex/Y-2434-2019	Shalek, Alex/0000-0001-5670-8778	Human Frontiers Science Program postdoctoral fellowships; Howard Hughes Medical Institute; US National Institutes of Health; Burroughs-Wellcome Fund Career Award at the Scientific Interface; Center for Excellence in Genome Science from the National Human Genome Research Institute [5P50HG006193-02]; Klarman Cell Observatory at the Broad Institute; New England Regional Center for Excellence/Biodefense and Emerging Infectious Disease [U54 AI057159]; Israeli Centers of Research Excellence (I-CORE) Gene Regulation in Complex Human Disease [41/11]; Human Frontiers Science Program Career Development Award; Israeli Science Foundation Bikura Institutional Research Grant Program; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; NATIONAL CANCER INSTITUTE [R01CA119176, DP1CA174427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026688] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002230] Funding Source: NIH RePORTER	Human Frontiers Science Program postdoctoral fellowships; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); Center for Excellence in Genome Science from the National Human Genome Research Institute; Klarman Cell Observatory at the Broad Institute; New England Regional Center for Excellence/Biodefense and Emerging Infectious Disease; Israeli Centers of Research Excellence (I-CORE) Gene Regulation in Complex Human Disease; Human Frontiers Science Program Career Development Award(Human Frontier Science Program); Israeli Science Foundation Bikura Institutional Research Grant Program; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. (Jimmie) Ye, J. Pickerel, M. Daly and E. Lander for comments and discussions. I.G.-V. and I.A. were supported by Human Frontiers Science Program postdoctoral fellowships. Work was supported by Howard Hughes Medical Institute, a US National Institutes of Health PIONEER award, a Burroughs-Wellcome Fund Career Award at the Scientific Interface (A.R.), a Center for Excellence in Genome Science grant 5P50HG006193-02 from the National Human Genome Research Institute (N.H. and A.R.), the Klarman Cell Observatory at the Broad Institute (A.R.), the New England Regional Center for Excellence/Biodefense and Emerging Infectious Disease U54 AI057159 (N.H.), the Israeli Centers of Research Excellence (I-CORE) Gene Regulation in Complex Human Disease, Center No. 41/11 (I.G.-V., R.W. and Y.S.), the Human Frontiers Science Program Career Development Award and an Israeli Science Foundation Bikura Institutional Research Grant Program (I.A.) and the Edmond J. Safra Center for Bioinformatics at Tel-Aviv University (R.W. and Y.S.). A.R. is a fellow of the Merkin Foundation for Stem Cell Research at the Broad Institute. I.G.-V. is a Faculty Fellow of the Edmond J. Safra Center for Bioinformatics at Tel Aviv University and an Alon Fellow.	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Banerjee S, 2008, GENETICS, V179, P2275, DOI 10.1534/genetics.108.088427; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Baum A, 2011, VIRULENCE, V2, P166, DOI 10.4161/viru.2.2.15481; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chen CH, 2001, FEBS LETT, V504, P16, DOI 10.1016/S0014-5793(01)02757-0; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dombroski BA, 2010, AM J HUM GENET, V86, P719, DOI 10.1016/j.ajhg.2010.03.017; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Falconer D. S., 1996, INTRO QUANTITATIVE G; Frazer KA, 2004, GENOME RES, V14, P1493, DOI 10.1101/gr.2627804; Gaglani S. M., 2009, BMC NEUROSCI, V9, P10; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Gilbert H, 2007, GENET SEL EVOL, V39, P139, DOI 10.1051/gse:2006039; Hackett CA, 2001, GENET RES, V77, P95, DOI 10.1017/S0016672300004869; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Maranville JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002162; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Scheffe H, 1959, ANAL VARIANCE; Shankar SP, 2012, J IMMUNOL, V188, P6347, DOI 10.4049/jimmunol.1103781; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Xie ST, 2010, J IMMUNOL, V184, P2289, DOI 10.4049/jimmunol.0903133; Xu CW, 2005, GENETICS, V169, P1045, DOI 10.1534/genetics.103.019406; Yang IV, 2009, GENETICS, V183, P1535, DOI 10.1534/genetics.109.107540; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932	50	31	32	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2013	31	4					342	+		10.1038/nbt.2519	http://dx.doi.org/10.1038/nbt.2519			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	120TI	23503680	Green Accepted, Green Submitted			2022-12-27	WOS:000317195500028
J	Tan, X; Hu, L; Luquette, LJ; Gao, G; Liu, YF; Qu, HJ; Xi, RB; Lu, ZJ; Park, PJ; Elledge, SJ				Tan, Xu; Hu, Long; Luquette, Lovelace J., III; Gao, Geng; Liu, Yifang; Qu, Hongjing; Xi, Ruibin; Lu, Zhi John; Park, Peter J.; Elledge, Stephen J.			Systematic identification of synergistic drug pairs targeting HIV	NATURE BIOTECHNOLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL-ACTIVATION; ANTIRETROVIRAL THERAPY; COMBINATION THERAPY; IMMUNE ACTIVATION; VIRAL LOAD; IN-VIVO; INFECTION; REPLICATION; DISCOVERY	The systematic identification of effective drug combinations has been hindered by the unavailability of methods that can explore the large combinatorial search space of drug interactions. Here we present multiplex screening for interacting compounds (MuSIC), which expedites the comprehensive assessment of pairwise compound interactions. We examined similar to 500,000 drug pairs from 1,000 US Food and Drug Administration (FDA)-approved or clinically tested drugs and identified drugs that synergize to inhibit HIV replication. Our analysis reveals an enrichment of anti-inflammatory drugs in drug combinations that synergize against HIV. As inflammation accompanies HIV infection, these findings indicate that inhibiting inflammation could curb HIV propagation. Multiple drug pairs identified in this study, including various glucocorticoids and nitazoxanide (NTZ), synergize by targeting different steps in the HIV life cycle. MuSIC can be applied to a wide variety of disease-relevant screens to facilitate efficient identification of compound combinations.	[Tan, Xu; Gao, Geng; Qu, Hongjing; Elledge, Stephen J.] Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Sch Med,Div Genet, Boston, MA 02115 USA; [Hu, Long; Liu, Yifang; Lu, Zhi John] Tsinghua Univ, MOE Key Lab Bioinformat, Sch Life Sci, Beijing 100084, Peoples R China; [Luquette, Lovelace J., III; Xi, Ruibin; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Tsinghua University; Harvard University; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Genet,Sch Med,Div Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	hu, long/GQI-0544-2022; Tan, Xu/E-7170-2011; liu, yifang/AAC-1520-2020	Tan, Xu/0000-0003-4861-4573; Park, Peter/0000-0001-9378-960X; Xi, Ruibin/0000-0001-7545-7361; Hu, Long/0000-0003-2120-3416	Damon Runyon Cancer Research Foundation [DRG 2008-09]; Charles A. King Trust, N.A.; Bank of America; National Natural Science Foundation of China [31100601]; National Key Basic Research Program [2012CB316503]	Damon Runyon Cancer Research Foundation; Charles A. King Trust, N.A.; Bank of America; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China)	We thank the Institute of Chemistry and Cell Biology (ICCB)-Longwood: C. Shamu, S. Chiang, S. Rudnicki, A. Daab, D. Flood, S. Johnston, Z. Cooper, T. Ren; We also thank A. Brass for help with the HIV infection assay, N. Yan, Y. Koh, K. Matreyek and A. Engelman for help with virology, M. Mankowski for help with ELISA, M. Mefford for the BlaM assay protocol, NIH AIDS Research & Reference Reagent Program for reagents, J. Zhu, Q. Xu and other Elledge laboratory members for discussion and D. Fusco for reading the manuscript. X.T. is supported by the Damon Runyon Cancer Research Foundation (DRG 2008-09) and the Charles A. King Trust, N.A., Bank of America, co-trustee. Z.J.L. is supported by grants from the National Natural Science Foundation of China (31100601) and the National Key Basic Research Program (2012CB316503); S.J.E. is an investigator with the Howard Hughes Medical Institute.	Andrieu JM, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-17; BLISS CI, 1956, BACTERIOL REV, V20, P243, DOI 10.1128/MMBR.20.4.243-258.1956; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Eggena MP, 2005, J INFECT DIS, V191, P694, DOI 10.1086/427516; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Hanley TM, 2011, J VIROL, V85, P10834, DOI 10.1128/JVI.00789-11; Hawkins T, 2010, ANTIVIR RES, V85, P201, DOI 10.1016/j.antiviral.2009.10.016; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Korba BE, 2008, ANTIVIR RES, V77, P56, DOI 10.1016/j.antiviral.2007.08.005; Kutsch O, 2004, ANTIMICROB AGENTS CH, V48, P1652, DOI 10.1128/AAC.48.5.1652-1663.2004; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Petraitis V, 2009, ANTIMICROB AGENTS CH, V53, P2382, DOI 10.1128/AAC.00329-09; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rossignol JF, 2009, J BIOL CHEM, V284, P29798, DOI 10.1074/jbc.M109.029470; Russo FO, 1999, VIRUS RES, V64, P87, DOI 10.1016/S0168-1702(99)00082-9; Severyn B, 2011, ACS CHEM BIOL, V6, P1391, DOI 10.1021/cb2003225; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Ulmer A, 2005, EUR J MED RES, V10, P105; WilsonLingardo L, 1996, J MED CHEM, V39, P2720, DOI 10.1021/jm960169g; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755	37	85	87	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1125	+		10.1038/nbt.2391	http://dx.doi.org/10.1038/nbt.2391			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23064238	Green Accepted, Green Submitted			2022-12-27	WOS:000311087500032
J	Schachter, B				Schachter, Beth			Partnering with the professor	NATURE BIOTECHNOLOGY			English	Article																		Cooke R., 2001, FOLKMANS WAR ANGIOGE; CULLITON BJ, 1977, SCIENCE, V195, P759, DOI 10.1126/science.195.4280.759; German Federal Ministry of Research and Education, BIOEC NEW CONC US NA; Kenney M., 1988, U CORPORATION; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480	6	12	13	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					944	952		10.1038/nbt.2385	http://dx.doi.org/10.1038/nbt.2385			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	23051810				2022-12-27	WOS:000309965500017
J	Lee, S; Knierim, M				Lee, Sandra; Knierim, Michael			Teva v. AstraZeneca nand secret prior art under 102(g)(2)	NATURE BIOTECHNOLOGY			English	Editorial Material								A recent Federal Circuit decision and the reasoning behind it could have a significant impact on the patentability of other life science inventions, even after changes in the patent law.	[Lee, Sandra; Knierim, Michael] Baker Botts, New York, NY USA		Lee, S (corresponding author), Baker Botts, New York, NY USA.	sandra.lee@bakerbotts.com						[Anonymous], US Patent, Patent No. [RE39,502, 39502]; Rich G.S., 1951, COMMUNICATION	2	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					831	834		10.1038/nbt.2353	http://dx.doi.org/10.1038/nbt.2353			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22965051				2022-12-27	WOS:000308705700014
J	Van Dyke, M				Van Dyke, Mark			How much risk are you prepared to take?	NATURE BIOTECHNOLOGY			English	Editorial Material								Any faculty member wishing to commercialize a discovery or technology should contemplate the pros and cons of pursuing the entrepreneurial route or licensing to an outside entity.	[Van Dyke, Mark] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest Baptist Medical Center	Van Dyke, M (corresponding author), Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA.	mvandyk5@vt.edu							0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					821	824		10.1038/nbt.2330	http://dx.doi.org/10.1038/nbt.2330			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22965046				2022-12-27	WOS:000308705700009
J	Haynes, BF; Kelsoe, G; Harrison, SC; Kepler, TB				Haynes, Barton F.; Kelsoe, Garnett; Harrison, Stephen C.; Kepler, Thomas B.			B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study	NATURE BIOTECHNOLOGY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; SURROGATE LIGHT-CHAIN; PROXIMAL EXTERNAL REGION; MOUSE BONE-MARROW; MU HEAVY-CHAIN; INFLUENZA-VIRUS; GERMINAL-CENTER; SELF-TOLERANCE	Failure of immunization with the HIV-1 envelope to induce broadly neutralizing antibodies against conserved epitopes is a major barrier to producing a preventive HIV-1 vaccine. Broadly neutralizing monoclonal antibodies (BnAbs) from those subjects who do produce them after years of chronic HIV-1 infection have one or more unusual characteristics, including polyreactivity for host antigens, extensive somatic hypermutation and long, variable heavy-chain third complementarity-determining regions, factors that may limit their expression by host immunoregulatory mechanisms. The isolation of BnAbs from HIV-1-infected subjects and the use of computationally derived clonal lineages as templates provide a new path for HIV-1 vaccine immunogen design. This approach, which should be applicable to many infectious agents, holds promise for the construction of vaccines that can drive B cells along rare but desirable maturation pathways.	[Haynes, Barton F.] Duke Univ, Sch Med, Dept Med, Duke Human Vaccine Inst, Durham, NC 27706 USA; [Haynes, Barton F.; Kelsoe, Garnett; Kepler, Thomas B.] Duke Univ, Sch Med, Dept Immunol, Duke Human Vaccine Inst, Durham, NC USA; [Harrison, Stephen C.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Harrison, Stephen C.] Harvard Univ, Sch Med, Boston, MA USA; [Kepler, Thomas B.] Duke Univ, Sch Med, Ctr Computat Immunol, Duke Human Vaccine Inst, Durham, NC USA	Duke University; Duke University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Duke University	Haynes, BF (corresponding author), Duke Univ, Sch Med, Dept Med, Duke Human Vaccine Inst, Durham, NC 27706 USA.	hayne002@mc.duke.edu		Kelsoe, Garnett/0000-0002-8770-040X; Kepler, Thomas/0000-0002-1383-6865	Vaccine Development Center from the Bill and Melinda Gates Foundation; NIH, National Institute of Allergy and Infectious Diseases (NIAID), Division of AIDS [U19 AI-067854]; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, R01AI081579, U01AI067854] Funding Source: NIH RePORTER	Vaccine Development Center from the Bill and Melinda Gates Foundation; NIH, National Institute of Allergy and Infectious Diseases (NIAID), Division of AIDS; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge H.-X. Liao, M. Anthony Moody, S. Munir Alam, L. Verkoczy, M. Bonsignori and G.D. Tomaras at Duke University School of Medicine and D. Dimitrov at the National Cancer Institute, US National Institutes of Health (NIH), USA, for discussions and key collaborations on the work cited in this review; H.-X. Liao for Figure 3; and K. McClammy and S. Devine for expert secretarial assistance. This work was supported by a Vaccine Development Center grant in the Collaboration for AIDS Vaccine Discovery Program from the Bill and Melinda Gates Foundation, by the NIH, National Institute of Allergy and Infectious Diseases (NIAID), Division of AIDS grant for the Center for HIV/AIDS Vaccine Immunology, cooperative agreement U19 AI-067854, and by an NIAID 'Modeling Immunity for Biodefense' contract. S.C.H. is an investigator of the Howard Hughes Medical Institute.	ADAMS E, 1990, P NATL ACAD SCI USA, V87, P5687, DOI 10.1073/pnas.87.15.5687; Alam SM, 2011, J VIROL, V85, P11725, DOI 10.1128/JVI.05680-11; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Bambini S, 2009, DRUG DISCOV TODAY, V14, P252, DOI 10.1016/j.drudis.2008.12.007; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Bonsignori M, 2009, J IMMUNOL, V183, P2708, DOI 10.4049/jimmunol.0901068; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CHEN C, 1994, J IMMUNOL, V152, P1970; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; CLARKE SH, 1990, J IMMUNOL, V144, P2795; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Garrone P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002330; Goldsby R.A., 2003, IMMUNOLOGY, P161; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; Gray ES, 2011, J VIROL, V85, P7719, DOI 10.1128/JVI.00563-11; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Grigorieff N, 2011, CURR OPIN STRUC BIOL, V21, P265, DOI 10.1016/j.sbi.2011.01.008; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Haynes Barton F., 2005, Human Antibodies, V14, P59; Haynes BF, 2011, TRENDS MOL MED, V17, P108, DOI 10.1016/j.molmed.2010.10.008; Haynes BF, 2010, CURR OPIN HIV AIDS, V5, P362, DOI 10.1097/COH.0b013e32833d2e90; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hilleman MR, 2002, INTERVIROLOGY, V45, P199, DOI 10.1159/000067911; Hong M, 2012, ANNU REV PHYS CHEM, V63, P1, DOI 10.1146/annurev-physchem-032511-143731; Irving MB, 2010, MOL IMMUNOL, V47, P1137, DOI 10.1016/j.molimm.2009.10.015; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kelsoe G, 1995, ADV IMMUNOL, V60, P267, DOI 10.1016/S0065-2776(08)60587-8; Kepler TB, 1997, MOL BIOL EVOL, V14, P637, DOI 10.1093/oxfordjournals.molbev.a025803; KEPLER TB, 1993, J THEOR BIOL, V164, P37, DOI 10.1006/jtbi.1993.1139; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Kwong PD, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007278; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Malherbe DC, 2011, J VIROL, V85, P5262, DOI 10.1128/JVI.02419-10; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Meffre E, 2004, J EXP MED, V199, P145, DOI 10.1084/jem.20031550; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Perez-Andres M, 2010, CYTOM PART B-CLIN CY, V78B, pS47, DOI 10.1002/cyto.b.20547; Phillips RS, 2011, BBA-PROTEINS PROTEOM, V1814, P1481, DOI 10.1016/j.bbapap.2010.12.003; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Plotkin SA, 2009, CLIN VACCINE IMMUNOL, V16, P1709, DOI 10.1128/CVI.00290-09; Polyansky AA, 2012, METHODS MOL BIOL, V819, P327, DOI 10.1007/978-1-61779-465-0_21; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Ray R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002772; RETH M, 1987, EMBO J, V6, P3299, DOI 10.1002/j.1460-2075.1987.tb02649.x; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scheid JF, 2011, P NATL ACAD SCI USA, V108, P18044, DOI 10.1073/pnas.1113395108; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Settembre EC, 2011, EMBO J, V30, P408, DOI 10.1038/emboj.2010.322; Shen XY, 2010, P NATL ACAD SCI USA, V107, P5972, DOI 10.1073/pnas.0912381107; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; tenBoekel E, 1997, IMMUNITY, V7, P357; Thimme R, 2008, BIOL CHEM, V389, P457, DOI 10.1515/BC.2008.061; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Tsuiji M, 2006, J EXP MED, V203, P393, DOI 10.1084/jem.20052033; Verkoczy L, 2011, J IMMUNOL, V187, P3785, DOI 10.4049/jimmunol.1101633; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang HS, 2007, J IMMUNOL, V179, P7544, DOI 10.4049/jimmunol.179.11.7544; Wang P, 2010, J AM CHEM SOC, V132, P17045, DOI 10.1021/ja1084628; Wardemann H, 2004, J EXP MED, V200, P191, DOI 10.1084/jem.20040818; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wardemann H, 2007, ADV IMMUNOL, V95, P83, DOI 10.1016/S0065-2776(07)95003-8; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yang TY, 2011, PROTEINS, V79, P1940, DOI 10.1002/prot.23018; Yuan Y, 2009, J AM CHEM SOC, V131, P5432, DOI 10.1021/ja808705v; Zhang JS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000800; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	152	337	359	1	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					423	433		10.1038/nbt.2197	http://dx.doi.org/10.1038/nbt.2197			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22565972	Green Accepted			2022-12-27	WOS:000303803200022
J	Pulido, J; Kottke, T; Thompson, J; Galivo, F; Wongthida, P; Diaz, RM; Rommelfanger, D; Ilett, E; Pease, L; Pandha, H; Harrington, K; Selby, P; Melcher, A; Vile, R				Pulido, Jose; Kottke, Timothy; Thompson, Jill; Galivo, Feorillo; Wongthida, Phonphimon; Diaz, Rosa Maria; Rommelfanger, Diana; Ilett, Elizabeth; Pease, Larry; Pandha, Hardev; Harrington, Kevin; Selby, Peter; Melcher, Alan; Vile, Richard			Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma	NATURE BIOTECHNOLOGY			English	Article							VESICULAR STOMATITIS-VIRUS; VACCINE VECTOR; ONCOLYTIC VIROTHERAPY; CANCER; AUTOIMMUNITY; IMMUNITY; IMMUNOTHERAPY; SELF; MELANOCYTES; PROTECTION	Multiple intravenous injections of a cDNA library, derived from human melanoma cell lines and expressed using the highly immunogenic vector vesicular stomatitis virus (VSV), cured mice with established melanoma tumors. Successful tumor eradication was associated with the ability of mouse lymphoid cells to mount a tumor-specific CD4(+) interleukin (IL)-17 recall response in vitro. We used this characteristic IL-17 response to screen the VSV-cDNA library and identified three different VSV-cDNA virus clones that, when used in combination but not alone, achieved the same efficacy against tumors as the complete parental virus library. VSV-expressed cDNA libraries can therefore be used to identify tumor rejection antigens that can cooperate to induce anti-tumor responses. This technology should be applicable to antigen discovery for other cancers, as well as for other diseases in which immune reactivity against more than one target antigen contributes to disease pathology.	[Pulido, Jose; Kottke, Timothy; Thompson, Jill; Galivo, Feorillo; Diaz, Rosa Maria; Rommelfanger, Diana; Ilett, Elizabeth; Vile, Richard] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Pulido, Jose] Mayo Clin, Dept Ophthalmol & Ocular Oncol, Rochester, MN USA; [Wongthida, Phonphimon] Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Ilett, Elizabeth; Selby, Peter; Melcher, Alan; Vile, Richard] St James Univ Hosp, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England; [Pease, Larry; Vile, Richard] Mayo Clin, Dept Immunol, Rochester, MN USA; [Pandha, Hardev] Univ Surrey, Guildford GU2 5XH, Surrey, England; [Harrington, Kevin] Inst Canc Res, London SW3 6JB, England	Mayo Clinic; Mayo Clinic; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Cancer Research UK; Saint James's University Hospital; University of Leeds; Mayo Clinic; University of Surrey; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Vile, R (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN USA.	vile.richard@mayo.edu		Harrington, Kevin/0000-0002-6014-348X; Galivo, Feorillo/0000-0002-0553-922X; Melcher, Alan/0000-0002-2042-3380; Ilett, Elizabeth/0000-0002-9875-0322	Richard M. Schulze Family Foundation; Mayo Foundation; Cancer Research UK; US National Institutes of Health [R01 CA107082, R01CA130878, R01 CA132734]; Cancer Research UK [13244] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA132734, R01CA107082, R01CA130878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	Richard M. Schulze Family Foundation; Mayo Foundation; Cancer Research UK(Cancer Research UK); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Higgins for expert secretarial assistance. This work was supported by the Richard M. Schulze Family Foundation, the Mayo Foundation, Cancer Research UK, the US National Institutes of Health grants R01 CA107082, R01CA130878 and R01 CA132734, and a grant from Terry and Judith Paul. MyD88 KO mice (MyD88<SUP>-/-</SUP>) were a kind gift from L. Pease, Mayo Clinic.	Alvarez-Breckenridge C, 2011, NAT MED, V17, P784, DOI 10.1038/nm0711-784; Braxton CL, 2010, J VIROL, V84, P3552, DOI 10.1128/JVI.01572-09; Bridle BW, 2010, MOL THER, V18, P1430, DOI 10.1038/mt.2010.98; Bridle BW, 2009, MOL THER, V17, P1814, DOI 10.1038/mt.2009.154; Cobleigh MA, 2010, J VIROL, V84, P7513, DOI 10.1128/JVI.00200-10; Daniels GA, 2004, NAT BIOTECHNOL, V22, P1125, DOI 10.1038/nbt1007; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Ferrone S, 2004, NAT BIOTECHNOL, V22, P1096, DOI 10.1038/nbt0904-1096; Galivo F, 2010, GENE THER, V17, P158, DOI 10.1038/gt.2009.161; Galivo F, 2010, HUM GENE THER, V21, P439, DOI 10.1089/hum.2009.143; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Guevara-Patino JA, 2006, J CLIN INVEST, V116, P1382, DOI 10.1172/JCI25591; Guevara-Patino JA, 2003, ADV CANCER RES, V90, P157, DOI 10.1016/S0065-230X(03)90005-4; HALL A, 1985, NUCLEIC ACIDS RES, V13, P5255, DOI 10.1093/nar/13.14.5255; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Koos D, 2010, CELL IMMUNOL, V263, P138, DOI 10.1016/j.cellimm.2010.03.019; Kottke T, 2007, CANCER RES, V67, P11970, DOI 10.1158/0008-5472.CAN-07-2259; Kottke T, 2011, NAT MED, V17, P854, DOI 10.1038/nm.2390; Kottke T, 2009, CANCER RES, V69, P7767, DOI 10.1158/0008-5472.CAN-09-1597; Linardakis E, 2002, CANCER RES, V62, P5495; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pardoll DM, 1998, NAT MED, V4, P525, DOI 10.1038/nm0598supp-525; Park TS, 2011, TRENDS BIOTECHNOL, V29, P550, DOI 10.1016/j.tibtech.2011.04.009; Poschke I, 2011, CANCER IMMUNOL IMMUN, V60, P1161, DOI 10.1007/s00262-011-1012-8; Qiao J, 2008, NAT MED, V14, P37, DOI 10.1038/nm1681; Rausch MP, 2010, J IMMUNOL, V185, P2828, DOI 10.4049/jimmunol.1000945; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Sanchez-Perez L, 2005, CANCER RES, V65, P2009, DOI 10.1158/0008-5472.CAN-04-3216; Sanchez-Perez L, 2006, J IMMUNOL, V177, P4168, DOI 10.4049/jimmunol.177.6.4168; Schwartz JA, 2010, J VIROL, V84, P4611, DOI 10.1128/JVI.02637-09; SHIBATA K, 1992, BIOCHEM BIOPH RES CO, V184, P568, DOI 10.1016/0006-291X(92)90627-W; SUZUKI H, 1989, J BIOL CHEM, V264, P1368; Tanaka S, 2000, CANCER GENE THER, V7, P1241, DOI 10.1038/sj.cgt.7700219; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Turk MJ, 2002, IMMUNOL REV, V188, P122, DOI 10.1034/j.1600-065X.2002.18811.x; Uchi H, 2006, ADV IMMUNOL, V90, P215, DOI 10.1016/S0065-2776(06)90006-6; Willmon C, 2011, MOL THER, V19, P140, DOI 10.1038/mt.2010.224; Wongthida P, 2011, MOL THER, V19, P150, DOI 10.1038/mt.2010.225	42	81	88	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2012	30	4					336	343		10.1038/nbt.2157	http://dx.doi.org/10.1038/nbt.2157			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	925TR	22426030	Green Accepted			2022-12-27	WOS:000302785000021
J	Eheman, KE				Eheman, Kenneth E., Jr.			Planning for the exit	NATURE BIOTECHNOLOGY			English	Editorial Material								As the biotech industry has matured, the exit process has evolved. Entrepreneurs need to build today's companies based on the new exit paradigm.	Wyrick Robbins Yates & Ponton LLP, Raleigh, NC USA		Eheman, KE (corresponding author), Wyrick Robbins Yates & Ponton LLP, Raleigh, NC USA.	keheman@wyrick.com							0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					132	134		10.1038/nbt.2093	http://dx.doi.org/10.1038/nbt.2093			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22318025				2022-12-27	WOS:000300269100009
J	Wang, XJ; Wei, XM; Thijssen, B; Das, J; Lipkin, SM; Yu, HY				Wang, Xiujuan; Wei, Xiaomu; Thijssen, Bram; Das, Jishnu; Lipkin, Steven M.; Yu, Haiyuan			Three-dimensional reconstruction of protein networks provides insight into human genetic disease	NATURE BIOTECHNOLOGY			English	Article							INTERACTION DATABASE; DOMAIN; MUTATIONS; WASP; POLYMERIZATION; VISUALIZATION; ACTIVATION; MAP	To better understand the molecular mechanisms and genetic basis of human disease, we systematically examine relationships between 3,949 genes, 62,663 mutations and 3,453 associated disorders by generating a three-dimensional, structurally resolved human interactome. This network consists of 4,222 high-quality binary protein-protein interactions with their atomic-resolution interfaces. We find that in-frame mutations (missense point mutations and in-frame insertions and deletions) are enriched on the interaction interfaces of proteins associated with the corresponding disorders, and that the disease specificity for different mutations of the same gene can be explained by their location within an interface. We also predict 292 candidate genes for 694 unknown disease-to-gene associations with proposed molecular mechanism hypotheses. This work indicates that knowledge of how in-frame disease mutations alter specific interactions is critical to understanding pathogenesis. Structurally resolved interaction networks should be valuable tools for interpreting the wealth of data being generated by large-scale structural genomics and disease association studies.	[Wang, Xiujuan; Das, Jishnu; Yu, Haiyuan] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; [Wang, Xiujuan; Wei, Xiaomu; Das, Jishnu; Yu, Haiyuan] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY USA; [Wei, Xiaomu; Lipkin, Steven M.] Weill Cornell Coll Med, Dept Med, New York, NY USA; [Thijssen, Bram] Maastricht Univ, Dept Bioinformat, Maastricht, Netherlands	Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Maastricht University	Yu, HY (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA.	haiyuan.yu@cornell.edu	Das, Jishnu/AAK-4950-2020; Das, Jishnu/C-6924-2015	Das, Jishnu/0000-0002-5747-064X; Das, Jishnu/0000-0002-5747-064X	Cornell University; National Cancer Institute [R01 CA098626, R21 CA122937]; Tata Graduate Fellowship; NATIONAL CANCER INSTITUTE [R01CA098626, R01CA167824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104424, R01GM097358] Funding Source: NIH RePORTER	Cornell University; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tata Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Startup Fund from Cornell University (to HI), National Cancer Institute R01 CA098626 (to S.M.L.), R21 CA122937 (to S.M.L.) and a generous donation by M. Bell (to S.M.L.). J.D. is supported by the Tata Graduate Fellowship. We thank A. Paccanaro, K. Salehi-Ashtiani, M.A. Yildirim and the anonymous reviewers for critical reading and constructive comments of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Ancliff PJ, 2006, BLOOD, V108, P2182, DOI 10.1182/blood-2006-01-010249; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bougeard G, 2003, EUR J HUM GENET, V11, P700, DOI 10.1038/sj.ejhg.5201004; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Chi SW, 1999, EMBO J, V18, P4438, DOI 10.1093/emboj/18.16.4438; CLORE GM, 1995, NAT STRUCT BIOL, V2, P321, DOI 10.1038/nsb0495-321; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Dermitzakis ET, 2009, SCIENCE, V326, P239, DOI 10.1126/science.1182009; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Hu ZJ, 2009, NUCLEIC ACIDS RES, V37, pW115, DOI 10.1093/nar/gkp406; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Moulding DA, 2007, J EXP MED, V204, P2213, DOI 10.1084/jem.20062324; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pasternak J., 2005, INTRO HUMAN MOL GENE; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schuster-Bockler B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r9; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Stein A, 2009, NUCLEIC ACIDS RES, V37, pD300, DOI 10.1093/nar/gkn690; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Turinsky AL, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq026; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HY, 2007, BIOINFORMATICS, V23, P2163, DOI 10.1093/bioinformatics/btm291; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	50	283	289	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					159	164		10.1038/nbt.2106	http://dx.doi.org/10.1038/nbt.2106			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22252508	Green Accepted, Bronze			2022-12-27	WOS:000300269100018
J	Haidet-Phillips, AM; Hester, ME; Miranda, CJ; Meyer, K; Braun, L; Frakes, A; Song, SW; Likhite, S; Murtha, MJ; Foust, KD; Rao, MH; Eagle, A; Kammesheidt, A; Christensen, A; Mendell, JR; Burghes, AHM; Kaspar, BK				Haidet-Phillips, Amanda M.; Hester, Mark E.; Miranda, Carlos J.; Meyer, Kathrin; Braun, Lyndsey; Frakes, Ashley; Song, SungWon; Likhite, Shibi; Murtha, Matthew J.; Foust, Kevin D.; Rao, Meghan; Eagle, Amy; Kammesheidt, Anja; Christensen, Ashley; Mendell, Jerry R.; Burghes, Arthur H. M.; Kaspar, Brian K.			Astrocytes from familial and sporadic ALS patients are toxic to motor neurons	NATURE BIOTECHNOLOGY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; WILD-TYPE; EXTEND SURVIVAL; STEM-CELLS; SOD1; BRAIN; PROGRESSION; DISEASE; SYSTEM; MODEL	Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease, with astrocytes implicated as contributing substantially to motor neuron death in familial (F)ALS(1-5). However, the proposed role of astrocytes in the pathology of ALS derives in part from rodent models of FALS based upon dominant mutations within the superoxide dismutase 1 (SOD1) gene, which account for <2% of all ALS cases(2,4,5). Their role in sporadic (S)ALS, which affects >90% of ALS patients, remains to be established. Using astrocytes generated from postmortem tissue from both FALS and SALS patients, we show that astrocytes derived from both patient groups are similarly toxic to motor neurons. We also demonstrate that SOD1 is a viable target for SALS, as its knockdown significantly attenuates astrocyte-mediated toxicity toward motor neurons. Our data highlight astrocytes as a non-cell autonomous component in SALS and provide an in vitro model system to investigate common disease mechanisms and evaluate potential therapies for SALS and FALS.	[Haidet-Phillips, Amanda M.; Hester, Mark E.; Miranda, Carlos J.; Meyer, Kathrin; Braun, Lyndsey; Frakes, Ashley; Song, SungWon; Likhite, Shibi; Murtha, Matthew J.; Foust, Kevin D.; Rao, Meghan; Eagle, Amy; Mendell, Jerry R.; Kaspar, Brian K.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Haidet-Phillips, Amanda M.; Frakes, Ashley; Mendell, Jerry R.; Kaspar, Brian K.] Ohio State Univ, Coll Med, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Song, SungWon; Likhite, Shibi; Murtha, Matthew J.; Kaspar, Brian K.] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [Kammesheidt, Anja; Christensen, Ashley] Ambry Genet, Aliso Viejo, CA USA; [Kaspar, Brian K.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kaspar, BK (corresponding author), Nationwide Childrens Hosp, Res Inst, Columbus, OH USA.	brian.kaspar@nationwidechildrens.org	Hester, Mark/AAY-8611-2020; Miranda, Carlos/B-7885-2008; Kaspar, Brian/E-3349-2011; Ribeiro, Carlos/Y-9828-2019	Miranda, Carlos/0000-0001-8208-7100; Ribeiro, Carlos/0000-0002-9180-8595; Meyer, Kathrin/0000-0002-5052-2101; Likhite, Shibi/0000-0002-7040-3820; Burghes, Arthur/0000-0001-9031-1555	US National Institutes of Health (NIH) [R01 NS644912-1A1, RC2 NS69476-01]; Project A.L.S.; Packard Center for ALS Research [P2ALS]; Helping Link Foundation; NIH [NRSAF31NS058224]; Swiss National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069476, R01NS064492, F31NS058224, T32NS077984] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project A.L.S.; Packard Center for ALS Research; Helping Link Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by US National Institutes of Health (NIH) R01 NS644912-1A1, RC2 NS69476-01, Project A.L.S. and Packard Center for ALS Research (P2ALS) and Helping Link Foundation to B.K.K., and an NIH grant NRSAF31NS058224 to A.M.H.-P., K.M. is supported by a fellowship from the Swiss National Science Foundation.	Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bendotti C, 2005, NEURODEGENER DIS, V2, P128, DOI 10.1159/000089617; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brown RH, 1997, ARCH NEUROL-CHICAGO, V54, P1246, DOI 10.1001/archneur.1997.00550220050013; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dodge JC, 2008, MOL THER, V16, P1056, DOI 10.1038/mt.2008.60; Dodge JC, 2010, MOL THER, V18, P2075, DOI 10.1038/mt.2010.206; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; HESTER ME, MOL THER IN PRESS; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Lobsiger CS, 2007, P NATL ACAD SCI USA, V104, P7319, DOI 10.1073/pnas.0702230104; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Miller TM, 2005, ANN NEUROL, V57, P773, DOI 10.1002/ana.20453; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Wang RG, 2011, GLIA, V59, P946, DOI 10.1002/glia.21167; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zetterstrom P, 2011, J BIOL CHEM, V286, P20130, DOI 10.1074/jbc.M111.218842	30	546	568	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2011	29	9					824	U79		10.1038/nbt.1957	http://dx.doi.org/10.1038/nbt.1957			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	817ZT	21832997	Green Accepted			2022-12-27	WOS:000294718400023
J	Trapnell, C; Cacchiarelli, D; Grimsby, J; Pokharel, P; Li, SQ; Morse, M; Lennon, NJ; Livak, KJ; Mikkelsen, TS; Rinn, JL				Trapnell, Cole; Cacchiarelli, Davide; Grimsby, Jonna; Pokharel, Prapti; Li, Shuqiang; Morse, Michael; Lennon, Niall J.; Livak, Kenneth J.; Mikkelsen, Tarjei S.; Rinn, John L.			The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells	NATURE BIOTECHNOLOGY			English	Article							TRAVELING SALESMAN PROBLEM; RNA-SEQ; CURVE RECONSTRUCTION; EXPRESSION ANALYSIS; GENE; TRANSCRIPTION; ALGORITHMS; CYTOMETRY; ALIGNMENT; MODELS	Defining the transcriptional dynamics of a temporal process such as cell differentiation is challenging owing to the high variability in gene expression between individual cells. Time-series gene expression analyses of bulk cells have difficulty distinguishing early and late phases of a transcriptional cascade or identifying rare subpopulations of cells, and single-cell proteomic methods rely on a priori knowledge of key distinguishing markers(1). Here we describe Monocle, an unsupervised algorithm that increases the temporal resolution of transcriptome dynamics using single-cell RNA-Seq data collected at multiple time points. Applied to the differentiation of primary human myoblasts, Monocle revealed switch-like changes in expression of key regulatory factors, sequential waves of gene regulation, and expression of regulators that were not known to act in differentiation. We validated some of these predicted regulators in a loss-of function screen. Monocle can in principle be used to recover single-cell gene expression kinetics from a wide array of cellular processes, including differentiation, proliferation and oncogenic transformation.	[Trapnell, Cole; Cacchiarelli, Davide; Morse, Michael; Mikkelsen, Tarjei S.; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Trapnell, Cole; Cacchiarelli, Davide; Grimsby, Jonna; Pokharel, Prapti; Morse, Michael; Lennon, Niall J.; Mikkelsen, Tarjei S.; Rinn, John L.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Cacchiarelli, Davide; Mikkelsen, Tarjei S.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Shuqiang; Livak, Kenneth J.] Fluidigm Corp, San Francisco, CA USA; [Rinn, John L.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Beth Israel Deaconess Medical Center	Rinn, JL (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	john_rinn@harvard.edu	Mikkelsen, Tarjei S/A-1306-2007; Cacchiarelli, Davide/AAC-2693-2022	Mikkelsen, Tarjei S/0000-0002-8133-3135; Cacchiarelli, Davide/0000-0002-9621-6716; Rinn, John/0000-0002-7231-7539	Damon Runyon Cancer Research Foundation Fellowship; Human Frontier Science Program Fellowship; Harvard Stem Cell Institute; US National Institutes of Health [1DP2OD00667, P01GM099117, P50HG006193-01]; Single Cell Genomics initiative; Broad Institute and Fluidigm Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006670] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation Fellowship; Human Frontier Science Program Fellowship(Human Frontier Science Program); Harvard Stem Cell Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Single Cell Genomics initiative; Broad Institute and Fluidigm Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to S. Bordbar, C. Zhu, A. Wagers and the Broad RNAi platform for technical assistance and to M. Soumillon for discussions. C.T. was supported by a Damon Runyon Cancer Research Foundation Fellowship. D.C. was supported by a Human Frontier Science Program Fellowship. D.C. and T.S.M. were supported by the Harvard Stem Cell Institute. This work was supported by US National Institutes of Health grants 1DP2OD00667, P01GM099117 and P50HG006193-01. This work was also supported in part by the Single Cell Genomics initiative, a collaboration between the Broad Institute and Fluidigm Inc.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; BOOTH KS, 1976, J COMPUT SYST SCI, V13, P335, DOI 10.1016/S0022-0000(76)80045-1; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; DEFIGUEIREDO LH, 1994, VISUAL COMPUT, V11, P105, DOI 10.1007/BF01889981; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Giesen J, 2000, DISCRETE COMPUT GEOM, V24, P577, DOI 10.1007/s004540010061; Giesen J, 1999, LECT NOTES COMPUT SC, V1568, P164; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Gupta A, 2008, IEEE ACM T COMPUT BI, V5, P172, DOI 10.1109/TCBB.2007.70233; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hastie T., 1986, STAT SCI, V1, P297; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lun Y, 1997, CELL GROWTH DIFFER, V8, P275; Magwene PM, 2003, BIOINFORMATICS, V19, P842, DOI 10.1093/bioinformatics/btg081; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Qiu P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001123; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yee TW, 1996, J ROY STAT SOC B MET, V58, P481; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	42	2299	2325	23	201	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					381	U251		10.1038/nbt.2859	http://dx.doi.org/10.1038/nbt.2859			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24658644	Green Accepted			2022-12-27	WOS:000334340800023
J	Wu, YC; Wawrzusin, P; Senseney, J; Fischer, RS; Christensen, R; Santella, A; York, AG; Winter, PW; Waterman, CM; Bao, ZR; Colon-Ramos, DA; McAuliffe, M; Shroff, H				Wu, Yicong; Wawrzusin, Peter; Senseney, Justin; Fischer, Robert S.; Christensen, Ryan; Santella, Anthony; York, Andrew G.; Winter, Peter W.; Waterman, Clare M.; Bao, Zhirong; Colon-Ramos, Daniel A.; McAuliffe, Matthew; Shroff, Hari			Spatially isotropic four-dimensional imaging with dual-view plane illumination microscopy	NATURE BIOTECHNOLOGY			English	Article							LIGHT-SHEET MICROSCOPE; IMPROVES RESOLUTION; CELL LINEAGE; LIVE; 3D; DYNAMICS; EMBRYOS; TTX-3; DEEP	Optimal four-dimensional imaging requires high spatial resolution in all dimensions, high speed and minimal photobleaching and damage. We developed a dual-view, plane illumination microscope with improved spatiotemporal resolution by switching illumination and detection between two perpendicular objectives in an alternating duty cycle. Computationally fusing the resulting volumetric views provides an isotropic resolution of 330 nm. As the sample is stationary and only two views are required, we achieve an imaging speed of 200 images/s (i.e., 0.5 s for a 50-plane volume). Unlike spinning-disk confocal or Bessel beam methods, which illuminate the sample outside the focal plane, we maintain high spatiotemporal resolution over hundreds of volumes with negligible photobleaching. To illustrate the ability of our method to study biological systems that require high-speed volumetric visualization and/or low photobleaching, we describe microtubule tracking in live cells, nuclear imaging over 14 h during nematode embryogenesis and imaging of neural wiring during Caenorhabditis elegans brain development over 5 h.	[Wu, Yicong; Wawrzusin, Peter; York, Andrew G.; Winter, Peter W.; Shroff, Hari] NIH, Sect High Resolut Opt Imaging, Natl Inst Biomed Imaging & Bioengn, Bethesda, MD 20892 USA; [Senseney, Justin; McAuliffe, Matthew] NIH, Biomed Imaging Res Serv Sect, Ctr Informat Technol, Bethesda, MD 20892 USA; [Fischer, Robert S.; Waterman, Clare M.] NHLBI, NIH, Bethesda, MD 20892 USA; [Christensen, Ryan; Colon-Ramos, Daniel A.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT USA; [Christensen, Ryan; Colon-Ramos, Daniel A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Santella, Anthony; Bao, Zhirong] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Yale University; Yale University; Memorial Sloan Kettering Cancer Center	Wu, YC (corresponding author), NIH, Sect High Resolut Opt Imaging, Natl Inst Biomed Imaging & Bioengn, Bldg 10, Bethesda, MD 20892 USA.	yicong.wu@nih.gov	Shroff, Hari/E-7247-2016	Shroff, Hari/0000-0003-3613-8215; Waterman, Clare/0000-0001-6142-6775; Bao, Zhirong/0000-0002-2201-2745; Fischer, Robert/0000-0003-0650-2696; Wawrzusin, Peter/0000-0003-0265-9012	National Institutes of Health (NIH) [GM097576, HD075602]; US National Institutes of Health (NIH) [R01 NS076558, U01HD075602]; Intramural Research Programs of the NIH National Institute of Biomedical Imaging and Bioengineering; National Institute of Heart, Lung, and Blood; Center for Information Technology; CENTER FOR INFORMATION TECHNOLOGY [ZIHCT000272] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD075602] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD016474] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Programs of the NIH National Institute of Biomedical Imaging and Bioengineering; National Institute of Heart, Lung, and Blood(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Information Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. McNally and C.-H. Lee for illuminating discussions, M. R. Reinhardt for helping us with the scientific cMOS, W. Mohler for helping us to share and view 4D data sets, G. Rondeau for help with mechanical design, A.Hoofring for help with illustrations and H. Eden for critical feedback on the manuscript. A.S. and Z.B. acknowledge funding from National Institutes of Health (NIH) grants GM097576 and HD075602. R.C. and D.C.-R. acknowledge funding from US National Institutes of Health (NIH) grants R01 NS076558 and U01HD075602. This work was supported by the Intramural Research Programs of the NIH National Institute of Biomedical Imaging and Bioengineering, the National Institute of Heart, Lung, and Blood, and the Center for Information Technology.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Bertrand V, 2009, DEV CELL, V16, P563, DOI 10.1016/j.devcel.2009.02.011; Bhattacharya R, 2009, J CELL SCI, V122, P4492, DOI 10.1242/jcs.050732; Bulow HE, 2002, P NATL ACAD SCI USA, V99, P6346, DOI 10.1073/pnas.092128099; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dey N, 2006, MICROSC RES TECHNIQ, V69, P260, DOI 10.1002/jemt.20294; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Fahrbach FO, 2010, NAT PHOTONICS, V4, P780, DOI [10.1038/nphoton.2010.204, 10.1038/NPHOTON.2010.204]; Fischer RS, 2012, NAT PROTOC, V7, P2056, DOI 10.1038/nprot.2012.127; Fischer RS, 2011, TRENDS CELL BIOL, V21, P682, DOI 10.1016/j.tcb.2011.09.008; Fischer RS, 2009, CURR BIOL, V19, P260, DOI 10.1016/j.cub.2008.12.045; Fuchs E, 2002, OPT EXPRESS, V10, P145, DOI 10.1364/OE.10.000145; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Giurumescu CA, 2012, DEVELOPMENT, V139, P4271, DOI 10.1242/dev.086256; Heiman MG, 2009, CELL, V137, P344, DOI 10.1016/j.cell.2009.01.057; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; Kandere-Grzybowska K, 2005, NAT METHODS, V2, P739, DOI 10.1038/NMETH796; Krzic U, 2009, THESIS U HEIDELBERG; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Lehmann TM, 1999, IEEE T MED IMAGING, V18, P1049, DOI 10.1109/42.816070; LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; Santella A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-580; Schmid B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3207; Stavoe AKH, 2012, GENE DEV, V26, P2206, DOI 10.1101/gad.193409.112; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Swoger J, 2003, OPT LETT, V28, P1654, DOI 10.1364/OL.28.001654; Swoger J, 2007, OPT EXPRESS, V15, P8029, DOI 10.1364/OE.15.008029; Temerinac-Ott M, 2012, IEEE T IMAGE PROCESS, V21, P1863, DOI 10.1109/TIP.2011.2181528; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Verveer PJ, 2007, NAT METHODS, V4, P311, DOI 10.1038/NMETH1017; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Woods R.P., 2000, HDB MED IMAGING PROC, P529; Wu YC, 2011, P NATL ACAD SCI USA, V108, P17708, DOI 10.1073/pnas.1108494108; York AG, 2012, NAT METHODS, V9, P749, DOI [10.1038/nmeth.2025, 10.1038/NMETH.2025]	47	196	203	2	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					1032	+		10.1038/nbt.2713	http://dx.doi.org/10.1038/nbt.2713			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24108093	Green Accepted			2022-12-27	WOS:000326921200026
J	Nugent, KL; Kulkarni, A				Nugent, Kathy L.; Kulkarni, Avi			An interdisciplinary shift in demand for talent within the biotech industry	NATURE BIOTECHNOLOGY			English	Editorial Material									[Nugent, Kathy L.] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Nugent, Kathy L.] BioAlabama, Birmingham, AL USA; [Kulkarni, Avi] Booz & Co, San Francisco, CA USA	University of Alabama System; University of Alabama Birmingham	Nugent, KL (corresponding author), Univ Alabama Birmingham, Birmingham, AL 35294 USA.	avi.kulkarni@booz.com							0	6	6	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					853	855		10.1038/nbt.2694	http://dx.doi.org/10.1038/nbt.2694			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	24022161	Bronze			2022-12-27	WOS:000324306300028
J	Alipanahi, B; Frey, BJ				Alipanahi, Babak; Frey, Brendan J.			Network cleanup	NATURE BIOTECHNOLOGY			English	Editorial Material									[Alipanahi, Babak; Frey, Brendan J.] Univ Toronto, Dept Elect, Toronto, ON, Canada; [Alipanahi, Babak; Frey, Brendan J.] Univ Toronto, Dept Comp Engn, Toronto, ON, Canada; [Alipanahi, Babak; Frey, Brendan J.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Alipanahi, B (corresponding author), Univ Toronto, Dept Elect, Toronto, ON, Canada.	babak@psi.toronto.edu; frey@psi.toronto.edu		Alipanahi, Babak/0000-0001-8216-7178				Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barzel B, 2013, NAT BIOTECHNOL, V31, P720, DOI 10.1038/nbt.2601; Feizi S, 2013, NAT BIOTECHNOL, V31, P726, DOI 10.1038/nbt.2635; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Pearl J, 1998, SOCIOL METHOD RES, V27, P226, DOI 10.1177/0049124198027002004; Pearl J, 2009, STAT SURV, V3, P96, DOI 10.1214/09-SS057; RAVEH A, 1985, AM STAT, V39, P39, DOI 10.2307/2683904; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Santhanam NP, 2012, IEEE T INFORM THEORY, V58, P4117, DOI 10.1109/TIT.2012.2191659; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Wright SS, 1921, J AGR RES, V20, P557	12	21	21	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					714	715		10.1038/nbt.2657	http://dx.doi.org/10.1038/nbt.2657			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23929347				2022-12-27	WOS:000322911000018
J	Theodosiou, M; Rennard, JP; Amir-Aslani, A				Theodosiou, Maria; Rennard, Jean-Philippe; Amir-Aslani, Arsia			Theory to practice: real-world case-based learning for management degrees	NATURE BIOTECHNOLOGY			English	Editorial Material								For scientists looking to break into the biotech industry, scientific knowledge and technical skills are only a partial requirement for success.	[Theodosiou, Maria; Rennard, Jean-Philippe; Amir-Aslani, Arsia] Grenoble Sch Management, Grenoble, France	Grenoble Ecole Management	Theodosiou, M (corresponding author), Grenoble Sch Management, Grenoble, France.	arsia.amir-aslani@grenoble-em.com						Theodosiou M, 2012, NAT BIOTECHNOL, V30, P367, DOI 10.1038/nbt.2180	1	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					894	895		10.1038/nbt.2362	http://dx.doi.org/10.1038/nbt.2362			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22965063				2022-12-27	WOS:000308705700025
J	Acton, G; Gomez-Yafal, A; Walsh, E				Acton, Gwen; Gomez-Yafal, Alicia; Walsh, Emily			From academic solos to industrial symphonies	NATURE BIOTECHNOLOGY			English	Editorial Material									[Acton, Gwen] Vivo Grp, Concord, MA USA; [Gomez-Yafal, Alicia] Shire Human Genet Therapies, Discovery Res, Lexington, MA USA; [Walsh, Emily] Halloran Consulting Grp, Waltham, MA USA	Shire Pharmaceuticals Limited	Acton, G (corresponding author), Vivo Grp, Concord, MA USA.	info@vivogroup.com; agomezyafal@shire.com; ewalsh@hallorancg.com							0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					585	587		10.1038/nbt.2245	http://dx.doi.org/10.1038/nbt.2245			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781674				2022-12-27	WOS:000306293400010
J	Zhang, GY; Liu, X; Quan, ZW; Cheng, SF; Xu, X; Pan, SK; Xie, M; Zeng, P; Yue, Z; Wang, WL; Tao, Y; Bian, C; Han, CL; Xia, QJ; Peng, XH; Cao, R; Yang, XH; Zhan, DL; Hu, JC; Zhang, YX; Li, HN; Li, H; Li, N; Wang, JY; Wang, CC; Wang, RY; Guo, T; Cai, YJ; Liu, CZ; Xiang, HT; Shi, QX; Huang, P; Chen, QC; Li, YR; Wang, J; Zhao, ZH; Wang, J				Zhang, Gengyun; Liu, Xin; Quan, Zhiwu; Cheng, Shifeng; Xu, Xun; Pan, Shengkai; Xie, Min; Zeng, Peng; Yue, Zhen; Wang, Wenliang; Tao, Ye; Bian, Chao; Han, Changlei; Xia, Qiuju; Peng, Xiaohua; Cao, Rui; Yang, Xinhua; Zhan, Dongliang; Hu, Jingchu; Zhang, Yinxin; Li, Henan; Li, Hua; Li, Ning; Wang, Junyi; Wang, Chanchan; Wang, Renyi; Guo, Tao; Cai, Yanjie; Liu, Chengzhang; Xiang, Haitao; Shi, Qiuxiang; Huang, Ping; Chen, Qingchun; Li, Yingrui; Wang, Jun; Zhao, Zhihai; Wang, Jian			Genome sequence of foxtail millet (Setaria italica) provides insights into grass evolution and biofuel potential	NATURE BIOTECHNOLOGY			English	Article							MOLECULAR EVOLUTION; CARBONIC-ANHYDRASE; GENE; IDENTIFICATION; ALIGNMENT; CONSTRUCTION; RESISTANCE; REVEALS; PROGRAM; MAPS	Foxtail millet (Setaria italica), a member of the Poaceae grass family, is an important food and fodder crop in arid regions and has potential for use as a C-4 biofuel. It is a model system for other biofuel grasses, including switchgrass and pearl millet. We produced a draft genome (similar to 423 Mb) anchored onto nine chromosomes and annotated 38,801 genes. Key chromosome reshuffling events were detected through collinearity identification between foxtail millet, rice and sorghum including two reshuffling events fusing rice chromosomes 7 and 9, 3 and 10 to foxtail millet chromosomes 2 and 9, respectively, that occurred after the divergence of foxtail millet and rice, and a single reshuffling event fusing rice chromosome 5 and 12 to foxtail millet chromosome 3 that occurred after the divergence of millet and sorghum. Rearrangements in the C-4 photosynthesis pathway were also identified.	[Zhang, Gengyun; Quan, Zhiwu; Xu, Xun; Xia, Qiuju; Peng, Xiaohua; Zhang, Yinxin; Li, Henan; Li, Hua; Li, Ning; Wang, Chanchan; Wang, Renyi; Guo, Tao; Cai, Yanjie; Liu, Chengzhang; Xiang, Haitao; Shi, Qiuxiang; Huang, Ping; Chen, Qingchun; Wang, Jian] Chinese Minist Agr, BGI Shenzhen, Key Lab Genom, Shenzhen, Peoples R China; [Xu, Xun] BGI Amer, Cambridge, MA USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Zhao, Zhihai] Zhangjiakou Acad Agr Sci, Inst Millet, Zhangjiakou, Peoples R China	Beijing Genomics Institute (BGI); Ministry of Agriculture & Rural Affairs; University of Copenhagen	Wang, J (corresponding author), Chinese Minist Agr, BGI Shenzhen, Key Lab Genom, Shenzhen, Peoples R China.	wangj@genomics.org.cn; zhaozhihai58@163.com; wangjian@genomics.org.cn	XIE, MIN/P-8062-2019; Xu, Xun/AAI-6763-2020; Ditadi, Andrea/K-3461-2016; Wang, Jun/A-7261-2013; Li, Yingrui/K-1064-2015; wang, junyi/GYA-3213-2022; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	XIE, MIN/0000-0002-5652-5039; Xu, Xun/0000-0002-5338-5173; Ditadi, Andrea/0000-0003-3283-8943; Wang, Jun/0000-0002-8540-8931; Bian, Chao/0000-0001-9904-721X; Wang, Jun/0000-0002-2113-5874; Liu, Xin/0000-0003-3256-2940; Hu, Jingchu/0000-0001-6144-7226	Shenzhen-National Science and Technology Plan Projects [ZYC200903240077A]; Basic Research Program of Shenzhen [JC2010526019]; Shenzhen City [CXB200903110066A]; Shenzhen Hundred-million Project; Ministry of Agriculture [2010-Z31]; National Science and Technology Ministry [2007CB815703, 2007CB815705]; National Natural Science Funds for Distinguished Young Scholar [30725008]	Shenzhen-National Science and Technology Plan Projects; Basic Research Program of Shenzhen; Shenzhen City; Shenzhen Hundred-million Project; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); National Science and Technology Ministry; National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	We thank L. Goodman for editing the manuscript and H.-M. Lam for providing valuable comments. This work was supported by the following funding to BGI-Shenzhen: Shenzhen-National Science and Technology Plan Projects (ZYC200903240077A), Basic Research Program of Shenzhen (JC2010526019), Key Laboratory Project Supported by Shenzhen City (CXB200903110066A), Shenzhen Hundred-million Project, Chinese 948 Program supported by the Ministry of Agriculture (2010-Z31), National Science and Technology Ministry Project -973 program (2007CB815703), National Science and Technology Ministry Project 973 program (2007CB815705), National Natural Science Funds for Distinguished Young Scholar (30725008).	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Delye C, 2002, PLANTA, V214, P421, DOI 10.1007/s004250100633; Devos KM, 1998, THEOR APPL GENET, V96, P63, DOI 10.1007/s001220050709; Devos KM, 2000, THEOR APPL GENET, V100, P190, DOI 10.1007/s001220050026; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Fukunaga K, 2002, MOL GENET GENOMICS, V268, P214, DOI 10.1007/s00438-002-0728-8; Fukunaga K, 2002, GENET RESOUR CROP EV, V49, P95, DOI 10.1023/A:1013852007770; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jia XP, 2007, GENET RESOUR CROP EV, V54, P233, DOI 10.1007/s10722-006-9139-8; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langdale JA, 2011, PLANT CELL, V23, P3879, DOI 10.1105/tpc.111.092098; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lashbrook CC, 1998, PLANT J, V15, P243, DOI 10.1046/j.1365-313X.1998.00202.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig M, 2012, PLANT CELL ENVIRON, V35, P22, DOI 10.1111/j.1365-3040.2011.02364.x; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Monson RK, 2003, INT J PLANT SCI, V164, pS43, DOI 10.1086/368400; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peng J, 2007, CROP SCI, V47, P2418, DOI 10.2135/cropsci2007.03.0137; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; PURUGGANAN MD, 1995, GENETICS, V140, P345; Sage RF, 1999, C4 PLANT BIOL; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schontz D, 1999, PLANT BREEDING, V118, P190, DOI 10.1046/j.1439-0523.1999.118002190.x; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tarailo-Graovac M., 2009, CURR PROT BIOINFORM, V25, P4101; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Tiwari A, 2005, PHOTOSYNTHETICA, V43, P1, DOI 10.1007/s11099-005-1011-0; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang CF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-90; Wang TY, 1997, EUPHYTICA, V94, P69, DOI 10.1023/A:1002989725995; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang ZM, 1998, THEOR APPL GENET, V96, P31, DOI 10.1007/s001220050705; Westhoff P, 2010, PLANT PHYSIOL, V154, P598, DOI 10.1104/pp.110.161729; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Zhang JP, 2007, GENOMICS, V90, P121, DOI 10.1016/j.ygeno.2007.03.016; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	78	424	514	5	132	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					549	+		10.1038/nbt.2195	http://dx.doi.org/10.1038/nbt.2195			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22580950	hybrid			2022-12-27	WOS:000305158600025
J	O'Leary, T; Heindryckx, B; Lierman, S; van Bruggen, D; Goeman, JJ; Vandewoestyne, M; Deforce, D; Lopes, SMCD; De Sutter, P				O'Leary, Thomas; Heindryckx, Bjorn; Lierman, Sylvie; van Bruggen, David; Goeman, Jelle J.; Vandewoestyne, Mado; Deforce, Dieter; Lopes, Susana M. Chuva de Sousa; De Sutter, Petra			Tracking the progression of the human inner cell mass during embryonic stem cell derivation	NATURE BIOTECHNOLOGY			English	Article							PRIMORDIAL GERM-CELLS; WNT/BETA-CATENIN; FATE DECISIONS; MOUSE EMBRYOS; EPIBLAST; PLURIPOTENCY; EXPRESSION; LINES; STATES; INACTIVATION	The different pluripotent states of mouse embryonic stem cells (ESCs) in vitro have been shown to correspond to stages of mouse embryonic development(1-6). For human cells, little is known about the events that precede the generation of ESCs or whether they correlate with in vivo developmental stages. Here we investigate the cellular and molecular changes that occur during the transition from the human inner cell mass (ICM) to ESCs in vitro. We demonstrate that human ESCs originate from a post-ICM intermediate (PICMI), a transient epiblast-like structure that has undergone X-inactivation in female cells and is both necessary and sufficient for ESC derivation. The PICMI is the result of progressive and defined ICM organization in vitro and has a distinct state of cell signaling. The PICMI can be cryopreserved without compromising ESC derivation capacity. As a closer progenitor of ESCs than the ICM, the PICMI provides insight into the pluripotent state of human stem cells.	[O'Leary, Thomas; Heindryckx, Bjorn; Lierman, Sylvie; De Sutter, Petra] Ghent Univ Hosp, Dept Reprod Med, Ghent, Belgium; [van Bruggen, David; Lopes, Susana M. Chuva de Sousa] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Goeman, Jelle J.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Vandewoestyne, Mado; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ghent University	O'Leary, T (corresponding author), Ghent Univ Hosp, Dept Reprod Med, Ghent, Belgium.	thomas.oleary@ugent.be	Goeman, Jelle/AAT-1300-2020; Deforce, Dieter LD/J-4725-2013	Goeman, Jelle/0000-0003-4283-0259; Deforce, Dieter LD/0000-0002-0635-661X; van Bruggen, David/0000-0001-6794-7731	Flemish Foundation for Scientific Research (FWO-Vlaanderen) [FWO-3G062910]; Netherlands Organisation for Scientific Research (NWO) [Veni 916.76.015]; Interuniversity Attraction Poles (PAI) [P6/20]; Ferring Company (Aalst, Belgium)	Flemish Foundation for Scientific Research (FWO-Vlaanderen)(FWO); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Interuniversity Attraction Poles (PAI); Ferring Company (Aalst, Belgium)	This research was supported by the Flemish Foundation for Scientific Research (FWO-Vlaanderen, grant FWO-3G062910). S.M.C.d.S.L. was supported by the Netherlands Organisation for Scientific Research (NWO) (Veni 916.76.015) and the Interuniversity Attraction Poles (PAI) (P6/20). P. D. S. is holder of a fundamental clinical research mandate by the Flemish Foundation for Scientific Research (FWO-Vlaanderen). We would like to thank Ferring Company (Aalst, Belgium) for financial support of this study. We thank C. Mummery for discussions and B. Roelen for comments on the manuscript; A. Egorova, C. Visseren and E. Mello-Aho for technical help with the qRT-PCR; A. Bernardo for technical help with the confocal; M. Van der Jeught and G. Duggal for help with culture maintenance; and the medical illustrator of Anatomy/LUMC, S. Blankevoort, for preparing Figure 3h.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Lopes SMCD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040030; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; HOLM S, 1979, SCAND J STAT, V6, P65; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Krenke BE, 2002, J FORENSIC SCI, V47, P773; Kuijk EW, 2011, HUM REPROD UPDATE, V17, P254, DOI 10.1093/humupd/dmq035; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; Lopes SMCD, 2010, DIFFERENTIATION, V79, P131, DOI 10.1016/j.diff.2009.11.003; Lopes SMCDS, 2010, HISTOL HISTOPATHOL, V25, P267, DOI 10.14670/HH-25.267; Mukaida T, 2003, HUM REPROD, V18, P384, DOI 10.1093/humrep/deg047; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; O'Leary T, 2011, STEM CELLS DEV, V20, P785, DOI 10.1089/scd.2010.0338; Pelton TA, 2002, J CELL SCI, V115, P329; Pera RAR, 2009, DIFFERENTIATION, V78, P18, DOI 10.1016/j.diff.2009.03.004; Rathjen J, 1999, J CELL SCI, V112, P601; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Stephenson EL, 2007, REGEN MED, V2, P349, DOI 10.2217/17460751.2.4.349; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanaka SS, 2002, MECH DEVELOP, V119, pS261, DOI 10.1016/S0925-4773(03)00126-6; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Vandewoestyne M, 2011, MITOCHONDRION, V11, P626, DOI 10.1016/j.mito.2011.03.123	41	97	97	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					278	+		10.1038/nbt.2135	http://dx.doi.org/10.1038/nbt.2135			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22371082				2022-12-27	WOS:000301303800025
J	Patwardhan, RP; Hiatt, JB; Witten, DM; Kim, MJ; Smith, RP; May, D; Lee, C; Andrie, JM; Lee, SI; Cooper, GM; Ahituv, N; Pennacchio, LA; Shendure, J				Patwardhan, Rupali P.; Hiatt, Joseph B.; Witten, Daniela M.; Kim, Mee J.; Smith, Robin P.; May, Dalit; Lee, Choli; Andrie, Jennifer M.; Lee, Su-In; Cooper, Gregory M.; Ahituv, Nadav; Pennacchio, Len A.; Shendure, Jay			Massively parallel functional dissection of mammalian enhancers in vivo	NATURE BIOTECHNOLOGY			English	Article							ALDOLASE-B GENE; EXPRESSION; IDENTIFICATION; CONSTRAINT; DYNAMICS	The functional consequences of genetic variation in mammalian regulatory elements are poorly understood. We report the in vivo dissection of three mammalian enhancers at single-nucleotide resolution through a massively parallel reporter assay. For each enhancer, we synthesized a library of >100,000 mutant haplotypes with 2-3% divergence from the wild-type sequence. Each haplotype was linked to a unique sequence tag embedded within a transcriptional cassette. We introduced each enhancer library into mouse liver and measured the relative activities of individual haplotypes en masse by sequencing the transcribed tags. Linear regression analysis yielded highly reproducible estimates of the effect of every possible single-nucleotide change on enhancer activity. The functional consequence of most mutations was modest, with similar to 22% affecting activity by >1.2-fold and similar to 3% by >2-fold. Several, but not all, positions with higher effects showed evidence for purifying selection, or co-localized with known liver-associated transcription factor binding sites, demonstrating the value of empirical high-resolution functional analysis.	[Patwardhan, Rupali P.; Hiatt, Joseph B.; Lee, Choli; Andrie, Jennifer M.; Lee, Su-In; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Witten, Daniela M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Kim, Mee J.; Smith, Robin P.; Ahituv, Nadav] Univ Calif San Francisco, Inst Human Genet, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [May, Dalit; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Lee, Su-In] Univ Washington, Dept Comp Sci, Seattle, WA 98195 USA; [Cooper, Gregory M.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Pennacchio, Len A.] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	nadav.ahituv@ucsf.edu; lapennacchio@lbl.gov; shendure@uw.edu	Shendure, Jay/AAU-3684-2021	Ahituv, Nadav/0000-0002-7434-8144; Shendure, Jay/0000-0002-1516-1865; Pennacchio, Len/0000-0002-8748-3732	National Human Genome Research Institute [HG003988]; US National Institutes of Health (NIH) [DP5OD009145]; National Institute of General Medical Sciences (NIGMS) [GM61390]; National Institute of Child Health and Human Development (NICHD) [R01HD059862]; University of California, San Francisco Liver Center [P30 DK026743]; National Institute on Aging [AG039173]; Achievement Rewards for College Scientists Foundation; NIH [T32 GM007175]; Amgen Research Excellence in Bioengineering and Therapeutic Sciences Fellowship; CIHR; Department of Energy, University of California [DE-AC02-05CH11231]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059862] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061390, U19GM061390, T32GM007175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG039173] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009145] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of California, San Francisco Liver Center(University of California System); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Achievement Rewards for College Scientists Foundation(General Electric); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Research Excellence in Bioengineering and Therapeutic Sciences Fellowship(Amgen); CIHR(Canadian Institutes of Health Research (CIHR)); Department of Energy, University of California(United States Department of Energy (DOE)University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Qiu and J. Kitzman for advice on experimental strategies, and B. Cohen and D. Pe'er for helpful discussions. This work was supported in part by grants HG003988 from the National Human Genome Research Institute (L. A. P.), US National Institutes of Health (NIH) grant DP5OD009145 (D. M. W.), National Institute of General Medical Sciences (NIGMS) award number GM61390 (N.A.), National Institute of Child Health and Human Development (NICHD) grant number R01HD059862 (N.A.), the Pilot/Feasibility grant from the University of California, San Francisco Liver Center (P30 DK026743) (N.A.), AG039173 from the National Institute on Aging (J. B. H.) and a fellowship from the Achievement Rewards for College Scientists Foundation (J. B. H.). M. J. K. was supported in part by NIH Training grant T32 GM007175 and the Amgen Research Excellence in Bioengineering and Therapeutic Sciences Fellowship. R. P. S. is supported by a CIHR fellowship in the area of hepatology. Parts of the research were conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231, University of California. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, NICHD, NHGRI or the NIGMS.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; BOTSTEIN D, 1985, SCIENCE, V229, P1193, DOI 10.1126/science.2994214; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; DANG Q, 1995, J BIOL CHEM, V270, P22577, DOI 10.1074/jbc.270.38.22577; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; GREGORI C, 1991, BIOCHEM BIOPH RES CO, V176, P722, DOI 10.1016/S0006-291X(05)80244-X; Gregori C, 2002, J BIOL CHEM, V277, P28618, DOI 10.1074/jbc.M204047200; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim MJ, 2011, CLIN PHARMACOL THER, V89, P571, DOI 10.1038/clpt.2010.353; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Sabourin JC, 1996, J BIOL CHEM, V271, P3469, DOI 10.1074/jbc.271.7.3469; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; VanderMeer JE, 2011, DEV DYNAM, V240, P920, DOI 10.1002/dvdy.22535; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	25	320	328	3	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					265	+		10.1038/nbt.2136	http://dx.doi.org/10.1038/nbt.2136			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22371081	Green Accepted, Green Submitted			2022-12-27	WOS:000301303800023
J	Fernandes, P				Fernandes, Prabhavathi			Headwinds into opportunity	NATURE BIOTECHNOLOGY			English	Editorial Material									Cempra Pharmaceut, Chapel Hill, NC USA		Fernandes, P (corresponding author), Cempra Pharmaceut, Chapel Hill, NC USA.	prabha@fernandes-domain.com							0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					864	866		10.1038/bioe.2011.8	http://dx.doi.org/10.1038/bioe.2011.8			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21997621				2022-12-27	WOS:000296273000007
J	Schillebeeckx, M; Maricque, B; Lewis, C				Schillebeeckx, Maximiliaan; Maricque, Brett; Lewis, Cory			The missing piece to changing the university culture	NATURE BIOTECHNOLOGY			English	Editorial Material								A new type of initiative is empowering graduate students and postdocs to reshape their academic training, providing another avenue to express their passion for research.	[Schillebeeckx, Maximiliaan; Maricque, Brett] Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA; [Lewis, Cory] Washington Univ, BRIGHT Inst, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Schillebeeckx, M (corresponding author), Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA.	mschillebeeckx@wustl.edu						Brasunas J. St., 2012, ST LOUIS TECH STARTU; Cyranoski D, 2011, NATURE, V472, P276, DOI 10.1038/472276a; Fiegener M. K., 2011, DOCTORATE RECIPIENTS; McCook A, 2011, NATURE, V472, P280, DOI 10.1038/472280a; National Institutes of Health, 2012, BIOM RES WORKF WORK; National Science Foundation, 2012, SCI ENG IND 2012; National Science Foundation, 2012, SCI ENG IND 2012 APP; Rockey S., 2013, EXTRAMURAL NEXUS; Russo Gene, 2011, Nature, V475, P533	9	71	71	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2013	31	10					938	941		10.1038/nbt.2706	http://dx.doi.org/10.1038/nbt.2706			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233CA	24104758				2022-12-27	WOS:000325541300024
J	Balazs, AB; Bloom, JD; Hong, CM; Rao, DS; Baltimore, D				Balazs, Alejandro B.; Bloom, Jesse D.; Hong, Christin M.; Rao, Dinesh S.; Baltimore, David			Broad protection against influenza infection by vectored immunoprophylaxis in mice	NATURE BIOTECHNOLOGY			English	Article							MEDIATED GENE-TRANSFER; A VIRUS; ANTIBODY; EVOLUTION; H5N1	Neutralizing antibodies that target epitopes conserved among many strains of influenza virus have been recently isolated from humans. Here we demonstrate that adeno-associated viruses (AAV) encoding two such broadly neutralizing antibodies are protective against diverse influenza strains. Serum from mice that received a single intramuscular AAV injection efficiently neutralized all H1, H2 and H5 influenza strains tested. After infection with diverse strains of H1N1 influenza, treated mice showed minimal weight loss and lung inflammation. Protection lasted for at least 11 months after AAV injection. Notably, even immunodeficient and older mice were protected by this method, suggesting that expression of a monoclonal antibody alone is sufficient to protect mice from illness. If translated to humans, this prophylactic approach may be uniquely capable of protecting immunocompromised or elderly patient populations not reliably protected by existing vaccines.	[Balazs, Alejandro B.; Hong, Christin M.; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Bloom, Jesse D.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Rao, Dinesh S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	California Institute of Technology; Fred Hutchinson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Bloom, Jesse D/K-3695-2019; Bloom, Jesse D/C-6837-2013; Rao, Dinesh/ABG-1257-2021; Rao, Dinesh/AAE-9625-2019	Bloom, Jesse D/0000-0003-1267-3408; Rao, Dinesh/0000-0002-0794-9337; Balazs, Alejandro/0000-0002-1767-3944; Hong, Christin/0000-0003-1826-9246	National Institute of Allergy and Infectious Disease (NIAID); Joint Center for Translational Medicine; Caltech Translational Innovation Partnership Award; amfAR postdoctoral research fellowship [107756-47-RFVA]; National Institutes of Health [1K08CA133521]; NATIONAL CANCER INSTITUTE [K08CA133521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI093789, K22AI102769] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Joint Center for Translational Medicine; Caltech Translational Innovation Partnership Award; amfAR postdoctoral research fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to thank D. Majumdar, A. Sigal and J. Zhao for their helpful comments, and other members of the Baltimore Lab for their assistance in carrying out this work. This project was supported by a contract from the National Institute of Allergy and Infectious Disease (NIAID) and by the Joint Center for Translational Medicine as well as a Caltech Translational Innovation Partnership Award. A. B. B. is supported by the amfAR postdoctoral research fellowship no. 107756-47-RFVA. D. S. R. is supported by career development award 1K08CA133521 from the National Institutes of Health. The bidirectional reverse-genetics plasmids<SUP>29</SUP> from the PR/34 strain of influenza were a kind gift from R. Webby of St. Jude Children's Research Hospital. The pHW2000 plasmid was a kind gift from Y. Kawaoka of the University of Wisconsin.	[Anonymous], 1993, MMWR Recomm Rep, V42, P1; Aspinall Richard, 2007, Immun Ageing, V4, P9, DOI 10.1186/1742-4933-4-9; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Croyle MA, 2001, GENE THER, V8, P1281, DOI 10.1038/sj.gt.3301527; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Enserink M, 2011, SCIENCE, V334, P1192, DOI 10.1126/science.334.6060.1192; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Marsh GA, 2007, J VIROL, V81, P9727, DOI 10.1128/JVI.01144-07; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Morens DM, 2010, INFLUENZA OTHER RESP, V4, P327, DOI 10.1111/j.1750-2659.2010.00148.x; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517	30	92	108	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2013	31	7					647	U110		10.1038/nbt.2618	http://dx.doi.org/10.1038/nbt.2618			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	180FS	23728362	Green Accepted, Bronze			2022-12-27	WOS:000321579700022
J	Driscoll, CT				Driscoll, Claire T.			Staying happy and productive as a mid-career professional	NATURE BIOTECHNOLOGY			English	Editorial Material									NHGRI, Technol Transfer Off, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Driscoll, CT (corresponding author), NHGRI, Technol Transfer Off, NIH, Rockville, MD USA.	cdriscol@mail.nih.gov						[Anonymous], ASS U TECHN MAN 2013; Goleman D., 1998, WORKING EMOTIONAL IN; Theodosiou M, 2012, NAT BIOTECHNOL, V30, P367, DOI 10.1038/nbt.2180; Vanderford NL, 2011, NAT BIOTECHNOL, V29, P368, DOI 10.1038/nbt.1841	4	0	0	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					567	568		10.1038/nbt.2606	http://dx.doi.org/10.1038/nbt.2606			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23752447				2022-12-27	WOS:000320113200038
J	Thiele, I; Swainston, N; Fleming, RMT; Hoppe, A; Sahoo, S; Aurich, MK; Haraldsdottir, H; Mo, ML; Rolfsson, O; Stobbe, MD; Thorleifsson, SG; Agren, R; Bolling, C; Bordel, S; Chavali, AK; Dobson, P; Dunn, WB; Endler, L; Hala, D; Hucka, M; Hull, D; Jameson, D; Jamshidi, N; Jonsson, JJ; Juty, N; Keating, S; Nookaew, I; Le Novere, N; Malys, N; Mazein, A; Papin, JA; Price, ND; Selkov, E; Sigurdsson, MI; Simeonidis, E; Sonnenschein, N; Smallbone, K; Sorokin, A; van Beek, JHGM; Weichart, D; Goryanin, I; Nielsen, J; Westerhoff, HV; Kell, DB; Mendes, P; Palsson, BO				Thiele, Ines; Swainston, Neil; Fleming, Ronan M. T.; Hoppe, Andreas; Sahoo, Swagatika; Aurich, Maike K.; Haraldsdottir, Hulda; Mo, Monica L.; Rolfsson, Ottar; Stobbe, Miranda D.; Thorleifsson, Stefan G.; Agren, Rasmus; Boelling, Christian; Bordel, Sergio; Chavali, Arvind K.; Dobson, Paul; Dunn, Warwick B.; Endler, Lukas; Hala, David; Hucka, Michael; Hull, Duncan; Jameson, Daniel; Jamshidi, Neema; Jonsson, Jon J.; Juty, Nick; Keating, Sarah; Nookaew, Intawat; Le Novere, Nicolas; Malys, Naglis; Mazein, Alexander; Papin, Jason A.; Price, Nathan D.; Selkov, Evgeni, Sr.; Sigurdsson, Martin I.; Simeonidis, Evangelos; Sonnenschein, Nikolaus; Smallbone, Kieran; Sorokin, Anatoly; van Beek, Johannes H. G. M.; Weichart, Dieter; Goryanin, Igor; Nielsen, Jens; Westerhoff, Hans V.; Kell, Douglas B.; Mendes, Pedro; Palsson, Bernhard O.			A community-driven global reconstruction of human metabolism	NATURE BIOTECHNOLOGY			English	Article							SYSTEMS BIOLOGY; INBORN-ERRORS; NETWORK; MODELS; KNOWLEDGEBASE; ANNOTATION; PREDICTION; CANCER; SBML	Multiple models of human metabolism have been reconstructed, but each represents only a subset of our knowledge. Here we describe Recon 2, a community-driven, consensus 'metabolic reconstruction', which is the most comprehensive representation of human metabolism that is applicable to computational modeling. Compared with its predecessors, the reconstruction has improved topological and functional features, including similar to 2x more reactions and similar to 1.7x more unique metabolites. Using Recon 2 we predicted changes in metabolite biomarkers for 49 inborn errors of metabolism with 77% accuracy when compared to experimental data. Mapping metabolomic data and drug information onto Recon 2 demonstrates its potential for integrating and analyzing diverse data types. Using protein expression data, we automatically generated a compendium of 65 cell type-specific models, providing a basis for manual curation or investigation of cell-specific metabolic properties. Recon 2 will facilitate many future biomedical studies and is freely available at http://humanmetabolism.org/.	[Thiele, Ines; Fleming, Ronan M. T.; Sahoo, Swagatika; Aurich, Maike K.; Haraldsdottir, Hulda; Rolfsson, Ottar; Thorleifsson, Stefan G.; Sigurdsson, Martin I.] Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland; [Thiele, Ines] Univ Iceland, Fac Ind Engn Mech Engn & Comp Sci, Reykjavik, Iceland; [Swainston, Neil; Dunn, Warwick B.; Jameson, Daniel; Malys, Naglis; Smallbone, Kieran; Weichart, Dieter] Univ Manchester, Manchester Inst Biotechnol, Manchester Ctr Integrat Syst Biol, Manchester, Lancs, England; [Swainston, Neil; Hull, Duncan; Jameson, Daniel] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Fleming, Ronan M. T.; Jonsson, Jon J.] Univ Iceland, Dept Biochem & Mol Biol, Reykjavik, Iceland; [Hoppe, Andreas; Boelling, Christian] Charite, Computat Syst Biochem Grp, D-13353 Berlin, Germany; [Mo, Monica L.; Jamshidi, Neema] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Stobbe, Miranda D.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinform, NL-1105 AZ Amsterdam, Netherlands; [Stobbe, Miranda D.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [Agren, Rasmus; Bordel, Sergio; Nookaew, Intawat; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Chavali, Arvind K.; Papin, Jason A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Dobson, Paul] Univ Sheffield, Dept Chem & Biol Engn, Sheffield, S Yorkshire, England; [Dunn, Warwick B.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, CADET, Manchester, Lancs, England; [Endler, Lukas] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Hala, David] Univ N Texas, Dept Biol, Denton, TX 76203 USA; [Hucka, Michael] CALTECH, Comp & Math Sci Dept, Pasadena, CA 91125 USA; [Juty, Nick; Keating, Sarah; Le Novere, Nicolas] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Le Novere, Nicolas] Babraham Inst, Cambridge, England; [Malys, Naglis] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Malys, Naglis] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Mazein, Alexander; Sorokin, Anatoly; Goryanin, Igor] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland; [Price, Nathan D.; Simeonidis, Evangelos] Inst Syst Biol, Seattle, WA USA; [Selkov, Evgeni, Sr.] Genome Designs Inc, Walnut Creek, CA USA; [Simeonidis, Evangelos] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Sonnenschein, Nikolaus] Univ Bremen, Sch Sci & Engn, D-28359 Bremen, Germany; [Smallbone, Kieran] Univ Manchester, Sch Math, Manchester, Lancs, England; [Sorokin, Anatoly] Russian Acad Sci, Inst Cell Biophys, Pushchino 142292, Moscow Region, Russia; [van Beek, Johannes H. G. M.; Westerhoff, Hans V.] Vrije Univ Amsterdam, Dept Mol Cell Physiol, Amsterdam, Netherlands; [van Beek, Johannes H. G. M.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Sect Med Gen, Amsterdam, Netherlands; [van Beek, Johannes H. G. M.] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [Weichart, Dieter] Univ Manchester, Sch Dent, Manchester, Lancs, England; [Goryanin, Igor] Okinawa Inst Sci & Technol, Okinawa, Japan; [Westerhoff, Hans V.] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester, Lancs, England; [Westerhoff, Hans V.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Kell, Douglas B.] Univ Manchester, Sch Chem, Manchester, Lancs, England; [Mendes, Pedro] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA	University of Iceland; University of Iceland; University of Manchester; University of Manchester; University of Iceland; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California San Diego; University of Amsterdam; Academic Medical Center Amsterdam; Chalmers University of Technology; University of Virginia; University of Sheffield; University of Manchester; University of Vienna; University of North Texas System; University of North Texas Denton; California Institute of Technology; European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Manchester; University of Warwick; University of Edinburgh; Institute for Systems Biology (ISB); University of Luxembourg; University of Bremen; University of Manchester; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Manchester; Okinawa Institute of Science & Technology Graduate University; University of Manchester; University of Amsterdam; University of Manchester; Virginia Polytechnic Institute & State University	Thiele, I (corresponding author), Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland.	ines.thiele@gmail.com	Sorokin, Anatoly/A-9090-2008; Thiele, Ines/A-7629-2014; Dunn, Warwick/CAJ-1648-2022; Malys, Naglis/Y-6961-2018; Bordel, Sergio/A-3325-2017; Fleming, Ronan MT/ABC-4093-2021; Jameson, Daniel/G-7386-2014; Hull, Duncan/HGB-6116-2022; Goryanin, Igor/AAB-1400-2022; Mazein, Alexander/C-1369-2013; Goryanin, Igor/J-1913-2015; Chavali, Arvind/L-7157-2016; Sigurdsson, Martin Ingi/I-9655-2016; Hucka, Michael/B-1896-2012; damiani, chiara/R-4256-2016; Westerhoff, Hans V/I-5762-2012; Sonnenschein, Nikolaus/F-6853-2012; Lukas, Endler/ABD-2002-2021; Kell, Douglas/E-8318-2011; Nielsen, Jens/Q-1347-2017	Sorokin, Anatoly/0000-0002-0047-0606; Thiele, Ines/0000-0002-8071-7110; Dunn, Warwick/0000-0001-6924-0027; Malys, Naglis/0000-0002-5010-310X; Bordel, Sergio/0000-0001-6162-6478; Fleming, Ronan MT/0000-0001-5346-9812; Jameson, Daniel/0000-0003-1183-2825; Hull, Duncan/0000-0003-2387-503X; Mazein, Alexander/0000-0001-7137-4171; Goryanin, Igor/0000-0002-8293-774X; Sigurdsson, Martin Ingi/0000-0001-7054-0844; Hucka, Michael/0000-0001-9105-5960; Westerhoff, Hans V/0000-0002-0443-6114; Sonnenschein, Nikolaus/0000-0002-7581-4936; Lukas, Endler/0000-0002-9115-8756; Kell, Douglas/0000-0001-5838-7963; Simeonidis, Vangelis/0000-0001-6153-4493; Mendes, Pedro/0000-0001-6507-9168; Price, Nathan/0000-0002-4157-0267; Papin, Jason/0000-0002-2769-5805; Rolfsson, Ottar/0000-0003-4258-6057; Sahoo, Swagatika/0000-0003-3773-8597; Keating, Sarah/0000-0002-3356-3542; Juty, Navtej/0000-0002-2036-8350; Palsson, Bernhard/0000-0003-2357-6785; Hoppe, Andreas/0000-0001-5181-6411; Nielsen, Jens/0000-0002-9955-6003; Smallbone, Kieran/0000-0003-2815-7045	Marie Curie International Reintegration Grant within the 7th European Community Framework Program [249261]; European Research Council [232816]; Rannis research grant [100406022]; Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council [BB/C008219/1]; European Union [201142]; Knut and Alice Wallenberg Foundation; BBSRC [BB/F005938, BB/F00561X]; German Federal Ministry for Education and Research within the Virtual Liver Network [0315756, 0315741]; US National Institutes of Health [GM088244]; National Science Foundation [0643548]; Cystic Fibrosis Research Foundation [1060]; National Cancer Institute; Science and Technology Facilities Council; US National Institute of General Medical Sciences [R01GM070923, R01GM080219]; BioRange programme of The Netherlands Bioinformatics Centre under a Besluit Subsidies Investeringen Kennisinfrastructuur grant through The Netherlands Genomics Initiative [SP1.2.4]; BBSRC [BB/J019305/1, BBS/E/B/000C0419, BB/E006248/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070923, R01GM088244, R01GM080219, U01GM102098] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/J019305/1, BBS/E/B/000C0419, BB/C008219/1, BB/E006248/1] Funding Source: researchfish	Marie Curie International Reintegration Grant within the 7th European Community Framework Program; European Research Council(European Research Council (ERC)European Commission); Rannis research grant; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Federal Ministry for Education and Research within the Virtual Liver Network; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Cystic Fibrosis Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BioRange programme of The Netherlands Bioinformatics Centre under a Besluit Subsidies Investeringen Kennisinfrastructuur grant through The Netherlands Genomics Initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	I.T. was supported, in part, by a Marie Curie International Reintegration Grant (249261) within the 7th European Community Framework Program. I. T., O. R., S. G. T. and M. A. were supported by the European Research Council grant proposal number 232816. S. S. and H. H. were supported by a Rannis research grant (100406022). Authors from Manchester thank the Biotechnology and Biological Sciences Research Council (BBSRC), and Engineering and Physical Sciences Research Council for their funding of the Manchester Centre for Integrative Systems Biology (grant BB/C008219/1), H. W. for Bioprocessing Research Industry Club grants, and P. M. and N. Swainston for support from the European Union FP7 project UNICELLSYS (grant agreement 201142). The Knut and Alice Wallenberg Foundation supported R. A., S. B. and I. N.; D. J. thanks the BBSRC for funding of Systems Approaches to Biological Research grants BB/F005938 and BB/F00561X. A. H. and C. B. were supported by the German Federal Ministry for Education and Research within the Virtual Liver Network (grant numbers 0315756 and 0315741). A. K. C. and J. A. P. acknowledge funding from the US National Institutes of Health (grant GM088244), National Science Foundation (grant 0643548) and Cystic Fibrosis Research Foundation (grant 1060). N. D. P. was supported by a National Cancer Institute to Independence Award in Cancer Research. I. G. thanks the Science and Technology Facilities Council for Scottish Bioinformatics Research Network funding. M. H. and P. M. thank the US National Institute of General Medical Sciences for support under grants R01GM070923 and R01GM080219. M. D. S. thanks the BioRange programme (project SP1.2.4) of The Netherlands Bioinformatics Centre for support under a Besluit Subsidies Investeringen Kennisinfrastructuur grant through The Netherlands Genomics Initiative.	Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Bordbar A, 2012, J INTERN MED, V271, P131, DOI 10.1111/j.1365-2796.2011.02494.x; Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68; Chang RL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000938; Claus SP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.56; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Gille C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.62; Gudmundsson S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-489; Hao T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-393; Haraldsdottir HS, 2012, BIOPHYS J, V102, P1703, DOI 10.1016/j.bpj.2012.02.032; Heavner BD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-55; Heinken A, 2013, GUT MICROBES, V4, P28, DOI 10.4161/gmic.22370; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hoppe A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-28; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Kell DB, 2005, NAT REV MICROBIOL, V3, P557, DOI 10.1038/nrmicro1177; Le Novere N, 2005, NAT BIOTECHNOL, V23, P1509, DOI 10.1038/nbt1156; McHugh DMS, 2011, GENET MED, V13, P230, DOI 10.1097/GIM.0b013e31820d5e67; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Paglia G, 2012, ANAL BIOANAL CHEM, V402, P1183, DOI 10.1007/s00216-011-5556-4; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Rolfsson O, 2013, BIOCHEM J, V449, P427, DOI 10.1042/BJ20120980; Rolfsson O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-155; Sahoo S., HUMAN MOL G IN PRESS; Sahoo S, 2012, MOL BIOSYST, V8, P2545, DOI 10.1039/c2mb25075f; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Shlomi T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.22; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Smallbone K, 2007, FEBS J, V274, P5576, DOI 10.1111/j.1742-4658.2007.06076.x; Smallbone K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-6; Stobbe MD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-165; Suhre K, 2011, NAT GENET, V43, P565, DOI 10.1038/ng.837; Swainston N, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-186; Swainston N, 2009, BIOINFORMATICS, V25, P2292, DOI 10.1093/bioinformatics/btp392; Thiele I, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-8; Thiele I, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.15; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thorleifsson SG, 2011, BIOINFORMATICS, V27, P2009, DOI 10.1093/bioinformatics/btr308; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Zelena E, 2009, ANAL CHEM, V81, P1357, DOI 10.1021/ac8019366	51	646	654	5	162	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					419	+		10.1038/nbt.2488	http://dx.doi.org/10.1038/nbt.2488			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23455439	Green Accepted, Green Published, Bronze			2022-12-27	WOS:000318589600021
J	Jiang, WY; Bikard, D; Cox, D; Zhang, F; Marraffini, LA				Jiang, Wenyan; Bikard, David; Cox, David; Zhang, Feng; Marraffini, Luciano A.			RNA-guided editing of bacterial genomes using CRISPR-Cas systems	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; IMMUNE-SYSTEM; STREPTOCOCCUS-THERMOPHILUS; SEED SEQUENCE; DNA CLEAVAGE; IN-VIVO; ENDONUCLEASE; PROTEIN; RECOMBINATION; INTERFERENCE	Here we use the clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated Cas9 endonuclease complexed with dual-RNAs to introduce precise mutations in the genomes of Streptococcus pneumoniae and Escherichia coli. The approach relies on dual-RNA:Cas9-directed cleavage at the targeted genomic site to kill unmutated cells and circumvents the need for selectable markers or counter-selection systems. We reprogram dual-RNA:Cas9 specificity by changing the sequence of short CRISPR RNA (crRNA) to make single- and multinucleotide changes carried on editing templates. Simultaneous use of two crRNAs enables multiplex mutagenesis. In S. pneumoniae, nearly 100% of cells that were recovered using our approach contained the desired mutation, and in E. coli, 65% that were recovered contained the mutation, when the approach was used in combination with recombineering. We exhaustively analyze dual-RNA:Cas9 target requirements to define the range of targetable sequences and show strategies for editing sites that do not meet these requirements, suggesting the versatility of this technique for bacterial genome engineering.	[Jiang, Wenyan; Bikard, David; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10021 USA; [Cox, David; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA USA; [Cox, David; Zhang, Feng] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Cox, David; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Rockefeller University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bikard, D (corresponding author), Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10021 USA.	dbikard@rockefeller.edu; marraffini@rockefeller.edu	Bikard, David/L-2971-2015; Bikard, David/AAZ-3752-2021; Macrae, Rhiannon/AAX-1536-2020	Bikard, David/0000-0002-5729-1211; Bikard, David/0000-0002-5729-1211; 	Harvey L. Karp Discovery Award; Bettencourt Schuller Foundation; Medical Scientist Training Program; US National Institutes of Health (NIH) [DP1MH100706]; Keck Foundation; McKnight Foundation; Gates Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation; Simons Foundation; Transformative R01; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; NIH [1DP2AI104556-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	Harvey L. Karp Discovery Award; Bettencourt Schuller Foundation; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Gates Foundation(Bill & Melinda Gates Foundation); Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Simons Foundation; Transformative R01; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank V. Fischetti and C. Euler for plasmid pLZ12spec, D. Court for the HME63 strain, J. Kern for plasmid pKD46, the Rockefeller University Genomic Resource Center for technical support and J. Roberts for the MG1655 strain. D.B. is supported by a Harvey L. Karp Discovery Award and the Bettencourt Schuller Foundation. D.C. is supported by the Medical Scientist Training Program. F.Z. is supported by a US National Institutes of Health (NIH) Director's Pioneer Award (DP1MH100706), Transformative R01, the Keck, McKnight, Gates, Damon Runyon, Searle Scholars, Klingenstein, and Simons Foundations, Bob Metcalfe, Mike Boylan and Jane Pauley. L.A.M. is supported by the Searle Scholars Program, the Rita Allen Scholars Program, a Irma T. Hirschl Award and a NIH Director's New Innovator Award (1DP2AI104556-01).	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Barrangou R, 2012, NAT BIOTECHNOL, V30, P836, DOI 10.1038/nbt.2357; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brouns SJJ, 2012, SCIENCE, V337, P808, DOI 10.1126/science.1227253; Carroll D, 2012, MOL THER, V20, P1658, DOI 10.1038/mt.2012.171; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Fischer S, 2012, J BIOL CHEM, V287, P33351, DOI 10.1074/jbc.M112.377002; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hosaka T, 2004, MOL GENET GENOMICS, V271, P317, DOI 10.1007/s00438-004-0982-z; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Motamedi MR, 1999, GENE DEV, V13, P2889, DOI 10.1101/gad.13.21.2889; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/NMETH.1971, 10.1038/nmeth.1971]; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Zahner D, 2000, J BACTERIOL, V182, P5919, DOI 10.1128/JB.182.20.5919-5921.2000	40	1499	2045	35	1053	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					233	239		10.1038/nbt.2508	http://dx.doi.org/10.1038/nbt.2508			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23360965	Green Accepted, Green Submitted			2022-12-27	WOS:000316439500018
J	Varshney, RK; Song, C; Saxena, RK; Azam, S; Yu, S; Sharpe, AG; Cannon, S; Baek, J; Rosen, BD; Tar'an, B; Millan, T; Zhang, XD; Ramsay, LD; Iwata, A; Wang, Y; Nelson, W; Farmer, AD; Gaur, PM; Soderlund, C; Penmetsa, RV; Xu, CY; Bharti, AK; He, WM; Winter, P; Zhao, SC; Hane, JK; Carrasquilla-Garcia, N; Condie, JA; Upadhyaya, HD; Luo, MC; Thudi, M; Gowda, CLL; Singh, NP; Lichtenzveig, J; Gali, KK; Rubio, J; Nadarajan, N; Dolezel, J; Bansal, KC; Xu, X; Edwards, D; Zhang, GY; Kahl, G; Gil, J; Singh, KB; Datta, SK; Jackson, SA; Wang, J; Cook, DR				Varshney, Rajeev K.; Song, Chi; Saxena, Rachit K.; Azam, Sarwar; Yu, Sheng; Sharpe, Andrew G.; Cannon, Steven; Baek, Jongmin; Rosen, Benjamin D.; Tar'an, Bunyamin; Millan, Teresa; Zhang, Xudong; Ramsay, Larissa D.; Iwata, Aiko; Wang, Ying; Nelson, William; Farmer, Andrew D.; Gaur, Pooran M.; Soderlund, Carol; Penmetsa, R. Varma; Xu, Chunyan; Bharti, Arvind K.; He, Weiming; Winter, Peter; Zhao, Shancen; Hane, James K.; Carrasquilla-Garcia, Noelia; Condie, Janet A.; Upadhyaya, Hari D.; Luo, Ming-Cheng; Thudi, Mahendar; Gowda, C. L. L.; Singh, Narendra P.; Lichtenzveig, Judith; Gali, Krishna K.; Rubio, Josefa; Nadarajan, N.; Dolezel, Jaroslav; Bansal, Kailash C.; Xu, Xun; Edwards, David; Zhang, Gengyun; Kahl, Guenter; Gil, Juan; Singh, Karam B.; Datta, Swapan K.; Jackson, Scott A.; Wang, Jun; Cook, Douglas R.			Draft genome sequence of chickpea (Cicer arietinum) provides a resource for trait improvement	NATURE BIOTECHNOLOGY			English	Article							L.; INTEGRATION; EVOLUTION; QUALITY; LEGUME	Chickpea (Cicer arietinum) is the second most widely grown legume crop after soybean, accounting for a substantial proportion of human dietary nitrogen intake and playing a crucial role in food security in developing countries. We report the similar to 738-Mb draft whole genome shotgun sequence of CDC Frontier, a kabuli chickpea variety, which contains an estimated 28,269 genes. Resequencing and analysis of 90 cultivated and wild genotypes from ten countries identifies targets of both breeding-associated genetic sweeps and breeding-associated balancing selection. Candidate genes for disease resistance and agronomic traits are highlighted, including traits that distinguish the two main market classes of cultivated chickpea-desi and kabuli. These data comprise a resource for chickpea improvement through molecular breeding and provide insights into both genome diversity and domestication.	[Varshney, Rajeev K.; Saxena, Rachit K.; Azam, Sarwar; Gaur, Pooran M.; Upadhyaya, Hari D.; Thudi, Mahendar; Gowda, C. L. L.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Varshney, Rajeev K.] CGIAR Generat Challenge Programme, Texcoco, Mexico; [Song, Chi; Yu, Sheng; Zhang, Xudong; Wang, Ying; Xu, Chunyan; He, Weiming; Zhao, Shancen; Zhang, Gengyun; Wang, Jun] Beijing Genom Inst BGI Shenzhen, Shenzhen, Peoples R China; [Sharpe, Andrew G.; Ramsay, Larissa D.; Condie, Janet A.; Gali, Krishna K.] Natl Res Council Canada NRC CNRC, Ottawa, ON, Canada; [Cannon, Steven] Iowa State Univ, USDA ARS, Ames, IA USA; [Baek, Jongmin; Rosen, Benjamin D.; Penmetsa, R. Varma; Carrasquilla-Garcia, Noelia; Luo, Ming-Cheng; Cook, Douglas R.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Tar'an, Bunyamin] Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK S7N 0W0, Canada; [Millan, Teresa; Rubio, Josefa; Gil, Juan] Univ Cordoba, Dept Genet, Cordoba, Spain; [Iwata, Aiko; Jackson, Scott A.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Nelson, William; Soderlund, Carol] Univ Arizona, Tucson, AZ USA; [Farmer, Andrew D.; Bharti, Arvind K.] NCGR, Santa Fe, NM USA; [Winter, Peter] GenXPro GmbH, Frankfurt, Germany; [Hane, James K.; Singh, Karam B.] CSIRO, Canberra, ACT, Australia; [Singh, Narendra P.] ICAR Res Complex, All India Coordinated Res Project Chickpea AICRP, New Delhi, India; [Lichtenzveig, Judith] Curtin Univ, Bentley, WA, Australia; [Nadarajan, N.] ICAR Res Complex, IIPR, Kanpur, Uttar Pradesh, India; [Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic; [Bansal, Kailash C.] ICAR Res Complex, NBPGR, New Delhi, India; [Edwards, David] ACPFG, St Lucia, Qld, Australia; [Edwards, David] Univ Queensland, St Lucia, Qld, Australia; [Kahl, Guenter] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Singh, Karam B.] Univ Western Australia, Univ Western Australia Inst Agr, Crawley, Australia; [Datta, Swapan K.] ICAR Res Complex, Div Crop Sci, New Delhi, India; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CGIAR; Beijing Genomics Institute (BGI); National Research Council Canada; Iowa State University; United States Department of Agriculture (USDA); University of California System; University of California Davis; University of Saskatchewan; Universidad de Cordoba; University System of Georgia; University of Georgia; University of Arizona; National Center for Genome Resources (NCGR); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Curtin University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Pulses Research; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; University of Queensland; Goethe University Frankfurt; University of Western Australia; University of Copenhagen	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India.	r.k.varshney@cgiar.org; wangj@genomics.org.cn; drcook@ucdavis.edu	Dolezel, Jaroslav/B-7716-2008; Updhayaya, Hari/C-4858-2014; Gaur, Pooran Mal/ABE-6102-2020; Xu, Xun/AAI-6763-2020; Rubio, Josefa/ABC-5786-2020; zhang, xian/GYA-0290-2022; Gil, Juan/L-7167-2014; Wang, Jun/A-7261-2013; Zhang, xiaoyu/GXA-3206-2022; Millan, Teresa/L-1362-2014; zhang, xu/GYE-3558-2022; THUDI, MAHENDAR/GXA-1578-2022; zhang, xu/GRX-9733-2022; Singh, Karam B/C-3235-2012; Hane, James/A-7062-2011; Edwards, David/H-3710-2015; Gaur, Pooran/AAR-5729-2021; Rubio, Josefa J Rubio/L-1868-2014; Varshney, Rajeev K/C-5295-2014; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Dolezel, Jaroslav/0000-0002-6263-0492; Updhayaya, Hari/0000-0002-5166-6844; Gaur, Pooran Mal/0000-0002-7086-5873; Xu, Xun/0000-0002-5338-5173; Rubio, Josefa/0000-0002-5185-2719; Gil, Juan/0000-0001-7938-442X; Millan, Teresa/0000-0003-1302-1794; THUDI, MAHENDAR/0000-0003-2851-6837; Singh, Karam B/0000-0002-2777-7448; Hane, James/0000-0002-7651-0977; Edwards, David/0000-0001-7599-6760; Rubio, Josefa J Rubio/0000-0002-5185-2719; Varshney, Rajeev K/0000-0002-4562-9131; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Iwata-Otsubo, Aiko/0000-0001-9378-3961; Ramsay, Larissa/0000-0002-8768-5959; Tar'an, Bunyamin/0000-0003-3583-3910; Yu, Sheng/0000-0001-7356-9343; Luo, Ming-Cheng/0000-0002-9744-5887; Datta, Swapan/0000-0003-2961-8915; jackson, scott/0000-0002-3172-1607	CGIAR Generation Challenge Programme [G7009.06]; US National Science Foundation [DBI 0605251, IOS-0965531, DBI 0822258]; Rural Development Administration of the Republic of Korea [PJ906910]; Indo-German Science Technology Centre; BGI, Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]; Grains Research Development Corporation [UWA00149]; Australian Research Council [DP0985953, LP110100200]; Saskatchewan Pulse Growers; Saskatchewan Agriculture Development Fund; University of Cordoba; National Institute for Agricultural and Food Research and Technology (INIA) [RTA2010-00059]; National Research Initiative of US Department of Agriculture's National Institute of Food and Agriculture [0214643]; Ministry of Education, Youth and Sports of the Czech Republic; European Regional Development Fund [ED0007/01/01]; Indian Council of Agricultural Research (ICAR); ICRISAT	CGIAR Generation Challenge Programme(CGIAR); US National Science Foundation(National Science Foundation (NSF)); Rural Development Administration of the Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Indo-German Science Technology Centre; BGI, Shenzhen Key Laboratory of Transomics Biotechnologies; Grains Research Development Corporation(Grains R&D Corp); Australian Research Council(Australian Research Council); Saskatchewan Pulse Growers; Saskatchewan Agriculture Development Fund; University of Cordoba; National Institute for Agricultural and Food Research and Technology (INIA)(Instituto de Investigacion Agropecuaria (INIA)); National Research Initiative of US Department of Agriculture's National Institute of Food and Agriculture; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund(European Commission); Indian Council of Agricultural Research (ICAR)(Indian Council of Agricultural Research (ICAR)); ICRISAT(CGIAR)	We would like to thank CGIAR Generation Challenge Programme (Theme Leader Discretionary grant to R.K.V., G7009.06 to D.R.C. and R.K.V.); US National Science Foundation (DBI 0605251 to D.R.C., IOS-0965531 to D.R.C. and R.K.V., and DBI 0822258 to S.A.J.); Rural Development Administration of the Republic of Korea (Woo Jang Choon Project No. PJ906910 to D.R.C.); Indo-German Science Technology Centre (R.K.V., G.K. and P.W.); BGI, Shenzhen Key Laboratory of Transomics Biotechnologies (CXB201108250096A); Grains Research Development Corporation (UWA00149 to K.S.B.), Australian Research Council (DP0985953, LP110100200 to D.E.); Saskatchewan Pulse Growers (B.T. and A.G.S.); Saskatchewan Agriculture Development Fund (to A.G.S.); University of Cordoba and National Institute for Agricultural and Food Research and Technology (INIA) (RTA2010-00059 to T.M.); National Research Initiative of US Department of Agriculture's National Institute of Food and Agriculture (#0214643 to M.-C.L.); Ministry of Education, Youth and Sports of the Czech Republic and the European Regional Development Fund (ED0007/01/01 to J.D. and J.A.C.); Indian Council of Agricultural Research (ICAR) and ICRISAT for financial support to undertake parts of research presented in this study. Thanks are due to K. Hobson of Pulse Breeding Australia (PBA) for providing seeds of some genotypes used in this study. We would also like to thank W.D. Dar (director general, ICRISAT), D.A. Hoisington (deputy director general-research, ICRISAT) and J.-M. Ribaut (director, CGIAR GCP) for their helpful advice and assistance, wherever required, during the course of the study.	Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Cannon SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011630; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; Millan T, 2010, EUPHYTICA, V175, P175, DOI 10.1007/s10681-010-0157-4; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pritchard JK, 2000, GENETICS, V155, P945; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Singh K.B., 1987, CHICKPEA, P11, DOI DOI 10.1016/J.YMPEV.2021.107235; Staginnus C, 1999, PLANT MOL BIOL, V39, P1037, DOI 10.1023/A:1006125430386; Thudi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027275; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2010, PLANT BREEDING REV, V33, P257; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Warkentin T, 2005, CAN J PLANT SCI, V85, P909, DOI 10.4141/P04-185; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zatloukalova P, 2011, CHROMOSOME RES, V19, P729, DOI 10.1007/s10577-011-9235-2; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhao J, 2009, PLANT CELL, V21, P2323, DOI 10.1105/tpc.109.067819; ZOHARY D, 1973, SCIENCE, V182, P887, DOI 10.1126/science.182.4115.887	28	740	771	12	206	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					240	246		10.1038/nbt.2491	http://dx.doi.org/10.1038/nbt.2491			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23354103	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000316439500019
J	Kapoor, N; Liang, WB; Marban, E; Cho, HC				Kapoor, Nidhi; Liang, Wenbin; Marban, Eduardo; Cho, Hee Cheol			Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18	NATURE BIOTECHNOLOGY			English	Article							CARDIAC GENE-EXPRESSION; BIOLOGICAL PACEMAKER; SINOATRIAL NODE; HUMAN FIBROBLASTS; STEM-CELLS; HEART; DIFFERENTIATION; INTEGRATION; INDUCTION; CHANNEL	The heartbeat originates within the sinoatrial node (SAN), a small structure containing <10,000 genuine pacemaker cells. If the SAN fails, the similar to 5 billion working cardiomyocytes downstream of it become quiescent, leading to circulatory collapse in the absence of electronic pacemaker therapy. Here we demonstrate conversion of rodent cardiomyocytes to SAN cells in vitro and in vivo by expression of Tbx18, a gene critical for early SAN specification. Within days of in vivo Tbx18 transduction, 9.2% of transduced, ventricular cardiomyocytes develop spontaneous electrical firing physiologically indistinguishable from that of SAN cells, along with morphological and epigenetic features characteristic of SAN cells. In vivo, focal Tbx18 gene transfer in the guinea-pig ventricle yields ectopic pacemaker activity, correcting a bradycardic disease phenotype. Myocytes transduced in vivo acquire the cardinal tapering morphology and physiological automaticity of native SAN pacemaker cells. The creation of induced SAN pacemaker (iSAN) cells opens new prospects for bioengineered pacemakers.	[Kapoor, Nidhi; Liang, Wenbin; Marban, Eduardo; Cho, Hee Cheol] Cedars Sinai Heart Inst, Los Angeles, CA USA	Cedars Sinai Medical Center	Marban, E (corresponding author), Cedars Sinai Heart Inst, Los Angeles, CA USA.	MarbanE@cshs.org; ChoHC@cshs.org	Marban, Eduardo/GWC-8514-2022		Cedars-Sinai Board of Governors Heart Stem Cell Center; Heart Rhythm Society fellowship; Heart and Stroke Foundation of Canada fellowship; American Heart Association [12SDG9020030]; NHLBI [1R01HL111646-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111646] Funding Source: NIH RePORTER	Cedars-Sinai Board of Governors Heart Stem Cell Center; Heart Rhythm Society fellowship; Heart and Stroke Foundation of Canada fellowship(Heart & Stroke Foundation of Canada); American Heart Association(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank G. Galang, R. Rafi, B. Sun and W. Liu for technical assistance; S. Groenke of J.I. Goldhaber's laboratory for help with SAN tissue dissection; and D. Sareen of Clive Svendsen's laboratory for RNA samples of human iPSCs and the parental fibroblasts. The study was supported by the Cedars-Sinai Board of Governors Heart Stem Cell Center. E. M. holds the Mark S. Siegel Family Professorship. N.K. is supported by the Heart Rhythm Society fellowship. W. L. is supported by the Heart and Stroke Foundation of Canada fellowship. H. C. C. is supported by grants from the American Heart Association (12SDG9020030) and NHLBI (1R01HL111646-01A1).	Bakker M.L., 2012, CARDIOVASC RES; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; BLEEKER WK, 1980, CIRC RES, V46, P11, DOI 10.1161/01.RES.46.1.11; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Cho HC, 2007, CIRC RES, V100, P1112, DOI 10.1161/01.RES.0000265845.04439.78; Cho HC, 2010, CIRC RES, V106, P674, DOI 10.1161/CIRCRESAHA.109.212936; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Dobrzynski H, 2005, CIRCULATION, V111, P846, DOI 10.1161/01.CIR.0000152100.04087.DB; Espinoza-Lewis RA, 2011, DEV BIOL, V356, P359, DOI 10.1016/j.ydbio.2011.05.663; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; Goldberger E, 1968, INTERPRET ELECTROCAR; Honjo H, 1996, J PHYSIOL-LONDON, V496, P795, DOI 10.1113/jphysiol.1996.sp021728; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Kapoor N, 2011, J BIOL CHEM, V286, P14073, DOI 10.1074/jbc.M110.185298; Kashiwakura Y, 2006, CIRCULATION, V114, P1682, DOI 10.1161/CIRCULATIONAHA.106.634865; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; KOJIMA M, 1990, BRIT J PHARMACOL, V99, P327, DOI 10.1111/j.1476-5381.1990.tb14703.x; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Lyashkov AE, 2007, CIRC RES, V100, P1723, DOI 10.1161/CIRCRESAHA.107.153676; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Miake J, 2002, NATURE, V419, P132, DOI 10.1038/419132b; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Nagashima M, 2001, J MOL CELL CARDIOL, V33, P533, DOI 10.1006/jmcc.2000.1327; NAKAYAMA T, 1984, PFLUG ARCH EUR J PHY, V402, P248, DOI 10.1007/BF00585507; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Qu JH, 2003, CIRCULATION, V107, P1106, DOI 10.1161/01.CIR.0000059939.97249.2C; Ripplinger CM, 2012, CIRCULATION, V125, P856, DOI 10.1161/CIRCULATIONAHA.111.086827; Rosemann M, 2003, CARCINOGENESIS, V24, P371, DOI 10.1093/carcin/24.3.371; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SOLA C, 1990, J HISTOCHEM CYTOCHEM, V38, P1123, DOI 10.1177/38.8.2142177; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TRAUTWEIN W, 1963, Z ZELLFORSCH MIK ANA, V61, P96, DOI 10.1007/BF00341523; VANGINNEKEN ACG, 1991, J PHYSIOL-LONDON, V434, P57, DOI 10.1113/jphysiol.1991.sp018459; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	56	210	225	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					54	+		10.1038/nbt.2465	http://dx.doi.org/10.1038/nbt.2465			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23242162	Green Accepted			2022-12-27	WOS:000313563600022
J	Lakatta, EG; Maltsev, VA				Lakatta, Edward G.; Maltsev, Victor A.			Reprogramming paces the heart	NATURE BIOTECHNOLOGY			English	Editorial Material							PACEMAKER; CELLS		[Lakatta, Edward G.; Maltsev, Victor A.] NIA, Lab Cardiovasc Sci, Intramural Res Program, US Natl Inst Hlth, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lakatta, EG (corresponding author), NIA, Lab Cardiovasc Sci, Intramural Res Program, US Natl Inst Hlth, Baltimore, MD 21224 USA.	lakattae@grc.nia.nih.gov; maltsevvi@mail.nih.gov	Maltsev, Victor/AAY-9460-2020; Lakatta, Edward G/AAL-1447-2020	Maltsev, Victor/0000-0002-3832-791X; Lakatta, Edward/0000-0002-4772-0035	Intramural NIH HHS [ZIA AG000260-04] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bakker ML, 2012, CARDIOVASC RES, V94, P439, DOI 10.1093/cvr/cvs120; Boink GJJ, 2012, CIRCULATION, V126, P528, DOI 10.1161/CIRCULATIONAHA.111.083584; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; Ebert SN, 2008, ANN NY ACAD SCI, V1148, P317, DOI 10.1196/annals.1410.008; Edelberg JM, 1998, J CLIN INVEST, V101, P337, DOI 10.1172/JCI1330; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Miake J, 2002, NATURE, V419, P132, DOI 10.1038/419132b; Qu JH, 2003, CIRCULATION, V107, P1106, DOI 10.1161/01.CIR.0000059939.97249.2C; Rosen MR, 2011, NAT REV CARDIOL, V8, P656, DOI 10.1038/nrcardio.2011.120	10	6	6	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					31	32		10.1038/nbt.2480	http://dx.doi.org/10.1038/nbt.2480			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23302930	Green Accepted			2022-12-27	WOS:000313563600016
J	McNamee, LM; Ledley, FD				McNamee, Laura M.; Ledley, Fred D.			Patterns of technological innovation in biotech	NATURE BIOTECHNOLOGY			English	Letter							GENE-THERAPY; DRUG DISCOVERY; SCIENCE; TRENDS; RNA		[McNamee, Laura M.; Ledley, Fred D.] Bentley Univ, Ctr Integrat Sci & Ind, Waltham, MA USA	Bentley University	McNamee, LM (corresponding author), Bentley Univ, Ctr Integrat Sci & Ind, Waltham, MA USA.	fledley@bentley.edu			ACTA Foundation; National Biomedical Research Foundation	ACTA Foundation; National Biomedical Research Foundation	This work was supported, in part, by the ACTA Foundation and the National Biomedical Research Foundation. The authors thank J. Janice Reichert (Tufts Center for the Study of Drug Development) for her generous consultation and sharing data on mAb development, I. Morgan (Finance Department, Bentley University) for his invaluable insights into biotech finance and management, and our colleagues and students for their many comments and insights. This work was presented, in part, at the Advances in Biopharmaceuticals, Keystone Symposia, 2010.	Agarwal P, 2009, NAT REV DRUG DISCOV, V8, P865, DOI 10.1038/nrd2973; Carlson RH, 2010, BIOL IS TECHNOLOGY P; Chen XL, 2005, DRUG DISCOV TODAY, V10, P587, DOI 10.1016/S1359-6446(05)03426-4; Christensen Clayton, 2003, INNOVATORS SOLUTION; Christensen CM, 1997, INNOVATORS DILEMMA R; Corey DR, 2007, NAT CHEM BIOL, V3, P8, DOI 10.1038/nchembio0107-8; Deloitte. Deloitte/Recap, 2010, THER MON ANT INS STR; Foster R. N., 1986, INNOVATION ATTACKERS; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949; Garfield E, 1997, CELL DEATH DIFFER, V4, P352, DOI 10.1038/sj.cdd.4400261; Jong S, 2011, NAT BIOTECHNOL, V29, P685, DOI 10.1038/bioe.2011.6; Kurzweil R, 2006, SINGULARITY IS NEAR; Marshall A, 2009, NAT BIOTECHNOL, V27, P789, DOI 10.1038/nbt0909-789; Moore G. E., 1965, ELECTRONICS, V38, P1, DOI DOI 10.1109/JPROC.1998.658762; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Pisano G., 2006, SCI BUSINESS PROMISE; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Sahal D., 1981, PATTERNS TECHNOLOGIC; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Scott CT, 2005, NAT BIOTECHNOL, V23, P1037, DOI 10.1038/nbt0905-1037; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Young LS, 2006, J PATHOL, V208, P299, DOI 10.1002/path.1896	23	21	21	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					937	943		10.1038/nbt.2389	http://dx.doi.org/10.1038/nbt.2389			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	23051809				2022-12-27	WOS:000309965500016
J	Yang, W				Yang, Walter			Biotech weathers 2Q12 slump	NATURE BIOTECHNOLOGY			English	News Item																			0	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					738	738		10.1038/nbt.2332	http://dx.doi.org/10.1038/nbt.2332			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22871704	Bronze			2022-12-27	WOS:000307416900009
J	Loman, NJ; Misra, RV; Dallman, TJ; Constantinidou, C; Gharbia, SE; Wain, J; Pallen, MJ				Loman, Nicholas J.; Misra, Raju V.; Dallman, Timothy J.; Constantinidou, Chrystala; Gharbia, Saheer E.; Wain, John; Pallen, Mark J.			Performance comparison of benchtop high-throughput sequencing platforms	NATURE BIOTECHNOLOGY			English	Article							COLI; OUTBREAK; GENES; DNA	Three benchtop high-throughput sequencing instruments are now available. The 454 GS Junior (Roche), MiSeq (Illumina) and Ion Torrent PGM (Life Technologies) are laser-printer sized and offer modest set-up and running costs. Each instrument can generate data required for a draft bacterial genome sequence in days, making them attractive for identifying and characterizing pathogens in the clinical setting. We compared the performance of these instruments by sequencing an isolate of Escherichia coli O104:H4, which caused an outbreak of food poisoning in Germany in 2011. The MiSeq had the highest throughput per run (1.6 Gb/run, 60 Mb/h) and lowest error rates. The 454 GS Junior generated the longest reads (up to 600 bases) and most contiguous assemblies but had the lowest throughput (70 Mb/run, 9 Mb/h). Run in 100-bp mode, the Ion Torrent PGM had the highest throughput (80-100 Mb/h). Unlike the MiSeq, the Ion Torrent PGM and 454 GS Junior both produced homopolymer-associated indel errors (1.5 and 0.38 errors per 100 bases, respectively).	[Loman, Nicholas J.; Constantinidou, Chrystala; Pallen, Mark J.] Univ Birmingham, Ctr Syst Biol, Birmingham, W Midlands, England; [Misra, Raju V.; Dallman, Timothy J.; Gharbia, Saheer E.; Wain, John] Hlth Protect Agcy, London, England; [Wain, John] Univ E Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England	University of Birmingham; Health Protection Agency; University of East Anglia	Pallen, MJ (corresponding author), Univ Birmingham, Ctr Syst Biol, Birmingham, W Midlands, England.	j.wain@uea.ac.uk; m.pallen@bham.ac.uk	Loman, Nicholas/Z-1573-2019; Dallman, Timothy J/ABD-6662-2021; Wain, John/B-3446-2013	Wain, John/0000-0002-1257-1148; Loman, Nicholas/0000-0002-9843-8988; Pallen, Mark/0000-0003-1807-3657	BBSRC [BBE0111791]; BBSRC [BB/E011179/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E011179/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We gratefully acknowledge the blogging community for helpful discussion in the comments section of our blog (http://pathogenomics.bham.ac.uk/blog/), and in particular to B. Chevreux, J. Johnson, K. Robison and L. Nederbragt. We are grateful to C. Hercus at Novocraft for help with the Novoalign software and to A. Darling for help with Mauve Assembly Metrics. We thank Roche Diagnostics, UK, for 454 GS FLX + and 454 FLX paired-end sequencing, technical support and helpful discussion. We thank Life Technologies for early access to 316 chips and instrument fluidics upgrade. We thank G. Smith and Illumina UK for early access to the MiSeq platform and public release of E. coli outbreak-strain data. We thank the three anonymous reviewers for their many helpful suggestions for improving the manuscript. The xBASE facility and N.J.L. are funded by BBSRC grant BBE0111791.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Buffalo V., 2012, QRQC QUICK READ QUAL; Chattaway MA, 2011, J INFECT DEV COUNTR, V5, P425, DOI 10.3855/jidc.2166; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Darling AE, 2011, BIOINFORMATICS, V27, P2756, DOI 10.1093/bioinformatics/btr451; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Pallen M.J., 2007, BACT PATH; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344	25	917	975	3	403	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					434	+		10.1038/nbt.2198	http://dx.doi.org/10.1038/nbt.2198			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22522955				2022-12-27	WOS:000303803200023
J	Cherf, GM; Lieberman, KR; Rashid, H; Lam, CE; Karplus, K; Akeson, M				Cherf, Gerald M.; Lieberman, Kate R.; Rashid, Hytham; Lam, Christopher E.; Karplus, Kevin; Akeson, Mark			Automated forward and reverse ratcheting of DNA in a nanopore at 5-angstrom precision	NATURE BIOTECHNOLOGY			English	Article							POLYNUCLEOTIDE MOLECULES; POLYMERASE COMPLEXES; ELECTRONIC CONTROL; REPLICATION; BINDING; PROTEIN; DISCRIMINATION; PORE	An emerging DNA sequencing technique uses protein or solid-state pores to analyze individual strands as they are driven in single-file order past a nanoscale sensor(1-3). However, uncontrolled electrophoresis of DNA through these nanopores is too fast for accurate base reads(4). Here, we describe forward and reverse ratcheting of DNA templates through the a-hemolysin nanopore controlled by phi29 DNA polymerase without the need for active voltage control. DNA strands were ratcheted through the pore at median rates of 2.5-40 nucleotides per second and were examined at one nucleotide spatial precision in real time. Up to 500 molecules were processed at similar to 130 molecules per hour through one pore. The probability of a registry error (an insertion or deletion) at individual positions during one pass along the template strand ranged from 10% to 24.5% without optimization. This strategy facilitates multiple reads of individual strands and is transferable to other nanopore devices for implementation of DNA sequence analysis.	[Cherf, Gerald M.; Lieberman, Kate R.; Rashid, Hytham; Lam, Christopher E.; Karplus, Kevin; Akeson, Mark] Univ Calif Santa Cruz, Dept Biomol Engn, Nanopore Grp, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Akeson, M (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Nanopore Grp, Santa Cruz, CA 95064 USA.	makeson@soe.ucsc.edu	Akeson, Mark/HCH-3046-2022; Karplus, Kevin J/B-8099-2009		National Human Genome Research Institute [HG006321]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006321, RC2HG005553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087484] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Oxford Nanopore Technologies (Oxford, UK) for supplying alpha-HL heptamers, P. Walker and Y. Tran (Stanford University Protein and Nucleic Acid Facility) for expert oligonucleotide synthesis, Enzymatics Corp. for supplying concentrated phi29 DNAP, and A. Mai for DNA purification. H. Wang, R. Abu-Shumays and H. Olsen commented on drafts of the manuscript. This work was supported by National Human Genome Research Institute grant HG006321.	Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Benner S, 2007, NAT NANOTECHNOL, V2, P718, DOI 10.1038/nnano.2007.344; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Church G, 1998, US Patent, Patent No. [5,795,782, 5795782]; Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Gyarfas B, 2009, ACS NANO, V3, P1457, DOI 10.1021/nn900303g; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hurt N, 2009, J AM CHEM SOC, V131, P3772, DOI 10.1021/ja809663f; Ibarra B, 2009, EMBO J, V28, P2794, DOI 10.1038/emboj.2009.219; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Lu B, 2011, BIOPHYS J, V101, P70, DOI 10.1016/j.bpj.2011.05.034; Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079; Movileanu L, 2003, BIOPHYS J, V85, P897, DOI 10.1016/S0006-3495(03)74529-9; Olasagasti F, 2010, NAT NANOTECHNOL, V5, P798, DOI [10.1038/nnano.2010.177, 10.1038/NNANO.2010.177]; SOENGAS MS, 1995, J MOL BIOL, V253, P517, DOI 10.1006/jmbi.1995.0570; Stoddart D, 2010, NANO LETT, V10, P3633, DOI 10.1021/nl101955a; Tsutsui M, 2010, NAT NANOTECHNOL, V5, P286, DOI [10.1038/NNANO.2010.42, 10.1038/nnano.2010.42]; Wilson NA, 2009, ACS NANO, V3, P995, DOI 10.1021/nn9000897	21	436	476	9	232	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2012	30	4					344	348		10.1038/nbt.2147	http://dx.doi.org/10.1038/nbt.2147			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	925TR	22334048	Green Accepted, Green Submitted			2022-12-27	WOS:000302785000022
J	Wahlberg, E; Karlberg, T; Kouznetsova, E; Markova, N; Macchiarulo, A; Thorsell, AG; Pol, E; Frostell, A; Ekblad, T; Oncu, D; Kull, B; Robertson, GM; Pellicciari, R; Schuler, H; Weigelt, J				Wahlberg, Elisabet; Karlberg, Tobias; Kouznetsova, Ekaterina; Markova, Natalia; Macchiarulo, Antonio; Thorsell, Ann-Gerd; Pol, Ewa; Frostell, Asa; Ekblad, Torun; Oncu, Delal; Kull, Bjorn; Robertson, Graeme Michael; Pellicciari, Roberto; Schuler, Herwig; Weigelt, Johan			Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors	NATURE BIOTECHNOLOGY			English	Article							PROMOTE PROTEIN STABILITY; POLY(ADP-RIBOSE) POLYMERASE; THERAPEUTIC STRATEGY; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; DNA-REPAIR; POTENT; MUTATION; TUMORS	Inhibitors of poly-ADP-ribose polymerase (PARP) family proteins are currently in clinical trials as cancer therapeutics, yet the specificity of many of these compounds is unknown. Here we evaluated a series of 185 small-molecule inhibitors, including research reagents and compounds being tested clinically, for the ability to bind to the catalytic domains of 13 of the 17 human PARP family members including the tankyrases, TNKS1 and TNKS2. Many of the best-known inhibitors, including TIQ-A, 6(5H)-phenanthridinone, olaparib, ABT-888 and rucaparib, bound to several PARP family members, suggesting that these molecules lack specificity and have promiscuous inhibitory activity. We also determined X-ray crystal structures for five TNKS2 ligand complexes and four PARP14 ligand complexes. In addition to showing that the majority of PARP inhibitors bind multiple targets, these results provide insight into the design of new inhibitors.	[Wahlberg, Elisabet; Karlberg, Tobias; Kouznetsova, Ekaterina; Markova, Natalia; Thorsell, Ann-Gerd; Ekblad, Torun; Schuler, Herwig; Weigelt, Johan] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden; [Macchiarulo, Antonio; Robertson, Graeme Michael; Pellicciari, Roberto] Univ Perugia, Dipartimento Chim & Tecnol Farmaco, I-06100 Perugia, Italy; [Pol, Ewa; Frostell, Asa] GE Healthcare Biosci AB, Uppsala, Sweden; [Oncu, Delal; Kull, Bjorn] Actar AB, Stockholm, Sweden	Karolinska Institutet; University of Perugia; General Electric	Schuler, H (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden.	herwig.schuler@ki.se	Macchiarulo, Antonio/L-2846-2017; Schuler, Herwig/E-5751-2011	Macchiarulo, Antonio/0000-0001-9535-4183; Schuler, Herwig/0000-0003-4059-3501; Kull, Bjorn/0000-0001-8190-1625	Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada through Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research [RBc08-0014]; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The study was also supported by grant RBc08-0014 from the Swedish Foundation for Strategic Research.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Ashworth A, 2008, CANCER RES, V68, P10021, DOI 10.1158/0008-5472.CAN-08-2287; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Carden CP, 2010, CURR OPIN ONCOL, V22, P473, DOI 10.1097/CCO.0b013e32833b5126; Chiarugi A, 2003, J PHARMACOL EXP THER, V305, P943, DOI 10.1124/jpet.103.048934; Chou HYE, 2006, J BIOL CHEM, V281, P15201, DOI 10.1074/jbc.M506745200; Citarelli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-308; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Hans CP, 2009, J PHARMACOL EXP THER, V329, P150, DOI 10.1124/jpet.108.145938; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Iwashita A, 2005, FEBS LETT, V579, P1389, DOI 10.1016/j.febslet.2005.01.036; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Karlberg T, 2010, J MED CHEM, V53, P5352, DOI 10.1021/jm100249w; Karlberg T, 2010, BIOCHEMISTRY-US, V49, P1056, DOI 10.1021/bi902079y; Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Lehtio L, 2009, J MED CHEM, V52, P3108, DOI 10.1021/jm900052j; Lehtio L, 2008, J MOL BIOL, V379, P136, DOI 10.1016/j.jmb.2008.03.058; McCabe N, 2009, ONCOGENE, V28, P1465, DOI 10.1038/onc.2008.483; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; Papeo G, 2009, EXPERT OPIN THER PAT, V19, P1377, DOI 10.1517/13543770903215883; Pellicciari Roberto, 2003, Farmaco (Lausanne), V58, P851, DOI 10.1016/S0014-827X(03)00143-5; Plummer R, 2010, CLIN CANCER RES, V16, P4527, DOI 10.1158/1078-0432.CCR-10-0984; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Strosznajder RP, 2010, MOL NEUROBIOL, V41, P187, DOI 10.1007/s12035-010-8124-6; SUGIMURA T, 1967, BIOCHIM BIOPHYS ACTA, V138, P438, DOI 10.1016/0005-2787(67)90507-2; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Yelamos J, 2008, TRENDS MOL MED, V14, P169, DOI 10.1016/j.molmed.2008.02.003; Yu M, 2005, ONCOGENE, V24, P1982, DOI 10.1038/sj.onc.1208410	43	364	395	2	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					283	+		10.1038/nbt.2121	http://dx.doi.org/10.1038/nbt.2121			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22343925				2022-12-27	WOS:000301303800026
J	Aggarwal, S				Aggarwal, Saurabh			What's fueling the biotech engine-2010 to 2011	NATURE BIOTECHNOLOGY			English	Article							C VIRUS-INFECTION; MULTIPLE-SCLEROSIS; TELAPREVIR; COST	In the past year, biologics sector sales grew by single digits, driven by monoclonal antibodies and insulin products. New product launches are showing mixed results and are facing rising challenges from changes to reimbursement policies.	Novel Hlth Strategies LLC, Bethesda, MD USA		Aggarwal, S (corresponding author), Novel Hlth Strategies LLC, Bethesda, MD USA.	saurabhaggarwal@gmail.com			American Society of Clinical Oncology (ASCO); American College of Rheumatology (ACR); American Association of Liver Diseases (AASLD); American Heart Association (AHA); American Society of Hematology (ASH); Biotechnology Industry Association (BIO)	American Society of Clinical Oncology (ASCO); American College of Rheumatology (ACR); American Association of Liver Diseases (AASLD); American Heart Association (AHA)(American Heart Association); American Society of Hematology (ASH); Biotechnology Industry Association (BIO)	SA thanks American Society of Clinical Oncology (ASCO), American College of Rheumatology (ACR), American Association of Liver Diseases (AASLD), American Heart Association (AHA), American Society of Hematology (ASH) and Biotechnology Industry Association (BIO) for providing support for this article.	AGGARWAL S, 2011, BIOSIMILARS BIOBETTE; AGGARWAL S, 2009, ISPOR 12 ANN EUR C O; Aggarwal S, 2008, NAT BIOTECHNOL, V26, P1227, DOI 10.1038/nbt1108-1227; Aggarwal S, 2007, NAT BIOTECHNOL, V25, P1097, DOI 10.1038/nbt1007-1097; Aggarwal S, 2010, NAT BIOTECHNOL, V28, P1165, DOI 10.1038/nbt1110-1165; Aggarwal S, 2010, NAT REV DRUG DISCOV, V9, P427, DOI 10.1038/nrd3186; Aggarwal S, 2009, NAT BIOTECHNOL, V27, P987, DOI 10.1038/nbt1109-987; [Anonymous], 2011, USE MED US REV 2010; [Anonymous], 2008, NY TIMES        0323; [Anonymous], 2011, REGENERON ANNOUNCES; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Daly K. L, 2009, IMPROPER PAYMENTS PR; Gower EW, 2011, ADVERSE EVENT RATES; Harrison C, 2011, NAT REV DRUG DISCOV, V10, P250, DOI 10.1038/nrd3415; HAYES E, 2010, PINK SHEET, V71; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kozlowski S, 2011, NEW ENGL J MED, V365, P385, DOI 10.1056/NEJMp1107285; Krilov LR, 2009, PEDIATRICS, V124, P1682, DOI 10.1542/peds.2009-2681; LAFFLER M, 2011, PINK SHEET       JUN, P28; LE J, 2006, Patent No. 7070775; LONDON S, 2009, SKIN ALLERGY NEW AUG, V40; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; NAULT K, 2011, LUPUS MAGAZINE  0402; Noyes K, 2011, NEUROLOGY, V77, P355, DOI 10.1212/WNL.0b013e3182270402; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rovensky J, 2008, AUTOIMMUN REV, V7, P235, DOI 10.1016/j.autrev.2007.11.014; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Xie JP, 2011, J MANAGE CARE PHARM, V17, P621, DOI 10.18553/jmcp.2011.17.8.621; Zinman B, 2011, LANCET, V377, P924, DOI 10.1016/S0140-6736(10)62305-7; 2011, AM COLL RHEUM 2011 A; 2011, SEEKING ALPHA   0803; 2011, PRESCRIPTION DRUG BE; 2011, IMS I REPORTS US SPE; 2010, PR NEWSWIRE     1104	34	61	75	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1083	1089		10.1038/nbt.2060	http://dx.doi.org/10.1038/nbt.2060			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22158359				2022-12-27	WOS:000298038700014
J	Altamirano-Bustamante, MM; de Hoyos, A; Olive, L				Altamirano-Bustamante, Myriam M.; de Hoyos, Adalberto; Olive, Leon			Theory of knowledge and biotech patents: worlds apart?	NATURE BIOTECHNOLOGY			English	Editorial Material									[Altamirano-Bustamante, Myriam M.] Mexican Inst Social Secur, Century Med Ctr 21, Res Unit Metab Dis, Mexico City, DF, Mexico; [Altamirano-Bustamante, Myriam M.; de Hoyos, Adalberto] Mexican Inst Social Secur, Century Med Ctr 21, Cross Funct Grp Clin Eth, Mexico City, DF, Mexico; [de Hoyos, Adalberto; Olive, Leon] Univ Nacl Autonoma Mexico, Inst Philosoph Res, Mexico City 04510, DF, Mexico	Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Universidad Nacional Autonoma de Mexico	Altamirano-Bustamante, MM (corresponding author), Mexican Inst Social Secur, Century Med Ctr 21, Res Unit Metab Dis, Mexico City, DF, Mexico.	olive@unam.mx	Altamirano, Myriam/GPW-5376-2022	de Hoyos, Adalberto/0000-0001-7509-7714				Aghion P., 2010, ECON POLICY, V25, P7; Collins HM, 2001, SOC STUD SCI, V31, P71, DOI 10.1177/030631201031001004; Das OP, 2005, NAT BIOTECHNOL, V23, P781, DOI 10.1038/bioent861; Echeverria J, 2008, ARBOR, V184, P609; Elliott G, 2007, AAPS J, V9, pE317, DOI 10.1208/aapsj0903035; European Parliament and European Union Council, 1998, DIR 98 44 EC EUR PAR; Henderson R, 2005, AM ECON REV, V95, P461, DOI 10.1257/0002828053828644; Ibarra A., 2009, CIENCIA SUS SUJETOS, P135; Joly Y, 2010, NAT BIOTECHNOL, V28, P417, DOI 10.1038/nbt0510-417; La Montagne JR, 2001, LANCET, V358, P1723, DOI 10.1016/S0140-6736(01)06717-4; Mills AE, 2010, NAT BIOTECHNOL, V28, P325, DOI 10.1038/nbt0410-325; Polanyi M., 1962, PERSONAL KNOWLEDGE; Simmons WJ, 2010, NAT BIOTECHNOL, V28, P801, DOI 10.1038/nbt0810-801; Stefik M., BREAKTHROUGH STORIES, P69; World Intellectual Property Organization (WIPO), 2004, INT PROP HDB POL LAW	15	1	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					977	978		10.1038/nbt.2026	http://dx.doi.org/10.1038/nbt.2026			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22068530				2022-12-27	WOS:000296801300014
J	Kwong, AD; Kauffman, RS; Hurter, P; Mueller, P				Kwong, Ann D.; Kauffman, Robert S.; Hurter, Patricia; Mueller, Peter			Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus	NATURE BIOTECHNOLOGY			English	Article							SUSTAINED VIROLOGICAL RESPONSE; POTENTIAL THERAPEUTIC AGENTS; PEGINTERFERON ALPHA-2A; CRYSTAL-STRUCTURE; PEGYLATED INTERFERON/RIBAVIRIN; NS3-CENTER-DOT-4A PROTEASE; COMBINATION THERAPY; ANTIVIRAL EFFICACY; PLUS RIBAVIRIN; VIRAL-RNA	Infection with hepatitis C virus (HCV) is a major medical problem with over 170 million people infected worldwide. Substantial morbidity and mortality are associated with hepatic manifestations (cirrhosis and hepatocellular carcinoma), which develop with increasing frequency in people infected with HCV for more than 20 years. Less well known is the burden of HCV disease associated with extrahepatic manifestations (diabetes, B-cell proliferative disorders, depression, cognitive disorders, arthritis and Sjogren's syndrome). For patients infected with genotype 1 HCV, treatment with polyethylene glycol decorated interferon (peginterferon) a and ribavirin (PR) is associated with a low (40-50%) success rate, substantial treatment-limiting side effects and a long (48-week) duration of treatment. In the past 15 years, major scientific advances have enabled the development of new classes of HCV therapy, the direct-acting antiviral agents, also known as specifically targeted antiviral therapy for hepatitis C (STAT-C). In combination with PR, the HCV NS3-4A protease inhibitor telaprevir has recently been approved for treatment of genotype 1 chronic HCV in the United States, Canada, European Union and Japan. Compared with PR, telaprevir combination therapy offers significantly improved viral cure rates and the possibility of shortened treatment duration for diverse patient populations. Developers of innovative drugs have to blaze a new path with few validated sign posts to guide the way. Indeed, telaprevir's development was once put on hold because of its performance in a standard IC50 assay. Data from new hypotheses and novel experiments were required to justify further investment and reduce risk that the drug might fail in the clinic. In addition, the poor drug-like properties of telaprevir were a formidable hurdle, which the manufacturing and formulation teams had to overcome to make the drug. Finally, novel clinical trial designs were developed to improve efficacy and shorten treatment in parallel instead of sequentially. Lessons learned from the development of telaprevir suggest that makers of innovative medicines cannot rely solely on traditional drug discovery metrics, but must develop innovative, scientifically guided pathways for success.	[Kwong, Ann D.; Kauffman, Robert S.; Hurter, Patricia; Mueller, Peter] Vertex Pharmaceut, Cambridge, MA 02139 USA	Vertex Pharmaceuticals	Kwong, AD (corresponding author), Vertex Pharmaceut, Cambridge, MA 02139 USA.	Ann_Kwong@vrtx.com						Adiwijaya BS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000745; Adiwijaya BS, 2009, ANTIVIR THER, V14, P591; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; [Anonymous], 2011, US PACK INS; [Anonymous], 2010, PRESCR INF; [Anonymous], 2011, JAP PACK INS; [Anonymous], 2011, CAN PROD MON; [Anonymous], 2011, PRESCR INF; [Anonymous], 2011, PRESCR INF; [Anonymous], 2003, INT C HARM GUID; Antiviral Drugs Advisory Committee, 2011, 201917 NDA ANT DRUGS; Backus L, 2010, HEPATOLOGY, V52, p428A; Bacon BR, 2009, HEPATOLOGY, V49, P1838, DOI 10.1002/hep.22871; Bartels DJ, 2008, J INFECT DIS, V198, P800, DOI 10.1086/591141; BARTENSCHLAGER R, 1995, J VIROL, V69, P198, DOI 10.1128/JVI.69.1.198-205.1995; Bartenschlager R, 2002, NAT REV DRUG DISCOV, V1, P911, DOI 10.1038/nrd942; Bonkovsky HL, 1999, HEPATOLOGY, V29, P264, DOI 10.1002/hep.510290124; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bruno S, 2010, HEPATOLOGY, V51, P2069, DOI 10.1002/hep.23528; Centers for Disease Control and Prevention and Department of Health and Human Services, 2010, HEP C FAC SHEET; Chary A, 2010, REV RECENT CLIN TRIA, V5, P158, DOI 10.2174/157488710792007293; Chen KX, 2009, CURR OPIN INVEST DR, V10, P821; Chen SH, 2005, CURR MED CHEM, V12, P2317, DOI 10.2174/0929867054864769; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Colvin HM, 2010, HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, P1; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Delang L, 2010, VIRUSES-BASEL, V2, P826, DOI 10.3390/v2040826; Dusheiko GM, 2011, J HEPATOL, V54, pS167, DOI 10.1016/S0168-8278(11)60417-0; Egan WJ, 2000, J MED CHEM, V43, P3867, DOI 10.1021/jm000292e; Ferguson MC, 2011, PHARMACOTHERAPY, V31, P92, DOI 10.1592/phco.31.1.92; Forestier N, 2007, HEPATOLOGY, V46, P640, DOI 10.1002/hep.21774; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fried MW, 2002, HEPATOLOGY, V36, pS237, DOI 10.1053/jhep.2002.36810; Gelman MA, 2011, TRENDS MOL MED, V17, P34, DOI 10.1016/j.molmed.2010.10.005; Gentile I, 2009, CURR MED CHEM, V16, P1115, DOI 10.2174/092986709787581789; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Grillot AL, 2011, ANTIVIRAL DRUGS: FROM BASIC DISCOVERY THROUGH CLINICAL TRIALS, P209; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Hinrichsen H, 2004, GASTROENTEROLOGY, V127, P1347, DOI 10.1053/j.gastro.2004.08.002; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Hoofnagle JH, 2009, NEW ENGL J MED, V360, P1899, DOI 10.1056/NEJMe0901869; Imperiale TF, 2000, AM J GASTROENTEROL, V95, P2328, DOI 10.1111/j.1572-0241.2000.02322.x; IncivoTM, 2011, EU SUMM PROD CHAR; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jensen DM, 2009, ANN INTERN MED, V150, P528, DOI 10.7326/0003-4819-150-8-200904210-00007; Kalkeri G, 2004, HEPATOLOGY, V40, p281A; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kieffer TL, 2010, HEPATOLOGY, V52, p879A; Kieffer TL, 2010, J ANTIMICROB CHEMOTH, V65, P202, DOI 10.1093/jac/dkp388; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kwong AD, 1999, ANTIVIR RES, V41, P65; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Landro JA, 1997, BIOCHEMISTRY-US, V36, P9340, DOI 10.1021/bi963054n; Lawitz E, 2008, J HEPATOL, V49, P163, DOI 10.1016/j.jhep.2008.03.027; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Lin C, 2005, J BIOL CHEM, V280, P36784, DOI 10.1074/jbc.M506462200; Lin C., 2006, Infectious Disorders - Drug Targets, V6, P3, DOI 10.2174/187152606776056706; Lin K, 2006, ANTIMICROB AGENTS CH, V50, P1813, DOI 10.1128/AAC.50.5.1813-1822.2006; Lin K, 2004, ANTIMICROB AGENTS CH, V48, P4784, DOI 10.1128/AAC.48.12.4784-4792.2004; Lin K, 2003, HEPATOLOGY, V38, p222A; Lindenbach B.D., 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Llinas-Brunet M, 1998, BIOORG MED CHEM LETT, V8, P1713, DOI 10.1016/S0960-894X(98)00299-6; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1; Main J, 1998, ANTIVIR CHEM CHEMOTH, V9, P449, DOI 10.1177/095632029800900601; Mani N, 2011, METH PRIN MED CHEM, V50, P307; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcellin P, 2011, HEPATOLOGY, V54, p1348A; Marcellin P, 2011, GASTROENTEROLOGY, V140, P459, DOI 10.1053/j.gastro.2010.10.046; McHutchison JG, 2010, NEW ENGL J MED, V362, P1647; McHutchison JG, 2009, NEW ENGL J MED, V361, P1516; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Mitchell AE, 2010, HEPATOLOGY, V51, P729, DOI 10.1002/hep.23561; Modi AA, 2008, ORAL DIS, V14, P10, DOI 10.1111/j.1601-0825.2007.01419.x; Morgan TR, 2009, HEPATOLOGY, V50, p357A; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Muir AJ, 2011, HEPATOLOGY, V54, P1538, DOI 10.1002/hep.24549; Nelson DR, 2011, LIVER INT, V31, P53, DOI 10.1111/j.1478-3231.2010.02391.x; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Pasquo A, 1998, FOLD DES, V3, P433, DOI 10.1016/S1359-0278(98)00060-1; Pawlotsky JM, 2006, HEPATOLOGY, V43, pS207, DOI 10.1002/hep.21064; Pawlotsky JM, 2005, J HEPATOL, V42, P951, DOI 10.1016/j.jhep.2005.03.008; Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006; Perni RB, 2004, BIOORG MED CHEM LETT, V14, P1939, DOI 10.1016/j.bmcl.2004.01.078; Perni RB, 2004, BIOORG MED CHEM LETT, V14, P1441, DOI 10.1016/j.bmcl.2004.01.022; Perni RB, 2003, BIOORG MED CHEM LETT, V13, P4059, DOI 10.1016/j.bmcl.2003.08.050; Perni RB, 2007, BIOORG MED CHEM LETT, V17, P3406, DOI 10.1016/j.bmcl.2007.03.090; Perni Robert B, 2002, Prog Med Chem, V39, P215, DOI 10.1016/S0079-6468(08)70072-9; Planas R, 2004, J HEPATOL, V40, P823, DOI 10.1016/j.jhep.2004.01.005; Poynard T, 2009, GASTROENTEROLOGY, V136, P1618, DOI 10.1053/j.gastro.2009.01.039; Pyenson B., 2009, CONSEQUENCES HEPATIT; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Reiser M, 2009, EXPERT REV ANTI-INFE, V7, P537, DOI 10.1586/ERI.09.30; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Shatin D, 2004, AM J MANAG CARE, V10, P250; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Siliciano JD, 2004, J ANTIMICROB CHEMOTH, V54, P6, DOI 10.1093/jac/dkh292; Steinkuhler C, 1998, BIOCHEMISTRY-US, V37, P8899, DOI 10.1021/bi980313v; Swan T, 2011, HEPATITIS C TREATMEN; Taremi SS, 1998, PROTEIN SCI, V7, P2143, DOI 10.1002/pro.5560071011; Tsantrizos YS, 2003, ANGEW CHEM INT EDIT, V42, P1355, DOI 10.1002/anie.200390347; Vanwolleghem T, 2007, GASTROENTEROLOGY, V133, P1144, DOI 10.1053/j.gastro.2007.07.007; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; Wedemeyer H, 1998, J HEPATOL, V29, P1010, DOI 10.1016/S0168-8278(98)80133-5; Weisberg IS, 2009, CLIN LIVER DIS, V13, P441, DOI 10.1016/j.cld.2009.05.009; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Yip Y, 2004, BIOORG MED CHEM LETT, V14, P251, DOI 10.1016/j.bmcl.2003.09.074; Yoshida T, 2011, CURR MED CHEM, V18, P1239, DOI 10.2174/092986711795029672; Yu L, 2001, ADV DRUG DELIVER REV, V48, P27, DOI 10.1016/S0169-409X(01)00098-9; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zeuzem S, 2010, HEPATOLOGY, V52, p436A; Zhou Y, 2008, ANTIMICROB AGENTS CH, V52, P110, DOI 10.1128/AAC.00863-07; Zhou Y, 2007, J BIOL CHEM, V282, P22619, DOI 10.1074/jbc.M610207200	121	206	211	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					993	1003		10.1038/nbt.2020	http://dx.doi.org/10.1038/nbt.2020			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22068541				2022-12-27	WOS:000296801300020
J	Peng, W				Peng, Wayne			The R&D partnership universe	NATURE BIOTECHNOLOGY			English	News Item									Nat Publishing Grp, London, England		Peng, W (corresponding author), Nat Publishing Grp, London, England.								0	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					961	961		10.1038/nbt.2035	http://dx.doi.org/10.1038/nbt.2035			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22068524				2022-12-27	WOS:000296801300007
J	Brakemann, T; Stiel, AC; Weber, G; Andresen, M; Testa, I; Grotjohann, T; Leutenegger, M; Plessmann, U; Urlaub, H; Eggeling, C; Wahl, MC; Hell, SW; Jakobs, S				Brakemann, Tanja; Stiel, Andre C.; Weber, Gert; Andresen, Martin; Testa, Ilaria; Grotjohann, Tim; Leutenegger, Marcel; Plessmann, Uwe; Urlaub, Henning; Eggeling, Christian; Wahl, Markus C.; Hell, Stefan W.; Jakobs, Stefan			A reversibly photoswitchable GFP-like protein with fluorescence excitation decoupled from switching	NATURE BIOTECHNOLOGY			English	Article							CRYSTAL-STRUCTURE; MICROSCOPY; MECHANISM; CYCLIZATION; NANOSCALE; LIGHT; TOOL	Photoswitchable fluorescent proteins have enabled new approaches for imaging cells, but their utility has been limited either because they cannot be switched repeatedly or because the wavelengths for switching and fluorescence imaging are strictly coupled. We report a bright, monomeric, reversibly photoswitchable variant of GFP, Dreiklang, whose fluorescence excitation spectrum is decoupled from that for optical switching. Reversible on-and-off switching in living cells is accomplished at illumination wavelengths of similar to 365 nm and similar to 405 nm, respectively, whereas fluorescence is elicited at similar to 515 nm. Mass spectrometry and high-resolution crystallographic analysis of the same protein crystal in the photoswitched on- and off-states demonstrate that switching is based on a reversible hydration/dehydration reaction that modifies the chromophore. The switching properties of Dreiklang enable far-field fluorescence nanoscopy in living mammalian cells using both a coordinate-targeted and a stochastic single molecule switching approach.	[Brakemann, Tanja; Stiel, Andre C.; Andresen, Martin; Testa, Ilaria; Grotjohann, Tim; Leutenegger, Marcel; Eggeling, Christian; Hell, Stefan W.; Jakobs, Stefan] Max Planck Inst Biophys Chem, Dept NanoBiophoton, Gottingen, Germany; [Weber, Gert; Wahl, Markus C.] Free Univ Berlin, Inst Chem & Biochem, AG Strukturbiochem, D-1000 Berlin, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, Gottingen, Germany; [Jakobs, Stefan] Univ Gottingen, Sch Med, Gottingen, Germany	Max Planck Society; Free University of Berlin; University of Gottingen; University of Gottingen	Hell, SW (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, Gottingen, Germany.	shell@gwdg.de; sjakobs@gwdg.de	Weber, Gert/I-1800-2013; Wahl, Markus C./D-6365-2017; Jakobs, Stefan/F-4898-2012; Stiel, Andre/B-1644-2014	Weber, Gert/0000-0003-3624-1060; Wahl, Markus C./0000-0002-2811-5307; Jakobs, Stefan/0000-0002-8028-3121; Stiel, Andre/0000-0001-8675-6797; Testa, Ilaria/0000-0003-4005-4997	Deutsche Forschungsgemeinschaft; DFG-Research Center for Molecular Physiology of the Brain	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG-Research Center for Molecular Physiology of the Brain(German Research Foundation (DFG))	We acknowledge access to beamline BL14.2 of the BESSY II storage ring (Berlin) through the Joint Berlin MX-Laboratory sponsored by the Helmholtz Zentrum Berlin fur Materialien und Energie, the Freie Universitat Berlin, the Humboldt-Universitat zu Berlin, the Max-Delbruck Centrum and the Leibniz-Institut fur Molekulare Pharmakologie. We thank V. Belov for insightful discussions and F. Lavoie-Cardinal for help with the set-up for targeted switching. We acknowledge A. Schonle for providing the software ImSpector. We also thank T. Gilat, S. Lobermann, R. Pick and E. Rothermel for excellent technical assistance, H.-H. Hsiao for help in ESI-MS and H. Schill and J. Jethwa for carefully reading the manuscript. We acknowledge R.Y. Tsien for sharing the plasmid pRSET-Citrine. This work was supported by the Deutsche Forschungsgemeinschaft through the Gottfried Wilhelm Leibniz Prize (to S.W.H.) and through the DFG-Research Center for Molecular Physiology of the Brain (to S.J.).	Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Barondeau DP, 2005, BIOCHEMISTRY-US, V44, P1960, DOI 10.1021/bi0479205; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bossi M, 2008, NANO LETT, V8, P2463, DOI 10.1021/nl801471d; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Chudakov DM, 2006, TRAFFIC, V7, P1304, DOI 10.1111/j.1600-0854.2006.00468.x; Cinelli RAG, 2001, APPL PHYS LETT, V79, P3353, DOI 10.1063/1.1419047; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Hell SW, 2003, APPL PHYS A-MATER, V77, P859, DOI 10.1007/s00339-003-2292-4; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Irie M, 2002, NATURE, V420, P759, DOI 10.1038/420759a; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Phair RD, 2001, NAT REV MOL CELL BIO, V2, P898, DOI 10.1038/35103000; Richter FM, 2010, MOL CELL PROTEOMICS, V9, P1729, DOI 10.1074/mcp.M110.001446; Rosenow MA, 2004, BIOCHEMISTRY-US, V43, P4464, DOI 10.1021/bi0361315; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sauer M, 2005, P NATL ACAD SCI USA, V102, P9433, DOI 10.1073/pnas.0504264102; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Siegbahn PEM, 2001, INT J QUANTUM CHEM, V81, P169, DOI 10.1002/1097-461X(2001)81:2<169::AID-QUA9>3.0.CO;2-N; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Stiel AC, 2008, BIOPHYS J, V95, P2989, DOI 10.1529/biophysj.108.130146; Stiel AC, 2007, BIOCHEM J, V402, P35, DOI 10.1042/BJ20061401; Subach FV, 2010, CHEM BIOL, V17, P745, DOI 10.1016/j.chembiol.2010.05.022; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Testa I, 2008, OPT EXPRESS, V16, P21093, DOI 10.1364/OE.16.021093; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509	48	203	213	2	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0733-222X	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					942	U132		10.1038/nbt.1952	http://dx.doi.org/10.1038/nbt.1952			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21909082	Green Published, Green Submitted			2022-12-27	WOS:000296273000022
J	Francisco, M				Francisco, Michael			Second-quarter biotech job picture	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2011	29	9												2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	817ZT	21904332	Bronze			2022-12-27	WOS:000294718400027
J	Wang, BL; Ghaderi, A; Zhou, H; Agresti, J; Weitz, DA; Fink, GR; Stephanopoulos, G				Wang, Benjamin L.; Ghaderi, Adel; Zhou, Hang; Agresti, Jeremy; Weitz, David A.; Fink, Gerald R.; Stephanopoulos, Gregory			Microfluidic high-throughput culturing of single cells for selection based on extracellular metabolite production or consumption	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; DIRECTED EVOLUTION; FERMENTATION; COMPARTMENTS; PATHWAY; OXIDASE; DROPS	Phenotyping single cells based on the products they secrete or consume is a key bottleneck in many biotechnology applications, such as combinatorial metabolic engineering for the overproduction of secreted metabolites. Here we present a flexible high-throughput approach that uses microfluidics to compartmentalize individual cells for growth and analysis in monodisperse nanoliter aqueous droplets surrounded by an immiscible fluorinated oil phase. We use this system to identify xylose-overconsuming Saccharomyces cerevisiae cells from a population containing one such cell per 10(4) cells and to screen a genomic library to identify multiple copies of the xylose isomerase gene as a genomic change contributing to high xylose consumption, a trait important for lignocellulosic feedstock utilization. We also enriched l-lactate-producing Escherichia coli clones 5,800x from a population containing one l-lactate producer per 104 d-lactate producers. Our approach has broad applications for single-cell analyses, such as in strain selection for the overproduction of fuels, chemicals and pharmaceuticals.	[Wang, Benjamin L.; Ghaderi, Adel; Zhou, Hang; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Agresti, Jeremy; Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Agresti, Jeremy; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Fink, Gerald R.] Whitehead Inst Biomed Res, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	gregstep@mit.edu			Department of Energy [DE-FC36-07G017058]; NATIONAL CANCER INSTITUTE [R01CA160458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035010] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support by Department of Energy Grant DE-FC36-07G017058, Royal Dutch Shell, and the Singapore-MIT Alliance. The authors would like to thank A. Abate for writing the LabView detection/sorting code, K. Humphry for her initial help on the project, Raindance Technologies for providing fluorinated surfactants and oils. We also thank the Ingram laboratory for providing strains TG108 and TG113.	Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Aharoni A, 2005, CHEM BIOL, V12, P1281, DOI 10.1016/j.chembiol.2005.09.012; Ahn K, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164911; Ahn K, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2218058; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bailey JE, 1996, BIOTECHNOL BIOENG, V52, P109, DOI 10.1002/(SICI)1097-0290(19961005)52:1<109::AID-BIT11>3.3.CO;2-1; Baret JC, 2010, CHEM BIOL, V17, P528, DOI 10.1016/j.chembiol.2010.04.010; Chundawat SPS, 2007, BIOTECHNOL BIOENG, V96, P219, DOI 10.1002/bit.21132; Grabar TB, 2006, BIOTECHNOL LETT, V28, P1527, DOI 10.1007/s10529-006-9122-7; Hahn-Hagerdal B, 2007, ADV BIOCHEM ENG BIOT, V108, P147, DOI 10.1007/10_2007_062; Huebner A, 2007, CHEM COMMUN, P1218, DOI 10.1039/b618570c; Jeffries TW, 2006, CURR OPIN BIOTECH, V17, P320, DOI 10.1016/j.copbio.2006.05.008; Kuyper M, 2005, FEMS YEAST RES, V5, P925, DOI 10.1016/j.femsyr.2005.04.004; Link DR, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.054503; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Miller OJ, 2006, NAT METHODS, V3, P561, DOI 10.1038/NMETH897; Ohnishi J, 2002, APPL MICROBIOL BIOT, V58, P217, DOI 10.1007/s00253-001-0883-6; Siegel AC, 2007, ADV MATER, V19, P727, DOI 10.1002/adma.200601787; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Sonderegger M, 2005, METAB ENG, V7, P4, DOI 10.1016/j.ymben.2004.05.005; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; Wagschal K, 2005, APPL ENVIRON MICROB, V71, P5318, DOI 10.1128/AEM.71.9.5318-5323.2005; WEAVER JC, 1988, BIO-TECHNOL, V6, P1084, DOI 10.1038/nbt0988-1084; Wei N, 2013, APPL ENVIRON MICROB, V79, P3193, DOI 10.1128/AEM.00490-13; Yamashita M, 2000, J BIOSCI BIOENG, V89, P350, DOI 10.1016/S1389-1723(00)88958-6; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhou H, 2012, METAB ENG, V14, P611, DOI 10.1016/j.ymben.2012.07.011; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391; Zhu AP, 2010, ANAL BIOCHEM, V403, P123, DOI 10.1016/j.ab.2010.04.008	35	227	240	9	378	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2014	32	5					473	U194		10.1038/nbt.2857	http://dx.doi.org/10.1038/nbt.2857			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AH3PH	24705516	Green Published, Green Accepted			2022-12-27	WOS:000336036100023
J	Stelzl, U				Stelzl, Ulrich			E-coli network upgrade	NATURE BIOTECHNOLOGY			English	Editorial Material							PROTEIN-PROTEIN INTERACTION; ESCHERICHIA-COLI; INTERACTION MAP; INTERACTOME; COMPLEXES		Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Max Planck Society	Stelzl, U (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	stelzl@molgen.mpg.de	Stelzl, Ulrich/J-9506-2015	Stelzl, Ulrich/0000-0003-2500-3585				Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Hauser R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002815; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Mosca R, 2013, NAT METHODS, V10, P47, DOI [10.1038/NMETH.2289, 10.1038/nmeth.2289]; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rajagopala SV, 2014, NAT BIOTECHNOL, V32, P285, DOI 10.1038/nbt.2831; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]	12	3	3	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					241	243		10.1038/nbt.2848	http://dx.doi.org/10.1038/nbt.2848			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24727776	Green Published			2022-12-27	WOS:000332819800020
J	Baeyens, L; Lemper, M; Leuckx, G; De Groef, S; Bonfanti, P; Stange, G; Shemer, R; Nord, C; Scheel, DW; Pan, FC; Ahlgren, U; Gu, GQ; Stoffers, DA; Dor, Y; Ferrer, J; Gradwohl, G; Wright, CVE; Van de Casteele, M; German, MS; Bouwens, L; Heimberg, H				Baeyens, Luc; Lemper, Marie; Leuckx, Gunter; De Groef, Sofie; Bonfanti, Paola; Stange, Geert; Shemer, Ruth; Nord, Christoffer; Scheel, David W.; Pan, Fong C.; Ahlgren, Ulf; Gu, Guoqiang; Stoffers, Doris A.; Dor, Yuval; Ferrer, Jorge; Gradwohl, Gerard; Wright, Christopher V. E.; Van de Casteele, Mark; German, Michael S.; Bouwens, Luc; Heimberg, Harry			Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice	NATURE BIOTECHNOLOGY			English	Article							DIGIT REGENERATION; ISLET CELLS; EXPRESSION; EXOCRINE; TRANSDIFFERENTIATION; DIFFERENTIATION; NOTCH; CNTF; PROGENITORS; NEUROGENIN3	Reprogramming of pancreatic exocrine cells into cells resembling beta cells may provide a strategy for treating diabetes. Here we show that transient administration of epidermal growth factor and ciliary neurotrophic factor to adult mice with chronic hyperglycemia efficiently stimulates the conversion of terminally differentiated acinar cells to beta-like cells. Newly generated beta-like cells are epigenetically reprogrammed, functional and glucose responsive, and they reinstate normal glycemic control for up to 248 d. The regenerative process depends on Stat3 signaling and requires a threshold number of Neurogenin 3 (Ngn3)-expressing acinar cells. In contrast to previous work demonstrating in vivo conversion of acinar cells to beta-like cells by viral delivery of exogenous transcription factors, our approach achieves acinar-to-beta-cell reprogramming through transient cytokine exposure rather than genetic modification.	[Baeyens, Luc; Lemper, Marie; Leuckx, Gunter; De Groef, Sofie; Bonfanti, Paola; Stange, Geert; Van de Casteele, Mark; Bouwens, Luc; Heimberg, Harry] Vrije Univ Brussel, Diabet Res Ctr, Brussels, Belgium; [Baeyens, Luc; Scheel, David W.; German, Michael S.] Univ Calif San Francisco, Calif Inst Regenerat Med, Ctr Diabet, San Francisco, CA 94143 USA; [Shemer, Ruth; Dor, Yuval] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Jerusalem, Israel; [Nord, Christoffer; Ahlgren, Ulf] Umea Univ, Umea Ctr Mol Med, Umea, Sweden; [Pan, Fong C.; Gu, Guoqiang; Wright, Christopher V. E.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Program Dev Biol, Nashville, TN USA; [Stoffers, Doris A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Ferrer, Jorge] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Ferrer, Jorge] Univ London Imperial Coll Sci Technol & Med, London, England; [Gradwohl, Gerard] Inst Genet & Mol & Cellular Biol, Dev & Stem Cells Program, Illkirch Graffenstaden, France	Vrije Universiteit Brussel; University of California System; University of California San Francisco; Hebrew University of Jerusalem; Umea University; Vanderbilt University; University of Pennsylvania; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm)	Heimberg, H (corresponding author), Vrije Univ Brussel, Diabet Res Ctr, Brussels, Belgium.	lucbo@expa.vub.ac.be; Harry.Heimberg@vub.ac.be	Ferrer, Jorge/A-3176-2012; Gradwohl, Gérard/AFM-9024-2022; Gradwohl, Gérard/H-8543-2014; stange, geert m/C-1092-2009	Ferrer, Jorge/0000-0002-5959-5729; Gradwohl, Gérard/0000-0002-6730-2615; Gradwohl, Gérard/0000-0002-6730-2615; stange, geert m/0000-0003-3148-1372; Bouwens, Luc/0000-0001-5767-7002; Heimberg, Harry/0000-0003-1954-7375; Van De Casteele, mark/0000-0002-8594-9260; Baeyens, Luc/0000-0003-1795-3804; Ahlgren, Ulf/0000-0001-5923-8572	Research Foundation - Flanders (FWO); Juvenile Diabetes Research Foundation; DON Foundation; European Foundation for the Study of Diabetes (EFSD); European Union [LSHB-CT-2005-512145, HEALTH-F5-2009-241883]; Diabetesfonds Nederland; NIH [U19 DK 042502, U01 DK 089570, P30 DK063720, U01 DK089541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, U01DK089541, R01DK021344, P01DK042502, U01DK089570, R01DK065949, U19DK042502] Funding Source: NIH RePORTER; European Foundation for the Study of Diabetes [NN 2014_1] Funding Source: researchfish	Research Foundation - Flanders (FWO)(FWO); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); DON Foundation; European Foundation for the Study of Diabetes (EFSD); European Union(European Commission); Diabetesfonds Nederland; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Foundation for the Study of Diabetes	Special thanks to V. Laurysens, A. Demarre, E. Quartier, J. De Jonge for technical advice and assistance, D. Pipeleers for logistic support and G. Bin for the Stat3<SUP>lox/lox</SUP> mouse strain. We thank J. Kornak for support on biostatistics. L.Ba. is a postdoctoral fellow of the Research Foundation - Flanders (FWO). Financial support was obtained from the Research Foundation - Flanders (FWO) (H. H., L.Ba. and L.Bo.), the Juvenile Diabetes Research Foundation (H. H. and L.Bo.), DON Foundation (www.sdon.nl) (H. H.), the European Foundation for the Study of Diabetes (EFSD) (L.Ba., P. B. and L.Bo.), the European Union Sixth (#LSHB-CT-2005-512145), Seventh (HEALTH-F5-2009-241883) Framework Program (H. H. and L.Bo.), Diabetesfonds Nederland (H. H.), NIH U19 DK 042502 and U01 DK 089570 (C. V. E. W. and F. C. P.), P30 DK063720 and U01 DK089541 (M.S.G.).	Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Baddour JA, 2012, BIRTH DEFECTS RES C, V96, P1, DOI 10.1002/bdrc.21006; Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Baeyens L, 2009, GASTROENTEROLOGY, V136, P1750, DOI 10.1053/j.gastro.2009.01.047; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gloaguen I, 1997, P NATL ACAD SCI USA, V94, P6456, DOI 10.1073/pnas.94.12.6456; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Han MJ, 2003, DEVELOPMENT, V130, P5123, DOI 10.1242/dev.00710; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Kopinke D, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-38; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Lardon J, 2004, HEPATOLOGY, V39, P1499, DOI 10.1002/hep.20213; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Mellitzer G, 2004, MOL ENDOCRINOL, V18, P2765, DOI 10.1210/me.2004-0243; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Miettinen P, 2008, BIOCHEM SOC T, V36, P280, DOI 10.1042/BST0360280; Miettinen PJ, 2000, DEVELOPMENT, V127, P2617; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Rezende LF, 2012, DIABETOLOGIA, V55, P1495, DOI 10.1007/s00125-012-2493-5; Rezende LF, 2009, CYTOKINE, V46, P65, DOI 10.1016/j.cyto.2008.12.014; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rooman I, 2000, DIABETOLOGIA, V43, P907, DOI 10.1007/s001250051468; Rooman I, 2004, DIABETOLOGIA, V47, P259, DOI 10.1007/s00125-003-1287-1; Rooman I, 2006, AM J PATHOL, V169, P1206, DOI 10.2353/ajpath.2006.050926; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Sleeman MW, 2003, P NATL ACAD SCI USA, V100, P14297, DOI 10.1073/pnas.2335926100; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Wadt KAW, 1998, DIABETES, V47, P1602, DOI 10.2337/diabetes.47.10.1602; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; WRIGHT CVE, 1989, DEVELOPMENT, V105, P787; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	50	140	144	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					76	+		10.1038/nbt.2747	http://dx.doi.org/10.1038/nbt.2747			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24240391	Green Accepted			2022-12-27	WOS:000329513000021
J	Belda, I; Penas, G; Alonso, A; Marquina, D; Navascues, E; Santos, A				Belda, Ignacio; Penas, Gerardo; Alonso, Alejandro; Marquina, Domingo; Navascues, Eva; Santos, Antonio			Biotech patents and science policy: the Spanish experience	NATURE BIOTECHNOLOGY			English	Editorial Material							TECHNOLOGY-TRANSFER; INNOVATION SYSTEMS; POLITICAL-ECONOMY; PERFORMANCE; IMPACT; SPAIN	In an environment of crisis and cuts, innovative patent management strategies may offer a way for countries to improve return on R&D investment.	[Belda, Ignacio; Alonso, Alejandro; Marquina, Domingo; Navascues, Eva; Santos, Antonio] Univ Complutense Madrid, Fac Biol, Dept Microbiol, Madrid, Spain; [Penas, Gerardo] Spanish Patent & Trademark Off, Dept Util Models Designs & Semicond, Madrid, Spain	Complutense University of Madrid	Belda, I (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Microbiol, Madrid, Spain.	ansantos@ucm.es	DE LA SEN, ANTONIO SANTOS/L-3118-2014; Navascués, Eva/N-4201-2017; Belda, Ignacio/C-1477-2015; MARQUINA, DOMINGO/M-2920-2014	DE LA SEN, ANTONIO SANTOS/0000-0002-1253-585X; Navascués, Eva/0000-0002-3185-2113; Belda, Ignacio/0000-0002-2607-5049; MARQUINA, DOMINGO/0000-0002-2528-0040; ALONSO CONDE, RAFAEL ALEJANDRO/0000-0002-4613-1503				Aghion P, 2009, RES POLICY, V38, P681, DOI 10.1016/j.respol.2009.01.016; [Anonymous], 2002, INT INT PROP RIGHTS; Breznitz D, 2009, REV POLICY RES, V26, P1, DOI 10.1111/j.1541-1338.2008.00388.x; Caldera A, 2010, RES POLICY, V39, P1160, DOI 10.1016/j.respol.2010.05.016; Coccia M, 2002, TECHNOVATION, V22, P291, DOI 10.1016/S0166-4972(01)00018-9; Coccia M, 2011, PROMETHEUS, V29, P121, DOI 10.1080/08109028.2011.601079; Coccia M, 2012, TECHNOVATION, V32, P370, DOI 10.1016/j.technovation.2012.03.005; Jimenez-Contreras E, 2003, RES POLICY, V32, P123, DOI 10.1016/S0048-7333(02)00008-2; Laursen L., 2013, NAT BIOTECHNOL, V31, P272; Moro-Martin A, 2012, NATURE, V482, P277, DOI 10.1038/482277a; MOSER P, 2003, DO PATENT LAWS INFLU; Mowery DC, 2002, MANAGE SCI, V48, P73, DOI 10.1287/mnsc.48.1.73.14278; Samara E, 2012, TECHNOVATION, V32, P624, DOI 10.1016/j.technovation.2012.06.002; Sohn SY, 2013, TECHNOVATION, V33, P13, DOI 10.1016/j.technovation.2012.10.003; Sterzi V, 2013, RES POLICY, V42, P564, DOI 10.1016/j.respol.2012.07.010; Vela C, 2012, NATURE, V486, P7, DOI 10.1038/486007a; Verspagen B, 2006, J ECON SURV, V20, P607, DOI 10.1111/j.1467-6419.2006.00261.x; Yu W, 2011, CHINA DAILY	18	5	5	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					59	62		10.1038/nbt.2781	http://dx.doi.org/10.1038/nbt.2781			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	287BM	24406929				2022-12-27	WOS:000329513000015
J	Jefferson, OA; Kollhofer, D; Ehrich, TH; Jefferson, RA				Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.			Transparency tools in gene patenting for informing policy and practice OPEN	NATURE BIOTECHNOLOGY			English	Editorial Material							INTELLECTUAL PROPERTY; GENOME ANNOTATION; US; ALIGNMENT; SECTOR	The Supreme Court's decision in Myriad highlights the need for tools enabling nuanced and precise analysis of gene patents at the global level.	[Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.] Cambia, Canberra, ACT, Australia; [Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.] Queensland Univ Technol, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT)	Jefferson, OA (corresponding author), Cambia, Canberra, ACT, Australia.	osmat@cambia.org; raj@cambia.org		Jefferson, Osmat Azzam/0000-0002-0607-8728; Ehrich, Thomas/0000-0003-3475-4321; Koellhofer, Deniz/0000-0003-0313-4672; Jefferson, Richard/0000-0001-5352-4498				Adelman DE, 2007, TEX LAW REV, V85, P1677; Aggarwal S, 2006, NAT BIOTECHNOL, V24, P643, DOI 10.1038/nbt0606-643; Andree PJ, 2008, WORLD PAT INF, V30, P300, DOI 10.1016/j.wpi.2008.04.005; Bacon N., 2006, CAMBIA PATENT LENS 0; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1091, DOI 10.1038/nbt0906-1091; Cook-Deegan R., 2008, FROM BIRTH TO DEATH, P69; Cook-Deegan R, 2010, ANNU REV GENOM HUM G, V11, P383, DOI 10.1146/annurev-genom-082509-141811; Coombe R.J., 2005, LAW POLICY, V27, P152, DOI 10.1111/j.1467-9930.2004.00195.x; Dobson AW, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-6-161, 10.1186/gb4027]; Gold ER, 2010, GENET MED, V12, pS39, DOI 10.1097/GIM.0b013e3181d72661; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hemphill TA, 2012, SCI PUBL POLICY, V39, P815, DOI 10.1093/scipol/scs051; Holman C.M., 2012, UMKC LAW REV, V80, P563; HOLMAN CM, 2007, UMKC L REV, V76, P295; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Laurencin CT, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004467; Leite Marcelo, 2004, Genet Mol Res, V3, P575; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Medina I, 2013, NUCLEIC ACIDS RES, V41, pW41, DOI 10.1093/nar/gkt530; Merges Robert P., 2009, BERKELEY TECH LJ, V24, P1583; Merz JF, 2005, COMMUNITY GENET, V8, P203, DOI 10.1159/000087956; Moore K., 2005, BERKELEY TECH LJ, V20, P1521; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Rimmer M., 2008, INTELLECTUAL PROPERT, P138; Than K., 2013, NATIONAL GEOGRAPHIC; Williams HL, 2013, J POLIT ECON, V121, P1, DOI 10.1086/669706	28	19	19	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1086	1093		10.1038/nbt.2755	http://dx.doi.org/10.1038/nbt.2755			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24316644	Green Published, hybrid			2022-12-27	WOS:000328251900019
J	Altschul, S; Demchak, B; Durbin, R; Gentleman, R; Krzywinski, M; Li, H; Nekrutenko, A; Robinson, J; Rasband, W; Taylor, J; Trapnell, C				Altschul, Stephen; Demchak, Barry; Durbin, Richard; Gentleman, Robert; Krzywinski, Martin; Li, Heng; Nekrutenko, Anton; Robinson, James; Rasband, Wayne; Taylor, James; Trapnell, Cole			The anatomy of successful computational biology software	NATURE BIOTECHNOLOGY			English	Editorial Material								Creators of software widely used in computational biology discuss the factors that contributed to their success	[Altschul, Stephen] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Demchak, Barry] Univ Calif San Diego, La Jolla, CA 92093 USA; [Durbin, Richard] Wellcome Trust Sanger Inst, Hinxton, England; [Gentleman, Robert] Genentech Inc, San Francisco, CA USA; [Krzywinski, Martin] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Li, Heng; Robinson, James] Broad Inst, Cambridge, MA USA; [Nekrutenko, Anton] Penn State Univ, University Pk, PA 16802 USA; [Rasband, Wayne] NIMH, Bethesda, MD 20892 USA; [Taylor, James] Emory Univ, Atlanta, GA 30322 USA; [Trapnell, Cole] Harvard Univ, Cambridge, MA 02138 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of California System; University of California San Diego; Wellcome Trust Sanger Institute; Roche Holding; Genentech; British Columbia Cancer Agency; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Emory University; Harvard University	Altschul, S (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA.		Durbin, Richard/AAE-7178-2019; Taylor, James/F-1026-2011; Li, Heng/D-9344-2011; Altschul, Stephen/R-4000-2019	Durbin, Richard/0000-0002-9130-1006; Taylor, James/0000-0001-5079-840X; Li, Heng/0000-0003-4874-2874; Demchak, Barry/0000-0001-7065-7786; Nekrutenko, Anton/0000-0002-5987-8032	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070743] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000072] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA LM000072-18] Funding Source: Medline; NIGMS NIH HHS [R01 GM070743] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	18	18	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2013	31	10					894	897		10.1038/nbt.2721	http://dx.doi.org/10.1038/nbt.2721			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233CA	24104757	Green Accepted, Bronze			2022-12-27	WOS:000325541300017
J	Kumar, V; Muratani, M; Rayan, NA; Kraus, P; Lufkin, T; Ng, HH; Prabhakar, S				Kumar, Vibhor; Muratani, Masafumi; Rayan, Nirmala Arul; Kraus, Petra; Lufkin, Thomas; Ng, Huck Hui; Prabhakar, Shyam			Uniform, optimal signal processing of mapped deep-sequencing data	NATURE BIOTECHNOLOGY			English	Article							CHIP-SEQ DATA; NEURAL STEM-CELLS; PROTEIN-DNA INTERACTIONS; FACTOR-BINDING SITES; GENOME-WIDE ANALYSIS; HISTONE MODIFICATION; GENE-EXPRESSION; NEURONAL DIFFERENTIATION; CHROMATIN FEATURES; TRANSCRIPTION	Despite their apparent diversity, many problems in the analysis of high-throughput sequencing data are merely special cases of two general problems, signal detection and signal estimation. Here we adapt formally optimal solutions from signal processing theory to analyze signals of DNA sequence reads mapped to a genome. We describe DFilter, a detection algorithm that identifies regulatory features in ChIP-seq, DNase-seq and FAIRE-seq data more accurately than assay-specific algorithms. We also describe EFilter, an estimation algorithm that accurately predicts mRNA levels from as few as 1-2 histone profiles (R similar to 0.9). Notably, the presence of regulatory motifs in promoters correlates more with histone modifications than with mRNA levels, suggesting that histone profiles are more predictive of cis-regulatory mechanisms. We show by applying DFilter and EFilter to embryonic forebrain ChIP-seq data that regulatory protein identification and functional annotation are feasible despite tissue heterogeneity. The mathematical formalism underlying our tools facilitates integrative analysis of data from virtually any sequencing-based functional profile.	[Kumar, Vibhor; Rayan, Nirmala Arul; Kraus, Petra; Lufkin, Thomas; Ng, Huck Hui; Prabhakar, Shyam] Genome Inst Singapore, Singapore, Singapore; [Muratani, Masafumi; Ng, Huck Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore, Singapore; [Kraus, Petra; Lufkin, Thomas] Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Clarkson University	Prabhakar, S (corresponding author), Genome Inst Singapore, Singapore, Singapore.	prabhakars@gis.a-star.edu.sg	Ng, Huck Hui/A-1135-2009; Lufkin, Thomas/AAG-7476-2019; Lufkin, Thomas/B-5352-2011; Kraus, Petra/I-5849-2014	Lufkin, Thomas/0000-0002-7902-4771; Lufkin, Thomas/0000-0002-7902-4771; Kraus, Petra/0000-0002-6716-5550; Kumar, Vibhor/0000-0002-9523-9422	Agency for Science, Technology and Research (A*STAR), Singapore; Joint Council Office of A*STAR [JCOAG03_FG02_2009]	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Joint Council Office of A*STAR(Agency for Science Technology & Research (A*STAR))	This study was supported by funds from the Agency for Science, Technology and Research (A*STAR), Singapore including grant JCOAG03_FG02_2009 from Joint Council Office of A*STAR. The authors would like to thank N. Clarke and N. Nagarajan for valuable feedback and comments on the manuscript.	Anthoni H, 2007, HUM MOL GENET, V16, P667, DOI 10.1093/hmg/ddm009; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106; Bailey T.L., 1994, P 2 INT C INT SYST M; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Caucci L, 2009, OPT EXPRESS, V17, P10946, DOI 10.1364/OE.17.010946; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng C, 2012, GENOME RES, V22, P1658, DOI 10.1101/gr.136838.111; Cheng C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r15; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Ferron SR, 2009, J NEUROSCI, V29, P14394, DOI 10.1523/JNEUROSCI.3836-09.2009; Gammill LS, 2003, NAT REV NEUROSCI, V4, P795, DOI 10.1038/nrn1219; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S2-S2; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Korhonen J, 2009, BIOINFORMATICS, V25, P3181, DOI 10.1093/bioinformatics/btp554; Lun DS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r142; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Need AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/hmg/ddp413; Ochoa-Espinosa A, 2006, CURR OPIN GENET DEV, V16, P165, DOI 10.1016/j.gde.2006.02.014; Rashid NU, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r67; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Su XH, 2004, MOL CELL BIOL, V24, P8018, DOI 10.1128/MCB.24.18.8018-8025.2004; Swiss VA, 2010, GLIA, V58, P377, DOI 10.1002/glia.20933; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wang CY, 2012, NUCLEIC ACIDS RES, V40, P6414, DOI 10.1093/nar/gks304; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; ZHAO LC, 1986, J MULTIVARIATE ANAL, V20, P1, DOI 10.1016/0047-259X(86)90017-5	53	104	106	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2013	31	7					615	U72		10.1038/nbt.2596	http://dx.doi.org/10.1038/nbt.2596			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	180FS	23770639	Bronze			2022-12-27	WOS:000321579700018
J	Goldman, SA				Goldman, Steven A.			White matter from fibroblasts	NATURE BIOTECHNOLOGY			English	Editorial Material							PROGENITOR CELLS; DEFINED FACTORS; INDUCTION; NEURONS; BRAIN	Myelinating oligodendrocytes are induced from murine embryonic fibroblasts by transcription factor-mediated reprogramming.	[Goldman, Steven A.] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Goldman, SA (corresponding author), Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA.	steven_goldman@urmc.rochester.edu		Goldman, Steven/0000-0002-5498-4303	NINDS NIH HHS [R01 NS075345] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075345] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Goldman SA, 2012, SCIENCE, V338, P491, DOI 10.1126/science.1218071; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564	11	6	6	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					412	413		10.1038/nbt.2570	http://dx.doi.org/10.1038/nbt.2570			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23657393	Green Accepted			2022-12-27	WOS:000318589600017
J	Yang, N; Zuchero, JB; Ahlenius, H; Marro, S; Ng, YH; Vierbuchen, T; Hawkins, JS; Geissler, R; Barres, BA; Wernig, M				Yang, Nan; Zuchero, J. Bradley; Ahlenius, Henrik; Marro, Samuele; Ng, Yi Han; Vierbuchen, Thomas; Hawkins, John S.; Geissler, Richard; Barres, Ben A.; Wernig, Marius			Generation of oligodendroglial cells by direct lineage conversion	NATURE BIOTECHNOLOGY			English	Article							NEURAL STEM-CELLS; HUMAN FIBROBLASTS; PROGENITOR CELLS; MOUSE FIBROBLASTS; MYELIN; NEURONS; REMYELINATE; EXPRESSION; INDUCTION; RESCUE	Transplantation of oligodendrocyte precursor cells (OPCs) is a promising potential therapeutic strategy for diseases affecting myelin. However, the derivation of engraftable OPCs from human pluripotent stem cells has proven difficult and primary OPCs are not readily available. Here we report the generation of induced OPCs (iOPCs) by direct lineage conversion. Forced expression of the three transcription factors Sox10, Olig2 and Zfp536 was sufficient to reprogram mouse and rat fibroblasts into iOPCs with morphologies and gene expression signatures resembling primary OPCs. More importantly, iOPCs gave rise to mature oligodendrocytes that could ensheath multiple host axons when co-cultured with primary dorsal root ganglion cells and formed myelin after transplantation into shiverer mice. We propose direct lineage reprogramming as a viable alternative approach for the generation of OPCs for use in disease modeling and regenerative medicine.	[Yang, Nan; Ahlenius, Henrik; Marro, Samuele; Ng, Yi Han; Vierbuchen, Thomas; Hawkins, John S.; Wernig, Marius] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Yang, Nan; Ahlenius, Henrik; Marro, Samuele; Ng, Yi Han; Vierbuchen, Thomas; Hawkins, John S.; Geissler, Richard; Wernig, Marius] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Zuchero, J. Bradley; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Zuchero, J. Bradley; Barres, Ben A.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Wernig, M (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	wernig@stanford.edu	Yang, Nan/H-3174-2012; Ahlenius, Henrik/L-8660-2015; Marro, Samuele G./I-4493-2014; Ahlenius, Henrik/GPG-1120-2022	Ahlenius, Henrik/0000-0001-8958-6148; Marro, Samuele G./0000-0002-9326-6945; Ahlenius, Henrik/0000-0001-8958-6148; Yang, Nan/0000-0003-3663-1288; Vierbuchen, Thomas/0000-0002-5690-5680; Zuchero, J. Bradley/0000-0002-4706-2538	Ellison Medical Foundation; Stinehart-Reed Foundation; National Institutes of Health [R01MH092931]; New York Stem Cell Foundation; Walter V. and Idun Berry Fellowship; Swedish Research Council; Swedish Society for Medical Research;  [R01EY10257]; NATIONAL EYE INSTITUTE [R01EY010257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092931] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Stinehart-Reed Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; Walter V. and Idun Berry Fellowship; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank W. Macklin for sharing the Plp-EGFP mouse line and B. Stallcup for providing the rabbit NG2 antibody. We are extremely grateful to N. Uchida for crucial advice and would also like to thank A. Olson for help with the confocal analysis and the Neuroscience Institute Imaging facility and the Stanford genomics core for microarray hybridization. This work was supported by the Ellison Medical Foundation (M. W.), the Stinehart-Reed Foundation (M. W.), the National Institutes of Health grants R01MH092931 (M. W.), the New York Stem Cell Foundation (M. W.) and R01EY10257 (B. A. B). N. Y. is the recipient of a Walter V. and Idun Berry Fellowship. J. B. Z. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. H. A. is supported by a postdoctoral fellowship from the Swedish Research Council and the Swedish Society for Medical Research. M. W. is a New York Stem Cell Foundation-Robertson Investigator.	BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1387; Goldman SA, 2011, ARCH NEUROL-CHICAGO, V68, P848, DOI 10.1001/archneurol.2011.46; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; LAZZARINI RA, 2004, MYELIN BIOL DISORDER, V2; Learish RD, 1999, ANN NEUROL, V46, P716, DOI 10.1002/1531-8249(199911)46:5<716::AID-ANA6>3.0.CO;2-M; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Najm FJ, 2011, NAT METHODS, V8, P957, DOI [10.1038/NMETH.1712, 10.1038/nmeth.1712]; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Potter GB, 2011, ARCH IMMUNOL THER EX, V59, P179, DOI 10.1007/s00005-011-0120-7; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; ROACH A, 1983, CELL, V34, P799, DOI 10.1016/0092-8674(83)90536-6; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	218	233	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					434	+		10.1038/nbt.2564	http://dx.doi.org/10.1038/nbt.2564			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23584610	Green Accepted			2022-12-27	WOS:000318589600023
J	Kwong, GA; von Maltzahn, G; Murugappan, G; Abudayyeh, O; Mo, S; Papayannopoulos, IA; Sverdlov, DY; Liu, SB; Warren, AD; Popov, Y; Schuppan, D; Bhatia, SN				Kwong, Gabriel A.; von Maltzahn, Geoffrey; Murugappan, Gayathree; Abudayyeh, Omar; Mo, Steven; Papayannopoulos, Ioannis A.; Sverdlov, Deanna Y.; Liu, Susan B.; Warren, Andrew D.; Popov, Yury; Schuppan, Detlef; Bhatia, Sangeeta N.			Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease	NATURE BIOTECHNOLOGY			English	Article							MATRIX-METALLOPROTEINASE; BILIARY FIBROSIS; CANCER-PATIENTS; LIVER FIBROSIS; DISCOVERY; PROTEASES; STRATEGY; TUMORS; DRUGS	Biomarkers are becoming increasingly important in the clinical management of complex diseases, yet our ability to discover new biomarkers remains limited by our dependence on endogenous molecules. Here we describe the development of exogenously administered 'synthetic biomarkers' composed of mass-encoded peptides conjugated to nanoparticles that leverage intrinsic features of human disease and physiology for noninvasive urinary monitoring. These protease-sensitive agents perform three functions in vivo: they target sites of disease, sample dysregulated protease activities and emit mass-encoded reporters into host urine for multiplexed detection by mass spectrometry. Using mouse models of liver fibrosis and cancer, we show that these agents can noninvasively monitor liver fibrosis and resolution without the need for invasive core biopsies and substantially improve early detection of cancer compared with current clinically used blood biomarkers. This approach of engineering synthetic biomarkers for multiplexed urinary monitoring should be broadly amenable to additional pathophysiological processes and point-of-care diagnostics.	[Kwong, Gabriel A.; von Maltzahn, Geoffrey; Murugappan, Gayathree; Abudayyeh, Omar; Mo, Steven; Warren, Andrew D.; Bhatia, Sangeeta N.] MIT, Harvard MIT Hlth Sci & Technol, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Kwong, Gabriel A.; von Maltzahn, Geoffrey; Papayannopoulos, Ioannis A.; Warren, Andrew D.; Bhatia, Sangeeta N.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Murugappan, Gayathree; Sverdlov, Deanna Y.; Liu, Susan B.; Popov, Yury; Schuppan, Detlef; Bhatia, Sangeeta N.] Harvard Univ, Sch Med, Boston, MA USA; [Papayannopoulos, Ioannis A.] MIT, Swanson Biotechnol Ctr, Cambridge, MA 02139 USA; [Sverdlov, Deanna Y.; Liu, Susan B.; Popov, Yury; Schuppan, Detlef] Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02215 USA; [Schuppan, Detlef] Johannes Gutenberg Univ Mainz, Dept Med 1, Div Mol & Translat Med, Sch Med, Mainz, Germany; [Bhatia, Sangeeta N.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Bhatia, Sangeeta N.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Johannes Gutenberg University of Mainz; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Bhatia, SN (corresponding author), MIT, Harvard MIT Hlth Sci & Technol, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sbhatia@mit.edu	Popov, Yury V./A-7781-2008; Kwong, Gabriel A/M-5376-2013; Abudayyeh, Omar/ABF-1746-2020; Kwong, Gabriel/AAO-8266-2021	Popov, Yury V./0000-0001-7973-942X; Kwong, Gabriel A/0000-0002-6255-6755; Abudayyeh, Omar/0000-0002-7979-3220; Kwong, Gabriel/0000-0002-6255-6755; /0000-0003-1948-0289	US National Institutes of Health (Bioengineering Research Partnership) [R01 CA124427]; Kathy and Curt Marble Cancer Research Fund; US National Institutes of Health [U19 AI066313, 1R21 DK075857]; Ruth L. Kirschstein National Research Service Award [F32CA159496-01]; NATIONAL CANCER INSTITUTE [F32CA159496, R01CA124427, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075857, R21DK076873] Funding Source: NIH RePORTER	US National Institutes of Health (Bioengineering Research Partnership)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kathy and Curt Marble Cancer Research Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Cook, N. Schiller and M. Brown (Swanson Biotechnology Center (SBC), Massachusetts Institute of Technology (MIT)) for peptide synthesis and tissue sectioning, C. Whittaker (SBC, MIT) for bioinformatic insight, R. Tomaino (Harvard Taplin mass spectrometry facility) for mass spectrometry analysis, F. Giammo and D. Kim (MIT) for initial probe work and urine purification, S. Carr (Broad Institute of MIT/Harvard) for mass spectrometry expertise and M. Sailor (University of California San Diego (UCSD)), J. Park (UCSD) and S. Friedman (Mount Sinai School of Medicine) for insightful discussions. This work was funded by the US National Institutes of Health (Bioengineering Research Partnership: R01 CA124427 to S. N. B.), the Kathy and Curt Marble Cancer Research Fund to S. N. B. and US National Institutes of Health grants U19 AI066313 and 1R21 DK075857 to D. S. G. A. K. is supported by the Ruth L. Kirschstein National Research Service Award (F32CA159496-01). S. N. B. is a Howard Hughes Institute Investigator.	Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Brown BB, 1995, MOL DIVERS, V1, P4, DOI 10.1007/BF01715804; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; D'Souza AL, 2009, P NATL ACAD SCI USA, V106, P17152, DOI 10.1073/pnas.0903437106; Dekker LJM, 2010, PROTEOMICS, V10, P2348, DOI 10.1002/pmic.200900682; Edgington LE, 2011, CURR OPIN CHEM BIOL, V15, P798, DOI 10.1016/j.cbpa.2011.10.012; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Findeisen P, 2012, PROTEOM CLIN APPL, V6, P60, DOI 10.1002/prca.201100058; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Haun JB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002048; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Hori SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003110; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Kulasingam V, 2010, NAT REV CANCER, V10, P371, DOI 10.1038/nrc2831; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; Lutz AM, 2008, PLOS MED, V5, P1287, DOI 10.1371/journal.pmed.0050170; Mahmood U, 2003, MOL CANCER THER, V2, P489; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Moon PG, 2011, MASS SPECTROM REV, V30, P1185, DOI 10.1002/mas.20319; Morris TA, 2003, THROMB RES, V110, P159, DOI 10.1016/S0049-3848(03)00334-7; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; Park JH, 2008, ADV MATER, V20, P1630, DOI 10.1002/adma.200800004; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Surinova S, 2011, J PROTEOME RES, V10, P5, DOI 10.1021/pr1008515; Thompson A, 2006, ANAL CHEM, V78, P4235, DOI 10.1021/ac060310l; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Villanueva J, 2008, MOL CELL PROTEOMICS, V7, P509, DOI 10.1074/mcp.M700397-MCP200	44	129	146	8	160	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					63	+		10.1038/nbt.2464	http://dx.doi.org/10.1038/nbt.2464			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23242163	Green Accepted, Green Submitted			2022-12-27	WOS:000313563600023
J	Dahiyat, B				Dahiyat, Bassil			Stranger in a strange land?	NATURE BIOTECHNOLOGY			English	Editorial Material									Xencor, Monrovia, CA USA		Dahiyat, B (corresponding author), Xencor, Monrovia, CA USA.	baz@xencor.com							0	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1030	1032		10.1038/nbt.2352	http://dx.doi.org/10.1038/nbt.2352			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138291				2022-12-27	WOS:000311087500013
J	Ramskold, D; Luo, SJ; Wang, YC; Li, R; Deng, QL; Faridani, OR; Daniels, GA; Khrebtukova, I; Loring, JF; Laurent, LC; Schroth, GP; Sandberg, R				Ramskold, Daniel; Luo, Shujun; Wang, Yu-Chieh; Li, Robin; Deng, Qiaolin; Faridani, Omid R.; Daniels, Gregory A.; Khrebtukova, Irina; Loring, Jeanne F.; Laurent, Louise C.; Schroth, Gary P.; Sandberg, Rickard			Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIATION; TRANSCRIPTOMES; MELANOMA; REVEALS; MARKERS	Genome-wide transcriptome analyses are routinely used to monitor tissue-, disease- and cell type specific gene expression, but it has been technically challenging to generate expression profiles from single cells. Here we describe a robust mRNA-Seq protocol (Smart-Seq) that is applicable down to single cell levels. Compared with existing methods, Smart-Seq has improved read coverage across transcripts, which enhances detailed analyses of alternative transcript isoforms and identification of single-nucleotide polymorphisms. We determined the sensitivity and quantitative accuracy of Smart-Seq for single-cell transcriptomics by evaluating it on total RNA dilution series. We found that although gene expression estimates from single cells have increased noise, hundreds of differentially expressed genes could be identified using few cells per cell type. Applying Smart-Seq to circulating tumor cells from melanomas, we identified distinct gene expression patterns, including candidate biomarkers for melanoma circulating tumor cells. Our protocol will be useful for addressing fundamental biological problems requiring genome-wide transcriptome profiling in rare cells.	[Ramskold, Daniel; Deng, Qiaolin; Faridani, Omid R.; Sandberg, Rickard] Ludwig Inst Canc Res, S-10401 Stockholm, Sweden; [Ramskold, Daniel; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Luo, Shujun; Li, Robin; Khrebtukova, Irina; Schroth, Gary P.] Illumina Inc, Hayward, CA USA; [Wang, Yu-Chieh; Loring, Jeanne F.] Scripps Res Inst, Ctr Regenerat Med, Dept Physiol Chem, La Jolla, CA 92037 USA; [Daniels, Gregory A.] Rebecca & John Moores Canc Ctr, La Jolla, CA USA; [Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; Karolinska Institutet; Illumina; Scripps Research Institute; University of California System; University of California San Diego	Sandberg, R (corresponding author), Ludwig Inst Canc Res, Stockholm Branch, S-10401 Stockholm, Sweden.	rickard.sandberg@ki.se	Loring, Jeanne F/A-1620-2011; Gotoh, Osamu/B-4704-2012; Deng, Qiaolin/AAD-6905-2020	Loring, Jeanne F/0000-0001-6226-9767; Sandberg, Rickard/0000-0001-6473-1740; Ramskold, Daniel/0000-0003-2892-673X; Laurent, Louise/0000-0002-2095-7534; Faridani, Omid/0000-0001-9330-887X; Deng, Qiaolin/0000-0001-5934-7816	Marie Mayer Foundation; US National Institutes of Health (NIH) [K12HD001259]; NIH [R33MH87925]; California Institute for Regenerative Medicine [CL1-00502, RT1-01108, TR1-01250, RN2-00931]; European Research Council [243066]; Swedish Research Council [2008-4562]; Foundation for Strategic Research [FFL4]; Ake Wiberg Foundation [756194131]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087925] Funding Source: NIH RePORTER	Marie Mayer Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation for Strategic Research; Ake Wiberg Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Burge and G. Winberg for critical reading of the manuscript, T. Juarez and J. Cotton at the University of California San Diego for their help in Internal Review Board protocol preparation and aquisition of clinical samples, A.A. Talasaz and G. Cann for assistance with the Magsweeper, members of the Science for Life laboratory (Stockholm) for assistance with MiSeq sequencer. Y.-C.W. was supported by a fellowship from the Marie Mayer Foundation. L.C.L. was supported by US National Institutes of Health (NIH) K12HD001259. J.F.L. was supported by NIH R33MH87925 and California Institute for Regenerative Medicine (CL1-00502, RT1-01108, TR1-01250, and RN2-00931). R.S. was supported by European Research Council (starting grant 243066), Swedish Research Council (2008-4562), Foundation for Strategic Research (FFL4) and Ake Wiberg Foundation (756194131).	Chomez P, 2001, CANCER RES, V61, P5544; Duncan LM, 1998, CANCER RES, V58, P1515; Fang D, 1999, BIOCHEM BIOPH RES CO, V256, P657, DOI 10.1006/bbrc.1999.0400; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jungbluth AA, 1999, VIRCHOWS ARCH, V434, P429, DOI 10.1007/s004280050362; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; TANG A, 1994, J CELL SCI, V107, P983; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; TOMITA Y, 1985, J INVEST DERMATOL, V85, P426, DOI 10.1111/1523-1747.ep12277121; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509	20	967	1081	19	353	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					777	782		10.1038/nbt.2282	http://dx.doi.org/10.1038/nbt.2282			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22820318	Green Accepted			2022-12-27	WOS:000307416900021
J	Al-Lazikani, B; Banerji, U; Workman, P				Al-Lazikani, Bissan; Banerji, Udai; Workman, Paul			Combinatorial drug therapy for cancer in the post-genomic era	NATURE BIOTECHNOLOGY			English	Review							PROTEIN-SIGNALING NETWORKS; CETUXIMAB PLUS IRINOTECAN; HSP90 MOLECULAR CHAPERONE; BREAST-CANCER; TYROSINE KINASE; TRASTUZUMAB RESISTANCE; QUANTITATIVE-ANALYSIS; CLINICAL DEVELOPMENT; ANTICANCER THERAPY; CHEMOTHERAPY PLUS	Over the past decade, whole genome sequencing and other 'omics' technologies have defined pathogenic driver mutations to which tumor cells are addicted. Such addictions, synthetic lethalities and other tumor vulnerabilities have yielded novel targets for a new generation of cancer drugs to treat discrete, genetically defined patient subgroups. This personalized cancer medicine strategy could eventually replace the conventional one-size-fits-all cytotoxic chemotherapy approach. However, the extraordinary intratumor genetic heterogeneity in cancers revealed by deep sequencing explains why de novo and acquired resistance arise with molecularly targeted drugs and cytotoxic chemotherapy, limiting their utility. One solution to the enduring challenge of polygenic cancer drug resistance is rational combinatorial targeted therapy.	[Al-Lazikani, Bissan; Banerji, Udai; Workman, Paul] Inst Canc Res, Haddow Labs, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, Sutton, Surrey, England; [Banerji, Udai] Inst Canc Res, Haddow Labs, Drug Dev Unit, Div Canc Therapeut, Sutton, Surrey, England; [Banerji, Udai] Inst Canc Res, Haddow Labs, Div Clin Studies, Sutton, Surrey, England; [Banerji, Udai] Royal Marsden Hosp NHS Fdn Trust, Sutton, Surrey, England	Cancer Research UK; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Al-Lazikani, B (corresponding author), Inst Canc Res, Haddow Labs, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, Sutton, Surrey, England.	bissan.al-lazikani@icr.ac.uk; udai.banerji@icr.ac.uk; paul.workman@icr.ac.uk	Al-Lazikani, Bissan/AAG-4723-2022; He, Liye/C-8843-2015; Al-Lazikani, Bissan/AFK-6457-2022	He, Liye/0000-0002-6632-2112; Al-Lazikani, Bissan/0000-0003-3367-2519; Banerji, Udai/0000-0003-1503-3123	Cancer Research UK [C309/A8274, C309/8992]; Experimental Cancer Centre (ECMC) Funding from Cancer Research UK, National Institute of Health Research (NIHR); National Health Service; Department of Health; Cancer Research UK [11566] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Experimental Cancer Centre (ECMC) Funding from Cancer Research UK, National Institute of Health Research (NIHR); National Health Service; Department of Health; Cancer Research UK(Cancer Research UK)	The authors acknowledge core support to the Cancer Therapeutics Unit from Cancer Research UK (program grant C309/A8274); P.W. is a Cancer Research UK Life Fellow (C309/8992). P.W. and U.B. acknowledge Experimental Cancer Centre (ECMC) Funding to the Drug Development Unit from Cancer Research UK, National Institute of Health Research (NIHR) and the Department of Health. All authors acknowledge funding from the National Health Service to the NIHR Biomedical Research Centre at the Institute of Cancer Research and the Royal Marsden Hospital. We thank V. Cornwell and A. Ford for excellent administrative support and our colleagues for helpful discussion.	Albain KS, 2009, LANCET, V374, P2055, DOI 10.1016/S0140-6736(09)61523-3; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ayyadurai VAS, 2011, CELL MOL BIOENG, V4, P28, DOI 10.1007/s12195-010-0143-x; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Baum M, 2002, LANCET, V359, P2131; BERENBAUM MC, 1985, J THEOR BIOL, V114, P413, DOI 10.1016/S0022-5193(85)80176-4; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Berry DA, 2012, NAT REV CLIN ONCOL, V9, P199, DOI 10.1038/nrclinonc.2011.165; Bickerton GR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-313; Bray F., 2012, LANCET ONCOL    0601, DOI [10.1016/S1470-2045(12)70211-52012, DOI 10.1016/S1470-2045(12)70211-52012]; BROCKMAN RW, 1963, ADV CANCER RES, V7, P129, DOI 10.1016/S0065-230X(08)60983-5; Brody H, 2012, NEW ENGL J MED, V366, P1949, DOI 10.1056/NEJMp1203365; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Catalanotti F, 2012, CLIN CANCER RES, V18, P2420, DOI 10.1158/1078-0432.CCR-12-0626; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Chandarlapaty S, 2010, ONCOGENE, V29, P325, DOI 10.1038/onc.2009.337; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Choi HG, 2010, J MED CHEM, V53, P5439, DOI 10.1021/jm901808w; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Clarke PA, 2001, BIOCHEM PHARMACOL, V62, P1311, DOI 10.1016/S0006-2952(01)00785-7; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Cosimo S., 2010, J CLIN ONCOL S, V28; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; De Palma M, 2012, MOL ONCOL, V6, P111, DOI 10.1016/j.molonc.2012.01.011; DEVITA VT, 1975, CANCER, V35, P98, DOI 10.1002/1097-0142(197501)35:1<98::AID-CNCR2820350115>3.0.CO;2-B; Dow LE, 2012, CELL, V148, P1099, DOI 10.1016/j.cell.2012.02.023; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Eder JP, 2010, CLIN CANCER RES, V16, P3507, DOI 10.1158/1078-0432.CCR-10-0574; Edwards AM, 2009, NAT CHEM BIOL, V5, P436, DOI 10.1038/nchembio0709-436; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Falchook G., 2010, J CLIN ONCOL S, V28; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foo J, 2010, J THEOR BIOL, V263, P179, DOI 10.1016/j.jtbi.2009.11.022; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Garrett MD, 2011, TRENDS PHARMACOL SCI, V32, P308, DOI 10.1016/j.tips.2011.02.014; Gaspar N, 2009, CANCER RES, V69, P1966, DOI 10.1158/0008-5472.CAN-08-3131; Geho DH, 2005, COLD SH Q B, V70, P517, DOI 10.1101/sqb.2005.70.022; George S, 2012, J CLIN ONCOL, V30, P2401, DOI 10.1200/JCO.2011.39.9394; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Halling-Brown MD, 2012, NUCLEIC ACIDS RES, V40, pD947, DOI 10.1093/nar/gkr881; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrap K R, 1975, Adv Enzyme Regul, V13, P77, DOI 10.1016/0065-2571(75)90009-6; Haw R, 2011, PROTEOMICS, V11, P3598, DOI 10.1002/pmic.201100066; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Higgins M.J., 2012, CLIN CANC RES   0315, DOI [10.1158/1078-0432, DOI 10.1158/1078-0432]; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoelder S, 2012, MOL ONCOL, V6, P155, DOI 10.1016/j.molonc.2012.02.004; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Hughey JJ, 2010, WIRES SYST BIOL MED, V2, P194, DOI 10.1002/wsbm.52; Iadevaia S, 2010, CANCER RES, V70, P6704, DOI 10.1158/0008-5472.CAN-10-0460; Infante JR, 2011, J CLIN ONCOL, V29; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Jackman A., 2004, DRUG DISCOV TODAY, V1, P445; JACKSON RC, 1980, INT J BIOMED COMPUT, V11, P197, DOI 10.1016/0020-7101(80)90045-8; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kataoka Y, 2010, ANN ONCOL, V21, P255, DOI 10.1093/annonc/mdp304; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Komarova NL, 2003, CANCER RES, V63, P6635; Kraatz BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012838; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Lee MS, 2007, CANCER RES, V67, P11359, DOI 10.1158/0008-5472.CAN-07-2235; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Little MP, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-19; Loewe S., 1928, ERGEBN PHYSL, V27, P47, DOI [10.1007/BF02322290, DOI 10.1007/BF02322290]; Lu Y, 2011, ONCOGENE, V30, P4567, DOI 10.1038/onc.2011.164; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; MacConaill LE, 2010, J CLIN ONCOL, V28, P5219, DOI 10.1200/JCO.2009.27.4944; Meng JR, 2009, CANCER BIOL THER, V8, P2073, DOI 10.4161/cbt.8.21.9844; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Moffat D, 2010, J MED CHEM, V53, P8663, DOI 10.1021/jm101177s; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Morris MK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001099; Mukherjee S., 2011, J CLIN INVEST, DOI [10.1172/JCI45710, DOI 10.1172/JCI45710]; Mulero-Navarro S, 2008, CRIT REV ONCOL HEMAT, V68, P1, DOI 10.1016/j.critrevonc.2008.03.001; Mullenders J, 2009, ONCOGENE, V28, P4409, DOI 10.1038/onc.2009.295; Mumenthaler SM, 2011, MOL PHARMACEUT, V8, P2069, DOI 10.1021/mp200270v; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Peifer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008919; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Rodon J, 2010, ONCOLOGIST, V15, P37, DOI 10.1634/theoncologist.2009-0117; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Saez-Rodriguez J, 2011, CANCER RES, V71, P5400, DOI 10.1158/0008-5472.CAN-10-4453; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; SCHIMKE RT, 1978, SCIENCE, V202, P1051, DOI 10.1126/science.715457; Sellers WR, 2011, CELL, V147, P26, DOI 10.1016/j.cell.2011.09.016; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shuttleworth SJ, 2011, CURR MED CHEM, V18, P2686; Sims D, 2010, BREAST CANCER RES TR, V124, P567, DOI 10.1007/s10549-010-0945-5; Singh M, 2012, CANCER RES, V72, P2695, DOI 10.1158/0008-5472.CAN-11-2786; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; Solit DB, 2005, CLIN CANCER RES, V11, P1983, DOI 10.1158/1078-0432.CCR-04-1347; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P2473, DOI 10.1073/pnas.0906885107; Tolcher AW, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.2502; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wells SA, 2012, J CLIN ONCOL, V30, P134, DOI 10.1200/JCO.2011.35.5040; Woodcock J, 2011, NEW ENGL J MED, V364, P985, DOI 10.1056/NEJMp1101548; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Workman P, 2012, CANCER CELL, V21, P455, DOI 10.1016/j.ccr.2012.03.030; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; Yan H, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-50; Yap T.A., J CLIN ONCO IN PRESS; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Yap TA, 2012, ANNU REV PHARMACOL, V52, P549, DOI 10.1146/annurev-pharmtox-010611-134532; Yap TA, 2010, NAT REV CANCER, V10, P514, DOI 10.1038/nrc2870; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhao XM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002323	167	662	690	3	189	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					679	691		10.1038/nbt.2284	http://dx.doi.org/10.1038/nbt.2284			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781697				2022-12-27	WOS:000306293400027
J	Kalhor, R; Tjong, H; Jayathilaka, N; Alber, F; Chen, L				Kalhor, Reza; Tjong, Harianto; Jayathilaka, Nimanthi; Alber, Frank; Chen, Lin			Genome architectures revealed by tethered chromosome conformation capture and population-based modeling	NATURE BIOTECHNOLOGY			English	Article							SPATIAL-ORGANIZATION; MACROMOLECULAR ASSEMBLIES; NUCLEAR ARCHITECTURE; GENE-EXPRESSION; YEAST GENOME; CHROMATIN; CELLS; TRANSCRIPTION; TERRITORIES; ASSOCIATIONS	We describe tethered conformation capture (TCC), a method for genome-wide mapping of chromatin interactions. By performing ligations on solid substrates rather than in solution, TCC substantially enhances the signal-to-noise ratio, thereby facilitating a detailed analysis of interactions within and between chromosomes. We identified a group of regions in each chromosome in human cells that account for the majority of interchromosomal interactions. These regions are marked by high transcriptional activity, suggesting that their interactions are mediated by transcriptional machinery. Each of these regions interacts with numerous other such regions throughout the genome in an indiscriminate fashion, partly driven by the accessibility of the partners. As a different combination of interactions is likely present in different cells, we developed a computational method to translate the TCC data into physical chromatin contacts in a population of three-dimensional genome structures. Statistical analysis of the resulting population demonstrates that the indiscriminate properties of interchromosomal interactions are consistent with the well-known architectural features of the human genome.	[Kalhor, Reza; Tjong, Harianto; Jayathilaka, Nimanthi; Alber, Frank; Chen, Lin] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Kalhor, Reza; Jayathilaka, Nimanthi] Univ So Calif, Keck Sch Med, Program Genet Mol & Cellular Biol, Los Angeles, CA 90033 USA; [Chen, Lin] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Chen, Lin] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Alber, F (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	alber@usc.edu; linchen@usc.edu	Tjong, Harianto/C-6959-2011; Jayathilaka, Nimanthi/AAG-3697-2019	Tjong, Harianto/0000-0001-7992-2697; Jayathilaka, Nimanthi/0000-0001-8741-3075	Human Frontier Science Program [RGY0079/2009-C]; Alfred P. Sloan Foundation; US National Institutes of Health (NIH) [GM064642, GM077320]; NIH [GM096089, RR022220]; Pew Charitable Trusts; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642, R01GM096089, R01GM077320] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge P. Laird, J. Knowles and J. Aman and the USC Epigenome Center for assistance in high-throughput sequencing, M. Michael and A. Williams for assistance in confocal microscopy, N. Bottini and Q.-L. Ying and members of their laboratories for assistance in cell culture, A.D. Smith for access to cluster computing, I. Slaymaker for graphic design and the integrative modeling platform team for support. Structure calculations were done on USC HPCC. We also thank N. Arnheim, A.D. Smith, O. Aparicio, S. Forsburg, W. Li, M.S. Madhusudhan, K. Gong, S. Srivastava, S. Al-Bassam, M. Murphy, J. Peace and Z. Ostrow for useful discussions and comments on the manuscript. This work is supported by Human Frontier Science Program grant RGY0079/2009-C to F.A., Alfred P. Sloan Foundation grant to F.A.; US National Institutes of Health (NIH) grants GM064642 and GM077320 to L.C., NIH grant GM096089 to F.A. and NIH grant RR022220 to F.A. and L.C.F.A. is a Pew Scholar in Biomedical Sciences, supported by the Pew Charitable Trusts.	Alber F, 2005, STRUCTURE, V13, P435, DOI 10.1016/j.str.2005.01.013; Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Alcobia I, 2003, EXP CELL RES, V290, P358, DOI 10.1016/S0014-4827(03)00335-5; Alcobia I, 2000, BLOOD, V95, P1608, DOI 10.1182/blood.V95.5.1608.005k32_1608_1615; Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Beatty B., 2002, FISH PRACTICAL APPRO; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Branco MR, 2007, TRENDS CELL BIOL, V17, P127, DOI 10.1016/j.tcb.2006.12.006; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Chotalia M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002031; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Gue M, 2005, CYTOM PART A, V67A, P18, DOI 10.1002/cyto.a.20170; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Kreth G, 2004, BIOPHYS J, V86, P2803, DOI 10.1016/S0006-3495(04)74333-7; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Misteli T, 2009, P NATL ACAD SCI USA, V106, P6885, DOI 10.1073/pnas.0902010106; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Srivastava S, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq670; Sullivan GJ, 2001, EMBO J, V20, P2867, DOI 10.1093/emboj/20.11.2867; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tolhuis B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001343; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; Volpi EV, 2000, J CELL SCI, V113, P1565; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	47	403	426	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					90	U139		10.1038/nbt.2057	http://dx.doi.org/10.1038/nbt.2057			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22198700	Green Accepted			2022-12-27	WOS:000299110600025
J	Stohl, W; Hilbert, DM				Stohl, William; Hilbert, David M.			The discovery and development of belimumab: the anti-BLyS-lupus connection	NATURE BIOTECHNOLOGY			English	Article							B-LYMPHOCYTE STIMULATOR; NECROSIS-FACTOR FAMILY; HUMAN MONOCLONAL-ANTIBODY; COMMON VARIABLE IMMUNODEFICIENCY; CELL MATURATION ANTIGEN; APRIL-DEFICIENT MICE; RHEUMATOID-ARTHRITIS; TNF RECEPTOR; AUTOIMMUNE-DISEASE; T-CELL	For the first time in more than 50 years, the US Food and Drug Administration has approved a drug specifically for the treatment of systemic lupus erythematosus (SLE). This drug, belimumab (Benlysta), is a human monoclonal antibody that neutralizes the B-cell survival factor, B-lymphocyte stimulator (BLyS). The approval of belimumab combined a pioneering approach to genomics-based gene discovery, an astute appreciation of translational medicine, a disciplined clinical strategy, a willingness to take calculated risks, a devoted cadre of patients and physicians and a healthy dose of serendipity. Collectively, these efforts have provided a model for the development of a new generation of drugs to treat the broad manifestations of SLE. However, as a substantial percentage of SLE patients do not respond to belimumab, further research is needed to better characterize the pathogenetic mechanisms of SLE, identify additional therapeutic targets, and develop effective and nontoxic novel agents against these targets.	[Stohl, William] Univ So Calif, Keck Sch Med, Div Rheumatol, Los Angeles, CA 90033 USA; [Hilbert, David M.] Zyngenia Inc, Gaithersburg, MD USA	University of Southern California	Stohl, W (corresponding author), Univ So Calif, Keck Sch Med, Div Rheumatol, Los Angeles, CA 90033 USA.	stohl@usc.edu			NIH [R01 AR050193]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050193] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank T.-S. Migone and W. Freimuth of HGS for helpful discussions and assistance with the time line. The work was supported in part by NIH grant R01 AR050193 to W.S.	ADAMS MD, 1995, NATURE, V377, P3; [Anonymous], 1998, Patent No. [WO 9818921, 9818921, 98/18921]; Baker KP, 2003, ARTHRITIS RHEUM-US, V48, P3253, DOI 10.1002/art.11299; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Becker-Merok A, 2006, LUPUS, V15, P570, DOI 10.1177/0961203306071871; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; BELOUSKI SS, 2007, ARTHRITIS RHEUM, V56, pS565; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Carbonatto M, 2008, TOXICOL SCI, V105, P200, DOI 10.1093/toxsci/kfn105; Carson KR, 2009, BLOOD, V113, P4834, DOI 10.1182/blood-2008-10-186999; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Collins CE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1855; Cragg Mark S., 2005, V8, P140; Dall'Era M, 2007, ARTHRITIS RHEUM, V56, P4142, DOI 10.1002/art.23047; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Furie R, 2009, ARTHRITIS RHEUM, V60, pS429; Furie R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2506; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Furie RA, 2009, ARTHRIT RHEUM-ARTHR, V61, P1143, DOI 10.1002/art.24698; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Haas KM, 2010, J IMMUNOL, V184, P4789, DOI 10.4049/jimmunol.0902391; Halpern WG, 2006, TOXICOL SCI, V91, P586, DOI 10.1093/toxsci/kfj148; Huard B, 2001, J IMMUNOL, V167, P6225, DOI 10.4049/jimmunol.167.11.6225; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jacob CO, 2006, J IMMUNOL, V177, P2671, DOI 10.4049/jimmunol.177.4.2671; Jacob N, 2011, J IMMUNOL, V186, P4984, DOI 10.4049/jimmunol.1000466; Jacob N, 2009, J IMMUNOL, V182, P2532, DOI 10.4049/jimmunol.0802948; Ju SQ, 2006, CLIN BIOCHEM, V39, P1131, DOI 10.1016/j.clinbiochem.2006.09.010; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Knight AK, 2007, CLIN IMMUNOL, V124, P182, DOI 10.1016/j.clim.2007.04.012; Leandro MJ, 2002, ARTHRITIS RHEUM-US, V46, P2673, DOI 10.1002/art.10541; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Looney RJ, 2010, DRUGS, V70, P529, DOI 10.2165/11535420-000000000-00000; Looney RJ, 2004, ARTHRITIS RHEUM, V50, P2580, DOI 10.1002/art.20430; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; McKay J, 2005, ARTHRITIS RHEUM-US, V52, pS710; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Nikbakht N, 2011, J IMMUNOL, V187, P37, DOI 10.4049/jimmunol.1003924; Ota M, 2010, J IMMUNOL, V185, P4128, DOI 10.4049/jimmunol.1002176; Petri M, 2008, ARTHRITIS RHEUM, V58, P2453, DOI 10.1002/art.23678; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Ramos-Casals M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1281, DOI 10.1002/art.24726; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Roschke V, 2002, J IMMUNOL, V169, P4314, DOI 10.4049/jimmunol.169.8.4314; SABAHI R, 2007, ARTHRITIS RHEUM, V56, pS566; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Stewart DM, 2003, CLIN IMMUNOL, V109, P137, DOI 10.1016/S1521-6616(03)00215-8; Stohl W, 2005, ARTHRITIS RHEUM-US, V52, pS444; Sutherland APR, 2005, J IMMUNOL, V174, P5537, DOI 10.4049/jimmunol.174.9.5537; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Tribouley C, 1999, BIOL CHEM, V380, P1443, DOI 10.1515/BC.1999.186; Varfolomeev E, 2004, MOL CELL BIOL, V24, P997, DOI 10.1128/MCB.24.3.997-1006.2004; Vugmeyster Y, 2006, AM J PATHOL, V168, P476, DOI 10.2353/ajpath.2006.050600; Wallace DJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P1168, DOI 10.1002/art.24699; Wang H, 2001, NAT IMMUNOL, V2, P632, DOI 10.1038/89782; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385; Zhou XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023629	80	99	115	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					69	77		10.1038/nbt.2076	http://dx.doi.org/10.1038/nbt.2076			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22231104	Green Accepted			2022-12-27	WOS:000299110600022
J	Varshney, RK; Chen, WB; Li, YP; Bharti, AK; Saxena, RK; Schlueter, JA; Donoghue, MTA; Azam, S; Fan, GY; Whaley, AM; Farmer, AD; Sheridan, J; Iwata, A; Tuteja, R; Penmetsa, RV; Wu, W; Upadhyaya, HD; Yang, SP; Shah, T; Saxena, KB; Michael, T; McCombie, WR; Yang, BC; Zhang, GY; Yang, HM; Wang, J; Spillane, C; Cook, DR; May, GD; Xu, X; Jackson, SA				Varshney, Rajeev K.; Chen, Wenbin; Li, Yupeng; Bharti, Arvind K.; Saxena, Rachit K.; Schlueter, Jessica A.; Donoghue, Mark T. A.; Azam, Sarwar; Fan, Guangyi; Whaley, Adam M.; Farmer, Andrew D.; Sheridan, Jaime; Iwata, Aiko; Tuteja, Reetu; Penmetsa, R. Varma; Wu, Wei; Upadhyaya, Hari D.; Yang, Shiaw-Pyng; Shah, Trushar; Saxena, K. B.; Michael, Todd; McCombie, W. Richard; Yang, Bicheng; Zhang, Gengyun; Yang, Huanming; Wang, Jun; Spillane, Charles; Cook, Douglas R.; May, Gregory D.; Xu, Xun; Jackson, Scott A.			Draft genome sequence of pigeonpea (Cajanus cajan), an orphan legume crop of resource-poor farmers	NATURE BIOTECHNOLOGY			English	Article							GENES; DIVERSIFICATION; SOFTWARE; DATABASE; PROGRAM; TOOL	Pigeonpea is an important legume food crop grown primarily by smallholder farmers in many semi-arid tropical regions of the world. We used the Illumina next-generation sequencing platform to generate 237.2 Gb of sequence, which along with Sanger-based bacterial artificial chromosome end sequences and a genetic map, we assembled into scaffolds representing 72.7% (605.78 Mb) of the 833.07 Mb pigeonpea genome. Genome analysis predicted 48,680 genes for pigeonpea and also showed the potential role that certain gene families, for example, drought tolerance-related genes, have played throughout the domestication of pigeonpea and the evolution of its ancestors. Although we found a few segmental duplication events, we did not observe the recent genome-wide duplication events observed in soybean. This reference genome sequence will facilitate the identification of the genetic basis of agronomically important traits, and accelerate the development of improved pigeonpea varieties that could improve food security in many developing countries.	[Varshney, Rajeev K.; Saxena, Rachit K.; Azam, Sarwar; Tuteja, Reetu; Upadhyaya, Hari D.; Shah, Trushar; Saxena, K. B.] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Andhra Pradesh, India; [Varshney, Rajeev K.] CIMMYT, CGIAR Generat Challenge Programme GCP, Mexico City 06600, DF, Mexico; [Chen, Wenbin; Fan, Guangyi; Yang, Bicheng; Zhang, Gengyun; Yang, Huanming; Wang, Jun; Xu, Xun] Beijing Genom Inst BGI Shenzhen, Shenzhen, Peoples R China; [Li, Yupeng; Iwata, Aiko; Jackson, Scott A.] Univ Georgia, Athens, GA 30602 USA; [Bharti, Arvind K.; Farmer, Andrew D.; May, Gregory D.] NCGR, Santa Fe, NM USA; [Schlueter, Jessica A.; Whaley, Adam M.; Sheridan, Jaime] Univ N Carolina, Charlotte, NC 28223 USA; [Donoghue, Mark T. A.; Tuteja, Reetu; Spillane, Charles] NUIG, Galway, Ireland; [Penmetsa, R. Varma; Cook, Douglas R.] Univ Calif Davis, Davis, CA 95616 USA; [Wu, Wei; Yang, Shiaw-Pyng; Michael, Todd] Monsanto Co, Creve Coeur, MO USA; [McCombie, W. Richard] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-1168 Copenhagen, Denmark; [Xu, Xun] BGI Amer, Cambridge, MA USA	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Beijing Genomics Institute (BGI); University System of Georgia; University of Georgia; National Center for Genome Resources (NCGR); University of North Carolina; University of North Carolina Charlotte; Ollscoil na Gaillimhe-University of Galway; University of California System; University of California Davis; Monsanto; Cold Spring Harbor Laboratory; University of Copenhagen	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Xu, Xun/AAI-6763-2020; Rachit, Rachit/C-6485-2014; Updhayaya, Hari/C-4858-2014; Wang, Jun/A-7261-2013; Li, Yupeng/A-7718-2012; Varshney, Rajeev K/C-5295-2014; Spillane, Charles/H-3786-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Xu, Xun/0000-0002-5338-5173; Updhayaya, Hari/0000-0002-5166-6844; Li, Yupeng/0000-0003-0843-7592; Varshney, Rajeev K/0000-0002-4562-9131; Shah, Trushar/0000-0002-0091-7981; Iwata-Otsubo, Aiko/0000-0001-9378-3961; Tuteja, Reetu/0000-0001-7628-4108; Schlueter, Jessica/0000-0002-6490-0580; McCombie, W. Richard/0000-0003-1899-0682; Spillane, Charles/0000-0003-3318-323X; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; jackson, scott/0000-0002-3172-1607; Michael, Todd/0000-0001-6272-2875	US National Science Foundation [DBI 0605251, BIO 0822258]; BGI-Shenzhen, China; International Crops Research Institute for the Semi-Arid Tropics (ICRISAT), India; Indian Council of Agricultural Research (ICAR), India; Division Of Integrative Organismal Systems [0822258] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); BGI-Shenzhen, China; International Crops Research Institute for the Semi-Arid Tropics (ICRISAT), India(CGIAR); Indian Council of Agricultural Research (ICAR), India(Indian Council of Agricultural Research (ICAR)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We would like to thank CGIAR Generation Challenge Programme, US National Science Foundation (DBI 0605251, BIO 0822258), BGI-Shenzhen, China, and The International Crops Research Institute for the Semi-Arid Tropics (ICRISAT), India, for their financial contribution to this study. Thanks are also due to Indian Council of Agricultural Research (ICAR), India for financial support to some earlier work that was used for analyzing genome sequence data. We would like to thank N.K. Singh, National Research Centre on Plant Biotechnology, Indian Agricultural Research Institute, New Delhi, India, for his immense help and support in various ways while carrying out this study. Our sincere appreciation to W.D. Dar, D.A. Hoisington, C.L.L. Gowda, O. Riera-Lizarazu from ICRISAT; J.-M. Ribaut from CGIAR Generation Challenge Programme; and M. dela Bastide from Cold Spring Harbor Laboratory for their helpful advice and assistance, wherever required, during the course of the study. We also thank D. Johnson from the University of Ottawa for providing 18S rRNA gene cloned from soybean (G. max).	Abhishek Bohra, 2010, Journal of Plant Biology, V37, P85; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Beckstette M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-389; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Brcic-Kostic K, 2005, GENET RES, V86, P53, DOI 10.1017/S0016672305007688; Cannon SB, 2009, PLANT PHYSIOL, V151, P970, DOI 10.1104/pp.109.144659; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; De D. N., 1974, Evolutionary Studies in World Crops., P79; Donoghue MTA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-47; Dubey A, 2011, DNA RES, V18, P153, DOI 10.1093/dnares/dsr007; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Guo WJ, 2007, COMP FUNCT GENOM, DOI 10.1155/2007/21676; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Isokpehi RD, 2011, BIOINFORM BIOL INSIG, V5, P41, DOI 10.4137/BBI.S6061; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LATHAM MC, 1997, FAO FOOD NUTR SERIES, V29; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mula M., 2010, LIFTING LEVEL AWAREN; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Royes W. V., 1976, Evolution of crop plants., P154; Rozen S, 2000, Methods Mol Biol, V132, P365; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schmid KJ, 2001, GENETICS, V159, P589; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Simillion C, 2008, BIOINFORMATICS, V24, P127, DOI 10.1093/bioinformatics/btm449; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Stokstad E, 2007, SCIENCE, V316, P196, DOI 10.1126/science.316.5822.196; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Varshney RK, 2010, MOL BREEDING, V26, P393, DOI 10.1007/s11032-009-9327-2; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004; Vavilov, 1951, CHRON BOT, V13, P13; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	53	505	525	6	126	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					83	U128		10.1038/nbt.2022	http://dx.doi.org/10.1038/nbt.2022			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22057054	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000299110600024
J	Berka, RM; Grigoriev, IV; Otillar, R; Salamov, A; Grimwood, J; Reid, I; Ishmael, N; John, T; Darmond, C; Moisan, MC; Henrissat, B; Coutinho, PM; Lombard, V; Natvig, DO; Lindquist, E; Schmutz, J; Lucas, S; Harris, P; Powlowski, J; Bellemare, A; Taylor, D; Butler, G; de Vries, RP; Allijn, IE; van den Brink, J; Ushinsky, S; Storms, R; Powell, AJ; Paulsen, IT; Elbourne, LDH; Baker, SE; Magnuson, J; LaBoissiere, S; Clutterbuck, AJ; Martinez, D; Wogulis, M; de Leon, AL; Rey, MW; Tsang, A				Berka, Randy M.; Grigoriev, Igor V.; Otillar, Robert; Salamov, Asaf; Grimwood, Jane; Reid, Ian; Ishmael, Nadeeza; John, Tricia; Darmond, Corinne; Moisan, Marie-Claude; Henrissat, Bernard; Coutinho, Pedro M.; Lombard, Vincent; Natvig, Donald O.; Lindquist, Erika; Schmutz, Jeremy; Lucas, Susan; Harris, Paul; Powlowski, Justin; Bellemare, Annie; Taylor, David; Butler, Gregory; de Vries, Ronald P.; Allijn, Iris E.; van den Brink, Joost; Ushinsky, Sophia; Storms, Reginald; Powell, Amy J.; Paulsen, Ian T.; Elbourne, Liam D. H.; Baker, Scott E.; Magnuson, Jon; LaBoissiere, Sylvie; Clutterbuck, A. John; Martinez, Diego; Wogulis, Mark; de Leon, Alfredo Lopez; Rey, Michael W.; Tsang, Adrian			Comparative genomic analysis of the thermophilic biomass-degrading fungi Myceliophthora thermophila and Thielavia terrestris	NATURE BIOTECHNOLOGY			English	Article							SPOROTRICHUM-THERMOPHILE; TALAROMYCES-EMERSONII; TRICHODERMA-REESEI; EXPRESSION; SEQUENCE; THERMOSTABILITY; GENE; ALIGNMENT; PROTEINS; CLASSIFICATION	Thermostable enzymes and thermophilic cell factories may afford economic advantages in the production of many chemicals and biomass-based fuels. Here we describe and compare the genomes of two thermophilic fungi, Myceliophthora thermophila and Thielavia terrestris. To our knowledge, these genomes are the first described for thermophilic eukaryotes and the first complete telomere-to-telomere genomes for filamentous fungi. Genome analyses and experimental data suggest that both thermophiles are capable of hydrolyzing all major polysaccharides found in biomass. Examination of transcriptome data and secreted proteins suggests that the two fungi use shared approaches in the hydrolysis of cellulose and xylan but distinct mechanisms in pectin degradation. Characterization of the biomass-hydrolyzing activity of recombinant enzymes suggests that these organisms are highly efficient in biomass decomposition at both moderate and high temperatures. Furthermore, we present evidence suggesting that aside from representing a potential reservoir of thermostable enzymes, thermophilic fungi are amenable to manipulation using classical and molecular genetics.	[Reid, Ian; Ishmael, Nadeeza; John, Tricia; Darmond, Corinne; Moisan, Marie-Claude; Powlowski, Justin; Bellemare, Annie; Taylor, David; Butler, Gregory; Ushinsky, Sophia; Storms, Reginald; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada; [Berka, Randy M.; Harris, Paul; Wogulis, Mark; de Leon, Alfredo Lopez; Rey, Michael W.] Novozymes Inc, Davis, CA USA; [Grigoriev, Igor V.; Otillar, Robert; Salamov, Asaf; Lindquist, Erika; Lucas, Susan] US Dept Energy Joint Genome Inst, Walnut Creek, CA USA; [Grimwood, Jane; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Henrissat, Bernard; Coutinho, Pedro M.; Lombard, Vincent] Univ Mediterranee, CNRS, Univ Aix Marseille 1, Marseille, France; [Natvig, Donald O.; Martinez, Diego] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [de Vries, Ronald P.; Allijn, Iris E.; van den Brink, Joost] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [de Vries, Ronald P.] Univ Utrecht, Microbiol & Kluyver Ctr Genom Ind Fermentat, Utrecht, Netherlands; [Powell, Amy J.] Sandia Natl Labs, Albuquerque, NM USA; [Paulsen, Ian T.; Elbourne, Liam D. H.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Baker, Scott E.; Magnuson, Jon] Pacific NW Natl Lab, Fungal Biotechnol Team, Richland, WA 99352 USA; [LaBoissiere, Sylvie] McGill Univ, Montreal, PQ, Canada; [LaBoissiere, Sylvie] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Clutterbuck, A. John] Univ Glasgow, Glasgow, Lanark, Scotland	Concordia University - Canada; Novozymes; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; HudsonAlpha Institute for Biotechnology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of New Mexico; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Utrecht University; United States Department of Energy (DOE); Sandia National Laboratories; Macquarie University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; McGill University; University of Glasgow	Tsang, A (corresponding author), Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada.	tsang@gene.concordia.ca	Baker, Scott E/X-2065-2018; Elbourne, Liam/G-6150-2011; Baker, Scott E./ABB-1635-2020; Storms, Reginald/B-2405-2013; Henrissat, Bernard/J-2475-2012; Allijn, Iris E/H-1479-2012; Schmutz, Jeremy/N-3173-2013; de Vries, Ronald P./F-8125-2011; Grimwood, Jane/ABD-5737-2021; Paulsen, Ian/K-3832-2012	Baker, Scott E/0000-0001-5085-3106; Elbourne, Liam/0000-0002-9784-0959; Baker, Scott E./0000-0001-5085-3106; Henrissat, Bernard/0000-0002-3434-8588; Allijn, Iris E/0000-0002-4026-3273; Schmutz, Jeremy/0000-0001-8062-9172; de Vries, Ronald P./0000-0002-4363-1123; Reid, Ian/0000-0002-1079-3724; Grigoriev, Igor/0000-0002-3136-8903; Magnuson, Jon/0000-0001-7712-7024; Lombard, Vincent/0000-0002-9684-7067; Paulsen, Ian/0000-0001-9015-9418	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Cellulosic Biofuel Network of the Agriculture Bioproducts Innovation Program of Agriculture and Agri-Food Canada, Genome Canada and Genome Quebec	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Cellulosic Biofuel Network of the Agriculture Bioproducts Innovation Program of Agriculture and Agri-Food Canada, Genome Canada and Genome Quebec	The genome sequencing and analysis were conducted by the US Department of Energy Joint Genome Institute and supported by the Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231. The work on transcriptomes, enzyme characterization and the Myceliophthora exo-proteome was supported by the Cellulosic Biofuel Network of the Agriculture Bioproducts Innovation Program of Agriculture and Agri-Food Canada, Genome Canada and Genome Quebec.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berka RM, 1998, APPL ENVIRON MICROB, V64, P4423; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; *BROAD I, 2005, CHAET GLOB GEN DAT; Detter JC, 2002, GENOMICS, V80, P691, DOI 10.1006/geno.2002.7020; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Glyakina AV, 2007, BIOINFORMATICS, V23, P2231, DOI 10.1093/bioinformatics/btm345; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; JENSEN EB, 1997, Patent No. 5602004; Jensen EB, 1997, US Patent, Patent No. [5,695,985, 5695985]; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karlsson J, 2001, EUR J BIOCHEM, V268, P6498, DOI 10.1046/j.0014-2956.2001.02605.x; Kaur G, 2004, BIORESOURCE TECHNOL, V94, P239, DOI 10.1016/j.biortech.2003.05.003; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MARGARITIS A, 1986, CRC CR REV BIOTECHN, V4, P327, DOI 10.3109/07388558609150799; Margaritis A, 1983, BIOTECHNOL BIOENG S, V13, P426; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Mouchacca J, 2000, WORLD J MICROB BIOT, V16, P881, DOI 10.1023/A:1008970306466; Murray P, 2004, PROTEIN EXPRES PURIF, V38, P248, DOI 10.1016/j.pep.2004.08.006; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Nishio Y, 2003, GENOME RES, V13, P1572, DOI 10.1101/gr.1285603; PAHKALA K, 2007, 15 EUR BIOM C EXH BE; ROY BP, 1993, APPL ENVIRON MICROB, V59, P1855, DOI 10.1128/AEM.59.6.1855-1863.1993; ROY SK, 1990, J GEN MICROBIOL, V136, P1967, DOI 10.1099/00221287-136-10-1967; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Semova N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-7; Smit AFA, 2010, REPEATMASKER OPEN 3; TANSEY MR, 1971, ARCH MIKROBIOL, V77, P1, DOI 10.1007/BF00407983; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsang A, 2009, FUNGAL GENET BIOL, V46, pS153, DOI 10.1016/j.fgb.2008.07.014; Vafiadi C, 2009, FEMS MICROBIOL LETT, V296, P178, DOI 10.1111/j.1574-6968.2009.01631.x; VANDENBRINK J, FUNGAL DIVERS, DOI DOI 10.1007/S13225-13011-10107-Z; Visser H., 2011, IND BIOTECHNOL, V7, P214, DOI [10.1089/ind.2011.7.214, DOI 10.1089/IND.2011.7.214]; VONKLOPOTEK A, 1976, ARCH MICROBIOL, V107, P223, DOI 10.1007/BF00446844; Voutilainen SP, 2010, PROTEIN ENG DES SEL, V23, P69, DOI 10.1093/protein/gzp072; Wang GZ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-263; WOJTCZAK G, 1987, APPL MICROBIOL BIOT, V27, P82, DOI 10.1007/BF00257258; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005	50	295	348	11	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					922	U222		10.1038/nbt.1976	http://dx.doi.org/10.1038/nbt.1976			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21964414	Green Submitted			2022-12-27	WOS:000296273000019
J	Aggarwal, SR				Aggarwal, Saurabh (Rob)			A survey of breakthrough therapy designations	NATURE BIOTECHNOLOGY			English	Article							HEPATITIS-C; GENOTYPE 1; TREATMENT-NAIVE; DACLATASVIR; ASUNAPREVIR; INHIBITOR; INFECTION; RIBAVIRIN; TRIAL	As of last month, 41 products have been granted breakthrough therapy designations by the US Food and Drug Administration-drugs against cancer, hepatitis C and monogenetic diseases predominate.	[Aggarwal, Saurabh (Rob)] Novel Hlth Strategies LLC, Bethesda, MD 20814 USA; [Aggarwal, Saurabh (Rob)] Inst Global Policy Res, Washington, DC USA		Aggarwal, SR (corresponding author), Novel Hlth Strategies LLC, Bethesda, MD 20814 USA.	sa2@novelhealthstrategies.com			Novel Health Strategies; Institute for Global Policy Research; American Society of Clinical Oncology; American College of Rheumatology; American Association of Liver Diseases, American Heart Association; American Society of Hematology; Biotechnology Industry Association	Novel Health Strategies; Institute for Global Policy Research; American Society of Clinical Oncology; American College of Rheumatology(General Electric); American Association of Liver Diseases, American Heart Association; American Society of Hematology; Biotechnology Industry Association	The author thanks Novel Health Strategies, the Institute for Global Policy Research, the American Society of Clinical Oncology, the American College of Rheumatology, the American Association of Liver Diseases, American Heart Association, the American Society of Hematology and the Biotechnology Industry Association for providing support for this article.	Aggarwal S, 2010, NAT REV DRUG DISCOV, V9, P427, DOI 10.1038/nrd3186; Aggarwal SR, 2014, NAT BIOTECHNOL, V32, P32, DOI 10.1038/nbt.2794; Aggarwal S, 2012, NAT BIOTECHNOL, V30, P1191, DOI 10.1038/nbt.2437; Beers SA, 2010, SEMIN HEMATOL, V47, P107, DOI 10.1053/j.seminhematol.2010.01.001; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Chen JM, 2013, GASTROENTEROLOGY, V144, P1450, DOI 10.1053/j.gastro.2013.02.039; Chustecka Z., 2014, IBRUTINIB IMBRUVICA; Collins T.R., 2013, NEUROLOGY TODAY, V13, P34; D'Cruz OJ, 2013, ONCOTARGETS THER, V6, P161, DOI 10.2147/OTT.S33732; Desmond R, 2014, BLOOD, V123, P1818, DOI 10.1182/blood-2013-10-534743; Dohner H., 2012, ASH ANN M EXP NEW OR; Eisai Inc., 2012, FDA ODAC BRIEF DOC; European Medicines Agency, 2014, REF MARK AUTH READ; Everson GT, 2014, GASTROENTEROLOGY, V146, P420, DOI 10.1053/j.gastro.2013.10.057; Fellner Chris, 2012, P T, V37, P503; Filippatos G, 2014, EUR HEART J, V35, P1041, DOI 10.1093/eurheartj/eht497; Finn R., 2013, SAN ANT BREAST CANC; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Hillman P., 2013, 55 ANN M AM SOC HEM; Hornberger J, 2012, LEUKEMIA LYMPHOMA, V53, P225, DOI 10.3109/10428194.2011.605918; IMS Health, 2012, TOT UN AUD GLOB PHAR; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Kuznar W., IBRUTINIB INDUCES RA; Lawitz E., 2013, 64 ANN M AM ASS STUD; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Llanos-Cuentas A, 2014, LANCET, V383, P1049, DOI 10.1016/S0140-6736(13)62568-4; Lowery M., 2013, DRUG TOPICS; Mitchell AE, 2010, HEPATOLOGY, V51, P729, DOI 10.1002/hep.23561; National Institute for Health Service, 2013, ASF ALF HYP; Pollack A., 2013, NY TIMES; Scioderm Inc., 2013, REC POS OP EUR ORPH; Senior M, 2013, NAT BIOTECHNOL, V31, P945, DOI 10.1038/nbt1113-945; Shaw AT, 2013, J CLIN ONCOL, V31; Sherman RE, 2013, NEW ENGL J MED, V369, P1877, DOI 10.1056/NEJMp1311439; Whitely C.B., 2013, N AM SOC PED GASTR H; Whyte MP, 2012, NEW ENGL J MED, V366, P904, DOI 10.1056/NEJMoa1106173; Yardley DA, 2013, J CLIN ONCOL, V31, P2128, DOI 10.1200/JCO.2012.43.7251	38	24	25	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					323	330		10.1038/nbt.2864	http://dx.doi.org/10.1038/nbt.2864			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24714478				2022-12-27	WOS:000334340800013
J	Hay, M; Thomas, DW; Craighead, JL; Economides, C; Rosenthal, J				Hay, Michael; Thomas, David W.; Craighead, John L.; Economides, Celia; Rosenthal, Jesse			Clinical development success rates for investigational drugs	NATURE BIOTECHNOLOGY			English	Article							PRODUCTIVITY; TRENDS; SCALE; RISKS; SCOPE	The most comprehensive survey of clinical success rates across the drug industry to date shows productivity may be even lower than previous estimates.	[Hay, Michael; Rosenthal, Jesse] Sagient Res Syst, BioMedTracker, San Diego, CA 92122 USA; [Thomas, David W.; Economides, Celia] BIO, Washington, DC USA; [Craighead, John L.] Biotech Strategy & Analyt, Rockville, MD USA		Hay, M (corresponding author), Sagient Res Syst, BioMedTracker, San Diego, CA 92122 USA.	mhay@sagientresearch.com			Sagient Research Systems; Biotechnology Industry Organization (BIO)	Sagient Research Systems; Biotechnology Industry Organization (BIO)	This research was supported by Sagient Research Systems and the Biotechnology Industry Organization (BIO). The authors are indebted to the analysts at BioMedTracker who have collected these data. We would also like to thank our colleagues at BIO and BioMedTracker for their input and advice in the development of this study. The authors are solely responsible for the design, conduct and analysis of the study, and the conclusions that are drawn. The opinions expressed in this article are those of the authors and do not necessarily reflect the views of their employers.	Abrantes-Metz R., 2004, PHARM DEV PHASES DUR; Arora A, 2009, MANAGE SCI, V55, P1638, DOI 10.1287/mnsc.1090.1055; Cockburn IM, 2001, J HEALTH ECON, V20, P1033, DOI 10.1016/S0167-6296(01)00108-4; Cohen FJ, 2005, NAT REV DRUG DISCOV, V4, P78, DOI 10.1038/nrd1610; Danzon PM, 2005, J HEALTH ECON, V24, P317, DOI 10.1016/j.jhealeco.2004.09.006; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DIMASI JA, 1995, CLIN PHARMACOL THER, V58, P1, DOI 10.1016/0009-9236(95)90066-7; DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; Edelman M.J., 2010, 2010 AM SOC CLIN ONC; EvaluatePharma, 2012, WORLD PREV 2018 EMBR; Henderson R, 1996, RAND J ECON, V27, P32, DOI 10.2307/2555791; Kaitin KI, 2011, CLIN PHARMACOL THER, V89, P183, DOI 10.1038/clpt.2010.286; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lloyd I., 2011, PHARM R D ANN REV 20; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P87, DOI 10.1038/nrd3946; Pharmaceutical Research and Manufacturers of America, 2011, PHARM RES MAN AM ANN; SHECK L, 1984, CLIN PHARMACOL THER, V36, P574, DOI 10.1038/clpt.1984.224; Tucker S.A., 1988, OUTCOME RES NEW MOL	20	1365	1423	16	262	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					40	51		10.1038/nbt.2786	http://dx.doi.org/10.1038/nbt.2786			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24406927				2022-12-27	WOS:000329513000013
J	Huggett, B				Huggett, Brady			Public biotech 2012-the numbers	NATURE BIOTECHNOLOGY			English	Article																			0	18	19	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					697	703		10.1038/nbt.2653	http://dx.doi.org/10.1038/nbt.2653			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23929343				2022-12-27	WOS:000322911000015
J	Perry, ACF				Perry, Anthony C. F.			A caffeine fix for human nuclear transfer?	NATURE BIOTECHNOLOGY			English	Editorial Material							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; MOUSE ZYGOTES; OOCYTES; EMBRYOS		Univ Bath, Dept Biol & Biochem, Lab Mammalian Mol Embryol, Bath BA2 7AY, Avon, England	University of Bath	Perry, ACF (corresponding author), Univ Bath, Dept Biol & Biochem, Lab Mammalian Mol Embryol, Bath BA2 7AY, Avon, England.	a.c.f.perry@bath.ac.uk		Perry, Tony/0000-0003-3136-5355	Medical Research Council [G1000839] Funding Source: Medline; MRC [G1000839] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Han ZM, 2010, J PROTEOME RES, V9, P6025, DOI 10.1021/pr100827j; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Nazor KL, 2012, EMBO REP, V13, P890, DOI 10.1038/embor.2012.134; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Perry ACF, 2008, EMBO REP, V9, P246, DOI 10.1038/embor.2008.22; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Stojkovic M, 2005, REPROD BIOMED ONLINE, V11, P226; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; VerMilyea MD, 2011, EMBO J, V30, P1841, DOI 10.1038/emboj.2011.92; WILLADSEN SM, 1986, NATURE, V320, P63, DOI 10.1038/320063a0	13	0	0	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					717	719		10.1038/nbt.2658	http://dx.doi.org/10.1038/nbt.2658			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23929349				2022-12-27	WOS:000322911000020
J	Friend, SH; Norman, TC				Friend, Stephen H.; Norman, Thea C.			Metcalfe's law and the biology information commons	NATURE BIOTECHNOLOGY			English	Editorial Material									[Friend, Stephen H.] Sage Bionetworks, Seattle, WA 98109 USA; [Norman, Thea C.] Sage Bionetworks, Strateg Dev, Seattle, WA USA		Friend, SH (corresponding author), Sage Bionetworks, Seattle, WA 98109 USA.	friend@sagebase.org; thea.norman@sagebase.org						Carse J.P., 1986, FINITE INFINITE GAME; Cheng W., SCI TRANSL IN PRESS; Gentleman R, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1034; Gray J., 2009, 4 PARADIGM DATA INTE, pxvii; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Hewitt J., 2011, HLTH LIFE SCI O WYMA; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; National Research Council (US), 2011, COMM FRAM DEV NEW TA; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Shapiro C., 1999, INFORM RULES; Sweeney L, 2000, 3 CARN MELL U; Wruck W, 2014, BRIEF BIOINFORM, V15, P65, DOI 10.1093/bib/bbs064	12	25	25	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2013	31	4					297	303		10.1038/nbt.2555	http://dx.doi.org/10.1038/nbt.2555			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	120TI	23563423	hybrid			2022-12-27	WOS:000317195500018
J	Bubela, T; Gold, ER; Graff, GD; Cahoy, DR; Nicol, D; Castle, D				Bubela, Tania; Gold, E. Richard; Graff, Gregory D.; Cahoy, Daniel R.; Nicol, Dianne; Castle, David			Patent landscaping for life sciences innovation: toward consistent and transparent practices	NATURE BIOTECHNOLOGY			English	Editorial Material							CITATIONS; QUALITY; GENOME		[Bubela, Tania] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Gold, E. Richard] McGill Univ, Fac Law, Montreal, PQ, Canada; [Graff, Gregory D.] Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA; [Cahoy, Daniel R.] Penn State Univ, Smeal Coll Business, University Pk, PA 16802 USA; [Nicol, Dianne] Univ Tasmania, Fac Law, Hobart, Tas, Australia; [Castle, David] Univ Edinburgh, Innogen Inst, Edinburgh, Midlothian, Scotland	University of Alberta; McGill University; Colorado State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Tasmania; University of Edinburgh	Bubela, T (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	tbubela@ualberta.ca	Nicol, Dianne/J-7253-2014; Bubela, Tania/F-4860-2014	Nicol, Dianne/0000-0002-6553-2839; Bubela, Tania/0000-0002-0807-2899; Graff, Gregory/0000-0002-9140-0901; Castle, David/0000-0002-6884-0001; Gold, E. Richard/0000-0002-3789-9238				Allison JR, 2011, GEORGETOWN LAW J, V99, P677; [Anonymous], 2012, MANAGING KNOWLEDGE S; Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Bonino D, 2010, WORLD PAT INF, V32, P30, DOI 10.1016/j.wpi.2009.05.008; Breitzman AF, 2002, J INFORM SCI, V28, P187, DOI 10.1177/016555150202800302; Bubela T, 2010, CELL STEM CELL, V7, P25, DOI 10.1016/j.stem.2010.06.010; Gold E.R., 2012, INF SCI, V22, P76; Hall BH, 2005, RAND J ECON, V36, P16; Hall Bronwyn H., 2001, 8498 NBER; Holman C.M., 2012, UMKC LAW REV, V80, P563; Holman CM, 2012, NAT BIOTECHNOL, V30, P240, DOI 10.1038/nbt.2146; Huys I, 2009, NAT BIOTECHNOL, V27, P903, DOI 10.1038/nbt1009-903; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Lanjouw JO, 2004, ECON J, V114, P441, DOI 10.1111/j.1468-0297.2004.00216.x; Lee S, 2009, TECHNOL FORECAST SOC, V76, P769, DOI 10.1016/j.techfore.2009.01.003; Lenoir T, 2009, J BIOMED DISCOV COLL, V4; OECD, 2009, MEAS CAP; Organisation for Economic Cooperation and Development (OECD), 2011, COLL MECH INT PROP M; Parliament, 2010, DEF STRAT; SMALL H, 1985, SCIENTOMETRICS, V8, P321, DOI 10.1007/BF02018057; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502; United Kingdom Intellectual Property Office, 2011, REG MED PAT LANDSC 2; United Nations Environment Program, 2010, FIN REP PAT CLEAN EN; Yang Y, 2008, WORLD PAT INF, V30, P280, DOI 10.1016/j.wpi.2008.01.007	24	37	39	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					202	207		10.1038/nbt.2521	http://dx.doi.org/10.1038/nbt.2521			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	110JX	23471065				2022-12-27	WOS:000316439500010
J	Wong, AP; Bear, CE; Chin, S; Pasceri, P; Thompson, TO; Huan, LJ; Ratjen, F; Ellis, J; Rossant, J				Wong, Amy P.; Bear, Christine E.; Chin, Stephanie; Pasceri, Peter; Thompson, Tadeo O.; Huan, Ling-Jun; Ratjen, Felix; Ellis, James; Rossant, Janet			Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein	NATURE BIOTECHNOLOGY			English	Article							CYSTIC-FIBROSIS; LUNG MORPHOGENESIS; DEFINITIVE ENDODERM; GROWTH-FACTOR; BASAL-CELLS; MOUSE LUNG; F508DEL-CFTR; MULTIPOTENT; MECHANISMS; GENERATION	Cystic fibrosis (CF) is a fatal genetic disease caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which regulates chloride and water transport across all epithelia and affects multiple organs, including the lungs. Here we report an in vitro directed differentiation protocol for generating functional CFTR-expressing airway epithelia from human embryonic stem cells. Carefully timed treatment by exogenous growth factors that mimic endoderm developmental pathways in vivo followed by air-liquid interface culture results in maturation of patches of tight junction-coupled differentiated airway epithelial cells that demonstrate active CFTR transport function. As a proof of concept, treatment of CF patient induced pluripotent stem cell-derived epithelial cells with a small-molecule compound to correct for the common CF processing mutation resulted in enhanced plasma membrane localization of mature CFTR protein. Our study provides a method for generating patient-specific airway epithelial cells for disease modeling and in vitro drug testing.	[Wong, Amy P.; Pasceri, Peter; Ellis, James; Rossant, Janet] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Wong, Amy P.; Thompson, Tadeo O.; Ellis, James] Ontario Human Induced Pluripotent Stem Cell Facil, Toronto, ON, Canada; [Bear, Christine E.; Chin, Stephanie; Huan, Ling-Jun] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Ratjen, Felix] Hosp Sick Children, Program Physiol & Expt Med, Toronto, ON M5G 1X8, Canada; [Ratjen, Felix] Hosp Sick Children, Div Resp Med, Toronto, ON M5G 1X8, Canada; [Ellis, James; Rossant, Janet] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Rossant, Janet] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Rossant, J (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jellis@sickkids.ca; janet.rossant@sickkids.ca	Ellis, James/F-4789-2011	Ellis, James/0000-0002-4400-0091; Ratjen, Felix/0000-0003-4057-6592; Wong, Amy/0000-0002-9580-1980	Canadian Institutes of Health Research [GPG-102171]; Ontario Ministry of Economic Development and Innovation (MEDI); MEDI Post-doctoral Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Economic Development and Innovation (MEDI); MEDI Post-doctoral Award	We would like to thank S. Yamanaka (CiRA, Kyoto, Japan) and A. Nagy (Samuel Lunenfeld Research Institute, Toronto, Ontario, Canada) for providing human iPSC lines (201B7, 253G1 and PB-4Fout, respectively). We would also like to thank R. Bridges (Rosalind Franklin University, Chicago) who provided the C18 analog. This work was funded by an Emerging Team grant from the Canadian Institutes of Health Research (GPG-102171) to C. E. B., F. R., J.E. and J.R. This work was supported (in part) by an Ontario Ministry of Economic Development and Innovation (MEDI) grant. A. P. W. was a recipient of the MEDI Post-doctoral Award. Monoclonal CFTR antibodies #450 and #660 were courtesy of J.R. Riordan (University of North Carolina, Chapel Hill, North Carolina, USA). CA1, CA2 hESC were obtained from A. Nagy (Mount Sinai Hospital, Toronto, Canada). H9 hESC were obtained from The WiCell Research Institute (Wisconsin, USA).	Ameri J, 2010, STEM CELLS, V28, P45, DOI 10.1002/stem.249; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bellusci S, 1997, DEVELOPMENT, V124, P53; Chiaw PK, 2010, MOL PHARMACOL, V78, P411, DOI 10.1124/mol.110.065862; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Davies JR, 2007, INT J BIOCHEM CELL B, V39, P1943, DOI 10.1016/j.biocel.2007.05.013; Desai TJ, 2006, DEV BIOL, V291, P12, DOI 10.1016/j.ydbio.2005.10.045; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hotta A, 2009, NAT PROTOC, V4, P1828, DOI 10.1038/nprot.2009.201; HUANG TH, 1994, AM J RESP CELL MOL, V10, P192, DOI 10.1165/ajrcmb.10.2.7509163; Kim SK, 1998, P NATL ACAD SCI USA, V95, P13036, DOI 10.1073/pnas.95.22.13036; Kimura J, 2007, PEDIATR DEVEL PATHOL, V10, P335, DOI 10.2350/07-06-0290.1; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; METZLER MD, 1993, ENDOCRINOLOGY, V133, P1990, DOI 10.1210/en.133.5.1990; Minoo P, 2007, MOL CELL BIOL, V27, P2155, DOI 10.1128/MCB.01133-06; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Pan QP, 2004, GENE, V331, P73, DOI 10.1016/j.gene.2004.01.026; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Samadikuchaksaraei A, 2006, TISSUE ENG, V12, P867, DOI 10.1089/ten.2006.12.867; Serls AE, 2005, DEVELOPMENT, V132, P35, DOI 10.1242/dev.01570; Shiratori M, 1996, AM J RESP CELL MOL, V15, P328, DOI 10.1165/ajrcmb.15.3.8810636; SOOD R, 1992, EMBO J, V11, P2487, DOI 10.1002/j.1460-2075.1992.tb05313.x; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Haute L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-105; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; Weaver M, 1999, DEVELOPMENT, V126, P4005; Whitsett JA, 2002, J BIOL CHEM, V277, P22743, DOI 10.1074/jbc.M202253200; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	32	271	302	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					876	U108		10.1038/nbt.2328	http://dx.doi.org/10.1038/nbt.2328			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22922672	Green Accepted			2022-12-27	WOS:000308705700022
J	Huggett, B				Huggett, Brady			Biotech's wellspring: a survey of the health of the private sector	NATURE BIOTECHNOLOGY			English	Article																			0	8	9	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					395	400		10.1038/nbt.2209	http://dx.doi.org/10.1038/nbt.2209			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22565961				2022-12-27	WOS:000303803200016
J	Melnikov, A; Murugan, A; Zhang, XL; Tesileanu, T; Wang, L; Rogov, P; Feizi, S; Gnirke, A; Callan, CG; Kinney, JB; Kellis, M; Lander, ES; Mikkelsen, TS				Melnikov, Alexandre; Murugan, Anand; Zhang, Xiaolan; Tesileanu, Tiberiu; Wang, Li; Rogov, Peter; Feizi, Soheil; Gnirke, Andreas; Callan, Curtis G., Jr.; Kinney, Justin B.; Kellis, Manolis; Lander, Eric S.; Mikkelsen, Tarjei S.			Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay	NATURE BIOTECHNOLOGY			English	Article							NUCLEOTIDE-SEQUENCE; GENE SYNTHESIS; HUMAN GENOME; PROMOTERS; ELEMENTS; DNA; INFORMATION; EXPRESSION; SELECTION; DESIGN	Learning to read and write the transcriptional regulatory code is of central importance to progress in genetic analysis and engineering. Here we describe a massively parallel reporter assay (MPRA) that facilitates the systematic dissection of transcriptional regulatory elements. In MPRA, microarray-synthesized DNA regulatory elements and unique sequence tags are cloned into plasmids to generate a library of reporter constructs. These constructs are transfected into cells and tag expression is assayed by high-throughput sequencing. We apply MPRA to compare >27,000 variants of two inducible enhancers in human cells: a synthetic cAMP-regulated enhancer and the virus-inducible interferon-beta enhancer. We first show that the resulting data define accurate maps of functional transcription factor binding sites in both enhancers at single-nucleotide resolution. We then use the data to train quantitative sequence-activity models (QSAMs) of the two enhancers. We show that QSAMs from two cellular states can be combined to design enhancer variants that optimize potentially conflicting objectives, such as maximizing induced activity while minimizing basal activity.	[Melnikov, Alexandre; Zhang, Xiaolan; Wang, Li; Rogov, Peter; Feizi, Soheil; Gnirke, Andreas; Kellis, Manolis; Lander, Eric S.; Mikkelsen, Tarjei S.] Broad Inst, Cambridge, MA USA; [Murugan, Anand; Tesileanu, Tiberiu; Callan, Curtis G., Jr.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Tesileanu, Tiberiu; Callan, Curtis G., Jr.] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Feizi, Soheil; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Kinney, Justin B.] Cold Spring Harbor Lab, Simons Ctr Quantitat Biol, Cold Spring Harbor, NY 11724 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Mikkelsen, Tarjei S.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Mikkelsen, Tarjei S.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Princeton University; Institute for Advanced Study - USA; Massachusetts Institute of Technology (MIT); Cold Spring Harbor Laboratory; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard University	Mikkelsen, TS (corresponding author), Broad Inst, Cambridge, MA USA.	tarjei@broadinstitute.org	Mikkelsen, Tarjei S/A-1306-2007; Kellis, Manolis/ABE-7385-2020	Mikkelsen, Tarjei S/0000-0002-8133-3135; Kellis, Manolis/0000-0001-7113-9630; PPCT, Leo/0000-0003-0897-4830; Kinney, Justin/0000-0003-1897-3778; Tesileanu, Tiberiu/0000-0003-3107-3088	Broad Institute; Harvard Stem Cell Institute; National Human Genome Research Institute [R01HG004037]; Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory; National Science Foundation (NSF) [PHY-0957573, PHY-1022140]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER; Division Of Physics [0957573] Funding Source: National Science Foundation	Broad Institute; Harvard Stem Cell Institute; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors would like to thank E. M. LeProust and S. Chen of Agilent for oligonucleotide library synthesis, R. P. Deering for assistance with Sendai virus infections and the staff of the Broad Institute and the Bauer Core facilities for assistance with data generation. This project was supported by funds from the Broad Institute, the Harvard Stem Cell Institute (T. S. M.), National Human Genome Research Institute grant R01HG004037 (M. K.), the Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory (J.B.K.), National Science Foundation (NSF) grant PHY-0957573 (C. G. C., T. T.) and NSF grant PHY-1022140 (A. Mur.).	Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; BENBROOK DM, 1994, NUCLEIC ACIDS RES, V22, P1463, DOI 10.1093/nar/22.8.1463; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bishop C. M, 2006, PATTERN RECOGNITION; Carey M., 2009, TRANSCRIPTIONAL REGU; De Mey M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-34; Dorer DE, 2009, ADV DRUG DELIVER REV, V61, P554, DOI 10.1016/j.addr.2009.03.013; Edelman GM, 2000, P NATL ACAD SCI USA, V97, P3038, DOI 10.1073/pnas.040569897; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662, DOI 10.1073/pnas.85.18.6662; Holland J. H., 1992, ADAPTATION NATURAL A; JONSSON J, 1993, NUCLEIC ACIDS RES, V21, P733, DOI 10.1093/nar/21.3.733; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Matzas M, 2010, NAT BIOTECHNOL, V28, P1291, DOI 10.1038/nbt.1710; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Schlabach MR, 2010, P NATL ACAD SCI USA, V107, P2538, DOI 10.1073/pnas.0914803107; SCHNEIDER TD, 1989, NUCLEIC ACIDS RES, V17, P659, DOI 10.1093/nar/17.2.659; STORMO GD, 1986, NUCLEIC ACIDS RES, V14, P6661, DOI 10.1093/nar/14.16.6661; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399	29	383	393	5	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					271	+		10.1038/nbt.2137	http://dx.doi.org/10.1038/nbt.2137			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22371084	Green Accepted, Green Submitted			2022-12-27	WOS:000301303800024
J	Huggett, B				Huggett, Brady			The blinded buyer	NATURE BIOTECHNOLOGY			English	Letter								Overpaying for an item, whether a used car or a biotech firm, happens because there is a disparity of knowledge between buyer and seller.											0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					139	140		10.1038/nbt.2094	http://dx.doi.org/10.1038/nbt.2094			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22318028				2022-12-27	WOS:000300269100012
J	De, S; Michor, F				De, Subhajyoti; Michor, Franziska			DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes	NATURE BIOTECHNOLOGY			English	Article							COPY-NUMBER; GENES; REPAIR; RECOMBINATION; CHECKPOINT; EVOLUTION; DISEASE; POOLS; CELLS	Somatic copy-number alterations (SCNA) are a hallmark of many cancer types, but the mechanistic basis underlying their genome-wide patterns remains incompletely understood. Here we integrate data on DNA replication timing, long-range interactions between genomic material, and 331,724 SCNAs from 2,792 cancer samples classified into 26 cancer types. We report that genomic regions of similar replication timing are clustered spatially in the nucleus, that the two boundaries of SCNAs tend to be found in such regions, and that regions replicated early and late display distinct patterns of frequencies of SCNA boundaries, SCNA size and a preference for deletions over insertions. We show that long-range interaction and replication timing data alone can identify a significant proportion of SCNAs in an independent test data set. We propose a model for the generation of SCNAs in cancer, suggesting that data on spatial proximity of regions replicating at the same time can be used to predict the mutational landscapes of cancer genomes.	[De, Subhajyoti; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [De, Subhajyoti; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	De, S (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	subho@jimmy.harvard.edu; michor@jimmy.harvard.edu			National Cancer Institute's initiative to found Physical Science-Oncology Centers [U54CA143798]; Human Frontier Science Program long-term fellowship; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	National Cancer Institute's initiative to found Physical Science-Oncology Centers; Human Frontier Science Program long-term fellowship(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank K. Polyak, A. Melnick, K.J. Patel, A. Chakravarti and R. Beroukhim for comments and discussions. S. D. is a recipient of Human Frontier Science Program long-term fellowship and is a Research Fellow at King's College, Cambridge. This work was funded by the National Cancer Institute's initiative to found Physical Science-Oncology Centers (U54CA143798).	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Fisher R. A., 1966, DESIGN EXPT; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gilbert DM, 2010, NAT REV GENET, V11, P673, DOI 10.1038/nrg2830; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Koboldt DC, 2010, BRIEF BIOINFORM, V11, P484, DOI 10.1093/bib/bbq016; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lukasova E, 1997, HUM GENET, V100, P525, DOI 10.1007/s004390050547; Meister P, 2006, CELL, V125, P1233, DOI 10.1016/j.cell.2006.06.014; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Rheinfurth MH, 1998, PROBABILITY STAT AER; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; SNYDER RD, 1988, MUTAT RES, V200, P193, DOI 10.1016/0027-5107(88)90082-6; Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Watanabe Y, 2002, HUM MOL GENET, V11, P13, DOI 10.1093/hmg/11.1.13; Wijchers PJ, 2011, TRENDS GENET, V27, P63, DOI 10.1016/j.tig.2010.11.001; Woodfine K, 2005, CELL CYCLE, V4, P172, DOI 10.4161/cc.4.1.1350; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	32	119	123	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1103	U119		10.1038/nbt.2030	http://dx.doi.org/10.1038/nbt.2030			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22101487	Green Accepted			2022-12-27	WOS:000298038700019
J	Fudenberg, G; Getz, G; Meyerson-, M; Mirny, LA				Fudenberg, Geoff; Getz, Gad; Meyerson-, Matthew; Mirny, Leonid A.			High order chromatin architecture shapes the landscape of chromosomal alterations in cancer	NATURE BIOTECHNOLOGY			English	Article							SEQUENCING REVEALS; COPY-NUMBER; GENOME; REARRANGEMENTS; TRANSLOCATIONS; MECHANISMS; PROXIMITY; MUTATION; CELLS; LOCI	The accumulation of data on structural variation in cancer genomes provides an opportunity to better understand the mechanisms of genomic alterations and the forces of selection that act upon these alterations in cancer. Here we test evidence supporting the influence of two major forces, spatial chromosome structure and purifying (or negative) selection, on the landscape of somatic copy-number alterations (SCNAs) in cancer(1). Using a maximum likelihood approach, we compare SCNA maps and three-dimensional genome architecture as determined by genome-wide chromosome conformation capture (HiC) and described by the proposed fractal-globule model(2,3). This analysis suggests that the distribution of chromosomal alterations in cancer is spatially related to three-dimensional genomic architecture and that purifying selection, as well as positive selection, influences SCNAs during somatic evolution of cancer cells.	[Getz, Gad; Meyerson-, Matthew; Mirny, Leonid A.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Fudenberg, Geoff] Harvard Univ, Program Biophys, Boston, MA 02115 USA; [Meyerson-, Matthew] Harvard Univ, Sch Med, Boston, MA USA; [Meyerson-, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Meyerson-, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Mirny, Leonid A.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Mirny, LA (corresponding author), Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA.	leonid@mit.edu	Meyerson, Matthew L/E-7123-2012; Mirny, Leonid/ABE-8083-2020	Mirny, Leonid/0000-0002-0785-5410; Fudenberg, Geoffrey/0000-0001-5905-6517; Meyerson, Matthew/0000-0002-9133-8108	US National Institutes of Health/National Cancer Institute Physical Sciences Oncology Center at MIT [U54CA143874]; TCGA (NIH) [U24CA143845, U24CA144025, U24CA143867]; NATIONAL CANCER INSTITUTE [U24CA143867, U24CA144025, U24CA143845, U54CA143874] Funding Source: NIH RePORTER	US National Institutes of Health/National Cancer Institute Physical Sciences Oncology Center at MIT; TCGA (NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Mirny Lab for helpful conversations, in particular with C. McFarland regarding purifying selection and M. Imakaev regarding fractal globules. We thank C. Mermel for an introduction to SCNA data. We thank V. Agarwala, J. Engrietz, R. McCord and J. Dekker for helpful comments and suggestions. This work was supported by the US National Institutes of Health/National Cancer Institute Physical Sciences Oncology Center at MIT (U54CA143874). G. G. and M. M. are TCGA-funded investigators (NIH U24CA143845, U24CA144025 and U24CA143867).	Armitage P, 2001, STAT METHODS MED RES, V4th; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; GROSBERG AY, 1988, J PHYS-PARIS, V49, P2095, DOI 10.1051/jphys:0198800490120209500; Haber DA, 2007, NATURE, V446, P145, DOI 10.1038/446145a; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2000, CELL, V103, P723, DOI 10.1016/S0092-8674(00)00176-8; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; Moran P., 1962, STAT PROCESSES EVOLU; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Wijchers PJ, 2011, TRENDS GENET, V27, P63, DOI 10.1016/j.tig.2010.11.001; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	27	145	149	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1109	U75		10.1038/nbt.2049	http://dx.doi.org/10.1038/nbt.2049			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22101486	Green Submitted, Green Accepted			2022-12-27	WOS:000298038700020
J	Bethencourt, V; Scott, C				Bethencourt, Victor; Scott, Christopher			Going viral	NATURE BIOTECHNOLOGY			English	Letter																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					975	975		10.1038/nbt.2033	http://dx.doi.org/10.1038/nbt.2033			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22068529				2022-12-27	WOS:000296801300013
J	Beylin, D; Chrisman, CJ; Weingarten, M				Beylin, David; Chrisman, Cara J.; Weingarten, Michael			Granting you success	NATURE BIOTECHNOLOGY			English	Editorial Material									[Beylin, David; Chrisman, Cara J.; Weingarten, Michael] NCI, Small Business Innovat Res Dev Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Beylin, D (corresponding author), NCI, Small Business Innovat Res Dev Ctr, Bethesda, MD 20892 USA.	ncisbir@mail.nih.gov							0	6	6	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2011	29	7					567	570		10.1038/bioe.2011.5	http://dx.doi.org/10.1038/bioe.2011.5			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	790NM	21874663				2022-12-27	WOS:000292595200008
J	Kaplan, N; Dekker, J				Kaplan, Noam; Dekker, Job			High-throughput genome scaffolding from in vivo DNA interaction frequency	NATURE BIOTECHNOLOGY			English	Article							MAMMALIAN GENOMES; ORGANIZATION; SEQUENCE; ASSEMBLIES; PRINCIPLES; LANDSCAPE; DOMAINS	Despite advances in DNA sequencing technology, assembly of complex genomes remains a major challenge, particularly for genomes sequenced using short reads, which yield highly fragmented assemblies(1-3). Here we show that genome-wide in vivo chromatin interaction frequency data, which are measurable with chromosome conformation capture-based experiments, can be used as genomic distance proxies to accurately position individual contigs without requiring any sequence overlap. We also use these data to construct approximate genome scaffolds de novo. Applying our approach to incomplete regions of the human genome, we predict the positions of 65 previously unplaced contigs, in agreement with alternative methods in 26/31 cases attempted in common. Our approach can theoretically bridge any gap size and should be applicable to any species for which global chromatin interaction data can be generated.	[Kaplan, Noam; Dekker, Job] Univ Massachusetts, Sch Med, Program Syst Biol, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Kaplan, N (corresponding author), Univ Massachusetts, Sch Med, Program Syst Biol, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	noam.kaplan2@gmail.com; job.dekker@umassmed.edu	Kaplan, Noam/K-4383-2019; Kaplan, Noam/A-3544-2011	Kaplan, Noam/0000-0001-9940-1987; Kaplan, Noam/0000-0001-9940-1987	National Human Genome Research Institute [HG003143]; Long-Term Fellowship from the Human Frontier Science Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Long-Term Fellowship from the Human Frontier Science Program(Human Frontier Science Program); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank B.R. Lajoie for help with processing of the Hi-C data. We thank the members of the Dekker Lab and G. Fudenberg for helpful discussions. This study is supported by the National Human Genome Research Institute (HG003143 to J.D.). N.K. is supported by a Long-Term Fellowship from the Human Frontier Science Program.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Baker M, 2012, NAT METHODS, V9, P333, DOI 10.1038/nmeth.1935; Birney E, 2011, NAT METHODS, V8, P59, DOI 10.1038/nmeth0111-59; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Genovese G, 2013, NAT GENET, V45, P406, DOI 10.1038/ng.2565; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Kaplan N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-196; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Moissiard G, 2012, SCIENCE, V336, P1448, DOI 10.1126/science.1221472; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; NOCEDAL J, 1980, MATH COMPUT, V35, P773, DOI 10.1090/S0025-5718-1980-0572855-7; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Su JH, 2020, CELL, V182, P1641, DOI 10.1016/j.cell.2020.07.032; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	31	110	122	5	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1143	+		10.1038/nbt.2768	http://dx.doi.org/10.1038/nbt.2768			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24270850	Green Accepted, Green Submitted			2022-12-27	WOS:000328251900029
J	Spiess, C; Merchant, M; Huang, A; Zheng, Z; Yang, NY; Peng, J; Ellerman, D; Shatz, W; Reilly, D; Yansura, DG; Scheer, JM				Spiess, Christoph; Merchant, Mark; Huang, Arthur; Zheng, Zhong; Yang, Nai-Ying; Peng, Jing; Ellerman, Diego; Shatz, Whitney; Reilly, Dorothea; Yansura, Daniel G.; Scheer, Justin M.			Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies	NATURE BIOTECHNOLOGY			English	Article							HEPATOCYTE GROWTH; MET AMPLIFICATION; EGFR; HETERODIMERS; EXCHANGE; CANCER	By enabling the simultaneous engagement of two distinct targets, bispecific antibodies broaden the potential utility of antibody-based therapies. However, bispecific-antibody design and production remain challenging, owing to the need to incorporate two distinct heavy and light chain pairs while maintaining natural nonimmunogenic antibody architecture. Here we present a bispecific-antibody production strategy that relies on co-culture of two bacterial strains, each expressing a half-antibody. Using this approach, we produce 28 unique bispecific antibodies. A bispecific antibody against the receptor tyrosine kinases MET and EGFR binds both targets monovalently, inhibits their signaling, and suppresses MET and EGFR-driven cell and tumor growth. Our strategy allows rapid generation of bispecific antibodies from any two existing antibodies and yields milligram to gram quantities of bispecific antibodies sufficient for a wide range of discovery and preclinical applications.	[Spiess, Christoph; Huang, Arthur; Yansura, Daniel G.] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Merchant, Mark; Zheng, Zhong; Yang, Nai-Ying; Peng, Jing] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Ellerman, Diego; Shatz, Whitney; Scheer, Justin M.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Reilly, Dorothea] Genentech Inc, Dept Early Stage Cell Culture, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Spiess, C (corresponding author), Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA.	spiess.christoph@gene.com; scheer.justin@gene.com		Merchant, Mark/0000-0003-0690-8581; Shatz-Binder, Whitney/0000-0003-2996-501X; Spiess, Christoph/0000-0002-0570-9700				Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; BAUMAL R, 1971, J EXP MED, V134, P1316, DOI 10.1084/jem.134.5.1316; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Chan CEZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010261; Chelius D, 2010, MABS-AUSTIN, V2, P309, DOI 10.4161/mabs.2.3.11791; Davis JH, 2010, PROTEIN ENG DES SEL, V23, P195, DOI 10.1093/protein/gzp094; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Jackman J, 2010, J BIOL CHEM, V285, P20850, DOI 10.1074/jbc.M110.113910; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Makino T, 2011, METAB ENG, V13, P241, DOI 10.1016/j.ymben.2010.11.002; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Reilly DE, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P331, DOI 10.1007/978-3-642-01147-4_26; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; Strop P, 2012, J MOL BIOL, V420, P204, DOI 10.1016/j.jmb.2012.04.020; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; Wu CB, 2009, MABS, V1, P339, DOI 10.4161/mabs.1.4.8755; Xu H, 2011, CLIN CANCER RES, V17, P4425, DOI 10.1158/1078-0432.CCR-10-3339; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zhang YW, 2010, CANCER RES, V70, P6880, DOI 10.1158/0008-5472.CAN-10-0898; Zhang YW, 2005, ONCOGENE, V24, P101, DOI 10.1038/sj.onc.1208181	30	132	219	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					753	+		10.1038/nbt.2621	http://dx.doi.org/10.1038/nbt.2621			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23831709				2022-12-27	WOS:000322911000026
J	Gilleron, J; Querbes, W; Zeigerer, A; Borodovsky, A; Marsico, G; Schubert, U; Manygoats, K; Seifert, S; Andree, C; Stoter, M; Epstein-Barash, H; Zhang, LG; Koteliansky, V; Fitzgerald, K; Fava, E; Bickle, M; Kalaidzidis, Y; Akinc, A; Maier, M; Zerial, M				Gilleron, Jerome; Querbes, William; Zeigerer, Anja; Borodovsky, Anna; Marsico, Giovanni; Schubert, Undine; Manygoats, Kevin; Seifert, Sarah; Andree, Cordula; Stoeter, Martin; Epstein-Barash, Hila; Zhang, Ligang; Koteliansky, Victor; Fitzgerald, Kevin; Fava, Eugenio; Bickle, Marc; Kalaidzidis, Yannis; Akinc, Akin; Maier, Martin; Zerial, Marino			Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape	NATURE BIOTECHNOLOGY			English	Article							IN-VIVO; TARGETED DELIVERY; RNAI THERAPEUTICS; CATIONIC LIPIDS; INTERFERING RNA; GENE; MECHANISMS; EFFICIENT; DESIGN; RAB	Delivery of short interfering RNAs (siRNAs) remains a key challenge in the development of RNA interference (RNAi) therapeutics. A better understanding of the mechanisms of siRNA cellular uptake, intracellular transport and endosomal release could critically contribute to the improvement of delivery methods. Here we monitored the uptake of lipid nanoparticles (LNPs) loaded with traceable siRNAs in different cell types in vitro and in mouse liver by quantitative fluorescence imaging and electron microscopy. We found that LNPs enter cells by both constitutive and inducible pathways in a cell type-specific manner using clathrin-mediated endocytosis as well as macropinocytosis. By directly detecting colloidal-gold particles conjugated to siRNAs, we estimated that escape of siRNAs from endosomes into the cytosol occurs at low efficiency (1-2%) and only during a limited window of time when the LNPs reside in a specific compartment sharing early and late endosomal characteristics. Our results provide insights into LNP-mediated siRNA delivery that can guide development of the next generation of delivery systems for RNAi therapeutics.	[Gilleron, Jerome; Zeigerer, Anja; Marsico, Giovanni; Schubert, Undine; Manygoats, Kevin; Seifert, Sarah; Andree, Cordula; Stoeter, Martin; Fava, Eugenio; Bickle, Marc; Kalaidzidis, Yannis; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Querbes, William; Borodovsky, Anna; Epstein-Barash, Hila; Zhang, Ligang; Koteliansky, Victor; Fitzgerald, Kevin; Akinc, Akin; Maier, Martin] Alnylam Pharmaceut, Cambridge, MA USA; [Fava, Eugenio] German Ctr Neurodegenerat Dis, Bonn, Germany; [Kalaidzidis, Yannis] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia	Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Lomonosov Moscow State University	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	zerial@mpi-cbg.de	Kalaidzidis, Yannis/H-3094-2016; Gilleron, Jerome/GRX-8574-2022; Zeigerer, Anja/AAC-8953-2021	Kalaidzidis, Yannis/0000-0002-6137-1193; Gilleron, Jerome/0000-0002-6389-8685; Fava, Eugenio/0000-0002-3737-0334; Zeigerer, Anja/0000-0003-4072-0566	Max Planck Society (M.P.G.); Virtual Liver initiative; German Federal Ministry of Research and Education (BMBF); DFG; Alnylam Pharmaceuticals; EMBO long-term fellowship	Max Planck Society (M.P.G.)(Max Planck Society); Virtual Liver initiative; German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Alnylam Pharmaceuticals; EMBO long-term fellowship(European Molecular Biology Organization (EMBO))	We acknowledge T. Galvez and E. Perini for discussions and comments on the manuscript. We thank J.-M. Verbavatz and J. Peychl, respectively, for the management of the Electron Microscopy Facility and the Light Microscopy Facility. We thank A. Giner for cell culture, W. John and A. Muench-Wuttke from the Biomedical Service Facility for mouse care and injections, A. Pal and R. Villasenor for Rab5-GFP primary human fibroblasts and H-RasG12V cells preparation. We thank D. Butler, R. Kallanthottathil and M. Manoharan for advice on chemistry. This work was financially supported by the Max Planck Society (M.P.G.), the Virtual Liver initiative (http://www.virtual-liver.de) funded by the German Federal Ministry of Research and Education (BMBF), the DFG and Alnylam Pharmaceuticals. J. G. was supported by a grant from EMBO long-term fellowship.	Addepalli H, 2010, NUCLEIC ACIDS RES, V38, P7320, DOI 10.1093/nar/gkq568; Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Akita H, 2010, J CONTROL RELEASE, V143, P311, DOI 10.1016/j.jconrel.2010.01.012; Andaloussi SEL, 2011, NUCLEIC ACIDS RES, V39, P3972, DOI 10.1093/nar/gkq1299; [Anonymous], 2011, NCT01437059, Patent No. [7,745,608, 7745608]; Bartz R, 2011, BIOCHEM J, V435, P475, DOI 10.1042/BJ20101021; Basha G, 2011, MOL THER, V19, P2186, DOI 10.1038/mt.2011.190; Bramsen JB, 2009, NUCLEIC ACIDS RES, V37, P2867, DOI 10.1093/nar/gkp106; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Damha M J, 1993, Methods Mol Biol, V20, P81; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Hafez IM, 2001, GENE THER, V8, P1188, DOI 10.1038/sj.gt.3301506; Hauser PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009463; Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; Landesman Yosef, 2010, Silence, V1, P16, DOI 10.1186/1758-907X-1-16; Lee SH, 2008, J CONTROL RELEASE, V125, P25, DOI 10.1016/j.jconrel.2007.09.011; Lewis J, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-19; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maier M., 2012, 8 ANN M OL THER SOC; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pei Y, 2010, RNA, V16, P2553, DOI 10.1261/rna.2255810; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Romberg B, 2008, PHARM RES, V25, P55, DOI 10.1007/s11095-007-9348-7; Sakurai Y, 2011, BIOMATERIALS, V32, P5733, DOI 10.1016/j.biomaterials.2011.04.047; Schmees C, 2012, MOL BIOL CELL, V23, P2571, DOI 10.1091/mbc.E11-04-0317; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Shim MS, 2010, FEBS J, V277, P4814, DOI 10.1111/j.1742-4658.2010.07904.x; Sliva K, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-248; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Tamura A, 2009, BIOMACROMOLECULES, V10, P1818, DOI 10.1021/bm900252d; Tomas MI, 2010, J VIROL, V84, P11101, DOI 10.1128/JVI.00988-10; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Valiunas V, 2005, J PHYSIOL-LONDON, V568, P459, DOI 10.1113/jphysiol.2005.090985; Wei J, 2011, MOL PHARMACOL, V79, P953, DOI 10.1124/mol.110.070409; Wheeler JJ, 1999, GENE THER, V6, P271, DOI 10.1038/sj.gt.3300821; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Xia CF, 2009, MOL PHARMACEUT, V6, P747, DOI 10.1021/mp800194y; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zhang SB, 2012, BIOORG CHEM, V40, P10, DOI 10.1016/j.bioorg.2011.07.005	49	793	831	30	522	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2013	31	7					638	U102		10.1038/nbt.2612	http://dx.doi.org/10.1038/nbt.2612			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	180FS	23792630				2022-12-27	WOS:000321579700021
J	Najm, FJ; Lager, AM; Zaremba, A; Wyatt, K; Caprariello, AV; Factor, DC; Karl, RT; Maeda, T; Miller, RH; Tesar, PJ				Najm, Fadi J.; Lager, Angela M.; Zaremba, Anita; Wyatt, Krysta; Caprariello, Andrew V.; Factor, Daniel C.; Karl, Robert T.; Maeda, Tadao; Miller, Robert H.; Tesar, Paul J.			Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells	NATURE BIOTECHNOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; DIRECT CONVERSION; GROWTH-FACTOR; DOPAMINERGIC-NEURONS; MOUSE FIBROBLASTS; PRECURSOR CELLS; DEFINED FACTORS; DIFFERENTIATION; INDUCTION	Cell-based therapies for myelin disorders, such as multiple sclerosis and leukodystrophies, require technologies to generate functional oligodendrocyte progenitor cells. Here we describe direct conversion of mouse embryonic and lung fibroblasts to induced oligodendrocyte progenitor cells (iOPCs) using sets of either eight or three defined transcription factors. iOPCs exhibit a bipolar morphology and global gene expression profile consistent with bona fide OPCs. They can be expanded in vitro for at least five passages while retaining the ability to differentiate into multiprocessed oligodendrocytes. When transplanted to hypomyelinated mice, iOPCs are capable of ensheathing host axons and generating compact myelin. Lineage conversion of somatic cells to expandable iOPCs provides a strategy to study the molecular control of oligodendrocyte lineage identity and may facilitate neurological disease modeling and autologous remyelinating therapies.	[Najm, Fadi J.; Lager, Angela M.; Factor, Daniel C.; Karl, Robert T.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Zaremba, Anita; Wyatt, Krysta; Caprariello, Andrew V.; Miller, Robert H.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Maeda, Tadao] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Tesar, PJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	paul.tesar@case.edu	Tesar, Paul/GPK-5942-2022; Caprariello, Andrew/L-2291-2019; Tesar, Paul J/C-9848-2014	Tesar, Paul/0000-0003-1532-3155; Caprariello, Andrew/0000-0002-2529-5621; Tesar, Paul J/0000-0003-1532-3155; Lager, Angela/0000-0002-6799-8755; Factor, Daniel/0000-0002-3200-7560	US National Institutes of Health (NIH) [MH087877, NS30800, EY019880]; NIH [F31NS083354, T32GM008056]; Case Western Reserve University School of Medicine; New York Stem Cell Foundation; Mt. Sinai Health Care Foundation; Cytometry & Imaging Microscopy; Gene Expression and Genotyping core facilities of the Case Comprehensive Cancer Center [P30CA043703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K08EY019880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS083354, R01NS030800] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University School of Medicine; New York Stem Cell Foundation; Mt. Sinai Health Care Foundation; Cytometry & Imaging Microscopy; Gene Expression and Genotyping core facilities of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by US National Institutes of Health (NIH) grants MH087877 (P. J. T. and R. H. M.), NS30800 (R. H. M.) and EY019880 (T. M.); NIH predoctoral training grants F31NS083354 (A. M. L.) and T32GM008056 (R. T. K.); Case Western Reserve University School of Medicine (P. J. T.); the New York Stem Cell Foundation (P. J. T.); the Mt. Sinai Health Care Foundation (P. J. T.); and the Cytometry & Imaging Microscopy, and the Gene Expression and Genotyping core facilities of the Case Comprehensive Cancer Center (P30CA043703). P. J. T. is a New York Stem Cell Foundation-Robertson Investigator. We are grateful to L. Cooperman, J. Wanta, M. Hitomi, J. Krasno, M. Karl, S. Fyffe-Maricich, S. Wu, M. Pendergast, O. Corradin, T. LaFramboise and P. Scacheri for technical assistance, I. Tsung for artwork, as well as N. Avishai and G. Kidd for 3D scanning electron microscopy imaging and data processing.	Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; CHERNOFF GF, 1981, J HERED, V72, P128, DOI 10.1093/oxfordjournals.jhered.a109442; Crang AT, 1998, J NEUROCYTOL, V27, P541, DOI 10.1023/A:1006960032023; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Goldman SA, 2012, SCIENCE, V338, P491, DOI 10.1126/science.1218071; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Liu ZJ, 2007, DEV BIOL, V302, P683, DOI 10.1016/j.ydbio.2006.10.007; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; Mikula S, 2012, NAT METHODS, V9, P1198, DOI [10.1038/nmeth.2213, 10.1038/NMETH.2213]; Najm FJ, 2011, NAT METHODS, V8, P957, DOI [10.1038/NMETH.1712, 10.1038/nmeth.1712]; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; NOLL E, 1993, DEVELOPMENT, V118, P563; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sim F., 2011, NAT BIOTECHNOL; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Yano S, 2003, J HISTOCHEM CYTOCHEM, V51, P199, DOI 10.1177/002215540305100208; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhang XD, 2005, STEM CELLS, V23, P442, DOI 10.1634/stemcells.2004-0274	37	191	208	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					426	+		10.1038/nbt.2561	http://dx.doi.org/10.1038/nbt.2561			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23584611	Green Accepted			2022-12-27	WOS:000318589600022
J	Brown, J; de Vos, WM; DiStefano, PS; Dore, J; Huttenhower, C; Knight, R; Lawley, TD; Raes, J; Turnbaugh, P				Brown, James; de Vos, Willem M.; DiStefano, Peter S.; Dore, Joel; Huttenhower, Curtis; Knight, Rob; Lawley, Trevor D.; Raes, Jeroen; Turnbaugh, Peter			Translating the human microbiome	NATURE BIOTECHNOLOGY			English	Article									[Brown, James] GlaxoSmithKline, Computat Biol, Collegeville, PA 19426 USA; [de Vos, Willem M.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [de Vos, Willem M.] Univ Helsinki, Acad Finland, Helsinki, Finland; [DiStefano, Peter S.] Second Genome Inc, Res & Dev, San Bruno, CA USA; [Dore, Joel] INRA, Microbiol Alimentat Serv Sante Humaine, Paris, France; [Huttenhower, Curtis] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Lawley, Trevor D.] Wellcome Sanger Trust Inst, Cambridge, England; [Raes, Jeroen] VIB, Flanders, Belgium; [Raes, Jeroen] Vrije Univ Brussel, Flanders, Belgium; [Turnbaugh, Peter] Harvard FAS Ctr Syst Biol, Cambridge, MA USA	GlaxoSmithKline; Wageningen University & Research; Academy of Finland; University of Helsinki; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Harvard T.H. Chan School of Public Health; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Harvard University	Brown, J (corresponding author), GlaxoSmithKline, Computat Biol, Collegeville, PA 19426 USA.	james.r.brown@gsk.com; willem.devos@wur.nl; psd@secondgenome.com; joel.dore@jouy.inra.fr; chuttenh@hsph.harvard.edu; rob.knight@colorado.edu; tl2@sanger.ac.uk; jeroen.raes@vib-vub.be; pturnbaugh@fas.harvard.edu	Knight, Rob/D-1299-2010; Dore, Joel/ABA-8921-2020; raes, jeroen/D-7835-2018	raes, jeroen/0000-0002-1337-041X; Huttenhower, Curtis/0000-0002-1110-0096; Turnbaugh, Peter/0000-0002-0888-2875; Knight, Rob/0000-0002-0975-9019					0	19	32	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2013	31	4					304	308		10.1038/nbt.2543	http://dx.doi.org/10.1038/nbt.2543			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	120TI	23563424				2022-12-27	WOS:000317195500019
J	Fernandez, JM; Stein, RM; Lo, AW				Fernandez, Jose-Maria; Stein, Roger M.; Lo, Andrew W.			Commercializing biomedical research through securitization techniques	NATURE BIOTECHNOLOGY			English	Review							DRUG DEVELOPMENT	Biomedical innovation has become riskier, more expensive and more difficult to finance with traditional sources such as private and public equity. Here we propose a financial structure in which a large number of biomedical programs at various stages of development are funded by a single entity to substantially reduce the portfolio's risk. The portfolio entity can finance its activities by issuing debt, a critical advantage because a much larger pool of capital is available for investment in debt versus equity. By employing financial engineering techniques such as securitization, it can raise even greater amounts of more-patient capital. In a simulation using historical data for new molecular entities in oncology from 1990 to 2011, we find that megafunds of $5-15 billion may yield average investment returns of 8.9-11.4% for equity holders and 5-8% for 'research-backed obligation' holders, which are lower than typical venture-capital hurdle rates but attractive to pension funds, insurance companies and other large institutional investors.	[Fernandez, Jose-Maria; Stein, Roger M.; Lo, Andrew W.] MIT Sloan Sch Management & Lab Financial Engn, Cambridge, MA USA; [Stein, Roger M.] Moodys Corp, New York, NY USA; [Lo, Andrew W.] MIT CSAIL, Cambridge, MA USA; [Lo, Andrew W.] AlphaSimplex Grp LLC, Cambridge, MA USA; [Lo, Andrew W.] EECS, Cambridge, MA USA	Massachusetts Institute of Technology (MIT)	Lo, AW (corresponding author), MIT Sloan Sch Management & Lab Financial Engn, Cambridge, MA USA.	alo@mit.edu			MIT Laboratory for Financial Engineering	MIT Laboratory for Financial Engineering	L. Han, J. Noraky, A. Singhal and C. Wilfong provided research assistance throughout the entire project, and we also acknowledge A. Bernard, H. H. Chen, M. J. Chen, R. Das and R. Garcia for research support during various phases of the project. Finally we thank the editor, K. Aschheim, and three reviewers for constructive comments and editorial advice, and D. Agus, J. Broderick, L. Cantley, S. Chinchalkar, J. Cox, J. Cummings, O. Dar, A. Das, J. Evans, J. Frangioni, A. Gilman, J. Goldfield, D. Higgons, T. Kalil, E. Kandel, M. Kanef, A. Kimball, D. Jamison, E. Lander, P. Legorreta, L. Lerer, J. Lewent, F. Maisonrouge, P. Mallick, M. Mansoura, N. Marko, A. Metz, R. Merton, F. Murray, K. Murthi, L. Nagahara, R. O'Neill, A. Powers, R. Riggs, D. Roth, M. Said, M. Stevens, K. Swarna, T. Tombrello, I. Wolff, A. Wood, G. Yago, and participants at the Financial Innovations Lab Workshop hosted by the Milken Institute and FasterCures in July 2011, the 2012 Milken Institute Conference, and the 2012 University of Southern California and National Cancer Institute Emerging Approaches in Oncology conference for helpful comments and discussion. The views and opinions expressed in this article are those of the authors only and do not represent the views and opinions of AlphaSimplex, MIT, Moody's Corporation, any of their affiliates or employees, or any of the individuals acknowledged above. Research support from the MIT Laboratory for Financial Engineering is gratefully acknowledged.	Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; American Cancer Society, 2011, CANC FACTS FIG 2011; American Cancer Society, 2011, GLOB CANC FACTS FIG; [Anonymous], 2010, WORLD PREVIEW 2016; [Anonymous], 2012, US KEY STATS; Blinder A.S., 2012, RETHINKING FINANCE N; Bluhm C, 2011, ANNU REV FINANC ECON, V3, P193, DOI 10.1146/annurev-financial-102710-144835; Bohn JR, 2009, WILEY FINANC SER, P1, DOI 10.1002/9781118266830; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; Ernst & Young, 2011, BORD GLOB BIOT REP; Federal Reserve Board of Governors, 2012, FED RES STAT REL TAB; Financial Innovations Lab, 2012, FIX FIN FIN INN TRAN; Finkelstein SN, 2008, REASONABLE RX SOLVIN; Gao X., 2012, PREPRINT; Goodman M, 2009, NAT REV DRUG DISCOV, V8, P927, DOI 10.1038/nrd3049; Harrington SE, 2012, OXFORD HDB EC BIOPHA, P75; Huggett B, 2012, NAT BIOTECHNOL, V30, P395, DOI 10.1038/nbt.2209; Lerner J., 2011, PRIVATE EQUITY VENTU; Lo AW, 2012, J ECON LIT, V50, P151, DOI 10.1257/jel.50.1.151; Lucas D., 2011, MEASURING MANAGING F, P131; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Merton R. C., 1990, CONTINUOUS TIME FINA; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Nanda R., 2011, PREPRINT; National Association of State Retirement Administrators, 2012, NASRA ISS BRIEF PUBL; National Venture Capital Association, 2011, NAT VENT CAP ASS YB; Neftci SN, 2008, ACAD PR ADV FINANC S, P1; Ou S., 2011, CORPORATE DEFAULT RE; Papadopoulos S., 2012, NAT BIOTECHNOL, V29, P184; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Pisano G., 2006, SCI BUSINESS PROMISE; Pisano G.P., 2010, EVOLUTION SCI BASED; Reinhart CM, 2009, THIS TIME IS DIFFERENT: EIGHT CENTURIES OF FINANCIAL FOLLY, P1; Standard & Poor's Rating Services, 2011, 2010 ANN GLOB CORP D; Thomas D., 2012, BIOTECH NOW     0223; United States Department of the Treasury, 2012, LEG SEC PUBL PRIV IN	37	56	56	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					964	975		10.1038/nbt.2374	http://dx.doi.org/10.1038/nbt.2374			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	022NG	23023199	Green Submitted			2022-12-27	WOS:000309965500023
J	Hook, AL; Chang, CY; Yang, J; Luckett, J; Cockayne, A; Atkinson, S; Mei, Y; Bayston, R; Irvine, DJ; Langer, R; Anderson, DG; Williams, P; Davies, MC; Alexander, MR				Hook, Andrew L.; Chang, Chien-Yi; Yang, Jing; Luckett, Jeni; Cockayne, Alan; Atkinson, Steve; Mei, Ying; Bayston, Roger; Irvine, Derek J.; Langer, Robert; Anderson, Daniel G.; Williams, Paul; Davies, Martyn C.; Alexander, Morgan R.			Combinatorial discovery of polymers resistant to bacterial attachment	NATURE BIOTECHNOLOGY			English	Article							CENTRAL VENOUS CATHETERS; THROUGHPUT SURFACE CHARACTERIZATION; BIOFILM FORMATION; BIOMATERIALS; PREVENTION; GROWTH; CHLORHEXIDINE; INFECTIONS; INHIBITION; EXPRESSION	Bacterial attachment and subsequent biofilm formation pose key challenges to the optimal performance of medical devices. In this study, we determined the attachment of selected bacterial species to hundreds of polymeric materials in a high-throughput microarray format. Using this method, we identified a group of structurally related materials comprising ester and cyclic hydrocarbon moieties that substantially reduced the attachment of pathogenic bacteria (Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli). Coating silicone with these 'hit' materials achieved up to a 30-fold (96.7%) reduction in the surface area covered by bacteria compared with a commercial silver hydrogel coating in vitro, and the same material coatings were effective at reducing bacterial attachment in vivo in a mouse implant infection model. These polymers represent a class of materials that reduce the attachment of bacteria that could not have been predicted to have this property from the current understanding of bacteria-surface interactions.	[Hook, Andrew L.; Yang, Jing; Davies, Martyn C.; Alexander, Morgan R.] Univ Nottingham, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England; [Chang, Chien-Yi; Luckett, Jeni; Cockayne, Alan; Atkinson, Steve; Williams, Paul] Univ Nottingham, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Mei, Ying; Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Bayston, Roger] Univ Nottingham, Queens Med Ctr, Sch Clin Sci, Nottingham NG7 2RD, England; [Irvine, Derek J.] Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England; [Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	University of Nottingham; University of Nottingham; Massachusetts Institute of Technology (MIT); University of Nottingham; University of Nottingham; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Alexander, MR (corresponding author), Univ Nottingham, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.	morgan.alexander@nottingham.ac.uk	Chang, Chien-Yi/E-1338-2012; Bayston, Roger/E-7699-2019; Williams, Paul/A-5629-2011; Chang, Chien-Yi/ABH-6848-2020; yang, jing/L-6313-2015; Alexander, Morgan R/C-2506-2009; Bayston, Roger/AAD-5427-2019; Williams, Paul/P-5224-2019; Hook, Andrew L/K-6924-2012	Chang, Chien-Yi/0000-0003-3570-4019; Chang, Chien-Yi/0000-0003-3570-4019; yang, jing/0000-0002-8822-7124; Alexander, Morgan R/0000-0001-5182-493X; Bayston, Roger/0000-0002-8312-3844; Williams, Paul/0000-0002-1920-5036; Hook, Andrew L/0000-0001-7756-8444; Irvine, Derek/0000-0003-1461-9851; Davies, Martyn/0000-0001-7695-0596; Mei, Ying/0000-0002-8508-4076; Atkinson, Steve/0000-0002-5705-8727	Wellcome Trust [085245]; Medical Research Council UK [G0802525]; Royal Society; Medical Research Council [MC_G0802525, G9219778] Funding Source: researchfish; MRC [G9219778, MC_G0802525] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding from the Wellcome Trust (grant no. 085245 and support from N. Shepherd) and the Medical Research Council UK (for the in vivo work; grant no. G0802525) is gratefully acknowledged. M. Alexander gratefully acknowledges the Royal Society for the provision of his Wolfson Research Merit Award. Assistance with ToF-SIMS measurements from D. Scurr is kindly acknowledged. Assistance with the preparation of polymer for in vivo studies by E. Eaves, N. Nguyen and J. Li is kindly acknowledged.	Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; BERGER H, 1982, J BACTERIOL, V152, P1241; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; Caillier L, 2009, EUR J MED CHEM, V44, P3201, DOI 10.1016/j.ejmech.2009.03.031; Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041; Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058; Conrad JC, 2011, BIOPHYS J, V100, P1608, DOI 10.1016/j.bpj.2011.02.020; Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dalton H.M., 2000, HDB BACTERIAL ADHESI, P43; Danese PN, 2002, CHEM BIOL, V9, P873, DOI 10.1016/S1074-5521(02)00192-8; Darouiche RO, 2008, J ANTIMICROB CHEMOTH, V61, P651, DOI 10.1093/jac/dkn006; Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Davies MC, 2010, J DRUG TARGET, V18, P741, DOI 10.3109/1061186X.2010.521941; Diggle SP, 2006, ENVIRON MICROBIOL, V8, P1095, DOI 10.1111/j.1462-2920.2006.001001.x; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gilbert KB, 2009, MOL MICROBIOL, V73, P1072, DOI 10.1111/j.1365-2958.2009.06832.x; GREENFELD JI, 1995, CRIT CARE MED, V23, P894, DOI 10.1097/00003246-199505000-00018; Guay DR, 2001, DRUGS, V61, P353, DOI 10.2165/00003495-200161030-00004; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Holmes PF, 2009, J BIOMED MATER RES A, V91A, P824, DOI 10.1002/jbm.a.32285; Hook AL, 2011, SOFT MATTER, V7, P7194, DOI 10.1039/c1sm06063e; Hook AL, 2010, BIOMATERIALS, V31, P187, DOI 10.1016/j.biomaterials.2009.09.037; Jaeger K, 2001, CHEMOTHERAPY, V47, P50, DOI 10.1159/000048501; Johansson EMV, 2008, CHEM BIOL, V15, P1249, DOI 10.1016/j.chembiol.2008.10.009; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; Krol JE, 2011, APPL ENVIRON MICROB, V77, P5079, DOI 10.1128/AEM.00090-11; Kuklin NA, 2003, ANTIMICROB AGENTS CH, V47, P2740, DOI 10.1128/AAC.47.9.2740-2748.2003; Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]; Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]; Mei Y, 2009, ADV MATER, V21, P2781, DOI 10.1002/adma.200803184; Messina M., 2010, THESIS U NOTTINGHAM; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e; Pernagallo S, 2011, J MATER CHEM, V21, P96, DOI 10.1039/c0jm01987a; Qazi SNA, 2001, MICROBIAL ECOL, V41, P301; Raad I, 1997, ANN INTERN MED, V127, P267, DOI 10.7326/0003-4819-127-4-199708150-00002; Schumm K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004013.pub3; Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007; Taylor M, 2007, LANGMUIR, V23, P6875, DOI 10.1021/la070100j; Taylor M, 2009, SURF INTERFACE ANAL, V41, P127, DOI 10.1002/sia.2969; Urquhart AJ, 2008, ANAL CHEM, V80, P135, DOI 10.1021/ac071560k; Urquhart AJ, 2007, ADV MATER, V19, P2486, DOI 10.1002/adma.200700949; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Yang J, 2010, BIOMATERIALS, V31, P8827, DOI 10.1016/j.biomaterials.2010.08.028; Yorganci K, 2002, INTENS CARE MED, V28, P438, DOI 10.1007/s00134-002-1243-4	50	255	260	5	353	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					868	U99		10.1038/nbt.2316	http://dx.doi.org/10.1038/nbt.2316			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22885723	Green Accepted, Green Published			2022-12-27	WOS:000308705700021
J	Bennetzen, JL; Schmutz, J; Wang, H; Percifield, R; Hawkins, J; Pontaroli, AC; Estep, M; Feng, L; Vaughn, JN; Grimwood, J; Jenkins, J; Barry, K; Lindquist, E; Hellsten, U; Deshpande, S; Wang, XW; Wu, XM; Mitros, T; Triplett, J; Yang, XH; Ye, CY; Mauro-Herrera, M; Wang, L; Li, PH; Sharma, M; Sharma, R; Ronald, PC; Panaud, O; Kellogg, EA; Brutnell, TP; Doust, AN; Tuskan, GA; Rokhsar, D; Devos, KM				Bennetzen, Jeffrey L.; Schmutz, Jeremy; Wang, Hao; Percifield, Ryan; Hawkins, Jennifer; Pontaroli, Ana C.; Estep, Matt; Feng, Liang; Vaughn, Justin N.; Grimwood, Jane; Jenkins, Jerry; Barry, Kerrie; Lindquist, Erika; Hellsten, Uffe; Deshpande, Shweta; Wang, Xuewen; Wu, Xiaomei; Mitros, Therese; Triplett, Jimmy; Yang, Xiaohan; Ye, Chu-Yu; Mauro-Herrera, Margarita; Wang, Lin; Li, Pinghua; Sharma, Manoj; Sharma, Rita; Ronald, Pamela C.; Panaud, Olivier; Kellogg, Elizabeth A.; Brutnell, Thomas P.; Doust, Andrew N.; Tuskan, Gerald A.; Rokhsar, Daniel; Devos, Katrien M.			Reference genome sequence of the model plant Setaria	NATURE BIOTECHNOLOGY			English	Article							FOXTAIL MILLET; SEGREGATION DISTORTION; TRANSPOSABLE ELEMENTS; MOLECULAR PHYLOGENY; GENETIC MAPS; LINKAGE MAPS; GRASS MODEL; ITALICA; POACEAE; CONSTRUCTION	We generated a high-quality reference genome sequence for foxtail millet (Setaria italica). The similar to 400-Mb assembly covers similar to 80% of the genome and > 95% of the gene space. The assembly was anchored to a 992-locus genetic map and was annotated by comparison with > 1.3 million expressed sequence tag reads. We produced more than 580 million RNA-Seq reads to facilitate expression analyses. We also sequenced Setaria viridis, the ancestral wild relative of S. italica, and identified regions of differential single-nucleotide polymorphism density, distribution of transposable elements, small RNA content, chromosomal rearrangement and segregation distortion. The genus Setaria includes natural and cultivated species that demonstrate a wide capacity for adaptation. The genetic basis of this adaptation was investigated by comparing five sequenced grass genomes. We also used the diploid Setaria genome to evaluate the ongoing genome assembly of a related polyploid, switchgrass (Panicum virgatum).	[Bennetzen, Jeffrey L.] Univ Georgia, Dept Genet, BioEnergy Sci Ctr, Athens, GA 30602 USA; [Schmutz, Jeremy; Grimwood, Jane; Jenkins, Jerry] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Schmutz, Jeremy; Grimwood, Jane; Jenkins, Jerry; Barry, Kerrie; Lindquist, Erika; Hellsten, Uffe; Deshpande, Shweta; Rokhsar, Daniel] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Estep, Matt; Triplett, Jimmy; Kellogg, Elizabeth A.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Wang, Xuewen; Wu, Xiaomei; Devos, Katrien M.] Univ Georgia, Dept Crop & Soil Sci, Inst Plant Breeding Genet & Genom, Athens, GA 30602 USA; [Wang, Xuewen; Wu, Xiaomei; Devos, Katrien M.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Mitros, Therese] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Yang, Xiaohan; Ye, Chu-Yu; Tuskan, Gerald A.] Oak Ridge Natl Lab, Biosci Div, Plant Syst Biol Grp, Oak Ridge, TN USA; [Yang, Xiaohan; Ye, Chu-Yu; Tuskan, Gerald A.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN USA; [Wang, Lin; Li, Pinghua; Brutnell, Thomas P.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [Mauro-Herrera, Margarita; Doust, Andrew N.] Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA; [Sharma, Manoj; Sharma, Rita; Ronald, Pamela C.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Sharma, Manoj; Sharma, Rita; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Sharma, Manoj; Sharma, Rita; Ronald, Pamela C.] Joint Bioenergy Inst, Emeryville, CA USA; [Panaud, Olivier] Univ Perpignan, F-66025 Perpignan, France	University System of Georgia; University of Georgia; HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Missouri System; University of Missouri Saint Louis; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of California System; University of California Berkeley; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); Cornell University; Boyce Thompson Institute for Plant Research; Oklahoma State University System; Oklahoma State University - Stillwater; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Universite Perpignan Via Domitia	Bennetzen, JL (corresponding author), Univ Georgia, Dept Genet, BioEnergy Sci Ctr, Athens, GA 30602 USA.	maize@uga.edu	Kellogg, Elizabeth/M-2845-2013; Barry, Kerrie Whitelaw/AAA-5500-2020; Jenkins, Jerry/ABE-6479-2020; Li, Ping/GYV-4914-2022; Sharma, Rita/G-2425-2017; Brutnell, Thomas/M-2840-2013; Tuskan, Gerald/A-6225-2011; Yang, Xiaohan/AAM-2449-2020; Schmutz, Jeremy/N-3173-2013; Wang, Xuewen/C-1362-2016; Yang, Xiaohan/A-6975-2011; Devos, Katrien M/B-1380-2014; Feng, Liang/I-5010-2014; Ronald, Pamela/AAK-7664-2020; Grimwood, Jane/ABD-5737-2021; Wang, Hao/C-7651-2009	Kellogg, Elizabeth/0000-0003-1671-7447; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Jenkins, Jerry/0000-0002-7943-3997; Brutnell, Thomas/0000-0002-3581-8211; Tuskan, Gerald/0000-0003-0106-1289; Yang, Xiaohan/0000-0001-5207-4210; Schmutz, Jeremy/0000-0001-8062-9172; Wang, Xuewen/0000-0003-2820-9255; Yang, Xiaohan/0000-0001-5207-4210; Vaughn, Justin/0000-0002-5261-5096; Wang, Hao/0000-0002-9634-8778; Sharma, Manoj K./0000-0002-4768-8733; Rokhsar, Daniel/0000-0002-8704-2224	Office of Science of the US Department of Energy [DE-AC02-05CH11231, DE-AC05-00OR22725]; Department of Energy [DE-FG02-08ER64636]; National Institute of Food and Agriculture [2008-35504-04851]; National Science Foundation [IOS-0701736, DBI-0607123]; Oklahoma Center for the Advancement of Science and Technology [PSB08-007, PS11-035B]; University of Missouri Research Board	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Science Foundation(National Science Foundation (NSF)); Oklahoma Center for the Advancement of Science and Technology; University of Missouri Research Board	The studies conducted by the US Department of Energy Joint Genome Institute, the BioEnergy Science Center and the Joint Bioenergy Institute are supported by the Office of Science of the US Department of Energy under contract numbers DE-AC02-05CH11231, DE-AC05-00OR22725 and DE-AC02-05CH11231, respectively. This research was also supported by grants from the Department of Energy (DE-FG02-08ER64636), National Institute of Food and Agriculture Plant Feedstock Genomics for Bioenergy Program (no. 2008-35504-04851), National Science Foundation (IOS-0701736 and DBI-0607123), the Oklahoma Center for the Advancement of Science and Technology (PSB08-007, PS11-035B), and the University of Missouri Research Board. We thank C. Saski at Clemson University for the construction of the Setaria italica and switchgrass BAC libraries, M. Udvardi at the Noble Foundation for providing switchgrass genomic DNA and B. Meyers at the University of Delaware for small RNA annotation advice.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Aliscioni SS, 2003, AM J BOT, V90, P796, DOI 10.3732/ajb.90.5.796; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennetzen JL, 2005, CURR OPIN GENET DEV, V15, P621, DOI 10.1016/j.gde.2005.09.010; Bennetzen JL, 2004, CURR OPIN PLANT BIOL, V7, P732, DOI 10.1016/j.pbi.2004.09.003; Bettinger RL, 2010, EVOL ANTHROPOL, V19, P9, DOI 10.1002/evan.20236; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Chardon F, 2005, J MOL EVOL, V61, P579, DOI 10.1007/s00239-004-0179-4; Christin PA, 2007, CURR BIOL, V17, P1241, DOI 10.1016/j.cub.2007.06.036; Christin PA, 2009, PLANT PHYSIOL, V149, P82, DOI 10.1104/pp.108.128553; Clayton WD, 1986, KEW B ADDITIONAL SER, V13; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; d'Ennequin ML, 2000, THEOR APPL GENET, V100, P1061, DOI 10.1007/s001220051387; Darmency H, 2005, CROP FERALITY AND VOLUNTEERISM, P81; DARMENCY H, 1985, WEED RES, V25, P175, DOI 10.1111/j.1365-3180.1985.tb00633.x; Dekker J, 2003, WEED SCI, V51, P641, DOI 10.1614/P2002-IR; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Devos KM, 2005, P NATL ACAD SCI USA, V102, P19243, DOI 10.1073/pnas.0509473102; Devos KM, 1998, THEOR APPL GENET, V96, P63, DOI 10.1007/s001220050709; Doust AN, 2002, AM J BOT, V89, P1203, DOI 10.3732/ajb.89.8.1203; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Drummond A., 2011, GENEIOUS V5 5; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Giussani LM, 2001, AM J BOT, V88, P1993, DOI 10.2307/3558427; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; Harlan J.R., 1975, CROPS MAN; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Hirano R, 2011, GENOME, V54, P498, DOI [10.1139/G11-015, 10.1139/g11-015]; Hunt HV, 2008, VEG HIST ARCHAEOBOT, V17, pS5, DOI 10.1007/s00334-008-0187-1; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jenczewski E, 1997, THEOR APPL GENET, V94, P682, DOI 10.1007/s001220050466; JUSUF M, 1985, THEOR APPL GENET, V71, P385, DOI 10.1007/BF00251177; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kellogg EA, 2009, INT J PLANT SCI, V170, P117, DOI 10.1086/593043; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim JS, 2005, GENETICS, V169, P1169, DOI 10.1534/genetics.104.035980; KIMBER G, 1967, GENET RES, V9, P111, DOI 10.1017/S0016672300010351; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu RY, 2007, P NATL ACAD SCI USA, V104, P11844, DOI 10.1073/pnas.0704258104; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; NACIRI Y, 1992, EUPHYTICA, V60, P97; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peterson D. G., 2000, Journal of Agricultural Genomics, V5, P1; Pontaroli AC, 2009, PLANT GENOME-US, V2, P93, DOI 10.3835/plantgenome2008.09.0007; R Core Team, 2020, R LANG ENV STAT COMP; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sang T, 2009, PLANT PHYSIOL, V149, P63, DOI 10.1104/pp.108.128827; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Scott BA, 2009, WEED TECHNOL, V23, P599, DOI 10.1614/WT-09-006.1; Sharma MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033892; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang CF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-90; Wang ZM, 1998, THEOR APPL GENET, V96, P31, DOI 10.1007/s001220050705; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang LX, 2009, P NATL ACAD SCI USA, V106, P19922, DOI 10.1073/pnas.0908008106; Yang LX, 2009, P NATL ACAD SCI USA, V106, P12832, DOI 10.1073/pnas.0905563106; ZAMIR D, 1986, BOT GAZ, V147, P355, DOI 10.1086/337602; Zhang JP, 2007, GENOMICS, V90, P121, DOI 10.1016/j.ygeno.2007.03.016; Zwickl DJ., 2006, THESIS	80	539	622	6	161	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					555	+		10.1038/nbt.2196	http://dx.doi.org/10.1038/nbt.2196			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22580951	Green Published, hybrid			2022-12-27	WOS:000305158600026
J	Abe, A; Kosugi, S; Yoshida, K; Natsume, S; Takagi, H; Kanzaki, H; Matsumura, H; Yoshida, K; Mitsuoka, C; Tamiru, M; Innan, H; Cano, L; Kamoun, S; Terauchi, R				Abe, Akira; Kosugi, Shunichi; Yoshida, Kentaro; Natsume, Satoshi; Takagi, Hiroki; Kanzaki, Hiroyuki; Matsumura, Hideo; Yoshida, Kakoto; Mitsuoka, Chikako; Tamiru, Muluneh; Innan, Hideki; Cano, Liliana; Kamoun, Sophien; Terauchi, Ryohei			Genome sequencing reveals agronomically important loci in rice using MutMap	NATURE BIOTECHNOLOGY			English	Article							IDENTIFICATION; ARABIDOPSIS; MUTATION; GENES; POPULATIONS; MARKERS; DNA	The majority of agronomic traits are controlled by multiple genes that cause minor phenotypic effects, making the identification of these genes difficult. Here we introduce MutMap, a method based on whole-genome resequencing of pooled DNA from a segregating population of plants that show a useful phenotype. In MutMap, a mutant is crossed directly to the original wild-type line and then selfed, allowing unequivocal segregation in second filial generation (F-2) progeny of subtle phenotypic differences. This approach is particularly amenable to crop species because it minimizes the number of genetic crosses (n = 1 or 0) and mutant F-2 progeny that are required. We applied MutMap to seven mutants of a Japanese elite rice cultivar and identified the unique genomic positions most probable to harbor mutations causing pale green leaves and semidwarfism, an agronomically relevant trait. These results show that MutMap can accelerate the genetic improvement of rice and other crop plants.	[Kosugi, Shunichi; Yoshida, Kentaro; Natsume, Satoshi; Takagi, Hiroki; Kanzaki, Hiroyuki; Matsumura, Hideo; Yoshida, Kakoto; Mitsuoka, Chikako; Tamiru, Muluneh; Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan; [Abe, Akira] Iwate Agr Res Ctr, Kitakami, Iwate, Japan; [Abe, Akira; Takagi, Hiroki] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 020, Japan; [Matsumura, Hideo] Shinshu Univ, Ctr Gene Res, Ueda, Nagano, Japan; [Innan, Hideki] Grad Univ Adv Studies, Hayama, Japan; [Cano, Liliana; Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England	Iwate Biotechnology Research Center; Iwate University; Shinshu University; Graduate University for Advanced Studies - Japan; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Terauchi, R (corresponding author), Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan.	terauchi@ibrc.or.jp	Terauchi, Ryohei/Y-2992-2019; Cano, Liliana M/O-7041-2016; Kamoun, Sophien/B-3529-2009	Terauchi, Ryohei/0000-0002-0095-4651; Cano, Liliana M/0000-0002-7996-4181; Kamoun, Sophien/0000-0002-0290-0315; Kosugi, Shunichi/0000-0002-5882-9255; Innan, Hideki/0000-0001-6375-9231; Matsumura, Hideo/0000-0003-4849-1016; Yoshida, Kentaro/0000-0002-3614-1759	Program for Promotion of Basic Research Activities for Innovative Biosciences; Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [PMI-0010]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23113009]; Gatsby Charitable Foundation; Grants-in-Aid for Scientific Research [22380009, 22510217, 23580065] Funding Source: KAKEN	Program for Promotion of Basic Research Activities for Innovative Biosciences; Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Gatsby Charitable Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences, to R.T., H.I. and A.A. Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation PMI-0010), Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research on Innovative Areas 23113009) to R.T. and a Daiwa Adrian Prize to S. Kamoun and R.T.L.C. and S. Kamoun were supported by the Gatsby Charitable Foundation. We thank S. Kuroda for general support and M.J. Terry, B. Wulff and K. Tsunewaki for suggestions to improve the paper.	Ashelford K, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r28; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Baulcombe D, 2010, SCIENCE, V327, P761, DOI 10.1126/science.1186705; Falconer D. S., 1996, INTRO QUANTITATIVE G; GIOVANNONI JJ, 1991, NUCLEIC ACIDS RES, V19, P6553, DOI 10.1093/nar/19.23.6553; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Lee S, 2005, PLANT MOL BIOL, V57, P805, DOI 10.1007/s11103-005-2066-9; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; PIENKOWSKA M, 1993, MUTAT RES, V288, P123, DOI 10.1016/0027-5107(93)90214-Z; ROBERTSON DS, 1985, J THEOR BIOL, V117, P1, DOI 10.1016/S0022-5193(85)80161-2; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Sujay Rakshit, 2010, The handbook of plant mutation screening: mining of natural and induced alleles, P187; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Zuryn S, 2010, GENETICS, V186, P427, DOI 10.1534/genetics.110.119230	17	717	787	27	375	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					174	178		10.1038/nbt.2095	http://dx.doi.org/10.1038/nbt.2095			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22267009	Bronze			2022-12-27	WOS:000300269100020
J	Lu, R; Neff, NF; Quake, SR; Weissman, IL				Lu, Rong; Neff, Norma F.; Quake, Stephen R.; Weissman, Irving L.			Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding	NATURE BIOTECHNOLOGY			English	Article							CLONAL ANALYSIS; SELF-RENEWAL; PROGENITOR CELLS; CANCER; COMPARTMENT; DIFFERENTIATION; SYSTEM; MOUSE; MICE; RECONSTITUTION	Disentangling cellular heterogeneity is a challenge in many fields, particularly in the stem cell and cancer biology fields. Here we demonstrate how to combine viral genetic barcoding with high-throughput sequencing to track single cells in a heterogeneous population. We use this technique to track the in vivo differentiation of unitary hematopoietic stem cells (HSCs). The results are consistent with single-cell transplantation studies but require two orders of magnitude fewer mice. In addition to its high throughput, the high sensitivity of the technique allows for a direct examination of the clonality of sparse cell populations such as HSCs. We show how these capabilities offer a clonal perspective of the HSC differentiation process. In particular, our data suggest that HSCs do not equally contribute to blood cells after irradiation-mediated transplantation, and that two distinct HSC differentiation patterns co-exist in the same recipient mouse after irradiation. This technique can be applied to any virus-accessible cell type for both in vitro and in vivo processes.	[Lu, Rong; Weissman, Irving L.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Lu, Rong; Weissman, Irving L.] Stanford Univ, Ludwig Ctr, Sch Med, Stanford, CA 94305 USA; [Neff, Norma F.; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Neff, Norma F.; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Lu, R (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	rlu@stanford.edu; irv@stanford.edu			NIH [R01-CA86065, U01-HL099999]; CIRM [TG2-01159]; NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099995, R01HL058770, U01HL099999] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank G. Mantalas, T. Snyder and B. Passarelli for helping with the high-throughput sequencing; K. Schepers, I. Dimov, J. Seita, A. Czechowicz, M. Inlay M. Drukker and D. Sahoo for helpful discussions; P. Lovelace for FACS core management. We also thank L. Jerabek and T. Storm for laboratory management; C. Muscat and T. Naik for antibody conjugation; A. Mosley for animal supervision. This work is supported by NIH-R01-CA86065 and NIH-U01-HL099999. R. L. is supported by CIRM-TG2-01159.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barese CN, 2011, HUM GENE THER, V22, P659, DOI 10.1089/hum.2010.237; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Drize NJ, 1996, BLOOD, V88, P2927, DOI 10.1182/blood.V88.8.2927.bloodjournal8882927; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Gonzalez-Murillo A, 2008, BLOOD, V112, P3138, DOI 10.1182/blood-2008-03-142661; Harkey MA, 2007, STEM CELLS DEV, V16, P381, DOI 10.1089/scd.2007.0015; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim S, 2010, J VIROL, V84, P11771, DOI 10.1128/JVI.01355-10; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Laukkanen MO, 2005, BLOOD, V105, P1010, DOI 10.1182/blood-2004-04-1498; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Maetzig T, 2011, BLOOD, V117, P3053, DOI 10.1182/blood-2010-08-303222; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; van Heijst JWJ, 2009, SCIENCE, V325, P1265, DOI 10.1126/science.1175455; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006	50	287	303	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2011	29	10					928	U229		10.1038/nbt.1977	http://dx.doi.org/10.1038/nbt.1977			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	838FQ	21964413	Green Accepted			2022-12-27	WOS:000296273000020
J	Acharya, A				Acharya, Anu			What mergers can do for you	NATURE BIOTECHNOLOGY			English	Editorial Material									Ocimum Biosolut, Hyderabad, Andhra Pradesh, India		Acharya, A (corresponding author), Ocimum Biosolut, Hyderabad, Andhra Pradesh, India.	anu@ocimumbio.com							0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2011	29	6					477	479		10.1038/bioe.2011.4	http://dx.doi.org/10.1038/bioe.2011.4			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	773WL	21796820	Bronze			2022-12-27	WOS:000291342100006
J	Boley, N; Stoiber, MH; Booth, BW; Wan, KH; Hoskins, RA; Bickel, PJ; Celniker, SE; Brown, JB				Boley, Nathan; Stoiber, Marcus H.; Booth, Benjamin W.; Wan, Kenneth H.; Hoskins, Roger A.; Bickel, Peter J.; Celniker, Susan E.; Brown, James B.			Genome-guided transcript assembly by integrative analysis of RNA sequence data	NATURE BIOTECHNOLOGY			English	Article							SEQ DATA; MESSENGER-RNA; EXPRESSION; QUANTIFICATION; NORMALIZATION; LOCALIZATION; PROMOTER; REVEALS	The identification of full length transcripts entirely from short-read RNA sequencing data (RNA-seq) remains a challenge in the annotation of genomes. Here we describe an automated pipeline for genome annotation that integrates RNA-seq and gene-boundary data sets, which we call Generalized RNA Integration Tool, or GRIT. Applying GRIT to Drosophila melanogaster short-read RNA-seq, cap analysis of gene expression (CAGE) and poly(A)-site-seq data collected for the modENCODE project, we recovered the vast majority of previously annotated transcripts and doubled the total number of transcripts cataloged. We found that 20% of protein coding genes encode multiple protein-localization signals and that, in 20-d-old adult fly heads, genes with multiple polyadenylation sites are more common than genes with alternative splicing or alternative promoters. GRIT demonstrates 30% higher precision and recall than the most widely used transcript assembly tools. GRIT will facilitate the automated generation of high-quality genome annotations without the need for extensive manual annotation.	[Boley, Nathan; Stoiber, Marcus H.] Univ Calif Berkeley, Dept Biostat, Berkeley, CA 94720 USA; [Booth, Benjamin W.; Wan, Kenneth H.; Hoskins, Roger A.; Celniker, Susan E.; Brown, James B.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Bickel, Peter J.; Celniker, Susan E.; Brown, James B.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Boley, N (corresponding author), Univ Calif Berkeley, Dept Biostat, Berkeley, CA 94720 USA.	celniker@fruitfly.org	Brown, James/H-2971-2015		National Human Genome Research Institute modENCODE Project [R21 HG006187, K99 HG006698, U01 HG004271, DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004271, R21HG006187, U01HG007031, K99HG006698] Funding Source: NIH RePORTER	National Human Genome Research Institute modENCODE Project; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the members of the modENCODE transcription consortium for generating the data and C. Cotterman, E. Frise, B. Graveley, H. Huang and J. Li for discussions and S. Kadri for producing the Scripture annotation. This work was funded by a contract from the National Human Genome Research Institute modENCODE Project, contracts R21 HG006187 to P. J. B.; K99 HG006698 to J.B.B.; and U01 HG004271 to S.E.C. under Department of Energy contract no. DE-AC02-05CH11231.	Bickel P. J., 2001, MATH STAT, V1, P394; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Celotto AM, 2001, GENETICS, V159, P599; Cenik C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001366; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hilgers V, 2011, P NATL ACAD SCI USA, V108, P15864, DOI 10.1073/pnas.1112672108; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; JENKINS C, 1993, MOL CELL ENDOCRINOL, V97, pR1, DOI 10.1016/0303-7207(93)90227-B; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Juneau K, 2009, GENETICS, V183, P185, DOI 10.1534/genetics.109.105155; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; Lawless C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-7; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; LIFTON RP, 1977, COLD SPRING HARB SYM, V42, P1047, DOI 10.1101/SQB.1978.042.01.105; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003; Pilanci M., 2012, ADV NEURAL INFORM PR, V25, P2429; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rojas-Duran MF, 2012, RNA, V18, P2299, DOI 10.1261/rna.035865.112; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tu Q, 2012, GENOME RES, V22, P2079, DOI 10.1101/gr.139170.112; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954	41	38	39	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					341	U198		10.1038/nbt.2850	http://dx.doi.org/10.1038/nbt.2850			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24633242	Green Accepted, Bronze			2022-12-27	WOS:000334340800018
J	Rieck, S; Wright, C				Rieck, Sebastian; Wright, Christopher			PIQ-ing into chromatin architecture	NATURE BIOTECHNOLOGY			English	Editorial Material							PIONEER TRANSCRIPTION FACTORS; CELLS		[Rieck, Sebastian; Wright, Christopher] Vanderbilt Univ, Ctr Stem Cell Biol, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Rieck, Sebastian; Wright, Christopher] Vanderbilt Univ, Program Dev Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	Rieck, S (corresponding author), Vanderbilt Univ, Ctr Stem Cell Biol, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	chris.wright@vanderbilt.edu						Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Yang YP, 2009, NAT CHEM BIOL, V5, P195, DOI 10.1038/nchembio0409-195; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	10	3	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					138	140		10.1038/nbt.2824	http://dx.doi.org/10.1038/nbt.2824			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24509760				2022-12-27	WOS:000331074000015
J	Lewis, NE; Liu, X; Li, YX; Nagarajan, H; Yerganian, G; O'Brien, E; Bordbar, A; Roth, AM; Rosenbloom, J; Bian, C; Xie, M; Chen, WB; Li, N; Baycin-Hizal, D; Latif, H; Forster, J; Betenbaugh, MJ; Famili, I; Xu, X; Wang, J; Palsson, BO				Lewis, Nathan E.; Liu, Xin; Li, Yuxiang; Nagarajan, Harish; Yerganian, George; O'Brien, Edward; Bordbar, Aarash; Roth, Anne M.; Rosenbloom, Jeffrey; Bian, Chao; Xie, Min; Chen, Wenbin; Li, Ning; Baycin-Hizal, Deniz; Latif, Haythem; Forster, Jochen; Betenbaugh, Michael J.; Famili, Iman; Xu, Xun; Wang, Jun; Palsson, Bernhard O.			Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome	NATURE BIOTECHNOLOGY			English	Article							COPY-NUMBER; CHROMOSOME REARRANGEMENT; DNA LIBRARIES; CHO; APOPTOSIS; SEQUENCE; CANCER; QUANTIFICATION; IDENTIFICATION; TRANSCRIPTOME	Chinese hamster ovary (CHO) cells, first isolated in 1957, are the preferred production host for many therapeutic proteins. Although genetic heterogeneity among CHO cell lines has been well documented, a systematic, nucleotide-resolution characterization of their genotypic differences has been stymied by the lack of a unifying genomic resource for CHO cells. Here we report a 2.4-Gb draft genome sequence of a female Chinese hamster, Cricetulus griseus, harboring 24,044 genes. We also resequenced and analyzed the genomes of six CHO cell lines from the CHO-K1, DG44 and CHO-S lineages. This analysis identified hamster genes missing in different CHO cell lines, and detected > 3.7 million single-nucleotide polymorphisms (SNPs), 551,240 indels and 7,063 copy number variations. Many mutations are located in genes with functions relevant to bioprocessing, such as apoptosis. The details of this genetic diversity highlight the value of the hamster genome as the reference upon which CHO cells can be studied and engineered for protein production.	[Lewis, Nathan E.; Nagarajan, Harish; O'Brien, Edward; Bordbar, Aarash; Latif, Haythem; Palsson, Bernhard O.] CHOmics Inc, San Diego, CA USA; [Liu, Xin; Li, Yuxiang; Bian, Chao; Xie, Min; Chen, Wenbin; Li, Ning; Xu, Xun; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Liu, Xin; Li, Ning; Xu, Xun] Copenhagen Bio Sci Pk, BGI Shenzhen, BGI Europe, Copenhagen, Denmark; [Yerganian, George] Cytogen Res & Dev Inc, West Roxbury, MA USA; [Yerganian, George] Brandeis Univ, Foster Biomed Res Lab, Waltham, MA 02254 USA; [Roth, Anne M.; Rosenbloom, Jeffrey; Famili, Iman] GT Life Sci, San Diego, CA USA; [Li, Ning] Copenhagen Bio Sci Pk, BGI Shenzhen, BGI Europe Inst, Copenhagen, Denmark; [Baycin-Hizal, Deniz; Betenbaugh, Michael J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Forster, Jochen; Betenbaugh, Michael J.; Palsson, Bernhard O.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	Beijing Genomics Institute (BGI); Brandeis University; Johns Hopkins University; Technical University of Denmark; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; King Abdulaziz University	Palsson, BO (corresponding author), CHOmics Inc, San Diego, CA USA.	wangj@genomics.org.cn; bpals@biosustain.dtu.dk	Wang, Jun/A-7261-2013; Betenbaugh, Michael J./A-3252-2010; /AAG-5264-2021; XIE, MIN/P-8062-2019; Xu, Xun/AAI-6763-2020; Li, yu/HHZ-5236-2022; Lewis, Nathan/ABE-7290-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Betenbaugh, Michael J./0000-0002-6336-4659; /0000-0001-6460-6771; XIE, MIN/0000-0002-5652-5039; Xu, Xun/0000-0002-5338-5173; Lewis, Nathan/0000-0001-7700-3654; Wang, Jun/0000-0002-8540-8931; Palsson, Bernhard/0000-0003-2357-6785; Liu, Xin/0000-0003-3256-2940; Bian, Chao/0000-0001-9904-721X; Wang, Jun/0000-0002-2113-5874	China National GeneBank-Shenzhen; Shenzhen Engineering Laboratory for Genomics-Assisted Animal Breeding; Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	China National GeneBank-Shenzhen; Shenzhen Engineering Laboratory for Genomics-Assisted Animal Breeding; Shenzhen Key Laboratory of Transomics Biotechnologies; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors would like to thank K. C. Hayes, at Brandeis University, for enabling the continued housing of the Chinese hamster colony from which CHO cells were derived. B. Monroe, L. Chasin and S. Gorfien kindly aided in delineating the history of the cell lines used in this study, and T. Omasa gave guidance in the chromosomal assignments of scaffolds. This work was funded in part by the China National GeneBank-Shenzhen, the Shenzhen Engineering Laboratory for Genomics-Assisted Animal Breeding, and the Shenzhen Key Laboratory of Transomics Biotechnologies (NO.CXB201108250096A). This work and the Center for Biosustainability at the Danish Technical University were also funded with generous support from the Novo Nordisk Foundation. Female Chinese hamsters were kindly provided by G. Yerganian. The authors would also like to thank L. Donahue-Hjelle for kindly providing their cell lines.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Arden N, 2007, BIOTECHNOL PROGR, V23, P506, DOI 10.1021/bp060222m; BALAJEE AS, 1995, CYTOGENET CELL GENET, V70, P95, DOI 10.1159/000134000; Baycin-Hizal D, 2012, J PROTEOME RES, V11, P5265, DOI 10.1021/pr300476w; Becker E, 2010, J BIOTECHNOL, V146, P198, DOI 10.1016/j.jbiotec.2009.11.018; Becker J, 2011, J BIOTECHNOL, V156, P227, DOI 10.1016/j.jbiotec.2011.09.014; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Bueno C, 2009, CARCINOGENESIS, V30, P1628, DOI 10.1093/carcin/bgp169; Cao YH, 2012, METHODS, V56, P418, DOI 10.1016/j.ymeth.2011.11.002; Cao YH, 2012, BIOTECHNOL BIOENG, V109, P1357, DOI 10.1002/bit.24347; Clarke C, 2012, BIOTECHNOL BIOENG, V109, P1368, DOI 10.1002/bit.24416; Cost GJ, 2010, BIOTECHNOL BIOENG, V105, P330, DOI 10.1002/bit.22541; Dasgupta A, 2010, BIOCHEM BIOPH RES CO, V400, P53, DOI 10.1016/j.bbrc.2010.08.001; Datta P, 2013, BIOTECHNOL BIOENG, V110, P1255, DOI 10.1002/bit.24841; Davies J, 2001, BIOTECHNOL APPL BIOC, V33, P99, DOI 10.1042/BA20000090; De Jesus M, 2011, EUR J PHARM BIOPHARM, V78, P184, DOI 10.1016/j.ejpb.2011.01.005; DEAVEN LL, 1973, CHROMOSOMA, V41, P129, DOI 10.1007/BF00319690; Derouazi M, 2006, BIOCHEM BIOPH RES CO, V340, P1069, DOI 10.1016/j.bbrc.2005.12.111; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Dorai H, 2010, BIOTECHNOL PROGR, V26, P1367, DOI 10.1002/btpr.426; Fussenegger M, 1998, NAT BIOTECHNOL, V16, P468, DOI 10.1038/nbt0598-468; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffin TJ, 2007, TRENDS BIOTECHNOL, V25, P401, DOI 10.1016/j.tibtech.2007.07.004; Hackl M, 2012, J BIOTECHNOL, V158, P151, DOI 10.1016/j.jbiotec.2012.01.019; IMS Institute for Healthcare Informatics, 2011, GLOB US MED OUTL 201; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Kantardjieff A, 2009, BIOTECHNOL ADV, V27, P1028, DOI 10.1016/j.biotechadv.2009.05.023; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kildegaard HF, 2013, CURR OPIN BIOTECH, V24, P1102, DOI 10.1016/j.copbio.2013.02.007; Kim SH, 2007, APPL MICROBIOL BIOT, V74, P152, DOI 10.1007/s00253-006-0654-5; Kim YG, 2009, J BIOTECHNOL, V144, P299, DOI 10.1016/j.jbiotec.2009.09.016; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Meleady P, 2012, BIOTECHNOL BIOENG, V109, P1386, DOI 10.1002/bit.24476; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Peng J, 2007, CROP SCI, V47, P2418, DOI 10.2135/cropsci2007.03.0137; Piganeau M, 2013, GENOME RES, V23, P1182, DOI 10.1101/gr.147314.112; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; Simi S, 1999, MUTAGENESIS, V14, P57, DOI 10.1093/mutage/14.1.57; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; URLAUB G, 1983, CELL, V33, P405, DOI 10.1016/0092-8674(83)90422-1; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Wang ZS, 2010, PROCESS BIOCHEM, V45, P1852, DOI 10.1016/j.procbio.2010.03.029; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei YYC, 2011, CYTOTECHNOLOGY, V63, P663, DOI 10.1007/s10616-011-9385-2; Wlaschin KF, 2005, BIOTECHNOL BIOENG, V91, P592, DOI 10.1002/bit.20511; WORTON RG, 1977, SOMAT CELL GENET, V3, P27, DOI 10.1007/BF01550985; Wuest DM, 2012, BIOTECHNOL ADV, V30, P629, DOI 10.1016/j.biotechadv.2011.10.010; Wurm FM, 2011, NAT BIOTECHNOL, V29, P718, DOI 10.1038/nbt.1943; Xiao Y, 1996, CYTOGENET CELL GENET, V75, P57, DOI 10.1159/000134457; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217	66	273	286	0	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2013	31	8					759	+		10.1038/nbt.2624	http://dx.doi.org/10.1038/nbt.2624			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	198GS	23873082	Green Published, hybrid			2022-12-27	WOS:000322911000027
J	Sherkow, JS				Sherkow, Jacob S.			Federal Trade Commission v. Actavis, Inc. and reverse-payment or pay-for-delay settlements	NATURE BIOTECHNOLOGY			English	Editorial Material									Stanford Law Sch, Ctr Law & Biosci, Stanford, CA 94305 USA	Stanford University	Sherkow, JS (corresponding author), Stanford Law Sch, Ctr Law & Biosci, Stanford, CA 94305 USA.	jsherkow@law.stanford.edu		Sherkow, Jacob/0000-0002-9724-9261				Elhauge E, 2012, TEX LAW REV, V91, P283; Higgins MJ, 2009, SCIENCE, V326, P370, DOI 10.1126/science.1176116; Reiffen D, 2005, REV ECON STAT, V87, P37, DOI 10.1162/0034653053327694	3	0	0	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2013	31	4					316	318		10.1038/nbt.2542	http://dx.doi.org/10.1038/nbt.2542			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	120TI	23563426	Green Published			2022-12-27	WOS:000317195500021
J	Lou, CB; Stanton, B; Chen, YJ; Munsky, B; Voigt, CA				Lou, Chunbo; Stanton, Brynne; Chen, Ying-Ja; Munsky, Brian; Voigt, Christopher A.			Ribozyme-based insulator parts buffer synthetic circuits from genetic context	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; NOISE-PROPAGATION; SELF-CLEAVAGE; RNA; CONSTRUCTION; SATELLITE; SEQUENCE; NETWORK; DESIGN	Synthetic genetic programs are built from circuits that integrate sensors and implement temporal control of gene expression(1-4). Transcriptional circuits are layered by using promoters to carry the signal between circuits. In other words, the output promoter of one circuit serves as the input promoter to the next. Thus, connecting circuits requires physically connecting a promoter to the next circuit. We show that the sequence at the junction between the input promoter and circuit can affect the input-output response (transfer function) of the circuit(5-9). A library of putative sequences that might reduce (or buffer) such context effects, which we refer to as 'insulator parts', is screened in Escherichia coli. We find that ribozymes that cleave the 5' untranslated region (5'-UTR) of the mRNA are effective insulators. They generate quantitatively identical transfer functions, irrespective of the identity of the input promoter. When these insulators are used to join synthetic gene circuits, the behavior of layered circuits can be predicted using a mathematical model. The inclusion of insulators will be critical in reliably permuting circuits to build different programs.	[Lou, Chunbo; Stanton, Brynne; Chen, Ying-Ja; Voigt, Christopher A.] MIT, Dept Biol Engn, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Munsky, Brian] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM USA; [Munsky, Brian] Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM USA	Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Voigt, CA (corresponding author), MIT, Dept Biol Engn, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cavoigt@gmail.com	Munsky, Brian/A-1947-2016	Munsky, Brian/0000-0001-6147-7329; hong, xizhi/0000-0001-6029-6761; Lou, Chunbo/0000-0002-7941-6038	Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA CLIO) [N66001-12-C-4018]; Office of Naval Research [N00014-10-1-0245]; National Science Foundation (NSF) [CCF-0943385]; National Institutes of Health [AI067699]; NSF Synthetic Biology Engineering Research Center (SynBERC) [SA5284-11210]; Life Technologies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067699, R56AI067699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095765] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA CLIO)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Synthetic Biology Engineering Research Center (SynBERC); Life Technologies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.A.V. is supported by Life Technologies, Defense Advanced Research Projects Agency Chronicle of Lineage Indicative of Origins (DARPA CLIO, N66001-12-C-4018), Office of Naval Research (N00014-10-1-0245), National Science Foundation (NSF) (CCF-0943385), National Institutes of Health (AI067699) and the NSF Synthetic Biology Engineering Research Center (SynBERC, SA5284-11210).	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Arkin A, 1998, GENETICS, V149, P1633; Arkin A, 2008, NAT BIOTECHNOL, V26, P771, DOI 10.1038/nbt0708-771; Baker D, 2006, SCI AM, V294, P44, DOI 10.1038/scientificamerican0606-44; Beal J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022490; BUZAYAN JM, 1986, P NATL ACAD SCI USA, V83, P8859, DOI 10.1073/pnas.83.23.8859; Carrier TA, 1997, BIOTECHNOL BIOENG, V55, P577, DOI 10.1002/(SICI)1097-0290(19970805)55:3<577::AID-BIT16>3.3.CO;2-6; Clancy K, 2010, CURR OPIN BIOTECH, V21, P572, DOI 10.1016/j.copbio.2010.07.005; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DiSerio F, 1997, J VIROL, V71, P6603, DOI 10.1128/JVI.71.9.6603-6610.1997; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; FORSTER AC, 1987, CELL, V50, P9, DOI 10.1016/0092-8674(87)90657-X; Galdzicki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grunberg R, 2010, NUCLEIC ACIDS RES, V38, P2663, DOI 10.1093/nar/gkq139; HERNANDEZ C, 1992, P NATL ACAD SCI USA, V89, P3711, DOI 10.1073/pnas.89.9.3711; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; KAPER JM, 1988, BIOCHEM BIOPH RES CO, V154, P318, DOI 10.1016/0006-291X(88)90687-0; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kim PM, 2003, GENOME RES, V13, P2391, DOI 10.1101/gr.1207003; Lou CB, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.2; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Munsky B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.75; Nelson JA, 2005, BIOCHEMISTRY-US, V44, P14577, DOI 10.1021/bi051130t; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Qi L, 2012, NAT BIOTECHNOL, V30, P1002, DOI 10.1038/nbt.2355; Rhodius VA, 2012, NUCLEIC ACIDS RES, V40, P2907, DOI 10.1093/nar/gkr1190; Rhodius VA, 2010, P NATL ACAD SCI USA, V107, P2854, DOI 10.1073/pnas.0915066107; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; ROOSSINCK MJ, 1992, MICROBIOL REV, V56, P265, DOI 10.1128/MMBR.56.2.265-279.1992; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Walczak AM, 2009, P NATL ACAD SCI USA, V106, P6529, DOI 10.1073/pnas.0811999106; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	48	233	240	4	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1137	+		10.1038/nbt.2401	http://dx.doi.org/10.1038/nbt.2401			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23034349	Green Accepted, Green Published			2022-12-27	WOS:000311087500034
J	Francisco, M				Francisco, Michael			Second-quarter biotech job picture	NATURE BIOTECHNOLOGY			English	Editorial Material																		2012, NAT BIOTECHNOL, V30, P467	1	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					803	803		10.1038/nbt.2326	http://dx.doi.org/10.1038/nbt.2326			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22871722	Bronze			2022-12-27	WOS:000307416900025
J	Lippmann, ES; Azarin, SM; Kay, JE; Nessler, RA; Wilson, HK; Al-Ahmad, A; Palecek, SP; Shusta, EV				Lippmann, Ethan S.; Azarin, Samira M.; Kay, Jennifer E.; Nessler, Randy A.; Wilson, Hannah K.; Al-Ahmad, Abraham; Palecek, Sean P.; Shusta, Eric V.			Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							PROTEIN-COUPLED RECEPTOR; TIGHT JUNCTION PROTEINS; IN-VITRO MODEL; CNS; DIFFERENTIATION; ANGIOGENESIS; FRIZZLED-4; TRANSPORTERS; EXPRESSION; INDUCTION	The blood-brain barrier (BBB) is crucial to the health of the brain and is often compromised in neurological disease. Moreover, because of its barrier properties, this endothelial interface restricts uptake of neurotherapeutics. Thus, a renewable source of human BBB endothelium could spur brain research and pharmaceutical development. Here we show that endothelial cells derived from human pluripotent stem cells (hPSCs) acquire BBB properties when co-differentiated with neural cells that provide relevant cues, including those involved in Wnt/beta-catenin signaling. The resulting endothelial cells have many BBB attributes, including well-organized tight junctions, appropriate expression of nutrient transporters and polarized efflux transporter activity. Notably, they respond to astrocytes, acquiring substantial barrier properties as measured by transendothelial electrical resistance (1,450 +/- 140 Omega cm(2)), and they possess molecular permeability that correlates well with in vivo rodent blood-brain transfer coefficients.	[Lippmann, Ethan S.; Azarin, Samira M.; Kay, Jennifer E.; Wilson, Hannah K.; Al-Ahmad, Abraham; Palecek, Sean P.; Shusta, Eric V.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Nessler, Randy A.] Univ Iowa, Cent Microscopy Res Facil, Iowa City, IA USA	University of Wisconsin System; University of Wisconsin Madison; University of Iowa	Shusta, EV (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	palecek@engr.wisc.edu; shusta@engr.wisc.edu	Alahmad, Abraham/K-3031-2012; Al-Ahmad/Alahmad, Abraham Jacob/E-1088-2013	Alahmad, Abraham/0000-0002-7716-4412; Al-Ahmad/Alahmad, Abraham Jacob/0000-0001-7463-3204; Song, Hannah/0000-0002-7238-7553	US National Institutes of Health (NIH) [NS056249, AA020476, EB007534]; US National Science Foundation (NSF) [EFRI-0735903]; NIH Chemistry Biology Interface traineeship [T32 GM008505]; NSF; WiCell Research Institute; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC4AA020476] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation (NSF)(National Science Foundation (NSF)); NIH Chemistry Biology Interface traineeship; NSF(National Science Foundation (NSF)); WiCell Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded in part by US National Institutes of Health (NIH) grants NS056249 (E.V.S.), AA020476 (E.V.S.) and EB007534 (S.P.P.) and US National Science Foundation (NSF) grant EFRI-0735903 (S.P.P.). E.S.L. is a recipient of a NIH Chemistry Biology Interface traineeship (T32 GM008505) and S.M.A. is the recipient of a NSF Graduate Research fellowship. We thank the WiCell Research Institute for providing research support and W.M. Pardridge (University of California-Los Angeles) for the gift of GLUT-1 antiserum.	Anderson KD, 2011, P NATL ACAD SCI USA, V108, P2807, DOI 10.1073/pnas.1019761108; BAUER HC, 1993, DEV BRAIN RES, V75, P269, DOI 10.1016/0165-3806(93)90031-5; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; Calabria AR, 2006, J NEUROCHEM, V97, P922, DOI 10.1111/j.1471-4159.2006.03793.x; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Goldman O, 2009, STEM CELLS, V27, P1750, DOI 10.1002/stem.100; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Kane NM, 2010, ARTERIOSCL THROM VAS, V30, P1389, DOI 10.1161/ATVBAHA.110.204800; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Malina KCK, 2009, BRAIN RES, V1284, P12, DOI 10.1016/j.brainres.2009.05.072; Man S, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/384982; Nakahara M, 2009, CLONING STEM CELLS, V11, P509, DOI 10.1089/clo.2009.0023; Pardridge W. M., 2003, MOL INTERV, V3, P151; Pardridge William M, 2003, Mol Interv, V3, P90, DOI 10.1124/mi.3.2.90; Perriere N, 2007, BRAIN RES, V1150, P1, DOI 10.1016/j.brainres.2007.02.091; Roberts LM, 2008, ENDOCRINOLOGY, V149, P6251, DOI 10.1210/en.2008-0378; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; STEWART PA, 1994, DEV BRAIN RES, V78, P25, DOI 10.1016/0165-3806(94)90005-1; Syvanen S, 2009, DRUG METAB DISPOS, V37, P635, DOI 10.1124/dmd.108.024745; Szeto W, 2001, CANCER RES, V61, P4197; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Warren MS, 2009, PHARMACOL RES, V59, P404, DOI 10.1016/j.phrs.2009.02.007; Weidenfeller C, 2007, J NEUROCHEM, V101, P555, DOI 10.1111/j.1471-4159.2006.04394.x; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	51	430	451	6	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2012	30	8					783	791		10.1038/nbt.2247	http://dx.doi.org/10.1038/nbt.2247			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	987KX	22729031	Green Accepted			2022-12-27	WOS:000307416900022
J	Cox, P; Dibling, B				Cox, Pamela; Dibling, Benjamin			Reaching across the table	NATURE BIOTECHNOLOGY			English	Editorial Material									[Cox, Pamela] Marshall Gerstein & Borun LLP, Chicago, IL USA; [Dibling, Benjamin] Univ Calif Los Angeles, Off Intellectual Property & Ind Sponsored Res, Los Angeles, CA USA	University of California System; University of California Los Angeles	Cox, P (corresponding author), Marshall Gerstein & Borun LLP, Chicago, IL USA.	pcox@marshallip.com; benjamin.dibling@research.ucla.edu						FISHER R, 1991, GETTING YES NEGOTIAT, P97	1	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					485	487		10.1038/nbt.2202	http://dx.doi.org/10.1038/nbt.2202			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22678378				2022-12-27	WOS:000305158600010
J	Knight, R; Jansson, J; Field, D; Fierer, N; Desai, N; Fuhrman, JA; Hugenholtz, P; van der Lelie, D; Meyer, F; Stevens, R; Bailey, MJ; Gordon, JI; Kowalchuk, GA; Gilbert, JA				Knight, Rob; Jansson, Janet; Field, Dawn; Fierer, Noah; Desai, Narayan; Fuhrman, Jed A.; Hugenholtz, Phil; van der Lelie, Daniel; Meyer, Folker; Stevens, Rick; Bailey, Mark J.; Gordon, Jeffrey I.; Kowalchuk, George A.; Gilbert, Jack A.			Unlocking the potential of metagenomics through replicated experimental design	NATURE BIOTECHNOLOGY			English	Article							COMPARATIVE-ANALYSIS SYSTEM; WESTERN ENGLISH-CHANNEL; GUT MICROBIOME; FUNCTIONAL-ANALYSIS; GLOBAL PATTERNS; BACTERIAL; COMMUNITIES; REVEALS; GENOMES; ENTEROTYPES	Metagenomics holds enormous promise for discovering novel enzymes and organisms that are biomarkers or drivers of processes relevant to disease, industry and the environment. In the past two years, we have seen a paradigm shift in metagenomics to the application of cross-sectional and longitudinal studies enabled by advances in DNA sequencing and high-performance computing. These technologies now make it possible to broadly assess microbial diversity and function, allowing systematic investigation of the largely unexplored frontier of microbial life. To achieve this aim, the global scientific community must collaborate and agree upon common objectives and data standards to enable comparative research across the Earth's microbiome. Improvements in comparability of data will facilitate the study of biotechnologically relevant processes, such as bioprospecting for new glycoside hydrolases or identifying novel energy sources.	[Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Jansson, Janet] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Jansson, Janet] Lawrence Berkeley Natl Lab, Joint Genome Inst, Walnut Creek, CA USA; [Jansson, Janet] Joint Bioenergy Inst, Emeryville, CA USA; [Field, Dawn; Bailey, Mark J.] Ctr Ecol & Hydrol, Oxford, England; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Desai, Narayan; Meyer, Folker; Stevens, Rick; Gilbert, Jack A.] Argonne Natl Lab, Argonne, IL 60439 USA; [Fuhrman, Jed A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Hugenholtz, Phil] Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Hugenholtz, Phil] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [van der Lelie, Daniel] RTI, Durham, NC USA; [Meyer, Folker; Stevens, Rick] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO USA; [Kowalchuk, George A.] Netherlands Inst Ecol NIOO KNAW, Wageningen, Netherlands; [Kowalchuk, George A.] Vrije Univ Amsterdam, Inst Ecol Sci, Amsterdam, Netherlands; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; UK Centre for Ecology & Hydrology (UKCEH); University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); Argonne National Laboratory; University of Southern California; University of Queensland; University of Queensland; Research Triangle Institute; University of Chicago; Washington University (WUSTL); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Vrije Universiteit Amsterdam; University of Chicago	Knight, R (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	rob.knight@colorado.edu	Gilbert, Jack/AAF-3270-2019; Knight, Rob/D-1299-2010; Jansson, Janet/H-5478-2018; bailey, mark j/I-7149-2012; Jansson, Janet/F-9951-2012; Fuhrman, Jed A/C-6461-2013; Kowalchuk, George A/C-4298-2011; Hugenholtz, Philip/AAD-9138-2019; Gordon, Iain/S-8076-2019; KNAW, NIOO-KNAW/A-4320-2012	Jansson, Janet/0000-0002-5487-4315; bailey, mark j/0000-0002-0147-7316; Fuhrman, Jed A/0000-0002-2361-1985; Hugenholtz, Philip/0000-0001-5386-7925; Gordon, Iain/0000-0001-9704-0946; Meyer, Folker/0000-0003-1112-2284; Knight, Rob/0000-0002-0975-9019; FIERER, NOAH/0000-0002-6432-4261; KNAW, NIOO-KNAW/0000-0002-3835-159X; Kowalchuk, George/0000-0003-3866-0832	US Department of Energy [DE-AC02-06CH11357, DE-AC02-05CH11231]; US National Institutes of Health; Natural Environment Research Council, UK; Crohn's and Colitis Foundation of America; Howard Hughes Medical Institute; Natural Environment Research Council [CEH010021] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Crohn's and Colitis Foundation of America; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We wish to thank J. Eisen for his constant support of the Earth Microbiome Project and his help with writing this work. This work was in part supported by the US Department of Energy under contracts DE-AC02-06CH11357 and DE-AC02-05CH11231, the US National Institutes of Health, the Natural Environment Research Council, UK, the Crohn's and Colitis Foundation of America, and the Howard Hughes Medical Institute. We thank J. Reeder, J. Stombaugh, C. Lozupone, D. McDonald, J. Kuczynski and J. Metcalf for comments on drafts.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Caporaso JG, 2012, ISME J, V6, P1089, DOI 10.1038/ismej.2011.162; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Davies N, 2012, NATURE, V481, P145, DOI 10.1038/481145a; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Delmont TO, 2011, ISME J, V5, P1837, DOI 10.1038/ismej.2011.61; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Desai N, 2012, CURR OPIN BIOTECH, V23, P72, DOI 10.1016/j.copbio.2011.12.017; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Farnelid H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019223; Field D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001088; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fisher RA, 1935, DESIGN EXPT; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gilbert J.A., 2012, METHODS MOL BIOL, V908; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Jansson J., 2011, MICROBE, V6, P309, DOI DOI 10.1128/MICR0BE.6.309.1; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Larsen PE, 2012, NAT METHODS, V9, P621, DOI [10.1038/NMETH.1975, 10.1038/nmeth.1975]; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Parsons RJ, 2012, ISME J, V6, P273, DOI 10.1038/ismej.2011.101; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rasche F, 2011, ISME J, V5, P389, DOI 10.1038/ismej.2010.138; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Woelfle M, 2011, NAT CHEM, V3, P745, DOI 10.1038/nchem.1149; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	56	192	200	0	189	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2012	30	6					513	520		10.1038/nbt.2235	http://dx.doi.org/10.1038/nbt.2235			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	957JV	22678395	Green Accepted, Green Submitted			2022-12-27	WOS:000305158600021
J	Amps, K; Andrews, PW; Anyfantis, G; Armstrong, L; Avery, S; Baharvand, H; Baker, J; Baker, D; Munoz, MB; Beil, S; Benvenisty, N; Ben-Yosef, D; Biancotti, JC; Bosman, A; Brena, RM; Brison, D; Caisander, G; Camarasa, MV; Chen, JM; Chiao, E; Choi, YM; Choo, ABH; Collins, D; Colman, A; Crook, JM; Daley, GQ; Dalton, A; De Sousa, PA; Denning, C; Downie, J; Dvorak, P; Montgomery, KD; Feki, A; Ford, A; Fox, V; Fraga, AM; Frumkin, T; Ge, L; Gokhale, PJ; Golan-Lev, T; Gourabi, H; Gropp, M; Lu, GX; Hampl, A; Harron, K; Healy, L; Herath, W; Holm, F; Hovatta, O; Hyllner, J; Inamdar, MS; Irwanto, AK; Ishii, T; Jaconi, M; Jin, Y; Kimber, S; Kiselev, S; Knowles, BB; Kopper, O; Kukharenko, V; Kuliev, A; Lagarkova, MA; Laird, PW; Lako, M; Laslett, AL; Lavon, N; Lee, DR; Lee, JE; Li, CL; Lim, LS; Ludwig, TE; Ma, Y; Maltby, E; Mateizel, I; Mayshar, Y; Mileikovsky, M; Minger, SL; Miyazaki, T; Moon, SY; Moore, H; Mummery, C; Nagy, A; Nakatsuji, N; Narwani, K; Oh, SKW; Oh, SK; Olson, C; Otonkoski, T; Pan, F; Park, IH; Pells, S; Pera, MF; Pereira, LV; Qi, O; Raj, GS; Reubinoff, B; Robins, A; Robson, P; Rossant, J; Salekdeh, GH; Schulz, TC; Sermon, K; Mohamed, JS; Shen, H; Sherrer, E; Sidhu, K; Sivarajah, S; Skottman, H; Spits, C; Stacey, GN; Strehl, R; Strelchenko, N; Suemori, H; Sun, BW; Suuronen, R; Takahashi, K; Tuuri, T; Venu, P; Verlinsky, Y; Ward-van Oostwaard, D; Weisenberger, DJ; Wu, Y; Yamanaka, S; Young, L; Zhou, Q				Amps, Katherine; Andrews, Peter W.; Anyfantis, George; Armstrong, Lyle; Avery, Stuart; Baharvand, Hossein; Baker, Julie; Baker, Duncan; Munoz, Maria B.; Beil, Stephen; Benvenisty, Nissim; Ben-Yosef, Dalit; Biancotti, Juan-Carlos; Bosman, Alexis; Brena, Romulo Martin; Brison, Daniel; Caisander, Gunilla; Camarasa, Maria V.; Chen, Jieming; Chiao, Eric; Choi, Young Min; Choo, Andre B. H.; Collins, Daniel; Colman, Alan; Crook, Jeremy M.; Daley, George Q.; Dalton, Anne; De Sousa, Paul A.; Denning, Chris; Downie, Janet; Dvorak, Petr; Montgomery, Karen D.; Feki, Anis; Ford, Angela; Fox, Victoria; Fraga, Ana M.; Frumkin, Tzvia; Ge, Lin; Gokhale, Paul J.; Golan-Lev, Tamar; Gourabi, Hamid; Gropp, Michal; Lu Guangxiu; Hampl, Ales; Harron, Katie; Healy, Lyn; Herath, Wishva; Holm, Frida; Hovatta, Outi; Hyllner, Johan; Inamdar, Maneesha S.; Irwanto, Astrid Kresentia; Ishii, Tetsuya; Jaconi, Marisa; Jin, Ying; Kimber, Susan; Kiselev, Sergey; Knowles, Barbara B.; Kopper, Oded; Kukharenko, Valeri; Kuliev, Anver; Lagarkova, Maria A.; Laird, Peter W.; Lako, Majlinda; Laslett, Andrew L.; Lavon, Neta; Lee, Dong Ryul; Lee, Jeoung Eun; Li, Chunliang; Lim, Linda S.; Ludwig, Tenneille E.; Ma, Yu; Maltby, Edna; Mateizel, Ileana; Mayshar, Yoav; Mileikovsky, Maria; Minger, Stephen L.; Miyazaki, Takamichi; Moon, Shin Yong; Moore, Harry; Mummery, Christine; Nagy, Andras; Nakatsuji, Norio; Narwani, Kavita; Oh, Steve K. W.; Oh, Sun Kyung; Olson, Cia; Otonkoski, Timo; Pan, Fei; Park, In-Hyun; Pells, Steve; Pera, Martin F.; Pereira, Lygia V.; Qi, Ouyang; Raj, Grace Selva; Reubinoff, Benjamin; Robins, Alan; Robson, Paul; Rossant, Janet; Salekdeh, Ghasem H.; Schulz, Thomas C.; Sermon, Karen; Mohamed, Jameelah Sheik; Shen, Hui; Sherrer, Eric; Sidhu, Kuldip; Sivarajah, Shirani; Skottman, Heli; Spits, Claudia; Stacey, Glyn N.; Strehl, Raimund; Strelchenko, Nick; Suemori, Hirofumi; Sun, Bowen; Suuronen, Riitta; Takahashi, Kazutoshi; Tuuri, Timo; Venu, Parvathy; Verlinsky, Yuri; Ward-van Oostwaard, Dorien; Weisenberger, Daniel J.; Wu, Yue; Yamanaka, Shinya; Young, Lorraine; Zhou, Qi		Int Stem Cell Initiative	Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage	NATURE BIOTECHNOLOGY			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; HUMAN ES CELLS; DNA-SEQUENCE; CULTURE; GENES; LINES; PLURIPOTENCY; REVEALS; NANOG	The International Stem Cell Initiative analyzed 125 human embryonic stem (ES) cell lines and 11 induced pluripotent stem (iPS) cell lines, from 38 laboratories worldwide, for genetic changes occurring during culture. Most lines were analyzed at an early and late passage. Single-nucleotide polymorphism (SNP) analysis revealed that they included representatives of most major ethnic groups. Most lines remained karyotypically normal, but there was a progressive tendency to acquire changes on prolonged culture, commonly affecting chromosomes 1, 12, 17 and 20. DNA methylation patterns changed haphazardly with no link to time in culture. Structural variants, determined from the SNP arrays, also appeared sporadically. No common variants related to culture were observed on chromosomes 1, 12 and 17, but a minimal amplicon in chromosome 20q11.21, including three genes expressed in human ES cells, ID1, BCL2L1 and HM13, occurred in >20% of the lines. Of these genes, BCL2L1 is a strong candidate for driving culture adaptation of ES cells.	[Amps, Katherine; Andrews, Peter W.; Ford, Angela; Gokhale, Paul J.; Moore, Harry] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Anyfantis, George; Armstrong, Lyle; Lako, Majlinda] Int Ctr Life, NE England Stem Cell Inst Life, Newcastle Upon Tyne, Tyne & Wear, England; [Avery, Stuart; Colman, Alan; Crook, Jeremy M.; Knowles, Barbara B.] ASTAR, Inst Med Biol, Immunos, Singapore; [Baharvand, Hossein; Gourabi, Hamid] Royan Inst Reprod Biomed, Dept Genet, Tehran, Iran; [Baker, Julie; Chiao, Eric] Stanford Univ, Stanford, CA 94305 USA; [Baker, Duncan; Dalton, Anne; Maltby, Edna] Sheffield Childrens NHS Trust, Sheffield Diagnost Genet Serv, Sheffield, S Yorkshire, England; [Munoz, Maria B.; Denning, Chris; Young, Lorraine] Univ Nottingham, Ctr Biomol Sci, Wolfson Ctr Stem Cells Tissue Engn & Modelling ST, Nottingham NG7 2RD, England; [Beil, Stephen; Fox, Victoria] Univ So Calif, Keck Sch Med, USC Stem Cell Core Facil, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Benvenisty, Nissim; Golan-Lev, Tamar; Kopper, Oded; Mayshar, Yoav] Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, Stem Cell Unit, IL-91904 Jerusalem, Israel; [Ben-Yosef, Dalit; Frumkin, Tzvia] Lis Matern Hosp, Tel Aviv Sourasky Med Ctr, Racine IVF Unit, Tel Aviv, Israel; [Ben-Yosef, Dalit] Tel Aviv Univ, Sackler Fac Med, Dept Cell Dev Biol, IL-69978 Tel Aviv, Israel; [Biancotti, Juan-Carlos; Lavon, Neta; Narwani, Kavita] Cedars Sinai Med Inst, Regenerat Med Inst, Los Angeles, CA USA; [Bosman, Alexis; Jaconi, Marisa] Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland; [Brena, Romulo Martin; Laird, Peter W.; Pan, Fei; Shen, Hui; Weisenberger, Daniel J.] Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Brison, Daniel] Cent Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Maryss Hosp, Dept Reprod Med, Manchester, Lancs, England; [Caisander, Gunilla; Hyllner, Johan; Strehl, Raimund] Cellartis AB, Gothenburg, Sweden; [Camarasa, Maria V.; Kimber, Susan] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Chen, Jieming; Herath, Wishva; Irwanto, Astrid Kresentia; Lim, Linda S.; Robson, Paul; Mohamed, Jameelah Sheik] Genome Inst Singapore, Singapore, Singapore; [Chiao, Eric] Hoffmann LaRoche, Nutley, NJ USA; [Choi, Young Min; Moon, Shin Yong] Seoul Natl Univ, Coll Med, Dept Obstet & Gynaecol, Seoul, South Korea; [Choo, Andre B. H.; Oh, Steve K. W.] Bioproc Technol Inst, Singapore, Singapore; [Collins, Daniel; De Sousa, Paul A.; Downie, Janet] Roslin Cells Ltd, Roslin Bioctr, Roslin, Midlothian, Scotland; [Colman, Alan; Crook, Jeremy M.; Raj, Grace Selva; Sivarajah, Shirani] ASTAR, Singapore Stem Cell Consortium, Singapore, Singapore; [Crook, Jeremy M.; Sivarajah, Shirani] Univ Melbourne, Ctr Neural Engn, Parkville, Vic 3052, Australia; [Crook, Jeremy M.; Sivarajah, Shirani] Univ Melbourne, Opt & Nanoelect Res Grp, NICTA Victorian Res Lab, Parkville, Vic 3052, Australia; [Crook, Jeremy M.] Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia; [Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA; [Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Stem Cell Inst, Boston, MA USA; [De Sousa, Paul A.; Pells, Steve] Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Dvorak, Petr] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic; [Montgomery, Karen D.; Ludwig, Tenneille E.] WiCell Res Inst, Madison, WI USA; [Feki, Anis] Hop Cantonal Fribourgois, Dept Obstet & Gynecol, Freibourg, Switzerland; [Fraga, Ana M.; Pereira, Lygia V.] Univ Sao Paulo, Dept Genet & Evolutionary Biol, Natl Lab Embryon Stem Cell Res LaNCE, Sao Paulo, Brazil; [Ge, Lin; Lu Guangxiu; Qi, Ouyang] Cent S Univ, Inst Reprod & Stem Cell Engn, Reprod & Genet Hosp CITIC XIANGYA, Changsha, Hunan, Peoples R China; [Gropp, Michal; Reubinoff, Benjamin] Hadassah Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Hadassah Human Embryon Stem Cell Res Ctr, Jerusalem, Israel; [Hampl, Ales] Masaryk Univ, Fac Med, Dept Histol & Embryol, Brno, Czech Republic; [Hampl, Ales] Inst Expt Med ASCR, Prague, Czech Republic; [Harron, Katie] UCL, Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England; [Healy, Lyn; Stacey, Glyn N.] Natl Inst Biol Stand & Controls, Div Cell Biol & Imaging, UK Stem Cell Bank, S Mimms, Herts, England; [Holm, Frida; Hovatta, Outi] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Inamdar, Maneesha S.; Venu, Parvathy] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India; [Ishii, Tetsuya; Takahashi, Kazutoshi; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Jin, Ying] CAS Shanghai Jiao Tong Univ, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol, Inst Hlth Sci,Sch Med, Shanghai, Peoples R China; [Kiselev, Sergey] NRC Kurchatov Inst, Stem Cell Dept, Moscow, Russia; [Kiselev, Sergey; Lagarkova, Maria A.] Vavilov Inst Gen Genet, Moscow, Russia; [Kukharenko, Valeri; Kuliev, Anver; Strelchenko, Nick; Verlinsky, Yuri] Illinois Masonic Med Ctr, Inst Reprod Genet, Chicago, IL 60657 USA; [Laslett, Andrew L.; Zhou, Qi] CSIRO Mat Sci & Engn, Clayton, Vic, Australia; [Laslett, Andrew L.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Lee, Dong Ryul] CHA Univ, CHA Stem Cell Inst, Dept Biomed Sci, Seoul, South Korea; [Li, Chunliang; Ma, Yu; Sun, Bowen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Shanghai 200030, Peoples R China; [Mateizel, Ileana; Sermon, Karen; Spits, Claudia] Vrije Univ Brussel, Dept Embryol & Genet, Brussels, Belgium; [Mileikovsky, Maria; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Minger, Stephen L.; Wu, Yue] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Minger, Stephen L.; Wu, Yue] GE Healthcare, Cardiff, S Glam, Wales; [Miyazaki, Takamichi; Suemori, Hirofumi] Kyoto Univ, Inst Frontier Med Sci, Stem Cell Res Ctr, Lab Embryon Stem Cell Res, Kyoto, Japan; [Mummery, Christine; Ward-van Oostwaard, Dorien] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Nakatsuji, Norio; Yamanaka, Shinya] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto, Japan; [Oh, Sun Kyung] Seoul Natl Univ, Med Res Ctr, Inst Reprod Med & Populat, Seoul, South Korea; [Olson, Cia; Otonkoski, Timo; Tuuri, Timo] Univ Helsinki, Res Programs Unit, Biomedicum Stem Cell Ctr, FIN-00014 Helsinki, Finland; [Otonkoski, Timo] Univ Helsinki, Childrens Hosp, FIN-00014 Helsinki, Finland; [Otonkoski, Timo] Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland; [Park, In-Hyun] Yale Univ, Sch Med, Dept Genet, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Robins, Alan; Schulz, Thomas C.; Sherrer, Eric] Viacyte, Athens, GA USA; [Rossant, Janet] Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; [Salekdeh, Ghasem H.] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Mol Syst Biol, Tehran, Iran; [Sidhu, Kuldip] Univ New S Wales, Fac Med, Stem Cell Lab, Sydney, NSW 2052, Australia; [Skottman, Heli; Suuronen, Riitta] Univ Tampere, Inst Regenerat Med, FIN-33101 Tampere, Finland; [Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	University of Sheffield; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Stanford University; Sheffield Children's NHS Foundation Trust; University of Nottingham; University of Southern California; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Cedars Sinai Medical Center; University of Geneva; University of Southern California; University of Manchester; Takara Bio Inc.; Cellartis; University of Manchester; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Seoul National University (SNU); Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; Agency for Science Technology & Research (A*STAR); University of Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; University of Edinburgh; Masaryk University Brno; WiCell Research Institute; Universidade de Sao Paulo; Central South University; Hebrew University of Jerusalem; Hadassah University Medical Center; Masaryk University Brno; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; University of London; University College London; National Institute for Biological Standards & Control; Karolinska Institutet; Karolinska University Hospital; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore; Kyoto University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Research Centre - Kurchatov Institute; Russian Academy of Sciences; Vavilov Institute of General Genetics; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; Pochon Cha University; Shanghai Jiao Tong University; Vrije Universiteit Brussel; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of London; King's College London; General Electric; Kyoto University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Kyoto University; Seoul National University (SNU); University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Yale University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Academic Center for Education, Culture & Research (ACECR); University of New South Wales Sydney; Tampere University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes	Amps, K (corresponding author), Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England.		Seppänen-Kaijasinkko, Riitta/AAE-1476-2021; SIDHU, kuldip/AAI-8361-2020; Kiselev, Sergey/AAO-1247-2020; Hampl, Ales/N-1632-2016; Weisenberger, Daniel/AAA-8314-2020; Armstrong, Lyle/B-7812-2013; Kuliev, Anver/P-5666-2018; Dvorak, Petr/G-2509-2013; Robson, Paul/A-3464-2009; Laslett, Andrew L/A-9760-2011; PERA, MARTIN/A-9812-2012; Takahashi, Kazutoshi/ABE-5504-2020; , chunliang.li@stjude.org/P-4373-2018; Dvorak, Petr/N-8936-2016; Salekdeh, Ghasem Hosseini/E-4198-2012; Vopenkova, Katerina/C-7133-2012; Camarasa, Maria V/L-3886-2014; De Sousa, Paul A/H-7416-2013; denning, chris/D-4777-2013; Shen, Hui/AAO-4387-2020; Lako, Majlinda/B-6297-2013; Choi, Young Min/J-2794-2012; Laird, Peter W/G-8683-2012; Moon, Shin-Yong/J-5467-2012; Spits, Claudia/J-1964-2014; Nagy, Andras/G-6465-2013; Jaconi, Marisa EE/J-4392-2013; Pereira, Lygia V/C-1049-2012; Crook, Jeremy Micah/AAH-8441-2020; Lagarkova, Maria/A-3296-2014	Hampl, Ales/0000-0002-8963-9235; Weisenberger, Daniel/0000-0001-8303-2603; Kuliev, Anver/0000-0002-2486-9339; Dvorak, Petr/0000-0002-3229-140X; Robson, Paul/0000-0002-0191-3958; Laslett, Andrew L/0000-0003-4729-8193; PERA, MARTIN/0000-0001-6239-0428; Takahashi, Kazutoshi/0000-0002-5329-8395; , chunliang.li@stjude.org/0000-0002-5938-5510; Dvorak, Petr/0000-0002-3229-140X; Salekdeh, Ghasem Hosseini/0000-0002-5124-4721; De Sousa, Paul A/0000-0003-0745-2504; Laird, Peter W/0000-0001-9117-3641; Spits, Claudia/0000-0002-0187-5138; Nagy, Andras/0000-0003-4311-0413; Pereira, Lygia V/0000-0002-0002-725X; Crook, Jeremy Micah/0000-0002-6415-1639; Jaconi, Marisa/0000-0002-2004-8226; Reubinoff, Benjamin/0000-0003-0353-1299; Harron, Katie/0000-0002-3418-2856; Healy, Lyn/0000-0002-7044-8789; Young, Lorraine/0000-0001-5450-5723; Gokhale, Paul/0000-0001-7225-4403; kiselev, sergey/0000-0001-7921-6987; Sermon, Karen/0000-0002-2311-9034; Ishii, Tetsuya/0000-0002-7085-7750; Anyfantis, George/0000-0001-5647-3841; Choo, Andre/0000-0001-9648-0755; Denning, Chris/0000-0003-0802-8617; Andrews, Peter/0000-0001-7215-4410; Seppanen-Kaijansinkko, Riitta/0000-0001-5348-7121; Skottman, Heli/0000-0002-4127-8792; Pells, Stephen/0000-0001-5866-5759; armstrong, lyle/0000-0002-7234-9362; Mummery, Christine/0000-0002-4549-6535; Mayshar, Yoav/0000-0002-5553-2472; Kimber, Susan/0000-0002-0568-6342; INAMDAR, MANEESHA/0000-0002-8243-2821; Knowles, Barbara B./0000-0002-2597-5619; Feki, Anis/0000-0002-9817-9445; Shen, Hui/0000-0001-9767-4084; Lagarkova, Maria/0000-0001-9594-1134; lako, majlinda/0000-0003-1327-8573; Chen, Jieming/0000-0003-3767-9486	International Stem Cell Forum; Ministry of Science and Technology of China [2006AA02A102]; Japan Society for the Promotion of Science (JSPS); MEXT; Swiss National Science Foundation [4046-114410]; North West Science Fund, UK; One North East Regional Developmental Agency; Medical Research Council, UK; Newcastle University; Australian Stem Cell Centre; Netherlands Proteomics Consortium [T4-3]; Stem Cell Network, Canada; MEXT, Japan; Singapore Stem Cell Consortium (SSCC); Agency for Science Technology and Research (A<SUP>star</SUP>STAR); Genome Institute of Singapore Core Genotyping Lab; Academy of Finland [218050]; Sigrid Juselius Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Departamento de Ciencia e Tecnologia do Ministerio da Saude (CNPq/MS/DECIT); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Judy; Sidney Swartz; Faculty of Medicine; University of New South Wales (UNSW); National Health and Medical Research Council (NHMRC) [568969]; South Eastern Sydney and Illawarra Area Health Service (SEIAHS); Tampere University Hospital [9F217]; Biotechnology and Biological Sciences Research Council [BB/E006159/1] Funding Source: researchfish; British Heart Foundation [PG/09/027/27141] Funding Source: researchfish; Medical Research Council [G0801059, G0700092, G0301182, G0700785, G0801098, MC_qA137914, G113/30, G0300484, G1001045, MC_qA137916, MC_qA137863, G0801057] Funding Source: researchfish; BBSRC [BB/E006159/1] Funding Source: UKRI; MRC [G113/30, MC_qA137914, MC_qA137916, G0300484, G0801098, G0700785, G0801059, G0301182, G0700092, G1001045, G0801057] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER	International Stem Cell Forum; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); North West Science Fund, UK; One North East Regional Developmental Agency; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newcastle University; Australian Stem Cell Centre; Netherlands Proteomics Consortium; Stem Cell Network, Canada; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Singapore Stem Cell Consortium (SSCC); Agency for Science Technology and Research (A<SUP>star</SUP>STAR)(Agency for Science Technology & Research (A*STAR)); Genome Institute of Singapore Core Genotyping Lab; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Departamento de Ciencia e Tecnologia do Ministerio da Saude (CNPq/MS/DECIT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Judy; Sidney Swartz; Faculty of Medicine; University of New South Wales (UNSW); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); South Eastern Sydney and Illawarra Area Health Service (SEIAHS); Tampere University Hospital; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The International Stem Cell Initiative is funded by The International Stem Cell Forum. The authors would like to acknowledge the following: Medical Research Council, UK (P. W. A., H. M.); Mohammad Pakzad & Adeleh Taei, Royan Institute (H. B., G. H. S.); California Institute for Regenerative Medicine (CIRM) (E. C., P. W. L.); Institute of Medical Biology, A<SUP>star</SUP>STAR, Singapore (J.M.C.); Ministry of Education, Youth and Sports of the Czech Republic (P. D., A. H.); Stem Cell Research Center of the 21st Century Frontier Research Program, Ministry of Education, Science & Technology, Republic of Korea (SC-1140) (D. R. L., S.K.O.); Ministry of Science and Technology of China (863 program 2006AA02A102) (L. G.); Swedish Research Council, Cellartis (O.H.); Department of Biotechnology, Government of India, UK-India Education and Research Initiative and the Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India (M. I.); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Leading Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the Japan Society for the Promotion of Science (JSPS), Grants in-Aid for Scientific Research of JSPS and MEXT (T. I., S.Y., K. T.); Swiss National Science Foundation (grant no. 4046-114410) (M.J.); Shanghai Science and Technology Developmental Foundation (06DJ14001), Chinese Ministry of Science and Technology (2007CB948004) (Y.J.); funding from the North West Science Fund, UK (S. K.); One North East Regional Developmental Agency, Medical Research Council, UK, Newcastle University (M. L.); research funding from the Australian Stem Cell Centre (A. L. L.); The Netherlands Proteomics Consortium grant T4-3 (C. M.); Stem Cell Network, Canada (A.N.); National BioResource Project, MEXT, Japan (N.N.); Singapore Stem Cell Consortium (SSCC) & the Agency for Science Technology and Research (A<SUP>star</SUP>STAR) (S. K. W.O., P. R.) and the Genome Institute of Singapore Core Genotyping Lab (P. R.); Academy of Finland, Sigrid Juselius Foundation (T.O.); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Departamento de Ciencia e Tecnologia do Ministerio da Saude (CNPq/MS/DECIT), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (L. V. P.); supported by the kind donation of Judy and Sidney Swartz (B. R.); financial support from the Faculty of Medicine, University of New South Wales (UNSW) and the National Health and Medical Research Council (NHMRC) Program Grant no. 568969 (Perminder Sachdev), South Eastern Sydney and Illawarra Area Health Service (SEIAHS) for making hES cell line Endeavour-2 available for this study, and H. Chung and J. Kim for their help in preparing the samples (K. S.); Academy of Finland (grant 218050), the Competitive Research Funding of the Tampere University Hospital (grant 9F217) (H. Skottman).	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x; Andrews PW, 2005, NAT BIOTECHNOL, V23, P795, DOI 10.1038/nbt0705-798; ANDREWS PW, 1980, INT J CANCER, V26, P269, DOI 10.1002/ijc.2910260304; Ardehali R, 2011, P NATL ACAD SCI USA, V108, P3282, DOI 10.1073/pnas.1019047108; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; ATKIN NB, 1982, LANCET, V2, P1349; Bai H, STEM CELL R IN PRESS; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Buzzard JJ, 2004, NAT BIOTECHNOL, V22, P381, DOI 10.1038/nbt0404-381; Caisander G, 2006, CHROMOSOME RES, V14, P131, DOI 10.1007/s10577-006-1019-8; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; HOOK EB, 1977, AM J HUM GENET, V29, P94; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Inzunza J, 2004, MOL HUM REPROD, V10, P461, DOI 10.1093/molehr/gah051; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Laurent LC, 2010, NAT METHODS, V7, P6, DOI 10.1038/nmeth0110-06; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liu X, 1997, DEV DYNAM, V209, P85; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; Looijenga LHJ, 2000, J PATHOL, V191, P187, DOI 10.1002/(SICI)1096-9896(200006)191:2<187::AID-PATH584>3.0.CO;2-T; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; MARTIN GR, 1974, CELL, V2, P163, DOI 10.1016/0092-8674(74)90090-7; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Misceo D, 2005, MOL BIOL EVOL, V22, P360, DOI 10.1093/molbev/msi021; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mosher JT, 2010, NEW ENGL J MED, V362, P183, DOI 10.1056/NEJMc0910371; Mostert M, 2000, LAB INVEST, V80, P1055, DOI 10.1038/labinvest.3780110; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Olariu V, 2010, STEM CELL RES, V4, P50, DOI 10.1016/j.scr.2009.09.001; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RODRIGUEZ E, 1993, GENE CHROMOSOME CANC, V8, P230, DOI 10.1002/gcc.2870080405; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Schneider DT, 2001, KLIN PADIATR, V213, P204, DOI 10.1055/s-2001-16852; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Skotheim RI, 2002, CANCER RES, V62, P2359; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; WANG N, 1980, CANCER RES, V40, P796; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wu H, 2008, STEM CELLS, V26, P1484, DOI 10.1634/stemcells.2007-0993; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	69	367	382	1	167	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1132	U113		10.1038/nbt.2051	http://dx.doi.org/10.1038/nbt.2051			15	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22119741	Green Accepted, Green Published			2022-12-27	WOS:000298038700025
J	Davis, MI; Hunt, JP; Herrgard, S; Ciceri, P; Wodicka, LM; Pallares, G; Hocker, M; Treiber, DK; Zarrinkar, PP				Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.			Comprehensive analysis of kinase inhibitor selectivity	NATURE BIOTECHNOLOGY			English	Article							INTERACTION MAP; KINOME; BINDING	We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome. Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend. The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compounds tested. Analysis of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily. The data set suggests compounds to use as tools to study kinases for which no dedicated inhibitors exist. It also provides a foundation for further exploring kinase inhibitor biology and toxicity, as well as for studying the structural basis of the observed interaction patterns. Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.	[Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.] Ambit Biosci, San Diego, CA USA		Zarrinkar, PP (corresponding author), Blueprint Med Corp, San Diego, CA 92121 USA.	dtreiber@discoverx.com; pzarrinkar@yahoo.com			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Buchanan SG, 2009, MOL CANCER THER, V8, P3181, DOI 10.1158/1535-7163.MCT-09-0477; Carlomagno F, 2004, ONCOGENE, V23, P6056, DOI 10.1038/sj.onc.1207810; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Hasinoff BB, 2010, TOXICOL APPL PHARM, V249, P132, DOI 10.1016/j.taap.2010.08.026; Huang DZ, 2010, BIOINFORMATICS, V26, P198, DOI 10.1093/bioinformatics/btp650; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Melnick JS, 2006, P NATL ACAD SCI USA, V103, P3153, DOI 10.1073/pnas.0511292103; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Miduturu CV, 2011, CHEM BIOL, V18, P868, DOI 10.1016/j.chembiol.2011.05.010; Muller MC, 2009, BLOOD, V114, P4944, DOI 10.1182/blood-2009-04-214221; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Olaharski AJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000446; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Posy SL, 2011, J MED CHEM, V54, P54, DOI 10.1021/jm101195a; Rix LLR, 2009, LEUKEMIA, V23, P477, DOI 10.1038/leu.2008.334; Simard JR, 2010, J AM CHEM SOC, V132, P4152, DOI 10.1021/ja908083e; Wodicka LM, 2010, CHEM BIOL, V17, P1241, DOI 10.1016/j.chembiol.2010.09.010; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yang XA, 2010, J BIOMED INFORM, V43, P376, DOI 10.1016/j.jbi.2010.04.006; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034	30	1204	1260	9	157	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1046	U124		10.1038/nbt.1990	http://dx.doi.org/10.1038/nbt.1990			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22037378				2022-12-27	WOS:000296801300028
J	Ankrum, JA; Ong, JF; Karp, JM				Ankrum, James A.; Ong, Joon Faii; Karp, Jeffrey M.			Mesenchymal stem cells: immune evasive, not immune privileged	NATURE BIOTECHNOLOGY			English	Article							MARROW STROMAL CELLS; IMMUNOSUPPRESSION INHIBITS REJECTION; VERSUS-HOST-DISEASE; IN-VITRO; MYOCARDIAL-INFARCTION; BONE; RESPONSES; THERAPY; TOLERANCE; TRANSPLANTATION	The diverse immunomodulatory properties of mesenchymal stem/stromal cells (MSCs) may be exploited for treatment of a multitude of inflammatory conditions. MSCs have long been reported to be hypoimmunogenic or 'immune privileged'; this property is thought to enable MSC transplantation across major histocompatibility barriers and the creation of off-the-shelf therapies consisting of MSCs grown in culture. However, recent studies describing generation of antibodies against and immune rejection of allogeneic donor MSCs suggest that MSCs may not actually be immune privileged. Nevertheless, whether rejection of donor MSCs influences the efficacy of allogeneic MSC therapies is not known, and no definitive clinical advantage of autologous MSCs over allogeneic MSCs has been demonstrated to date. Although MSCs may exert therapeutic function through a brief 'hit and run' mechanism, protecting MSCs from immune detection and prolonging their persistence in vivo may improve clinical outcomes and prevent patient sensitization toward donor antigens.	[Ankrum, James A.; Ong, Joon Faii; Karp, Jeffrey M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Biomed Engn,Dept Med, Boston, MA 02115 USA; [Ankrum, James A.; Karp, Jeffrey M.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Karp, Jeffrey M.] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University	Karp, JM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Biomed Engn,Dept Med, Boston, MA 02115 USA.	jeffkarp.bwh@gmail.com	Ankrum, James/N-4175-2014	Ankrum, James/0000-0003-3959-6158	National Institutes of Health [HL095722]; Department of Defense [W81XVVH-13-1-0305]; Movember-Prostate Cancer Foundation; Hugh Hampton Young Memorial Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Movember-Prostate Cancer Foundation; Hugh Hampton Young Memorial Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL095722, Department of Defense grant no. W81XVVH-13-1-0305 and by a Movember-Prostate Cancer Foundation Challenge Award to J.M.K. J.A.A. was supported by the Hugh Hampton Young Memorial Fellowship.	Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; Ankrum JA, 2014, NAT PROTOC, V9, P233, DOI 10.1038/nprot.2014.002; Badillo AT, 2007, BIOL BLOOD MARROW TR, V13, P412, DOI 10.1016/j.bbmt.2006.12.447; Ball LM, 2013, BRIT J HAEMATOL, V163, P501, DOI 10.1111/bjh.12545; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503; Bernardo ME, 2011, BONE MARROW TRANSPL, V46, P200, DOI 10.1038/bmt.2010.87; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Brandenberger R, 2011, BIOPROCESS INT S, V9, P30; Bravery CA, 2013, CYTOTHERAPY, V15, P9, DOI 10.1016/j.jcyt.2012.10.008; Buron F, 2009, TRANSPL P, V41, P3347, DOI 10.1016/j.transproceed.2009.08.030; Camp DM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-17; Campeau PM, 2009, MOL THER, V17, P369, DOI 10.1038/mt.2008.270; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Casiraghi F, 2008, J IMMUNOL, V181, P3933, DOI 10.4049/jimmunol.181.6.3933; Chan CKF, 2013, P NATL ACAD SCI USA, V110, P12643, DOI 10.1073/pnas.1310212110; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x; Cyranoski D, 2012, NAT BIOTECHNOL, V30, P571; de la Garza-Rodea AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014493; DelaRosa O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00182; Dembinski JL, 2013, CYTOTHERAPY, V15, P20, DOI 10.1016/j.jcyt.2012.10.003; Devine SM, 2000, CURR OPIN HEMATOL, V7, P358, DOI 10.1097/00062752-200011000-00007; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Fibbe WE, 2013, NAT MED, V19, P812, DOI 10.1038/nm.3222; Forslow U, 2012, EUR J HAEMATOL, V89, P220, DOI 10.1111/j.1600-0609.2012.01824.x; Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189; Francois M, 2009, BLOOD, V114, P2632, DOI 10.1182/blood-2009-02-207795; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Ge W, 2009, AM J TRANSPLANT, V9, P1760, DOI 10.1111/j.1600-6143.2009.02721.x; Griffin MD, 2013, IMMUNOL CELL BIOL, V91, P40, DOI 10.1038/icb.2012.67; Grinnemo KH, 2004, J THORAC CARDIOV SUR, V127, P1293, DOI 10.1016/j.jtcvs.2003.07.037; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; Hemeda H, 2010, STEM CELLS DEV, V19, P693, DOI 10.1089/scd.2009.0365; Huang WH, 2003, TRANSPLANTATION, V76, P1159, DOI 10.1097/01.TP.0000092304.18324.42; Huang WH, 2003, TRANSPLANTATION, V75, P368, DOI 10.1097/01.TP.0000044360.20396.AB; Isakova IA, 2010, EXP HEMATOL, V38, P957, DOI 10.1016/j.exphem.2010.06.011; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; James AW, 2012, STEM CELL TRANSL MED, V1, P673, DOI 10.5966/sctm.2012-0053; Jung YJ, 2012, STEM CELLS, V30, P42, DOI 10.1002/stem.727; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Klyushnenkova E, 1998, BLOOD, V92, p642A; Ko IK, 2009, BIOMATERIALS, V30, P3702, DOI 10.1016/j.biomaterials.2009.03.038; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Krampera M, 2013, CYTOTHERAPY, V15, P1054, DOI 10.1016/j.jcyt.2013.02.010; Kurtzberg J, 2014, BIOL BLOOD MARROW TR, V20, P229, DOI 10.1016/j.bbmt.2013.11.001; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Lazarus H, 2000, BLOOD, V96, p392A; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Leonard DA, 2013, TRANSPLANTATION, V95, P403, DOI 10.1097/TP.0b013e31826d886d; Levy O, 2013, BLOOD, V122, pe23; Li Y, 2012, BLOOD, V120, P3436, DOI 10.1182/blood-2012-03-420612; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Luznik L, 2010, BLOOD, V115, P3224, DOI 10.1182/blood-2009-11-251595; Maccario R, 2005, BIOL BLOOD MARROW TR, V11, P1031, DOI 10.1016/j.bbmt.2005.08.039; Mastri M, 2012, AM J PHYSIOL-CELL PH, V303, pC1021, DOI 10.1152/ajpcell.00191.2012; Melief SM, 2013, STEM CELL TRANSL MED, V2, P455, DOI 10.5966/sctm.2012-0184; Moll G, 2012, STEM CELLS, V30, P1565, DOI 10.1002/stem.1111; Moll G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021703; Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Penn MS, 2012, CIRC RES, V110, P304, DOI 10.1161/CIRCRESAHA.111.253427; Phinney DG, 2013, NAT MED, V19, P812, DOI 10.1038/nm.3220; Pittenger MF, 2013, NAT MED, V19, P811, DOI 10.1038/nm.3219; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Prockop DJ, 2013, STEM CELLS, V31, P2042, DOI 10.1002/stem.1400; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Riordan NH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-29; Sarkar D, 2008, BIOCONJUGATE CHEM, V19, P2105, DOI 10.1021/bc800345q; Sarkar D, 2011, BIOMATERIALS, V32, P3053, DOI 10.1016/j.biomaterials.2010.12.036; Sarkar D, 2010, BIOMATERIALS, V31, P5266, DOI 10.1016/j.biomaterials.2010.03.006; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Shen HL, 2013, NATURE, V499, P389, DOI 10.1038/499389a; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Soland MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036163; Stagg J, 2006, BLOOD, V107, P2570, DOI 10.1182/blood-2005-07-2793; Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722; Toma C, 2009, CIRC RES, V104, P398, DOI 10.1161/CIRCRESAHA.108.187724; Tse W.T., 2000, BLOOD, V96, p1034a; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Verovskaya E, 2013, BLOOD, V122, P523, DOI 10.1182/blood-2013-01-481135; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; von Bahr L, 2012, STEM CELLS, V30, P1575, DOI 10.1002/stem.1118; von Bahr L, 2012, BIOL BLOOD MARROW TR, V18, P557, DOI 10.1016/j.bbmt.2011.07.023; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Xia ZD, 2004, J BIOMED MATER RES A, V71A, P538, DOI 10.1002/jbm.a.30185; Yang H., 2011, NAT BIOTECHNOL, V29, P857, DOI DOI 10.1038/NBT1011-857B; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217; Zanotti L, 2013, LEUKEMIA, V27, P500, DOI 10.1038/leu.2012.202; Zhao WA, 2011, NAT NANOTECHNOL, V6, P524, DOI [10.1038/NNANO.2011.101, 10.1038/nnano.2011.101]; Zhukareva V, 2010, CYTOKINE, V50, P317, DOI 10.1016/j.cyto.2010.01.004	110	854	884	15	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					252	260		10.1038/nbt.2816	http://dx.doi.org/10.1038/nbt.2816			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24561556	Green Accepted			2022-12-27	WOS:000332819800023
J	Bouchie, A; Allison, M; Webb, S; DeFrancesco, L				Bouchie, Aaron; Allison, Malorye; Webb, Sarah; DeFrancesco, Laura			Nature Biotechnology's academic spinouts of 2013	NATURE BIOTECHNOLOGY			English	Article																			0	6	6	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2014	32	3					229	238		10.1038/nbt.2846	http://dx.doi.org/10.1038/nbt.2846			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AC8YA	24727773				2022-12-27	WOS:000332819800018
J	Anders, L; Guenther, MG; Qi, J; Fan, ZP; Marineau, JJ; Rahl, PB; Loven, J; Sigova, AA; Smith, WB; Lee, TI; Bradner, JE; Young, RA				Anders, Lars; Guenther, Matthew G.; Qi, Jun; Fan, Zi Peng; Marineau, Jason J.; Rahl, Peter B.; Loven, Jakob; Sigova, Alla A.; Smith, William B.; Lee, Tong Ihn; Bradner, James E.; Young, Richard A.			Genome-wide localization of small molecules	NATURE BIOTECHNOLOGY			English	Article							DEPENDENT KINASE INHIBITOR; SELECTIVE-INHIBITION; GENE-EXPRESSION; DRUG DISCOVERY; C-MYC; CHROMATIN; TARGET; LEUKEMIA; CANCER; BROMODOMAINS	A vast number of small-molecule ligands, including therapeutic drugs under development and in clinical use, elicit their effects by binding specific proteins associated with the genome. An ability to map the direct interactions of a chemical entity with chromatin genome-wide could provide important insights into chemical perturbation of cellular function. Here we describe a method that couples ligand-affinity capture and massively parallel DNA sequencing (Chem-seq) to identify the sites bound by small chemical molecules throughout the human genome. We show how Chem-seq can be combined with ChIP-seq to gain unique insights into the interaction of drugs with their target proteins throughout the genome of tumor cells. These methods will be broadly useful to enhance understanding of therapeutic action and to characterize the specificity of chemical entities that interact with DNA or genome-associated proteins.	[Anders, Lars; Guenther, Matthew G.; Fan, Zi Peng; Rahl, Peter B.; Loven, Jakob; Sigova, Alla A.; Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Qi, Jun; Marineau, Jason J.; Smith, William B.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Fan, Zi Peng] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	james_bradner@dfci.harvard.edu; young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	US National Institutes of Health [HG002668, CA109901, CA146445]; Swedish Research Council [VR-B0086301]; American Cancer Society [PF-11-042-01-DMC]; Leukemia & Lymphoma Society; Damon-Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA146445, P01CA109901] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); American Cancer Society(American Cancer Society); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Damon-Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Volkert, J. Love, J.-A. Kwon and S. Gupta at the Whitehead Genome Technology Core for Solexa sequencing, E. Cohick for help with cell culture, and A. Federation and R. St. Pierre at the Dana-Farber Cancer Institute for biochemistry support. This work was supported by US National Institutes of Health grants HG002668 (R.A.Y.), CA109901 (R.A.Y.) and CA146445 (R.A.Y., T. I. L.), Swedish Research Council Postdoctoral Fellowship VR-B0086301 (J. L.), American Cancer Society Postdoctoral Fellowship PF-11-042-01-DMC (P. B. R.), the Leukemia & Lymphoma Society (J. Q. and J. E. B.) and the Damon-Runyon Cancer Research Foundation (J.E.B.).	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Deshpande AJ, 2012, TRENDS IMMUNOL, V33, P563, DOI 10.1016/j.it.2012.06.002; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gilbert DM, 2010, NAT REV GENET, V11, P673, DOI 10.1038/nrg2830; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Northrup DL, 2011, IMMUNITY, V34, P830, DOI 10.1016/j.immuni.2011.06.002; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Raida M, 2011, CURR OPIN CHEM BIOL, V15, P570, DOI 10.1016/j.cbpa.2011.06.016; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Santo L, 2010, ONCOGENE, V29, P2325, DOI 10.1038/onc.2009.510; Squires MS, 2010, MOL CANCER THER, V9, P920, DOI 10.1158/1535-7163.MCT-09-1071; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tung SY, 2012, CELL MOL LIFE SCI, V69, P641, DOI 10.1007/s00018-011-0771-x; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	43	128	153	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2014	32	1					92	+		10.1038/nbt.2776	http://dx.doi.org/10.1038/nbt.2776			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	287BM	24336317	Green Submitted, Green Accepted			2022-12-27	WOS:000329513000023
J	Themeli, M; Kloss, CC; Ciriello, G; Fedorov, VD; Perna, F; Gonen, M; Sadelain, M				Themeli, Maria; Kloss, Christopher C.; Ciriello, Giovanni; Fedorov, Victor D.; Perna, Fabiana; Gonen, Mithat; Sadelain, Michel			Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy	NATURE BIOTECHNOLOGY			English	Article							HEMATOPOIETIC PROGENITORS; ANTIGEN; EXPRESSION; DIFFERENTIATION; IMMUNOTHERAPY; PRINCIPLES; MALIGNANCY; INDUCTION; LEUKEMIA; LESSONS	Progress in adoptive T-cell therapy for cancer and infectious diseases(1,2) is hampered by the lack of readily available, antigen-specific, human T lymphocytes. Pluripotent stem cells could provide an unlimited source of T lymphocytes, but the therapeutic potential of human pluripotent stem cell-derived lymphoid cells generated to date remains uncertain(3-6). Here we combine induced pluripotent stem cell (iPSC)(7) and chimeric antigen receptor (CAR)(8) technologies to generate human T cells targeted to CD19, an antigen expressed by malignant B cells, in tissue culture. These iPSC-derived, CAR-expressing T cells display a phenotype resembling that of innate gamma delta T cells. Similar to CAR-transduced, peripheral blood gamma delta T cells, the iPSC-derived T cells potently inhibit tumor growth in a xenograft model. This approach of generating therapeutic human T cells 'in the dish' may be useful for cancer immunotherapy and other medical applications.	[Themeli, Maria; Kloss, Christopher C.; Fedorov, Victor D.; Perna, Fabiana; Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Ciriello, Giovanni] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Sadelain, M (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.	m-sadelain@ski.mskcc.org	Gonen, Mithat/E-4826-2012	Gonen, Mithat/0000-0001-8683-8477; Perna, Fabiana/0000-0002-3744-8672; Themeli, Maria/0000-0003-0585-7786; Ciriello, Giovanni/0000-0003-2021-8683	Sloan-Kettering Institute's Clinical Scholars Biomedical Research Training Program; C.A. Dana Foundation; Department of Defense Prostate Cancer Training Award [PC101964]; Majors Family Foundation; Lake Road Foundation	Sloan-Kettering Institute's Clinical Scholars Biomedical Research Training Program; C.A. Dana Foundation; Department of Defense Prostate Cancer Training Award(United States Department of Defense); Majors Family Foundation; Lake Road Foundation	We thank J. Anderson for valuable advice on gamma delta T-cell expansion; U.K. Bhanot and A. Manzo for their help with teratoma assay evaluation; J. Plotkin and G. Gunset for outstanding technical assistance; M. Condomines, J. Mansilla-Soto and E. Oricchio for reviewing the manuscript. This work was supported by the Sloan-Kettering Institute's Clinical Scholars Biomedical Research Training Program with funds granted by the C.A. Dana Foundation (M.T.), the Department of Defense Prostate Cancer Training Award PC101964 (C.C.K.), the Majors Family Foundation, The Lake Road Foundation, Mr. and Mrs. Mallah, and Mr. L. Sanders.	Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Collins RH, 1997, J CLIN ONCOL, V15, P433, DOI 10.1200/JCO.1997.15.2.433; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Doubrovina E, 2012, BLOOD, V119, P2644, DOI 10.1182/blood-2011-08-371971; Egawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001512; Ellis J, 2010, CELL STEM CELL, V7, P429, DOI 10.1016/j.stem.2010.09.010; Fournie JJ, 2013, CELL MOL IMMUNOL, V10, P35, DOI 10.1038/cmi.2012.39; Goff SL, 2010, J IMMUNOTHER, V33, P840, DOI 10.1097/CJI.0b013e3181f05b91; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Markley JC, 2010, BLOOD, V115, P3508, DOI 10.1182/blood-2009-09-241398; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Ness-Schwickerath KJ, 2011, CELL MOL LIFE SCI, V68, P2371, DOI 10.1007/s00018-011-0700-z; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Pang DJ, 2012, IMMUNOLOGY, V136, P283, DOI 10.1111/j.1365-2567.2012.03582.x; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Pont F, 2012, EUR J IMMUNOL, V42, P228, DOI 10.1002/eji.201141870; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; RIDDELL SR, 1995, ANNU REV IMMUNOL, V13, P545; Riolobos L, 2013, MOL THER, V21, P1232, DOI 10.1038/mt.2013.59; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Slukvin II, 2013, CELL CYCLE, V12, P720, DOI 10.4161/cc.23823; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor CJ, 2012, CELL STEM CELL, V11, P147, DOI 10.1016/j.stem.2012.07.014; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; Timmermans F, 2009, J IMMUNOL, V182, P6879, DOI 10.4049/jimmunol.0803670; Turatti F, 2007, J IMMUNOTHER, V30, P684, DOI 10.1097/CJI.0b013e3180de5d90; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zhao YB, 2007, CANCER RES, V67, P2425, DOI 10.1158/0008-5472.CAN-06-3977	42	254	304	10	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2013	31	10					928	+		10.1038/nbt.2678	http://dx.doi.org/10.1038/nbt.2678			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	233CA	23934177	Green Accepted			2022-12-27	WOS:000325541300022
J	Zhang, CH; Zhang, YP				Zhang, Cynthia H.; Zhang, Y. Philip			Maximizing the commercial value of personalized therapeutics and companion diagnostics	NATURE BIOTECHNOLOGY			English	Editorial Material									[Zhang, Cynthia H.] Agilent Technol, Singapore, Singapore; [Zhang, Y. Philip] Milstein Zhang & Wu LLC, Newton, MA USA	Agilent Technologies	Zhang, CH (corresponding author), Agilent Technol, Singapore, Singapore.	philip.zhang@mzwiplaw.com						FDA, 2004, DRUG DIAGN COD CONC; FDA, 2011, DRAFT GUID IND FOOD; Jorgensen JT, 2007, ONCOLOGIST, V12, P397, DOI 10.1634/theoncologist.12-4-397; Jorgensen JT, 2012, DRUG DEVELOP RES, V73, P390, DOI 10.1002/ddr.21029; Mahn T.G, 2006, UPDATE FOOD DRUG JUL, P8; Naylor S., 2010, DRUG DISCOVERY WORLD, V11, P67; President's Council of Advisors on Science and Technology, 2008, PRIORITIES PERSONALI; Ziegler A, 2012, HUM GENET, V131, P1627, DOI 10.1007/s00439-012-1188-9	8	7	8	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					803	806		10.1038/nbt.2679	http://dx.doi.org/10.1038/nbt.2679			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	24022154				2022-12-27	WOS:000324306300016
J	Chun, MGH; Shaw, RJ				Chun, Matthew G. H.; Shaw, Reuben J.			Cancer metabolism in breadth and depth	NATURE BIOTECHNOLOGY			English	Editorial Material							GLUTAMINE; GROWTH		[Chun, Matthew G. H.; Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Shaw, Reuben J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Chun, MGH (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shaw@salk.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Warburg O, 1924, BIOCHEM Z, V152, P309; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	12	5	5	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					505	507		10.1038/nbt.2611	http://dx.doi.org/10.1038/nbt.2611			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23752435				2022-12-27	WOS:000320113200020
J	Francisco, M				Francisco, Michael			First-quarter biotech job picture	NATURE BIOTECHNOLOGY			English	Editorial Material																		2013, NAT BIOTECHNOL, V31, P175	1	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					465	465		10.1038/nbt.2581	http://dx.doi.org/10.1038/nbt.2581			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23657398	Bronze			2022-12-27	WOS:000318589600028
J	Shepard, K; Ito, T; Griffith, AJ				Shepard, Kenneth; Ito, Taku; Griffith, Andrew J.			Extracting energy from the inner ear	NATURE BIOTECHNOLOGY			English	Editorial Material									[Shepard, Kenneth] Columbia Univ, Dept Elect Engn & Biomed Engn, New York, NY USA; [Ito, Taku; Griffith, Andrew J.] Natl Inst Deafness & Other Commun Disorders, Otolaryngol Branch, US Natl Inst Hlth, Rockville, MD USA	Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Shepard, K (corresponding author), Columbia Univ, Dept Elect Engn & Biomed Engn, New York, NY USA.	shepard@ee.columbia.edu; griffita@nidcd.nih.gov			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000060] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Eisen MD, 2003, OTOL NEUROTOL, V24, P500, DOI 10.1097/00129492-200305000-00025; Halamkova L, 2012, J AM CHEM SOC, V134, P5040, DOI 10.1021/ja211714w; Himes C, 2010, IEEE T NANOTECHNOL, V9, P2, DOI 10.1109/TNANO.2009.2032293; Meniere P, 1861, GAZ MED PARIS, V16, P88; Merchant S.N., 2010, SCHUKNECHTS PATHOLOG, V3; Mercier PP, 2012, NAT BIOTECHNOL, V30, P1240, DOI 10.1038/nbt.2394; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; Panasonic Industry, 2022, ULTRA LOW POWER BIOE, DOI 10.1017/CBO9780511841446; VONBEKESY G, 1952, NATURE, V169, P241; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888	10	2	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1204	1205		10.1038/nbt.2448	http://dx.doi.org/10.1038/nbt.2448			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222789				2022-12-27	WOS:000312092400021
J	Tiels, P; Baranova, E; Piens, K; De Visscher, C; Pynaert, G; Nerinckx, W; Stout, J; Fudalej, F; Hulpiau, P; Tannler, S; Geysens, S; Van Hecke, A; Valevska, A; Vervecken, W; Remaut, H; Callewaert, N				Tiels, Petra; Baranova, Ekaterina; Piens, Kathleen; De Visscher, Charlotte; Pynaert, Gwenda; Nerinckx, Wim; Stout, Jan; Fudalej, Franck; Hulpiau, Paco; Tannler, Simon; Geysens, Steven; Van Hecke, Annelies; Valevska, Albena; Vervecken, Wouter; Remaut, Han; Callewaert, Nico			A bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes	NATURE BIOTECHNOLOGY			English	Article							ACID ALPHA-GLUCOSIDASE; MANNOSE 6-PHOSPHATE RECEPTORS; MOUSE MODEL; N-GLYCANS; PHOSPHORYLATION; REPLACEMENT; STORAGE; TRANSPORT; IDENTIFICATION; THERAPIES	Lysosomal storage diseases are treated with human lysosomal enzymes produced in mammalian cells. Such enzyme therapeutics contain relatively low levels of mannose-6-phosphate, which is required to target them to the lysosomes of patient cells. Here we describe a method for increasing mannose-6-phosphate modification of lysosomal enzymes produced in yeast. We identified a glycosidase from C. cellulans that 'uncaps' N-glycans modified by yeast-type mannose-Pi-6-mannose to generate mammalian-type N-glycans with a mannose-6-phosphate substitution. Determination of the crystal structure of this glycosidase provided insight into its substrate specificity. We used this uncapping enzyme together with alpha-mannosidase to produce in yeast a form of the Pompe disease enzyme alpha-glucosidase rich in mannose-6-phosphate. Compared with the currently used therapeutic version, this form of alpha-glucosidase was more efficiently taken up by fibroblasts from Pompe disease patients, and it more effectively reduced cardiac muscular glycogen storage in a mouse model of the disease.	[Tiels, Petra; De Visscher, Charlotte; Nerinckx, Wim; Van Hecke, Annelies; Callewaert, Nico] VIB, Unit Med Biotechnol, Dept Mol Biomed Res, Ghent, Belgium; [Tiels, Petra; De Visscher, Charlotte; Nerinckx, Wim; Van Hecke, Annelies; Callewaert, Nico] Univ Ghent, Lab Prot Biochem & Biomol Engn, Dept Biochem & Microbiol, B-9000 Ghent, Belgium; [Baranova, Ekaterina; Remaut, Han] VIB, Dept Biol Struct, Brussels, Belgium; [Baranova, Ekaterina; Remaut, Han] Vrije Univ Brussel, Brussels, Belgium; [Piens, Kathleen; Pynaert, Gwenda; Stout, Jan; Fudalej, Franck; Tannler, Simon; Geysens, Steven; Valevska, Albena; Vervecken, Wouter] Oxyrane, Ghent, Belgium; [Hulpiau, Paco] VIB, Bio IT Core Facil, Dept Mol Biomed Res, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Callewaert, N (corresponding author), VIB, Unit Med Biotechnol, Dept Mol Biomed Res, Ghent, Belgium.	wvervecken@oxyrane.com; han.remaut@vib-vub.be; nico.callewaert@dmbr.vib-ugent.be	Hulpiau, Paco/C-3215-2009	Hulpiau, Paco/0000-0002-6692-2150; Van Hecke, Annelies/0000-0002-3010-8034; Baranova, Ekaterina/0000-0003-3211-7134; Remaut, Han/0000-0002-9775-4102; Callewaert, Nico/0000-0003-2069-6917	IWT-Flanders [080775, 110379]; Marie Curie Excellence Grant under EU Framework Program 6 [MEXT-014292]; FWO-Vlaanderen [G.0.327.11.N.10]; Institute for the Advancement of Scientific and Technological Research in Industry (IWT); VIB grant [PRJ9]; Odysseus program of the FWO-Vlaanderen	IWT-Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Marie Curie Excellence Grant under EU Framework Program 6; FWO-Vlaanderen(FWO); Institute for the Advancement of Scientific and Technological Research in Industry (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); VIB grant; Odysseus program of the FWO-Vlaanderen	This work was supported by an R&D grant from IWT-Flanders (projects 080775 and 110379), the Marie Curie Excellence Grant MEXT-014292 under EU Framework Program 6 and by grant G.0.327.11.N.10 of FWO-Vlaanderen.; P.T. holds a doctor-assistant position at Ghent University. C. D. V. holds a fellowship of the Institute for the Advancement of Scientific and Technological Research in Industry (IWT). H. R. is supported by VIB grant PRJ9 and the Odysseus program of the FWO-Vlaanderen. We thank J.-M. Nicaud (CNRS-INRA-INAPG UMR2585, France) for donating Y. lipolytica Po1d lnuga, A. Reuser for providing GAA KO mice and TNO Triskelion for executing the in vivo part of the mouse studies. We acknowledge M. Zawisza, D. Bracke, T. Herman, H. Van Put, S. Poiz and I. Dewerte for their excellent technical assistance during the project and thank the Protein Service Facility (Y. Leoen and J. Haustraete) for their assistance, as well as Y.-C. Lin for handling the genome sequencing data. We dedicate this paper to the memory of the late Prof. Dr. Yoshifumi Jigami, one of the pioneers in glyco-engineering of yeasts.	Akeboshi H, 2009, GLYCOBIOLOGY, V19, P1002, DOI 10.1093/glycob/cwp080; BALLOU DL, 1975, J BACTERIOL, V123, P616, DOI 10.1128/JB.123.2.616-619.1975; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Bijvoet AGA, 1998, HUM MOL GENET, V7, P53, DOI 10.1093/hmg/7.1.53; BRAULKE T, 1987, J CELL BIOL, V104, P1735, DOI 10.1083/jcb.104.6.1735; Breuer P, 1997, MOL BIOL CELL, V8, P567, DOI 10.1091/mbc.8.4.567; Chiba Y, 2002, GLYCOBIOLOGY, V12, P821, DOI 10.1093/glycob/cwf096; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; De Pourcq K, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-53; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fickers P, 2005, FUNGAL GENET BIOL, V42, P264, DOI 10.1016/j.fgb.2004.12.003; Fickers P, 2003, J MICROBIOL METH, V55, P727, DOI 10.1016/j.mimet.2003.07.003; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; HILLEREHFELD A, 1995, BBA-REV BIOMEMBRANES, V1241, P177, DOI 10.1016/0304-4157(95)00004-B; Jigami Y, 1999, BBA-GEN SUBJECTS, V1426, P335, DOI 10.1016/S0304-4165(98)00134-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Lee K, 2003, GLYCOBIOLOGY, V13, P305, DOI 10.1093/glycob/cwg034; METCALFE G, 1957, J GEN MICROBIOL, V17, P567, DOI 10.1099/00221287-17-3-567; Miura M, 2004, GENE, V324, P129, DOI 10.1016/j.gene.2003.09.023; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odani T, 1996, GLYCOBIOLOGY, V6, P805, DOI 10.1093/glycob/6.8.805; Pohl S, 2009, BIOL CHEM, V390, P521, DOI 10.1515/BC.2009.076; REUSER AJJ, 1984, EXP CELL RES, V155, P178, DOI 10.1016/0014-4827(84)90779-1; Schumann P, 2001, INT J SYST EVOL MICR, V51, P1007, DOI 10.1099/00207713-51-3-1007; Schwientek P, 2011, J BIOTECHNOL, V155, P68, DOI 10.1016/j.jbiotec.2011.04.010; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; Takashiba M, 2006, ANAL CHEM, V78, P5208, DOI 10.1021/ac060072u; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vervecken W, 2004, APPL ENVIRON MICROB, V70, P2639, DOI 10.1128/AEM.70.5.2639-2646.2004; York SJ, 1999, J BIOL CHEM, V274, P1164, DOI 10.1074/jbc.274.2.1164; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]; Zhu YX, 2009, MOL THER, V17, P954, DOI 10.1038/mt.2009.37; Zhu YX, 2005, BIOCHEM J, V389, P619, DOI 10.1042/BJ20050364	41	74	80	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1225	+		10.1038/nbt.2427	http://dx.doi.org/10.1038/nbt.2427			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23159880				2022-12-27	WOS:000312092400026
J	Xu, X; Nagarajan, H; Lewis, NE; Pan, SK; Cai, ZM; Liu, X; Chen, WB; Xie, M; Wang, WL; Hammond, S; Andersen, MR; Neff, N; Passarelli, B; Koh, W; Fan, HC; Wang, JB; Gui, YT; Lee, KH; Betenbaugh, MJ; Quake, SR; Famili, I; Palsson, BO; Wang, J				Xu, Xun; Nagarajan, Harish; Lewis, Nathan E.; Pan, Shengkai; Cai, Zhiming; Liu, Xin; Chen, Wenbin; Xie, Min; Wang, Wenliang; Hammond, Stephanie; Andersen, Mikael R.; Neff, Norma; Passarelli, Benedetto; Koh, Winston; Fan, H. Christina; Wang, Jianbin; Gui, Yaoting; Lee, Kelvin H.; Betenbaugh, Michael J.; Quake, Stephen R.; Famili, Iman; Palsson, Bernhard O.; Wang, Jun			The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line	NATURE BIOTECHNOLOGY			English	Article							HERPES-SIMPLEX-VIRUS; HEPARAN-SULFATE 6-SULFOTRANSFERASE; THERAPEUTIC ANTIBODIES; SIALIC-ACID; GLYCOSYLATION; EXPRESSION; CHO; SURFACE; PURIFICATION; RECEPTORS	Chinese hamster ovary (CHO)-derived cell lines are the preferred host cells for the production of therapeutic proteins. Here we present a draft genomic sequence of the CHO-K1 ancestral cell line. The assembly comprises 2.45 Gb of genomic sequence, with 24,383 predicted genes. We associate most of the assembled scaffolds with 21 chromosomes isolated by microfluidics to identify chromosomal locations of genes. Furthermore, we investigate genes involved in glycosylation, which affect therapeutic protein quality, and viral susceptibility genes, which are relevant to cell engineering and regulatory concerns. Homologs of most human glycosylation-associated genes are present in the CHO-K1 genome, although 141 of these homologs are not expressed under exponential growth conditions. Many important viral entry genes are also present in the genome but not expressed, which may explain the unusual viral resistance property of CHO cell lines. We discuss how the availability of this genome sequence may facilitate genome-scale science for the optimization of biopharmaceutical protein production.	[Xu, Xun; Pan, Shengkai; Liu, Xin; Chen, Wenbin; Xie, Min; Wang, Wenliang; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Nagarajan, Harish; Lewis, Nathan E.; Famili, Iman; Palsson, Bernhard O.] GT Life Sci, San Diego, CA USA; [Cai, Zhiming; Gui, Yaoting] Peking Univ, Shenzhen PKU HKUST Med Ctr, Guangdong Key Lab Male Reprod Med & Genet, Shenzhen Hosp, Shenzhen, Peoples R China; [Hammond, Stephanie; Lee, Kelvin H.] Univ Delaware, Dept Chem Engn, Newark, DE USA; [Hammond, Stephanie; Lee, Kelvin H.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA; [Andersen, Mikael R.] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Neff, Norma; Passarelli, Benedetto; Koh, Winston; Fan, H. Christina; Wang, Jianbin; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Neff, Norma; Passarelli, Benedetto; Koh, Winston; Fan, H. Christina; Wang, Jianbin; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Betenbaugh, Michael J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Betenbaugh, Michael J.; Palsson, Bernhard O.] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, Horsholm, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Beijing Genomics Institute (BGI); Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; University of Delaware; University of Delaware; Technical University of Denmark; Stanford University; Howard Hughes Medical Institute; Stanford University; Johns Hopkins University; Novo Nordisk Foundation; Technical University of Denmark; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	palsson@ucsd.edu; wangj@genomics.org.cn	Lewis, Nathan/ABE-7290-2020; Wang, Jun/A-7261-2013; Betenbaugh, Michael J./A-3252-2010; Andersen, Mikael R/F-9377-2013; Andersen, Mikael Rørdam/P-6743-2019; Crozier, Laura/C-2170-2011; Xu, Xun/AAI-6763-2020; Chen, Wenbin/ABI-1111-2020; gui, yaoting/GLT-3684-2022; Wang, Jianbin/G-7533-2015; Koh, Lian Chye Winston/GYD-5873-2022; XIE, MIN/P-8062-2019; Lee, Kelvin H/A-4673-2010; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Lewis, Nathan/0000-0001-7700-3654; Betenbaugh, Michael J./0000-0002-6336-4659; Andersen, Mikael R/0000-0003-4794-6808; Andersen, Mikael Rørdam/0000-0003-4794-6808; Xu, Xun/0000-0002-5338-5173; Chen, Wenbin/0000-0002-8690-4822; Wang, Jianbin/0000-0001-6725-7925; Koh, Lian Chye Winston/0000-0003-4611-6490; XIE, MIN/0000-0002-5652-5039; Lee, Kelvin H/0000-0003-0908-2981; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Liu, Xin/0000-0003-3256-2940; Palsson, Bernhard/0000-0003-2357-6785	National Natural Science Foundation (NSFC) of China [30725008]; Shenzhen government [ZYC200903240077A]; Guangdong Innovation Team; National Basic Research Program of China (973 program) [2007CB815703]; US National Institutes of Health (NIH) [2P20RR016472-10]; National Cancer Institute [NIH R44CA139977]; Danish Agency for Science, Technology and Innovation [07-015498];  [CXB200903110066A]; NATIONAL CANCER INSTITUTE [R44CA139977] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	National Natural Science Foundation (NSFC) of China(National Natural Science Foundation of China (NSFC)); Shenzhen government; Guangdong Innovation Team; National Basic Research Program of China (973 program)(National Basic Research Program of China); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Danish Agency for Science, Technology and Innovation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors wish to acknowledge B. Kingham at the University of Delaware for technical assistance. This work was funded in part by National Natural Science Foundation (NSFC) of China award to a young scientist (30725008), funding from Shenzhen government (ZYC200903240077A), funding for Shenzhen Key labs (CXB200903110066A), Guangdong Innovation Team Funding, National Basic Research Program of China (973 program, 2007CB815703), US National Institutes of Health (NIH) 2P20RR016472-10 and National Cancer Institute Small Business Innovation Research grant (NIH R44CA139977). M.R.A. acknowledges funding from the Danish Agency for Science, Technology and Innovation grant 07-015498.	Beck A, 2008, CURR PHARM BIOTECHNO, V9, P482, DOI 10.2174/138920108786786411; Bosques CJ, 2010, NAT BIOTECHNOL, V28, P1153, DOI 10.1038/nbt1110-1153; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; CAMPBELL C, 1984, J BIOL CHEM, V259, P3370; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Conner J, 2005, J VIROL, V79, P9970, DOI 10.1128/JVI.79.15.9970-9981.2005; DEAVEN LL, 1973, CHROMOSOMA, V41, P129, DOI 10.1007/BF00319690; Dechecchi MC, 2001, J VIROL, V75, P8772, DOI 10.1128/JVI.75.18.8772-8780.2001; Derouazi M, 2007, CELL TECHNOLOGY FOR CELL PRODUCTS, P443, DOI 10.1007/978-1-4020-5476-1_73; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Gao Shan-dian, 2008, Virologica Sinica, V23, P1, DOI 10.1007/s12250-008-2886-2; Ghaderi D, 2010, NAT BIOTECHNOL, V28, P863, DOI 10.1038/nbt.1651; Gianni T, 2010, P NATL ACAD SCI USA, V107, P22260, DOI 10.1073/pnas.1014923108; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Habuchi H, 1998, J BIOL CHEM, V273, P9208, DOI 10.1074/jbc.273.15.9208; HABUCHI H, 1995, J BIOL CHEM, V270, P4172, DOI 10.1074/jbc.270.8.4172; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Ianelli CJ, 1998, J BIOL CHEM, V273, P23367, DOI 10.1074/jbc.273.36.23367; Jenkins N, 1996, NAT BIOTECHNOL, V14, P975, DOI 10.1038/nbt0896-975; Kanda Y, 2007, J BIOTECHNOL, V130, P300, DOI 10.1016/j.jbiotec.2007.04.025; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; Kobayashi M, 1996, J BIOL CHEM, V271, P7645, DOI 10.1074/jbc.271.13.7645; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lim Y, 2010, BIOTECHNOL APPL BIOC, V55, P175, DOI 10.1042/BA20090363; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Mullins LJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-221; Nakano K, 2005, MOL THER, V11, P617, DOI 10.1016/j.ymthe.2004.12.012; Natsume A, 2006, J BIOCHEM, V140, P359, DOI 10.1093/jb/mvj157; Park JM, 2009, BIOTECHNOL ADV, V27, P979, DOI 10.1016/j.biotechadv.2009.05.019; Pilbrough W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008432; Rostand KS, 1997, INFECT IMMUN, V65, P1; Satoh M, 2006, EXPERT OPIN BIOL TH, V6, P1161, DOI 10.1517/14712598.6.11.1161; SAWITZKY D, 1990, ARCH VIROL, V115, P309, DOI 10.1007/BF01310539; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Seth G, 2007, CURR OPIN BIOTECH, V18, P557, DOI 10.1016/j.copbio.2007.10.012; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Smit A, 1996, REPEATMASKER OPEN 30; Smit A., 2008, REPEATMASKER OPEN 1; SPEHNER D, 1988, J VIROL, V62, P1297, DOI 10.1128/JVI.62.4.1297-1304.1988; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiebe M.E., 1989, MULTIFACETED APPROAC; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Xie M, 2005, CHINESE MED J-PEKING, V118, P2072; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Yoo EM, 2010, MABS-AUSTIN, V2, P320, DOI 10.4161/mabs.2.3.11802	55	551	615	3	143	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2011	29	8					735	U131		10.1038/nbt.1932	http://dx.doi.org/10.1038/nbt.1932			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	804ZV	21804562	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000293696500026
J	Chowdhury, P; Khan, SA; Dutta, P; Mahanta, J				Chowdhury, Pritom; Khan, Siraj A.; Dutta, Prafulla; Mahanta, Jagadish			Pharmaceutical and biotech product patents in India: doldrums or blissfulness?	NATURE BIOTECHNOLOGY			English	Editorial Material							DRUGS					pritomc@gmail.com						Bajpai V., 2013, ISRN PUBLIC HLTH, V2013; Chien CV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000278; Mehtas PS, 1998, SCHWEIZERISCHES JB E, V17, P97; Sharma C.K., 2011, EC REFORMS; Wainberg MA, 2005, NEW ENGL J MED, V352, P747, DOI 10.1056/NEJMp048356	5	4	4	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					133	134		10.1038/nbt.2809	http://dx.doi.org/10.1038/nbt.2809			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24509757				2022-12-27	WOS:000331074000013
J	Wang, SJ				Wang, Shyh-Jen			Patent portfolios for biotech inventions	NATURE BIOTECHNOLOGY			English	Editorial Material							PROSECUTION; REJECTION; BARRIER; DISEASE		[Wang, Shyh-Jen] Natl Yang Ming Univ, Div Expt Surg, Dept Surg, Taipei Vet Gen Hosp, Taipei 112, Taiwan; [Wang, Shyh-Jen] Natl Yang Ming Univ, Inst Hosp, Taipei 112, Taiwan; [Wang, Shyh-Jen] Natl Yang Ming Univ, Hlth Care Adm, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wang, SJ (corresponding author), Natl Yang Ming Univ, Div Expt Surg, Dept Surg, Taipei Vet Gen Hosp, Taipei 112, Taiwan.	wangsj@vghtpe.gov.tw						Cohen Stanley N, 1980, US Patent, Patent No. [4,237,224, 4237224]; Elias S, 2003, PATENT COPYRIGHT TRA; Goldenson D, 2009, NAT BIOTECHNOL, V27, P538, DOI 10.1038/nbt0609-538; Goldstein H, 2006, IEEE SPECTRUM, V43, P44, DOI 10.1109/SPEC.2006.247960; Granstrand O., 1999, EC MANAGEMENT INTELL; Kamm MA, 2011, INFLAMM BOWEL DIS, V17, P2366, DOI 10.1002/ibd.21655; LE JM, 1989, LAB INVEST, V61, P588; Palazzoli F, 2011, NAT BIOTECHNOL, V29, P593, DOI 10.1038/nbt.1907; PRESENT DH, 1989, ANN INTERN MED, V111, P641, DOI 10.7326/0003-4819-111-8-641; Simon BM, 2011, NAT BIOTECHNOL, V29, P229, DOI 10.1038/nbt.1795; Vilela EG, 2012, WORLD J GASTROENTERO, V18, P872, DOI 10.3748/wjg.v18.i9.872; Wang SJ, 2008, NAT BIOTECHNOL, V26, P519, DOI 10.1038/nbt0508-519; Wang SJ, 2011, HUM VACCINES, V7, P569, DOI 10.4161/hv.7.5.14358; Wang SJ, 2011, HUM VACCINES, V7, P475, DOI 10.4161/hv.7.4.14134; Wang SJ, 2009, NAT BIOTECHNOL, V27, P1125, DOI 10.1038/nbt1209-1125	15	4	5	4	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2013	31	6					501	503		10.1038/nbt.2598	http://dx.doi.org/10.1038/nbt.2598			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	160IO	23752433				2022-12-27	WOS:000320113200018
J	Khoddami, V; Cairns, BR				Khoddami, Vahid; Cairns, Bradley R.			Identification of direct targets and modified bases of RNA cytosine methyltransferases	NATURE BIOTECHNOLOGY			English	Article							HUMAN DNMT2; MISU NSUN2; DNA; METHYLATION; HOMOLOG; 5-METHYLCYTOSINE; 5-AZACYTIDINE; MECHANISM; TRNA(ASP); MUTATION	The extent and biological impact of RNA cytosine methylation are poorly understood, in part owing to limitations of current techniques for determining the targets of RNA methyltransferases. Here we describe 5-azacytidine-mediated RNA immunoprecipitation (Aza-IP), a technique that exploits the covalent bond formed between an RNA methyltransferase and the cytidine analog 5-azacytidine to recover RNA targets by immunoprecipitation. Targets are subsequently identified by high-throughput sequencing. When applied in a human cell line to the RNA methyltransferases DNMT2 and NSUN2, Aza-IP enabled >200-fold enrichment of tRNAs that are known targets of the enzymes. In addition, it revealed many tRNA and noncoding RNA targets not previously associated with NSUN2. Notably, we observed a high frequency of C -> G transversions at the cytosine residues targeted by both enzymes, allowing identification of the specific methylated cytosine(s) in target RNAs. Given the mechanistic similarity of RNA cytosine methyltransferases, Aza-IP may be generally applicable for target identification.	[Khoddami, Vahid; Cairns, Bradley R.] Univ Utah, Howard Hughes Med Inst, Dept Oncol Sci, Huntsman Canc Inst,Sch Med, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Cairns, BR (corresponding author), Univ Utah, Howard Hughes Med Inst, Dept Oncol Sci, Huntsman Canc Inst,Sch Med, Salt Lake City, UT 84112 USA.	brad.cairns@hci.utah.edu			Howard Hughes Medical Institute; Samuel Waxman Foundation; National Cancer Institute [CA24014]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Samuel Waxman Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. Clapier (hDNMT2 protein expression and purification), K. Rai (MTase assay set-up), V. Planelles, University of Utah (gift of the lentiviral expression construct), C. Maximiliano Rego Monteiro Filho and S. Dehghanizadeh (lentiviral protein expression, assays and IP experiments), J. Xu and A. Yerra (help on data not shown), and X. Cheng, Emory University (gift of pQE9 plasmid). We thank B. Dalley and N. Moss (library preparation and sequencing), T. Parnell, D. Nix, B. Milash, Y. Sun and K. Boucher (help and advice on analysis) and the Center for High Performance Computing, especially W. R. Cardoen. We thank C. J. Burrows for advice on reaction mechanisms, and D. A. Jones, C. J. Burrows and D. R. Davis for many helpful comments. This work was supported by the Howard Hughes Medical Institute, the Samuel Waxman Foundation and the National Cancer Institute CA24014 (for core facilities).	Abbasi-Moheb L, 2012, AM J HUM GENET, V90, P847, DOI 10.1016/j.ajhg.2012.03.021; Auxilien S, 2012, RNA BIOL, V9, P1331, DOI 10.4161/rna.22180; Becker M, 2012, NUCLEIC ACIDS RES, V40, P11648, DOI 10.1093/nar/gks956; Blanco S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002403; Brzezicha B, 2006, NUCLEIC ACIDS RES, V34, P6034, DOI 10.1093/nar/gkl765; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; Durdevic Z, 2013, EMBO REP, V14, P269, DOI 10.1038/embor.2013.3; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Gerard MA, 2010, NUCLEIC ACIDS RES, V38, P370, DOI 10.1093/nar/gkp988; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Guelorget A, 2011, STRUCTURE, V19, P282, DOI 10.1016/j.str.2011.01.005; Hu SS, 2012, INT J BIOCHEM CELL B, V44, P1847, DOI 10.1016/j.biocel.2012.07.013; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; JacksonGrusby L, 1997, P NATL ACAD SCI USA, V94, P4681, DOI 10.1073/pnas.94.9.4681; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; Khan MA, 2012, AM J HUM GENET, V90, P856, DOI 10.1016/j.ajhg.2012.03.023; King MY, 2002, BIOCHEMISTRY-US, V41, P11218, DOI 10.1021/bi026055q; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu K, 2003, MOL CELL BIOL, V23, P2709, DOI 10.1128/MCB.23.8.2709-2719.2003; LU LJW, 1979, CANCER RES, V39, P940; LU LW, 1976, BIOCHEM BIOPH RES CO, V68, P1094, DOI 10.1016/0006-291X(76)90308-9; Martinez FJ, 2012, J MED GENET, V49, P380, DOI 10.1136/jmedgenet-2011-100686; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Rai K, 2007, GENE DEV, V21, P261, DOI 10.1101/gad.1472907; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sakita-Suto S, 2007, MOL BIOL CELL, V18, P1107, DOI 10.1091/mbc.E06-11-1021; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Schaefer M, 2009, CANCER RES, V69, P8127, DOI 10.1158/0008-5472.CAN-09-0458; Schermelleh L, 2005, NAT METHODS, V2, P751, DOI 10.1038/NMETH794; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	289	300	5	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2013	31	5					458	+		10.1038/nbt.2566	http://dx.doi.org/10.1038/nbt.2566			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	139NM	23604283	Green Accepted			2022-12-27	WOS:000318589600027
J	Rychlik, B				Rychlik, Bruce			Pay increases for nonfounder executives at private life sciences companies rebound	NATURE BIOTECHNOLOGY			English	Editorial Material									Pk Sq Execut Search LLC, Cambridge, MA USA		Rychlik, B (corresponding author), Pk Sq Execut Search LLC, Cambridge, MA USA.	bruce@parksquaresearch.com							0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					259	261		10.1038/nbt.2526	http://dx.doi.org/10.1038/nbt.2526			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23471072				2022-12-27	WOS:000316439500022
J	Hanada, K; Restifo, NP				Hanada, Ken-ichi; Restifo, Nicholas P.			Double or nothing on cancer immunotherapy	NATURE BIOTECHNOLOGY			English	Editorial Material							T-CELLS; ADOPTIVE IMMUNOTHERAPY; ERBB2		[Hanada, Ken-ichi; Restifo, Nicholas P.] NCI, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hanada, K (corresponding author), NCI, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA.	restifo@nih.gov	Restifo, Nicholas P/A-5713-2008; Restifo, Nicholas Phillip/Z-1614-2019; Hanada, Kenichi/L-2481-2013; Restifo, Nicholas Phillip/M-6549-2019	Hanada, Kenichi/0000-0003-2959-1257; Restifo, Nicholas P./0000-0003-4229-4580	NATIONAL CANCER INSTITUTE [ZIABC010763] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC010763-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Davila ML, 2012, ONCOIMMUNOLOGY, V1, P1577, DOI 10.4161/onci.22524; Duong CPM, 2011, IMMUNOTHERAPY-UK, V3, P33, DOI 10.2217/IMT.10.81; Kloss C.C., 2013, NAT BIOTECHNOL, V30, P71; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Morgan RA, J IMMUNOTHE IN PRESS; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Wilkie S, 2012, J CLIN IMMUNOL, V32, P1059, DOI 10.1007/s10875-012-9689-9	11	11	11	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					33	34		10.1038/nbt.2471	http://dx.doi.org/10.1038/nbt.2471			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23302931	Green Accepted			2022-12-27	WOS:000313563600017
J	Fambrough, D				Fambrough, Douglas			Weathering a storm	NATURE BIOTECHNOLOGY			English	Editorial Material									Dicerna Pharmaceut, Watertown, MA USA		Fambrough, D (corresponding author), Dicerna Pharmaceut, Watertown, MA USA.	dfambrough@dicerna.com							0	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1166	1168		10.1038/nbt.2433	http://dx.doi.org/10.1038/nbt.2433			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222778	Bronze			2022-12-27	WOS:000312092400011
J	Mulleder, M; Capuano, F; Pir, P; Christen, S; Sauer, U; Oliver, SG; Ralser, M				Muelleder, Michael; Capuano, Floriana; Pir, Pinar; Christen, Stefan; Sauer, Uwe; Oliver, Stephen G.; Ralser, Markus			A prototrophic deletion mutant collection for yeast metabolomics and systems biology	NATURE BIOTECHNOLOGY			English	Letter							SACCHAROMYCES-CEREVISIAE; STRAINS; LONGEVITY; NETWORK		[Muelleder, Michael; Capuano, Floriana; Pir, Pinar; Oliver, Stephen G.; Ralser, Markus] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Muelleder, Michael; Capuano, Floriana; Pir, Pinar; Oliver, Stephen G.; Ralser, Markus] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Christen, Stefan; Sauer, Uwe] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland	University of Cambridge; University of Cambridge; Swiss Federal Institutes of Technology Domain; ETH Zurich	Mulleder, M (corresponding author), Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England.	mr559@cam.ac.uk	Pir, Pinar/AAA-5103-2022; Sauer, Uwe/Y-3556-2019; Oliver, Stephen/AAQ-5992-2021	Oliver, Stephen/0000-0003-3410-6439; Mulleder, Michael/0000-0001-9792-3861; Ralser, Markus/0000-0001-9535-7413; Pir, Pinar/0000-0002-0078-4904	Biotechnology and Biological Sciences Research Council [BB/C505140/2, BB/C505140/1] Funding Source: Medline; European Research Council [260809] Funding Source: Medline; Wellcome Trust [093735] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Canelas AB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1150; Gruning NM, 2010, TRENDS BIOCHEM SCI, V35, P220, DOI 10.1016/j.tibs.2009.12.001; Heavner BD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-55; Li LH, 2009, MOL BIOL CELL, V20, P3851, DOI 10.1091/mbc.E09-04-0347; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Pronk JT, 2002, APPL ENVIRON MICROB, V68, P2095, DOI 10.1128/AEM.68.5.2095-2100.2002; SIKORSKI RS, 1989, GENETICS, V122, P19; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	9	67	67	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1176	1178		10.1038/nbt.2442	http://dx.doi.org/10.1038/nbt.2442			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222782	Green Accepted			2022-12-27	WOS:000312092400015
J	Vanderschuren, H				Vanderschuren, Herve			Strengthening African R&D through effective transfer of tropical crop biotech to African institutions	NATURE BIOTECHNOLOGY			English	Letter							AGROBACTERIUM-MEDIATED TRANSFORMATION; TRANSGENIC CASSAVA; MAIZE		Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland	ETH Zurich	Vanderschuren, H (corresponding author), Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland.	hvanderschuren@ethz.ch	Vanderschuren, Hervé/AAF-5118-2021	Vanderschuren, Herve/0000-0003-2102-9737				Bull SE, 2009, NAT PROTOC, V4, P1845, DOI 10.1038/nprot.2009.208; Bull SE, 2011, PLANT CELL REP, V30, P779, DOI 10.1007/s00299-010-0986-6; Chetty CC, 2013, NEW BIOTECHNOL, V30, P136, DOI 10.1016/j.nbt.2012.04.006; Ezezika OC, 2012, NAT BIOTECHNOL, V30, P38, DOI 10.1038/nbt.2088; Juma C, 2011, SCIENCE, V334, P1323, DOI 10.1126/science.1217148; Shepherd DN, 2007, PLANT BIOTECHNOL J, V5, P759, DOI 10.1111/j.1467-7652.2007.00279.x; Tripathi L, 2010, MOL PLANT PATHOL, V11, P721, DOI 10.1111/j.1364-3703.2010.00639.x; Turok N, 2011, NATURE, V474, P567, DOI 10.1038/474567a; Vanderschuren H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045277; Vasil IK, 1996, NAT BIOTECHNOL, V14, P702, DOI 10.1038/nbt0696-702	10	10	10	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2012	30	12					1170	1172		10.1038/nbt.2405	http://dx.doi.org/10.1038/nbt.2405			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	050ZA	23222780				2022-12-27	WOS:000312092400013
J	Martell, JD; Deerinck, TJ; Sancak, Y; Poulos, TL; Mootha, VK; Sosinsky, GE; Ellisman, MH; Ting, AY				Martell, Jeffrey D.; Deerinck, Thomas J.; Sancak, Yasemin; Poulos, Thomas L.; Mootha, Vamsi K.; Sosinsky, Gina E.; Ellisman, Mark H.; Ting, Alice Y.			Engineered ascorbate peroxidase as a genetically encoded reporter for electron microscopy	NATURE BIOTECHNOLOGY			English	Article							HORSERADISH-PEROXIDASE; CRYSTAL-STRUCTURE; CORRELATED LIGHT; PROTEIN; LOCALIZATION; FLUORESCENCE; MEMBRANE; COMPLEX; MARKER; ENZYME	Electron microscopy (EM) is the standard method for imaging cellular structures with nanometer resolution, but existing genetic tags are inactive in most cellular compartments(1) or require light and can be difficult to use(2). Here we report the development of 'APEX', a genetically encodable EM tag that is active in all cellular compartments and does not require light. APEX is a monomeric 28-kDa peroxidase that withstands strong EM fixation to give excellent ultrastructural preservation. We demonstrate the utility of APEX for high-resolution EM imaging of a variety of mammalian organelles and specific proteins using a simple and robust labeling procedure. We also fused APEX to the N or C terminus of the mitochondrial calcium uniporter (MCU), a recently identified channel whose topology is disputed(3,4). These fusions give EM contrast exclusively in the mitochondrial matrix, suggesting that both the N and C termini of MCU face the matrix. Because APEX staining is not dependent on light activation, APEX should make EM imaging of any cellular protein straightforward, regardless of the size or thickness of the specimen.	[Martell, Jeffrey D.; Ting, Alice Y.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Deerinck, Thomas J.; Sosinsky, Gina E.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Sancak, Yasemin; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Sancak, Yasemin; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sancak, Yasemin; Mootha, Vamsi K.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sancak, Yasemin; Mootha, Vamsi K.] Broad Inst, Cambridge, MA USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA USA; [Sosinsky, Gina E.; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Diego	Ting, AY (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	ating@mit.edu		Ting, Alice/0000-0002-8277-5226	US National Institutes of Health [DP1 OD003961, P41RR004050, P41GM103412, GM065937, GM072881, GM077465, GM42614]; National Science Foundation Graduate Research Fellowship; National Defense Science and Engineering Graduate Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250, P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465, P41GM103412, R01GM072881, R01GM065937, R01GM042614] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003961] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Defense Science and Engineering Graduate Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Keating for use of her gel filtration chromatography system and A. Thor, A. Cone and M. Terada for assistance with electron tomography. The IMS-APEX EM data were obtained by H.-W. Rhee, P. Zou, J.D.M. and E. Vasile (Microscopy and Imaging Core Facility, Koch Institute at MIT). C. Uttamapinant (MIT) and H. Fraser (Stanford) provided helpful feedback on the manuscript. Funding was provided by US National Institutes of Health grants DP1 OD003961 (A.Y.T.), P41RR004050 (M.H.E.), P41GM103412 (M.H.E.), GM065937 (G. E. S.), GM072881 (G.E.S.), GM077465 (V.K.M.) and GM42614 (T.L.P.). J.D.M. was supported by a National Science Foundation Graduate Research Fellowship and a National Defense Science and Engineering Graduate Fellowship.	Barrows TP, 2005, BIOCHEMISTRY-US, V44, P14062, DOI 10.1021/bi0507128; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Cheek J, 1999, J BIOL INORG CHEM, V4, P64, DOI 10.1007/s007750050290; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; Costantini LM, 2012, TRAFFIC, V13, P643, DOI 10.1111/j.1600-0854.2012.01336.x; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; DEMEY J, 1981, CELL BIOL INT REP, V5, P889, DOI 10.1016/0309-1651(81)90204-6; Ellisman MH, 2012, METHOD CELL BIOL, V111, P139, DOI 10.1016/B978-0-12-416026-2.00008-X; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Giepmans BNG, 2005, NAT METHODS, V2, P743, DOI 10.1038/NMETH791; HENDERSON D, 1979, EXP CELL RES, V124, P301, DOI 10.1016/0014-4827(79)90206-4; Henriksen A, 1999, J BIOL CHEM, V274, P35005, DOI 10.1074/jbc.274.49.35005; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hopkins C, 2000, METHOD ENZYMOL, V327, P35, DOI 10.1016/S0076-6879(00)27265-0; Kirmse R, 2010, METHOD CELL BIOL, V96, P565, DOI 10.1016/S0091-679X(10)96023-8; KOSHIBA T, 1993, PLANT CELL PHYSIOL, V34, P713, DOI 10.1093/oxfordjournals.pcp.a078474; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lad L, 2002, BIOCHEMISTRY-US, V41, P13774, DOI 10.1021/bi0261591; Lauf U, 2001, FEBS LETT, V498, P11, DOI 10.1016/S0014-5793(01)02462-0; Lawrence A, 2006, J STRUCT BIOL, V154, P144, DOI 10.1016/j.jsb.2005.12.012; Li JL, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.006.2010; Mandelman D, 1998, PROTEIN SCI, V7, P2089, DOI 10.1002/pro.5560071005; Martone ME, 2002, J STRUCT BIOL, V138, P145, DOI 10.1016/S1047-8477(02)00006-0; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4331, DOI 10.1021/bi00013a023; PORSTMANN B, 1985, J IMMUNOL METHODS, V79, P27, DOI 10.1016/0022-1759(85)90388-6; Qi YCB, 2012, P NATL ACAD SCI USA, V109, P7499, DOI 10.1073/pnas.1204096109; RICHARDS MK, 1994, BIOCHEMISTRY-US, V33, P14723, DOI 10.1021/bi00253a010; Ryan BJ, 2006, TRENDS BIOTECHNOL, V24, P355, DOI 10.1016/j.tibtech.2006.06.007; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Sharp KH, 2004, BIOCHEMISTRY-US, V43, P8644, DOI 10.1021/bi049343q; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sosinsky GE, 2003, CELL COMMUN ADHES, V10, P181, DOI 10.1080/714040424; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Tsien RY, 2003, NAT REV MOL CELL BIO, pSS16, DOI 10.1038/nrm1196; Uttamapinant C, 2010, P NATL ACAD SCI USA, V107, P10914, DOI 10.1073/pnas.0914067107	38	411	427	6	153	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0733-222X	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1143	+		10.1038/nbt.2375	http://dx.doi.org/10.1038/nbt.2375			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23086203	Green Accepted, Green Submitted			2022-12-27	WOS:000311087500035
J	Komori, J; Boone, L; DeWard, A; Hoppo, T; Lagasse, E				Komori, Junji; Boone, Lindsey; DeWard, Aaron; Hoppo, Toshitaka; Lagasse, Eric			The mouse lymph node as an ectopic transplantation site for multiple tissues	NATURE BIOTECHNOLOGY			English	Article							HUMAN HEPATOCYTE TRANSPLANTATION; FIBROBLASTIC RETICULAR CELLS; STEM-CELLS; REJECTION; MODEL; FLOW	Cell-based therapy has been viewed as a promising alternative to organ transplantation, but cell transplantation aimed at organ repair is not always possible. Here we show that the mouse lymph node can support the engraftment and growth of healthy cells from multiple tissues. Direct injection of hepatocytes into a single mouse lymph node generated enough ectopic liver mass to rescue the survival of mice with lethal metabolic disease. Furthermore, thymuses transplanted into single lymph nodes of athymic nude mice generated functional immune systems that were capable of rejecting allogeneic and xenogeneic grafts. Additionally, pancreatic islets injected into the lymph nodes of diabetic mice restored normal glucose control. Collectively, these results suggest the practical approach of targeting lymph nodes to restore, maintain or improve tissue and organ functions.	[Komori, Junji; Boone, Lindsey; DeWard, Aaron; Hoppo, Toshitaka; Lagasse, Eric] Univ Pittsburgh, Sch Med, Dept Pathol, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lagasse, E (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.	lagasse@pitt.edu			US National Institutes of Health [R01 DK085711];  [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085711] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank S. Thorne and R. Sikorski for the in vivo imaging and the luciferase C57BL/6 transgenic mice. 129sv and 129sv Fah<SUP>-/-</SUP> mice were a kind gift from M. Grompe (Oregon Health and Sciences University). CTLA4-Ig and MR1 antibodies were a kind gift from F. Lakkis (University of Pittsburgh). This project used University of Pittsburgh Cancer Institute shared resources that are supported in part by award P30CA047904. This work was supported by the US National Institutes of Health grant R01 DK085711 (J.K., L.B., A.D. and E.L.).	Bumgardner GL, 1998, TRANSPLANTATION, V66, P1841, DOI 10.1097/00007890-199812270-00047; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44; Dressel R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002622; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Gao DH, 2000, HEPATOLOGY, V32, P1018, DOI 10.1053/jhep.2000.19325; Gerber SA, 2006, AM J PATHOL, V169, P1739, DOI 10.2353/ajpath.2006.051222; Gordon R D, 1988, Clin Transpl, P5; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Hoppo T, 2011, GASTROENTEROLOGY, V140, P656, DOI 10.1053/j.gastro.2010.11.006; Jiang JF, 1999, MICROSURG, V19, P56, DOI 10.1002/(SICI)1098-2752(1999)19:2<56::AID-MICR3>3.0.CO;2-F; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kim M, 2011, VET RADIOL ULTRASOUN, V52, P302, DOI 10.1111/j.1740-8261.2010.01794.x; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lakkis FG, 2000, NAT MED, V6, P686, DOI 10.1038/76267; Lawenda BD, 2009, CA-CANCER J CLIN, V59, P8, DOI 10.3322/caac.20001; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Markert ML, 2010, CLIN IMMUNOL, V135, P236, DOI 10.1016/j.clim.2010.02.007; Markert ML, 1999, NEW ENGL J MED, V341, P1180, DOI 10.1056/NEJM199910143411603; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Notenboom RGE, 1996, DEVELOPMENT, V122, P321; Odoux C, 2008, CANCER RES, V68, P6932, DOI 10.1158/0008-5472.CAN-07-5779; Ohashi K, 2005, HEPATOLOGY, V41, P132, DOI 10.1002/hep.20484; Overturf K, 1997, AM J PATHOL, V151, P1273; Pearse G, 2006, TOXICOL PATHOL, V34, P504, DOI 10.1080/01926230600865549; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Rice HE, 2004, J PEDIATR SURG, V39, P1607, DOI 10.1016/j.jpedsurg.2004.07.020; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Rodeck B, 1999, Pediatr Transplant, V3, P328, DOI 10.1034/j.1399-3046.1999.00060.x; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; SIEGLER EL, 1979, IMMUNOGENETICS, V9, P207, DOI 10.1007/BF01570415; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; STAMPFL DA, 1990, GASTROENTEROLOGY, V99, P1834, DOI 10.1016/0016-5085(90)90497-O; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	48	68	73	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2012	30	10					976	+		10.1038/nbt.2379	http://dx.doi.org/10.1038/nbt.2379			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	022NG	23000933	Green Accepted			2022-12-27	WOS:000309965500024
J	Lusser, M; Parisi, C; Plan, D; Rodriguez-Cerezo, E				Lusser, Maria; Parisi, Claudia; Plan, Damien; Rodriguez-Cerezo, Emilio			Deployment of new biotechnologies in plant breeding	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; MUTAGENESIS; GENOMICS; GENES	The first crops obtained through new plant breeding techniques are close to commercialization. Regulatory issues will determine the adoption of the techniques by breeders.	[Lusser, Maria; Parisi, Claudia; Rodriguez-Cerezo, Emilio] European Commiss Joint Res Ctr, Inst Prospect Technol Studies, AGRILIFE, Seville, Spain; [Plan, Damien] European Commiss JRC IHCP, Inst Hlth & Consumer Protect, Ispra, Italy	European Commission Joint Research Centre; EC JRC Institute for Prospective Technological Studies (IPTS); European Commission Joint Research Centre; EC JRC ISPRA Site	Lusser, M (corresponding author), European Commiss Joint Res Ctr, Inst Prospect Technol Studies, AGRILIFE, Seville, Spain.	maria.lusser@ec.europa.eu						Andersson HC, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2561; [Anonymous], 2011, NAT BIOTECHNOL, V29, P681, DOI 10.1038/nbt.1935; [Anonymous], DATABASE NOTIFICATIO; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Beetham PR, 1999, P NATL ACAD SCI USA, V96, P8774, DOI 10.1073/pnas.96.15.8774; Bradford KJ, 2005, NAT BIOTECHNOL, V23, P439, DOI 10.1038/nbt1084; Cantley M, 2007, OVERVIEW REGULATORY; COGEM, 2006, CGM06102402 COGEM; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; D'Halluin K, 2008, PLANT BIOTECHNOL J, V6, P93, DOI 10.1111/j.1467-7652.2007.00305.x; de Pater S, 2009, PLANT BIOTECHNOL J, V7, P821, DOI 10.1111/j.1467-7652.2009.00446.x; Dirks R, 2009, PLANT BIOTECHNOL J, V7, P837, DOI 10.1111/j.1467-7652.2009.00450.x; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; European Commission, 2001, OFFICIAL J EUROPEA L, P1; Flachowsky H, 2009, PLANT BREEDING, V128, P217, DOI 10.1111/j.1439-0523.2008.01591.x; Food and Agriculture Organization of the United Nations, 2009, EXP M FEED WORLD 205; Glandorf B., 2011, NEW PLANT BREEDING T, P141; International Service for the Acquisition of Agribiotech Applications (ISAAA), 2010, AGR BIOT LOT MOR JUS; Kalaitzandonakes N, 2007, NAT BIOTECHNOL, V25, P509, DOI 10.1038/nbt0507-509; Kuzma J, 2011, EMBO REP, V12, P883, DOI 10.1038/embor.2011.160; Li J, 2007, CURR OPIN PLANT BIOL, V10, P131, DOI 10.1016/j.pbi.2007.01.007; Lusser M., 2011, NEW PLANT BREEDING T, P157; Lusser M., 2011, 24760 JRC EUR EN; Martinez C, 2010, 20102 STI ORG EC COO; McDougall P., 2011, GETTING BIOTECH CROP; McElroy D, 2003, NAT BIOTECHNOL, V21, P996, DOI 10.1038/nbt0903-996; Miller JK, 2010, NAT BIOTECHNOL, V28, P1012, DOI 10.1038/nbt1010-1012; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Schaart J.G., 2010, PLANT TRANSFORMATION; Schaart J. G., 2009, 200902 COGEM; Schouten HJ, 2008, TRENDS PLANT SCI, V13, P260, DOI 10.1016/j.tplants.2008.04.005; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Stegemann S, 2009, SCIENCE, V324, P649, DOI 10.1126/science.1170397; Stein A.J., 2009, GLOBAL PIPELINE NEW; Stein AJ, 2010, NAT BIOTECHNOL, V28, P23, DOI 10.1038/nbt0110-23b; Tait J, 2011, EMBO REP, V12, P763, DOI 10.1038/embor.2011.135; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Varshney RK, 2005, TRENDS PLANT SCI, V10, P621, DOI 10.1016/j.tplants.2005.10.004; Vezina LP, 2009, PLANT BIOTECHNOL J, V7, P442, DOI 10.1111/j.1467-7652.2009.00414.x; Zhu T, 2000, NAT BIOTECHNOL, V18, P555, DOI 10.1038/75435	41	196	214	3	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2012	30	3					231	239		10.1038/nbt.2142	http://dx.doi.org/10.1038/nbt.2142			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	905VI	22398616	Bronze, Green Published			2022-12-27	WOS:000301303800015
J	Scott, CT; Caulfield, T; Borgelt, E; Illes, J				Scott, Christopher Thomas; Caulfield, Timothy; Borgelt, Emily; Illes, Judy			Personal medicine-the new banking crisis	NATURE BIOTECHNOLOGY			English	Article							CONSENT	As the healthcare industry moves from a twentieth century approach of providing treatments of last resort to a future of individualized medicine, biobanks will play a pivotal role in this transition. Yet at the cutting edge of biobanking research are new ethical, social and policy challenges beyond those familiar to basic biomedical research.	[Scott, Christopher Thomas] Ctr Biomed Eth, Stanford, CA USA; [Scott, Christopher Thomas; Borgelt, Emily; Illes, Judy] Univ British Columbia, Natl Core Neuroeth, Vancouver, BC V5Z 1M9, Canada; [Caulfield, Timothy] Univ Alberta, Fac Law, Edmonton, AB, Canada; [Caulfield, Timothy] Univ Alberta, Sch Publ Hlth, Hlth Law & Sci Policy Grp, Edmonton, AB, Canada	University of British Columbia; University of Alberta; University of Alberta	Scott, CT (corresponding author), Ctr Biomed Eth, Stanford, CA USA.	cscott@stanford.edu	Kam, Grace/F-5364-2012		Stanford Center for Biomedical Ethics; AllerGen (National Centres of Excellence); Cancer Stem Cell Consortium; ICDC, University of Alberta; NIH/National Institute of Mental Health [MH 9R01MH84282]; Canadian Institutes of Health Research/Institute of Neurosciences, Mental Health and Addiction [CNE85117]; British Columbia Knowledge Development Fund; Canadian Foundation for Innovation; NIH, National Human Genome Research Institute [2-R01-HG003178]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084282] Funding Source: NIH RePORTER	Stanford Center for Biomedical Ethics; AllerGen (National Centres of Excellence); Cancer Stem Cell Consortium; ICDC, University of Alberta; NIH/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Canadian Institutes of Health Research/Institute of Neurosciences, Mental Health and Addiction(Canadian Institutes of Health Research (CIHR)); British Columbia Knowledge Development Fund; Canadian Foundation for Innovation(Canada Foundation for Innovation); NIH, National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	C.T.S. acknowledges support from the Stanford Center for Biomedical Ethics. T.C. thanks AllerGen (National Centres of Excellence program) the Cancer Stem Cell Consortium and the ICDC, University of Alberta. J.I. and E.B.'s contributions to this paper were enabled by NIH/National Institute of Mental Health R01 no. MH 9R01MH84282, Canadian Institutes of Health Research/Institute of Neurosciences, Mental Health and Addiction no. CNE85117, the British Columbia Knowledge Development Fund and the Canadian Foundation for Innovation. J.I. is a member of the NIH, National Human Genome Research Institute grant no. 2-R01-HG003178.	[Anonymous], 2010, HARRIS INTERACT 0617; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Caulfield T, 2011, HARVARD HLTH POLICY, V2011, P21; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Illes J, 2006, SCIENCE, V311, P783, DOI 10.1126/science.1124665; Institute of Medicine, 2011, EST PREC COLL STIM G; Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203; Melsin E. M., 2009, BIOBANKS ELECT HLTH; National Institutes of Health Roadmap Working Group, 2004, REENG CLIN ENT; Salvaterra E, 2008, EMBO REP, V9, P307, DOI 10.1038/embor.2008.41; Simon CM, 2011, GENET MED, V13, P821, DOI 10.1097/GIM.0b013e31821d2f88; The National Bioethics Advisory Commission (NBAC), 1999, RES INV HUM BIOL MAT, V1; Toga AW, 2002, NAT REV NEUROSCI, V3, P302, DOI 10.1038/nrn782; United Nations Educational Scientific and Cultural Organization (UNESCO), 2008, REP INT BIOETH COMM; Vaught J., 2011, J NATL CANC I MONOGR, V42, P24	15	66	66	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2012	30	2					141	147		10.1038/nbt.2116	http://dx.doi.org/10.1038/nbt.2116			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	892EI	22318029				2022-12-27	WOS:000300269100013
J	Lee, EC; Liang, Q; Ali, H; Bayliss, L; Beasley, A; Bloomfield-Gerdes, T; Bonoli, L; Brown, R; Campbell, J; Carpenter, A; Chalk, S; Davis, A; England, N; Fane-Dremucheva, A; Franz, B; Germaschewski, V; Holmes, H; Holmes, S; Kirby, I; Kosmac, M; Legent, A; Lui, H; Manin, A; O'Leary, S; Paterson, J; Sciarrillo, R; Speak, A; Spensberger, D; Tuffery, L; Waddell, N; Wang, W; Wells, S; Wong, V; Wood, A; Owen, MJ; Friedrich, GA; Bradley, A				Lee, E-Chiang; Liang, Qi; Ali, Hanif; Bayliss, Luke; Beasley, Alastair; Bloomfield-Gerdes, Tara; Bonoli, Laura; Brown, Richard; Campbell, Jamie; Carpenter, Adam; Chalk, Sara; Davis, Alison; England, Nick; Fane-Dremucheva, Alla; Franz, Bettina; Germaschewski, Volker; Holmes, Helen; Holmes, Steve; Kirby, Ian; Kosmac, Miha; Legent, Anais; Lui, Hui; Manin, Anais; O'Leary, Siobhan; Paterson, Jemima; Sciarrillo, Rocco; Speak, Anneliese; Spensberger, Dominik; Tuffery, Laura; Waddell, Nikole; Wang, Wei; Wells, Sophie; Wong, Vivian; Wood, Andrew; Owen, Michael J.; Friedrich, Glenn A.; Bradley, Allan			Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; MONOCLONAL-ANTIBODIES; STAPHYLOCOCCUS-AUREUS; CHIMERIC MICE; RECOMBINATION; EXPRESSION; HEAVY; GENE; FRAGMENT; AFFINITY	If immunized with an antigen of interest, transgenic mice with large portions of unrearranged human immunoglobulin loci can produce fully human antigen-specific antibodies; several such antibodies are in clinical use. However, technical limitations inherent to conventional transgenic technology and sequence divergence between the human and mouse immunoglobulin constant regions limit the utility of these mice. Here, using repetitive cycles of genome engineering in embryonic stem cells, we have inserted the entire human immunoglobulin variable-gene repertoire (2.7 Mb) into the mouse genome, leaving the mouse constant regions intact. These transgenic mice are viable and fertile, with an immune system resembling that of wild-type mice. Antigen immunization results in production of high-affinity antibodies with long human-like complementarity-determining region 3 (CDR3H), broad epitope coverage and strong signatures of somatic hypermutation. These mice provide a robust system for the discovery of therapeutic human monoclonal antibodies; as a surrogate readout of the human antibody response, they may also aid vaccine design efforts.	[Lee, E-Chiang; Liang, Qi; Ali, Hanif; Bayliss, Luke; Beasley, Alastair; Bloomfield-Gerdes, Tara; Bonoli, Laura; Brown, Richard; Campbell, Jamie; Carpenter, Adam; Chalk, Sara; Davis, Alison; England, Nick; Fane-Dremucheva, Alla; Franz, Bettina; Germaschewski, Volker; Holmes, Helen; Holmes, Steve; Kirby, Ian; Kosmac, Miha; Legent, Anais; Lui, Hui; Manin, Anais; O'Leary, Siobhan; Paterson, Jemima; Sciarrillo, Rocco; Spensberger, Dominik; Tuffery, Laura; Waddell, Nikole; Wells, Sophie; Wong, Vivian; Wood, Andrew; Owen, Michael J.; Friedrich, Glenn A.; Bradley, Allan] Kymab Ltd, Cambridge, England; [Speak, Anneliese; Wang, Wei; Bradley, Allan] Wellcome Trust Sanger Inst, Cambridge, England	Wellcome Trust Sanger Institute	Bradley, A (corresponding author), Kymab Ltd, Babraham Res Campus, Cambridge, England.	abradley@kymab.com		Kosmac, Miha/0000-0002-5372-7233; Sciarrillo, Rocco/0000-0003-4329-8823; Bradley, Allan/0000-0002-2349-8839; Spensberger, Dominik/0000-0002-9798-2949; Tuffery, Laura/0000-0002-2765-2151; Speak, Anneliese/0000-0003-4890-4685	Wellcome Trust, London	Wellcome Trust, London(Wellcome Trust)	We thank A. Sandham, J. Clube and D. Casson for frequent critical input and discussions on this work and P. Alexander, A. Muncey and A. Lloyd for administrative support. Kymab was funded by investments from the Wellcome Trust, London.	Araki K, 1997, J BIOCHEM, V122, P977, DOI 10.1093/oxfordjournals.jbchem.a021860; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Fishwild DM, 1996, NAT BIOTECHNOL, V14, P845, DOI 10.1038/nbt0796-845; Fraser P, 1998, CURR OPIN CELL BIOL, V10, P361, DOI 10.1016/S0955-0674(98)80012-4; Giudicelli V, 1997, NUCLEIC ACIDS RES, V25, P206, DOI 10.1093/nar/25.1.206; GREENMAN L, 1994, NEW STATESMAN SOC, V7, P13, DOI 10.1038/ng0594-13; Han C, 2009, BIOL REPROD, V80, P1001, DOI 10.1095/biolreprod.108.073700; Hernandez D, 1999, HUM MOL GENET, V8, P923, DOI 10.1093/hmg/8.5.923; Karpusas M, 2001, STRUCTURE, V9, P321, DOI 10.1016/S0969-2126(01)00590-1; Lee E-Chiang, 2012, Methods Mol Biol, V901, P137, DOI 10.1007/978-1-61779-931-0_8; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LONBERG N, 1994, NATURE, V368, P856, DOI 10.1038/368856a0; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Neuberger MS, 2000, APPL BIOCHEM BIOTECH, V83, P53, DOI 10.1385/ABAB:83:1-3:53; Osborn MJ, 2013, J IMMUNOL, V190, P1481, DOI 10.4049/jimmunol.1203041; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Radaev S, 2010, STRUCTURE, V18, P934, DOI 10.1016/j.str.2010.04.019; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Rudolf M, 2011, World patent, Patent No. [WO2011018208, 2011018208]; Rudolf M., 2011, Patent No. [PCT/ EP2010/ 004884, 2010004884]; Sattentau QJ, 2011, NATURE, V480, P324, DOI 10.1038/480324a; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Sellman B. R., 2006, Patent No. [WO/ 2012/ 109285, 2012109285]; Sellman B. R., 2006, Patent No. [PCT/ US2012/ 024201, 2012024201]; TAYLOR LD, 1992, NUCLEIC ACIDS RES, V20, P6287, DOI 10.1093/nar/20.23.6287; Tkaczyk C, 2012, CLIN VACCINE IMMUNOL, V19, P377, DOI 10.1128/CVI.05589-11; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Varriale S, 2010, MOL PHYLOGENET EVOL, V57, P1238, DOI 10.1016/j.ympev.2010.09.022; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	37	94	150	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2014	32	4					356	U219		10.1038/nbt.2825	http://dx.doi.org/10.1038/nbt.2825			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AE9PT	24633243	Bronze			2022-12-27	WOS:000334340800020
J	Francisco, M				Francisco, Michael			Fourth-quarter biotech job picture	NATURE BIOTECHNOLOGY			English	Editorial Material																		2013, NAT BIOTECHNOL, V31, P1053	1	0	0	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					199	199		10.1038/nbt.2814	http://dx.doi.org/10.1038/nbt.2814			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24509764	Bronze			2022-12-27	WOS:000331074000026
J	Ebeling, CG; Jorgensen, EM				Ebeling, Carl G.; Jorgensen, Erik M.			Two views on light sheets	NATURE BIOTECHNOLOGY			English	Editorial Material							PLANE ILLUMINATION MICROSCOPY; FLUORESCENCE EXCITATION; EMBRYOS; DEEP		[Ebeling, Carl G.; Jorgensen, Erik M.] Univ Utah, Dept Biol, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Ebeling, Carl G.] Univ Utah, Dept Phys, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ebeling, CG (corresponding author), Univ Utah, Dept Biol, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu						Fahrbach FO, 2013, OPT EXPRESS, V21, P13824, DOI 10.1364/OE.21.013824; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2007, OPT LETT, V32, P2608, DOI 10.1364/OL.32.002608; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Wu YC, 2013, NAT BIOTECHNOL, V31, P1032, DOI 10.1038/nbt.2713	10	1	1	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					992	993		10.1038/nbt.2739	http://dx.doi.org/10.1038/nbt.2739			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24213774				2022-12-27	WOS:000326921200018
J	Hinrichs, CS; Restifo, NP				Hinrichs, Christian S.; Restifo, Nicholas P.			Reassessing target antigens for adoptive T-cell therapy	NATURE BIOTECHNOLOGY			English	Review							TUMOR GENE WT1; PROSTATE-SPECIFIC ANTIGEN; CARBONIC-ANHYDRASE-IX; TELOMERASE ACTIVITY; NORMAL-TISSUES; ANTITUMOR-ACTIVITY; CANCER REGRESSION; HUMAN-LYMPHOCYTES; TYROSINE KINASE; NAIVE RATHER	Adoptive T-cell therapy can target and kill widespread malignant cells thereby inducing durable clinical responses in melanoma and selected other malignances. However, many commonly targeted tumor antigens are also expressed by healthy tissues, and T cells do not distinguish between benign and malignant tissues if both express the target antigen. Autoimmune toxicity from T cell-mediated destruction of normal tissue has limited the development and adoption of this otherwise promising type of cancer therapy. A review of the unique biology of T-cell therapy and of recent clinical experience compels a reassessment of target antigens that traditionally have been viewed from the perspective of weaker immunotherapeutic modalities. It is important that target antigens chosen for adoptive T-cell therapy are expressed by tumors and not by essential healthy tissues. The risk of adverse autoimmune events can be further mitigated by generating antigen receptors using strategies that reduce the chance of cross-reactivity against epitopes in unintended targets. In general, a circumspect approach to target selection and thoughtful preclinical and clinical studies are pivotal to the ongoing advancement of these promising treatments.	[Hinrichs, Christian S.; Restifo, Nicholas P.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Restifo, NP (corresponding author), NCI, Surg Branch, NIH, Bethesda, MD 20892 USA.	restifo@nih.gov	Hinrichs, Christian/V-9851-2019; Restifo, Nicholas Phillip/Z-1614-2019; Restifo, Nicholas Phillip/M-6549-2019	Hinrichs, Christian/0000-0001-5597-2841; Restifo, Nicholas P./0000-0003-4229-4580	NATIONAL CANCER INSTITUTE [ZIABC011479] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA BC010763-07] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alvarez-Rueda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025220; American Cancer Society, 2013, CANC FACTS FIG 2013; Anderson LD, 2011, CANCER IMMUNOL IMMUN, V60, P985, DOI 10.1007/s00262-011-1009-3; [Anonymous], 2013, NAT BIOTECHNOL, V31, P365, DOI 10.1038/nbt.2587; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Atanackovic D, 2008, P NATL ACAD SCI USA, V105, P1650, DOI 10.1073/pnas.0707140104; Ayyoub M, 2002, J IMMUNOL, V168, P1717, DOI 10.4049/jimmunol.168.4.1717; BATTYANI Z, 1993, PIGM CELL RES, V6, P400; Bos R, 2008, CANCER RES, V68, P8446, DOI 10.1158/0008-5472.CAN-08-1864; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brouwers AH, 2008, J CLIN ONCOL, V26, P3808, DOI 10.1200/JCO.2008.17.6073; Brouwers AH, 2005, J CLIN ONCOL, V23, P6540, DOI 10.1200/JCO.2005.07.732; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Cao Y, 1997, J HISTOCHEM CYTOCHEM, V45, P1547, DOI 10.1177/002215549704501111; Carpenter RO, 2013, CLIN CANCER RES, V19, P2048, DOI 10.1158/1078-0432.CCR-12-2422; Chapuis AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004916; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chinnasamy N, 2011, J IMMUNOL, V186, P685, DOI 10.4049/jimmunol.1001775; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Elgamal AAA, 1996, J UROLOGY, V156, P464, DOI 10.1016/S0022-5347(01)65883-X; Evans M, 2001, J IMMUNOL, V167, P5420, DOI 10.4049/jimmunol.167.9.5420; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; GRUBB GR, 1994, LAB INVEST, V71, P472; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Gulley JL, 2008, CLIN CANCER RES, V14, P3060, DOI 10.1158/1078-0432.CCR-08-0126; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hanada K, 2013, NAT BIOTECHNOL, V31, P33, DOI 10.1038/nbt.2471; Haso W, 2013, BLOOD, V121, P1165, DOI 10.1182/blood-2012-06-438002; HERSEY P, 1988, INT J CANCER, V41, P336, DOI 10.1002/ijc.2910410303; Heslop HE, 2010, BLOOD, V115, P925, DOI 10.1182/blood-2009-08-239186; Hillerdal V, 2012, P NATL ACAD SCI USA, V109, P15877, DOI 10.1073/pnas.1209042109; Hinrichs CS, 2011, BLOOD, V117, P808, DOI 10.1182/blood-2010-05-286286; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Hinrichs CS, 2005, J IMMUNOTHER, V28, P517, DOI 10.1097/01.cji.0000177999.95831.7b; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; Hiyama E, 1996, INT J ONCOL, V9, P453; Hiyama E, 2001, NEOPLASIA, V3, P17, DOI 10.1038/sj.neo.7900134; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Inoue K, 1997, BLOOD, V89, P1405, DOI 10.1182/blood.V89.4.1405; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Ishikawa T, 1998, JPN J CLIN ONCOL, V28, P723, DOI 10.1093/jjco/28.12.723; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Jones KL, 2009, LANCET ONCOL, V10, P1179, DOI 10.1016/S1470-2045(09)70315-8; Kalos M, 2011, SCI TRANSL MED, V3; Kawashima I, 1998, HUM IMMUNOL, V59, P1, DOI 10.1016/S0198-8859(97)00255-3; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Kloss CC, 2013, NAT BIOTECHNOL, V31, P71, DOI 10.1038/nbt.2459; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; Leibovich BC, 2007, J CLIN ONCOL, V25, P4757, DOI 10.1200/JCO.2007.12.1087; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Marshall JL, 2005, J CLIN ONCOL, V23, P720, DOI 10.1200/JCO.2005.10.206; Maus MV, 2013, CLIN CANCER RES, V19, P1917, DOI 10.1158/1078-0432.CCR-13-0168; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; MENNEL HD, 1992, EXP TOXICOL PATHOL, V44, P317, DOI 10.1016/S0940-2993(11)80218-6; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; NATALI PG, 1990, INT J CANCER, V45, P457, DOI 10.1002/ijc.2910450314; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; Ottaviani S, 2005, CANCER IMMUNOL IMMUN, V54, P1214, DOI 10.1007/s00262-005-0705-2; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Palmer DC, 2004, J IMMUNOL, V173, P7209, DOI 10.4049/jimmunol.173.12.7209; Palmer DC, 2008, P NATL ACAD SCI USA, V105, P8061, DOI 10.1073/pnas.0710929105; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Ramani P, 1996, J PATHOL, V179, P162, DOI 10.1002/(SICI)1096-9896(199606)179:2<162::AID-PATH545>3.0.CO;2-0; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Riemer AB, 2010, J BIOL CHEM, V285, P29608, DOI 10.1074/jbc.M110.126722; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Seregni E, 1997, TUMORI J, V83, P625, DOI 10.1177/030089169708300301; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Silver DA, 1997, CLIN CANCER RES, V3, P81; STURROCK AB, 1992, J BIOL CHEM, V267, P21193; Taylor RS, 1996, J INVEST DERMATOL, V106, P759, DOI 10.1111/1523-1747.ep12345811; Theoret MR, 2008, HUM GENE THER, V19, P1219, DOI [10.1089/hum.2008.083, 10.1089/hgt.2008.083]; UCKUN FM, 1988, BLOOD, V71, P13; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Ullenhag GJ, 2004, CLIN CANCER RES, V10, P3273, DOI 10.1158/1078-0432.CCR-03-0706; van Baren N, 2005, J CLIN ONCOL, V23, P9008, DOI 10.1200/JCO.2005.08.375; Warren RL, 2010, HUM IMMUNOL, V71, P245, DOI 10.1016/j.humimm.2009.12.007; Wolfgang CD, 2000, P NATL ACAD SCI USA, V97, P9437, DOI 10.1073/pnas.160270597; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yuki N, 1997, J NEUROL SCI, V149, P127, DOI 10.1016/S0022-510X(97)05390-2; Zhang SL, 1997, INT J CANCER, V73, P42, DOI 10.1002/(SICI)1097-0215(19970926)73:1<42::AID-IJC8>3.0.CO;2-1; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415; Zhong S, 2013, P NATL ACAD SCI USA, V110, P6973, DOI 10.1073/pnas.1221609110	108	141	160	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					999	1008		10.1038/nbt.2725	http://dx.doi.org/10.1038/nbt.2725			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24142051	Green Accepted, Bronze			2022-12-27	WOS:000326921200021
J	Marshel, JH; Deisseroth, K				Marshel, James H.; Deisseroth, Karl			Genetically encoded voltage sensor goes live	NATURE BIOTECHNOLOGY			English	Editorial Material							NEURONS; ELECTROPHYSIOLOGY		[Marshel, James H.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Marshel, JH (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Marshel, James/W-2792-2019	Marshel, James/0000-0003-3517-8493				Ahrens KF, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00015; Akemann W, 2013, SCI REP-UK, V3, DOI 10.1038/srep02231; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Kuhn B, 2008, P NATL ACAD SCI USA, V105, P7588, DOI 10.1073/pnas.0802462105; Miller EW, 2012, P NATL ACAD SCI USA, V109, P2114, DOI 10.1073/pnas.1120694109; Mutoh H, 2013, PFLUG ARCH EUR J PHY, V465, P361, DOI 10.1007/s00424-012-1202-z; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	12	3	3	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					994	995		10.1038/nbt.2738	http://dx.doi.org/10.1038/nbt.2738			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24213775				2022-12-27	WOS:000326921200019
J	't Hoen, PAC; Friedlander, MR; Almlof, J; Sammeth, M; Pulyakhina, I; Anvar, SY; Laros, JFJ; Buermans, HPJ; Karlberg, O; Brannvall, M; den Dunnen, JT; van Ommen, GJB; Gut, IG; Guigo, R; Estivill, X; Syvanen, AC; Dermitzakis, ET; Lappalainen, T				't Hoen, Peter A. C.; Friedlaender, Marc R.; Almloef, Jonas; Sammeth, Michael; Pulyakhina, Irina; Anvar, Seyed Yahya; Laros, Jeroen F. J.; Buermans, Henk P. J.; Karlberg, Olof; Brannvall, Mathias; den Dunnen, Johan T.; van Ommen, Gert-Jan B.; Gut, Ivo G.; Guigo, Roderic; Estivill, Xavier; Syvanen, Ann-Christine; Dermitzakis, Emmanouil T.; Lappalainen, Tuuli		GEUVADIS Consortium	Reproducibility of high-throughput mRNA and small RNA sequencing across laboratories	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION; QUALITY-CONTROL; LENGTH BIAS; SEQ DATA; TRANSCRIPTOME; POWER; TOOL	RNA sequencing is an increasingly popular technology for genome-wide analysis of transcript sequence and abundance. However, understanding of the sources of technical and interlaboratory variation is still limited. To address this, the GEUVADIS consortium sequenced mRNAs and small RNAs of lymphoblastoid cell lines of 465 individuals in seven sequencing centers, with a large number of replicates. The variation between laboratories appeared to be considerably smaller than the already limited biological variation. Laboratory effects were mainly seen in differences in insert size and GC content and could be adequately corrected for. In small-RNA sequencing, the microRNA ( miRNA) content differed widely between samples owing to competitive sequencing of rRNA fragments. This did not affect relative quantification of miRNAs. We conclude that distributing RNA sequencing among different laboratories is feasible, given proper standardization and randomization procedures. We provide a set of quality measures and guidelines for assessing technical biases in RNA-seq data.	['t Hoen, Peter A. C.; Pulyakhina, Irina; Anvar, Seyed Yahya; Laros, Jeroen F. J.; Buermans, Henk P. J.; den Dunnen, Johan T.; van Ommen, Gert-Jan B.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; ['t Hoen, Peter A. C.; Laros, Jeroen F. J.; den Dunnen, Johan T.] Netherlands Bioinformat Ctr, Leiden, Netherlands; [Friedlaender, Marc R.; Sammeth, Michael; Guigo, Roderic; Estivill, Xavier] Ctr Genom Regulat CRG, Barcelona, Catalonia, Spain; [Friedlaender, Marc R.; Sammeth, Michael; Guigo, Roderic; Estivill, Xavier] UPF, Barcelona, Catalonia, Spain; [Friedlaender, Marc R.; Sammeth, Michael; Guigo, Roderic; Estivill, Xavier] Mar Res Inst, CRG Hosp, Barcelona, Catalonia, Spain; [Friedlaender, Marc R.; Estivill, Xavier] CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Catalonia, Spain; [Almloef, Jonas; Karlberg, Olof; Brannvall, Mathias; Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden; [Sammeth, Michael; Gut, Ivo G.] CNAG, Barcelona, Catalonia, Spain; [Anvar, Seyed Yahya; Laros, Jeroen F. J.; Buermans, Henk P. J.; den Dunnen, Johan T.] Leiden Univ, Leiden Genome Technol Ctr, Med Ctr, Leiden, Netherlands; [Dermitzakis, Emmanouil T.; Lappalainen, Tuuli] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Dermitzakis, Emmanouil T.; Lappalainen, Tuuli] Univ Geneva, Inst Genet & Genom Geneva iG3, Geneva, Switzerland; [Dermitzakis, Emmanouil T.; Lappalainen, Tuuli] Swiss Inst Bioinformat, Geneva, Switzerland	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Uppsala University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics	't Hoen, PAC (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands.	p.a.c.hoen@lumc.nl; tuuli.e.lappalainen@gmail.com	Hoen, Peter A 't/D-3950-2018; Almlöf, Jonas/E-1608-2017; dunnen, johan den/ABH-4228-2020; Häsler, Robert/A-4908-2009; Meitinger, Thomas/O-1318-2015; Guigo, Roderic/D-1303-2010; Gut, Ivo/ABF-3188-2020; Antonarakis, Stylianos E/N-8866-2014; Esser, Daniela/ABB-9383-2020; Sammeth, Michael/C-1157-2014; Estivill, Xavier/A-3125-2013; Beltran, Sergi/I-3408-2015; Lappalainen, Tuuli/AAE-6532-2020	Hoen, Peter A 't/0000-0003-4450-3112; Almlöf, Jonas/0000-0002-1211-9821; dunnen, johan den/0000-0002-6304-1710; Häsler, Robert/0000-0003-4174-8229; Guigo, Roderic/0000-0002-5738-4477; Gut, Ivo/0000-0001-7219-632X; Antonarakis, Stylianos E/0000-0001-8907-5823; Sammeth, Michael/0000-0002-6528-9883; Estivill, Xavier/0000-0002-0723-2256; Beltran, Sergi/0000-0002-2810-3445; Lappalainen, Tuuli/0000-0002-7746-8109; Kilpinen, Helena/0000-0001-6692-6154; Brannvall, Mathias/0000-0003-4979-4123; Brazma, Alvis/0000-0001-5988-7409; Gonzalez-Porta, Mar/0000-0002-1661-7254; Meitinger, Thomas/0000-0002-8838-8403; Laros, Jeroen F.J./0000-0002-8715-7371; Friedlander, Marc/0000-0001-6577-4363; Carracedo, Angel/0000-0003-1085-8986; Kurbatova, Natalja/0000-0002-3973-2909; Ongen, Halit/0000-0002-4197-5790; Bertier, Gabrielle/0000-0002-3319-3721	European Commission [261123]; Swiss National Science Foundation [130326, 130342]; Louis Jeantet Foundation; ERC [260927, 294653]; NIH-NIMH [MH090941]; Spanish Plan Nacional [SAF2008-00357, BIO2011-26205]; Generalitat de Catalunya AGAUR [SGR-1502]; Instituto de Salud Carlos III [FIS/FEDER PI11/00733]; ESGI, READNA [Health-F4-2008-201418]; Spanish Ministry of Economy and Competitiveness (MINECO); Generalitat de Catalunya; Centre for Medical Systems Biology within the framework of The Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO); Swedish Research Council [C0524801, A028001]; Knut and Alice Wallenberg Foundation [2011.0073]; EMBO long-term fellowship [ALTF 225-2011]; Emil Aaltonen Foundation and Academy of Finland fellowships; SNP&SEQ Technology Platform in Uppsala;  [FP7/2007-2013];  [HEALTH-F4-2007-201413]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090941] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Louis Jeantet Foundation; ERC(European Research Council (ERC)European Commission); NIH-NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Spanish Plan Nacional(Spanish Government); Generalitat de Catalunya AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ESGI, READNA; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Centre for Medical Systems Biology within the framework of The Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Emil Aaltonen Foundation and Academy of Finland fellowships; SNP&SEQ Technology Platform in Uppsala; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was funded by the European Commission 7th Framework Program (FP7) (261123; GEUVADIS); the Swiss National Science Foundation (130326, 130342), the Louis Jeantet Foundation, and ERC (260927) (E. T. D.); NIH-NIMH (MH090941) (E. T. D., R. G.); Spanish Plan Nacional SAF2008-00357 (NOVADIS), the Generalitat de Catalunya AGAUR 2009 SGR-1502, and the Instituto de Salud Carlos III (FIS/FEDER PI11/00733) (X. E.); Spanish Plan Nacional (BIO2011-26205) and ERC (294653) (R. G.); ESGI, READNA (FP7 Health-F4-2008-201418), Spanish Ministry of Economy and Competitiveness (MINECO) and the Generalitat de Catalunya (I. G. G.); FP7/2007-2013, ENGAGE project, HEALTH-F4-2007-201413, and the Centre for Medical Systems Biology within the framework of The Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) (P.A.C.t.H. & G.-J.B.v.O.); The Swedish Research Council (C0524801, A028001) and the Knut and Alice Wallenberg Foundation (2011.0073) (A.-C. S.); EMBO long-term fellowship ALTF 225-2011 (M. R. F.); Emil Aaltonen Foundation and Academy of Finland fellowships (T. L.). We acknowledge the SNP&SEQ Technology Platform in Uppsala for sequencing, and the Swedish National Infrastructure for Computing (SNIC-UPPMAX) for compute resources for data analysis. The authors would like to thank P. G. M. van Overveld for help with preparation of the figures.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Berninger P, 2008, METHODS, V44, P13, DOI 10.1016/j.ymeth.2007.10.002; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Gao LY, 2011, BIOINFORMATICS, V27, P662, DOI 10.1093/bioinformatics/btr005; Gordon D., 2006, ENCY GENETICS GENOMI; Griebel T, 2012, NUCLEIC ACIDS RES, V40, P10073, DOI 10.1093/nar/gks666; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Huang JY, 2013, BIOINFORMATICS, V29, P1463, DOI 10.1093/bioinformatics/btt155; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kosters W.A., 2007, 27 SGAI INT C INN TE, P293; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pantano L, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1127; Parts L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002704; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Raghavachari N, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-28; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sirbu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050986; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; van Iterson M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-439; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Westra HJ, 2011, BIOINFORMATICS, V27, P2104, DOI 10.1093/bioinformatics/btr323	43	159	159	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2013	31	11					1015	+		10.1038/nbt.2702	http://dx.doi.org/10.1038/nbt.2702			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	251IM	24037425				2022-12-27	WOS:000326921200023
J	DeFrancesco, L				DeFrancesco, Laura			How safe does transgenic food need to be?	NATURE BIOTECHNOLOGY			English	Article							GENETICALLY-MODIFIED MAIZE; LONG-TERM; TOXICITY; HEALTH; PERFORMANCE; SOYBEANS; NUCLEI; SYSTEM; IMPACT; GROWTH											Andersson HC, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2150; [Anonymous], 1992, FDA FED REG, V57; [Anonymous], 2003, B C L REV; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; Battistelli S, 2010, EUR J HISTOCHEM, V54, P154, DOI 10.4081/ejh.2010.e36; BETTON G, 1994, HUM EXP TOXICOL, V13, P221, DOI 10.1177/096032719401300401; Brake DG, 2004, J AGR FOOD CHEM, V52, P2097, DOI 10.1021/jf0347362; Brake DG, 2004, FOOD CHEM TOXICOL, V42, P29, DOI 10.1016/j.fct.2003.08.003; Brasil FB, 2009, ANAT REC, V292, P587, DOI 10.1002/ar.20878; Buzoianu SG, 2013, J ANIM SCI, V91, P318, DOI 10.2527/jas.2012-5360; Buzoianu SG, 2012, ANIMAL, V6, P1609, DOI 10.1017/S1751731112000249; Buzoianu SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047851; Buzoianu SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033668; Committee on Identifying and Assessing the Unintended Effects of Genetically Engineered Food on Human Health, 2004, SAF GEN ENG FOODS; Coordinated Framework for Regulation of Biotechnology, 1986, FED REG         0626, V51; Daleprane JB, 2010, J FOOD SCI, V75, pT126, DOI 10.1111/j.1750-3841.2010.01773.x; Daleprane JB, 2009, BRAZ ARCH BIOL TECHN, V52, P841, DOI 10.1590/S1516-89132009000400007; Daleprane JB, 2009, PLANT FOOD HUM NUTR, V64, P1, DOI 10.1007/s11130-008-0101-0; Domingo JL, 2011, ENVIRON INT, V37, P734, DOI 10.1016/j.envint.2011.01.003; European Commission, 2010, DEC EU FUND GMC RES; Haryu Y., 2009, Open Plant Science Journal, V3, P49, DOI 10.2174/1874294700903010049; Helm RM., 2001, TOPIC 5 STABILITY KN; Herman RA, 2013, J AGR FOOD CHEM, V61, P11695, DOI 10.1021/jf400135r; Herman Rod A, 2009, Clin Mol Allergy, V7, P9, DOI 10.1186/1476-7961-7-9; Joint FAO/WHO, 1996, EXP CONS BIOT FOOD S; Kilic A, 2008, FOOD CHEM TOXICOL, V46, P1164, DOI 10.1016/j.fct.2007.11.016; Krzyzowska M, 2010, POL J VET SCI, V13, P423; Kuiper H.A, 2013, PLANT BIOTECHNOL J, DOI [10.1111/pbl12091, DOI 10.1111/PBL12091]; Kuiper HA, 2001, PLANT J, V27, P503, DOI 10.1046/j.1365-313X.2001.01119.x; Malatesta M, 2005, EUR J HISTOCHEM, V49, P237; Malatesta M, 2003, EUR J HISTOCHEM, V47, P385; Malatesta M, 2002, CELL STRUCT FUNCT, V27, P173, DOI 10.1247/csf.27.173; Malatesta M, 2002, J ANAT, V201, P409, DOI 10.1046/j.0021-8782.2002.00103.x; Malatesta M, 2008, HISTOCHEM CELL BIOL, V130, P967, DOI 10.1007/s00418-008-0476-x; Nordlee JA, 1996, NEW ENGL J MED, V334, P688, DOI 10.1056/NEJM199603143341103; Rhee GS, 2005, J TOXICOL ENV HEAL A, V68, P2263, DOI 10.1080/15287390500182446; Sakamoto Y, 2007, J FOOD HYG SOC JPN, V48, P41, DOI 10.3358/shokueishi.48.41; Seralini GE, 2012, FOOD CHEM TOXICOL, V50, P4221, DOI 10.1016/j.fct.2012.08.005; Sissener NH, 2009, AQUACULTURE, V294, P108, DOI 10.1016/j.aquaculture.2009.05.002; Snell C, 2012, FOOD CHEM TOXICOL, V50, P1134, DOI 10.1016/j.fct.2011.11.048; Steinke K, 2010, J ANIM PHYSIOL AN N, V94, pe185, DOI 10.1111/j.1439-0396.2010.01003.x; Trabalza-Marinucci M, 2008, LIVEST SCI, V113, P178, DOI 10.1016/j.livsci.2007.03.009; Tudisco R, 2010, ANIMAL, V1, P10; van Haver E, 2008, FOOD CHEM TOXICOL, V46, pS2, DOI 10.1016/j.fct.2008.02.008; Vecchio L, 2004, EUR J HISTOCHEM, V48, P449; Velimirov A., 2008, BIOL EFFECTS TRANSGE, V3; Walsh MC, 2013, BRIT J NUTR, V109, P873, DOI 10.1017/S0007114512002607; Walsh MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036141	48	47	51	2	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					794	802		10.1038/nbt.2686	http://dx.doi.org/10.1038/nbt.2686			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	24022153				2022-12-27	WOS:000324306300015
J	Zhang, YC; Yu, Y; Wang, CY; Li, ZY; Liu, Q; Xu, J; Liao, JY; Wang, XJ; Qu, LH; Chen, F; Xin, PY; Yan, CY; Chu, JF; Li, HQ; Chen, YQ				Zhang, Yu-Chan; Yu, Yang; Wang, Cong-Ying; Li, Ze-Yuan; Liu, Qing; Xu, Jie; Liao, Jian-You; Wang, Xiao-Jing; Qu, Liang-Hu; Chen, Fan; Xin, Peiyong; Yan, Cunyu; Chu, Jinfang; Li, Hong-Qing; Chen, Yue-Qin			Overexpression of microRNA OsmiR397 improves rice yield by increasing grain size and promoting panicle branching	NATURE BIOTECHNOLOGY			English	Article							SMALL RNAS; NATURAL VARIATION; ARABIDOPSIS; CYTOCHROME-P450; IDENTIFICATION; ELONGATION; ENCODES; OSSPL14; MUTANT; TISSUE	Increasing grain yields is a major focus of crop breeders around the world. Here we report that overexpression of the rice microRNA (miRNA) OsmiR397, which is naturally highly expressed in young panicles and grains, enlarges grain size and promotes panicle branching, leading to an increase in overall grain yield of up to 25% in a field trial. To our knowledge, no previous report has shown a positive regulatory role of miRNA in the control of plant seed size and grain yield. We determined that OsmiR397 increases grain yield by downregulating its target, OsLAC, whose product is a laccase-like protein that we found to be involved in the sensitivity of plants to brassinosteroids. As miR397 is highly conserved across different species, our results suggest that manipulating miR397 may be useful for increasing grain yield not only in rice but also in other cereal crops.	[Zhang, Yu-Chan; Yu, Yang; Wang, Cong-Ying; Li, Ze-Yuan; Liu, Qing; Liao, Jian-You; Qu, Liang-Hu; Chen, Yue-Qin] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Jie; Wang, Xiao-Jing; Li, Hong-Qing] S China Normal Univ, Coll Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China; [Chen, Fan; Xin, Peiyong; Yan, Cunyu; Chu, Jinfang] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China	Sun Yat Sen University; South China Normal University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Chen, YQ (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	hqli@scnu.edu.cn; lsscyq@mail.sysu.edu.cn	li, zeyuan/HCI-0269-2022	Qu, Liang-Hu/0000-0003-3657-2863; Chen, Fan/0000-0003-4482-3116; Yan, Cunyu/0000-0002-3603-2421	National Natural Science Foundation of China [U0631001, 90917011]; Ph.D. Programs Foundation of Ministry of Education of China [20120171130003]; Natural Science and Technology Department of Guangdong Province [2009A020102001, S2011020001232]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Natural Science and Technology Department of Guangdong Province	We thank Q. Qian for helping with the field trial and C.C. Chu for the comments on brassinosteroid analysis. This research was supported by a key project of the National Natural Science Foundation of China (No. U0631001 and 90917011), funds from Ph.D. Programs Foundation of Ministry of Education of China (20120171130003), and from the Natural Science and Technology Department of Guangdong Province (2009A020102001 and S2011020001232).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berthet S, 2011, PLANT CELL, V23, P1124, DOI 10.1105/tpc.110.082792; Chen CJ, 2011, RNA BIOL, V8, P538, DOI 10.4161/rna.8.3.15199; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; [胡旭霞 Hu Xuxia], 2006, [分子植物育种, Molecular Plant Breeding], V4, P621; Ikeda-Kawakatsu K, 2009, PLANT PHYSIOL, V150, P736, DOI 10.1104/pp.109.136739; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; KOUCHI H, 1993, MOL GEN GENET, V238, P106, DOI 10.1007/BF00279537; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Nakamura A, 2006, PLANT PHYSIOL, V140, P580, DOI 10.1104/pp.105.072330; Riva S, 2006, TRENDS BIOTECHNOL, V24, P219, DOI 10.1016/j.tibtech.2006.03.006; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Sakamoto T, 2003, NAT BIOTECHNOL, V21, P909, DOI 10.1038/nbt847; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Suzaki T, 2004, DEVELOPMENT, V131, P5649, DOI 10.1242/dev.01441; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Terao T, 2010, THEOR APPL GENET, V120, P875, DOI 10.1007/s00122-009-1218-8; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Xin PY, 2013, PLANT PHYSIOL, V162, P2056, DOI 10.1104/pp.113.221952; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang LY, 2009, PLANT CELL, V21, P3767, DOI 10.1105/tpc.109.070441; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	32	261	300	20	294	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					848	+		10.1038/nbt.2646	http://dx.doi.org/10.1038/nbt.2646			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	23873084				2022-12-27	WOS:000324306300027
J	Zhu, J; Larman, HB; Gao, G; Somwar, R; Zhang, ZJ; Laserson, U; Ciccia, A; Pavlova, N; Church, G; Zhang, W; Kesari, S; Elledge, SJ				Zhu, Jian; Larman, H. Benjamin; Gao, Geng; Somwar, Romel; Zhang, Zijuan; Laserson, Uri; Ciccia, Alberto; Pavlova, Natalya; Church, George; Zhang, Wei; Kesari, Santosh; Elledge, Stephen J.			Protein interaction discovery using parallel analysis of translated ORFs (PLATO)	NATURE BIOTECHNOLOGY			English	Article							EXPRESSION; SRC	Identifying physical interactions between proteins and other molecules is a critical aspect of biological analysis. Here we describe PLATO, an in vitro method for mapping such interactions by affinity enrichment of a library of full-length open reading frames displayed on ribosomes, followed by massively parallel analysis using DNA sequencing. We demonstrate the broad utility of the method for human proteins by identifying known and previously unidentified interacting partners of LYN kinase, patient autoantibodies, and the small-molecules gefitinib and dasatinib.	[Zhu, Jian; Larman, H. Benjamin; Gao, Geng; Ciccia, Alberto; Pavlova, Natalya; Elledge, Stephen J.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Zhu, Jian; Larman, H. Benjamin; Laserson, Uri; Ciccia, Alberto; Pavlova, Natalya; Church, George; Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Zhu, Jian; Larman, H. Benjamin; Gao, Geng; Ciccia, Alberto; Pavlova, Natalya; Elledge, Stephen J.] Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Larman, H. Benjamin; Laserson, Uri; Church, George] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Larman, H. Benjamin] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Somwar, Romel] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Zhang, Zijuan; Zhang, Wei] Univ Massachusetts, Dept Chem, Boston, MA 02125 USA; [Laserson, Uri] MIT, Dept Math, Cambridge, MA 02139 USA; [Kesari, Santosh] Univ Calif San Diego, Moores Canc Ctr, Dept Neurosci, Div Neurooncol,Translat Neurooncol Labs, La Jolla, CA 92093 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Memorial Sloan Kettering Cancer Center; University of Massachusetts System; University of Massachusetts Boston; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego	Elledge, SJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Zhang, Zijuan/AAM-8639-2020; Kesari, Santosh/E-8461-2013	church, george/0000-0001-6232-9969	US National Institutes of Health [U54 CA156734]; NIH [3P30CA023100-25S8]; NATIONAL CANCER INSTITUTE [U54CA156734, P30CA023100] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank K. Waraska, M. Cicero, S. Alian and A. Gagne for assistance with Illumina sequencing, and J. Laserson for statistical advice. Thanks to D. Zhu for help with synthesis of biotin-dasatinib, which was partially supported by US National Institutes of Health U54 CA156734 to the University of Massachusetts Boston-Dana-Farber Harvard Cancer Center U54 Comprehensive Partnership (Project 3, Co-PIs: N.S. Gray, W. Zhang, and P.L. Yang). We also thank N. Gray at Harvard Medical School for valuable advice, and H. Varmus at the National Cancer Institute for providing gefitinib reagents and advice. This work was supported in part by NIH grant 3P30CA023100-25S8 to S.K. S.J.E. is an investigator with the Howard Hughes Medical Institute.	Amstutz P, 2006, CELL BIOL A LAB HDB, V1, P497; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Brehmer D, 2005, CANCER RES, V65, P379; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Faix PH, 2004, BIOTECHNIQUES, V36, P1018, DOI 10.2144/04366RR03; Jeong JS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016253; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Samuels AL, 2009, BLOOD, V113, P3845, DOI 10.1182/blood-2008-04-153452; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; Zhu H, 2003, ANNU REV BIOCHEM, V72, P783, DOI 10.1146/annurev.biochem.72.121801.161511	11	35	37	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2013	31	4					331	334		10.1038/nbt.2539	http://dx.doi.org/10.1038/nbt.2539			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	120TI	23503679	Green Accepted			2022-12-27	WOS:000317195500026
J	Boyle, J				Boyle, John			There and back again	NATURE BIOTECHNOLOGY			English	Editorial Material									Inst Syst Biol, Seattle, WA USA	Institute for Systems Biology (ISB)	Boyle, J (corresponding author), Inst Syst Biol, Seattle, WA USA.	john.boyle@systemsbiology.org		Boyle, John/0000-0002-5378-5361					0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2013	31	1					13	15		10.1038/nbt.2466	http://dx.doi.org/10.1038/nbt.2466			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	071CP	23302922				2022-12-27	WOS:000313563600008
J	Shendure, J; Aiden, EL				Shendure, Jay; Aiden, Erez Lieberman			The expanding scope of DNA sequencing	NATURE BIOTECHNOLOGY			English	Review							PLURIPOTENT STEM-CELLS; IN-VIVO; MOLECULAR CHARACTERIZATION; NUCLEOTIDE RESOLUTION; ERROR-CORRECTION; GENOME; RNA; PARALLEL; AMPLIFICATION; TRANSCRIPTION	In just seven years, next-generation technologies have reduced the cost and increased the speed of DNA sequencing by four orders of magnitude, and experiments requiring many millions of sequencing reads are now routine. In research, sequencing is being applied not only to assemble genomes and to investigate the genetic basis of human disease, but also to explore myriad phenomena in organismic and cellular biology. In the clinic, the utility of sequence data is being intensively evaluated in diverse contexts, including reproductive medicine, oncology and infectious disease. A recurrent theme in the development of new sequencing applications is the creative 'recombination' of existing experimental building blocks. However, there remain many potentially high-impact applications of next-generation DNA sequencing that are not yet fully realized.	[Aiden, Erez Lieberman] Harvard Univ, Sch Engn & Appl Sci, Lab Large, Cambridge, MA 02138 USA; [Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Aiden, Erez Lieberman] Harvard Univ, Broad Inst Harvard & MIT, Cambridge, MA 02138 USA; [Aiden, Erez Lieberman] Harvard Univ, Harvard Soc Fellows, Cambridge, MA 02138 USA	Harvard University; University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Aiden, EL (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Lab Large, Cambridge, MA 02138 USA.	shendure@uw.edu; erez@erez.com	Shendure, Jay/AAU-3684-2021; Aiden, Erez Lieberman/A-2908-2010	Shendure, Jay/0000-0002-1516-1865	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008540] Funding Source: NIH RePORTER; NIH HHS [DP2 OD008540] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Armour CD, 2009, NAT METHODS, V6, P647, DOI [10.1038/NMETH.1360, 10.1038/nmeth.1360]; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/nmeth.1330, 10.1038/NMETH.1330]; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Botvinnik A, 2010, NAT METHODS, V7, P74, DOI [10.1038/nmeth.1407, 10.1038/NMETH.1407]; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carlson CA, 2012, NAT METHODS, V9, P78, DOI [10.1038/nmeth.1781, 10.1038/NMETH.1781]; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Codoner FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019461; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; CULLEN KE, 1993, SCIENCE, V261, P203, DOI 10.1126/science.8327891; Dahl F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni070; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Di Niro R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq052; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Findeiss S, 2011, BIOL CHEM, V392, P305, DOI 10.1515/BC.2011.043; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gallagher LA, 2011, MBIO, V2, DOI 10.1128/mBio.00315-10; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Howorka S, 2012, NAT BIOTECHNOL, V30, P506, DOI 10.1038/nbt.2264; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jones SJM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r82; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kohane IS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004208; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Logan AC, 2011, P NATL ACAD SCI USA, V108, P21194, DOI 10.1073/pnas.1118357109; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Ma L, 2010, NAT METHODS, V7, P299, DOI [10.1038/NMETH.1443, 10.1038/nmeth.1443]; Mamanova L, 2010, NAT METHODS, V7, P130, DOI [10.1038/NMETH.1417, 10.1038/nmeth.1417]; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nett JH, 2011, YEAST, V28, P237, DOI 10.1002/yea.1835; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Ponts N, 2010, GENOME RES, V20, P228, DOI 10.1101/gr.101063.109; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Roberts N.J., 2012, SCI TRANSL MED, V4; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tessler LA, 2009, ANAL CHEM, V81, P7141, DOI 10.1021/ac901068x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wang CL, 2010, P NATL ACAD SCI USA, V107, P1518, DOI 10.1073/pnas.0913939107; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497; Wetterstrand K.A., DNA SEQUENCING COSTS; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Yu Z, 2011, J BACTERIOL, V193, P1308, DOI 10.1128/JB.01209-10; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873	140	205	215	0	209	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1084	1094		10.1038/nbt.2421	http://dx.doi.org/10.1038/nbt.2421			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138308	Green Accepted			2022-12-27	WOS:000311087500028
J	[Anonymous]				[Anonymous]			Knocking on the clinic door	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2012	30	11					1009	1009		10.1038/nbt.2428	http://dx.doi.org/10.1038/nbt.2428			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	037FL	23138274	Bronze			2022-12-27	WOS:000311087500001
J	Bradley, E				Bradley, Edward			Incorporating biomarkers into clinical trial designs: points to consider	NATURE BIOTECHNOLOGY			English	Letter								In an environment where the regulatory and reimbursement authorities continue to raise the bar for new oncology therapies, how are sponsors adapting clinical trial designs?	MedImmune, Clin Dev, Oncol, Gaithersburg, MD USA	AstraZeneca; Medimmune	Bradley, E (corresponding author), MedImmune, Clin Dev, Oncol, Gaithersburg, MD USA.	bradleyed@Medimmune.com						[Anonymous], 2010, BIOCENTURY, V39, pA1; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Beckman RA, 2011, NAT REV DRUG DISCOV, V10, P735, DOI 10.1038/nrd3550; Chen K, 2008, CONTEMP CLIN TRIALS, V29, P32, DOI 10.1016/j.cct.2007.04.008; D'Agostino RB, 2011, NEW ENGL J MED, V365, DOI [10.1056/nejmp1106984, 10.1056/NEJMp1106984]; Fleming TR, 2004, J INFECT DIS, V190, P666, DOI 10.1086/422603; Heinemann V, 2009, CANCER TREAT REV, V35, P262, DOI 10.1016/j.ctrv.2008.11.005; Hoos A, 2010, JNCI-J NATL CANCER I, V102, P1388, DOI 10.1093/jnci/djq310; Jallal B., 2011, EURO PHARM REV, V16, P29; LaVallee T., 2011, ONC NEWS, V6, P52; Maitland ML, 2011, J CLIN ONCOL, V29, P3109, DOI 10.1200/JCO.2011.36.3887; Patlak M., 2011, NATL CANC POLICY SUM; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Sikorski R, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000287; Thall P.F, 2007, DEP BIOSTATISTICS WO; Vickers AJ, 2007, CLIN CANCER RES, V13, P972, DOI 10.1158/1078-0432.CCR-06-0909	16	14	14	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2012	30	7					596	599		10.1038/nbt.2296	http://dx.doi.org/10.1038/nbt.2296			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	972QV	22781677				2022-12-27	WOS:000306293400013
J	Modarresi, F; Faghihi, MA; Lopez-Toledano, MA; Fatemi, RP; Magistri, M; Brothers, SP; van der Brug, MP; Wahlestedt, C				Modarresi, Farzaneh; Faghihi, Mohammad Ali; Lopez-Toledano, Miguel A.; Fatemi, Roya Pedram; Magistri, Marco; Brothers, Shaun P.; van der Brug, Marcel P.; Wahlestedt, Claes			Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation	NATURE BIOTECHNOLOGY			English	Article							NEUROTROPHIC FACTOR; NONCODING RNAS; ALZHEIMERS-DISEASE; BDNF GENES; EXPRESSION; ASSOCIATIONS; MODULATION; MATURATION; LOCUS; MODEL	The ability to specifically upregulate genes in vivo holds great therapeutic promise. Here we show that inhibition or degradation of natural antisense transcripts (NATs) by single-stranded oligonucleotides or siRNAs can transiently and reversibly upregulate locus-specific gene expression. Brain-derived neurotrophic factor (BDNF) is normally repressed by a conserved noncoding antisense RNA transcript, BDNF-AS. Inhibition of this transcript upregulates BDNF mRNA by two- to sevenfold, alters chromatin marks at the BDNF locus, leads to increased protein levels and induces neuronal outgrowth and differentiation both in vitro and in vivo. We also show that inhibition of NATs leads to increases in glial-derived neurotrophic factor (GDNF) and ephrin receptor B2 (EPHB2) mRNA. Our data suggest that pharmacological approaches targeting NATs can confer locus-specific gene upregulation effects.	[Modarresi, Farzaneh; Faghihi, Mohammad Ali; Fatemi, Roya Pedram; Magistri, Marco; Brothers, Shaun P.; Wahlestedt, Claes] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Modarresi, Farzaneh; Faghihi, Mohammad Ali; Fatemi, Roya Pedram; Magistri, Marco; Brothers, Shaun P.; Wahlestedt, Claes] Univ Miami, Miller Sch Med, Ctr Therapeut Innovat, John P Hussman Inst Human Genom, Miami, FL 33136 USA	University of Miami; University of Miami	Wahlestedt, C (corresponding author), Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA.	cwahlestedt@med.miami.edu	Lopez-Toledano, Miguel A./C-3471-2008; Faghihi, Mohammad Ali/AAD-7159-2020; Brothers, Shaun/G-8690-2012; Faghihi, Mohammad Ali/AAH-3139-2019	Lopez-Toledano, Miguel A./0000-0002-5743-3750; Faghihi, Mohammad Ali/0000-0002-8330-9067; Brothers, Shaun/0000-0003-2184-4037	US National Institutes of Health [5R01NS063974, 5RC2AG036596]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036596] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Q.-R. Liu from the National Institute of Drug Abuse kindly provided us with constructs that contain three splice variants of the human BDNF-AS transcript. We thank C. Coito, P. Frost, J. Hsiao and O. Khorkova at OPKO-CURNA for helpful discussions. The US National Institutes of Health (5R01NS063974 and 5RC2AG036596) funded this work. A significant portion of this study was carried out when the investigators were employed at The Scripps Research Institute and/or the Karolinska Institutet.	Abuhatzira L, 2007, EPIGENETICS-US, V2, P214, DOI 10.4161/epi.2.4.5212; Ortega JA, 2010, CEREB CORTEX, V20, P2132, DOI 10.1093/cercor/bhp275; Antal A, 2010, BRAIN STIMUL, V3, P230, DOI 10.1016/j.brs.2009.12.003; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Castillo DV, 2011, BEHAV BRAIN RES, V217, P248, DOI 10.1016/j.bbr.2010.10.013; Chapleau CA, 2009, J NEURODEV DISORD, V1, P185, DOI 10.1007/s11689-009-9027-6; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Choi DC, 2010, P NATL ACAD SCI USA, V107, P2675, DOI 10.1073/pnas.0909359107; Dell'Osso L, 2010, NEUROPSYCHOBIOLOGY, V62, P207, DOI 10.1159/000319946; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Frade JM, 2010, CELL CYCLE, V9, P1934, DOI 10.4161/cc.9.10.11582; Gonul AS, 2011, WORLD J BIOL PSYCHIA, V12, P110, DOI 10.3109/15622975.2010.507786; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Hawkins PG, 2010, TRANSCR-AUSTIN, V1, P165, DOI 10.4161/trns.1.3.13332; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Im SH, 2010, NEUROSCIENCE, V169, P259, DOI 10.1016/j.neuroscience.2010.04.038; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khalil AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001486; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Laske C, 2011, INT J NEUROPSYCHOPH, V14, P399, DOI 10.1017/S1461145710001008; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Luo KR, 2010, PROG NEURO-PSYCHOPH, V34, P1433, DOI 10.1016/j.pnpbp.2010.07.033; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mehler MF, 2006, J PHYSIOL-LONDON, V575, P333, DOI 10.1113/jphysiol.2006.113191; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Morris KV, 2009, EPIGENETICS-US, V4, P296, DOI 10.4161/epi.4.5.9282; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Nikolakopoulou AM, 2010, J COMP NEUROL, V518, P972, DOI 10.1002/cne.22258; Ogier M, 2007, J NEUROSCI, V27, P10912, DOI 10.1523/JNEUROSCI.1869-07.2007; Park HR, 2010, NEUROSCI LETT, V482, P235, DOI 10.1016/j.neulet.2010.07.046; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Scheele C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-74; Trzaska KA, 2009, J NEUROCHEM, V110, P1058, DOI 10.1111/j.1471-4159.2009.06201.x; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Watts JK, 2010, NUCLEIC ACIDS RES, V38, P5242, DOI 10.1093/nar/gkq258; Wu SY, 2011, BRAIN BEHAV IMMUN, V25, P135, DOI 10.1016/j.bbi.2010.09.006; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Yoshimura R, 2009, NEUROSCI LETT, V450, P262, DOI 10.1016/j.neulet.2008.12.010; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zeng Y, 2010, J ALZHEIMERS DIS, V21, P823, DOI 10.3233/JAD-2010-100264; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	50	440	486	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					453	+		10.1038/nbt.2158	http://dx.doi.org/10.1038/nbt.2158			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22446693	Green Accepted			2022-12-27	WOS:000303803200026
J	Mercer, TR; Gerhardt, DJ; Dinger, ME; Crawford, J; Trapnell, C; Jeddeloh, JA; Mattick, JS; Rinn, JL				Mercer, Tim R.; Gerhardt, Daniel J.; Dinger, Marcel E.; Crawford, Joanna; Trapnell, Cole; Jeddeloh, Jeffrey A.; Mattick, John S.; Rinn, John L.			Targeted RNA sequencing reveals the deep complexity of the human transcriptome	NATURE BIOTECHNOLOGY			English	Article							NONCODING RNAS; GENE-EXPRESSION; HUMAN EXOMES; GENOME; SEQ; DEMARCATION; LANDSCAPE; VARIANTS; FEATURES; ELEMENTS	Transcriptomic analyses have revealed an unexpected complexity to the human transcriptome, whose breadth and depth exceeds current RNA sequencing capability(1-4). Using tiling arrays to target and sequence select portions of the transcriptome, we identify and characterize unannotated transcripts whose rare or transient expression is below the detection limits of conventional sequencing approaches. We use the unprecedented depth of coverage afforded by this technique to reach the deepest limits of the human transcriptome, exposing widespread, regulated and remarkably complex noncoding transcription in intergenic regions, as well as unannotated exons and splicing patterns in even intensively studied protein-coding loci such as p53 and HOX. The data also show that intermittent sequenced reads observed in conventional RNA sequencing data sets, previously dismissed as noise, are in fact indicative of unassembled rare transcripts. Collectively, these results reveal the range, depth and complexity of a human transcriptome that is far from fully characterized.	[Gerhardt, Daniel J.; Jeddeloh, Jeffrey A.] Roche NimbleGen Inc, Res & Dev, Madison, WI 53719 USA; [Mercer, Tim R.; Dinger, Marcel E.; Crawford, Joanna; Mattick, John S.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Trapnell, Cole; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Roche Holding; University of Queensland; Harvard University	Jeddeloh, JA (corresponding author), Roche NimbleGen Inc, Res & Dev, Madison, WI 53719 USA.	jeffrey.jeddeloh@roche.com; j.mattick@uq.edu.au; john_rinn@harvard.edu	Mattick, John S/I-7789-2012; Dinger, Marcel/N-1398-2019; Mattick, John/ABH-6130-2020; Crawford, Joanna/F-9135-2013; Mercer, Tim/AAK-5060-2020	Mattick, John S/0000-0002-7680-7527; Mattick, John/0000-0002-7680-7527; Crawford, Joanna/0000-0003-0786-6889; Mercer, Tim/0000-0001-8780-894X; Dinger, Marcel/0000-0003-4423-934X; Rinn, John/0000-0002-7231-7539	Human Frontiers Science Program; Queensland Government Department of Employment, Economic Development and Innovation; Australian Research Council/University of Queensland [FF0561986]; Australian National Health and Medical Research Council Australia [631668]; Career Development Award [CDA631542]; Damon Runyon-Rachleff; Searle; Smith Family Foundation; Richard Merkin Foundation; US National Institutes of Health [1DP2OD00667-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006102] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006670] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Queensland Government Department of Employment, Economic Development and Innovation; Australian Research Council/University of Queensland(University of QueenslandAustralian Research Council); Australian National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Career Development Award; Damon Runyon-Rachleff; Searle; Smith Family Foundation; Richard Merkin Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank M. Garber for his design of the arrays and constructive contribution to the manuscript; M. Koziol and K. Thomas for preparing cDNA and sequencing libraries; T. Albert, T. Arnold, J. Affourtit, B. Dessany, T. Jarvie, D. Green and T. Millard provided sequencing support. The authors would like to thank the following funding sources: Human Frontiers Science Program (to T.R.M.); Queensland Government Department of Employment, Economic Development and Innovation Smart Futures Fellowship (to M.E.D.); Australian Research Council/University of Queensland co-sponsored Federation Fellowship (FF0561986; to J.S.M.); Australian National Health and Medical Research Council Australia Fellowship (631668; to J.S.M.) and Career Development Award (CDA631542; to M.E.D.); Damon Runyon-Rachleff, Searle, Smith Family Foundation and Richard Merkin Foundation Scholar (to J.L.R.); and US National Institutes of Health (1DP2OD00667-01; to J.L.R. and C.T.).	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Crider-Miller SJ, 1997, GENOMICS, V46, P355, DOI 10.1006/geno.1997.5061; Fu Y, 2010, PLANT J, V62, P898, DOI 10.1111/j.1365-313X.2010.04196.x; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hiller M, 2008, TRENDS GENET, V24, P246, DOI 10.1016/j.tig.2008.03.003; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kloc M, 2011, BIOCHIMIE, V93, P1955, DOI 10.1016/j.biochi.2011.07.008; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Olivares-Illana V, 2010, ONCOGENE, V29, P5113, DOI 10.1038/onc.2010.266; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van Bakel H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001102; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; YEHLE CO, 1987, MOL CELL PROBE, V1, P177, DOI 10.1016/0890-8508(87)90026-0	38	323	335	5	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2012	30	1					99	U147		10.1038/nbt.2024	http://dx.doi.org/10.1038/nbt.2024			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	876MC	22081020	Green Accepted			2022-12-27	WOS:000299110600026
J	Kothamasi, D; Spurlock, M; Kiers, ET				Kothamasi, David; Spurlock, Matthew; Kiers, E. Toby			Agricultural microbial resources: private property or global commons?	NATURE BIOTECHNOLOGY			English	Editorial Material							INDIGENOUS KNOWLEDGE; MANAGEMENT; MICROORGANISMS; DIVERSITY; GROWTH; COMMERCIALIZATION; FERTILIZATION; CONSERVATION; BIODIVERSITY; PROTECTION	Agricultural microbes have become an attractive target for patenting, but the lack of a consistent global patent regime and increasingly heated debates over microbial ownership rights are barriers to the development of this resource.	[Kothamasi, David] Univ Delhi, Lab Soil Biol & Microbial Ecol, Dept Environm Studies, Delhi 110007, India; [Spurlock, Matthew] Harvard Univ, Sch Law, Cambridge, MA 02138 USA; [Kiers, E. Toby] Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands	University of Delhi; Harvard University; Vrije Universiteit Amsterdam	Kothamasi, D (corresponding author), Univ Delhi, Lab Soil Biol & Microbial Ecol, Dept Environm Studies, Delhi 110007, India.	toby.kiers@vu.nl	Toby, Kiers/H-4819-2017	Toby, Kiers/0000-0002-0597-1653; Kothamasi, David/0000-0002-6344-9249	University of Delhi; Dutch Science Foundation (NWO)	University of Delhi(University of Delhi); Dutch Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank D. Sharma for manuscript comments. D. K. received a research grant from the University of Delhi and E. T. K. is funded by a Vidi and a Meervoud grant from the Dutch Science Foundation (NWO).	Affokpon A, 2011, BIOL FERT SOILS, V47, P207, DOI 10.1007/s00374-010-0525-1; Barea JM, 2005, J EXP BOT, V56, P1761, DOI 10.1093/jxb/eri197; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Bhat PI, 2009, J INTELLECT PROP RIG, V14, P214; Bialy H, 1998, NAT BIOTECHNOL, V16, P986, DOI 10.1038/3401; Commission on Intellectual Property Rights, 2002, INT INT PROP RIGHTS; Consultative Group on International Agricultural Research (CGIAR, 2010, LEAV ROOM CBDS ABS P; . Convention on Biological Diversity (CBD), 1996, ACC MICR GEN RES; Cullet P., 2003, DELHI LAW REV, V24, P41; Dedeurwaerdere T., 2009, USE EXCHANGE MICROBI; Dedeurwaerdere T, 2010, RES MICROBIOL, V161, P414, DOI 10.1016/j.resmic.2010.04.012; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; Freitag TE, 2005, APPL ENVIRON MICROB, V71, P8323, DOI 10.1128/AEM.71.12.8323-8334.2005; Gelernter WD, 2007, J INVERTEBR PATHOL, V95, P161, DOI 10.1016/j.jip.2007.03.004; German Federal Ministry for Economic Cooperation and Development (GIZ), 2010, TRIGG SYN INT PROP R; Halewood M., 2010, INT J COMMONS, V4, P404, DOI DOI 10.18352/ijc.152; Hayden C., 2005, REV HARVARD REV LATI, V3, P40; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Hofte M, 2010, RES MICROBIOL, V161, P464, DOI 10.1016/j.resmic.2010.04.007; ITPGRFA, 2009, INT TREAT PLANT GEN; JACOBY CD, 1997, STAN ENV LJ, V16, P74; Kahiluoto H, 2009, AGR ECOSYST ENVIRON, V134, P36, DOI 10.1016/j.agee.2009.05.016; Kameri-Mbote AP, 1999, J ENVIRON LAW, V11, P257, DOI 10.1093/jel/11.2.257; Kiers ET, 2002, J APPL ECOL, V39, P745, DOI 10.1046/j.1365-2664.2002.00755.x; Kothamasi D, 2009, CONSERV BIOL, V23, P1328, DOI 10.1111/j.1523-1739.2009.01252.x; Kuldip G, 2011, INDIAN J TRADIT KNOW, V10, P508; Lindstrom K, 2010, RES MICROBIOL, V161, P453, DOI 10.1016/j.resmic.2010.05.005; Lwoga ET, 2011, LIBRI, V61, P226, DOI 10.1515/libr.2011.019; Maloy S, 2006, INT MICROBIOL, V9, P1; Martin G., 2005, CAPITALISM NATURE SO, V16, P27; Materechera SA, 2010, NUTR CYCL AGROECOSYS, V87, P415, DOI 10.1007/s10705-010-9347-7; Millum J, 2010, HASTINGS CENT REP, V40, P24; Montesinos E, 2003, INT MICROBIOL, V6, P245, DOI 10.1007/s10123-003-0144-x; Perez-Garcia A, 2011, CURR OPIN BIOTECH, V22, P187, DOI 10.1016/j.copbio.2010.12.003; Roa-Rodriguez C, 2008, J WORLD INTELLECT PR, V11, P176, DOI 10.1111/j.1747-1796.2008.00342.x; Safrin S, 2004, AM J INT LAW, V98, P641, DOI 10.2307/3216691; Senan S, 2011, CURR SCI INDIA, V100, P159; Shepherd CJ, 2010, CURR ANTHROPOL, V51, P629, DOI 10.1086/656424; Singh C, 1986, COMMON PROPERTY COMM; SOUZA V, 1994, APPL ENVIRON MICROB, V60, P1260, DOI 10.1128/AEM.60.4.1260-1268.1994; Souza Valeria, 1997, Journal of Ethnobiology, V17, P249; Thrall PH, 2011, EVOL APPL, V4, P200, DOI 10.1111/j.1752-4571.2010.00179.x; Tikhonovich IA, 2011, ANN APPL BIOL, V159, P155, DOI 10.1111/j.1744-7348.2011.00489.x; Toljander JF, 2008, FEMS MICROBIOL ECOL, V65, P323, DOI 10.1111/j.1574-6941.2008.00512.x; Verbruggen E, 2010, EVOL APPL, V3, P547, DOI 10.1111/j.1752-4571.2010.00145.x; Vermeylen S, 2008, INT J CULT PROP, V15, P201, DOI 10.1017/S0940739108080144; Wang MY, 2009, PEDOSPHERE, V19, P663, DOI 10.1016/S1002-0160(09)60161-2; Webber PM, 2006, NAT REV DRUG DISCOV, V5, P13, DOI 10.1038/nrd1948; Wolff F., 2004, ENV LAW NETW INT, V1, P1; Zohary D, 2004, ECON BOT, V58, P5, DOI 10.1663/0013-0001(2004)058[0005:USATEO]2.0.CO;2	50	5	5	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1091	1094		10.1038/nbt.2056	http://dx.doi.org/10.1038/nbt.2056			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	861SE	22158360				2022-12-27	WOS:000298038700015
J	von Roth, P; Canny, BJ; Volk, HD; Noble, JA; Prober, CG; Perka, C; Duda, GN				von Roth, Philipp; Canny, Benedict J.; Volk, Hans-Dieter; Noble, J. Alison; Prober, Charles G.; Perka, Carsten; Duda, Georg N.			The challenges of modern interdisciplinary medical research	NATURE BIOTECHNOLOGY			English	Editorial Material							ORTHOPEDIC CLINICIAN-SCIENTIST	The increasing complexity of medical science poses significant challenges to medical education, leading to a growing gap between medical researchers and treating practitioners.	[von Roth, Philipp; Perka, Carsten; Duda, Georg N.] Charite Univ Med Berlin, Berlin Brandenburg Sch Regenerat Therapies, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [von Roth, Philipp; Perka, Carsten; Duda, Georg N.] Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany; [von Roth, Philipp; Perka, Carsten; Duda, Georg N.] Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Berlin, Germany; [Canny, Benedict J.] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia; [Volk, Hans-Dieter] Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany; [Noble, J. Alison] Univ Oxford, Inst Biomed Engn, Oxford, England; [Noble, J. Alison] Univ Oxford, RCUK Ctr Doctoral Training Healthcare Innovat, Dept Engn Sci, Oxford, England; [Prober, Charles G.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Monash University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Oxford; University of Oxford; Stanford University	von Roth, P (corresponding author), Charite Univ Med Berlin, Berlin Brandenburg Sch Regenerat Therapies, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.	georg.duda@charite.de	Perka, Carsten/ABG-6505-2021; volk, hans-dieter/AAV-8053-2021; Duda, Georg N/H-2085-2016	volk, hans-dieter/0000-0002-7743-6668; Duda, Georg N/0000-0001-7605-3908; Perka, Carsten/0000-0002-0993-581X; Noble, Alison/0000-0002-3060-3772				Ahn J, 2008, J BONE JOINT SURG AM, V90A, P1794, DOI 10.2106/JBJS.G.00460; Butler D, 2008, NATURE, V453, P840, DOI 10.1038/453840a; GOLDSTEIN JL, 1986, J CLIN INVEST, V78, P848, DOI 10.1172/JCI112652; Jayasundera T, 2003, CLIN EXP OPHTHALMOL, V31, P294, DOI 10.1046/j.1442-9071.2003.00678.x; McKelvie J, 2009, CLIN EXP OPHTHALMOL, V37, P247, DOI 10.1111/j.1442-9071.2009.02040.x; Moran CJ, 2010, ARTHROSCOPY, V26, P1417, DOI 10.1016/j.arthro.2010.09.002; Sherwin T, 2003, CLIN EXP OPHTHALMOL, V31, P284, DOI 10.1046/j.1442-9071.2003.00680.x	7	9	9	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1145	1148		10.1038/nbt.2062	http://dx.doi.org/10.1038/nbt.2062			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22158370				2022-12-27	WOS:000298038700026
J	Compeau, PEC; Pevzner, PA; Tesler, G				Compeau, Phillip E. C.; Pevzner, Pavel A.; Tesler, Glenn			How to apply de Bruijn graphs to genome assembly	NATURE BIOTECHNOLOGY			English	Article							SEQUENCE; DNA; ALGORITHMS		[Compeau, Phillip E. C.; Tesler, Glenn] Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA; [Pevzner, Pavel A.] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Compeau, PEC (corresponding author), Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA.	ppevzner@ucsd.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR024851, P41RR008605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103484] Funding Source: NIH RePORTER; Howard Hughes Medical Institute [52005726] Funding Source: Medline; NCRR NIH HHS [3P41RR024851-02S1, P41 RR024851, P41 RR008605] Funding Source: Medline; NIGMS NIH HHS [P41 GM103484] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bandeira N, 2008, NAT BIOTECHNOL, V26, P1336, DOI 10.1038/nbt1208-1336; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; DRMANAC R, 1989, GENOMICS, V4, P114; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FULER I, 1741, COMMENTARII ACAD SCI, V8, P128; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Idury R M, 1995, J Comput Biol, V2, P291, DOI 10.1089/cmb.1995.2.291; KECECIOGLU JD, 1995, ALGORITHMICA, V13, P7, DOI 10.1007/BF01188580; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; LYSOV YP, 1988, DOKL AKAD NAUK SSSR, V303, P1508; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; PEVZNER PA, 1989, J BIOMOL STRUCT DYN, V7, P63, DOI 10.1080/07391102.1989.10507752; Pevzner PA, 2004, GENOME RES, V14, P1786, DOI 10.1101/gr.2395204; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pham SK, 2010, BIOINFORMATICS, V26, P2509, DOI 10.1093/bioinformatics/btq465; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Skiena S. S., 2008, ALGORITHM DESIGN MAN; SOUTHERN E, 1988, Patent No. GB8810400; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; [No title captured]	26	312	346	3	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					987	991		10.1038/nbt.2023	http://dx.doi.org/10.1038/nbt.2023			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22068540	Green Accepted			2022-12-27	WOS:000296801300019
J	Prosser, HM; Koike-Yusa, H; Cooper, JD; Law, FC; Bradley, A				Prosser, Haydn M.; Koike-Yusa, Hiroko; Cooper, James D.; Law, Frances C.; Bradley, Allan			A resource of vectors and ES cells for targeted deletion of microRNAs in mice	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; SITE-SPECIFIC RECOMBINATION; MAMMALIAN-CELLS; FLP RECOMBINASE; ENZYME DICER; CRE; DIFFERENTIATION; GENES; RECOGNITION; EXPRESSION	The 21-23 nucleotide, single-stranded RNAs classified as microRNAs (miRNA) perform fundamental roles in diverse cellular and developmental processes. In contrast to the situation for protein-coding genes, no public resource of miRNA mouse mutant alleles exists. Here we describe a collection of 428 miRNA targeting vectors covering 476 of the miRNA genes annotated in the miRBase registry. Using these vectors, we generated a library of highly germline-transmissible C57BL/6N mouse embryonic stem (ES) cell clones harboring targeted deletions for 392 miRNA genes. For most of these targeted clones, chimerism and germline transmission can be scored through a coat color marker. The targeted alleles have been designed to be adaptable research tools that can be efficiently altered by recombinase-mediated cassette exchange to create reporter, conditional and other allelic variants. This miRNA knockout (mirKO) resource can be searched electronically and is available from ES cell repositories for distribution to the scientific community.	[Prosser, Haydn M.; Koike-Yusa, Hiroko; Cooper, James D.; Law, Frances C.; Bradley, Allan] Wellcome Trust Sanger Inst, Cambridge, England	Wellcome Trust Sanger Institute	Prosser, HM (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	hmp@sanger.ac.uk		Bradley, Allan/0000-0002-2349-8839; Cooper, James/0000-0002-4932-1740	Wellcome Trust [WT079643]; European Union; US National Institutes of Health	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Y. Mok, D. Thomas, M. Li and G. Duddy for assistance with sections of the project. For database support and high-throughput vector designs, we are indebted to V. Iyer, D. Oakley, W. Yang, D. Klose and S. Briois. We thank A. West for advice on long range PCR genotyping. We are grateful for the advice and reagents for high-throughput vector construction received from P. Liu. We thank E. Miska for helpful comments on the manuscript. We thank R. Rad for advice with Q-PCR. We thank the Sanger Institute mouse mutant generation and animal facilities teams. We thank the public distribution repositories at MMRRC University of California Davis, USA, and as part of the EUCOMMTOOLS initiative EuMMCR at the Helmholtz Zentrum Munchen, Munich, Germany, for agreeing to support the future distribution of the mirKO resource. This work was funded by the Wellcome Trust (WT079643). The IKMC database was developed with funding from the European Union and the US National Institutes of Health.	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Saba R, 2010, BRAIN RES, V1338, P3, DOI 10.1016/j.brainres.2010.03.107; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Seibler J, 1998, BIOCHEMISTRY-US, V37, P6229, DOI 10.1021/bi980288t; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wobus A M, 2002, Methods Mol Biol, V185, P127; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	41	66	82	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2011	29	9					843	U102		10.1038/nbt.1929	http://dx.doi.org/10.1038/nbt.1929			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	817ZT	21822254	Green Submitted, Green Accepted			2022-12-27	WOS:000294718400026
J	Rouet, R; Christ, D				Rouet, Romain; Christ, Daniel			Bispecific antibodies with native chain structure	NATURE BIOTECHNOLOGY			English	Editorial Material							VARIABLE DOMAINS; IGG		[Rouet, Romain; Christ, Daniel] Garvan Inst Med Res, Sydney, NSW, Australia; [Rouet, Romain; Christ, Daniel] Univ New S Wales, Fac Med, Sydney, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	Rouet, R (corresponding author), Garvan Inst Med Res, Sydney, NSW, Australia.	d.christ@garvan.org.au	Christ, Daniel/C-1861-2018; Rouet, Romain/U-3511-2019	Christ, Daniel/0000-0002-7313-3977; Rouet, Romain/0000-0003-4210-9613				Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Lewis SM, 2014, NAT BIOTECHNOL, V32, P191, DOI 10.1038/nbt.2797; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Rouet R, 2014, FEBS LETT, V588, P269, DOI 10.1016/j.febslet.2013.11.029; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621	9	14	15	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2014	32	2					136	138		10.1038/nbt.2812	http://dx.doi.org/10.1038/nbt.2812			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	AA4NY	24509759				2022-12-27	WOS:000331074000014
J	Vanderford, NL				Vanderford, Nathan L.			Fixing the broken graduate education experience	NATURE BIOTECHNOLOGY			English	Editorial Material								The current academic culture needs to change its mission, which is narrowly focused on training PhDs to be the next generation of academic tenure-track scientists.	[Vanderford, Nathan L.] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Vanderford, Nathan L.] Integrat Acad Solut, Lexington, KY USA	University of Kentucky	Vanderford, NL (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA.	nathan.vanderford@uky.edu						National Science Board, 2012, SCI ENG IND 2012; Schillebeeckx M, 2013, NAT BIOTECHNOL, V31, P938, DOI 10.1038/nbt.2706	2	2	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2013	31	12					1149	1149		10.1038/nbt.2767	http://dx.doi.org/10.1038/nbt.2767			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	269OW	24316655				2022-12-27	WOS:000328251900035
J	Langlois, RA; Albrecht, RA; Kimble, B; Sutton, T; Shapiro, JS; Finch, C; Angel, M; Chua, MA; Gonzalez-Reiche, AS; Xu, KM; Perez, D; Garcia-Sastre, A; tenOever, BR				Langlois, Ryan A.; Albrecht, Randy A.; Kimble, Brian; Sutton, Troy; Shapiro, Jillian S.; Finch, Courtney; Angel, Matthew; Chua, Mark A.; Gonzalez-Reiche, Ana Silvia; Xu, Kemin; Perez, Daniel; Garcia-Sastre, Adolfo; tenOever, Benjamin R.			MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies	NATURE BIOTECHNOLOGY			English	Article							MULTIBASIC CLEAVAGE SITE; A VIRUS; RESPIRATORY DROPLET; TRANSMISSION; FERRETS; INFECTION; HEMAGGLUTININ; REPLICATION; HOST; PIGS	Recent gain-of-function studies in influenza A virus H5N1 strains revealed that as few as three-amino-acid changes in the hemagglutinin protein confer the capacity for viral transmission between ferrets(1,2). As transmission between ferrets is considered a surrogate indicator of transmissibility between humans, these studies raised concerns about the risks of gain-of-function influenza A virus research. Here we present an approach to strengthen the biosafety of gain-of-function influenza experiments. We exploit species-specific endogenous small RNAs to restrict influenza A virus tropism. In particular, we found that the microRNA miR-192 was expressed in primary human respiratory tract epithelial cells as well as in mouse lungs but absent from the ferret respiratory tract. Incorporation of miR-192 target sites into influenza A virus did not prevent influenza replication and transmissibility in ferrets, but did attenuate influenza pathogenicity in mice. This molecular biocontainment approach should be applicable beyond influenza A virus to minimize the risk of experiments involving other pathogenic viruses.	[Langlois, Ryan A.; Albrecht, Randy A.; Shapiro, Jillian S.; Chua, Mark A.; Garcia-Sastre, Adolfo; tenOever, Benjamin R.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA; [Langlois, Ryan A.; Albrecht, Randy A.; Garcia-Sastre, Adolfo; tenOever, Benjamin R.] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY USA; [Kimble, Brian; Sutton, Troy; Finch, Courtney; Angel, Matthew; Gonzalez-Reiche, Ana Silvia; Xu, Kemin; Perez, Daniel] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA; [Garcia-Sastre, Adolfo; tenOever, Benjamin R.] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University System of Maryland; University of Maryland College Park; Icahn School of Medicine at Mount Sinai	Perez, D (corresponding author), Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA.	dperez1@umd.edu; adolfo.garcia-sastre@mssm.edu; benjamin.tenoever@mssm.edu	Albrecht, Randy A./H-5119-2019; Perez, Daniel R./D-5044-2016; Gonzalez-Reiche, Ana/ABH-2585-2020	Albrecht, Randy A./0000-0003-4008-503X; Perez, Daniel R./0000-0002-6569-5689; Gonzalez-Reiche, Ana/0000-0003-3583-4497; tenOever, Benjamin/0000-0003-0324-3078; Garcia-Sastre, Adolfo/0000-0002-6551-1827	Center for Research on Influenza Pathogenesis, a National Institute of Allergy and Infectious Diseases; Center of Excellence in Influenza Research and Surveillance [HHSN266200700010C]; US Army Research Office [W911NF-12-R-0012, W911NF-08-1-0413]; Burroughs Wellcome Fund	Center for Research on Influenza Pathogenesis, a National Institute of Allergy and Infectious Diseases; Center of Excellence in Influenza Research and Surveillance; US Army Research Office; Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by the Center for Research on Influenza Pathogenesis, a National Institute of Allergy and Infectious Diseases-funded Center of Excellence in Influenza Research and Surveillance (HHSN266200700010C). B.R.T. is supported in part by the US Army Research Office under grant numbers W911NF-12-R-0012 and W911NF-08-1-0413 and the Burroughs Wellcome Fund. MDCK cells were kindly provided by P. Palese (Mount Sinai School of Medicine).	Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Chua MA, 2013, CELL REP, V3, P23, DOI 10.1016/j.celrep.2012.12.010; Fouchier RAM, 2012, SCIENCE, V335, P400, DOI [10.1126/science.1219412, 10.1126/science.335.6067.400]; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Heiss BL, 2012, J VIROL, V86, P5647, DOI 10.1128/JVI.07125-11; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Langlois RA, 2012, P NATL ACAD SCI USA, V109, P12117, DOI 10.1073/pnas.1206039109; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Perez JT, 2009, NAT BIOTECHNOL, V27, P572, DOI 10.1038/nbt.1542; Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Schrauwen EJA, 2012, J VIROL, V86, P3975, DOI 10.1128/JVI.06828-11; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Suguitan AL, 2012, J VIROL, V86, P2706, DOI 10.1128/JVI.05546-11; Tharakaraman K, 2013, CELL, V153, P1475, DOI 10.1016/j.cell.2013.05.035; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	24	63	67	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2013	31	9					844	+		10.1038/nbt.2666	http://dx.doi.org/10.1038/nbt.2666			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	216TC	23934176	Green Accepted, Green Published			2022-12-27	WOS:000324306300026
J	Taipale, M; Krykbaeva, I; Whitesell, L; Santagata, S; Zhang, JM; Liu, QS; Gray, NS; Lindquist, S				Taipale, Mikko; Krykbaeva, Irina; Whitesell, Luke; Santagata, Sandro; Zhang, Jianming; Liu, Qingsong; Gray, Nathanael S.; Lindquist, Susan			Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells	NATURE BIOTECHNOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; PROTEIN-TYROSINE KINASE; BCR-ABL; INFANTILE FIBROSARCOMA; QUANTITATIVE-ANALYSIS; PONATINIB AP24534; MAMMALIAN-CELLS; INTERACTION MAP; BINDING-SITE; RECEPTOR	The interaction between the HSP90 chaperone and its client kinases is sensitive to the conformational status of the kinase, and stabilization of the kinase fold by small molecules strongly decreases chaperone interaction. Here we exploit this observation and assay small-molecule binding to kinases in living cells, using chaperones as 'thermodynamic sensors'. The method allows determination of target specificities of both ATP-competitive and allosteric inhibitors in the kinases' native cellular context in high throughput. We profile target specificities of 30 diverse kinase inhibitors against >300 kinases. Demonstrating the value of the assay, we identify ETV6-NTRK3 as a target of the FDA-approved drug crizotinib (Xalkori). Crizotinib inhibits proliferation of ETV6-NTRK3-dependent tumor cells with nanomolar potency and induces the regression of established tumor xenografts in mice. Finally, we show that our approach is applicable to other chaperone and target classes by assaying HSP70/steroid hormone receptor and CDC37/kinase interactions, suggesting that chaperone interactions will have broad application in detecting drug-target interactions in vivo.	[Taipale, Mikko; Krykbaeva, Irina; Whitesell, Luke; Santagata, Sandro; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Santagata, Sandro] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Santagata, Sandro] Harvard Univ, Sch Med, Boston, MA USA; [Zhang, Jianming; Liu, Qingsong; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhang, Jianming; Liu, Qingsong; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA USA; [Lindquist, Susan] Howard Hughes Med Inst, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	刘, 青松/AEM-1932-2022; Liu, Qingsong/AFS-0714-2022	刘, 青松/0000-0002-7829-2547; Liu, Qingsong/0000-0002-7829-2547; Santagata, Sandro/0000-0002-7528-9668; Taipale, Mikko/0000-0003-3811-1761; Krykbaeva, Irina/0000-0003-1380-7607; Zhang, Jianming/0000-0001-6326-3906	Human Frontier Science Programme long-term fellowship; US National Institutes of Health (NIH) [UL1-DE019585]; NIH [RL1-GM084437, RL1-CA133834, RL1-HG004671]; NATIONAL CANCER INSTITUTE [P30CA014051, RL1CA133834] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084437] Funding Source: NIH RePORTER	Human Frontier Science Programme long-term fellowship(Human Frontier Science Program); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Lindquist laboratory members for valuable discussions and comments on the manuscript. We also thank M. Azam (Cincinnati Children's Hospital Medical Center) for providing mutant BCR-ABL clones and P. Thiru, I. Barrasa and G. Bell (Whitehead Institute) for help with primer design and statistical analysis. M. T. was supported by Human Frontier Science Programme long-term fellowship. S. L. is a Howard Hughes Medical Institute investigator. Support for this study was also provided by the US National Institutes of Health (NIH) Genomics Based Drug Discovery-Driving Medical Projects grant UL1-DE019585, administratively linked to NIH grants RL1-GM084437, RL1-CA133834 and RL1-HG004671.	Adcock IM, 1999, BRIT J PHARMACOL, V127, P1003, DOI 10.1038/sj.bjp.0702613; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Atanassov II, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-14; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Chaires JB, 2008, ANNU REV BIOPHYS, V37, P135, DOI 10.1146/annurev.biophys.36.040306.132812; COUTURE P, 1993, ENDOCRINOLOGY, V132, P179, DOI 10.1210/en.132.1.179; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Eck MJ, 2009, CURR OPIN CELL BIOL, V21, P288, DOI 10.1016/j.ceb.2009.01.014; Eguchi M, 1999, BLOOD, V93, P1355, DOI 10.1182/blood.V93.4.1355; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Gadd S, 2012, J PATHOL, V228, P119, DOI 10.1002/path.4010; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Gozgit JM, 2012, MOL CANCER THER, V11, P690, DOI 10.1158/1535-7163.MCT-11-0450; Gozgit JM, 2011, MOL CANCER THER, V10, P1028, DOI 10.1158/1535-7163.MCT-10-1044; Iacob RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015929; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Kralik JM, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-19; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Mosse Y.P., 2012, J CLIN ONCOL S; Novo FJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-33; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Okabe M, 1995, LEUKEMIA RES, V19, P933, DOI 10.1016/0145-2126(95)00039-9; Orbach D, 2010, J CLIN ONCOL, V28, P318, DOI 10.1200/JCO.2009.21.9972; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; Posy SL, 2011, J MED CHEM, V54, P54, DOI 10.1021/jm101195a; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Skalova A, 2010, AM J SURG PATHOL, V34, P599, DOI 10.1097/PAS.0b013e3181d9efcc; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tognon C, 2001, CANCER RES, V61, P8909; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Waldron TT, 2003, BIOCHEMISTRY-US, V42, P5058, DOI 10.1021/bi034212v; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	46	86	103	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2013	31	7					630	U90		10.1038/nbt.2620	http://dx.doi.org/10.1038/nbt.2620			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	180FS	23811600	Green Accepted, Green Submitted			2022-12-27	WOS:000321579700020
J	Hwang, WY; Fu, YF; Reyon, D; Maeder, ML; Tsai, SQ; Sander, JD; Peterson, RT; Yeh, JRJ; Joung, JK				Hwang, Woong Y.; Fu, Yanfang; Reyon, Deepak; Maeder, Morgan L.; Tsai, Shengdar Q.; Sander, Jeffry D.; Peterson, Randall T.; Yeh, J-R Joanna; Joung, J. Keith			Efficient genome editing in zebrafish using a CRISPR-Cas system	NATURE BIOTECHNOLOGY			English	Article								In bacteria, foreign nucleic acids are silenced by clustered, regularly interspaced, short palindromic repeats (CRISPR) CRISPR-associated (Gas) systems. Bacterial type II CRISPR systems have been adapted to create guide RNAs that direct site-specific DNA cleavage by the Cas9 endonuclease in cultured cells. Here we show that the CRISPR-Cas system functions in vivo to induce targeted genetic modifications in zebrafish embryos with efficiencies similar to those obtained using zinc finger nucleases and transcription activator like effector nucleases.	[Hwang, Woong Y.; Peterson, Randall T.; Yeh, J-R Joanna] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA; [Fu, Yanfang; Reyon, Deepak; Maeder, Morgan L.; Tsai, Shengdar Q.; Sander, Jeffry D.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA; [Fu, Yanfang; Reyon, Deepak; Maeder, Morgan L.; Tsai, Shengdar Q.; Sander, Jeffry D.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Fu, Yanfang; Reyon, Deepak; Tsai, Shengdar Q.; Sander, Jeffry D.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Maeder, Morgan L.; Joung, J. Keith] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA USA; [Peterson, Randall T.; Yeh, J-R Joanna] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Yeh, J-R Joanna] Broad Inst, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA.	jyeh1@partners.org; jjoung@partners.org	Tsai, Shengdar Q./G-4600-2012; Wilson, Matthew H/K-3193-2013; Reyon, Deepak/HCH-3183-2022	Tsai, Shengdar Q./0000-0001-9161-3993; Peterson, Randall/0000-0003-0727-3469; Yeh, Jing-Ruey Joanna/0000-0002-7768-4901; Hwang, Woong/0000-0002-0575-0033	US National Institutes of Health (NIH) [DP1 GM105378]; NIH [R01 GM088040, P50 HG005550, K01 AG031300]; Jim and Ann Orr Research Scholar Award; Massachusetts General Hospital; NATIONAL CANCER INSTITUTE [R01CA140188] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378, F32GM105189, R01GM088040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG031300] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr Research Scholar Award; Massachusetts General Hospital(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a US National Institutes of Health (NIH) Director's Pioneer Award DP1 GM105378 (J.K.J.), NIH R01 GM088040 (J.K.J. & R.T.P.), NIH P50 HG005550 (J.K.J.), the Jim and Ann Orr Research Scholar Award (J.K.J.), NIH K01 AG031300 (J.-R.J.Y.) and a Massachusetts General Hospital Claflin award (J.-R.J.Y.). We thank G. Church, J. Aach and P. Mali for sharing unpublished results and helpful discussions.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; SCHNEIDER TD, 1989, NUCLEIC ACIDS RES, V17, P659, DOI 10.1093/nar/17.2.659; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	20	1989	2377	34	1227	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2013	31	3					227	229		10.1038/nbt.2501	http://dx.doi.org/10.1038/nbt.2501			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	110JX	23360964	Green Submitted, Green Accepted			2022-12-27	WOS:000316439500016
J	Bodenmiller, B; Zunder, ER; Finck, R; Chen, TJ; Savig, ES; Bruggner, RV; Simonds, EF; Bendall, SC; Sachs, K; Krutzik, PO; Nolan, GP				Bodenmiller, Bernd; Zunder, Eli R.; Finck, Rachel; Chen, Tiffany J.; Savig, Erica S.; Bruggner, Robert V.; Simonds, Erin F.; Bendall, Sean C.; Sachs, Karen; Krutzik, Peter O.; Nolan, Garry P.			Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators	NATURE BIOTECHNOLOGY			English	Article							KINASE INHIBITOR SELECTIVITY; POLYCHROMATIC FLOW-CYTOMETRY; FUNCTIONAL GENOMICS; DRUG DISCOVERY; IMMUNE-SYSTEM; CANCER; CELLS; PROTEOMICS; RESPONSES; POPULATIONS	Mass cytometry facilitates high-dimensional, quantitative analysis of the effects of bioactive molecules on human samples at single-cell resolution, but instruments process only one sample at a time. Here we describe mass-tag cellular barcoding (MCB), which increases mass cytometry throughput by using n metal ion tags to multiplex up to 2(n) samples. We used seven tags to multiplex an entire 96-well plate, and applied MCB to characterize human peripheral blood mononuclear cell (PBMC) signaling dynamics and cell-to-cell communication, signaling variability between PBMCs from eight human donors, and the effects of 27 inhibitors on this system. For each inhibitor, we measured 14 phosphorylation sites in 14 PBMC types at 96 conditions, resulting in 18,816 quantified phosphorylation levels from each multiplexed sample. This high-dimensional, systems-level inquiry allowed analysis across cell-type and signaling space, reclassified inhibitors and revealed off-target effects. High-content, high-throughput screening with MCB should be useful for drug discovery, preclinical testing and mechanistic investigation of human disease.	[Bodenmiller, Bernd; Zunder, Eli R.; Finck, Rachel; Chen, Tiffany J.; Savig, Erica S.; Bruggner, Robert V.; Simonds, Erin F.; Bendall, Sean C.; Sachs, Karen; Krutzik, Peter O.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Chen, Tiffany J.; Bruggner, Robert V.] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA; [Chen, Tiffany J.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Savig, Erica S.] Stanford Univ, Canc Biol Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Nolan, Garry/AAE-7903-2019; Bendall, Sean/AGG-0126-2022	Zunder, Eli/0000-0002-0356-1685; Simonds, Erin/0000-0002-3497-4861; Nolan, Garry/0000-0002-8862-9043; Bendall, Sean/0000-0003-1341-2453	Swiss National Science Foundation (SNF); European Molecular Biology Organization (EMBO); Marie Curie IOF; National Institute of General Medical Sciences [F32GM093508]; Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program; Stanford Graduate Fellowship in Science and Engineering; Damon Runyon Cancer Research Foundation Fellowship [DRG-2017-09]; Rachford and Carlota A. Harris Endowed Professorship; European Commission [HEALTH.2010.1.2-1]; Bill and Melinda Gates Foundation [GF12141-137101];  [U19 AI057229];  [P01 CA034233];  [HHSN272200700038C];  [1R01CA130826];  [CIRM DR1-01477];  [RB2-01592];  [NCI RFA CA 09-011];  [NHLBI-HV-10-05(2)]; NATIONAL CANCER INSTITUTE [R01CA130826, U54CA149145, T32CA009302, P01CA034233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, U19AI100627, U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093508] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Marie Curie IOF(European Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program; Stanford Graduate Fellowship in Science and Engineering; Damon Runyon Cancer Research Foundation Fellowship; Rachford and Carlota A. Harris Endowed Professorship; European Commission(European CommissionEuropean Commission Joint Research Centre); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We would like to thank A. Trejo, M. Clutter, K. Gibbs and G. Behbahani for their experimental support and discussions, and D. Pe'er and El-ad D. Amir for their feedback on data analysis. B. B. was supported by fellowships of the Swiss National Science Foundation (SNF), the European Molecular Biology Organization (EMBO), and the Marie Curie IOF. E.R.Z. is supported by a fellowship from National Institute of General Medical Sciences (F32GM093508). T.J.C. is supported by the Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program, and the Stanford Graduate Fellowship in Science and Engineering. S. C. B. is supported by the Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09). G.P.N. is supported by the Rachford and Carlota A. Harris Endowed Professorship and grants from U19 AI057229, P01 CA034233, HHSN272200700038C, 1R01CA130826, CIRM DR1-01477 and RB2-01592, NCI RFA CA 09-011, NHLBI-HV-10-05(2), European Commission HEALTH.2010.1.2-1, and the Bill and Melinda Gates Foundation (GF12141-137101).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; ANDERSSON U, 1989, EUR J IMMUNOL, V19, P1157, DOI 10.1002/eji.1830190629; Arrell DK, 2010, CLIN PHARMACOL THER, V88, P120, DOI 10.1038/clpt.2010.91; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bantscheff M, 2009, DRUG DISCOV TODAY, V14, P1021, DOI 10.1016/j.drudis.2009.07.001; Bartsch JW, 2004, ANAL CHEM, V76, P3810, DOI 10.1021/ac049870f; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Deisseroth A, 2012, CLIN CANCER RES, V18, P3212, DOI 10.1158/1078-0432.CCR-12-0653; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Geva-Zatorsky N, 2010, CELL, V140, P643, DOI 10.1016/j.cell.2010.02.011; HULETT HR, 1969, SCIENCE, V166, P747, DOI 10.1126/science.166.3906.747; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Kramer JA, 2007, NAT REV DRUG DISCOV, V6, P636, DOI 10.1038/nrd2378; Kramer R, 2004, NAT REV DRUG DISCOV, V3, P965, DOI 10.1038/nrd1552; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lou XD, 2007, ANGEW CHEM INT EDIT, V46, P6111, DOI 10.1002/anie.200700796; LOWN JW, 1983, MOL CELL BIOCHEM, V55, P17, DOI 10.1007/BF00229240; Melnick JS, 2006, P NATL ACAD SCI USA, V103, P3153, DOI 10.1073/pnas.0511292103; Nolan GP, 2007, NAT CHEM BIOL, V3, P187, DOI 10.1038/nchembio0407-187; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Perez-Oliva AB, 2011, GLYCOBIOLOGY, V21, P757, DOI 10.1093/glycob/cwq220; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Singh DK, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.22; Young SM, 2005, J BIOMOL SCREEN, V10, P374, DOI 10.1177/1087057105274532; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	50	363	377	5	196	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2012	30	9					858	U89		10.1038/nbt.2317	http://dx.doi.org/10.1038/nbt.2317			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	004UD	22902532	Green Accepted			2022-12-27	WOS:000308705700020
J	Camacho, JA				Camacho, Jennifer A.			Biotech innovation in a first-to-file world	NATURE BIOTECHNOLOGY			English	Editorial Material									Greenberg Traurig LLP, Boston, MA 02110 USA		Camacho, JA (corresponding author), Greenberg Traurig LLP, Boston, MA 02110 USA.	camachoj@gtlaw.com							0	0	0	2	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					401	403		10.1038/nbt.2204	http://dx.doi.org/10.1038/nbt.2204			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22565962				2022-12-27	WOS:000303803200017
J	Reyon, D; Tsai, SQ; Khayter, C; Foden, JA; Sander, JD; Joung, JK				Reyon, Deepak; Tsai, Shengdar Q.; Khayter, Cyd; Foden, Jennifer A.; Sander, Jeffry D.; Joung, J. Keith			FLASH assembly of TALENs for high-throughput genome editing	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; DNA-BINDING SPECIFICITY; EFFECTORS; CELLS; PROTEINS; KNOCKOUT	Engineered transcription activator-like effector nucleases (TALENs) have shown promise as facile and broadly applicable genome editing tools. However, no publicly available high-throughput method for constructing TALENs has been published, and large-scale assessments of the success rate and targeting range of the technology remain lacking. Here we describe the fast ligation-based automatable solid-phase high-throughput (FLASH) system, a rapid and cost-effective method for large-scale assembly of TALENs. We tested 48 FLASH-assembled TALEN pairs in a human cell-based EGFP reporter system and found that all 48 possessed efficient gene-modification activities. We also used FLASH to assemble TALENs for 96 endogenous human genes implicated in cancer and/or epigenetic regulation and found that 84 pairs were able to efficiently introduce targeted alterations. Our results establish the robustness of TALEN technology and demonstrate that FLASH facilitates high-throughput genome editing at a scale not currently possible with other genome modification technologies.	[Reyon, Deepak; Tsai, Shengdar Q.; Khayter, Cyd; Foden, Jennifer A.; Sander, Jeffry D.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Reyon, Deepak; Tsai, Shengdar Q.; Khayter, Cyd; Foden, Jennifer A.; Sander, Jeffry D.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Reyon, Deepak] Iowa State Univ, Dept Genet Dev & Cell Biol, Interdept Grad Program Bioinformat & Computat Bio, Ames, IA USA; [Reyon, Deepak; Tsai, Shengdar Q.; Sander, Jeffry D.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Iowa State University; Harvard University; Harvard Medical School	Joung, JK (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA.	jsander@partners.org; jjoung@partners.org	Tsai, Shengdar Q./G-4600-2012; Reyon, Deepak/HCH-3183-2022; Ha, Dat Thinh/D-4995-2015	Tsai, Shengdar Q./0000-0001-9161-3993; Ha, Dat Thinh/0000-0003-4260-4876	US National Institutes of Health (NIH) [DP1 OD006862]; NIH [P50HG005550, T32 CA009216]; Jim and Ann Orr MGH Research Scholar Award; National Science Foundation [DBI-0923827]; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr MGH Research Scholar Award; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank T. Cathomen for providing polyclonal U2OS-EGFP reporter cells and a T7EI protocol, Y. Fu for deriving the clonal U2OS-EGFP cell line, D. Dobbs for support and encouragement, and M. Maeder, J. Angstman and C. Ramirez for helpful comments. This work was supported by a US National Institutes of Health (NIH) Director's Pioneer Award DP1 OD006862 (J.K.J.), NIH P50HG005550 (J.K.J.), the Jim and Ann Orr MGH Research Scholar Award (J.K.J.), NIH T32 CA009216 (J.D.S.) and National Science Foundation DBI-0923827 (D.R.).	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	32	777	976	13	270	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2012	30	5					460	+		10.1038/nbt.2170	http://dx.doi.org/10.1038/nbt.2170			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	939IP	22484455	Green Accepted			2022-12-27	WOS:000303803200027
J	Dalerba, P; Kalisky, T; Sahoo, D; Rajendran, PS; Rothenberg, ME; Leyrat, AA; Sim, S; Okamoto, J; Johnston, DM; Qian, DL; Zabala, M; Bueno, J; Neff, NF; Wang, JB; Shelton, AA; Visser, B; Hisamori, S; Shimono, Y; van de Wetering, M; Clevers, H; Clarke, MF; Quake, SR				Dalerba, Piero; Kalisky, Tomer; Sahoo, Debashis; Rajendran, Pradeep S.; Rothenberg, Michael E.; Leyrat, Anne A.; Sim, Sopheak; Okamoto, Jennifer; Johnston, Darius M.; Qian, Dalong; Zabala, Maider; Bueno, Janet; Neff, Norma F.; Wang, Jianbin; Shelton, Andrew A.; Visser, Brendan; Hisamori, Shigeo; Shimono, Yohei; van de Wetering, Marc; Clevers, Hans; Clarke, Michael F.; Quake, Stephen R.			Single-cell dissection of transcriptional heterogeneity in human colon tumors	NATURE BIOTECHNOLOGY			English	Article							CANCER STEM-CELLS; GENE-EXPRESSION; DIFFERENTIATION; MARKER; PROGRESSION; EPITHELIUM; PHENOTYPE; EVOLUTION; ADENOMA; DISEASE	Cancer is often viewed as a caricature of normal developmental processes, but the extent to which its cellular heterogeneity truly recapitulates multilineage differentiation processes of normal tissues remains unknown. Here we implement single-cell PCR gene-expression analysis to dissect the cellular composition of primary human normal colon and colon cancer epithelia. We show that human colon cancer tissues contain distinct cell populations whose transcriptional identities mirror those of the different cellular lineages of normal colon. By creating monoclonal tumor xenografts from injection of a single (n = 1) cell, we demonstrate that the transcriptional diversity of cancer tissues is largely explained by in vivo multilineage differentiation and not only by clonal genetic heterogeneity. Finally, we show that the different gene-expression programs linked to multilineage differentiation are strongly associated with patient survival. We develop two-gene classifier systems (KRT20 versus CA1, MS4A12, CD177, SLC26A3) that predict clinical outcomes with hazard ratios superior to those of pathological grade and comparable to those of microarray-derived multigene expression signatures.	[Kalisky, Tomer; Leyrat, Anne A.; Okamoto, Jennifer; Johnston, Darius M.; Neff, Norma F.; Wang, Jianbin; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Dalerba, Piero; Clarke, Michael F.] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Dalerba, Piero; Sahoo, Debashis; Rajendran, Pradeep S.; Rothenberg, Michael E.; Sim, Sopheak; Johnston, Darius M.; Qian, Dalong; Zabala, Maider; Hisamori, Shigeo; Shimono, Yohei; Clarke, Michael F.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Rothenberg, Michael E.] Stanford Univ, Dept Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Okamoto, Jennifer; Johnston, Darius M.; Quake, Stephen R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Bueno, Janet] Stanford Univ, Tissue Bank, Stanford, CA 94305 USA; [Shelton, Andrew A.; Visser, Brendan] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [van de Wetering, Marc; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	mfclarke@stanford.edu; quake@stanford.edu	Wang, Jianbin/G-7533-2015; Dalerba, Piero/E-2543-2018	Wang, Jianbin/0000-0001-6725-7925; Dalerba, Piero/0000-0002-8815-4981; Shimono, Yohei/0000-0002-6256-4704	National Institutes of Health (NIH) [U54-CA126524, P01-CA139490, K99-CA151673]; Ludwig foundation; California Institute for Regenerative Medicine (CIRM); BD Biosciences Stem Cell Research Grant; Machiah Foundation; Department of Defense [W81XWH-10-1-0500]; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; NATIONAL CANCER INSTITUTE [U54CA126524, P01CA139490, K99CA151673] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig foundation; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); BD Biosciences Stem Cell Research Grant; Machiah Foundation; Department of Defense(United States Department of Defense); Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health (NIH) grants U54-CA126524 and P01-CA139490 (to S. R. Q. and M. F. C.), the NIH Director's Pioneer Awards (to S. R. Q.) and a grant from the Ludwig foundation (to M. F. C.). P. D. was supported by a training grant from the California Institute for Regenerative Medicine (CIRM) and by a BD Biosciences Stem Cell Research Grant (Summer 2011). T. K. was supported by a fellowship from the Machiah Foundation. D. S. was supported by NIH grant K99-CA151673, by Department of Defense grant W81XWH-10-1-0500 and a grant from the Siebel Stem Cell Institute and the Thomas and Stacey Siebel Foundation. We wish to thank R. Tibshirani, D. Witten, L. Warren, R. A. White III, E. Gilbert, P. Lovelace, M. Palmor, C. Donkers and S. P. Miranda for helpful discussion and technical support in many moments during the completion of this study.	Bardia A, 2010, SEMIN ONCOL, V37, P39, DOI 10.1053/j.seminoncol.2009.12.005; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Becker L, 2008, THESCIENTIFICWORLDJO, V8, P1168, DOI 10.1100/tsw.2008.148; Beider K, 2008, FRONT BIOSCI-LANDMRK, V13, P6820, DOI 10.2741/3190; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Dalerba P, 2005, CANCER RES, V65, P2321, DOI 10.1158/0008-5472.CAN-04-3678; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; DALLAFAVERA R, 1982, NATURE, V299, P61; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fischer Helene, 2001, BMC Physiology, V1, P1, DOI 10.1186/1472-6793-1-1; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Guastadisegni C, 2010, EUR J CANCER, V46, P2788, DOI 10.1016/j.ejca.2010.05.009; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jiao YF, 2008, ONCOLOGY-BASEL, V74, P127, DOI 10.1159/000151359; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; KIRKLAND SC, 1988, CANCER, V61, P1359, DOI 10.1002/1097-0142(19880401)61:7<1359::AID-CNCR2820610714>3.0.CO;2-0; Koslowski M, 2008, CANCER RES, V68, P3458, DOI 10.1158/0008-5472.CAN-07-5768; Losi L, 2005, CARCINOGENESIS, V26, P916, DOI 10.1093/carcin/bgi044; Lugli A, 2008, MODERN PATHOL, V21, P1403, DOI 10.1038/modpathol.2008.117; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Odoux C, 2008, CANCER RES, V68, P6932, DOI 10.1158/0008-5472.CAN-07-5779; Oien KA, 2009, SEMIN ONCOL, V36, P8, DOI 10.1053/j.seminoncol.2008.10.009; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Prall F, 1996, J HISTOCHEM CYTOCHEM, V44, P35, DOI 10.1177/44.1.8543780; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Sahoo D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r157; Sahoo D, 2007, NUCLEIC ACIDS RES, V35, P3705, DOI 10.1093/nar/gkm284; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Wang GP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn125; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	50	512	562	5	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2011	29	12					1120	U11		10.1038/nbt.2038	http://dx.doi.org/10.1038/nbt.2038			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	861SE	22081019	Green Accepted			2022-12-27	WOS:000298038700023
J	Francisco, M				Francisco, Michael			Third-quarter biotech job picture	NATURE BIOTECHNOLOGY			English	Editorial Material																		2011, NAT BIOTECHNOL, V29, P846	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2011	29	11					1053	1053						1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	845CT	22068542	Bronze			2022-12-27	WOS:000296801300029
J	Tang, C; Lee, AS; Volkmer, JP; Sahoo, D; Nag, D; Mosley, AR; Inlay, MA; Ardehali, R; Chavez, SL; Pera, RR; Behr, B; Wu, JC; Weissman, IL; Drukker, M				Tang, Chad; Lee, Andrew S.; Volkmer, Jens-Peter; Sahoo, Debashis; Nag, Divya; Mosley, Adriane R.; Inlay, Matthew A.; Ardehali, Reza; Chavez, Shawn L.; Pera, Renee Reijo; Behr, Barry; Wu, Joseph C.; Weissman, Irving L.; Drukker, Micha			An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells	NATURE BIOTECHNOLOGY			English	Article							MONOCLONAL-ANTIBODY; CYTOTOXIC ANTIBODY; DIFFERENTIATION; ANTIGENS; STAGE; SURFACE; LINES; GLYCOSPHINGOLIPIDS; EXPRESSION; SERIES	An important risk in the clinical application of human pluripotent stem cells (hPSCs), including human embryonic and induced pluripotent stem cells (hESCs and hiPSCs), is teratoma formation by residual undifferentiated cells. We raised a monoclonal antibody against hESCs, designated anti-stage-specific embryonic antigen (SSEA)-5, which binds a previously unidentified antigen highly and specifically expressed on hPSCs-the H type-1 glycan. Separation based on SSEA-5 expression through fluorescence-activated cell sorting (FACS) greatly reduced teratoma-formation potential of heterogeneously differentiated cultures. To ensure complete removal of teratoma-forming cells, we identified additional pluripotency surface markers (PSMs) exhibiting a large dynamic expression range during differentiation: CD9, CD30, CD50, CD90 and CD200. Immunohistochemistry studies of human fetal tissues and bioinformatics analysis of a microarray database revealed that concurrent expression of these markers is both common and specific to hPSCs. Immunodepletion with antibodies against SSEA-5 and two additional PSMs completely removed teratoma-formation potential from incompletely differentiated hESC cultures.	[Tang, Chad; Volkmer, Jens-Peter; Sahoo, Debashis; Mosley, Adriane R.; Inlay, Matthew A.; Ardehali, Reza; Chavez, Shawn L.; Pera, Renee Reijo; Weissman, Irving L.; Drukker, Micha] Stanford Univ Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA; [Lee, Andrew S.; Nag, Divya; Wu, Joseph C.] Stanford Univ Sch Med, Dept Radiol, Div Cardiol, Stanford, CA USA; [Lee, Andrew S.; Nag, Divya; Wu, Joseph C.] Stanford Univ Sch Med, Dept Med, Div Cardiol, Stanford, CA USA; [Volkmer, Jens-Peter] Univ Duesseldorf, Dept Urol, Dusseldorf, Germany; [Behr, Barry] Stanford Univ Sch Med, Dept Gynecol & Obstet, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Stanford University	Drukker, M (corresponding author), Stanford Univ Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA.	irv@stanford.edu; dmicha@stanford.edu	Chavez, Shawn L./ABF-6125-2021; Lee, Andrew/GVU-2817-2022; Wu, Joseph/H-1067-2013	Chavez, Shawn L./0000-0002-8285-0222; Drukker, Micha/0000-0002-4279-1125; Wu, Joseph/0000-0002-6068-8041	California Institute of Regenerative Medicine (CIRM) [RC1-00354-1]; Stanford Medical Scholars Program; Deutsche Forschungsgemeinschaft; NATIONAL CANCER INSTITUTE [T32CA009151, R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Stanford Medical Scholars Program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge C.Contag for providing luciferase constructs, M. van de Rijn and K. Montgomery for their assistance scanning fetal array slides and providing online access to these slides, P. Chu for assistance with hematoxylin and eosin staining, C. Muscat and T. Naik for assistance with hybridoma culture, W. Zhang for assistance in cell culturing, the Consortium for Functional Glycomics for providing and testing glycan arrays, and T. Serwold and C. Bertozzi for critical advice. This work was supported by funds provided by the California Institute of Regenerative Medicine (CIRM) (Comprehensive grant RC1-00354-1). C.T. and A.S.L. are supported by the Howard Hughes Medical Institute Medical Fellows and the Stanford Medical Scholars Program, J.-P.V. is supported by the Deutsche Forschungsgemeinschaft, C.T., M.A.I., R.A. and M.D. are supported by CIRM (Comprehensive grant RC1-00354-1).	ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Behr B, 2000, J ASSIST REPROD GEN, V17, P349, DOI 10.1023/A:1009461213139; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Cao F, 2007, CLONING STEM CELLS, V9, P107, DOI 10.1089/clo.2006.0E16; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Drukker Micha, 2007, V407, P63, DOI 10.1007/978-1-59745-536-7_6; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Mateizel I, 2009, HUM REPROD, V24, P2477, DOI 10.1093/humrep/dep234; Nagano K, 2008, PROTEOMICS, V8, P4025, DOI 10.1002/pmic.200800073; Raman R, 2006, GLYCOBIOLOGY, V16, p82R, DOI 10.1093/glycob/cwj080; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Sahoo D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r157; Sahoo D, 2010, P NATL ACAD SCI USA, V107, P5732, DOI 10.1073/pnas.0913635107; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; SHEVINSKY LH, 1982, CELL, V30, P697, DOI 10.1016/0092-8674(82)90274-4; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tang C, 2011, SEMIN IMMUNOPATHOL, V33, P563, DOI 10.1007/s00281-011-0269-5; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TORRADO J, 1990, TISSUE ANTIGENS, V36, P8, DOI 10.1111/j.1399-0039.1990.tb01791.x; VODYANIK MA, 2007, CURR PROTOC CELL BIO, V36; Wu JC, 2001, MOL THER, V4, P297, DOI 10.1006/mthe.2001.0460; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	32	282	301	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2011	29	9					829	U86		10.1038/nbt.1947	http://dx.doi.org/10.1038/nbt.1947			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	817ZT	21841799	Green Accepted			2022-12-27	WOS:000294718400024
